HGNC ID,Approved symbol,Approved name,Status,Previous symbols,Alias symbols,Chromosome,Locus type,Locus group,Ensembl gene ID,NCBI Gene ID(supplied by NCBI),Ensembl ID(supplied by Ensembl),UniProt ID(supplied by UniProt),Mouse genome database ID(supplied by MGI),Rat genome database ID(supplied by RGD),chr,MIM_Number,morbid,phen,phen_MIM_number,inheritance,phen_additional,phen_MIM_number_additional,inheritance_additional,ClinicalSynopsis,Neurologic_ClinicalSynopsis,intellectual_disability,seizures,motor_development,language_development,spasticity,ataxia,gene_category,pseudoautosomal,f_m_misc_OMIM,monogenic_disorder,Function [CC],Gene ontology (biological process),Gene ontology (molecular function),Subcellular location [CC],Subunit structure [CC],Chromosome/scaffold name,Gene start (bp),Gene end (bp),Karyotype band,pLI,LOEUF,syn_z,mis_z,exp_lof,CpG_density,transcript_ID,exon_score,promoter_score,CDS_length,number_paralogues_90_perc,paralogues_90_perc,paralogues_90_logic,number_paralogues_95_perc,paralogues_95_perc,paralogues_95_logic,tau,max_expression_log2,max_tissue,tissue_specificity,Other_Brain_tissues,Cerebellar_tissues,brain_high,XCI,BS_Pre_Post,BS_Pre_Post1,BS_Pre_Post2,BS_Post1_Post2,gene_group
HGNC:10274,RP2,RP2 activator of ARL3 GTPase,Approved,,"TBCCD2, NME10, NM23-H10",Xp11.3,gene with protein product,protein-coding gene,ENSG00000102218,6102,ENSG00000102218,O75695,MGI:1277953,RGD:1565124,X,300757,TRUE,Retinitis pigmentosa 2,312600,X-linked,,,,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,TRUE,confirmed,"FUNCTION: Acts as a GTPase-activating protein (GAP) involved in trafficking between the Golgi and the ciliary membrane. Involved in localization of proteins, such as NPHP3, to the cilium membrane by inducing hydrolysis of GTP ARL3, leading to the release of UNC119 (or UNC119B). Acts as a GTPase-activating protein (GAP) for tubulin in concert with tubulin-specific chaperone C, but does not enhance tubulin heterodimerization. Acts as guanine nucleotide dissociation inhibitor towards ADP-ribosylation factor-like proteins. {ECO:0000269|PubMed:11847227, ECO:0000269|PubMed:18376416, ECO:0000269|PubMed:20106869, ECO:0000269|PubMed:22085962}.",cell morphogenesis [GO:0000902]; post-Golgi vesicle-mediated transport [GO:0006892]; protein folding [GO:0006457]; protein transport [GO:0015031]; visual perception [GO:0007601],GTPase activator activity [GO:0005096]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; unfolded protein binding [GO:0051082],"SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10942419, ECO:0000269|PubMed:12417528}; Lipid-anchor {ECO:0000269|PubMed:10942419}; Cytoplasmic side {ECO:0000269|PubMed:10942419}. Cell projection, cilium {ECO:0000269|PubMed:20106869}. Note=Detected predominantly at the plasma membrane of rod and cone photoreceptors. Not detected in the nucleus. {ECO:0000269|PubMed:12417528}.","SUBUNIT: Found in a complex with ARL3, RP2 and UNC119 (or UNC119B); RP2 induces hydrolysis of GTP ARL3 in the complex, leading to the release of UNC119 (or UNC119B). Interacts with ARL3; interaction is direct and stimulated with the activated GTP-bound form of ARL3. {ECO:0000269|PubMed:11847227, ECO:0000269|PubMed:16472755, ECO:0000269|PubMed:18376416, ECO:0000269|PubMed:18588884}.",X,46837043,46882358,p11.3,0.95597,0.306,0.93152,0.63317,9.7865,0.6268241562359209,ENST00000218340,0.9282051282051282,0.15396150962259436,1053,,,,,,,0.3494398624608468,4.332929869652255,Cells - Cultured fibroblasts,broadly expressed,1.5950500616411951,1.9528087945959831,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:10295,RPGR,retinitis pigmentosa GTPase regulator,Approved,"CRD, RP3, RP15, COD1",CORDX1,Xp11.4,gene with protein product,protein-coding gene,ENSG00000156313,6103,ENSG00000156313,Q92834,MGI:1344037,RGD:1560136,X,312610,TRUE,"Cone-rod dystrophy, X-linked, 1 // Macular degeneration, X-linked atrophic // Retinitis pigmentosa 3 // Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness",304020 // 300834 // 300029 // 300455,X-linked // X-linked recessive //  //,,,,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Could be a guanine-nucleotide releasing factor. Plays a role in ciliogenesis. Probably regulates cilia formation by regulating actin stress filaments and cell contractility. Plays an important role in photoreceptor integrity. May play a critical role in spermatogenesis and in intraflagellar transport processes (By similarity). May be involved in microtubule organization and regulation of transport in primary cilia. {ECO:0000250, ECO:0000269|PubMed:21933838}.",cilium assembly [GO:0060271]; intracellular protein transport [GO:0006886]; intraciliary transport [GO:0042073]; response to stimulus [GO:0050896]; visual perception [GO:0007601],guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723],"SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, flagellum axoneme {ECO:0000250|UniProtKB:Q9R0X5}. Golgi apparatus {ECO:0000269|PubMed:15772089}. Cell projection, cilium {ECO:0000250|UniProtKB:Q9R0X5}. Note=In the retinal photoreceptor cell layer, localizes at the connecting cilium (By similarity). Colocalizes with WHRN in the photoreceptor connecting cilium (By similarity). Colocalizes with CEP290 in the photoreceptor connecting cilium (By similarity). Colocalizes with RPGRIP1 in the photoreceptor connecting cilium (By similarity). {ECO:0000250|UniProtKB:Q9R0X5}.; SUBCELLULAR LOCATION: [Isoform 6]: Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. Cytoplasm, cytoskeleton, cilium basal body. Cytoplasm, cytoskeleton, cilium axoneme.","SUBUNIT: Interacts with SPATA7 (By similarity). Interacts with CEP290 (By similarity). Interacts with WHRN (By similarity). Interacts with PDE6D (PubMed:9990021, PubMed:23559067, PubMed:24981858). Interacts with RPGRIP1 (PubMed:10958648, PubMed:24981858). Interacts with RPGRIP1L (PubMed:19430481, PubMed:24981858). PDE6D, RPGRIP1 and RPGRIP1L may compete for the same binding sites (PubMed:24981858). Isoform 6 interacts with NPM1 (via C-terminus) (PubMed:15772089). Isoform 6 interacts with SMC1A and SMC3 (PubMed:16043481). {ECO:0000250|UniProtKB:Q9R0X5, ECO:0000269|PubMed:10958648, ECO:0000269|PubMed:15772089, ECO:0000269|PubMed:16043481, ECO:0000269|PubMed:19430481, ECO:0000269|PubMed:23559067, ECO:0000269|PubMed:24981858, ECO:0000269|PubMed:9990021}.",X,38269163,38327544,p11.4,0.99804,0.21,-1.4812,1.246,22.631,0.5135721671154743,ENST00000642395,0.5029820261437908,0.05791052236940765,2448,,,,,,,0.3729476633212499,4.386079758945703,Pituitary,broadly expressed,1.8791842632320697,2.800127495519908,FALSE,high confidence non-escapee,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:10298,RPL10,ribosomal protein L10,Approved,,"NOV, QM, DXS648E, DXS648, FLJ23544, L10",Xq28,gene with protein product,protein-coding gene,ENSG00000147403,6134,ENSG00000147403,P27635,MGI:105943,RGD:621178,X,312173,TRUE,"Mental retardation, X-linked, syndromic, 35",300998,X-linked recessive,"{Autism, susceptibility to, X-linked 5}",300847,,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Component of the large ribosomal subunit (PubMed:26290468). Plays a role in the formation of actively translating ribosomes (PubMed:26290468). May play a role in the embryonic brain development (PubMed:25316788). {ECO:0000269|PubMed:25316788, ECO:0000269|PubMed:26290468, ECO:0000305|PubMed:12962325}.","embryonic brain development [GO:1990403]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of translation [GO:0006417]; ribosomal large subunit assembly [GO:0000027]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]",RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182],"","SUBUNIT: Component of the large ribosomal subunit. Mature ribosomes consist of a small (40S) and a large (60S) subunit. The 40S subunit contains about 33 different proteins and 1 molecule of RNA (18S). The 60S subunit contains about 49 different proteins and 3 molecules of RNA (28S, 5.8S and 5S). {ECO:0000305|PubMed:12962325}.",X,154389955,154409168,q28,0.90915,0.387,-1.078,2.6137,7.7277,0.6831521216203214,ENST00000369817,0.9410852713178295,0.14968757810547365,645,1,"RPL10L (96, 96, chr14)",TRUE,1,"RPL10L (96, 96, chr14)",TRUE,0.13493108272033372,12.525317701704385,Ovary,broadly expressed,8.807271191790713,9.39491601120085,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:10350,RPL39,ribosomal protein L39,Approved,RPL39P42,L39,Xq24,gene with protein product,protein-coding gene,ENSG00000198918,6170,ENSG00000198918,P62891,MGI:1914498,RGD:3593,X,300899,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cytoplasmic translation [GO:0002181]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response in mucosa [GO:0002227]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]",RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],"",SUBUNIT: Interacts with IMPACT. {ECO:0000250|UniProtKB:P62892}.,X,119786504,119791630,q24,0.57637,1.098,0.18398,1.3311,2.6438,0.6140950158513275,ENST00000361575,0.9756410256410256,0.05713571607098226,156,1,"RPL39L (92, 92, chr3)",TRUE,1,"RPL39L (92, 92, chr3)",TRUE,0.1926275732902649,8.109203827066983,Ovary,broadly expressed,4.816901729593972,4.98371873158398,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post1_higher_vs_Post2,no disorder
HGNC:10359,RPL36A,ribosomal protein L36a,Approved,RPL44,L36A,Xq22.1,gene with protein product,protein-coding gene,ENSG00000241343,6173,ENSG00000241343,P83881,MGI:1201789,RGD:1306640,X,300902,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","cytoplasmic translation [GO:0002181]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]",RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],SUBCELLULAR LOCATION: Cytoplasm.,"",X,101390824,101396155,q22.1,0.42737000000000003,0.891,-1.6747,0.7418,5.3197,0.47602167417835617,ENST00000553110,0.9763239875389408,0.10497375656085979,321,2,"RPL36AL (74, 99, chr14); RPL36A-HNRNPH2 (70, 85, chrX)",TRUE,,,,0.18454126405146937,10.166702893625626,Ovary,broadly expressed,7.05760189882958,7.442582776996771,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:1036,BEX1,brain expressed X-linked 1,Approved,,,Xq22.1,gene with protein product,protein-coding gene,ENSG00000133169,55859,ENSG00000133169,Q9HBH7,MGI:1338017,,X,300690,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Signaling adapter molecule involved in p75NTR/NGFR signaling. Plays a role in cell cycle progression and neuronal differentiation. Inhibits neuronal differentiation in response to nerve growth factor (NGF). May act as a link between the cell cycle and neurotrophic factor signaling, possibly by functioning as an upstream modulator of receptor signaling, coordinating biological responses to external signals with internal cellular states (By similarity). {ECO:0000250}.",cell differentiation [GO:0030154]; nervous system development [GO:0007399]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; signal transduction [GO:0007165],RNA polymerase II activating transcription factor binding [GO:0001102]; signaling receptor binding [GO:0005102],SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Note=Shuttles between the cytoplasm and the nucleus. {ECO:0000250}.,SUBUNIT: Interacts with neurotrophin receptor p75NTR/NGFR. Interacts with OMP (By similarity). {ECO:0000250}.,X,103062651,103064171,q22.1,0.54273,1.216,-0.91539,0.37397,2.326,0.4384328358208955,ENST00000372728,0.37037037037037035,0.12941764558860286,378,1,"BEX2 (91, 71, chrX)",TRUE,,,,0.6727400143162398,9.41790524400419,Pituitary,tissue-specific,8.349657198462403,8.880547786853105,FALSE,low confidence non-escapee,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:10424,RPS4X,ribosomal protein S4 X-linked,Approved,,"DXS306, CCG2, SCAR, SCR10, FLJ40595, RPS4, S4",Xq13.1,gene with protein product,protein-coding gene,ENSG00000198034,6191,ENSG00000198034,P62701,MGI:98158,RGD:2324318,X,312760,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","multicellular organism development [GO:0007275]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of translation [GO:0045727]; response to ethanol [GO:0045471]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]",RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17289661}. Note=Localized in cytoplasmic mRNP granules containing untranslated mRNAs.,SUBUNIT: Identified in a IGF2BP1-dependent mRNP granule complex containing untranslated mRNAs. {ECO:0000269|PubMed:17289661}.,X,72255679,72277248,q13.1,0.93222,0.349,0.68758,2.2887,8.5713,0.5271400907465131,ENST00000316084,0.9641414141414142,0.11972006998250437,792,2,"RPS4Y1 (93, 93, chrY); RPS4Y2 (92, 92, chrY)",TRUE,2,"RPS4Y1 (93, 93, chrY); RPS4Y2 (92, 92, chrY)",TRUE,0.1657030856638001,11.142400673315565,Ovary,broadly expressed,7.673436288621513,8.211559818992106,FALSE,high confidence escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:10432,RPS6KA3,ribosomal protein S6 kinase A3,Approved,"MRX19, CLS","RSK2, HU-3",Xp22.12,gene with protein product,protein-coding gene,ENSG00000177189,6197,ENSG00000177189,P51812,MGI:104557,RGD:1563860,X,300075,TRUE,"Coffin-Lowry syndrome // Mental retardation, X-linked 19",303600 // 300844,X-linked dominant // X-linked dominant,,,,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Serine/threonine-protein kinase that acts downstream of ERK (MAPK1/ERK2 and MAPK3/ERK1) signaling and mediates mitogenic and stress-induced activation of the transcription factors CREB1, ETV1/ER81 and NR4A1/NUR77, regulates translation through RPS6 and EIF4B phosphorylation, and mediates cellular proliferation, survival, and differentiation by modulating mTOR signaling and repressing pro-apoptotic function of BAD and DAPK1 (PubMed:9770464, PubMed:16223362, PubMed:17360704, PubMed:16213824). In fibroblast, is required for EGF-stimulated phosphorylation of CREB1 and histone H3 at 'Ser-10', which results in the subsequent transcriptional activation of several immediate-early genes (PubMed:9770464, PubMed:10436156). In response to mitogenic stimulation (EGF and PMA), phosphorylates and activates NR4A1/NUR77 and ETV1/ER81 transcription factors and the cofactor CREBBP (PubMed:16223362). Upon insulin-derived signal, acts indirectly on the transcription regulation of several genes by phosphorylating GSK3B at 'Ser-9' and inhibiting its activity (PubMed:8250835). Phosphorylates RPS6 in response to serum or EGF via an mTOR-independent mechanism and promotes translation initiation by facilitating assembly of the preinitiation complex (PubMed:17360704). In response to insulin, phosphorylates EIF4B, enhancing EIF4B affinity for the EIF3 complex and stimulating cap-dependent translation (PubMed:18508509, PubMed:18813292). Is involved in the mTOR nutrient-sensing pathway by directly phosphorylating TSC2 at 'Ser-1798', which potently inhibits TSC2 ability to suppress mTOR signaling, and mediates phosphorylation of RPTOR, which regulates mTORC1 activity and may promote rapamycin-sensitive signaling independently of the PI3K/AKT pathway (PubMed:18722121). Mediates cell survival by phosphorylating the pro-apoptotic proteins BAD and DAPK1 and suppressing their pro-apoptotic function (PubMed:16213824). Promotes the survival of hepatic stellate cells by phosphorylating CEBPB in response to the hepatotoxin carbon tetrachloride (CCl4) (PubMed:18508509, PubMed:18813292). Is involved in cell cycle regulation by phosphorylating the CDK inhibitor CDKN1B, which promotes CDKN1B association with 14-3-3 proteins and prevents its translocation to the nucleus and inhibition of G1 progression (By similarity). In LPS-stimulated dendritic cells, is involved in TLR4-induced macropinocytosis, and in myeloma cells, acts as effector of FGFR3-mediated transformation signaling, after direct phosphorylation at Tyr-529 by FGFR3 (By similarity). Negatively regulates EGF-induced MAPK1/3 phosphorylation via phosphorylation of SOS1 (By similarity). Phosphorylates SOS1 at 'Ser-1134' and 'Ser-1161' that create YWHAB and YWHAE binding sites and which contribute to the negative regulation of MAPK1/3 phosphorylation (By similarity). Phosphorylates EPHA2 at 'Ser-897', the RPS6KA-EPHA2 signaling pathway controls cell migration (PubMed:26158630). Acts as a regulator of osteoblast differentiation by mediating phosphorylation of ATF4, thereby promoting ATF4 transactivation activity (By similarity). {ECO:0000250|UniProtKB:P18654, ECO:0000269|PubMed:10436156, ECO:0000269|PubMed:16213824, ECO:0000269|PubMed:16223362, ECO:0000269|PubMed:17360704, ECO:0000269|PubMed:18722121, ECO:0000269|PubMed:26158630, ECO:0000269|PubMed:8250835, ECO:0000269|PubMed:9770464, ECO:0000303|PubMed:18508509, ECO:0000303|PubMed:18813292}.",cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224],ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; ribosomal protein S6 kinase activity [GO:0004711],SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:17213202}. Cytoplasm {ECO:0000269|PubMed:17213202}.,"SUBUNIT: Forms a complex with either MAPK1/ERK2 or MAPK3/ERK1 in quiescent cells. Transiently dissociates following mitogenic stimulation (By similarity). Interacts with NFATC4, ETV1/ER81 and FGFR1. {ECO:0000250, ECO:0000269|PubMed:17213202}.",X,20149911,20267519,p22.12,0.99999,0.087,1.4109,4.5208,34.136,0.7641600765791735,ENST00000379565,0.9677013045434099,0.4246188452886778,2223,3,"RPS6KA2 (81, 79, chr6); RPS6KA1 (79, 79, chr1); RPS6KA6 (78, 77, chrX)",TRUE,,,,0.20603918340969374,5.263669202254487,Lung,broadly expressed,2.886222357869,4.368998770844892,FALSE,low confidence non-escapee,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:10435,RPS6KA6,ribosomal protein S6 kinase A6,Approved,,RSK4,Xq21.1,gene with protein product,protein-coding gene,ENSG00000072133,27330,ENSG00000072133,Q9UK32,MGI:1914321,RGD:1560817,X,300303,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Constitutively active serine/threonine-protein kinase that exhibits growth-factor-independent kinase activity and that may participate in p53/TP53-dependent cell growth arrest signaling and play an inhibitory role during embryogenesis. {ECO:0000269|PubMed:15042092, ECO:0000269|PubMed:15632195}.","central nervous system development [GO:0007417]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; negative regulation of embryonic development [GO:0045992]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of mesoderm development [GO:2000381]; signal transduction [GO:0007165]",ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; ribosomal protein S6 kinase activity [GO:0004711],"SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:15632195}. Nucleus {ECO:0000269|PubMed:15632195}. Note=Predominantly cytosolic.",SUBUNIT: Forms a complex with MAPK3/ERK1 but not with MAPK9 or MAPK14 in serum-starved cells.,X,84058346,84188199,q21.1,0.9865,0.295,0.58386,1.8679,26.254,0.6402403115836183,ENST00000262752,0.9529490616621984,0.15103724068982755,2238,3,"RPS6KA3 (77, 78, chrX); RPS6KA2 (74, 72, chr6); RPS6KA1 (71, 72, chr1)",TRUE,,,,0.5612815886084437,3.5922895852244787,Pituitary,broadly expressed,1.683579686714104,2.900082348136222,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:1044,BGN,biglycan,Approved,,"DSPG1, SLRR1A",Xq28,gene with protein product,protein-coding gene,ENSG00000182492,633,ENSG00000182492,P21810,MGI:88158,RGD:2207,X,301870,TRUE,"Meester-Loeys syndrome // Spondyloepimetaphyseal dysplasia, X-linked",300989 // 300106,X-linked // X-linked recessive,,,,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,FUNCTION: May be involved in collagen fiber assembly. {ECO:0000250}.,blood vessel remodeling [GO:0001974]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate catabolic process [GO:0030207]; dermatan sulfate biosynthetic process [GO:0030208]; extracellular matrix organization [GO:0030198]; peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan [GO:0019800],extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; glycosaminoglycan binding [GO:0005539],"SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular matrix {ECO:0000250}.",SUBUNIT: Homodimer. Forms a ternary complex with MFAP2 and ELN (By similarity). {ECO:0000250}.,X,153494980,153509546,q28,0.45229,0.637,-0.82633,0.71353,9.8846,0.32559441161591696,ENST00000331595,0.4772357723577236,0.02751812046988253,1107,1,"DCN (54, 55, chr12)",TRUE,,,,0.4256082977979501,12.995715927935928,Artery - Aorta,broadly expressed,5.004254180316652,4.19548934087175,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Post1_higher_vs_Pre,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:10457,RS1,retinoschisin 1,Approved,RS,XLRS1,Xp22.13,gene with protein product,protein-coding gene,ENSG00000102104,6247,ENSG00000102104,O15537,MGI:1336189,RGD:1642515,X,300839,TRUE,Retinoschisis,312700,X-linked recessive,,,,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,TRUE,confirmed,"FUNCTION: Binds negatively charged membrane lipids, such as phosphatidylserine and phosphoinositides (By similarity). May play a role in cell-cell adhesion processes in the retina, via homomeric interaction between octamers present on the surface of two neighboring cells (PubMed:27114531). Required for normal structure and function of the retina (PubMed:19093009). {ECO:0000250|UniProtKB:Q9Z1L4, ECO:0000269|PubMed:19093009, ECO:0000305|PubMed:27114531}.",adaptation of rhodopsin mediated signaling [GO:0016062]; cell adhesion [GO:0007155]; multicellular organism development [GO:0007275]; protein homooligomerization [GO:0051260]; retina layer formation [GO:0010842]; visual perception [GO:0007601],phosphatidylserine binding [GO:0001786],"SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:10915776, ECO:0000269|PubMed:19849666, ECO:0000269|PubMed:26812435}. Cell membrane {ECO:0000250|UniProtKB:Q9Z1L4}; Peripheral membrane protein {ECO:0000250|UniProtKB:Q9Z1L4}; Extracellular side {ECO:0000250|UniProtKB:Q9Z1L4}. Note=Binds to phosphatidylserine-containing lipid membranes and embeds itself partially into the lipid bilayer. Lipid-binding requires the presence of Ca(2+) ions. {ECO:0000250|UniProtKB:Q9Z1L4}.","SUBUNIT: Homooctamer of 4 homodimers; disulfide-linked (PubMed:15644328, PubMed:19849666). The homooctamer has a flat, cogwheel structure with a diameter of about 14 nm (PubMed:27798099, PubMed:26812435, PubMed:27114531). Two stacked octamers can assemble to form a hexadecamer (PubMed:27798099, PubMed:26812435, PubMed:27114531). {ECO:0000269|PubMed:15644328, ECO:0000269|PubMed:19849666, ECO:0000269|PubMed:26812435, ECO:0000269|PubMed:27114531, ECO:0000269|PubMed:27798099}.",X,18639688,18672108,p22.13,0.95743,0.303,0.91755,0.96911,9.8803,0.41138521273313416,ENST00000379984,0.9251851851851852,0.12934266433391653,675,,,,,,,0.9196708065256007,1.6904841440925065,Lung,tissue-specific,0.7264397620723893,0.6689922855934829,FALSE,discordant,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:10540,SAT1,spermidine/spermine N1-acetyltransferase 1,Approved,SAT,SSAT,Xp22.11,gene with protein product,protein-coding gene,ENSG00000130066,6303,ENSG00000130066,P21673,MGI:98233,RGD:1586174,X,313020,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Enzyme which catalyzes the acetylation of polyamines (PubMed:15283699, PubMed:16455797, PubMed:17516632). Substrate specificity: norspermidine = spermidine >> spermine > N(1)-acetylspermine > putrescine (PubMed:17516632). This highly regulated enzyme allows a fine attenuation of the intracellular concentration of polyamines (PubMed:16455797). Also involved in the regulation of polyamine transport out of cells (PubMed:16455797). Acts on 1,3-diaminopropane, 1,5-diaminopentane, putrescine, spermidine (forming N(1)- and N(8)-acetylspermidine), spermine, N(1)-acetylspermidine and N(8)-acetylspermidine (PubMed:16455797, PubMed:17516632). {ECO:0000269|PubMed:15283699, ECO:0000269|PubMed:16455797, ECO:0000269|PubMed:17516632}.",angiogenesis [GO:0001525]; polyamine biosynthetic process [GO:0006596]; putrescine catabolic process [GO:0009447]; regulation of cell population proliferation [GO:0042127]; spermidine acetylation [GO:0032918],diamine N-acetyltransferase activity [GO:0004145]; identical protein binding [GO:0042802]; N-acetyltransferase activity [GO:0008080]; spermidine binding [GO:0019809],"SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000305|PubMed:1985966, ECO:0000305|PubMed:2241897}.","SUBUNIT: Homodimer. {ECO:0000269|PubMed:16455797, ECO:0000269|PubMed:16544326, ECO:0000269|PubMed:17516632}.",X,23783173,23786226,p22.11,0.8706,0.448,-2.1685,1.7058,6.6801,0.5509265805010994,ENST00000379270,0.9339147286821705,0.31484628842789303,516,,,,,,,0.21735128248939026,10.1999544769922,Lung,broadly expressed,6.730069285704156,6.211754966820074,FALSE,low confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,no difference_Post1_Post2,no disorder
HGNC:10580,SCML1,Scm polycomb group protein like 1,Approved,,,Xp22.13,gene with protein product,protein-coding gene,ENSG00000047634,6322,ENSG00000047634,Q9UN30,,RGD:7723901,X,300227,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Putative Polycomb group (PcG) protein. PcG proteins act by forming multiprotein complexes, which are required to maintain the transcriptionally repressive state of homeotic genes throughout development. May be involved in spermatogenesis during sexual maturation (By similarity). {ECO:0000250}.","negative regulation of transcription, DNA-templated [GO:0045892]",chromatin binding [GO:0003682]; histone binding [GO:0042393],SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.,"",X,17737449,17754988,p22.13,0.96276,0.292,1.1282,2.2678,10.252,0.7088468662108705,ENST00000380041,0.2295959595959596,0.1482629342664334,990,,,,,,,0.3137351397630064,6.0478611617763915,Ovary,broadly expressed,2.6135057218916673,3.622561432864211,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:10581,SCML2,Scm polycomb group protein like 2,Approved,,,Xp22.13,gene with protein product,protein-coding gene,ENSG00000102098,10389,ENSG00000102098,Q9UQR0,MGI:1340042,RGD:1564289,X,300208,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Putative Polycomb group (PcG) protein. PcG proteins act by forming multiprotein complexes, which are required to maintain the transcriptionally repressive state of homeotic genes throughout development (By similarity). {ECO:0000250}.","anatomical structure morphogenesis [GO:0009653]; negative regulation of transcription, DNA-templated [GO:0045892]",chromatin binding [GO:0003682]; histone binding [GO:0042393],SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.,"",X,18239313,18354688,p22.13,0.99961,0.132,1.6888,2.3993,22.56,0.865951855482257,ENST00000251900,0.7754160722776985,0.10819795051237191,2103,,,,,,,0.6032803397429971,3.6768089943477884,Testis,tissue-specific,0.7765815779703431,1.6273243410558986,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:10665,UTP14A,UTP14A small subunit processome component,Approved,SDCCAG16,"NY-CO-16, Utp14",Xq26.1,gene with protein product,protein-coding gene,ENSG00000156697,10813,ENSG00000156697,Q9BVJ6,MGI:1919804,RGD:1359313,X,300508,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May be required for ribosome biogenesis. {ECO:0000250}.,rRNA processing [GO:0006364],RNA binding [GO:0003723],"SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:12429849}.",SUBUNIT: Interacts with DHX37. {ECO:0000269|PubMed:30582406}.,X,129906121,129929761,q26.1,0.99983,0.162,1.133,1.4856,29.207,0.6125938722984169,ENST00000394422,0.6819516407599309,0.11077230692326918,2316,1,"UTP14C (90, 90, chr13)",TRUE,1,"UTP14C (90, 90, chr13)",TRUE,0.3081275710080103,4.8329608816542295,Cells - Cultured fibroblasts,broadly expressed,2.2544428725985823,3.3057487752823436,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,no disorder
HGNC:1068,BMP15,bone morphogenetic protein 15,Approved,,GDF9B,Xp11.22,gene with protein product,protein-coding gene,ENSG00000130385,9210,ENSG00000130385,O95972,MGI:1316745,RGD:70990,X,300247,TRUE,Ovarian dysgenesis 2 // Premature ovarian failure 4,300510 // 300510,X-linked // X-linked,,,,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,FUNCTION: May be involved in follicular development. Oocyte-specific growth/differentiation factor that stimulates folliculogenesis and granulosa cell (GC) growth. {ECO:0000269|PubMed:18227435}.,"BMP signaling pathway [GO:0030509]; cellular protein metabolic process [GO:0044267]; female gamete generation [GO:0007292]; granulosa cell development [GO:0060016]; ovarian follicle development [GO:0001541]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription, DNA-templated [GO:0045893]; post-translational protein modification [GO:0043687]; SMAD protein signal transduction [GO:0060395]",cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; type I activin receptor binding [GO:0070698],SUBCELLULAR LOCATION: Secreted.,"SUBUNIT: Homodimer. But, in contrast to other members of this family, cannot be disulfide-linked.",X,50910735,50916641,p11.22,1.832e-4,1.277,0.060911,0.06994,10.28,0.15653844908182102,ENST00000252677,0.42697201017811703,0.13941514621344664,1179,,,,,,,0.9767441860465116,0.4707148971218592,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:1079,BMX,BMX non-receptor tyrosine kinase,Approved,,"ETK, PSCTK3",Xp22.2,gene with protein product,protein-coding gene,ENSG00000102010,660,ENSG00000102010,P51813,MGI:1101778,RGD:1565643,X,300101,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Non-receptor tyrosine kinase that plays central but diverse modulatory roles in various signaling processes involved in the regulation of actin reorganization, cell migration, cell proliferation and survival, cell adhesion, and apoptosis. Participates in signal transduction stimulated by growth factor receptors, cytokine receptors, G-protein coupled receptors, antigen receptors and integrins. Induces tyrosine phosphorylation of BCAR1 in response to integrin regulation. Activation of BMX by integrins is mediated by PTK2/FAK1, a key mediator of integrin signaling events leading to the regulation of actin cytoskeleton and cell motility. Plays a critical role in TNF-induced angiogenesis, and implicated in the signaling of TEK and FLT1 receptors, 2 important receptor families essential for angiogenesis. Required for the phosphorylation and activation of STAT3, a transcription factor involved in cell differentiation. Also involved in interleukin-6 (IL6) induced differentiation. Plays also a role in programming adaptive cytoprotection against extracellular stress in different cell systems, salivary epithelial cells, brain endothelial cells, and dermal fibroblasts. May be involved in regulation of endocytosis through its interaction with an endosomal protein RUFY1. May also play a role in the growth and differentiation of hematopoietic cells; as well as in signal transduction in endocardial and arterial endothelial cells. {ECO:0000269|PubMed:10688651, ECO:0000269|PubMed:11331870, ECO:0000269|PubMed:12370298, ECO:0000269|PubMed:12832404, ECO:0000269|PubMed:15788485, ECO:0000269|PubMed:18292575, ECO:0000269|PubMed:9520419}.",adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; B cell receptor signaling pathway [GO:0050853]; cell adhesion [GO:0007155]; intracellular signal transduction [GO:0035556]; mesoderm development [GO:0007498]; peptidyl-tyrosine autophosphorylation [GO:0038083]; phosphatidylinositol biosynthetic process [GO:0006661]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12832404}. Note=Localizes to the edges of spreading cells when complexed with BCAR1.,"SUBUNIT: Interacts with BCAR1, CAV1, MYD88, PTK2/FAK1, RUFY1, RUFY2, STAT3, TIRAP and TNFRSF1B. {ECO:0000269|PubMed:10688651, ECO:0000269|PubMed:11331870, ECO:0000269|PubMed:11751885, ECO:0000269|PubMed:11877430, ECO:0000269|PubMed:12370298, ECO:0000269|PubMed:12832404, ECO:0000269|PubMed:18292575}.",X,15464246,15556529,p22.2,0.006673,0.564,-0.21802,0.99111,27.858,0.28113242533541494,ENST00000348343,0.7523175542406312,0.1448137965508623,2028,,,,,,,0.5646126270184435,4.045460445159225,Whole Blood,broadly expressed,0.1807576624712793,0.10084164460715243,FALSE,discordant,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:10820,SH2D1A,SH2 domain containing 1A,Approved,"IMD5, LYP","XLP, MTCP1, DSHP, XLPD, EBVS, SAP",Xq25,gene with protein product,protein-coding gene,ENSG00000183918,4068,ENSG00000183918,O60880,MGI:1328352,RGD:1562408,X,300490,TRUE,"Lymphoproliferative syndrome, X-linked, 1",308240,X-linked recessive,,,,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Cytoplasmic adapter regulating receptors of the signaling lymphocytic activation molecule (SLAM) family such as SLAMF1, CD244, LY9, CD84, SLAMF6 and SLAMF7. In SLAM signaling seems to cooperate with SH2D1B/EAT-2. Initially it has been proposed that association with SLAMF1 prevents SLAMF1 binding to inhibitory effectors including INPP5D/SHIP1 and PTPN11/SHP-2 (PubMed:11806999). However, by simultaneous interactions, recruits FYN which subsequently phosphorylates and activates SLAMF1 (PubMed:12458214). Positively regulates CD244/2B4- and CD84-mediated natural killer (NK) cell functions. Can also promote CD48-, SLAMF6 -, LY9-, and SLAMF7-mediated NK cell activation. In the context of NK cell-mediated cytotoxicity enhances conjugate formation with target cells (By similarity). May also regulate the activity of the neurotrophin receptors NTRK1, NTRK2 and NTRK3. {ECO:0000250|UniProtKB:O88890, ECO:0000269|PubMed:11806999, ECO:0000269|PubMed:12458214, ECO:0000305|PubMed:21219180}.",adaptive immune response [GO:0002250]; cell-cell signaling [GO:0007267]; cellular defense response [GO:0006968]; humoral immune response [GO:0006959]; innate immune response [GO:0045087]; negative regulation of T cell receptor signaling pathway [GO:0050860]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; regulation of immune response [GO:0050776],"",SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}.,"SUBUNIT: Interacts with NTRK1, NTRK2 and NTRK3 (By similarity). Interacts with CD84, CD244, LY9, SLAMF1 and FYN. {ECO:0000250, ECO:0000269|PubMed:11389028, ECO:0000269|PubMed:11477068, ECO:0000269|PubMed:11806999, ECO:0000269|PubMed:11823424, ECO:0000269|PubMed:12115647, ECO:0000269|PubMed:12458214, ECO:0000269|PubMed:12545174}.",X,124227868,124373197,q25,0.38935,0.959,0.25982,1.6869,4.9306,0.28285653673599276,ENST00000371139,0.8834625322997416,0.15571107223194203,387,,,,,,,0.7990622140907936,3.358265434419237,Spleen,tissue-specific,0.20344424796369426,0.06684873522281004,FALSE,variable escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:10823,SH3BGRL,SH3 domain binding glutamate rich protein like,Approved,,MGC117402,Xq21.1,gene with protein product,protein-coding gene,ENSG00000131171,6451,ENSG00000131171,O75368,MGI:1930849,RGD:1560520,X,300190,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","",SH3 domain binding [GO:0017124],"","",X,81202102,81298547,q21.1,0.30081,1.172,-1.1338,0.52829,3.9873,0.26708655157099687,ENST00000373212,0.9579710144927536,0.18170457385653588,345,1,"SH3BGRL2 (59, 63, chr6)",TRUE,,,,0.25751535209123694,8.933852912140905,Artery - Tibial,broadly expressed,6.353104470526531,4.670896973237183,FALSE,discordant,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,Post2_higher_vs_Post1,no disorder
HGNC:10853,SHOX,short stature homeobox,Approved,,"PHOG, GCFX, SS, SHOXY",Xp22.33 and Yp11.32,gene with protein product,protein-coding gene,ENSG00000185960,6473,ENSG00000185960,O15266,,RGD:1586239,X,"312865, 400020",TRUE,"Langer mesomelic dysplasia // Leri-Weill dyschondrosteosis // Short stature, idiopathic familial",249700 // 127300 // 300582,Pseudoautosomal recessive // Pseudoautosomal dominant //,,,,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,TRUE,,confirmed,FUNCTION: Controls fundamental aspects of growth and development.,positive regulation of transcription by RNA polymerase II [GO:0045944]; skeletal system development [GO:0001501],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]","SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00108, ECO:0000255|PROSITE-ProRule:PRU00138}.","",X,624344,659411,p22.33,0.66566,0.515,-3.4115,-0.53811,12.218,0.41724847353157457,ENST00000381578,0.8930602957906713,0.018920487521764364,879,1,"SHOX2 (71, 59, chr3)",TRUE,,,,0.932634237974301,1.2804397008987058,Adipose - Subcutaneous,tissue-specific,0,0.04415571397889924,FALSE,low confidence escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:10923,SLC16A2,solute carrier family 16 member 2,Approved,"DXS128, AHDS, MRX22","XPCT, MCT8, MCT7",Xq13.2,gene with protein product,protein-coding gene,ENSG00000147100,6567,ENSG00000147100,P36021,MGI:1203732,RGD:628608,X,300095,TRUE,Allan-Herndon-Dudley syndrome,300523,X-linked,,,,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE,confirmed +CS,FALSE,TRUE,confirmed,"FUNCTION: Very active and specific thyroid hormone transporter. Stimulates cellular uptake of thyroxine (T4), triiodothyronine (T3), reverse triiodothyronine (rT3) and diidothyronine. Does not transport Leu, Phe, Trp or Tyr. {ECO:0000269|PubMed:23550058, ECO:0000269|PubMed:26426690}.",amino acid import across plasma membrane [GO:0089718]; cellular amino acid metabolic process [GO:0006520]; monocarboxylic acid transport [GO:0015718]; negative regulation of neural precursor cell proliferation [GO:2000178]; sodium-independent organic anion transport [GO:0043252]; thyroid hormone generation [GO:0006590]; thyroid hormone metabolic process [GO:0042403]; thyroid hormone transport [GO:0070327]; thyroid-stimulating hormone secretion [GO:0070460]; transport across blood-brain barrier [GO:0150104],amino acid transmembrane transporter activity [GO:0015171]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; thyroid hormone transmembrane transporter activity [GO:0015349]; transporter activity [GO:0005215],"SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:23550058, ECO:0000269|PubMed:25527620, ECO:0000269|PubMed:26426690}; Multi-pass membrane protein {ECO:0000269|PubMed:23550058, ECO:0000269|PubMed:25527620}.","SUBUNIT: Homodimer. {ECO:0000269|PubMed:19797118, ECO:0000269|PubMed:25527620}.",X,74421493,74533917,q13.2,0.98828,0.223,0.88871,2.3824,13.408,0.5533700498295305,ENST00000587091,0.8411111111111111,0.2485378655336166,1620,,,,,,,0.35774984295380324,5.688874117995128,Adrenal Gland,broadly expressed,3.3202897060543064,4.0197997511093435,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:10984,SLC25A14,solute carrier family 25 member 14,Approved,,"BMCP1, UCP5",Xq26.1,gene with protein product,protein-coding gene,ENSG00000102078,9016,ENSG00000102078,O95258,MGI:1330823,RGD:621433,X,300242,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Participates in the mitochondrial proton leak measured in brain mitochondria.,aerobic respiration [GO:0009060]; malate transmembrane transport [GO:0071423]; mitochondrial transport [GO:0006839]; oxaloacetate transport [GO:0015729]; phosphate ion transmembrane transport [GO:0035435]; proton transmembrane transport [GO:1902600]; succinate transmembrane transport [GO:0071422]; sulfate transport [GO:0008272]; thiosulfate transport [GO:0015709],antiporter activity [GO:0015297]; malate transmembrane transporter activity [GO:0015140]; oxaloacetate transmembrane transporter activity [GO:0015131]; succinate transmembrane transporter activity [GO:0015141]; sulfate transmembrane transporter activity [GO:0015116]; thiosulfate transmembrane transporter activity [GO:0015117],SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}.,"",X,130339888,130373361,q26.1,0.98821,0.223,0.61023,2.4975,13.392,0.49850778532401907,ENST00000545805,0.870961145194274,0.2250937265683579,978,1,"SLC25A30 (66, 80, chr13)",TRUE,,,,0.3713979958879727,4.643377135493738,Pituitary,broadly expressed,3.0991268520368793,4.253172415190249,FALSE,high confidence non-escapee,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:10991,SLC25A5,solute carrier family 25 member 5,Approved,ANT2,"T2, 2F1, T3",Xq24,gene with protein product,protein-coding gene,ENSG00000005022,292,ENSG00000005022,P05141,MGI:1353496,RGD:620353,X,300150,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Catalyzes the exchange of cytoplasmic ADP with mitochondrial ATP across the mitochondrial inner membrane. As part of the mitotic spindle-associated MMXD complex it may play a role in chromosome segregation. {ECO:0000269|PubMed:20797633}.,adenine nucleotide transport [GO:0051503]; cellular response to leukemia inhibitory factor [GO:1990830]; chromosome segregation [GO:0007059]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; positive regulation of cell population proliferation [GO:0008284]; regulation of insulin secretion [GO:0050796]; viral process [GO:0016032],adenine nucleotide transmembrane transporter activity [GO:0000295]; adenine transmembrane transporter activity [GO:0015207]; ATP transmembrane transporter activity [GO:0005347]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625],SUBCELLULAR LOCATION: Mitochondrion inner membrane; Multi-pass membrane protein.,"SUBUNIT: Homodimer. Component of the MMXD complex, which includes CIAO1, ERCC2, CIAO2B, MMS19 and SLC25A5 (PubMed:20797633). Interacts with AK4 (PubMed:19130895). {ECO:0000269|PubMed:19130895, ECO:0000269|PubMed:20797633}.; SUBUNIT: (Microbial infection) Interacts with HIV-1 Vpr. {ECO:0000269|PubMed:16120388}.",X,119468422,119471396,q24,0.93194,0.349,1.1435,2.6524,8.5598,0.6047094480387014,ENST00000317881,0.8759197324414716,0.22999250187453135,897,3,"SLC25A6 (92, 92, chrX); SLC25A4 (89, 89, chr4); SLC25A31 (71, 67, chr4)",TRUE,2,"SLC25A6 (92, 92, chrX); SLC25A4 (89, 89, chr4)",TRUE,0.16304281714008992,9.429157726972056,Cells - EBV-transformed lymphocytes,broadly expressed,7.063837260222875,7.69794405664259,FALSE,low confidence non-escapee,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,no difference_Post1_Post2,no disorder
HGNC:10992,SLC25A6,solute carrier family 25 member 6,Approved,ANT3,"ANT3Y, MGC17525",Xp22.32 and Yp11.3,gene with protein product,protein-coding gene,ENSG00000169100,293,ENSG00000169100,P12236,,RGD:1560896,X,"300151, 403000",FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,TRUE,,no disorder,FUNCTION: Catalyzes the exchange of cytoplasmic ADP with mitochondrial ATP across the mitochondrial inner membrane. May participate in the formation of the permeability transition pore complex (PTPC) responsible for the release of mitochondrial products that triggers apoptosis. {ECO:0000269|PubMed:15033708}.,apoptotic process [GO:0006915]; protein targeting to mitochondrion [GO:0006626]; regulation of insulin secretion [GO:0050796]; viral process [GO:0016032],ATP:ADP antiporter activity [GO:0005471],"SUBCELLULAR LOCATION: Mitochondrion inner membrane; Multi-pass membrane protein. Note=The complex formed with ARL2BP, ARL2 and SLC25A6 is expressed in mitochondria. {ECO:0000250}.","SUBUNIT: Found in a complex with ARL2, ARL2BP and SLC25A6 (By similarity). Homodimer. {ECO:0000250}.; SUBUNIT: (Microbial infection) Interacts with influenza A virus PB1-F2 protein. {ECO:0000269|PubMed:16201016}.; SUBUNIT: (Microbial infection) Interacts with HIV-1 Vpr. {ECO:0000269|PubMed:16120388}.",X,1386152,1392113,p22.33,0.13859,0.779,-1.9211,0.55956,9.9496,0.7490507222577542,ENST00000381401,0.9012263099219621,0.06985753561609598,897,3,"SLC25A5 (92, 92, chrX); SLC25A4 (88, 88, chr4); SLC25A31 (70, 67, chr4)",TRUE,2,"SLC25A5 (92, 92, chrX); SLC25A4 (88, 88, chr4)",TRUE,0.12799184249761827,10.025485656808389,Cells - EBV-transformed lymphocytes,broadly expressed,7.82068317919761,8.313313884720692,FALSE,low confidence escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:11022,SLC35A2,solute carrier family 35 member A2,Approved,UGALT,"UGAT, UGT, UGT1, UGT2, UGTL",Xp11.23,gene with protein product,protein-coding gene,ENSG00000102100,7355,ENSG00000102100,P78381,MGI:1345297,RGD:2293497,X,314375,TRUE,"Congenital disorder of glycosylation, type IIm",300896,"X-linked dominant, Somatic mosaicism",,,,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,TRUE,confirmed,FUNCTION: Transports nucleotide sugars from the cytosol into Golgi vesicles where glycosyltransferases function.,carbohydrate transport [GO:0008643]; galactose metabolic process [GO:0006012]; UDP-galactose transmembrane transport [GO:0072334],sialic acid transmembrane transporter activity [GO:0015136]; UDP-galactose transmembrane transporter activity [GO:0005459],SUBCELLULAR LOCATION: Golgi apparatus membrane; Multi-pass membrane protein.,SUBUNIT: Interacts with SLC35A3. {ECO:0000269|PubMed:23089177}.,X,48903180,48911958,p11.23,0.71792,0.559,-0.29672,2.4957,8.4845,0.4483753229532623,ENST00000247138,0.8517212426532326,0.20457385653586604,1191,,,,,,,0.21499481317799024,4.543737137294877,Cells - Cultured fibroblasts,broadly expressed,2.665060712849666,2.9904484672367584,FALSE,high confidence non-escapee,no_difference_Pre_Post,Pre_higher_vs_Post1,no difference_Pre_Post2,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:11047,SLC6A14,solute carrier family 6 member 14,Approved,,,Xq23,gene with protein product,protein-coding gene,ENSG00000268104,11254,ENSG00000268104,Q9UN76,MGI:1890216,RGD:1561810,X,300444,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Mediates the uptake of a broad range of neutral and cationic amino acids (with the exception of proline) in a Na(+)/Cl(-)-dependent manner. {ECO:0000269|PubMed:10446133}.,alanine transport [GO:0032328]; amino acid import across plasma membrane [GO:0089718]; amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; response to toxic substance [GO:0009636],alanine transmembrane transporter activity [GO:0022858]; amino acid transmembrane transporter activity [GO:0015171]; symporter activity [GO:0015293],SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.,"",X,116436606,116461458,q23,0.56419,0.433,-0.71049,1.2816,24.288,0.16714215728653353,ENST00000598581,0.7654224987039917,0.23781554611347164,1929,,,,,,,0.9016853624512082,4.934148468338544,Minor Salivary Gland,tissue-specific,0,0,FALSE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:11055,SLC6A8,solute carrier family 6 member 8,Approved,,"CRTR, CT1",Xq28,gene with protein product,protein-coding gene,ENSG00000130821,6535,ENSG00000130821,P48029,MGI:2147834,RGD:619711,X,300036,TRUE,Cerebral creatine deficiency syndrome 1,300352,X-linked recessive,,,,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,confirmed +CS,FALSE,TRUE,confirmed,FUNCTION: Required for the uptake of creatine in muscles and brain.,creatine metabolic process [GO:0006600]; creatine transmembrane transport [GO:0015881]; muscle contraction [GO:0006936]; neurotransmitter transport [GO:0006836]; nitrogen compound transport [GO:0071705],creatine:sodium symporter activity [GO:0005309]; creatine transmembrane transporter activity [GO:0005308],SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.,"",X,153687926,153696588,q28,0.99778,0.213,-1.1651,3.0483,22.289,0.608489754884453,ENST00000253122,0.6790880503144654,0.12519370157460635,1908,1,"AC136616.1 (95, 95, chrKI270728.1)",TRUE,1,"AC136616.1 (95, 95, chrKI270728.1)",TRUE,0.25056448646086493,6.488343080982375,Colon - Sigmoid,broadly expressed,5.529655433058223,6.256900261396571,FALSE,,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:11061,SLC7A3,solute carrier family 7 member 3,Approved,,"CAT-3, ATRC3, FLJ14541",Xq13.1,gene with protein product,protein-coding gene,ENSG00000165349,84889,ENSG00000165349,Q8WY07,MGI:1100521,RGD:68342,X,300443,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Mediates the uptake of the cationic amino acids arginine, lysine and ornithine in a sodium-independent manner. {ECO:0000269|PubMed:11591158}.",amino acid transport [GO:0006865]; L-arginine import across plasma membrane [GO:0097638]; L-lysine import across plasma membrane [GO:0097639]; L-ornithine import across plasma membrane [GO:0097640]; L-ornithine transmembrane transport [GO:1903352]; transport across blood-brain barrier [GO:0150104],amino acid transmembrane transporter activity [GO:0015171]; arginine transmembrane transporter activity [GO:0015181]; L-arginine transmembrane transporter activity [GO:0061459]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064],SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.,"",X,70925579,70931125,q13.1,0.99614,0.182,-0.35459,1.9016,16.398,0.34677179772631883,ENST00000374299,0.6724193548387096,0.22749312671832042,1860,1,"SLC7A1 (59, 58, chr13)",TRUE,,,,0.842918870645457,2.8967852754841195,Uterus,tissue-specific,0.5631356720310904,0.02894894117647957,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:11079,SLC9A6,solute carrier family 9 member A6,Approved,,"NHE6, KIAA0267",Xq26.3,gene with protein product,protein-coding gene,ENSG00000198689,10479,ENSG00000198689,Q92581,MGI:2443511,RGD:1563582,X,300231,TRUE,"Mental retardation, X-linked syndromic, Christianson type",300243,X-linked dominant,,,,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,confirmed +CS,FALSE,TRUE,confirmed,FUNCTION: Electroneutral exchange of protons for Na(+) and K(+) across the early and recycling endosome membranes. Contributes to calcium homeostasis.,axon extension [GO:0048675]; brain-derived neurotrophic factor receptor signaling pathway [GO:0031547]; dendrite extension [GO:0097484]; dendritic spine development [GO:0060996]; ion transport [GO:0006811]; neuron projection morphogenesis [GO:0048812]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; regulation of neurotrophin TRK receptor signaling pathway [GO:0051386]; sodium ion import across plasma membrane [GO:0098719]; synapse organization [GO:0050808],potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385],"SUBCELLULAR LOCATION: Endosome membrane {ECO:0000269|PubMed:11940519}; Multi-pass membrane protein {ECO:0000269|PubMed:11940519}. Note=Is present in the recycling compartments including early and recycling endosomes, and only appears transiently on the plasma membrane.; SUBCELLULAR LOCATION: [Isoform 2]: Recycling endosome membrane {ECO:0000269|PubMed:30296617}; Multi-pass membrane protein {ECO:0000255}.",SUBUNIT: Homodimer (in vitro). {ECO:0000269|PubMed:30296617}.,X,135973841,136047269,q26.3,0.99833,0.206,0.35852,2.9537,23.057,0.508441431458184,ENST00000630721,0.8980392156862745,0.206623344163959,2040,2,"SLC9A7 (67, 68, chrX); SLC9A9 (54, 62, chr3)",TRUE,,,,0.390016922950324,5.001624371325791,Cerebellar_tissues,broadly expressed,4.4429766608707615,5.001624371325791,TRUE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:11097,SMARCA1,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1",Approved,"SNF2L1, SNF2L","SNF2LB, NURF140, ISWI, SWI, hSNF2L",Xq25-q26.1,gene with protein product,protein-coding gene,ENSG00000102038,6594,ENSG00000102038,P28370,MGI:1935127,RGD:1561046,X,300012,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Energy-transducing component of NURF (nucleosome-remodeling factor) and CERF (CECR2-containing-remodeling factor) complexes. Both complexes facilitate the perturbation of chromatin structure in an ATP-dependent manner. Potentiates neurite outgrowth. May be involved in brain development by regulating En-1 and En-2 expression. May be involved in the development of luteal cells. {ECO:0000269|PubMed:14609955, ECO:0000269|PubMed:15310751, ECO:0000269|PubMed:15640247, ECO:0000269|PubMed:16740656}.","ATP-dependent chromatin remodeling [GO:0043044]; brain development [GO:0007420]; chromatin remodeling [GO:0006338]; neuron differentiation [GO:0030182]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]",annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; nucleosome binding [GO:0031491]; transcription factor binding [GO:0008134],SUBCELLULAR LOCATION: Nucleus.,"SUBUNIT: Part of the nucleosome-remodeling factor (NURF) complex which consists of SMARCA1; BPTF; RBBP4 and RBBP7 (PubMed:14609955). Part of the CECR2-containing-remodeling factor (CERF) complex which contains CECR2 and SMARCA1 (PubMed:15640247). Interacts with PRLR (PubMed:16740656). Interacts with ERCC6 (PubMed:26030138). {ECO:0000269|PubMed:14609955, ECO:0000269|PubMed:15640247, ECO:0000269|PubMed:16740656, ECO:0000269|PubMed:26030138}.",X,129446501,129523500,q26.1,1,0.137,0.78549,2.4397,46.036,0.5875952121871599,ENST00000371121,0.9526921879863056,0.4052736815796051,3213,1,"SMARCA5 (79, 81, chr4)",TRUE,,,,0.2832673610719456,6.670514627930451,Ovary,broadly expressed,4.327622700100557,5.084746746478407,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:11111,SMC1A,structural maintenance of chromosomes 1A,Approved,SMC1L1,"DXS423E, KIAA0178, SB1.8, Smcb",Xp11.22,gene with protein product,protein-coding gene,ENSG00000072501,8243,ENSG00000072501,Q14683,MGI:1344345,RGD:61991,X,300040,TRUE,"Cornelia de Lange syndrome 2 // Epileptic encephalopathy, early infantile, 85, with or without midline brain defects",300590 // 301044,X-linked dominant //,,,,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Involved in chromosome cohesion during cell cycle and in DNA repair. Central component of cohesin complex. The cohesin complex is required for the cohesion of sister chromatids after DNA replication. The cohesin complex apparently forms a large proteinaceous ring within which sister chromatids can be trapped. At anaphase, the complex is cleaved and dissociates from chromatin, allowing sister chromatids to segregate. The cohesin complex may also play a role in spindle pole assembly during mitosis. Involved in DNA repair via its interaction with BRCA1 and its related phosphorylation by ATM, or via its phosphorylation by ATR. Works as a downstream effector both in the ATM/NBS1 branch and in the ATR/MSH2 branch of S-phase checkpoint. {ECO:0000269|PubMed:11877377}.",cell division [GO:0051301]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; mitotic sister chromatid cohesion [GO:0007064]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; response to DNA damage checkpoint signaling [GO:0072423]; response to radiation [GO:0009314]; sister chromatid cohesion [GO:0007062]; stem cell population maintenance [GO:0019827],ATP binding [GO:0005524]; chromatin binding [GO:0003682]; mediator complex binding [GO:0036033]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723],"SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12199140}. Chromosome {ECO:0000269|PubMed:12199140}. Chromosome, centromere, kinetochore {ECO:0000269|PubMed:12199140}. Note=Associates with chromatin. Before prophase it is scattered along chromosome arms. During prophase, most of cohesin complexes dissociate from chromatin probably because of phosphorylation by PLK, except at centromeres, where cohesin complexes remain. At anaphase, the RAD21 subunit of the cohesin complex is cleaved, leading to the dissociation of the complex from chromosomes, allowing chromosome separation. In germ cells, cohesin complex dissociates from chromatin at prophase I, and may be replaced by a meiosis-specific cohesin complex. The phosphorylated form on Ser-957 and Ser-966 associates with chromatin during G1/S/G2 phases but not during M phase, suggesting that phosphorylation does not regulate cohesin function. Integral component of the functional centromere-kinetochore complex at the kinetochore region during mitosis.","SUBUNIT: Forms a heterodimer with SMC3 in cohesin complexes (PubMed:22628566). Cohesin complexes are composed of the SMC1 (SMC1A or SMC1B) and SMC3 heterodimer attached via their SMC hinge domain, RAD21 which link them, and one STAG protein (STAG1, STAG2 or STAG3), which interacts with RAD21 (PubMed:11076961). In germ cell cohesin complexes, SMC1A is mutually exclusive with SMC1B (By similarity). Interacts with BRCA1 (PubMed:11877377). Found in a complex with CDCA5, SMC3 and RAD21, PDS5A/SCC-112 and PDS5B/APRIN (PubMed:15837422). Interacts with NDC80 (PubMed:9295362, PubMed:10409732,). Interacts with BRAT1 (PubMed:22977523). Found in a complex containing POLE and SMC3. Interacts with RPGR, STAG3 and SYCP2 (By similarity). Found in a cohesin complex with SMC3, STAG1 and RAD21 (PubMed:22628566). The SMC1A-SMC3 heterodimer interacts with the NIPBL-MAU2 heterodimer (PubMed:22628566). {ECO:0000250|UniProtKB:O97593, ECO:0000250|UniProtKB:Q9CU62, ECO:0000250|UniProtKB:Q9Z1M9, ECO:0000269|PubMed:10409732, ECO:0000269|PubMed:11076961, ECO:0000269|PubMed:11877377, ECO:0000269|PubMed:15837422, ECO:0000269|PubMed:22628566, ECO:0000269|PubMed:22977523, ECO:0000269|PubMed:9295362}.",X,53374149,53422728,p11.22,1,0.062,0.1895,6.4479,48.078,0.4785079454575129,ENST00000322213,0.9085359265262021,0.15878530367408147,3702,1,"SMC1B (54, 54, chr22)",TRUE,,,,0.2715890767183839,5.688773431680851,Cells - EBV-transformed lymphocytes,broadly expressed,2.918983417111902,4.987780162921254,FALSE,high confidence escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:11114,KDM5C,lysine demethylase 5C,Approved,"SMCX, JARID1C, MRX13","DXS1272E, XE169",Xp11.22,gene with protein product,protein-coding gene,ENSG00000126012,8242,ENSG00000126012,P41229,MGI:99781,RGD:1560601,X,314690,TRUE,"Mental retardation, X-linked, syndromic, Claes-Jensen type",300534,X-linked recessive,,,,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,confirmed +CS,FALSE,TRUE,confirmed,"FUNCTION: Histone demethylase that specifically demethylates 'Lys-4' of histone H3, thereby playing a central role in histone code (PubMed:28262558). Does not demethylate histone H3 'Lys-9', H3 'Lys-27', H3 'Lys-36', H3 'Lys-79' or H4 'Lys-20'. Demethylates trimethylated and dimethylated but not monomethylated H3 'Lys-4'. Participates in transcriptional repression of neuronal genes by recruiting histone deacetylases and REST at neuron-restrictive silencer elements. Represses the CLOCK-ARNTL/BMAL1 heterodimer-mediated transcriptional activation of the core clock component PER2 (By similarity). {ECO:0000250|UniProtKB:P41230, ECO:0000269|PubMed:17320160, ECO:0000269|PubMed:17320161, ECO:0000269|PubMed:17468742, ECO:0000269|PubMed:26645689, ECO:0000269|PubMed:28262558}.","chromatin remodeling [GO:0006338]; histone H3-K4 demethylation [GO:0034720]; negative regulation of transcription, DNA-templated [GO:0045892]; rhythmic process [GO:0048511]",dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K4 specific) [GO:0032453]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; zinc ion binding [GO:0008270],"SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00355, ECO:0000255|PROSITE-ProRule:PRU00537, ECO:0000269|PubMed:17468742}.","SUBUNIT: Part of two distinct complexes, one containing E2F6, and the other containing REST. {ECO:0000269|PubMed:17468742}.",X,53191321,53225422,p11.22,1,0.166,-0.58207,5.1452,55.095,0.49158215516810716,ENST00000375401,0.8342088404868674,0.33979005248687827,4683,1,"KDM5D (85, 84, chrY)",TRUE,1,"KDM5D (85, 84, chrY)",TRUE,0.15898430081537984,6.28928302312349,Ovary,broadly expressed,4.043729452192397,6.012093730563705,FALSE,high confidence escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:11122,SMPX,small muscle protein X-linked,Approved,DFN6,"DFNX4, Chisel, Csl",Xp22.12,gene with protein product,protein-coding gene,ENSG00000091482,23676,ENSG00000091482,Q9UHP9,MGI:1913356,RGD:69233,X,300226,TRUE,"Deafness, X-linked 4",300066,X-linked dominant,,,,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,TRUE,confirmed,"FUNCTION: Plays a role in the regulatory network through which muscle cells coordinate their structural and functional states during growth, adaptation, and repair. {ECO:0000250}.",striated muscle contraction [GO:0006941],"","","",X,21705978,21758116,p22.12,0.62317,0.951,-1.4735,-0.041672,3.1083,0.19895831112816467,ENST00000379494,0.9213483146067416,0.25173706573356663,267,,,,,,,0.8339949928700043,8.36604676435332,Heart - Left Ventricle,tissue-specific,0.32733900610771205,2.3373357428144135,FALSE,high confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:11123,SMS,spermine synthase,Approved,SRS,"SPMSY, SpS, MRSR",Xp22.11,gene with protein product,protein-coding gene,ENSG00000102172,6611,ENSG00000102172,P52788,"MGI:109490, MGI:3705601",RGD:1564826,X,300105,TRUE,"Mental retardation, X-linked, Snyder-Robinson type",309583,X-linked recessive,,,,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,TRUE,confirmed,FUNCTION: Catalyzes the production of spermine from spermidine and decarboxylated S-adenosylmethionine (dcSAM).,methionine metabolic process [GO:0006555]; polyamine metabolic process [GO:0006595]; spermine biosynthetic process [GO:0006597],spermine synthase activity [GO:0016768],"",SUBUNIT: Homodimer. Dimerization is mediated through the N-terminal domain and seems to be required for activity as deletion of the N-terminal domain causes complete loss of activity. {ECO:0000269|PubMed:18367445}.,X,21940709,21994837,p22.11,0.97297,0.305,-0.28884,2.3162,15.542,0.7049187109585074,ENST00000404933,0.9287011807447775,0.1738565358660335,1101,,,,,,,0.20921702792605748,7.175544560761445,Cells - EBV-transformed lymphocytes,broadly expressed,5.346421539569095,6.554268046583041,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:1113,BRS3,bombesin receptor subtype 3,Approved,,"BB3, BB3R, BBR3",Xq26.3,gene with protein product,protein-coding gene,ENSG00000102239,680,ENSG00000102239,P32247,MGI:1100501,RGD:628645,X,300107,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Role in sperm cell division, maturation, or function. This receptor mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system.",adult feeding behavior [GO:0008343]; glucose metabolic process [GO:0006006]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of blood pressure [GO:0008217],bombesin receptor activity [GO:0004946]; G protein-coupled receptor activity [GO:0004930],SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.,SUBUNIT: Interacts with C6orf89. {ECO:0000269|PubMed:21857995}.,X,136487947,136493780,q26.3,0.94849000000000006,0.32,-0.27446,0.93894,9.3475,0.20245252251098067,ENST00000370648,0.8235833333333333,0.29427643089227695,1200,,,,,,,0.9148410418373992,1.0129047268858258,Ovary,tissue-specific,0.047928638380192214,0,FALSE,variable escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:11199,SOX3,SRY-box transcription factor 3,Approved,PHP,,Xq27.1,gene with protein product,protein-coding gene,ENSG00000134595,6658,ENSG00000134595,P41225,MGI:98365,RGD:1591839,X,313430,TRUE,"Mental retardation, X-linked, with isolated growth hormone deficiency // Panhypopituitarism, X-linked",300123 // 312000,// X-linked,,,,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Transcription factor required during the formation of the hypothalamo-pituitary axis. May function as a switch in neuronal development. Keeps neural cells undifferentiated by counteracting the activity of proneural proteins and suppresses neuronal differentiation. Required also within the pharyngeal epithelia for craniofacial morphogenesis. Controls a genetic switch in male development. Is necessary for initiating male sex determination by directing the development of supporting cell precursors (pre-Sertoli cells) as Sertoli rather than granulosa cells (By similarity). {ECO:0000250, ECO:0000269|PubMed:21183788}.","anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; face development [GO:0060324]; hypothalamus development [GO:0021854]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pituitary gland development [GO:0021983]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; sex determination [GO:0007530]","DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",SUBCELLULAR LOCATION: Nucleus.,SUBUNIT: Interacts with SOX2 and FGFR1. {ECO:0000250}.,X,140502985,140505069,q27.1,0.44948,0.855,1.1074,2.2112,5.5441,0.8368747956848643,ENST00000370536,0.819537658463833,0.5017995501124719,1341,,,,,,,0.9199994626918461,2.7193455565559637,Testis,tissue-specific,1.106770411898616,0.6337757419854179,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post1_higher_vs_Post2,confirmed monogenic disorder
HGNC:11218,SPANXA1,"sperm protein associated with the nucleus, X-linked, family member A1",Approved,SPANX,"NAP-X, SPAN-Xa, SPAN-Xb, CT11.1",Xq27.2,gene with protein product,protein-coding gene,ENSG00000198021,30014,ENSG00000198021,Q9NS26,,,X,300305,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",spermatogenesis [GO:0007283],"",SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10906052}. Nucleus {ECO:0000269|PubMed:10906052}. Note=Associated with nuclear craters.,"",X,141583674,141585011,q27.2,,,,,,0.34950225547430125,ENST00000370519,0.03605442176870748,0.13686578355411147,294,4,"SPANXA2 (100, 100, chrX); SPANXC (94, 94, chrX); SPANXD (94, 94, chrX); SPANXB1 (85, 80, chrX)",TRUE,3,"SPANXA2 (100, 100, chrX); SPANXC (94, 94, chrX); SPANXD (94, 94, chrX)",TRUE,0.9767441860465116,0.24819962562341963,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:11271,SPRY3,sprouty RTK signaling antagonist 3,Approved,,HSPRY3,Xq28 and Yq12,gene with protein product,protein-coding gene,ENSG00000168939,10251,ENSG00000168939,O43610,MGI:1345188,RGD:1562172,X,300531,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,TRUE,,no disorder,FUNCTION: May function as an antagonist of fibroblast growth factor (FGF) pathways and may negatively modulate respiratory organogenesis.,animal organ development [GO:0048513]; axon development [GO:0061564]; multicellular organism development [GO:0007275]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of Ras protein signal transduction [GO:0046580],"",SUBCELLULAR LOCATION: Cytoplasm. Membrane; Peripheral membrane protein. Note=Found in the cytoplasm in unstimulated cells but is translocated to the membrane ruffles in cells stimulated with EGF (epidermal growth factor).,"",X,155612572,155782459,q28,0.0038066,1.154,-0.30606,0.019847,9.099,0.35449266544093333,ENST00000675360,0.8277970011534025,0.08030492376905773,867,,,,,,,0.6199549530416246,3.169122479533766,Cerebellar_tissues,tissue-specific,1.0702725335653964,3.169122479533766,TRUE,high confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:11309,SRPX,sushi repeat containing protein X-linked,Approved,,ETX1,Xp11.4,gene with protein product,protein-coding gene,ENSG00000101955,8406,ENSG00000101955,P78539,MGI:1858306,RGD:70950,X,300187,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: May be involved in phagocytosis during disk shedding, cell adhesion to cells other than the pigment epithelium or signal transduction.",autophagy [GO:0006914]; cell adhesion [GO:0007155]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; phagolysosome assembly [GO:0001845]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; response to endoplasmic reticulum stress [GO:0034976],"",SUBCELLULAR LOCATION: Cell surface {ECO:0000305}. Note=Possibly surface of photoreceptor cell.,"",X,38149336,38220924,p11.4,0.0030756,0.774,-0.16782,-0.61721,16.986,0.44608359676852827,ENST00000378533,0.89584229390681,0.10277430642339415,1395,,,,,,,0.3827871385183607,8.529465693786856,Cells - Cultured fibroblasts,broadly expressed,2.0926404522943485,3.8639597537992247,FALSE,discordant,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,no difference_Post1_Post2,no disorder
HGNC:11326,SSR4,signal sequence receptor subunit 4,Approved,,TRAPD,Xq28,gene with protein product,protein-coding gene,ENSG00000180879,6748,ENSG00000180879,P51571,MGI:1099464,RGD:62034,X,300090,TRUE,"Congenital disorder of glycosylation, type Iy",300934,X-linked recessive,,,,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,TRUE,confirmed,FUNCTION: TRAP proteins are part of a complex whose function is to bind calcium to the ER membrane and thereby regulate the retention of ER resident proteins.,"","",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Single-pass type I membrane protein.,"SUBUNIT: Heterotetramer of TRAP-alpha, TRAP-beta, TRAP-delta and TRAP-gamma.",X,153793516,153798499,q28,0.87499,0.441,-1.1828,0.90192,6.784,0.5521048999309869,ENST00000370086,0.8452107279693487,0.09522619345163709,522,,,,,,,0.23194315360186582,7.468053775516261,Pituitary,broadly expressed,4.287051127456259,5.140146724932344,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:1133,BTK,Bruton tyrosine kinase,Approved,"AGMX1, IMD1","ATK, XLA, PSCTK1",Xq22.1,gene with protein product,protein-coding gene,ENSG00000010671,695,ENSG00000010671,Q06187,MGI:88216,RGD:1359683,X,300300,TRUE,"Agammaglobulinemia, X-linked 1 // Isolated growth hormone deficiency, type III, with agammaglobulinemia",300755 // 307200,X-linked recessive // X-linked recessive,,,,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Non-receptor tyrosine kinase indispensable for B lymphocyte development, differentiation and signaling. Binding of antigen to the B-cell antigen receptor (BCR) triggers signaling that ultimately leads to B-cell activation. After BCR engagement and activation at the plasma membrane, phosphorylates PLCG2 at several sites, igniting the downstream signaling pathway through calcium mobilization, followed by activation of the protein kinase C (PKC) family members. PLCG2 phosphorylation is performed in close cooperation with the adapter protein B-cell linker protein BLNK. BTK acts as a platform to bring together a diverse array of signaling proteins and is implicated in cytokine receptor signaling pathways. Plays an important role in the function of immune cells of innate as well as adaptive immunity, as a component of the Toll-like receptors (TLR) pathway. The TLR pathway acts as a primary surveillance system for the detection of pathogens and are crucial to the activation of host defense. Especially, is a critical molecule in regulating TLR9 activation in splenic B-cells. Within the TLR pathway, induces tyrosine phosphorylation of TIRAP which leads to TIRAP degradation. BTK plays also a critical role in transcription regulation. Induces the activity of NF-kappa-B, which is involved in regulating the expression of hundreds of genes. BTK is involved on the signaling pathway linking TLR8 and TLR9 to NF-kappa-B. Transiently phosphorylates transcription factor GTF2I on tyrosine residues in response to BCR. GTF2I then translocates to the nucleus to bind regulatory enhancer elements to modulate gene expression. ARID3A and NFAT are other transcriptional target of BTK. BTK is required for the formation of functional ARID3A DNA-binding complexes. There is however no evidence that BTK itself binds directly to DNA. BTK has a dual role in the regulation of apoptosis. {ECO:0000269|PubMed:11606584, ECO:0000269|PubMed:16415872, ECO:0000269|PubMed:16517732, ECO:0000269|PubMed:16738337, ECO:0000269|PubMed:17932028, ECO:0000269|PubMed:9012831}.",adaptive immune response [GO:0002250]; apoptotic signaling pathway [GO:0097190]; B cell activation [GO:0042113]; B cell affinity maturation [GO:0002344]; B cell receptor signaling pathway [GO:0050853]; calcium-mediated signaling [GO:0019722]; cell maturation [GO:0048469]; cellular response to interleukin-7 [GO:0098761]; cellular response to molecule of fungal origin [GO:0071226]; cellular response to reactive oxygen species [GO:0034614]; Fc-epsilon receptor signaling pathway [GO:0038095]; G protein-coupled receptor signaling pathway [GO:0007186]; histamine secretion by mast cell [GO:0002553]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; mesoderm development [GO:0007498]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cytokine production [GO:0001818]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of type I hypersensitivity [GO:0001812]; positive regulation of type III hypersensitivity [GO:0001805]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of B cell apoptotic process [GO:0002902]; regulation of B cell cytokine production [GO:0002721],"ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein tyrosine kinase activity [GO:0004713]","SUBCELLULAR LOCATION: Cytoplasm. Cell membrane; Peripheral membrane protein. Nucleus. Note=In steady state, BTK is predominantly cytosolic. Following B-cell receptor (BCR) engagement by antigen, translocates to the plasma membrane through its PH domain. Plasma membrane localization is a critical step in the activation of BTK. A fraction of BTK also shuttles between the nucleus and the cytoplasm, and nuclear export is mediated by the nuclear export receptor CRM1.","SUBUNIT: Binds GTF2I through the PH domain. Interacts with SH3BP5 via the SH3 domain. Interacts with IBTK via its PH domain. Interacts with ARID3A, CAV1, FASLG, PIN1, TLR8 and TLR9. {ECO:0000269|PubMed:10196129, ECO:0000269|PubMed:10339589, ECO:0000269|PubMed:11577348, ECO:0000269|PubMed:11751885, ECO:0000269|PubMed:16644721, ECO:0000269|PubMed:16738337, ECO:0000269|PubMed:17932028, ECO:0000269|PubMed:19807924, ECO:0000269|PubMed:20052711, ECO:0000269|PubMed:21280133, ECO:0000269|PubMed:9218782, ECO:0000269|PubMed:9571151, ECO:0000269|Ref.46, ECO:0000269|Ref.47}.",X,101349447,101390796,q22.1,0.99996,0.103,1.3351,4.0394,28.976,0.2309061323005004,ENST00000308731,0.9468686868686869,0.18730317420644838,1980,,,,,,,0.7193168013977203,6.845490050944375,Cells - EBV-transformed lymphocytes,tissue-specific,0.8756802109644691,0.4412237073472942,FALSE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:11335,SSX1,SSX family member 1,Approved,,CT5.1,Xp11.23,gene with protein product,protein-coding gene,ENSG00000126752,6756,ENSG00000126752,Q16384,,,X,312820,TRUE,,,,"?Sarcoma, synovial",300813,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PMT -CS,FALSE,,PMT,FUNCTION: Could act as a modulator of transcription.,"",DNA-binding transcription factor activity [GO:0003700]; nucleic acid binding [GO:0003676],"","",X,48255317,48267444,p11.23,3.6857e-45,1.996,-0.56674,-4.3737,6.921,0.2929062609839848,ENST00000376919,0.19717813051146385,0.017670582354411397,567,7,"SSX4 (79, 79, chrX); SSX4B (79, 79, chrX); SSX7 (78, 78, chrX); SSX5 (76, 62, chrX); SSX2 (64, 54, chrX); SSX2B (64, 54, chrX); SSX3 (63, 59, chrX)",TRUE,,,,0.9747251903623706,4.045635177499736,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,PMT
HGNC:11336,SSX2,SSX family member 2,Approved,SSX,"HOM-MEL-40, HD21, MGC3884, MGC15364, MGC119055, CT5.2a",Xp11.22,gene with protein product,protein-coding gene,ENSG00000241476,6757,ENSG00000241476,Q16385,,,X,300192,TRUE,,,,"?Sarcoma, synovial",300813,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PMT -CS,FALSE,,PMT,FUNCTION: Could act as a modulator of transcription.,"regulation of transcription, DNA-templated [GO:0006355]",nucleic acid binding [GO:0003676],SUBCELLULAR LOCATION: Nucleus.,SUBUNIT: Interacts via its N-terminal region with RAB3IP and SSX2IP. {ECO:0000269|PubMed:12007189}.,X,52696896,52707189,p11.22,,,,,,0.4390735146022155,ENST00000337502,0.09400352733686067,0.10202449387653087,567,7,"SSX2B (100, 100, chrX); SSX3 (64, 70, chrX); SSX7 (61, 72, chrX); SSX5 (61, 59, chrX); SSX4 (56, 66, chrX); SSX4B (56, 66, chrX); SSX1 (54, 64, chrX)",TRUE,1,"SSX2B (100, 100, chrX)",TRUE,0.9719552995302632,0.18572068305469816,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,PMT
HGNC:11337,SSX3,SSX family member 3,Approved,,CT5.3,Xp11.23,gene with protein product,protein-coding gene,ENSG00000165584,10214,ENSG00000165584,Q99909,,,X,300325,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Could act as a modulator of transcription.,"regulation of transcription, DNA-templated [GO:0006355]",nucleic acid binding [GO:0003676],"",SUBUNIT: Interacts with SSX2IP. {ECO:0000269|PubMed:12007189}.,X,48346427,48356707,p11.23,0.009026,1.278,-1.5913,-0.48413,7.1296,0.3522112928276202,ENST00000298396,0.16455026455026456,0.13256685828542863,567,7,"SSX2 (70, 64, chrX); SSX2B (70, 64, chrX); SSX5 (67, 59, chrX); SSX7 (66, 71, chrX); SSX4 (62, 67, chrX); SSX4B (62, 67, chrX); SSX1 (59, 63, chrX)",TRUE,,,,0.9763155669073269,4.301229123067721,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:11338,SSX4,SSX family member 4,Approved,,CT5.4,Xp11.23,gene with protein product,protein-coding gene,ENSG00000268009,6759,ENSG00000268009,O60224,MGI:2446771,,X,300326,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Could act as a modulator of transcription.,"regulation of transcription, DNA-templated [GO:0006355]",nucleic acid binding [GO:0003676],"","",X,48383516,48393347,p11.23,0.5203,1.299,0.68438,-0.41657,2.1198,0.34801264309461033,ENST00000595689,0.18024691358024691,0.11882029492626843,567,7,"SSX4B (100, 100, chrX); SSX7 (81, 81, chrX); SSX1 (79, 79, chrX); SSX5 (78, 64, chrX); SSX3 (67, 62, chrX); SSX2 (66, 56, chrX); SSX2B (66, 56, chrX)",TRUE,1,"SSX4B (100, 100, chrX)",TRUE,0.9767441860465116,0.03191416257719825,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:11339,SSX5,SSX family member 5,Approved,,,Xp11.23,gene with protein product,protein-coding gene,ENSG00000165583,6758,ENSG00000165583,O60225,,,X,300327,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Could act as a modulator of transcription.,"regulation of transcription, DNA-templated [GO:0006355]",nucleic acid binding [GO:0003676],"","",X,48186220,48196763,p11.23,1.0514e-8,1.851,-3.1955,-1.3052,8.8362,0.3225820706233788,ENST00000311798,0.1544927536231884,0.08277930517370657,690,7,"SSX7 (68, 82, chrX); SSX4 (64, 78, chrX); SSX4B (64, 78, chrX); SSX1 (62, 76, chrX); SSX3 (59, 67, chrX); SSX2 (59, 61, chrX); SSX2B (59, 61, chrX)",TRUE,,,,0.9739037895524829,1.2340597993615392,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:11355,STAG2,stromal antigen 2,Approved,,"SA-2, SCC3B, SA2",Xq25,gene with protein product,protein-coding gene,ENSG00000101972,10735,ENSG00000101972,Q8N3U4,MGI:1098583,RGD:1562042,X,300826,TRUE,"Holoprosencephaly 13, X-linked // Mullegama-Klein-Martinez syndrome",301043 // 301022,"X-linked dominant, X-linked recessive // X-linked",,,,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Component of cohesin complex, a complex required for the cohesion of sister chromatids after DNA replication. The cohesin complex apparently forms a large proteinaceous ring within which sister chromatids can be trapped. At anaphase, the complex is cleaved and dissociates from chromatin, allowing sister chromatids to segregate. The cohesin complex may also play a role in spindle pole assembly during mitosis. {ECO:0000269|PubMed:12034751}.",cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; mitotic spindle assembly [GO:0090307]; sister chromatid cohesion [GO:0007062],chromatin binding [GO:0003682],"SUBCELLULAR LOCATION: Nucleus. Chromosome. Chromosome, centromere. Note=Associates with chromatin. Before prophase it is scattered along chromosome arms. During prophase, most of cohesin complexes dissociate from chromatin probably because of phosphorylation by PLK1, except at centromeres, where cohesin complexes remain. At anaphase, the RAD21 subunit of cohesin is cleaved, leading to the dissociation of the complex from chromosomes, allowing chromosome separation. In germ cells, cohesin complex dissociates from chromatin at prophase I, and may be replaced by a meiosis-specific cohesin complex.","SUBUNIT: Interacts directly with RAD21 in cohesin complex. Cohesin complexes are composed of a heterodimer between a SMC1 protein (SMC1A or SMC1B) and SMC3, which are attached via their hinge domain, and RAD21 which link them at their heads, and one STAG protein (STAG1, STAG2 or STAG3). In cohesin complexes, STAG2 is mutually exclusive with STAG1 and STAG3. {ECO:0000269|PubMed:11076961}.",X,123960212,124422664,q25,1,0.09,-0.36861,4.938,52.845,0.7092846057150081,ENST00000371145,0.975177304964539,0.7313671582104474,3807,1,"STAG1 (71, 71, chr3)",TRUE,,,,0.22016116184604032,5.66862123408726,Cells - EBV-transformed lymphocytes,broadly expressed,3.509429824469578,4.771151370453609,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:11402,SRPK3,SRSF protein kinase 3,Approved,STK23,MSSK1,Xq28,gene with protein product,protein-coding gene,ENSG00000184343,26576,ENSG00000184343,Q9UPE1,MGI:1891338,RGD:727856,X,301002,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Serine/arginine-rich protein-specific kinase which specifically phosphorylates its substrates at serine residues located in regions rich in arginine/serine dipeptides, known as RS domains. Phosphorylates the SR splicing factor SRSF1 and the lamin-B receptor (LBR) in vitro. Required for normal muscle development (By similarity). {ECO:0000250}.",cell differentiation [GO:0030154]; intracellular signal transduction [GO:0035556]; muscle tissue development [GO:0060537]; regulation of gene expression [GO:0010468]; regulation of mRNA processing [GO:0050684]; skeletal muscle tissue development [GO:0007519]; spliceosomal complex assembly [GO:0000245],ATP binding [GO:0005524]; MAP kinase activity [GO:0004707],"","",X,153776412,153785732,q28,0.29235,0.495,-3.2284,0.030709,21.234,0.35922766052986077,ENST00000370101,0.6241197183098591,0.1669582604348913,1704,,,,,,,0.6070463944705231,5.498831658786639,Muscle - Skeletal,tissue-specific,1.7700763230568166,4.345087619242289,FALSE,discordant,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:11411,CDKL5,cyclin dependent kinase like 5,Approved,STK9,"EIEE2, CFAP247",Xp22.13,gene with protein product,protein-coding gene,ENSG00000008086,6792,ENSG00000008086,O76039,MGI:1278336,RGD:2324133,X,300203,TRUE,Developmental and epileptic encephalopathy 2,300672,X-linked dominant,,,,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,confirmed +CS,FALSE,TRUE,confirmed,"FUNCTION: Mediates phosphorylation of MECP2 (PubMed:15917271, PubMed:16935860). May regulate ciliogenesis (PubMed:29420175). {ECO:0000269|PubMed:15917271, ECO:0000269|PubMed:16935860, ECO:0000269|PubMed:29420175}.",neuron migration [GO:0001764]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of GTPase activity [GO:0043547]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cilium assembly [GO:1902017]; regulation of dendrite development [GO:0050773],ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; Rac GTPase binding [GO:0048365],"SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:16935860}. Cytoplasm, cytoskeleton, cilium basal body {ECO:0000269|PubMed:29420175}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000269|PubMed:29420175}.",SUBUNIT: Interacts with MECP2. {ECO:0000269|PubMed:15917271}.,X,18425583,18653629,p22.13,0.99932,0.226,-0.49763,2.7357,34.287,0.7133141907208704,ENST00000623535,0.9521331945889698,0.5320419895026244,2883,,,,,,,0.3861516795098512,3.231275718833947,Artery - Aorta,broadly expressed,2.460632490214182,2.405423335656092,FALSE,high confidence non-escapee,no_difference_Pre_Post,Post1_higher_vs_Pre,no difference_Pre_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:11425,STS,steroid sulfatase,Approved,ARSC1,ARSC,Xp22.31,gene with protein product,protein-coding gene,ENSG00000101846,412,ENSG00000101846,P08842,,RGD:3783,X,300747,TRUE,"Ichthyosis, X-linked",308100,X-linked recessive,,,,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,TRUE,confirmed,"FUNCTION: Catalyzes the conversion of sulfated steroid precursors, such as dehydroepiandrosterone sulfate (DHEA-S) and estrone sulfate to the free steroid. {ECO:0000269|PubMed:10844566, ECO:0000269|PubMed:23466819, ECO:0000269|PubMed:9252398}.",epidermis development [GO:0008544]; female pregnancy [GO:0007565]; glycosphingolipid metabolic process [GO:0006687]; steroid catabolic process [GO:0006706],arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; steryl-sulfatase activity [GO:0004773]; sulfuric ester hydrolase activity [GO:0008484],"SUBCELLULAR LOCATION: Cytoplasmic vesicle, secretory vesicle, microneme membrane {ECO:0000269|PubMed:2668275}; Multi-pass membrane protein. Endoplasmic reticulum membrane {ECO:0000269|PubMed:2668275}; Multi-pass membrane protein.",SUBUNIT: Homodimer. {ECO:0000269|PubMed:12657638}.,X,7147237,7804358,p22.31,0.80886,0.442,-0.8272,1.0869,14.229,0.6858000831887675,ENST00000674429,0.5462291306850893,0.03741564608847788,1737,,,,,,,0.40971577602770975,4.764701773877492,Artery - Tibial,broadly expressed,2.5225504605063205,2.6542797140331578,FALSE,high confidence escapee,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:11479,SUV39H1,suppressor of variegation 3-9 homolog 1,Approved,SUV39H,KMT1A,Xp11.23,gene with protein product,protein-coding gene,ENSG00000101945,6839,ENSG00000101945,O43463,MGI:1099440,RGD:1565692,X,300254,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Histone methyltransferase that specifically trimethylates 'Lys-9' of histone H3 using monomethylated H3 'Lys-9' as substrate. Also weakly methylates histone H1 (in vitro). H3 'Lys-9' trimethylation represents a specific tag for epigenetic transcriptional repression by recruiting HP1 (CBX1, CBX3 and/or CBX5) proteins to methylated histones. Mainly functions in heterochromatin regions, thereby playing a central role in the establishment of constitutive heterochromatin at pericentric and telomere regions. H3 'Lys-9' trimethylation is also required to direct DNA methylation at pericentric repeats. SUV39H1 is targeted to histone H3 via its interaction with RB1 and is involved in many processes, such as repression of MYOD1-stimulated differentiation, regulation of the control switch for exiting the cell cycle and entering differentiation, repression by the PML-RARA fusion protein, BMP-induced repression, repression of switch recombination to IgA and regulation of telomere length. Component of the eNoSC (energy-dependent nucleolar silencing) complex, a complex that mediates silencing of rDNA in response to intracellular energy status and acts by recruiting histone-modifying enzymes. The eNoSC complex is able to sense the energy status of cell: upon glucose starvation, elevation of NAD(+)/NADP(+) ratio activates SIRT1, leading to histone H3 deacetylation followed by dimethylation of H3 at 'Lys-9' (H3K9me2) by SUV39H1 and the formation of silent chromatin in the rDNA locus. Recruited by the large PER complex to the E-box elements of the circadian target genes such as PER2 itself or PER1, contributes to the conversion of local chromatin to a heterochromatin-like repressive state through H3 'Lys-9' trimethylation. {ECO:0000269|PubMed:14765126, ECO:0000269|PubMed:16449642, ECO:0000269|PubMed:16818776, ECO:0000269|PubMed:16858404, ECO:0000269|PubMed:18004385, ECO:0000269|PubMed:18485871}.","cell cycle [GO:0007049]; cell differentiation [GO:0030154]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; chromatin organization [GO:0006325]; histone H3-K9 dimethylation [GO:0036123]; histone H3-K9 trimethylation [GO:0036124]; histone lysine methylation [GO:0034968]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; rDNA heterochromatin assembly [GO:0000183]; rhythmic process [GO:0048511]; rRNA processing [GO:0006364]; viral process [GO:0016032]",chromatin binding [GO:0003682]; histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; protein N-terminus binding [GO:0047485]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270],"SUBCELLULAR LOCATION: Nucleus. Nucleus lamina. Nucleus, nucleoplasm. Chromosome, centromere. Note=Associates with centromeric constitutive heterochromatin.","SUBUNIT: Interacts with H3 and H4 histones. Interacts with GFI1B, DNMT3B, CBX1, CBX4, CCAR2, MBD1, RUNX1, RUNX3, MYOD1, SMAD5 and RB1. Interacts with SBF1 through the SET domain. Interacts with HDAC1 and HDAC2 through the N-terminus and associates with the core histone deacetylase complex composed of HDAC1, HDAC2, RBBP4 and RBBP7. Component of the eNoSC complex, composed of SIRT1, SUV39H1 and RRP8. Interacts (via SET domain) with MECOM; enhances MECOM transcriptional repression activity. Interacts with LMNA; the interaction increases stability of SUV39H1. The large PER complex involved in the histone methylation is composed of at least PER2, CBX3, TRIM28, SUV39H1 and/or SUV39H2; CBX3 mediates the formation of the complex. {ECO:0000269|PubMed:10202156, ECO:0000269|PubMed:10848615, ECO:0000269|PubMed:11242053, ECO:0000269|PubMed:11484059, ECO:0000269|PubMed:12101246, ECO:0000269|PubMed:12711603, ECO:0000269|PubMed:12789259, ECO:0000269|PubMed:12917624, ECO:0000269|PubMed:15107829, ECO:0000269|PubMed:16103223, ECO:0000269|PubMed:16652147, ECO:0000269|PubMed:16688220, ECO:0000269|PubMed:16858404, ECO:0000269|PubMed:18485871, ECO:0000269|PubMed:19218236, ECO:0000269|PubMed:23695662}.; SUBUNIT: (Microbial infection) Interacts with HTLV-1 Tax protein, leading to abrogate Tax transactivation of HTLV-1 LTR. {ECO:0000269|PubMed:16409643}.",X,48695554,48709016,p11.23,0.98957,0.218,0.6424,3.4884,13.725,0.5887040238268374,ENST00000376687,0.7840193704600484,0.17373156710822293,1239,1,"SUV39H2 (57, 59, chr10)",TRUE,,,,0.39858184483728326,4.454728644870777,Cells - EBV-transformed lymphocytes,broadly expressed,2.393185526562148,3.4154652850974263,FALSE,low confidence non-escapee,no_difference_Pre_Post,Pre_higher_vs_Post1,no difference_Pre_Post2,Post2_higher_vs_Post1,no disorder
HGNC:11486,VAMP7,vesicle associated membrane protein 7,Approved,SYBL1,"VAMP-7, TI-VAMP",Xq28 and Yq12,gene with protein product,protein-coding gene,ENSG00000124333,6845,ENSG00000124333,P51809,MGI:1096399,RGD:621558,X,300053,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,TRUE,,no disorder,"FUNCTION: Involved in the targeting and/or fusion of transport vesicles to their target membrane during transport of proteins from the early endosome to the lysosome. Required for heterotypic fusion of late endosomes with lysosomes and homotypic lysosomal fusion. Required for calcium regulated lysosomal exocytosis. Involved in the export of chylomicrons from the endoplasmic reticulum to the cis Golgi. Required for exocytosis of mediators during eosinophil and neutrophil degranulation, and target cell killing by natural killer cells. Required for focal exocytosis of late endocytic vesicles during phagosome formation. {ECO:0000269|PubMed:10888671, ECO:0000269|PubMed:16677249, ECO:0000269|PubMed:18042464}.","calcium-ion regulated exocytosis [GO:0017156]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosome to lysosome transport [GO:0008333]; eosinophil degranulation [GO:0043308]; exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; membrane organization [GO:0061024]; natural killer cell degranulation [GO:0043320]; neutrophil degranulation [GO:0043312]; phagocytosis, engulfment [GO:0006911]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of histamine secretion by mast cell [GO:1903595]; post-Golgi vesicle-mediated transport [GO:0006892]; regulation of protein targeting to vacuolar membrane [GO:1900483]; SNARE complex assembly [GO:0035493]; triglyceride transport [GO:0034197]; vesicle fusion [GO:0006906]; vesicle fusion with Golgi apparatus [GO:0048280]; vesicle-mediated transport [GO:0016192]; vesicle transport along microtubule [GO:0047496]",SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905],"SUBCELLULAR LOCATION: Cytoplasmic vesicle, secretory vesicle membrane {ECO:0000250}; Single-pass type IV membrane protein {ECO:0000250}. Golgi apparatus, trans-Golgi network membrane {ECO:0000250}; Single-pass type IV membrane protein {ECO:0000250}. Late endosome membrane {ECO:0000250}; Single-pass type IV membrane protein {ECO:0000250}. Lysosome membrane {ECO:0000269|PubMed:17897319}; Single-pass type IV membrane protein {ECO:0000269|PubMed:17897319}. Endoplasmic reticulum membrane {ECO:0000250}; Single-pass type IV membrane protein {ECO:0000250}. Cytoplasmic vesicle, phagosome membrane {ECO:0000250}; Single-pass type IV membrane protein {ECO:0000250}. Cell junction, synapse, synaptosome {ECO:0000250}. Note=In immature neurons expression is localized in vesicular structures in axons and dendrites while in mature neurons it is localized to the somatodendritic region. Colocalizes with LAMP1 in kidney cells. Localization to the endoplasmic reticulum membrane was observed in the intestine but not in liver or kidney (By similarity). {ECO:0000250}.","SUBUNIT: Component of the SNARE complex composed of STX4, SNAP23 and VAMP7 that binds SYT7 during lysosomal exocytosis. Component of the SNARE complex composed of STX7, STX8, VAMP7 and VTI1B that is required for heterotypic fusion of late endosomes with lysosomes. May interact with STX17 (By similarity). Interacts with PICALM (PubMed:23741335). Interacts with RAB21 (PubMed:25648148). {ECO:0000250, ECO:0000269|PubMed:23741335, ECO:0000269|PubMed:25648148}.",X,155881345,155943769,q28,0.013777,0.858,0.15789,0.65631,12.254,0.4591273485137687,ENST00000286448,0.94947209653092,0.11849537615596101,663,,,,,,,0.16974040821284175,5.809620234841894,Artery - Tibial,broadly expressed,4.413702388782177,4.3171484723744245,FALSE,high confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:11494,SYN1,synapsin I,Approved,MRX50,,Xp11.3-p11.23,gene with protein product,protein-coding gene,ENSG00000008056,6853,ENSG00000008056,P17600,MGI:98460,RGD:3797,X,313440,TRUE,"Epilepsy, X-linked, with variable learning disabilities and behavior disorders",300491,"X-linked dominant, X-linked recessive",,,,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,TRUE,confirmed,"FUNCTION: Neuronal phosphoprotein that coats synaptic vesicles, binds to the cytoskeleton, and is believed to function in the regulation of neurotransmitter release. The complex formed with NOS1 and CAPON proteins is necessary for specific nitric-oxid functions at a presynaptic level.",chemical synaptic transmission [GO:0007268]; neuron development [GO:0048666]; neurotransmitter secretion [GO:0007269]; regulation of neurotransmitter secretion [GO:0046928]; regulation of synaptic vesicle exocytosis [GO:2000300]; synapse organization [GO:0050808]; synaptic vesicle clustering [GO:0097091],actin binding [GO:0003779]; ATP binding [GO:0005524]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; transporter activity [GO:0005215],"SUBCELLULAR LOCATION: Cell junction, synapse. Golgi apparatus {ECO:0000250}.",SUBUNIT: Homodimer. Interacts with CAPON. Forms a ternary complex with NOS1. Isoform Ib interacts with PRNP (By similarity). {ECO:0000250}.,X,47571901,47619857,p11.23,0.99216,0.251,1.4353,2.9674,18.902,0.4901994868550053,ENST00000295987,0.8333333333333334,0.3161209697575606,2118,,,,,,,0.790640355333488,7.860121683916929,Cerebellar_tissues,tissue-specific,6.527175142349008,7.860121683916929,TRUE,low confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:11506,SYP,synaptophysin,Approved,,MRX96,Xp11.23,gene with protein product,protein-coding gene,ENSG00000102003,6855,ENSG00000102003,P08247,MGI:98467,RGD:3802,X,313475,TRUE,"Mental retardation, X-linked 96",300802,X-linked recessive,,,,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,FUNCTION: Possibly involved in structural functions as organizing other membrane components or in targeting the vesicles to the plasma membrane. Involved in the regulation of short-term and long-term synaptic plasticity (By similarity). {ECO:0000250}.,cellular response to organic substance [GO:0071310]; endocytosis [GO:0006897]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of opioid receptor signaling pathway [GO:2000474]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle membrane organization [GO:0048499],cholesterol binding [GO:0015485]; identical protein binding [GO:0042802]; protein self-association [GO:0043621]; SH2 domain binding [GO:0042169]; syntaxin-1 binding [GO:0017075],"SUBCELLULAR LOCATION: Cytoplasmic vesicle, secretory vesicle, synaptic vesicle membrane {ECO:0000269|PubMed:18662323}; Multi-pass membrane protein {ECO:0000255}. Cell junction, synapse, synaptosome {ECO:0000269|PubMed:18662323}.","SUBUNIT: Homohexamer or homotetramer. Interacts with SRCIN1 (PubMed:18662323). Interacts with VAMP2; the interaction is inhibit by interaction of VAPM2 with SEPT8 (By similarity). {ECO:0000250|UniProtKB:P07825, ECO:0000269|PubMed:18662323}.",X,49187815,49200199,p11.23,0.91549,0.385,-1.0863,1.3345,12.334,0.4469757047076635,ENST00000263233,0.8725053078556263,0.1876280929767558,942,1,"SYNPR (55, 61, chr3)",TRUE,,,,0.7302822151321717,8.509818541791944,Cerebellar_tissues,tissue-specific,6.793271654498083,8.509818541791944,TRUE,high confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:11535,TAF1,TATA-box binding protein associated factor 1,Approved,"TAF2A, BA2R, CCG1, CCGS, DYT3","NSCL2, TAFII250, KAT4, DYT3/TAF1",Xq13.1,gene with protein product,protein-coding gene,ENSG00000147133,6872,ENSG00000147133,P21675,MGI:1336878,RGD:1562050,X,313650,TRUE,"Dystonia-Parkinsonism, X-linked // Mental retardation, X-linked, syndromic 33",314250 // 300966,X-linked recessive // X-linked recessive,,,,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Largest component and core scaffold of the TFIID basal transcription factor complex (PubMed:25412659, PubMed:27007846). Contains novel N- and C-terminal Ser/Thr kinase domains which can autophosphorylate or transphosphorylate other transcription factors. Phosphorylates TP53 on 'Thr-55' which leads to MDM2-mediated degradation of TP53. Phosphorylates GTF2A1 and GTF2F1 on Ser residues. Possesses DNA-binding activity (PubMed:25412659). Essential for progression of the G1 phase of the cell cycle (PubMed:11278496, PubMed:15053879, PubMed:2038334, PubMed:8450888, PubMed:8625415, PubMed:9660973, PubMed:9858607). Exhibits histone acetyltransferase activity towards histones H3 and H4 (PubMed:15870300). {ECO:0000269|PubMed:11278496, ECO:0000269|PubMed:15053879, ECO:0000269|PubMed:15870300, ECO:0000269|PubMed:2038334, ECO:0000269|PubMed:25412659, ECO:0000269|PubMed:27007846, ECO:0000269|PubMed:8450888, ECO:0000269|PubMed:8625415, ECO:0000269|PubMed:9660973, ECO:0000269|PubMed:9858607}.",cell cycle [GO:0007049]; cellular response to ATP [GO:0071318]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; midbrain development [GO:0030901]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of gene expression [GO:0010629]; negative regulation of protein autoubiquitination [GO:1905524]; negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1903026]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of androgen receptor activity [GO:2000825]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein polyubiquitination [GO:0000209]; protein stabilization [GO:0050821]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of signal transduction by p53 class mediator [GO:1901796]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription factor catabolic process [GO:0036369]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription initiation from RNA polymerase I promoter [GO:0006361]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032],ATP binding [GO:0005524]; DNA-binding transcription factor inhibitor activity [GO:0140416]; histone acetyltransferase activity [GO:0004402]; kinase activity [GO:0016301]; lysine-acetylated histone binding [GO:0070577]; nuclear hormone receptor binding [GO:0035257]; p53 binding [GO:0002039]; protein heterodimerization activity [GO:0046982]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase I general transcription initiation factor activity [GO:0001181]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]; ubiquitin conjugating enzyme activity [GO:0061631],"SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:2038334, ECO:0000269|PubMed:27007846}.","SUBUNIT: TAF1 is the largest component of transcription factor TFIID that is composed of TBP and a variety of TBP-associated factors (PubMed:7680771). TAF1, when part of the TFIID complex, interacts with C-terminus of TP53 (PubMed:15053879). Part of a TFIID-containing RNA polymerase II pre-initiation complex that is composed of TBP and at least GTF2A1, GTF2A2, GTF2E1, GTF2E2, GTF2F1, GTF2H2, GTF2H3, GTF2H4, GTF2H5, GTF2B, TCEA1, ERCC2, ERCC3, TAF1, TAF2, TAF3, TAF4, TAF5, TAF6, TAF7, TAF8, TAF9, TAF10, TAF11, TAF12 and TAF13 (PubMed:27007846). Interacts with TAF7; the interaction is direct (PubMed:25412659). Component of some MLL1/MLL complex, at least composed of the core components KMT2A/MLL1, ASH2L, HCFC1/HCF1, WDR5 and RBBP5, as well as the facultative components BAP18, CHD8, E2F6, HSP70, INO80C, KANSL1, LAS1L, MAX, MCRS1, MGA, KAT8/MOF, PELP1, PHF20, PRP31, RING2, RUVB1/TIP49A, RUVB2/TIP49B, SENP3, TAF1, TAF4, TAF6, TAF7, TAF9 and TEX10. RB1 interacts with the N-terminal domain of TAF1. Interacts with ASF1A and ASF1B (PubMed:10759893, PubMed:12093919, PubMed:12842904). Interacts (via bromo domains) with acetylated lysine residues on the N-terminus of histone H1.4, H2A, H2B, H3 and H4 (in vitro) (PubMed:22464331). {ECO:0000269|PubMed:10759893, ECO:0000269|PubMed:12093919, ECO:0000269|PubMed:12842904, ECO:0000269|PubMed:15053879, ECO:0000269|PubMed:15960975, ECO:0000269|PubMed:22464331, ECO:0000269|PubMed:25412659, ECO:0000269|PubMed:27007846, ECO:0000269|PubMed:7680771, ECO:0000269|PubMed:9858607}.; SUBUNIT: (Microbial infection) Interacts with SV40 Large T antigen. {ECO:0000269|PubMed:8647434}.; SUBUNIT: (Microbial infection) Interacts with herpes simplex virus 1 ICP4. {ECO:0000269|PubMed:8649420}.",X,71366264,71532374,q13.1,1,0.043,-1.0712,5.486,68.906,0.6127119039835613,ENST00000423759,0.9491817858413376,0.14551362159460135,5622,1,"TAF1L (90, 92, chr9)",TRUE,1,"TAF1L (90, 92, chr9)",TRUE,0.19484146354490373,4.779028534399957,Uterus,broadly expressed,2.656203454276715,4.186944200553793,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:11548,TAF7L,TATA-box binding protein associated factor 7 like,Approved,TAF2Q,CT40,Xq22.1,gene with protein product,protein-coding gene,ENSG00000102387,54457,ENSG00000102387,Q5H9L4,MGI:1921719,RGD:1564898,X,300314,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Probably functions as a spermatogenesis-specific component of the DNA-binding general transcription factor complex TFIID, a multimeric protein complex that plays a central role in mediating promoter responses to various activators and repressors. May play a role in spermatogenesis (By similarity). {ECO:0000250}.",cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; spermatogenesis [GO:0007283],histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976],"SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Cytoplasm {ECO:0000250}. Note=Cytoplasmic in spermatogonia and early spermatocytes (preleptotene, leptotene, and zygotene); translocates into the nuclei of pachytene spermatocytes and round spermatids. {ECO:0000250}.",SUBUNIT: TFIID is composed of TATA binding protein (TBP) and a number of TBP-associated factors (TAFs). TAF7L may replace TAF7 in a spermatogenesis-specific form of TFIID. Interacts with TBP; the interaction occurs in a sub-population of cells (pachytene and haploid round spermatids) and is developmentally regulated through differential intracellular localization of the two proteins. Interacts with TAF1 (By similarity). {ECO:0000250}.,X,101268253,101293057,q22.1,0.98636,0.273,0.76027,0.14419,17.407,0.6921549698548296,ENST00000356784,0.6814323607427055,0.07238190452386903,1131,,,,,,,0.9131587205862135,6.026485818534338,Testis,tissue-specific,0.7515374179903763,0.061278926357395416,FALSE,high confidence escapee,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,no difference_Post1_Post2,no disorder
HGNC:11577,TAZ,tafazzin,Approved,"CMD3A, EFE2, EFE","BTHS, XAP-2, G4.5, TAZ1",Xq28,gene with protein product,protein-coding gene,ENSG00000102125,6901,ENSG00000102125,Q16635,MGI:109626,RGD:1588532,X,300394,TRUE,Barth syndrome,302060,X-linked recessive,,,,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Some isoforms may be involved in cardiolipin (CL) metabolism. {ECO:0000269|PubMed:12930833, ECO:0000269|PubMed:19164547}.",cardiac muscle contraction [GO:0060048]; cardiac muscle tissue development [GO:0048738]; cardiolipin acyl-chain remodeling [GO:0035965]; cardiolipin biosynthetic process [GO:0032049]; cristae formation [GO:0042407]; heart development [GO:0007507]; hemopoiesis [GO:0030097]; inner mitochondrial membrane organization [GO:0007007]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; mitochondrial respiratory chain complex I assembly [GO:0032981]; muscle contraction [GO:0006936]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of cardiolipin metabolic process [GO:1900210]; skeletal muscle tissue development [GO:0007519],1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; O-acyltransferase activity [GO:0008374],SUBCELLULAR LOCATION: [Isoform 1]: Membrane; Single-pass membrane protein.; SUBCELLULAR LOCATION: [Isoform 2]: Cytoplasm {ECO:0000305}.; SUBCELLULAR LOCATION: [Isoform 3]: Membrane; Single-pass membrane protein.; SUBCELLULAR LOCATION: [Isoform 4]: Membrane; Single-pass membrane protein.; SUBCELLULAR LOCATION: [Isoform 5]: Membrane; Single-pass membrane protein.; SUBCELLULAR LOCATION: [Isoform 6]: Cytoplasm {ECO:0000305}.; SUBCELLULAR LOCATION: [Isoform 7]: Membrane; Single-pass membrane protein.; SUBCELLULAR LOCATION: [Isoform 8]: Cytoplasm {ECO:0000305}.; SUBCELLULAR LOCATION: [Isoform 9]: Cytoplasm {ECO:0000305}.,"",X,154411524,154421726,q28,0.72591,0.485,0.9293,2.2089,12.979,0.5039741090891426,ENST00000601016,0.7683731513083049,0.12199450137465634,879,,,,,,,0.18367107458159462,6.4857922850905085,Spleen,broadly expressed,4.280555509538747,5.9593064897596575,FALSE,low confidence non-escapee,no_difference_Pre_Post,Pre_higher_vs_Post1,no difference_Pre_Post2,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:11583,SERPINA7,serpin family A member 7,Approved,TBG,,Xq22.3,gene with protein product,protein-coding gene,ENSG00000123561,6906,ENSG00000123561,P05543,MGI:3041197,RGD:619833,X,314200,TRUE,,,,[Thyroxine-binding globulin QTL],300932,X-linked,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PMT +CS,FALSE,,PMT,FUNCTION: Major thyroid hormone transport protein in serum.,negative regulation of endopeptidase activity [GO:0010951]; thyroid hormone transport [GO:0070327],serine-type endopeptidase inhibitor activity [GO:0004867],SUBCELLULAR LOCATION: Secreted.,"",X,106032435,106038727,q22.3,0.0026137,1.266,-1.9334,-0.65563,8.282,0.08658433458495798,ENST00000372563,0.4716346153846154,0.13891527118220445,1248,,,,,,,0.9742377494827835,5.709811698653873,Liver,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,PMT
HGNC:11585,TBL1X,transducin beta like 1 X-linked,Approved,TBL1,EBI,Xp22.31-p22.2,gene with protein product,protein-coding gene,ENSG00000101849,6907,ENSG00000101849,O60907,MGI:1336172,RGD:1563868,X,300196,TRUE,"Hypothyroidism, congenital, nongoitrous, 8",301033,X-linked,,,,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,TRUE,confirmed,"FUNCTION: F-box-like protein involved in the recruitment of the ubiquitin/19S proteasome complex to nuclear receptor-regulated transcription units (PubMed:14980219). Plays an essential role in transcription activation mediated by nuclear receptors. Probably acts as integral component of corepressor complexes that mediates the recruitment of the 19S proteasome complex, leading to the subsequent proteasomal degradation of transcription repressor complexes, thereby allowing cofactor exchange (PubMed:21240272). {ECO:0000269|PubMed:14980219, ECO:0000269|PubMed:21240272}.","histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; proteolysis [GO:0006508]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory perception of sound [GO:0007605]",beta-catenin binding [GO:0008013]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976],SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Note=Colocalized with MECP2 to the heterochromatin foci. {ECO:0000250|UniProtKB:Q9QXE7}.,"SUBUNIT: Homotetramer; dimer of dimers (PubMed:21240272). Component of the N-Cor repressor complex, at least composed of NCOR1, NCOR2, HDAC3, TBL1X, TBL1R, CORO2A and GPS2 (PubMed:10809664, PubMed:21240272). Interacts with GPS2 (when sumoylated); leading to protect GPS2 against degradation by the proteasome (PubMed:24943844). Component of a E3 ubiquitin ligase complex containing UBE2D1, SIAH1, CACYBP/SIP, SKP1, APC and TBL1X (PubMed:11389839). Probably part of other corepressor complexes, that do not contain NCOR1 and NCOR2. Interacts with histones H2B, H3a and H4. Interacts with MECP2; recruits TBL1X to the heterochromatin foci (By similarity). {ECO:0000250|UniProtKB:Q9QXE7, ECO:0000269|PubMed:10809664, ECO:0000269|PubMed:11389839, ECO:0000269|PubMed:21240272, ECO:0000269|PubMed:24943844}.",X,9463295,9741037,p22.31,0.97946,0.309,-0.33846,2.4787,25.112,0.7324587490727313,ENST00000645353,0.8313725490196079,0.22629342664333918,1734,2,"TBL1Y (83, 91, chrY); TBL1XR1 (79, 88, chr3)",TRUE,1,"TBL1Y (83, 91, chrY)",TRUE,0.3684053433773486,6.318486772847789,Uterus,broadly expressed,3.396144415243029,2.866881279632861,FALSE,variable escapee,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:11600,TBX22,T-box transcription factor 22,Approved,"CPX, CLPA",,Xq21.1,gene with protein product,protein-coding gene,ENSG00000122145,50945,ENSG00000122145,Q9Y458,MGI:2389465,RGD:1589764,X,300307,TRUE,Cleft palate with ankyloglossia,303400,X-linked,?Abruzzo-Erickson syndrome,302905,X-linked,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,TRUE,confirmed,FUNCTION: Probable transcriptional regulator involved in developmental processes. This is major determinant crucial to palatogenesis.,"cell fate specification [GO:0001708]; heart looping [GO:0001947]; multicellular organism development [GO:0007275]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]","DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]",SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00201}.,"",X,80014753,80031774,q21.1,0.97704,0.297,-0.26597,-0.12605,15.989,0.19897885158803089,ENST00000373296,0.7470889315419066,0.07980504873781555,1563,,,,,,,0.9509431763164418,5.307249998851366,Testis,tissue-specific,0,0,FALSE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:11616,TCEAL1,transcription elongation factor A like 1,Approved,,"p21, pp21, SIIR, P21, WEX9",Xq22.2,gene with protein product,protein-coding gene,ENSG00000172465,9338,ENSG00000172465,Q15170,MGI:2385317,RGD:1549724,X,300237,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: May be involved in transcriptional regulation. Modulates various viral and cellular promoters in a promoter context-dependent manner. For example, transcription from the FOS promoter is increased, while Rous sarcoma virus (RSV) long terminal repeat (LTR) promoter activity is repressed. Does not bind DNA directly.","",WW domain binding [GO:0050699],SUBCELLULAR LOCATION: Nucleus.,"",X,103628704,103630953,q22.2,0.58578,1.067,-0.032816,1.045,2.7349,0.49412308921550074,ENST00000372625,0.68375,0.2498125468632842,480,,,,,,,0.30582977385981086,8.321454632895463,Ovary,broadly expressed,5.1388267533785985,6.512034841033579,FALSE,low confidence non-escapee,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,no difference_Post1_Post2,no disorder
HGNC:11694,DYNLT3,dynein light chain Tctex-type 3,Approved,TCTE1L,TCTEX1L,Xp11.4,gene with protein product,protein-coding gene,ENSG00000165169,6990,ENSG00000165169,P51808,MGI:1914367,RGD:1549755,X,300302,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Acts as one of several non-catalytic accessory components of the cytoplasmic dynein 1 complex that are thought to be involved in linking dynein to cargos and to adapter proteins that regulate dynein function. Cytoplasmic dynein 1 acts as a motor for the intracellular retrograde motility of vesicles and organelles along microtubules. Probably binds BUB3 as part of transport cargo. Required for the efficient progression through mitosis (By similarity). {ECO:0000250}.,cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of mitotic cell cycle [GO:0045931]; regulation of mitotic cell cycle [GO:0007346],identical protein binding [GO:0042802]; motor activity [GO:0003774],"SUBCELLULAR LOCATION: Nucleus. Cytoplasm, cytoskeleton. Chromosome, centromere, kinetochore. Note=Colocalizes with BUB3 at kinetochores specifically during prometaphase.","SUBUNIT: Homodimer. The cytoplasmic dynein 1 complex consists of two catalytic heavy chains (HCs) and a number of non-catalytic subunits presented by intermediate chains (ICs), light intermediate chains (LICs) and light chains (LCs); the composition seems to vary in respect to the IC, LIC and LC composition. The heavy chain homodimer serves as a scaffold for the probable homodimeric assembly of the respective non-catalytic subunits. The ICs and LICs bind directly to the HC dimer and the LCs assemble on the IC dimer. DYNLT1 and DYNLT3 compete for association with dynein IC (DYNC1I1 or DYNC1I2). Self-associates. Interacts with DYNC1I1 and DYNC1I2 (By similarity). Interacts with BUB3. Interacts with SATB1 in nucleus to form complex with matrix attachment regions (MARs) of DNA. {ECO:0000250, ECO:0000269|PubMed:16079286, ECO:0000269|PubMed:17289665}.",X,37836757,37847571,p11.4,0.71894,0.715,-0.72515,0.11749,4.1834,0.5109250879313688,ENST00000378578,0.9230769230769231,0.13544113971507124,351,,,,,,,0.24307561753542878,5.994183698045687,Artery - Tibial,broadly expressed,4.820429178085619,4.951140146766206,FALSE,high confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:11733,TEX11,testis expressed 11,Approved,,"TSGA3, TGC1, ZIP4, MZIP4, Spo22",Xp11,gene with protein product,protein-coding gene,ENSG00000120498,56159,ENSG00000120498,Q8IYF3,MGI:1933237,RGD:1560239,X,300311,TRUE,"Spermatogenic failure, X-linked, 2",309120,X-linked recessive,,,,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,FUNCTION: Regulator of crossing-over during meiosis. Involved in initiation and/or maintenance of chromosome synapsis and formation of crossovers. {ECO:0000250|UniProtKB:Q14AT2}.,chiasma assembly [GO:0051026]; fertilization [GO:0009566]; male gonad development [GO:0008584]; male meiosis chromosome segregation [GO:0007060]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; reciprocal meiotic recombination [GO:0007131]; resolution of meiotic recombination intermediates [GO:0000712]; synaptonemal complex assembly [GO:0007130],"",SUBCELLULAR LOCATION: Chromosome {ECO:0000250|UniProtKB:Q14AT2}. Note=Forms arrays of discrete foci along synaptonemal complexes in spermatocytes and fetal oocytes. {ECO:0000250|UniProtKB:Q14AT2}.,"SUBUNIT: Interacts with SYCP2. Interacts with PBXIP1; may prevent interaction between PBXIP1 and ESR2 (By similarity). Interacts with SHOC1 (PubMed:29742103). {ECO:0000250|UniProtKB:Q14AT2, ECO:0000269|PubMed:29742103}.",X,70528940,70908731,q13.1,1,0.08,-1.6877,1.814,37.057,0.5219410352968722,ENST00000374333,0.6643988480921527,0.0939265183704074,2778,,,,,,,0.944587667010778,4.419660234591652,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:11735,TEX13A,testis expressed 13A,Approved,,,Xq22.3,gene with protein product,protein-coding gene,ENSG00000268629,56157,ENSG00000268629,Q9BXU3,MGI:1915194,RGD:2323888,X,300312,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","",metal ion binding [GO:0046872],"","",X,105218929,105220694,q22.3,0.019784,1.488,-2.0222,-0.81616,5.0362,0.2748809554016222,ENST00000600991,0.1826829268292683,0.07845538615346163,1230,,,,,,,0.9767441860465116,4.698757443096515,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:11736,TEX13B,testis expressed 13B,Approved,,"TSGA5, TGC3B",Xq22.3,gene with protein product,protein-coding gene,ENSG00000170925,56156,ENSG00000170925,Q9BXU2,MGI:1890544,RGD:1587018,X,300313,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,107980864,107982370,q22.3,0.011098,1.725,-0.14797,0.53883,3.9243,0.30238699321700413,ENST00000302917,0.18668796592119277,0.0812546863284179,939,,,,,,,0.9767441860465116,0.8083611600050722,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:11752,TFE3,transcription factor binding to IGHM enhancer 3,Approved,,"TFEA, bHLHe33",Xp11.23,gene with protein product,protein-coding gene,ENSG00000068323,7030,ENSG00000068323,P19532,MGI:98511,RGD:1559642,X,314310,TRUE,"Renal cell carcinoma, papillary, 1",300854,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed -CS,FALSE,,confirmed,"FUNCTION: Transcription factor that acts as a master regulator of lysosomal biogenesis and immune response (PubMed:2338243, PubMed:29146937, PubMed:30733432, PubMed:31672913). Specifically recognizes and binds E-box sequences (5'-CANNTG-3'); efficient DNA-binding requires dimerization with itself or with another MiT/TFE family member such as TFEB or MITF (By similarity). Involved in the cellular response to amino acid availability by acting downstream of MTOR: in the presence of nutrients, TFE3 phosphorylation by MTOR promotes its cytosolic retention and subsequent inactivation (PubMed:31672913). Upon starvation or lysosomal stress, inhibition of MTOR induces TFE3 dephosphorylation, resulting in nuclear localization and transcription factor activity (PubMed:31672913). In association with TFEB, activates the expression of CD40L in T-cells, thereby playing a role in T-cell-dependent antibody responses in activated CD4(+) T-cells and thymus-dependent humoral immunity (By similarity). Specifically recognizes the MUE3 box, a subset of E-boxes, present in the immunoglobulin enhancer (PubMed:2338243). It also binds very well to a USF/MLTF site (PubMed:2338243). May regulate lysosomal positioning in response to nutrient deprivation by promoting the expression of PIP4P1 (PubMed:29146937). Acts as a positive regulator of browning of adipose tissue by promoting expression of target genes; mTOR-dependent phosphorylation promotes cytoplasmic retention of TFE3 and inhibits browning of adipose tissue (By similarity). Maintains the pluripotent state of embryonic stem cells by promoting the expression of genes such as ESRRB; mTOR-dependent nuclear exclusion promotes exit from pluripotency (By similarity). Required to maintain the naive pluripotent state of hematopoietic stem cell; mTOR-dependent cytoplasmic retention of TFE3 promotes the exit of hematopoietic stem cell from pluripotency (PubMed:30733432). {ECO:0000250|UniProtKB:Q64092, ECO:0000269|PubMed:2338243, ECO:0000269|PubMed:29146937, ECO:0000269|PubMed:30733432, ECO:0000269|PubMed:31672913}.","adaptive immune response [GO:0002250]; humoral immune response [GO:0006959]; negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cell adhesion [GO:0045785]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of osteoclast differentiation [GO:0045670]","DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription regulatory region sequence-specific DNA binding [GO:0000976]","SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:21209915, ECO:0000269|PubMed:22692423, ECO:0000269|PubMed:30733432}. Nucleus {ECO:0000269|PubMed:21209915, ECO:0000269|PubMed:22692423, ECO:0000269|PubMed:30733432}. Note=When nutrients are present, phosphorylation by MTOR prevents nuclear translocation and activity (PubMed:22692423, PubMed:30733432). Conversely, inhibition of mTORC1, starvation and lysosomal disruption, promotes dephosphorylation and translocation to the nucleus (PubMed:22692423, PubMed:30733432). {ECO:0000269|PubMed:22692423, ECO:0000269|PubMed:30733432}.","SUBUNIT: Homodimer and heterodimer; with TFEB or MITF. {ECO:0000269|PubMed:15507434, ECO:0000269|PubMed:1748288}.",X,49028726,49043410,p11.23,0.97985,0.29,0.83031,2.1546,16.347,0.5443713701487155,ENST00000315869,0.7868055555555555,0.24128967758060485,1728,,,,,,,0.13800638346641078,6.87034005791893,Fallopian Tube,broadly expressed,5.274399586747828,6.026275548787031,FALSE,high confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:11817,TIMM8A,translocase of inner mitochondrial membrane 8A,Approved,DFN1,"DDP, MTS",Xq22.1,gene with protein product,protein-coding gene,ENSG00000126953,1678,ENSG00000126953,O60220,MGI:1353433,RGD:621801,X,300356,TRUE,Mohr-Tranebjaerg syndrome,304700,X-linked recessive,,,,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Mitochondrial intermembrane chaperone that participates in the import and insertion of some multi-pass transmembrane proteins into the mitochondrial inner membrane. Also required for the transfer of beta-barrel precursors from the TOM complex to the sorting and assembly machinery (SAM complex) of the outer membrane. Acts as a chaperone-like protein that protects the hydrophobic precursors from aggregation and guide them through the mitochondrial intermembrane space. The TIMM8-TIMM13 complex mediates the import of proteins such as TIMM23, SLC25A12/ARALAR1 and SLC25A13/ARALAR2, while the predominant TIMM9-TIMM10 70 kDa complex mediates the import of much more proteins. Probably necessary for normal neurologic development. {ECO:0000269|PubMed:11489896, ECO:0000269|PubMed:15254020}.",chaperone-mediated protein transport [GO:0072321]; nervous system development [GO:0007399],metal ion binding [GO:0046872],SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000269|PubMed:11489896}; Peripheral membrane protein {ECO:0000269|PubMed:11489896}; Intermembrane side {ECO:0000269|PubMed:11489896}.,"SUBUNIT: Heterohexamer; composed of 3 copies of TIMM8A and 3 copies of TIMM13, named soluble 70 kDa complex. Associates with the TIM22 complex, whose core is composed of TIMM22.",X,101345661,101348742,q22.1,0.65195,0.872,-0.64257,1.1492,3.4106,0.482672977342487,ENST00000372902,0.9319727891156463,0.17248187953011748,294,,,,,,,0.4337889416145089,3.905495315908434,Cells - EBV-transformed lymphocytes,broadly expressed,1.8373297138416516,1.9558781636346152,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:11820,TIMP1,TIMP metallopeptidase inhibitor 1,Approved,"TIMP, CLGI",EPO,Xp11.3,gene with protein product,protein-coding gene,ENSG00000102265,7076,ENSG00000102265,P01033,MGI:98752,RGD:621675,X,305370,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Metalloproteinase inhibitor that functions by forming one to one complexes with target metalloproteinases, such as collagenases, and irreversibly inactivates them by binding to their catalytic zinc cofactor. Acts on MMP1, MMP2, MMP3, MMP7, MMP8, MMP9, MMP10, MMP11, MMP12, MMP13 and MMP16. Does not act on MMP14. Also functions as a growth factor that regulates cell differentiation, migration and cell death and activates cellular signaling cascades via CD63 and ITGB1. Plays a role in integrin signaling. Mediates erythropoiesis in vitro; but, unlike IL3, it is species-specific, stimulating the growth and differentiation of only human and murine erythroid progenitors. {ECO:0000269|PubMed:1420137, ECO:0000269|PubMed:16917503, ECO:0000269|PubMed:17050530, ECO:0000269|PubMed:1730286, ECO:0000269|PubMed:20545310, ECO:0000269|PubMed:22427646, ECO:0000269|PubMed:24635319, ECO:0000269|PubMed:3839290, ECO:0000269|PubMed:3903517, ECO:0000269|PubMed:8541540, ECO:0000269|PubMed:8576151, ECO:0000269|PubMed:9065415}.",aging [GO:0007568]; cartilage development [GO:0051216]; cell activation [GO:0001775]; cellular protein metabolic process [GO:0044267]; cellular response to UV-A [GO:0071492]; connective tissue replacement involved in inflammatory response wound healing [GO:0002248]; cytokine-mediated signaling pathway [GO:0019221]; extracellular matrix disassembly [GO:0022617]; negative regulation of apoptotic process [GO:0043066]; negative regulation of catalytic activity [GO:0043086]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; negative regulation of metallopeptidase activity [GO:1905049]; negative regulation of trophoblast cell migration [GO:1901164]; platelet degranulation [GO:0002576]; positive regulation of cell population proliferation [GO:0008284]; post-translational protein modification [GO:0043687]; regulation of integrin-mediated signaling pathway [GO:2001044]; response to cytokine [GO:0034097]; response to hormone [GO:0009725]; response to organic substance [GO:0010033]; response to peptide hormone [GO:0043434],cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; metalloendopeptidase inhibitor activity [GO:0008191]; peptidase inhibitor activity [GO:0030414]; protease binding [GO:0002020]; zinc ion binding [GO:0008270],"SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:1730286, ECO:0000269|PubMed:24635319, ECO:0000269|PubMed:3010309, ECO:0000269|PubMed:3839290, ECO:0000269|PubMed:3903517, ECO:0000269|PubMed:8541540}.","SUBUNIT: Interacts with MMP1, MMP3, MMP10 and MMP13, but has only very low affinity for MMP14. Interacts with CD63; identified in a complex with CD63 and ITGB1. {ECO:0000269|PubMed:12834347, ECO:0000269|PubMed:16917503, ECO:0000269|PubMed:17050530, ECO:0000269|PubMed:20545310, ECO:0000269|PubMed:22427646, ECO:0000269|PubMed:23522389, ECO:0000269|PubMed:8541540, ECO:0000269|PubMed:8576151, ECO:0000269|PubMed:9065415, ECO:0000269|PubMed:9288970}.",X,47582408,47586789,p11.3,0.4993,0.784,1.1687,1.0267,6.0493,0.2580709381708116,ENST00000218388,0.6338141025641025,0.13326668332916772,624,,,,,,,0.28814334943557834,10.919064425550035,Artery - Coronary,broadly expressed,4.400722353241104,4.856487779495678,FALSE,variable escapee,Post_higher_vs_Pre,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:11835,TKTL1,transketolase like 1,Approved,,"TKR, TKT2",Xq28,gene with protein product,protein-coding gene,ENSG00000007350,8277,ENSG00000007350,P51854,MGI:1933244,RGD:1593490,X,300044,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Catalyzes the transfer of a two-carbon ketol group from a ketose donor to an aldose acceptor, via a covalent intermediate with the cofactor thiamine pyrophosphate. {ECO:0000250}.",glucose catabolic process [GO:0006007]; thiamine metabolic process [GO:0006772],metal ion binding [GO:0046872]; thiamine pyrophosphate binding [GO:0030976]; transketolase activity [GO:0004802],"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16465194, ECO:0000269|PubMed:16969476}. Nucleus {ECO:0000269|PubMed:16465194, ECO:0000269|PubMed:16969476}. Note=Predominantly cytoplasmic and to a lesser extent also nuclear (PubMed:16969476).",SUBUNIT: Homodimer. {ECO:0000250}.,X,154295795,154330350,q28,0.99933,0.142,-2.8215,-0.84515,21.078,0.5733702916801509,ENST00000369915,0.7184812953657175,0.04433891527118221,1791,2,"TKTL2 (73, 70, chr4); TKT (62, 58, chr3)",TRUE,,,,0.9342188437247348,7.415226277098806,Testis,tissue-specific,0.15960206238286098,0.05921252404849084,FALSE,discordant,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:11854,TSPAN7,tetraspanin 7,Approved,"MXS1, TM4SF2, MRX58","DXS1692E, TALLA-1, A15, CD231",Xp11.4,gene with protein product,protein-coding gene,ENSG00000156298,7102,ENSG00000156298,P41732,MGI:1298407,RGD:1589725,X,300096,TRUE,"Mental retardation, X-linked 58",300210,X-linked recessive,,,,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,FUNCTION: May be involved in cell proliferation and cell motility.,viral process [GO:0016032],"",SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.,SUBUNIT: (Microbial infection) Interacts with herpes simplex virus 1 (HHV-1) UL35. {ECO:0000269|PubMed:20630051}.,X,38561542,38688920,p11.4,0.78986,0.499,0.4553,1.8579,9.5158,0.6190107731682638,ENST00000378482,0.9324,0.30269932516870784,750,2,"AF241726.1 (85, 81, chrX); TSPAN6 (55, 59, chrX)",TRUE,,,,0.44874281775090075,8.93053481390121,Cerebellar_tissues,broadly expressed,8.475575374256406,8.93053481390121,TRUE,low confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:11858,TSPAN6,tetraspanin 6,Approved,TM4SF6,"T245, TSPAN-6",Xq22.1,gene with protein product,protein-coding gene,ENSG00000000003,7105,ENSG00000000003,O43657,MGI:1926264,RGD:1560160,X,300191,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway [GO:0039532]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123],"",SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.,"",X,100627108,100639991,q22.1,0.066079,0.985,-0.47468,0.59223,7.865,0.4923465531058639,ENST00000373020,0.8292682926829268,0.2971257185703574,738,1,"TSPAN7 (59, 55, chrX)",TRUE,,,,0.39292518285274064,6.214628028483213,Ovary,broadly expressed,2.6677876934854035,1.621200891117666,FALSE,discordant,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post1_higher_vs_Post2,no disorder
HGNC:11881,TMSB4X,thymosin beta 4 X-linked,Approved,TMSB4,TB4X,Xp22.2,gene with protein product,protein-coding gene,ENSG00000205542,7114,ENSG00000205542,P62328,MGI:99510,RGD:621622,X,300159,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Plays an important role in the organization of the cytoskeleton (By similarity). Binds to and sequesters actin monomers (G actin) and therefore inhibits actin polymerization. {ECO:0000250}.; FUNCTION: Seraspenide inhibits the entry of hematopoietic pluripotent stem cells into the S-phase. {ECO:0000250}.,"actin filament organization [GO:0007015]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1903026]; platelet degranulation [GO:0002576]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of proton-transporting ATP synthase activity, rotational mechanism [GO:1905273]; regulation of cell migration [GO:0030334]; regulation of inflammatory response [GO:0050727]; regulation of NIK/NF-kappaB signaling [GO:1901222]; sequestering of actin monomers [GO:0042989]; tumor necrosis factor-mediated signaling pathway [GO:0033209]",actin monomer binding [GO:0003785]; enzyme binding [GO:0019899]; RNA binding [GO:0003723],"SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton.","SUBUNIT: Interacts with SERPINB1 (By similarity). Identified in a complex composed of ACTA1, COBL, GSN AND TMSB4X. {ECO:0000250, ECO:0000269|PubMed:10848969, ECO:0000269|PubMed:1999398, ECO:0000269|PubMed:23009842}.",X,12975110,12977227,p22.2,0.41205,1.673,-1.4219,0.98298,1.1644,0.672508027335702,ENST00000451311,0.9918518518518519,0.20434891277180706,135,1,"TMSB4Y (93, 93, chrY)",TRUE,1,"TMSB4Y (93, 93, chrY)",TRUE,0.21907064299646375,13.116187985774763,Cells - EBV-transformed lymphocytes,broadly expressed,9.746526077627566,8.992073026010111,FALSE,discordant,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:11935,CD40LG,CD40 ligand,Approved,"HIGM1, IMD3, TNFSF5","CD40L, TRAP, gp39, hCD40L, CD154",Xq26.3,gene with protein product,protein-coding gene,ENSG00000102245,959,ENSG00000102245,P29965,MGI:88337,RGD:708418,X,300386,TRUE,"Immunodeficiency, X-linked, with hyper-IgM",308230,X-linked recessive,,,,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Cytokine that acts as a ligand to CD40/TNFRSF5 (PubMed:1280226, PubMed:31331973). Costimulates T-cell proliferation and cytokine production (PubMed:8617933). Its cross-linking on T-cells generates a costimulatory signal which enhances the production of IL4 and IL10 in conjunction with the TCR/CD3 ligation and CD28 costimulation (PubMed:8617933). Induces the activation of NF-kappa-B (PubMed:15067037, PubMed:31331973). Induces the activation of kinases MAPK8 and PAK2 in T-cells (PubMed:15067037). Induces tyrosine phosphorylation of isoform 3 of CD28 (PubMed:15067037). Mediates B-cell proliferation in the absence of co-stimulus as well as IgE production in the presence of IL4 (By similarity). Involved in immunoglobulin class switching (By similarity). {ECO:0000250|UniProtKB:P27548, ECO:0000269|PubMed:1280226, ECO:0000269|PubMed:15067037, ECO:0000269|PubMed:31331973, ECO:0000269|PubMed:8617933}.; FUNCTION: [CD40 ligand, soluble form]: Acts as a ligand for integrins, specifically ITGA5:ITGB1 and ITGAV:ITGB3; both integrins and the CD40 receptor are required for activation of CD40-CD40LG signaling, which have cell-type dependent effects, such as B-cell activation, NF-kappa-B signaling and anti-apoptotic signaling. {ECO:0000269|PubMed:31331973}.",activation of JUN kinase activity [GO:0007257]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; CD40 signaling pathway [GO:0023035]; immunoglobulin secretion [GO:0048305]; inflammatory response [GO:0006954]; integrin-mediated signaling pathway [GO:0007229]; isotype switching [GO:0045190]; leukocyte cell-cell adhesion [GO:0007159]; negative regulation of apoptotic process [GO:0043066]; platelet activation [GO:0030168]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell proliferation [GO:0042102]; regulation of immune response [GO:0050776]; regulation of immunoglobulin secretion [GO:0051023]; T cell costimulation [GO:0031295]; tumor necrosis factor-mediated signaling pathway [GO:0033209],CD40 receptor binding [GO:0005174]; cytokine activity [GO:0005125]; integrin binding [GO:0005178]; tumor necrosis factor receptor binding [GO:0005164],"SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:8626375}; Single-pass type II membrane protein {ECO:0000303|PubMed:8626375}. Cell surface {ECO:0000269|PubMed:15067037, ECO:0000269|PubMed:7678552}.; SUBCELLULAR LOCATION: [CD40 ligand, soluble form]: Secreted {ECO:0000269|PubMed:8626375}. Note=Release of soluble CD40L from platelets is partially regulated by GP IIb/IIIa, actin polymerization, and a matrix metalloproteinases (MMP) inhibitor-sensitive pathway. {ECO:0000269|PubMed:15193700}.","SUBUNIT: Homotrimer (PubMed:8626375, PubMed:11676606, PubMed:8589998). Interacts with isoform 3 of CD28 (PubMed:15067037). CD40 ligand, soluble form: Exists as either a monomer or a homotrimer (PubMed:8626375, PubMed:31331973). Forms a ternary complex between CD40 and integrins for CD40-CD40LG signaling (PubMed:31331973). {ECO:0000269|PubMed:11676606, ECO:0000269|PubMed:15067037, ECO:0000269|PubMed:31331973, ECO:0000269|PubMed:8589998, ECO:0000269|PubMed:8626375}.",X,136648158,136660390,q26.3,0.72079,0.557,1.0262,1.3013,8.522,0.17002646036789476,ENST00000370629,0.7874045801526718,0.25053736565858536,786,,,,,,,0.7778361848528181,2.7023672022721126,Spleen,tissue-specific,0.02843590891372496,0,FALSE,variable escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:11957,MED12,mediator complex subunit 12,Approved,"TNRC11, FGS1","CAGH45, HOPA, OPA1, TRAP230, KIAA0192, OKS, ARC240, Kto",Xq13.1,gene with protein product,protein-coding gene,ENSG00000184634,9968,ENSG00000184634,Q93074,MGI:1926212,RGD:1585896,X,300188,TRUE,"Lujan-Fryns syndrome // Ohdo syndrome, X-linked // Opitz-Kaveggia syndrome",309520 // 300895 // 305450,X-linked recessive // X-linked recessive // X-linked recessive,,,,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. This subunit may specifically regulate transcription of targets of the Wnt signaling pathway and SHH signaling pathway. {ECO:0000269|PubMed:16565090, ECO:0000269|PubMed:16595664, ECO:0000269|PubMed:17000779}.","axis elongation involved in somitogenesis [GO:0090245]; canonical Wnt signaling pathway [GO:0060070]; embryonic brain development [GO:1990403]; embryonic neurocranium morphogenesis [GO:0048702]; endoderm development [GO:0007492]; heart development [GO:0007507]; neural tube closure [GO:0001843]; oligodendrocyte development [GO:0014003]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; post-anal tail morphogenesis [GO:0036342]; regulation of transcription by RNA polymerase II [GO:0006357]; Schwann cell development [GO:0014044]; spinal cord development [GO:0021510]; stem cell population maintenance [GO:0019827]; transcription initiation from RNA polymerase II promoter [GO:0006367]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]",beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; nuclear receptor transcription coactivator activity [GO:0030374]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; ubiquitin protein ligase activity [GO:0061630]; vitamin D receptor binding [GO:0042809],SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.,"SUBUNIT: Component of the Mediator complex, which is composed of MED1, MED4, MED6, MED7, MED8, MED9, MED10, MED11, MED12, MED13, MED13L, MED14, MED15, MED16, MED17, MED18, MED19, MED20, MED21, MED22, MED23, MED24, MED25, MED26, MED27, MED29, MED30, MED31, CCNC, CDK8 and CDC2L6/CDK11. The MED12, MED13, CCNC and CDK8 subunits form a distinct module termed the CDK8 module. Mediator containing the CDK8 module is less active than Mediator lacking this module in supporting transcriptional activation. Individual preparations of the Mediator complex lacking one or more distinct subunits have been variously termed ARC, CRSP, DRIP, PC2, SMCC and TRAP. Also interacts with CTNNB1 and GLI3. {ECO:0000269|PubMed:10198638, ECO:0000269|PubMed:10235266, ECO:0000269|PubMed:10235267, ECO:0000269|PubMed:15175163, ECO:0000269|PubMed:15989967, ECO:0000269|PubMed:16565090, ECO:0000269|PubMed:16595664, ECO:0000269|PubMed:17000779}.",X,71118556,71142454,q13.1,1,0.071,1.2454,6.5797,88.673,0.47056657238285704,ENST00000374080,0.9249923477196205,0.2566358410397401,6534,1,"MED12L (60, 61, chr3)",TRUE,,,,0.22300611887523153,5.794613411064664,Ovary,broadly expressed,3.0271805974145702,4.526450724643553,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:12270,TREX2,three prime repair exonuclease 2,Approved,,,Xq28,gene with protein product,protein-coding gene,ENSG00000183479,11219,ENSG00000183479,Q9BQ50,MGI:1346343,RGD:1562245,X,300370,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Exonuclease with a preference for double-stranded DNA with mismatched 3' termini. May play a role in DNA repair. {ECO:0000269|PubMed:11279105}.,DNA metabolic process [GO:0006259]; DNA repair [GO:0006281],3'-5'-exodeoxyribonuclease activity [GO:0008296]; exodeoxyribonuclease III activity [GO:0008853]; magnesium ion binding [GO:0000287]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803],SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.,SUBUNIT: Homodimer. {ECO:0000269|PubMed:15661738}.,X,153444720,153470587,q28,0.45433,1.54,-1.235,-0.65773,1.5323,0.4111266318312725,ENST00000330912,0.43023909985935305,0.09265183704073982,711,,,,,,,0.662312859709024,4.770628217360742,Skin - Sun Exposed (Lower leg),tissue-specific,0.5505323118624075,0.5008265225888522,FALSE,high confidence non-escapee,no_difference_Pre_Post,Pre_higher_vs_Post1,no difference_Pre_Post2,Post2_higher_vs_Post1,no disorder
HGNC:12326,TRO,trophinin,Approved,,"MAGE-D3, KIAA1114, MAGED3",Xp11.21,gene with protein product,protein-coding gene,ENSG00000067445,7216,ENSG00000067445,Q12816,MGI:1928994,RGD:6488256,X,300132,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Could be involved with bystin and tastin in a cell adhesion molecule complex that mediates an initial attachment of the blastocyst to uterine epithelial cells at the time of the embryo implantation. Directly responsible for homophilic cell adhesion.,embryo implantation [GO:0007566]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156],"","","SUBUNIT: Directly binds bystin, and indirectly tastin.",X,54920462,54931431,p11.21,3.8486e-5,0.795,0.60469,1.0439,22.899,0.370396092321226,ENST00000173898,0.31843575418994413,0.1604098975256186,4296,,,,,,,0.43683612903527075,5.982368461511869,Ovary,broadly expressed,4.007168585200864,4.989706706994214,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:12337,TRPC5,transient receptor potential cation channel subfamily C member 5,Approved,,PPP1R159,Xq23,gene with protein product,protein-coding gene,ENSG00000072315,7224,ENSG00000072315,Q9UL62,MGI:109524,RGD:619787,X,300334,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Thought to form a receptor-activated non-selective calcium permeant cation channel. Probably is operated by a phosphatidylinositol second messenger system activated by receptor tyrosine kinases or G-protein coupled receptors. Has also been shown to be calcium-selective (By similarity). May also be activated by intracellular calcium store depletion. {ECO:0000250, ECO:0000269|PubMed:16284075}.",calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; manganese ion transport [GO:0006828]; negative regulation of dendrite morphogenesis [GO:0050774]; nervous system development [GO:0007399]; neuron differentiation [GO:0030182]; positive regulation of axon extension [GO:0045773]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of membrane hyperpolarization [GO:1902630],"actin binding [GO:0003779]; actinin binding [GO:0042805]; ATPase binding [GO:0051117]; calcium channel activity [GO:0005262]; clathrin binding [GO:0030276]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]",SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:16284075}; Multi-pass membrane protein {ECO:0000269|PubMed:16284075}.,"SUBUNIT: Interacts with TRPC4AP (By similarity). Homotetramer and heterotetramer with TRPC1 and/or TRPC4. Interacts with NHERF (By similarity). Interacts with MX1 and RNF24. Interacts (via C-terminus) with CABP1. Interacts with SESTD1 (via the spectrin 1 repeat). {ECO:0000250, ECO:0000269|PubMed:12032305, ECO:0000269|PubMed:15757897, ECO:0000269|PubMed:15895247, ECO:0000269|PubMed:17850865, ECO:0000269|PubMed:20164195}.",X,111774315,112082776,q23,0.99973,0.17,-0.4133,3.2725,27.932,0.3949636793535405,ENST00000262839,0.9395619438740589,0.24608847788052987,2922,1,"TRPC4 (66, 65, chr13)",TRUE,,,,0.9066223878990555,0.27176091134069474,Cerebellar_tissues,tissue-specific,0.14914358099906533,0.27176091134069474,TRUE,variable escapee,no_difference_Pre_Post,Pre_higher_vs_Post1,no difference_Pre_Post2,Post2_higher_vs_Post1,no disorder
HGNC:12469,UBA1,ubiquitin like modifier activating enzyme 1,Approved,"A1S9T, GXP1, UBE1","UBE1X, POC20, CFAP124",Xp11.3,gene with protein product,protein-coding gene,ENSG00000130985,7317,ENSG00000130985,P22314,MGI:98890,RGD:1359327,X,314370,TRUE,"Spinal muscular atrophy, X-linked 2, infantile // VEXAS syndrome, somatic",301830 // 301054,X-linked recessive //,,,,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Catalyzes the first step in ubiquitin conjugation to mark cellular proteins for degradation through the ubiquitin-proteasome system (PubMed:1606621, PubMed:1447181). Activates ubiquitin by first adenylating its C-terminal glycine residue with ATP, and thereafter linking this residue to the side chain of a cysteine residue in E1, yielding a ubiquitin-E1 thioester and free AMP (PubMed:1447181). Essential for the formation of radiation-induced foci, timely DNA repair and for response to replication stress. Promotes the recruitment of TP53BP1 and BRCA1 at DNA damage sites (PubMed:22456334). {ECO:0000269|PubMed:1447181, ECO:0000269|PubMed:1606621, ECO:0000269|PubMed:22456334}.",cellular response to DNA damage stimulus [GO:0006974]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],ATP binding [GO:0005524]; RNA binding [GO:0003723]; ubiquitin activating enzyme activity [GO:0004839],"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:1376922}. Mitochondrion {ECO:0000269|PubMed:1376922}. Nucleus {ECO:0000269|PubMed:1376922, ECO:0000269|PubMed:22456334}.; SUBCELLULAR LOCATION: [Isoform 1]: Nucleus {ECO:0000269|PubMed:7528747, ECO:0000269|PubMed:9099746}.; SUBCELLULAR LOCATION: [Isoform 2]: Cytoplasm {ECO:0000269|PubMed:7528747}.","SUBUNIT: Monomer (By similarity). Interacts with GAN (via BTB domain). {ECO:0000250, ECO:0000269|PubMed:16227972}.",X,47190861,47215128,p11.3,1,0.108,-1.1364,3.4752,44.101,0.45282946461550266,ENST00000335972,0.845294302801385,0.1851787053236691,3177,,,,,,,0.11740456941475862,7.5902726540952195,Thyroid,broadly expressed,5.623723498027513,7.132340349613531,FALSE,high confidence escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:12472,UBE2A,ubiquitin conjugating enzyme E2 A,Approved,,"UBC2, HHR6A, RAD6A, HR6A",Xq24,gene with protein product,protein-coding gene,ENSG00000077721,7319,ENSG00000077721,P49459,MGI:102959,RGD:1359534,X,312180,TRUE,"Mental retardation, X-linked syndromic, Nascimento-type",300860,X-linked recessive,,,,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Accepts ubiquitin from the E1 complex and catalyzes its covalent attachment to other proteins. In association with the E3 enzyme BRE1 (RNF20 and/or RNF40), it plays a role in transcription regulation by catalyzing the monoubiquitination of histone H2B at 'Lys-120' to form H2BK120ub1. H2BK120ub1 gives a specific tag for epigenetic transcriptional activation, elongation by RNA polymerase II, telomeric silencing, and is also a prerequisite for H3K4me and H3K79me formation. In vitro catalyzes 'Lys-11', as well as 'Lys-48'-linked polyubiquitination. Required for postreplication repair of UV-damaged DNA. {ECO:0000269|PubMed:16337599, ECO:0000269|PubMed:20061386}.",blastocyst hatching [GO:0001835]; DNA repair [GO:0006281]; histone H2A ubiquitination [GO:0033522]; histone ubiquitination [GO:0016574]; maternal process involved in female pregnancy [GO:0060135]; positive regulation of cell population proliferation [GO:0008284]; postreplication repair [GO:0006301]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to UV [GO:0009411]; ubiquitin-dependent protein catabolic process [GO:0006511],ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842],"","SUBUNIT: Interacts with RAD18 and WAC (PubMed:21329877). Interacts with RFPL4A and CCNB1 (By similarity). {ECO:0000250|UniProtKB:Q9Z255, ECO:0000269|PubMed:21329877}.",X,119574536,119591083,q24,0.815,0.537,0.38442,2.4624,5.5739,0.5595366542793754,ENST00000371558,0.9581699346405229,0.19250187453136716,459,1,"UBE2B (95, 95, chr5)",TRUE,1,"UBE2B (95, 95, chr5)",TRUE,0.13384447721047144,6.5329917009949545,Cells - Cultured fibroblasts,broadly expressed,5.016291275753809,5.523873983521712,FALSE,high confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:12505,UBL4A,ubiquitin like 4A,Approved,UBL4,"GDX, DXS254E, GET5, MDY2, TMA24",Xq28,gene with protein product,protein-coding gene,ENSG00000102178,8266,ENSG00000102178,P11441,"MGI:95049, MGI:5621304",RGD:1563983,X,312070,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: As part of a cytosolic protein quality control complex, the BAG6/BAT3 complex, maintains misfolded and hydrophobic patches-containing proteins in a soluble state and participates in their proper delivery to the endoplasmic reticulum or alternatively can promote their sorting to the proteasome where they undergo degradation (PubMed:20676083, PubMed:21636303, PubMed:21743475, PubMed:28104892). The BAG6/BAT3 complex is involved in the post-translational delivery of tail-anchored/type II transmembrane proteins to the endoplasmic reticulum membrane. Recruited to ribosomes, it interacts with the transmembrane region of newly synthesized tail-anchored proteins and together with SGTA and ASNA1 mediates their delivery to the endoplasmic reticulum (PubMed:20676083, PubMed:28104892, PubMed:25535373). Client proteins that cannot be properly delivered to the endoplasmic reticulum are ubiquitinated and sorted to the proteasome (PubMed:28104892). Similarly, the BAG6/BAT3 complex also functions as a sorting platform for proteins of the secretory pathway that are mislocalized to the cytosol either delivering them to the proteasome for degradation or to the endoplasmic reticulum (PubMed:21743475). The BAG6/BAT3 complex also plays a role in the endoplasmic reticulum-associated degradation (ERAD), a quality control mechanism that eliminates unwanted proteins of the endoplasmic reticulum through their retrotranslocation to the cytosol and their targeting to the proteasome. It maintains these retrotranslocated proteins in an unfolded yet soluble state condition in the cytosol to ensure their proper delivery to the proteasome (PubMed:21636303). {ECO:0000269|PubMed:20676083, ECO:0000269|PubMed:21636303, ECO:0000269|PubMed:21743475, ECO:0000269|PubMed:25535373, ECO:0000269|PubMed:28104892}.",cellular protein modification process [GO:0006464]; tail-anchored membrane protein insertion into ER membrane [GO:0071816],chaperone binding [GO:0051087]; ubiquitin-like protein transferase activity [GO:0019787],"SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:20676083, ECO:0000269|PubMed:21636303}. Nucleus {ECO:0000269|PubMed:21636303}.","SUBUNIT: Component of the BAG6/BAT3 complex, at least composed of BAG6, UBL4A and GET4/TRC35 (PubMed:20676083, PubMed:25535373). Interacts with BAG6; the interaction is direct and required for UBL4A protein stability (PubMed:25713138, PubMed:25535373). Interacts with USP13; may be indirect via BAG6 (PubMed:24424410). {ECO:0000269|PubMed:20676083, ECO:0000269|PubMed:24424410, ECO:0000269|PubMed:25535373, ECO:0000269|PubMed:25713138}.",X,154483717,154486615,q28,0.29855,1.179,-1.0663,0.70403,3.9622,0.5355125515339133,ENST00000369660,0.6052742616033755,0.3681329667583104,474,,,,,,,0.09449090681418965,5.664548260777954,Muscle - Skeletal,broadly expressed,4.65205620360686,5.408567516381094,FALSE,low confidence non-escapee,no_difference_Pre_Post,Pre_higher_vs_Post1,no difference_Pre_Post2,Post2_higher_vs_Post1,no disorder
HGNC:12509,UBQLN2,ubiquilin 2,Approved,,"Chap1, Dsk2, RIHFB2157, LIC-2, CHAP1/DSK2, PLIC-2, N4BP4, PLIC2",Xp11.21,gene with protein product,protein-coding gene,ENSG00000188021,29978,ENSG00000188021,Q9UHD9,MGI:1860283,RGD:1563566,X,300264,TRUE,"Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia",300857,X-linked dominant,,,,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,confirmed +CS,FALSE,TRUE,confirmed,"FUNCTION: Plays an important role in the regulation of different protein degradation mechanisms and pathways including ubiquitin-proteasome system (UPS), autophagy and the endoplasmic reticulum-associated protein degradation (ERAD) pathway. Mediates the proteasomal targeting of misfolded or accumulated proteins for degradation by binding (via UBA domain) to their polyubiquitin chains and by interacting (via ubiquitin-like domain) with the subunits of the proteasome (PubMed:10983987). Plays a role in the ERAD pathway via its interaction with ER-localized proteins FAF2/UBXD8 and HERPUD1 and may form a link between the polyubiquitinated ERAD substrates and the proteasome (PubMed:24215460, PubMed:18307982). Involved in the regulation of macroautophagy and autophagosome formation; required for maturation of autophagy-related protein LC3 from the cytosolic form LC3-I to the membrane-bound form LC3-II and may assist in the maturation of autophagosomes to autolysosomes by mediating autophagosome-lysosome fusion (PubMed:19148225, PubMed:20529957). Negatively regulates the endocytosis of GPCR receptors: AVPR2 and ADRB2, by specifically reducing the rate at which receptor-arrestin complexes concentrate in clathrin-coated pits (CCPs) (PubMed:18199683). {ECO:0000269|PubMed:10983987, ECO:0000269|PubMed:18199683, ECO:0000269|PubMed:18307982, ECO:0000269|PubMed:19148225, ECO:0000269|PubMed:20529957, ECO:0000269|PubMed:24215460}.",autophagosome assembly [GO:0000045]; negative regulation of clathrin-dependent endocytosis [GO:1900186]; negative regulation of G protein-coupled receptor internalization [GO:1904021]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; regulation of autophagosome assembly [GO:2000785]; regulation of macroautophagy [GO:0016241]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511],identical protein binding [GO:0042802]; polyubiquitin modification-dependent protein binding [GO:0031593],"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:18199683}. Nucleus {ECO:0000269|PubMed:9853615}. Membrane {ECO:0000250|UniProtKB:Q9QZM0}. Cytoplasmic vesicle, autophagosome {ECO:0000269|PubMed:19148225}. Note=Colocalizes with a subset of proteasomes, namely those that are cytoskeleton associated or free in the cytosol. Associated with fibers in mitotic cells. {ECO:0000269|PubMed:10983987}.","SUBUNIT: Homodimer. Forms heterodimer with UBQLN1. Binds UBE3A and BTRC. Interacts with the 19S proteasome subunit. Interacts with C9orf72. Interacts with HNRNPA1 and HNRNPU. Found in a complex with UBQLN1 and MAP1LC3A/B/C. Interacts with EPS15, EPN1 and EPN2. Interacts with HERPUD1. Interacts with RAD23A. Interacts with TARDBP. Interacts (via C-terminus) with FAF2 (via N-terminus). Interacts with UBQLN4. Binds CD47 (By similarity). {ECO:0000250|UniProtKB:Q9QZM0, ECO:0000269|PubMed:10675567, ECO:0000269|PubMed:10983987, ECO:0000269|PubMed:16813565, ECO:0000269|PubMed:17098253, ECO:0000269|PubMed:18199683, ECO:0000269|PubMed:18307982, ECO:0000269|PubMed:20529957, ECO:0000269|PubMed:23459205, ECO:0000269|PubMed:23541532, ECO:0000269|PubMed:24215460, ECO:0000269|PubMed:24549040, ECO:0000269|PubMed:25616961}.",X,56563627,56567868,p11.21,0.84968,0.448,-1.5123,1.499,10.6,0.5673134529093155,ENST00000338222,0.85728,0.4783304173956511,1875,2,"UBQLN1 (76, 80, chr9); UBQLN4 (57, 60, chr1)",TRUE,,,,0.22630211628865832,5.971728620886241,Cerebellar_tissues,broadly expressed,4.8383971654161755,5.971728620886241,TRUE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,no difference_Pre_Post2,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:12609,USP11,ubiquitin specific peptidase 11,Approved,,UHX1,Xp11.3,gene with protein product,protein-coding gene,ENSG00000102226,8237,ENSG00000102226,P51784,MGI:2384312,RGD:1303052,X,300050,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Protease that can remove conjugated ubiquitin from target proteins and polyubiquitin chains (PubMed:12084015, PubMed:15314155, PubMed:17897950, PubMed:19874889, PubMed:20233726, PubMed:24724799). Inhibits the degradation of target proteins by the proteasome (PubMed:12084015). Cleaves preferentially 'Lys-6' and 'Lys-63'-linked ubiquitin chains. Has lower activity with 'Lys-11' and 'Lys-33'-linked ubiquitin chains, and extremely low activity with 'Lys-27', 'Lys-29' and 'Lys-48'-linked ubiquitin chains (in vitro) (PubMed:24724799). Plays a role in the regulation of pathways leading to NF-kappa-B activation (PubMed:17897950, PubMed:19874889). Plays a role in the regulation of DNA repair after double-stranded DNA breaks (PubMed:15314155, PubMed:20233726). Acts as a chromatin regulator via its association with the Polycomb group (PcG) multiprotein PRC1-like complex; may act by deubiquitinating components of the PRC1-like complex (PubMed:20601937). {ECO:0000269|PubMed:15314155, ECO:0000269|PubMed:17897950, ECO:0000269|PubMed:18408009, ECO:0000269|PubMed:19874889, ECO:0000269|PubMed:20233726, ECO:0000269|PubMed:24724799}.",protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032],cysteine-type endopeptidase activity [GO:0004197]; RNA polymerase II transcription corepressor binding [GO:0001226]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459],"SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12084015, ECO:0000269|PubMed:15314155, ECO:0000269|PubMed:20233726}. Cytoplasm {ECO:0000269|PubMed:15314155}. Chromosome {ECO:0000269|PubMed:20233726, ECO:0000269|PubMed:20601937}. Note=Predominantly nuclear (PubMed:12084015, PubMed:15314155). Associates with chromatin (PubMed:20601937, PubMed:20233726). {ECO:0000269|PubMed:12084015, ECO:0000269|PubMed:15314155, ECO:0000269|PubMed:20233726, ECO:0000269|PubMed:20601937}.","SUBUNIT: Monomer (PubMed:24724799). Interacts with RANBP9/RANBPM (PubMed:12084015). Interacts with BRCA2 (PubMed:15314155). Interacts with CHUK/IKKA (PubMed:17897950). Interacts with NFKBIA (PubMed:19874889). Associated component of the Polycomb group (PcG) multiprotein PRC1-like complex (PubMed:20601937). {ECO:0000269|PubMed:12084015, ECO:0000269|PubMed:15314155, ECO:0000269|PubMed:17897950, ECO:0000269|PubMed:19874889, ECO:0000269|PubMed:24724799}.; SUBUNIT: (Microbial infection) Interacts with papilloma virus protein 16E7 (PubMed:18408009). {ECO:0000269|PubMed:18408009}.",X,47232866,47248328,p11.3,0.99996,0.167,-0.81148,3.5731,37.605,0.5675660577621362,ENST00000377107,0.7041259500542888,0.1757310672331917,2763,,,,,,,0.2534352203944125,7.768687195029899,Pituitary,broadly expressed,6.81433251596398,7.72275289552992,FALSE,discordant,no_difference_Pre_Post,Pre_higher_vs_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:12632,USP9X,ubiquitin specific peptidase 9 X-linked,Approved,,"DFFRX, FAF, MRX99",Xp11.4,gene with protein product,protein-coding gene,ENSG00000124486,8239,ENSG00000124486,Q93008,MGI:894681,RGD:1560056,X,300072,TRUE,"Mental retardation, X-linked 99 // Mental retardation, X-linked 99, syndromic, female-restricted",300919 // 300968,X-linked recessive // X-linked dominant,,,,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Deubiquitinase involved both in the processing of ubiquitin precursors and of ubiquitinated proteins. May therefore play an important regulatory role at the level of protein turnover by preventing degradation of proteins through the removal of conjugated ubiquitin. Specifically hydrolyzes 'Lys-48'-, 'Lys-29'- and 'Lys-33'-linked polyubiquitins chains. Essential component of TGF-beta/BMP signaling cascade. Specifically deubiquitinates monoubiquitinated SMAD4, opposing the activity of E3 ubiquitin-protein ligase TRIM33. Deubiquitinates alkylation repair enzyme ALKBH3. OTUD4 recruits USP7 and USP9X to stabilize ALKBH3, thereby promoting the repair of alkylated DNA lesions (PubMed:25944111). Regulates chromosome alignment and segregation in mitosis by regulating the localization of BIRC5/survivin to mitotic centromeres. Involved in axonal growth and neuronal cell migration (PubMed:16322459, PubMed:18254724, PubMed:19135894, PubMed:24607389). Regulates cellular clock function by enhancing the protein stability and transcriptional activity of the core circadian protein ARNTL/BMAL1 via its deubiquitinating activity (PubMed:29626158). {ECO:0000269|PubMed:16322459, ECO:0000269|PubMed:18254724, ECO:0000269|PubMed:19135894, ECO:0000269|PubMed:24607389, ECO:0000269|PubMed:25944111, ECO:0000269|PubMed:29626158}.",axon extension [GO:0048675]; BMP signaling pathway [GO:0030509]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; cellular protein metabolic process [GO:0044267]; chromosome segregation [GO:0007059]; female gamete generation [GO:0007292]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; positive regulation of DNA demethylation [GO:1901537]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transforming growth factor beta receptor signaling pathway [GO:0007179],co-SMAD binding [GO:0070410]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; ubiquitinyl hydrolase activity [GO:0101005],"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19135894}. Cell projection, growth cone {ECO:0000269|PubMed:24607389}.","SUBUNIT: Interacts with SMAD4, MARK4, NUAK1 and BIRC5/survivin. Interacts with DCX. Interacts with OTUD4 and USP7; the interaction is direct (PubMed:25944111). Interacts with ARNTL/BMAL1 (PubMed:29626158). {ECO:0000269|PubMed:16322459, ECO:0000269|PubMed:18254724, ECO:0000269|PubMed:19135894, ECO:0000269|PubMed:24607389, ECO:0000269|PubMed:25944111, ECO:0000269|PubMed:29626158}.",X,41085445,41236579,p11.4,1,0.051,0.4066,6.4105,93.474,0.8089173507956762,ENST00000378308,0.9819178082191781,0.25291177205698573,7665,1,"USP9Y (91, 92, chrY)",TRUE,1,"USP9Y (91, 92, chrY)",TRUE,0.17103551817572912,5.5165447105662775,Cells - Cultured fibroblasts,broadly expressed,3.69462393849068,4.672643144193013,FALSE,high confidence escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:12637,KDM6A,lysine demethylase 6A,Approved,UTX,,Xp11.3,gene with protein product,protein-coding gene,ENSG00000147050,7403,ENSG00000147050,O15550,MGI:1095419,RGD:9275041,X,300128,TRUE,Kabuki syndrome 2,300867,X-linked dominant,,,,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Histone demethylase that specifically demethylates 'Lys-27' of histone H3, thereby playing a central role in histone code (PubMed:17851529, PubMed:17713478, PubMed:17761849). Demethylates trimethylated and dimethylated but not monomethylated H3 'Lys-27' (PubMed:17851529, PubMed:17713478, PubMed:17761849). Plays a central role in regulation of posterior development, by regulating HOX gene expression (PubMed:17851529). Demethylation of 'Lys-27' of histone H3 is concomitant with methylation of 'Lys-4' of histone H3, and regulates the recruitment of the PRC1 complex and monoubiquitination of histone H2A (PubMed:17761849). Plays a demethylase-independent role in chromatin remodeling to regulate T-box family member-dependent gene expression (By similarity). {ECO:0000250|UniProtKB:O70546, ECO:0000269|PubMed:17713478, ECO:0000269|PubMed:17761849, ECO:0000269|PubMed:17851529, ECO:0000269|PubMed:18003914}.",canonical Wnt signaling pathway [GO:0060070]; cardiovascular system development [GO:0072358]; chromatin remodeling [GO:0006338]; heart morphogenesis [GO:0003007]; histone H3-K4 methylation [GO:0051568]; in utero embryonic development [GO:0001701]; mesodermal cell differentiation [GO:0048333]; multicellular organism growth [GO:0035264]; neural tube closure [GO:0001843]; notochord morphogenesis [GO:0048570]; positive regulation of gene expression [GO:0010628]; respiratory system process [GO:0003016]; somite rostral/caudal axis specification [GO:0032525],chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity (H3-K27 specific) [GO:0071558]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565],SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.,"SUBUNIT: Interacts with TLE1 (By similarity). Component of the MLL2/3 complex (also named ASCOM complex), at least composed of KMT2D/MLL2 or KMT2C/MLL3, ASH2L, RBBP5, WDR5, NCOA6, DPY30, KDM6A (or KDM6B), PAXIP1/PTIP, PAGR1 and alpha- and beta-tubulin (PubMed:17500065, PubMed:17713478). Interacts with SUPT6H. Interacts with SMARCA4 (By similarity). {ECO:0000250|UniProtKB:O70546, ECO:0000269|PubMed:17500065, ECO:0000269|PubMed:17713478}.",X,44873188,45112779,p11.3,1,0.161,0.095036,2.946,57.007,0.8465538204890923,ENST00000611820,0.9942457588262265,0.41857035741064735,4362,1,"UTY (86, 86, chrY)",TRUE,1,"UTY (86, 86, chrY)",TRUE,0.2493361801623457,4.724939436538397,Ovary,broadly expressed,1.972630166496385,3.6521365343944203,FALSE,high confidence escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:12641,UXT,ubiquitously expressed prefoldin like chaperone,Approved,,"ART-27, STAP1",Xp11.23,gene with protein product,protein-coding gene,ENSG00000126756,8409,ENSG00000126756,Q9UBK9,MGI:1277988,RGD:1359326,X,300234,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Involved in gene transcription regulation (PubMed:28106301, PubMed:21730289). Acts in concert with the corepressor URI1 to regulate androgen receptor AR-mediated transcription (PubMed:11854421, PubMed:21730289). Together with URI1, associates with chromatin to the NKX3-1 promoter region (PubMed:21730289). Negatively regulates the transcriptional activity of the estrogen receptor ESR1 by inducing its translocation into the cytoplasm (PubMed:28106301). May act as nuclear chaperone that facilitates the formation of the NF-kappa-B enhanceosome and thus positively regulates NF-kappa-B transcription activity (PubMed:17620405, PubMed:21307340). Potential component of mitochondrial-associated LRPPRC, a multidomain organizer that potentially integrates mitochondria and the microtubular cytoskeleton with chromosome remodeling (PubMed:17554592). Increasing concentrations of UXT contributes to progressive aggregation of mitochondria and cell death potentially through its association with LRPPRC (PubMed:17554592). Suppresses cell transformation and it might mediate this function by interaction and inhibition of the biological activity of cell proliferation and survival stimulatory factors like MECOM (PubMed:17635584). {ECO:0000269|PubMed:11827465, ECO:0000269|PubMed:11854421, ECO:0000269|PubMed:16221885, ECO:0000269|PubMed:17554592, ECO:0000269|PubMed:17620405, ECO:0000269|PubMed:17635584, ECO:0000269|PubMed:21307340, ECO:0000269|PubMed:21730289, ECO:0000269|PubMed:28106301}.; FUNCTION: [Isoform 1]: Plays a role in protecting cells against TNF-alpha-induced apoptosis by preventing the recruitment of FADD and caspase 8 to the apoptotic complex I, composed of TRADD, TRAF2 and RIPK1/RIP. {ECO:0000269|PubMed:21307340}.",apoptotic process [GO:0006915]; centrosome cycle [GO:0007098]; microtubule cytoskeleton organization [GO:0000226]; mitochondrion transport along microtubule [GO:0047497]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],beta-tubulin binding [GO:0048487]; chromatin binding [GO:0003682]; microtubule binding [GO:0008017]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714],"SUBCELLULAR LOCATION: [Isoform 1]: Cytoplasm {ECO:0000269|PubMed:21307340}.; SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:21307340, ECO:0000305|PubMed:28106301}. Nucleus {ECO:0000269|PubMed:11854421, ECO:0000269|PubMed:17620405, ECO:0000269|PubMed:21307340, ECO:0000305|PubMed:28106301}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000269|PubMed:16221885}. Cytoplasm, cytoskeleton, spindle pole {ECO:0000269|PubMed:16221885}. Note=Predominantly localizes to the nucleus (PubMed:16221885). Localizes to spindle pole during mitosis (PubMed:16221885). {ECO:0000269|PubMed:16221885, ECO:0000269|PubMed:21307340}.","SUBUNIT: Homohexamer (PubMed:16221885). Interacts with LRPPRC (PubMed:11827465, PubMed:17554592). Interacts with androgen receptor AR (via N-terminus) (PubMed:11854421). Interacts with estrogen receptor ESR1; the interaction relocalizes ESR1 from the nucleus to the cytoplasm (PubMed:28106301). In the nucleus, interacts specifically with RELA (via RHD domain) and forms a dynamic complex with NF-kappa-B and is recruited to the NF-kappa-B enhanceosome upon stimulation (PubMed:17620405). Interacts with MECOM (PubMed:17635584). Interacts with URI1 (PubMed:21730289). Isoform 1 is part of complex I composed of TNF-alpha receptor TNFRSF1A, TRADD, TRAF2 and RIPK1 formed in response to TNF-alpha stimulation. Within the complex, interacts (via TPQE motif) with TRAF2; the interaction prevents the recruitment of FADD and CASP8/caspase 8 to complex I (PubMed:21307340). {ECO:0000269|PubMed:11827465, ECO:0000269|PubMed:11854421, ECO:0000269|PubMed:16221885, ECO:0000269|PubMed:17554592, ECO:0000269|PubMed:17620405, ECO:0000269|PubMed:17635584, ECO:0000269|PubMed:21307340, ECO:0000269|PubMed:21730289, ECO:0000269|PubMed:28106301}.",X,47651796,47659180,p11.23,0.86302,0.46,0.1145,0.69306,6.5077,0.4690591720422518,ENST00000335890,0.907843137254902,0.19927518120469884,510,,,,,,,0.13411536850248829,7.795059086944676,Ovary,broadly expressed,5.373435932337675,5.771775999236457,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:12662,VBP1,VHL binding protein 1,Approved,,"PFD3, PFDN3",Xq28,gene with protein product,protein-coding gene,ENSG00000155959,7411,ENSG00000155959,P61758,MGI:1333804,RGD:1590535,X,300133,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Binds specifically to cytosolic chaperonin (c-CPN) and transfers target proteins to it. Binds to nascent polypeptide chain and promotes folding in an environment in which there are many competing pathways for nonnative proteins. {ECO:0000269|PubMed:9630229}.,microtubule-based process [GO:0007017]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021],tubulin binding [GO:0015631],SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Note=In complex with VHL can translocate to the nucleus.,SUBUNIT: Heterohexamer of two PFD-alpha type and four PFD-beta type subunits. Binds to the C-terminal part of VHL.,X,155197007,155239841,q28,0.88445,0.426,-0.76559,1.3571,7.0197,0.5019424661252858,ENST00000286428,0.9055555555555556,0.05938515371157211,594,,,,,,,0.21016554823037978,6.452588845835792,Cells - EBV-transformed lymphocytes,broadly expressed,5.549046866594348,5.980974670611715,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:12667,VCX,variable charge X-linked,Approved,,"VCX1, VCX10R, VCX-10r, VCX-B1",Xp22.31,gene with protein product,protein-coding gene,ENSG00000182583,26609,ENSG00000182583,Q9H320,,,X,300229,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May mediate a process in spermatogenesis or may play a role in sex ratio distortion.,brain development [GO:0007420]; chromatin organization [GO:0006325]; ribosome assembly [GO:0042255]; spermatogenesis [GO:0007283],chromatin binding [GO:0003682],"","",X,7842262,7844143,p22.31,0.34444,1.821,-2.1099,-2.8068,0.57654,0.3764659158722788,ENST00000381059,0.04428341384863124,0.1617595601099725,621,5,"VCX3B (97, 81, chrX); VCX3A (89, 98, chrX); VCX2 (60, 89, chrX); VCY1B (53, 87, chrY); VCY (53, 87, chrY)",TRUE,1,"VCX3A (89, 98, chrX)",TRUE,0.970592768798734,4.434094415118396,Testis,tissue-specific,0.13879481352260084,0.08153488260307458,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:12731,WAS,WASP actin nucleation promoting factor,Approved,"IMD2, THC","WASP, WASPA",Xp11.23,gene with protein product,protein-coding gene,ENSG00000015285,7454,ENSG00000015285,P42768,MGI:105059,RGD:1563567,X,300392,TRUE,"Neutropenia, severe congenital, X-linked // Thrombocytopenia, X-linked // Thrombocytopenia, X-linked, intermittent // Wiskott-Aldrich syndrome",300299 // 313900 // 313900 // 301000,X-linked recessive // X-linked recessive // X-linked recessive // X-linked recessive,,,,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Effector protein for Rho-type GTPases that regulates actin filament reorganization via its interaction with the Arp2/3 complex (PubMed:12235133, PubMed:12769847, PubMed:16275905). Important for efficient actin polymerization (PubMed:8625410, PubMed:12235133, PubMed:16275905). Possible regulator of lymphocyte and platelet function (PubMed:9405671). Mediates actin filament reorganization and the formation of actin pedestals upon infection by pathogenic bacteria (PubMed:18650809). In addition to its role in the cytoplasmic cytoskeleton, also promotes actin polymerization in the nucleus, thereby regulating gene transcription and repair of damaged DNA (PubMed:20574068). Promotes homologous recombination (HR) repair in response to DNA damage by promoting nuclear actin polymerization, leading to drive motility of double-strand breaks (DSBs) (PubMed:29925947). {ECO:0000269|PubMed:12235133, ECO:0000269|PubMed:12769847, ECO:0000269|PubMed:16275905, ECO:0000269|PubMed:18650809, ECO:0000269|PubMed:20574068, ECO:0000269|PubMed:29925947, ECO:0000269|PubMed:8625410, ECO:0000269|PubMed:9405671}.",actin filament-based movement [GO:0030048]; actin filament polymerization [GO:0030041]; actin polymerization or depolymerization [GO:0008154]; blood coagulation [GO:0007596]; Cdc42 protein signal transduction [GO:0032488]; cellular response to interferon-gamma [GO:0071346]; defense response [GO:0006952]; endosomal transport [GO:0016197]; epidermis development [GO:0008544]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; immune response [GO:0006955]; negative regulation of cell motility [GO:2000146]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of lamellipodium assembly [GO:0010591]; regulation of stress fiber assembly [GO:0051492]; regulation of T cell antigen processing and presentation [GO:0002625]; T cell activation [GO:0042110]; T cell receptor signaling pathway [GO:0050852],actin binding [GO:0003779]; GTPase regulator activity [GO:0030695]; identical protein binding [GO:0042802]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; Rac GTPase binding [GO:0048365]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267],"SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000269|PubMed:8625410}. Nucleus {ECO:0000269|PubMed:20574068, ECO:0000269|PubMed:29925947}.","SUBUNIT: Binds the Arp2/3 complex (PubMed:12769847). Interacts with CDC42, RAC, NCK, HCK, FYN, SRC kinase FGR, BTK, ABL1, PSTPIP1, WIP, and to the p85 subunit of PLC-gamma (PubMed:8643625, PubMed:9405671, PubMed:12235133, PubMed:10360578, PubMed:15235593). Interacts (via C-terminus) with ALDOA (PubMed:17329259). Interacts with NCK1 (via SH3 domains) (By similarity). Interacts with FCHSD2 (By similarity). {ECO:0000250|UniProtKB:P70315, ECO:0000269|PubMed:10360578, ECO:0000269|PubMed:12235133, ECO:0000269|PubMed:12769847, ECO:0000269|PubMed:15235593, ECO:0000269|PubMed:17329259, ECO:0000269|PubMed:8643625, ECO:0000269|PubMed:9405671}.; SUBUNIT: (Microbial infection) Interacts with E.coli effector protein EspF(U). {ECO:0000269|PubMed:18650809}.",X,48676596,48691427,p11.23,0.99901,0.149,0.61681,1.9754,20.034,0.270013865576881,ENST00000376701,0.6535453943008614,0.15261184703824043,1509,,,,,,,0.6431243930495905,8.24115851689629,Whole Blood,tissue-specific,1.8544625019765346,2.00352668209369,FALSE,variable escapee,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:12806,XG,Xg glycoprotein (Xg blood group),Approved,PBDX,,Xp22.33,gene with protein product,protein-coding gene,ENSG00000124343,7499,ENSG00000124343,P55808,,,X,300879,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",homotypic cell-cell adhesion [GO:0034109]; positive regulation of neutrophil extravasation [GO:2000391]; T cell extravasation [GO:0072683],"",SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:7533029}; Single-pass type I membrane protein {ECO:0000269|PubMed:7533029}.,"",X,2752040,2816500,p22.33,9.691e-9,1.664,-0.28923,-0.032323,11.452,0.30925855262009333,ENST00000644266,0.1792517006802721,0.013196700824793801,588,,,,,,,0.6970513535646444,5.726705901975527,Skin - Sun Exposed (Lower leg),tissue-specific,0.05487611536511456,0.055344428836127946,FALSE,high confidence escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:12811,XK,X-linked Kx blood group,Approved,"NA, NAC","XKR1, Kx, X1k",Xp21.1,gene with protein product,protein-coding gene,ENSG00000047597,7504,ENSG00000047597,P51811,MGI:103569,RGD:1359650,X,314850,TRUE,McLeod syndrome with or without chronic granulomatous disease,300842,X-linked,,,,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,TRUE,confirmed,FUNCTION: May be involved in sodium-dependent transport of neutral amino acids or oligopeptides.,amino acid transport [GO:0006865]; cellular calcium ion homeostasis [GO:0006874]; cellular magnesium ion homeostasis [GO:0010961]; myelination [GO:0042552]; regulation of axon diameter [GO:0031133]; regulation of cell size [GO:0008361]; skeletal muscle fiber development [GO:0048741],transporter activity [GO:0005215],SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.,SUBUNIT: Heterodimer with Kell; disulfide-linked. {ECO:0000269|PubMed:9593744}.,X,37685791,37732130,p21.1,0.95373,0.31,-0.63322,2.1242,9.648,0.5726063715261007,ENST00000378616,0.7813483146067416,0.2405898525368658,1335,,,,,,,0.5958034752455227,3.5620592132181104,Colon - Sigmoid,broadly expressed,1.4266995107637754,3.3101786809855325,FALSE,discordant,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:12823,XPNPEP2,X-prolyl aminopeptidase 2,Approved,,,Xq26.1,gene with protein product,protein-coding gene,ENSG00000122121,7512,ENSG00000122121,O43895,MGI:2180001,RGD:621277,X,300145,TRUE,,,,"{Angioedema induced by ACE inhibitors, susceptibility to}",300909,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PMT -CS,FALSE,,PMT,"FUNCTION: Membrane-bound metalloprotease which catalyzes the removal of a penultimate prolyl residue from the N-termini of peptides, such as Arg-Pro-Pro. May play a role in the metabolism of the vasodilator bradykinin. {ECO:0000269|PubMed:15361070}.","",aminopeptidase activity [GO:0004177]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006],"SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q95333}; Lipid-anchor, GPI-anchor {ECO:0000250|UniProtKB:Q95333}.",SUBUNIT: Homotrimer. {ECO:0000250|UniProtKB:Q95333}.,X,129738974,129769536,q26.1,2.867e-13,1.107,-0.7795,-0.33774,29.426,0.2039322507929687,ENST00000371106,0.7065185185185185,0.09665083729067733,2025,,,,,,,0.6422347698736393,5.760604194609025,Small Intestine - Terminal Ileum,tissue-specific,0.09429053308953199,0.0854304351797689,FALSE,discordant,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,PMT
HGNC:12865,ZFP92,ZFP92 zinc finger protein,Approved,,ZNF897,Xq28,gene with protein product,protein-coding gene,ENSG00000189420,139735,ENSG00000189420,A6NM28,MGI:108094,RGD:1559446,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May be involved in transcriptional regulation. {ECO:0000250}.,"regulation of transcription, DNA-templated [GO:0006355]",DNA binding [GO:0003677]; metal ion binding [GO:0046872],SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.,"",X,153418322,153426481,q28,0.65179,0.618,1.4023,2.0456,7.6771,0.25855150112487857,ENST00000338647,0.21750599520383693,0.044288927768057984,1251,,,,,,,0.5864218066730975,3.1506262859573573,Ovary,broadly expressed,1.4348550381602498,3.074205700062597,FALSE,,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,no difference_Post1_Post2,no disorder
HGNC:12869,ZFX,zinc finger protein X-linked,Approved,,ZNF926,Xp22.11,gene with protein product,protein-coding gene,ENSG00000005889,7543,ENSG00000005889,P17010,MGI:99211,RGD:1562664,X,314980,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Probable transcriptional activator.,"","DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]",SUBCELLULAR LOCATION: Nucleus.,"",X,24149173,24216255,p22.11,0.99831,0.16,-0.080378,3.1463,18.613,0.8563505872118312,ENST00000304543,0.9555831265508685,0.3455386153461635,2418,2,"ZFY (88, 93, chrY); ZNF711 (57, 59, chrX)",TRUE,1,"ZFY (88, 93, chrY)",TRUE,0.2864042906596217,4.676431033827764,Uterus,broadly expressed,2.0396297391952953,3.3833379569268907,FALSE,high confidence escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,no disorder
HGNC:12874,ZIC3,Zic family member 3,Approved,HTX1,"HTX, ZNF203",Xq26.3,gene with protein product,protein-coding gene,ENSG00000156925,7547,ENSG00000156925,O60481,MGI:106676,RGD:1561261,X,300265,TRUE,"Congenital heart defects, nonsyndromic, 1, X-linked // Heterotaxy, visceral, 1, X-linked // VACTERL association, X-linked",306955 // 306955 // 314390,X-linked recessive // X-linked recessive // X-linked recessive,,,,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,FUNCTION: Acts as transcriptional activator. Required in the earliest stages in both axial midline development and left-right (LR) asymmetry specification. Binds to the minimal GLI-consensus sequence 5'-GGGTGGTC-3'. {ECO:0000269|PubMed:17764085}.,"anterior/posterior pattern specification [GO:0009952]; cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of left/right asymmetry in nervous system [GO:0035545]; determination of left/right symmetry [GO:0007368]; determination of liver left/right asymmetry [GO:0071910]; determination of pancreatic left/right asymmetry [GO:0035469]; heart looping [GO:0001947]; lung development [GO:0030324]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic stem cell population maintenance [GO:0035019]","DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]",SUBCELLULAR LOCATION: Nucleus. Cytoplasm {ECO:0000250}. Note=Localizes in the cytoplasm in presence of MDFIC overexpression (By similarity). Translocation to the nucleus requires KPNA1 or KPNA6. {ECO:0000250}.,"SUBUNIT: Interacts (via the C2H2-type domains 3, 4 and 5) with MDFIC (via the C2H2-type domains 3, 4 and 5); the interaction reduces its transcriptional activity (By similarity). Interacts with KPNA1 and KPNA6. Interacts (via C2H2-type domains 3, 4 and 5) with GLI3; the interaction enhances its transcriptional activity. {ECO:0000250, ECO:0000269|PubMed:17764085, ECO:0000269|PubMed:18716025}.",X,137566127,137577691,q26.3,0.92495,0.361,0.91675,2.5168,8.28,0.734880571348527,ENST00000287538,0.918019943019943,0.5154461384653837,1404,2,"ZIC2 (69, 60, chr13); ZIC1 (65, 68, chr3)",TRUE,,,,0.9632298163258857,4.8243096203442555,Cerebellar_tissues,tissue-specific,0.9028492415345568,4.8243096203442555,TRUE,low confidence non-escapee,Pre_higher_vs_Post,no difference_Pre_Post1,Pre_higher_vs_Post2,Post1_higher_vs_Post2,confirmed monogenic disorder
HGNC:12942,ZNF157,zinc finger protein 157,Approved,,HZF22,Xp11.3,gene with protein product,protein-coding gene,ENSG00000147117,7712,ENSG00000147117,P51786,,RGD:1359435,X,300024,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May be involved in transcriptional regulation.,"regulation of transcription, DNA-templated [GO:0006355]",DNA binding [GO:0003677]; metal ion binding [GO:0046872],SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.,"",X,47370578,47414498,p11.3,9.6717e-6,1.321,0.51286,0.31416,11.877,0.25421797992637274,ENST00000377073,0.3574621959237344,0.17433141714571357,1521,,,,,,,0.8078418567637878,1.7473745087980372,Cerebellar_tissues,tissue-specific,0.4158787058684106,1.7473745087980372,TRUE,discordant,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:12974,RNF113A,ring finger protein 113A,Approved,ZNF183,"RNF113, Cwc24",Xq24,gene with protein product,protein-coding gene,ENSG00000125352,7737,ENSG00000125352,O15541,"MGI:1913631, MGI:1917192",RGD:1359693,X,300951,TRUE,"Trichothiodystrophy 5, nonphotosensitive",300953,X-linked dominant,,,,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,confirmed +CS,FALSE,TRUE,confirmed,"FUNCTION: Required for pre-mRNA splicing as component of the spliceosome (PubMed:29361316, PubMed:29360106). E3 ubiquitin-protein ligase that catalyzes the transfer of ubiquitin onto target proteins (PubMed:28978524, PubMed:29144457). Catalyzes polyubiquitination of SNRNP200/BRR2 with non-canonical 'Lys-63'-linked polyubiquitin chains (PubMed:29144457). Plays a role in DNA repair via its role in the synthesis of 'Lys-63'-linked polyubiquitin chains that recruit ALKBH3 and the ASCC complex to sites of DNA damage by alkylating agents (PubMed:29144457). Ubiquitinates CXCR4, leading to its degradation, and thereby contributes to the termination of CXCR4 signaling (PubMed:28978524). {ECO:0000269|PubMed:28978524, ECO:0000269|PubMed:29144457, ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316}.","DNA repair [GO:0006281]; isopeptide cross-linking via N6-glycyl-L-lysine [GO:0018276]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; protein ubiquitination [GO:0016567]; snoRNA splicing [GO:0034247]",metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630],"SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316}. Nucleus speckle {ECO:0000269|PubMed:29144457}. Note=Colocalizes with ASCC2 in nuclear foci after DNA damage by alkylating agents. In the absence of DNA damage, colocalizes with the spliceosome components SNRNP200/BRR2 and PRPF8 in nuclear speckles. {ECO:0000269|PubMed:29144457}.","SUBUNIT: Component of pre-catalytic and catalytic spliceosome complexes (PubMed:22365833, PubMed:29361316, PubMed:29360106). Interacts (via N-terminus) with the spliceosome subunit SNRNP200/BRR2 (PubMed:29144457). {ECO:0000269|PubMed:22365833, ECO:0000269|PubMed:29144457, ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316}.",X,119870475,119871733,q24,0.88873,0.42,0.72142,1.7697,7.132,0.727783560554131,ENST00000371442,0.7427325581395349,0.2636090977255686,1032,1,"RNF113B (69, 74, chr13)",TRUE,,,,0.25444758537496204,5.919590363076415,Cells - EBV-transformed lymphocytes,broadly expressed,3.9128989142565302,5.044540567330901,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:12976,ZNF185,zinc finger protein 185 with LIM domain,Approved,,SCELL,Xq28,gene with protein product,protein-coding gene,ENSG00000147394,7739,ENSG00000147394,O15231,MGI:108095,RGD:1586351,X,300381,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May be involved in the regulation of cellular proliferation and/or differentiation.,"",actin filament binding [GO:0051015]; zinc ion binding [GO:0008270],"SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000269|PubMed:16799630}. Cell junction, focal adhesion {ECO:0000269|PubMed:16799630}.","",X,152914442,152973480,q28,6.3026e-13,1.139,-0.21143,0.13689,27.578,0.2422452338979885,ENST00000318504,0.35911251980982567,0.061959510122469384,1893,,,,,,,0.6190953644236548,8.6075411537715,Esophagus - Mucosa,tissue-specific,2.006624770340491,2.3996974789077608,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,no disorder
HGNC:13001,ZNF182,zinc finger protein 182,Approved,ZNF21,"KOX14, HHZ150, Zfp182",Xp11.23,gene with protein product,protein-coding gene,ENSG00000147118,7569,ENSG00000147118,P17025,MGI:2442220,RGD:6490591,X,314993,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May be involved in transcriptional regulation.,"regulation of transcription, DNA-templated [GO:0006355]",DNA binding [GO:0003677]; metal ion binding [GO:0046872],SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.,"",X,47974851,48003989,p11.23,0.98405,0.279,0.46559,1.5727,16.983,0.38902937171756463,ENST00000376943,0.33682232957595276,0.16053486628342914,1863,,,,,,,0.2793035223909842,4.586320399307703,Thyroid,broadly expressed,2.6129846452277503,4.541375444894232,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,no disorder
HGNC:13054,ZMYM3,zinc finger MYM-type containing 3,Approved,ZNF261,"ZNF198L2, DXS6673E, KIAA0385, MYM",Xq13.1,gene with protein product,protein-coding gene,ENSG00000147130,9203,ENSG00000147130,Q14202,MGI:1927231,RGD:1564967,X,300061,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Plays a role in the regulation of cell morphology and cytoskeletal organization. {ECO:0000269|PubMed:21834987}.,cytoskeleton organization [GO:0007010]; multicellular organism development [GO:0007275]; regulation of cell morphogenesis [GO:0022604]; regulation of transcription by RNA polymerase II [GO:0006357],"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]",SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.,"SUBUNIT: May be a component of a BHC histone deacetylase complex that contains HDAC1, HDAC2, HMG20B/BRAF35, KDM1A, RCOR1/CoREST, PHF21A/BHC80, ZMYM2, ZNF217, ZMYM3, GSE1 and GTF2I. {ECO:0000269|PubMed:12493763}.",X,71239624,71255146,q13.1,1,0.106,-0.29728,4.306,44.558,0.3592195954289306,ENST00000314425,0.9175784099197666,0.45808547863034244,4113,,,,,,,0.30218170332230654,6.100426863549368,Ovary,broadly expressed,3.796701571199496,4.9823045660762375,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,no disorder
HGNC:13069,ZNF275,zinc finger protein 275,Approved,,,Xq28,gene with protein product,protein-coding gene,ENSG00000063587,10838,ENSG00000063587,Q9NSD4,MGI:1350985,RGD:1564630,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May be involved in transcriptional regulation.,"",DNA binding [GO:0003677]; metal ion binding [GO:0046872],SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.,"",X,153334147,153360110,q28,2.2666e-4,1.228,0.48714,0.96583,10.696,0.46754905090489407,ENST00000650114,0.28093023255813954,0.20879780054986255,1290,,,,,,,0.4834163144752185,6.181961231571061,Adrenal Gland,broadly expressed,2.881635256164527,3.8213989919436564,FALSE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:13107,ZNF41,zinc finger protein 41,Approved,,"MGC8941, MRX89",Xp11.3,gene with protein product,protein-coding gene,ENSG00000147124,7592,ENSG00000147124,P51814,,,X,314995,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May be involved in transcriptional regulation.,"regulation of transcription, DNA-templated [GO:0006355]",DNA binding [GO:0003677]; metal ion binding [GO:0046872],SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.,"",X,47445879,47482946,p11.3,0.035083,0.618,0.38324,1.3031,19.149,0.5666562632118343,ENST00000377065,0.24816239316239316,0.12464383904023994,2340,,,,,,,0.20691864774311283,3.29590077947479,Cerebellar_tissues,broadly expressed,2.1469484230230025,3.29590077947479,TRUE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:13128,ZNF711,zinc finger protein 711,Approved,"ZNF6, MRX65","CMPX1, ZNF4, ZNF5, dJ75N13.1, Zfp711, MRX97",Xq21.1,gene with protein product,protein-coding gene,ENSG00000147180,7552,ENSG00000147180,Q9Y462,MGI:3045342,RGD:1562768,X,314990,TRUE,"Mental retardation, X-linked 97",300803,X-linked,,,,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Transcription regulator required for brain development. Probably acts as a transcription factor that binds to the promoter of target genes and recruits PHF8 histone demethylase, leading to activate expression of genes involved in neuron development, such as KDM5C. {ECO:0000269|PubMed:20346720}.","positive regulation of reciprocal meiotic recombination [GO:0010845]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]","DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]",SUBCELLULAR LOCATION: Nucleus {ECO:0000305|PubMed:20346720}.,SUBUNIT: Interacts with PHF8. {ECO:0000269|PubMed:20346720}.,X,85243991,85273362,q21.1,0.97887,0.305,0.24652,2.4017,20.626,0.6470933283936896,ENST00000674551,0.9784240924092409,0.28470382404398903,2424,2,"ZFX (59, 57, chrX); ZFY (58, 59, chrY)",TRUE,,,,0.585675799763064,5.9889345808048,Testis,broadly expressed,3.1281762515281546,4.248098348793903,FALSE,discordant,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:13145,ZNF75D,zinc finger protein 75D,Approved,"ZNF82, ZNF75","ZKSCAN24, D8C6, ZSCAN28",Xq26.3,gene with protein product,protein-coding gene,ENSG00000186376,7626,ENSG00000186376,P51815,,RGD:1584423,X,314997,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May be involved in transcriptional regulation.,"regulation of transcription, DNA-templated [GO:0006355]",DNA binding [GO:0003677]; zinc ion binding [GO:0008270],SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00187}.,"",X,135248920,135344109,q26.3,2.6527e-4,0.964,1.0665,0.38051,14.981,0.5082048801687942,ENST00000370766,0.33287671232876714,0.06138465383654086,1533,1,"ZNF75A (67, 64, chr16)",TRUE,,,,0.23997570941944157,3.9732990098282017,Thyroid,broadly expressed,1.820109507105963,3.0614081338212205,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:13156,ZNF81,zinc finger protein 81,Approved,MRX45,HFZ20,Xp11.23,gene with protein product,protein-coding gene,ENSG00000197779,347344,ENSG00000197779,P51508,,RGD:2323171,X,314998,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May be involved in transcriptional regulation.,"regulation of transcription, DNA-templated [GO:0006355]",DNA binding [GO:0003677]; metal ion binding [GO:0046872],SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.,"",X,47836902,48002561,p11.23,0.55402,0.505,0.67283,1.4226,15.362,0.3264972961942659,ENST00000338637,0.3052366565961732,0.1963259185203699,1986,,,,,,,0.2917030086661355,2.212650264458228,Cervix - Ectocervix,broadly expressed,0.7923381378025417,1.7923556311794917,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:13198,ZXDA,zinc finger X-linked duplicated A,Approved,,ZNF896,Xp11.21,gene with protein product,protein-coding gene,ENSG00000198205,7789,ENSG00000198205,P98168,MGI:3694898,,X,300235,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Cooperates with CIITA to promote transcription of MHC class I and MHC class II genes. {ECO:0000269|PubMed:17493635}.,"positive regulation of transcription, DNA-templated [GO:0045893]",C2H2 zinc finger domain binding [GO:0070742]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872],SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.,SUBUNIT: Self-associates. Interacts with ZXDC and CIITA. {ECO:0000269|PubMed:17493635}.,X,57906708,57910820,p11.21,0.0043723,1.116,-0.65929,0.19299,9.4143,0.6414392822025565,ENST00000358697,0.61425,0.26720819795051237,2400,1,"ZXDB (96, 96, chrX)",TRUE,1,"ZXDB (96, 96, chrX)",TRUE,0.3269942453025773,2.365051383565612,Uterus,broadly expressed,0.9273010532989439,1.7819996035776802,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:13199,ZXDB,zinc finger X-linked duplicated B,Approved,,ZNF905,Xp11.21,gene with protein product,protein-coding gene,ENSG00000198455,158586,ENSG00000198455,P98169,MGI:3694898,RGD:1563355,X,300236,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Cooperates with CIITA to promote transcription of MHC class I and MHC class II genes. {ECO:0000250}.,"",metal ion binding [GO:0046872],SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.,SUBUNIT: Self-associates. Interacts with ZXDC and CIITA (By similarity). {ECO:0000250}.,X,57591652,57597545,p11.21,0.95266,0.312,-2.1969,0.9635,9.584,0.6398091110699208,ENST00000374888,0.5793946932006634,0.24393901524618847,2412,2,"ZXDA (96, 96, chrX); ZXDC (56, 52, chr3)",TRUE,1,"ZXDA (96, 96, chrX)",TRUE,0.24057145056667567,3.4235290943139067,Cerebellar_tissues,broadly expressed,2.0249685332435634,3.4235290943139067,TRUE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,no disorder
HGNC:13254,FTSJ1,FtsJ RNA 2'-O-methyltransferase 1,Approved,"MRX9, MRX44","JM23, CDLIV, SPB1, TRM7, TRMT7",Xp11.23,gene with protein product,protein-coding gene,ENSG00000068438,24140,ENSG00000068438,Q9UET6,MGI:1859648,RGD:1561061,X,300499,TRUE,"Mental retardation, X-linked 9/44",309549,X-linked recessive,,,,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,FUNCTION: Methylates the 2'-O-ribose of nucleotides at positions 32 and 34 of the tRNA anticodon loop of substrate tRNAs. {ECO:0000255|HAMAP-Rule:MF_03162}.,cytoplasmic translation [GO:0002181]; RNA methylation [GO:0001510]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]; tRNA nucleoside ribose methylation [GO:0002128],RNA methyltransferase activity [GO:0008173]; tRNA (cytosine-2'-O-)-methyltransferase activity [GO:0052666]; tRNA (guanosine-2'-O-)-methyltransferase activity [GO:0009020]; tRNA methyltransferase activity [GO:0008175],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_03162}.,"",X,48476021,48486364,p11.23,0.99254,0.204,0.46001,2.172,14.629,0.5195371756610715,ENST00000348411,0.8379797979797979,0.1,990,,,,,,,0.19981586334507104,5.635345202118539,Cells - Cultured fibroblasts,broadly expressed,3.6636975639268576,5.011104229670533,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:13315,HDAC8,histone deacetylase 8,Approved,"HDACL1, WTS, MRXS6","RPD3, KDAC8",Xq13.1,gene with protein product,protein-coding gene,ENSG00000147099,55869,ENSG00000147099,Q9BY41,MGI:1917565,RGD:1562895,X,300269,TRUE,Cornelia de Lange syndrome 5,300882,X-linked dominant,,,,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,TRUE,confirmed,"FUNCTION: Responsible for the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4). Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events. Histone deacetylases act via the formation of large multiprotein complexes. Also involved in the deacetylation of cohesin complex protein SMC3 regulating release of cohesin complexes from chromatin. May play a role in smooth muscle cell contractility. {ECO:0000269|PubMed:10748112, ECO:0000269|PubMed:10922473, ECO:0000269|PubMed:10926844, ECO:0000269|PubMed:14701748, ECO:0000269|PubMed:22885700}.",chromatin assembly or disassembly [GO:0006333]; chromatin organization [GO:0006325]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cohesin loading [GO:0071922]; regulation of protein stability [GO:0031647]; regulation of telomere maintenance [GO:0032204]; sister chromatid cohesion [GO:0007062],histone deacetylase activity [GO:0004407]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; metal ion binding [GO:0046872]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; transcription factor binding [GO:0008134],SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Note=Excluded from the nucleoli. Found in the cytoplasm of cells showing smooth muscle differentiation.,"SUBUNIT: Interacts with PEPB2-MYH11, a fusion protein consisting of the 165 N-terminal residues of CBF-beta (PEPB2) with the tail region of MYH11 produced by the inversion Inv(16)(p13q22), a translocation associated with acute myeloid leukemia of M4EO subtype. The PEPB2-MYH1 fusion protein also interacts with RUNX1, a well known transcriptional regulator, suggesting that the interaction with HDAC8 may participate in the conversion of RUNX1 into a constitutive transcriptional repressor. Interacts with CBFA2T3. Interacts with phosphorylated SMG5/EST1B; this interaction protects SMG5 from ubiquitin-mediated degradation. Associates with alpha-SMA (smooth muscle alpha-actin). {ECO:0000269|PubMed:11533236, ECO:0000269|PubMed:12509458, ECO:0000269|PubMed:16809764, ECO:0000269|PubMed:17721440}.",X,72329516,72573101,q13.1,0.97707,0.297,0.33944,2.8212,15.993,0.4963027948364457,ENST00000373573,0.9473544973544974,0.16558360409897527,1134,1,"AL133500.1 (89, 67, chrX)",TRUE,,,,0.21066386921343774,3.4683226439478676,Adrenal Gland,broadly expressed,2.327882775767554,3.3654223914730785,FALSE,high confidence non-escapee,no_difference_Pre_Post,Pre_higher_vs_Post1,no difference_Pre_Post2,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:13339,KIF4A,kinesin family member 4A,Approved,,"KIF4-G1, KIF4, HSA271784, FLJ12530, FLJ12655, FLJ14204, FLJ20631, MRX100",Xq13.1,gene with protein product,protein-coding gene,ENSG00000090889,24137,ENSG00000090889,O95239,MGI:108389,RGD:620526,X,300521,TRUE,,,,"?Mental retardation, X-linked 100",300923,X-linked recessive,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,PMT +CS,FALSE,,PMT,"FUNCTION: Iron-sulfur (Fe-S) cluster binding motor protein that has a role in chromosome segregation during mitosis (PubMed:29848660). Translocates PRC1 to the plus ends of interdigitating spindle microtubules during the metaphase to anaphase transition, an essential step for the formation of an organized central spindle midzone and midbody and for successful cytokinesis (PubMed:15297875, PubMed:15625105). May play a role in mitotic chromosomal positioning and bipolar spindle stabilization (By similarity). {ECO:0000250|UniProtKB:P33174, ECO:0000269|PubMed:15297875, ECO:0000269|PubMed:15625105, ECO:0000269|PubMed:29848660}.","anterograde axonal transport [GO:0008089]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; mitotic spindle organization [GO:0007052]; organelle organization [GO:0006996]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",ATP binding [GO:0005524]; DNA binding [GO:0003677]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777],"SUBCELLULAR LOCATION: Nucleus matrix {ECO:0000269|PubMed:11736643}. Cytoplasm {ECO:0000269|PubMed:11736643}. Cytoplasm, cytoskeleton, spindle {ECO:0000269|PubMed:15297875, ECO:0000269|PubMed:29848660}. Midbody {ECO:0000269|PubMed:15297875, ECO:0000269|PubMed:29848660}. Chromosome {ECO:0000269|PubMed:11736643, ECO:0000269|PubMed:15297875, ECO:0000269|PubMed:29848660}. Note=Associates with chromosomes at all stage of mitosis (PubMed:11736643, PubMed:15297875, PubMed:15625105). Chromatin localization is dependent on iron-sulfur cluster binding (PubMed:29848660). In anaphase, associates with the mitotic spindle midzone (PubMed:15297875). In telophase and cytokinesis, co-localizes with CIAO2B at the spindle midzone and midbody (PubMed:29848660, PubMed:15297875). Co-localizes with PRC1 in early mitosis and at the spindle midzone from anaphase B to telophase (PubMed:15297875, PubMed:15625105). Does not localize to the nucleolus (PubMed:11736643). {ECO:0000269|PubMed:11736643, ECO:0000269|PubMed:15297875, ECO:0000269|PubMed:15625105, ECO:0000269|PubMed:29848660}.","SUBUNIT: Interacts with the cytosolic iron-sulfur protein assembly (CIA) complex components CIAO2B and MMS19; the interactions facilitate the transfer of Fe-S clusters to KIF4A to ensure proper localization of KIF4A to mitotic machinery components (PubMed:29848660). Interacts (via C-terminus) with unphosphorylated PRC1 (via N-terminus); the interaction is required for the progression of mitosis (PubMed:15297875, PubMed:15625105, PubMed:29848660). {ECO:0000269|PubMed:15297875, ECO:0000269|PubMed:15625105, ECO:0000269|PubMed:29848660}.",X,70290104,70420886,q13.1,0.99998,0.2,0.7402,2.5594,52.534,0.467214804296544,ENST00000374403,0.8905650175723169,0.20967258185453636,3699,1,"KIF4B (94, 94, chr5)",TRUE,1,"KIF4B (94, 94, chr5)",TRUE,0.8227408669895502,4.677942282157065,Cells - EBV-transformed lymphocytes,tissue-specific,0.33999476383516397,0.15604577057016908,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,PMT
HGNC:13388,BEX3,brain expressed X-linked 3,Approved,NGFRAP1,"HGR74, Bex, NADE, DXS6984E",Xq22.2,gene with protein product,protein-coding gene,ENSG00000166681,27018,ENSG00000166681,Q00994,MGI:1338016,RGD:3148,X,300361,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May be a signaling adapter molecule involved in p75NTR-mediated apoptosis induced by NGF. Plays a role in zinc-triggered neuronal death (By similarity). May play an important role in the pathogenesis of neurogenetic diseases. {ECO:0000250}.,activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; multicellular organism development [GO:0007275]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; signal transduction [GO:0007165],cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; nerve growth factor receptor binding [GO:0005163]; signaling receptor binding [GO:0005102],SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Note=Shuttles between the cytoplasm and the nucleus. Associates with replicating mitochondria (By similarity). {ECO:0000250}.,SUBUNIT: Self-associates. Binds to the DEATH domain of p75NTR/NGFR. Interacts with 14-3-3 epsilon (YWHAE). Interacts with DIABLO/SMAC. {ECO:0000250|UniProtKB:Q9WTZ9}.,X,103376395,103378164,q22.2,0.62141,0.956,-0.7567,0.99505,3.0902,0.62652008950287,ENST00000361298,0.9879084967320262,0.26708322919270183,306,1,"BEX5 (59, 59, chrX)",TRUE,,,,0.2507353534042177,9.507854090692481,Ovary,broadly expressed,8.500475434281682,8.79270246126417,FALSE,high confidence non-escapee,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:13398,NSDHL,NAD(P) dependent steroid dehydrogenase-like,Approved,,"XAP104, H105e3, SDR31E1",Xq28,gene with protein product,protein-coding gene,ENSG00000147383,50814,ENSG00000147383,Q15738,MGI:1099438,RGD:1359337,X,300275,TRUE,CHILD syndrome // CK syndrome,308050 // 300831,X-linked dominant // X-linked recessive,,,,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,FUNCTION: Catalyzes the NAD(P)(+)-dependent oxidative decarboxylation of the C4 methyl groups of 4-alpha-carboxysterols in post-squalene cholesterol biosynthesis (By similarity). Plays also a role in the regulation of the endocytic trafficking of EGFR (By similarity). {ECO:0000250|UniProtKB:Q9R1J0}.,cholesterol biosynthetic process [GO:0006695]; cholesterol metabolic process [GO:0008203]; hair follicle development [GO:0001942]; labyrinthine layer blood vessel development [GO:0060716]; smoothened signaling pathway [GO:0007224],"3-beta-hydroxy-delta5-steroid dehydrogenase activity [GO:0003854]; 4alpha-carboxy-4beta-methyl-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-oxidoreductase (decarboxylating) activity [GO:0103066]; 4alpha-carboxy-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-dehydrogenase (decarboxylating) activity [GO:0103067]; C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity [GO:0000252]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity [GO:0047012]",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:21129721}; Single-pass membrane protein {ECO:0000255}. Lipid droplet {ECO:0000250|UniProtKB:Q9R1J0}. Note=Trafficking through the Golgi is necessary for ER membrane localization. {ECO:0000250|UniProtKB:Q9R1J0}.,SUBUNIT: Homodimer. {ECO:0000269|PubMed:32140747}.,X,152830967,152869729,q28,0.96393,0.289,-1.0188,0.86892,10.341,0.44529750479846447,ENST00000370274,0.7657754010695187,0.10037490627343164,1122,,,,,,,0.29487205828431606,6.053480653878704,Esophagus - Mucosa,broadly expressed,3.5074394715506965,3.7888161944955825,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:13415,PNCK,pregnancy up-regulated nonubiquitous CaM kinase,Approved,,"MGC45419, CaMK1b",Xq28,gene with protein product,protein-coding gene,ENSG00000130822,139728,ENSG00000130822,Q6P2M8,MGI:1347357,RGD:69249,X,300680,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Calcium/calmodulin-dependent protein kinase belonging to a proposed calcium-triggered signaling cascade. In vitro phosphorylates CREB1 and SYN1/synapsin I. Phosphorylates and activates CAMK1 (By similarity). {ECO:0000250}.,peptidyl-serine phosphorylation [GO:0018105],ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein serine/threonine kinase activity [GO:0004674],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus {ECO:0000250}.,"",X,153669733,153689010,q28,1.0166e-5,1.096,-0.034292,1.5077,15.477,0.5476275477618344,ENST00000340888,0.7909883720930233,0.11017245688577856,1032,,,,,,,0.7293663176754531,6.140349218351171,Colon - Sigmoid,tissue-specific,4.522601930877328,3.7109386459932248,FALSE,discordant,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:13417,PPP2R3B,protein phosphatase 2 regulatory subunit B''beta,Approved,PPP2R3L,"PPP2R3LY, PR48, PR70",Xp22.3 and Yp11.3,gene with protein product,protein-coding gene,ENSG00000167393,28227,ENSG00000167393,Q9Y5P8,,RGD:1588134,X,300339,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,TRUE,,no disorder,"FUNCTION: The B regulatory subunit might modulate substrate selectivity and catalytic activity, and also might direct the localization of the catalytic enzyme to a particular subcellular compartment.",cell cycle arrest [GO:0007050]; protein dephosphorylation [GO:0006470],calcium ion binding [GO:0005509]; protein phosphatase regulator activity [GO:0019888],SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10629059}.,"SUBUNIT: PP2A consists of a common heterodimeric core enzyme, composed of a 36 kDa catalytic subunit (subunit C) and a 65 kDa constant regulatory subunit (PR65 or subunit A), that associates with a variety of regulatory subunits. Proteins that associate with the core dimer include three families of regulatory subunits B (the R2/B/PR55/B55, R3/B''/PR72/PR130/PR59 and R5/B'/B56 families), the 48 kDa variable regulatory subunit, viral proteins, and cell signaling molecules. Interacts with N-terminal region of CDC6. Interacts with NOD2 (PubMed:27812135). {ECO:0000269|PubMed:10629059, ECO:0000269|PubMed:27812135}.",X,333933,386955,p22.33,4.9344e-8,0.892,-4.1501,-1.4039,27.23,0.7924886426267574,ENST00000390665,0.677025462962963,0.04408897775556111,1728,,,,,,,0.33667141858103955,6.011298829215715,Muscle - Skeletal,broadly expressed,3.3377282160034114,3.8587021623712263,FALSE,low confidence escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:13429,RLIM,"ring finger protein, LIM domain interacting",Approved,RNF12,"NY-REN-43, MGC15161",Xq13.2,gene with protein product,protein-coding gene,ENSG00000131263,51132,ENSG00000131263,Q9NVW2,MGI:1342291,RGD:1559832,X,300379,TRUE,Tonne-Kalscheuer syndrome,300978,X-linked,,,,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,confirmed +CS,FALSE,TRUE,confirmed,"FUNCTION: E3 ubiquitin-protein ligase. Acts as a negative coregulator for LIM homeodomain transcription factors by mediating the ubiquitination and subsequent degradation of LIM cofactors LDB1 and LDB2 and by mediating the recruitment the SIN3a/histone deacetylase corepressor complex. Ubiquitination and degradation of LIM cofactors LDB1 and LDB2 allows DNA-bound LIM homeodomain transcription factors to interact with other protein partners such as RLIM. Plays a role in telomere length-mediated growth suppression by mediating the ubiquitination and degradation of TERF1. By targeting ZFP42 for degradation, acts as an activator of random inactivation of X chromosome in the embryo, a stochastic process in which one X chromosome is inactivated to minimize sex-related dosage differences of X-encoded genes in somatic cells of female placental mammals. {ECO:0000269|PubMed:19164295, ECO:0000269|PubMed:19945382}.","negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; random inactivation of X chromosome [GO:0060816]; regulation of dosage compensation by inactivation of X chromosome [GO:1900095]; ubiquitin-dependent protein catabolic process [GO:0006511]",metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842],"SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:19117995, ECO:0000269|PubMed:19164295}.","SUBUNIT: Interacts with LIM/homeobox factors such as LHX3. Interacts with LDB1, LDB2 and SIN3A (By similarity). Interacts with LIMK1 (By similarity). Interacts (via N-terminus) with TERF1. Interacts (via C-terminus) with ESR1. {ECO:0000250, ECO:0000269|PubMed:19117995, ECO:0000269|PubMed:19164295}.",X,74582976,74614624,q13.2,0.99301,0.247,-1.8374,2.4248,19.213,0.587750385399882,ENST00000332687,0.8888533333333334,0.25631092226943264,1875,,,,,,,0.21309028234372296,4.927801661190209,Cells - Cultured fibroblasts,broadly expressed,3.632465990778897,4.252540551146851,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:13449,SLITRK2,SLIT and NTRK like family member 2,Approved,"SLITL1, TMEM257, CXorf1","KIAA1854, CXorf2",Xq27.3,gene with protein product,protein-coding gene,ENSG00000185985,84631,ENSG00000185985,Q9H156,MGI:2679449,RGD:1561361,X,300561,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: It is involved in synaptogenesis and promotes excitatory synapse differentiation (PubMed:27273464, PubMed:27812321). Suppresses neurite outgrowth (By similarity). {ECO:0000250|UniProtKB:Q810C0, ECO:0000269|PubMed:27273464, ECO:0000269|PubMed:27812321}.",axonogenesis [GO:0007409]; positive regulation of synapse assembly [GO:0051965]; regulation of presynapse assembly [GO:1905606]; synaptic membrane adhesion [GO:0099560],"",SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}. Cell membrane {ECO:0000269|PubMed:27812321}.,SUBUNIT: Interacts with PTPRD; this interaction is PTPRD splicing-dependent and may induce pre-synaptic differentiation. {ECO:0000250|UniProtKB:Q810C0}.,X,145817829,145829856,q27.3,0.0064131,0.694,-0.72514,2.1956,18.942,0.6592549826550803,ENST00000335565,0.8867218282111899,0.11272181954511372,2538,,,,,,,0.7799885007571242,4.323816788566489,Nerve - Tibial,tissue-specific,3.4054573745039947,2.832416124918924,FALSE,high confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,no difference_Post1_Post2,no disorder
HGNC:13485,USP26,ubiquitin specific peptidase 26,Approved,,,Xq26.2,gene with protein product,protein-coding gene,ENSG00000134588,83844,ENSG00000134588,Q9BXU7,MGI:1933247,RGD:1563443,X,300309,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Involved in the ubiquitin-dependent proteolytic pathway in conjunction with the 26S proteasome (By similarity). Deubiquitinates the androgen receptor and regulates the androgen receptor signaling pathway. {ECO:0000250, ECO:0000269|PubMed:20501646}.",G1/S transition of mitotic cell cycle [GO:0000082]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511],cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843],SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:20501646}.,SUBUNIT: Interacts with AR. {ECO:0000269|PubMed:20501646}.,X,133024631,133097109,q26.2,,,-0.29962,-0.08368,,0.44688905459581224,ENST00000511190,0.2289204959883297,0.0200449887528118,2742,,,,,,,0.9767441860465116,0.840882133702046,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:13486,USP27X,ubiquitin specific peptidase 27 X-linked,Approved,,USP27,Xp11.23,gene with protein product,protein-coding gene,ENSG00000273820,389856,ENSG00000273820,A6NNY8,MGI:1859645,RGD:1564628,X,300975,TRUE,"Mental retardation, X-linked 105",300984,X-linked recessive,,,,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Deubiquitinase that can reduce the levels of BCL2L11/BIM ubiquitination and stabilize BCL2L11 in response to the RAF-MAPK-degradation signal. By acting on BCL2L11 levels, may counteract the anti-apoptotic effects of MAPK activity. {ECO:0000250|UniProtKB:Q8CEG8}.",positive regulation of apoptotic process [GO:0043065]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; protein stabilization [GO:0050821]; ubiquitin-dependent protein catabolic process [GO:0006511],Lys48-specific deubiquitinase activity [GO:1990380]; Lys63-specific deubiquitinase activity [GO:0061578]; thiol-dependent ubiquitin-specific protease activity [GO:0004843],"SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000250|UniProtKB:Q8CEG8}. Nucleus {ECO:0000250|UniProtKB:Q8CEG8}.",SUBUNIT: Interacts with phosphorylated BCL2L11 isoform BIMEL; this interaction leads to BCL2L11 deubiquitination and stabilization. {ECO:0000250|UniProtKB:Q8CEG8}.,X,49879484,49882558,p11.23,0.92373,0.363,2.105,3.1795,8.2339,0.5178738817974563,ENST00000621775,0.9670463173880031,0.6100724818795301,1317,1,"USP22 (80, 67, chr17)",TRUE,,,,0.5761057655700088,5.4198304347666255,Cerebellar_tissues,broadly expressed,2.481528865665201,5.4198304347666255,TRUE,,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:13554,ATP11C,ATPase phospholipid transporting 11C,Approved,,"ATPIG, ATPIQ",Xq27.1,gene with protein product,protein-coding gene,ENSG00000101974,286410,ENSG00000101974,Q8NB49,MGI:1859661,RGD:1564481,X,300516,TRUE,,,,"?Hemolytic anemia, congenital, X-linked",301015,X-linked recessive,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PMT +CS,FALSE,,PMT,"FUNCTION: Catalytic component of a P4-ATPase flippase complex which catalyzes the hydrolysis of ATP coupled to the transport of aminophospholipids from the outer to the inner leaflet of various membranes and ensures the maintenance of asymmetric distribution of phospholipids. In the cell membrane of erythrocytes, it is required to maintain phosphatidylserine (PS) in the inner leaflet preventing its exposure on the surface. This asymmetric distribution is critical for the survival of erythrocytes in circulation since externalized PS is a phagocytic signal for splenic macrophages (PubMed:26944472). Phospholipid translocation seems also to be implicated in vesicle formation and in uptake of lipid signaling molecules (By similarity). Required for B cell differentiation past the pro-B cell stage (By similarity). Seems to mediate PS flipping in pro-B cells (By similarity). May be involved in the transport of cholestatic bile acids (By similarity). {ECO:0000250|UniProtKB:Q9QZW0, ECO:0000269|PubMed:26944472}.",ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332]; positive regulation of B cell differentiation [GO:0045579]; pre-B cell differentiation [GO:0002329],ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287],SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:21914794}; Multi-pass membrane protein {ECO:0000269|PubMed:21914794}. Endoplasmic reticulum membrane {ECO:0000269|PubMed:21914794}. Note=Efficient exit from the endoplasmic reticulum requires the presence of TMEM30A. Some cell membrane localization observed in the presence of TMEM30B.,"SUBUNIT: Component of a P4-ATPase flippase complex which consists of a catalytic alpha subunit and an accessory beta subunit (Probable). Interacts with beta subunit TMEM30A. {ECO:0000269|PubMed:21914794, ECO:0000305}.",X,139726346,139945276,q27.1,0.9997,0.232,1.2954,1.9874,45.324,0.75088319242965,ENST00000370557,0.8660083782166368,0.12684328917770557,3342,2,"ATP11A (64, 60, chr13); ATP11B (55, 53, chr3)",TRUE,,,,0.2752453431550792,4.402919960924567,Cells - EBV-transformed lymphocytes,broadly expressed,1.5883584520414211,2.3951629070119727,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,PMT
HGNC:13557,ACE2,angiotensin I converting enzyme 2,Approved,,,Xp22.2,gene with protein product,protein-coding gene,ENSG00000130234,59272,ENSG00000130234,Q9BYF1,MGI:1917258,RGD:728890,X,300335,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Essential counter-regulatory carboxypeptidase of the renin-angiotensin hormone system that is a critical regulator of blood volume, systemic vascular resistance, and thus cardiovascular homeostasis (PubMed:27217402). Converts angiotensin I to angiotensin 1-9, a nine-amino acid peptide with anti-hypertrophic effects in cardiomyocytes, and angiotensin II to angiotensin 1-7, which then acts as a beneficial vasodilator and anti-proliferation agent, counterbalancing the actions of the vasoconstrictor angiotensin II (PubMed:10969042, PubMed:10924499, PubMed:11815627, PubMed:19021774, PubMed:14504186). Also removes the C-terminal residue from three other vasoactive peptides, neurotensin, kinetensin, and des-Arg bradykinin, but is not active on bradykinin (PubMed:10969042, PubMed:11815627). Also cleaves other biological peptides, such as apelins (apelin-13, [Pyr1]apelin-13, apelin-17, apelin-36), casomorphins (beta-casomorphin-7, neocasomorphin) and dynorphin A with high efficiency (PubMed:11815627, PubMed:27217402, PubMed:28293165). In addition, ACE2 C-terminus is homologous to collectrin and is responsible for the trafficking of the neutral amino acid transporter SL6A19 to the plasma membrane of gut epithelial cells via direct interaction, regulating its expression on the cell surface and its catalytic activity (PubMed:18424768, PubMed:19185582). {ECO:0000269|PubMed:10924499, ECO:0000269|PubMed:10969042, ECO:0000269|PubMed:11815627, ECO:0000269|PubMed:14504186, ECO:0000269|PubMed:18424768, ECO:0000269|PubMed:19021774, ECO:0000269|PubMed:19185582, ECO:0000269|PubMed:27217402}.; FUNCTION: (Microbial infection) Acts as a receptor for human coronaviruses SARS-CoV and SARS-CoV-2, as well as human coronavirus NL63/HCoV-NL63. {ECO:0000269|PubMed:14647384, ECO:0000269|PubMed:15452268, ECO:0000269|PubMed:15791205, ECO:0000269|PubMed:15897467, ECO:0000269|PubMed:24227843, ECO:0000269|PubMed:32142651, ECO:0000269|PubMed:32155444, ECO:0000269|PubMed:32221306, ECO:0000269|PubMed:32225175}.",angiotensin maturation [GO:0002003]; angiotensin-mediated drinking behavior [GO:0003051]; positive regulation of amino acid transport [GO:0051957]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of gap junction assembly [GO:1903598]; positive regulation of L-proline import across plasma membrane [GO:1905737]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; receptor biosynthetic process [GO:0032800]; receptor-mediated virion attachment to host cell [GO:0046813]; regulation of blood vessel diameter [GO:0097746]; regulation of cardiac conduction [GO:1903779]; regulation of cell population proliferation [GO:0042127]; regulation of cytokine production [GO:0001817]; regulation of inflammatory response [GO:0050727]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; regulation of transmembrane transporter activity [GO:0022898]; regulation of vasoconstriction [GO:0019229]; tryptophan transport [GO:0015827]; viral entry into host cell [GO:0046718],carboxypeptidase activity [GO:0004180]; endopeptidase activity [GO:0004175]; metallocarboxypeptidase activity [GO:0004181]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270],SUBCELLULAR LOCATION: [Processed angiotensin-converting enzyme 2]: Secreted {ECO:0000269|PubMed:15983030}.; SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:18424768}; Single-pass type I membrane protein {ECO:0000255}. Cytoplasm {ECO:0000250|UniProtKB:Q8R0I0}. Note=Detected in both cell membrane and cytoplasm in neurons. {ECO:0000250|UniProtKB:Q8R0I0}.,"SUBUNIT: Homodimer (PubMed:32132184). Interacts with ITGB1 (PubMed:15276642). Interacts with the catalytically active form of TMPRSS2 (PubMed:21068237). Interacts with SLC6A19; this interaction is essential for expression and function of SLC6A19 in intestine (By similarity). {ECO:0000250|UniProtKB:Q8R0I0, ECO:0000269|PubMed:15276642, ECO:0000269|PubMed:21068237, ECO:0000269|PubMed:32132184}.; SUBUNIT: (Microbial infection) Interacts with SARS coronavirus/SARS-CoV spike protein. {ECO:0000269|PubMed:14647384, ECO:0000269|PubMed:15452268, ECO:0000269|PubMed:15791205, ECO:0000269|PubMed:32225175}.; SUBUNIT: (Microbial infection) Interacts with SARS coronavirus-2/SARS-CoV-2 spike protein. {ECO:0000269|PubMed:32075877, ECO:0000269|PubMed:32132184, ECO:0000269|PubMed:32155444, ECO:0000269|PubMed:32225175}.; SUBUNIT: (Microbial infection) Interacts with human coronavirus NL63/HCoV-NL63 spike glycoprotein. {ECO:0000269|PubMed:15897467}.",X,15561033,15602148,p22.2,0.99769,0.25,1.3311,1.2455,31.007,0.20905263226662052,ENST00000252519,0.7208436724565757,0.20819795051237192,2418,,,,,,,0.7713134482174303,5.570790779008565,Testis,tissue-specific,0.1151660500332622,0.12021370311836993,FALSE,high confidence escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:13574,MAGEC2,MAGE family member C2,Approved,MAGEE1,"CT10, MAGE-C2, HCA587",Xq27.2,gene with protein product,protein-coding gene,ENSG00000046774,51438,ENSG00000046774,Q9UBF1,,RGD:1563272,X,300468,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Proposed to enhance ubiquitin ligase activity of RING-type zinc finger-containing E3 ubiquitin-protein ligases. In vitro enhances ubiquitin ligase activity of TRIM28 and stimulates p53/TP53 ubiquitination in presence of Ubl-conjugating enzyme UBE2H leading to p53/TP53 degradation. Proposed to act through recruitment and/or stabilization of the Ubl-conjugating enzymes (E2) at the E3:substrate complex. {ECO:0000269|PubMed:20864041}.,cellular protein catabolic process [GO:0044257]; positive regulation of ubiquitin-protein transferase activity [GO:0051443],ubiquitin protein ligase binding [GO:0031625],"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12920247}. Nucleus {ECO:0000269|PubMed:12920247}. Note=Nuclear in germ cells. Cytoplasmic in well-differentiated hepatocellular carcinoma, nuclear in moderately- and poorly-differentiated hepatocellular carcinoma.","SUBUNIT: Interacts with TRIM28 and UBE2H. {ECO:0000269|PubMed:17942928, ECO:0000269|PubMed:20864041}.",X,142202342,142205290,q27.2,,,-1.9861,-0.65349,,0.2372685642879175,ENST00000247452,0.06408199643493762,0.07635591102224444,1122,,,,,,,0.9765483992488664,5.451418844961791,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:13629,PABPC5,poly(A) binding protein cytoplasmic 5,Approved,,PABP5,Xq21.31,gene with protein product,protein-coding gene,ENSG00000174740,140886,ENSG00000174740,Q96DU9,MGI:2136401,RGD:1587661,X,300407,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Binds the poly(A) tail of mRNA. May be involved in cytoplasmic regulatory processes of mRNA metabolism. Can probably bind to cytoplasmic RNA sequences other than poly(A) in vivo (By similarity). {ECO:0000250}.,"",mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.; SUBCELLULAR LOCATION: [Isoform 2]: Mitochondrion matrix {ECO:0000269|PubMed:23275553}. Note=Co-fractionates with mtDNA and co-immunoprecipitates with the mitochondrial poly(A) polymerase.,"",X,91434595,91438584,q21.31,0.89297,0.413,-0.31895,1.9555,7.2469,0.5376394169540065,ENST00000312600,0.8751087902523934,0.45448637840539863,1149,1,"PABPC4L (60, 62, chr4)",TRUE,,,,0.5552268119359064,2.997153280680187,Ovary,broadly expressed,0.9213891034796927,0.831129358514196,FALSE,,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:13705,TMEM187,transmembrane protein 187,Approved,CXorf12,"ITBA1, DXS9878E",Xq28,gene with protein product,protein-coding gene,ENSG00000177854,8269,ENSG00000177854,Q14656,,,X,300059,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","",SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.,"",X,153972754,153983194,q28,0.015717,1.592,-0.19382,0.13532,4.5759,0.7623725648208552,ENST00000369982,0.47951653944020356,0.25051237190702325,786,,,,,,,0.20019865598004422,4.147705583005973,Nerve - Tibial,broadly expressed,2.411374719983468,2.5498625848501026,FALSE,variable escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:13711,POF1B,POF1B actin binding protein,Approved,,"POF, FLJ22792",Xq21.1,gene with protein product,protein-coding gene,ENSG00000124429,79983,ENSG00000124429,Q8WVV4,MGI:1916943,RGD:1560798,X,300603,TRUE,,,,?Premature ovarian failure 2B,300604,X-linked recessive,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PMT +CS,FALSE,,PMT,"FUNCTION: Plays a key role in the organization of epithelial monolayers by regulating the actin cytoskeleton. May be involved in ovary development. {ECO:0000269|PubMed:16773570, ECO:0000269|PubMed:21940798}.",actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; bicellular tight junction assembly [GO:0070830]; epithelial cell morphogenesis [GO:0003382],actin filament binding [GO:0051015],"SUBCELLULAR LOCATION: Cell junction, tight junction {ECO:0000269|PubMed:21940798}.",SUBUNIT: Interacts with nonmuscle actin. {ECO:0000269|PubMed:16773570}.,X,85277396,85379717,q21.1,4.507e-11,1.138,-0.2091,0.78017,24.496,0.12580990123922753,ENST00000262753,0.9285875706214689,0.22039490127468134,1770,,,,,,,0.8174616246074463,7.73425574335536,Skin - Sun Exposed (Lower leg),tissue-specific,0.03610421203161467,0.11345507346397395,FALSE,variable escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,PMT
HGNC:13749,FAM3A,FAM3 metabolism regulating signaling molecule A,Approved,,"DXS560S, 2-19, XAP-7",Xq28,gene with protein product,protein-coding gene,ENSG00000071889,60343,ENSG00000071889,P98173,MGI:1913544,RGD:1562076,X,300492,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May act as a defensin against invading fungal microorganisms.,antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; negative regulation of antifungal innate immune response [GO:1905035]; negative regulation of gluconeogenesis [GO:0045721]; regulation of lipid biosynthetic process [GO:0046890],"",SUBCELLULAR LOCATION: Secreted {ECO:0000305}.,"",X,154506159,154516242,q28,0.66899,0.602,-0.85132,0.92684,7.8781,0.556553340372981,ENST00000447601,0.8383838383838383,0.04271432141964509,693,,,,,,,0.16485126117710466,6.705521805299992,Ovary,broadly expressed,5.210805745569293,5.623657662926543,FALSE,low confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,no difference_Post1_Post2,no disorder
HGNC:1378,CA5B,carbonic anhydrase 5B,Approved,,,Xp22.2,gene with protein product,protein-coding gene,ENSG00000169239,11238,ENSG00000169239,Q9Y2D0,MGI:1926249,RGD:1549783,X,300230,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Reversible hydration of carbon dioxide.,bicarbonate transport [GO:0015701]; one-carbon metabolic process [GO:0006730]; response to bacterium [GO:0009617],carbonate dehydratase activity [GO:0004089]; hydro-lyase activity [GO:0016836]; zinc ion binding [GO:0008270],SUBCELLULAR LOCATION: Mitochondrion.,"",X,15688830,15788411,p22.2,2.6112e-4,1.196,0.28559,-0.048138,10.983,0.4254796100715751,ENST00000318636,0.7637316561844864,0.09105223694076481,954,1,"CA5A (58, 60, chr16)",TRUE,,,,0.4199327482279291,3.955889319830197,Artery - Aorta,broadly expressed,2.0818542968657945,1.7499010624534506,FALSE,low confidence escapee,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:13817,CHST7,carbohydrate sulfotransferase 7,Approved,,"C6ST-2, C6ST2",Xp11.3,gene with protein product,protein-coding gene,ENSG00000147119,56548,ENSG00000147119,Q9NS84,MGI:1891767,RGD:1303028,X,300375,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) as sulfonate donor to catalyze the transfer of sulfate to position 6 of non-reducing N-acetylglucosamine (GlcNAc) residues. Preferentially acts on mannose-linked GlcNAc. Also able to catalyze the transfer of sulfate to position 6 of the N-acetylgalactosamine (GalNAc) residue of chondroitin. Also acts on core 2 mucin-type oligosaccharide and N-acetyllactosamine oligomer with a lower efficiency. Has weak or no activity toward keratan sulfate and oligosaccharides containing the Galbeta1-4GlcNAc. Catalyzes 6-O-sulfation of beta-benzyl GlcNAc but not alpha- or beta-benzyl GalNAc. {ECO:0000269|PubMed:10781596, ECO:0000269|PubMed:10913333, ECO:0000269|PubMed:10956661}.",chondroitin sulfate biosynthetic process [GO:0030206]; N-acetylglucosamine metabolic process [GO:0006044]; polysaccharide metabolic process [GO:0005976]; sulfur compound metabolic process [GO:0006790],chondroitin 6-sulfotransferase activity [GO:0008459]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517],SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000250}; Single-pass type II membrane protein {ECO:0000250}.,"",X,46573765,46598496,p11.3,0.068651,0.973,0.21941,1.9383,7.9659,0.7858960268589753,ENST00000276055,0.6309377138945927,0.27905523619095224,1461,,,,,,,0.45995106136293074,6.039223952663368,Ovary,broadly expressed,2.9238698724442784,2.861557427073723,FALSE,high confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,no difference_Pre_Post2,Post1_higher_vs_Post2,no disorder
HGNC:13867,SH3KBP1,SH3 domain containing kinase binding protein 1,Approved,,CIN85,Xp22.12,gene with protein product,protein-coding gene,ENSG00000147010,30011,ENSG00000147010,Q96B97,MGI:1889583,RGD:620904,X,300374,TRUE,,,,?Immunodeficiency 61,300310,X-linked recessive,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PMT +CS,FALSE,,PMT,"FUNCTION: Adapter protein involved in regulating diverse signal transduction pathways. Involved in the regulation of endocytosis and lysosomal degradation of ligand-induced receptor tyrosine kinases, including EGFR and MET/hepatocyte growth factor receptor, through an association with CBL and endophilins. The association with CBL, and thus the receptor internalization, may be inhibited by an interaction with PDCD6IP and/or SPRY2. Involved in regulation of ligand-dependent endocytosis of the IgE receptor. Attenuates phosphatidylinositol 3-kinase activity by interaction with its regulatory subunit (By similarity). May be involved in regulation of cell adhesion; promotes the interaction between TTK2B and PDCD6IP. May be involved in the regulation of cellular stress response via the MAPK pathways through its interaction with MAP3K4. Is involved in modulation of tumor necrosis factor mediated apoptosis. Plays a role in the regulation of cell morphology and cytoskeletal organization. Required in the control of cell shape and migration. Has an essential role in the stimulation of B cell activation (PubMed:29636373). {ECO:0000250, ECO:0000269|PubMed:11894095, ECO:0000269|PubMed:11894096, ECO:0000269|PubMed:12177062, ECO:0000269|PubMed:12734385, ECO:0000269|PubMed:12771190, ECO:0000269|PubMed:15090612, ECO:0000269|PubMed:15707590, ECO:0000269|PubMed:16177060, ECO:0000269|PubMed:16256071, ECO:0000269|PubMed:21834987, ECO:0000269|PubMed:29636373}.",actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; cell-cell signaling [GO:0007267]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; membrane organization [GO:0061024]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; positive regulation of B cell activation [GO:0050871]; regulation of cell shape [GO:0008360],SH3 domain binding [GO:0017124],"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:20221403}. Cytoplasm, cytoskeleton. Cytoplasmic vesicle membrane; Peripheral membrane protein. Cell junction, synapse, synaptosome. Cell junction, focal adhesion {ECO:0000250}. Note=Localized in endocytic vesicles containing clustered receptors. Colocalizes with ASAP1 in vesicular structures. Colocalized with actin microfilaments and focal adhesions (By similarity). Colocalized with MAGI2 in synaptosomes. Translocation to EGFR containing vesicles upon EGF stimulation is inhibited in the presence of SH3KBP1 (By similarity). Colocalizes with ZFP36 in the cytoplasm (PubMed:20221403). {ECO:0000250|UniProtKB:Q8R550, ECO:0000269|PubMed:20221403}.","SUBUNIT: Can self-associate and form homotetramers. Interacts with CD2, F-actin capping protein, PIK3R3, GRB2, EGFR, MET, BLNK, MAP3K4, PDCD6IP, SPRY2, ARHGAP17, ARHGAP27, MAGI2, CRK, BCAR1, SOS1, ASAP1, ARAP3, HIP1R, SYNJ2, INPP5D and STAP1. Interacts with CBL and CBLB, but does not interact with CBLC. Two molecules of SH3KBP1 seem to bind through their respective SH3 1 domain to one molecule of CBLB. The interaction with CBL or CBLB and EGFR is increased upon EGF stimulation. The interaction with CBL is attenuated by PDCD6IP. Interacts through its proline-rich region with the SH3 domain of endophilins SH3GL1, SH3GL2 and SH3GL3. The SH3KBP1-endophilin complex seems to associate with a complex containing the phosphorylated receptor (EGFR or MET) and phosphorylated CBL. Probably associates with ASAP1 and phosphorylated EGFR. Probably part of a complex consisting of at least SH3KBP1, ASAP1 and ARAP3. Interacts with focal adhesion kinases PTK2/FAK1 AND PTK2B/PYK2, probably as a dimer. Interacts with DAB2 and probably associates with chathrin through its interaction with DAB2. Part of a complex consisting of SH3KBP1, DAB2, and clathrin heavy chain. DAB2 and clathrin dissociate from SH3KBP1 following growth factor treatment, enabling interaction with CBL. Interacts with DDN and probably associates with MAGI2 through its interaction with DDN. Interacts with the SH3 domains of SRC tyrosine-protein kinases SRC, LCK, LYN, FGR, FYN and HCK. Interacts with TRADD, BIRC2, TRAF1, TRAF2 and TNFR1, and the association with a TNFR1-associated complex upon stimulation with TNF-alpha seems to be mediated by SRC. Interacts (via SH3 domains) with SHKBP1 (via PXXXPR motifs) (By similarity). Interaction with CBL is abolished in the presence of SHKBP1 (By similarity). Interacts (via SH3 domains) with ZFP36 (via extreme C-terminal region) (PubMed:20221403). Interacts with MAP3K4; this interaction enhances the association with ZFP36 (PubMed:20221403). {ECO:0000250|UniProtKB:Q8R550, ECO:0000269|PubMed:10679202, ECO:0000269|PubMed:11071869, ECO:0000269|PubMed:11894095, ECO:0000269|PubMed:11894096, ECO:0000269|PubMed:12177062, ECO:0000269|PubMed:12690097, ECO:0000269|PubMed:12771190, ECO:0000269|PubMed:14596919, ECO:0000269|PubMed:15090612, ECO:0000269|PubMed:15456872, ECO:0000269|PubMed:15707590, ECO:0000269|PubMed:15962011, ECO:0000269|PubMed:16228008, ECO:0000269|PubMed:16256071, ECO:0000269|PubMed:16678097, ECO:0000269|PubMed:16751601, ECO:0000269|PubMed:16895919, ECO:0000269|PubMed:20221403}.",X,19533977,19887600,p22.12,0.99899,0.194,-1.2493,2.0512,24.405,0.7017022225525905,ENST00000397821,0.9372872872872873,0.20957260684828793,1998,,,,,,,0.46730559107273334,7.177708546387882,Cells - EBV-transformed lymphocytes,broadly expressed,4.0613614711443295,2.2128587826051063,FALSE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,PMT
HGNC:13910,DMRTC1,DMRT like family C1,Approved,,,Xq13.1,gene with protein product,protein-coding gene,ENSG00000269502,63947,ENSG00000269502,Q5HYR2,MGI:1918137,RGD:11451771,X,300878,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]","","",X,72872025,72943814,q13.1,0.023698,1.886,0.59389,0.8579,1.9033,0.3039824319118661,ENST00000595412,0.2233160621761658,0.05346163459135216,579,1,"DMRTC1B (100, 100, chrX)",TRUE,1,"DMRTC1B (100, 100, chrX)",TRUE,0.9483438505562375,0.0891956141729681,Pituitary,tissue-specific,0.02259081425063253,0.0392128785748224,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:1393,CACNA1F,calcium voltage-gated channel subunit alpha1 F,Approved,"CSNB2, AIED","Cav1.4, JM8, JMC8, CSNBX2, CORDX3, CSNB2A, OA2",Xp11.23,gene with protein product,protein-coding gene,ENSG00000102001,778,ENSG00000102001,O60840,MGI:1859639,RGD:621535,X,300110,TRUE,"Aland Island eye disease // Cone-rod dystrophy, X-linked, 3 // Night blindness, congenital stationary (incomplete), 2A, X-linked",300600 // 300476 // 300071,X-linked // X-linked recessive // X-linked,,,,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: [Isoform 1]: Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. The isoform alpha-1F gives rise to L-type calcium currents. Long-lasting (L-type) calcium channels belong to the 'high-voltage activated' (HVA) group. They are blocked by dihydropyridines (DHP), phenylalkylamines, and by benzothiazepines. Activates at more negative voltages and does not undergo calcium-dependent inactivation (CDI), due to incoming calcium ions, during depolarization. {ECO:0000269|PubMed:27226626}.; FUNCTION: [Isoform 4]: Voltage-dependent L-type calcium channel activates at more hyperpolarized voltages and exhibits a robust calcium-dependent inactivation (CDI), due to incoming calcium ions, during depolarizations. {ECO:0000269|PubMed:27226626}.; FUNCTION: [Isoform 6]: Voltage-dependent L-type calcium channel activates at more hyperpolarized voltages and exibits a robust calcium-dependent inactivation (CDI), due to incoming calcium ions, during depolarizations. {ECO:0000269|PubMed:27226626}.",calcium ion import [GO:0070509]; calcium ion transport [GO:0006816]; cardiac conduction [GO:0061337]; detection of light stimulus involved in visual perception [GO:0050908]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; regulation of ion transmembrane transport [GO:0034765]; regulation of T cell receptor signaling pathway [GO:0050856]; T cell homeostasis [GO:0043029]; visual perception [GO:0007601],high voltage-gated calcium channel activity [GO:0008331]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245],SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.,"SUBUNIT: Voltage-dependent calcium channels are multisubunit complexes, consisting of alpha-1, alpha-2, beta and delta subunits in a 1:1:1:1 ratio. The channel activity is directed by the pore-forming and voltage-sensitive alpha-1 subunit. In many cases, this subunit is sufficient to generate voltage-sensitive calcium channel activity. The auxiliary subunits beta and alpha-2/delta linked by a disulfide bridge regulate the channel activity. Interacts (via IQ domain) with CABP4; in a calcium independent manner (By similarity). {ECO:0000250, ECO:0000305}.; SUBUNIT: [Isoform 4]: interacts with CABP4; suppreses robust calcium-dependent inactivation of channel whithout enhances the hyperpolarized voltage-dependent activation (PubMed:27226626). {ECO:0000269|PubMed:27226626}.",X,49205063,49233371,p11.23,1.2337e-5,0.448,1.6007,2.6007,72.744,0.4259760992869698,ENST00000323022,0.7522453821386206,0.30332416895776054,5901,3,"CACNA1D (66, 60, chr3); CACNA1C (62, 56, chr12); CACNA1S (55, 58, chr1)",TRUE,,,,0.7434704229451442,1.8010551591934145,Small Intestine - Terminal Ileum,tissue-specific,0.4133026979057711,1.645039868149109,FALSE,high confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:14064,HDAC6,histone deacetylase 6,Approved,,"KIAA0901, JM21, HD6, FLJ16239, PPP1R90",Xp11.23,gene with protein product,protein-coding gene,ENSG00000094631,10013,ENSG00000094631,Q9UBN7,MGI:1333752,RGD:619981,X,300272,TRUE,,,,"?Chondrodysplasia with platyspondyly, distinctive brachydactyly, hydrocephaly, and microphthalmia",300863,X-linked dominant,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,PMT +CS,FALSE,,PMT,"FUNCTION: Responsible for the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4) (PubMed:10220385). Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events (PubMed:10220385). Histone deacetylases act via the formation of large multiprotein complexes (PubMed:10220385). In addition to histones, deacetylates other proteins: plays a central role in microtubule-dependent cell motility by mediating deacetylation of tubulin (PubMed:12024216, PubMed:20308065). Promotes deacetylation of CTTN, leading to actin polymerization, promotion of autophagosome-lysosome fusion and completion of autophagy (PubMed:30538141). Involved in the MTA1-mediated epigenetic regulation of ESR1 expression in breast cancer (PubMed:24413532). In addition to its protein deacetylase activity, plays a key role in the degradation of misfolded proteins: when misfolded proteins are too abundant to be degraded by the chaperone refolding system and the ubiquitin-proteasome, mediates the transport of misfolded proteins to a cytoplasmic juxtanuclear structure called aggresome (PubMed:17846173). Probably acts as an adapter that recognizes polyubiquitinated misfolded proteins and target them to the aggresome, facilitating their clearance by autophagy (PubMed:17846173). {ECO:0000269|PubMed:10220385, ECO:0000269|PubMed:12024216, ECO:0000269|PubMed:17846173, ECO:0000269|PubMed:20308065, ECO:0000269|PubMed:24413532, ECO:0000269|PubMed:30538141}.","aggresome assembly [GO:0070842]; autophagy [GO:0006914]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to misfolded protein [GO:0071218]; cellular response to topologically incorrect protein [GO:0035967]; cilium assembly [GO:0060271]; collateral sprouting [GO:0048668]; dendritic spine morphogenesis [GO:0060997]; histone deacetylation [GO:0016575]; Hsp90 deacetylation [GO:0070846]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; mitochondrion localization [GO:0051646]; negative regulation of hydrogen peroxide metabolic process [GO:0010727]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of protein-containing complex disassembly [GO:0043242]; negative regulation of proteolysis [GO:0045861]; negative regulation of transcription, DNA-templated [GO:0045892]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; peptidyl-lysine deacetylation [GO:0034983]; polyubiquitinated misfolded protein transport [GO:0070845]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of hydrogen peroxide-mediated programmed cell death [GO:1901300]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of receptor biosynthetic process [GO:0010870]; protein-containing complex disassembly [GO:0032984]; protein deacetylation [GO:0006476]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of autophagy [GO:0010506]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of establishment of protein localization [GO:0070201]; regulation of fat cell differentiation [GO:0045598]; regulation of gene expression, epigenetic [GO:0040029]; regulation of macroautophagy [GO:0016241]; regulation of microtubule-based movement [GO:0060632]; regulation of protein stability [GO:0031647]; response to growth factor [GO:0070848]; response to misfolded protein [GO:0051788]; tubulin deacetylation [GO:0090042]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]",actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-catenin binding [GO:0008013]; beta-tubulin binding [GO:0048487]; dynein complex binding [GO:0070840]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; Hsp90 protein binding [GO:0051879]; microtubule binding [GO:0008017]; misfolded protein binding [GO:0051787]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein deacetylase activity [GO:0033558]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription corepressor binding [GO:0001226]; tau protein binding [GO:0048156]; tubulin deacetylase activity [GO:0042903]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12024216, ECO:0000269|PubMed:24687993}. Cytoplasm, cytoskeleton {ECO:0000269|PubMed:12024216}. Nucleus {ECO:0000250|UniProtKB:Q9Z2V5}. Perikaryon {ECO:0000250|UniProtKB:Q9Z2V5}. Cell projection, dendrite {ECO:0000250|UniProtKB:Q9Z2V5}. Cell projection, axon {ECO:0000250|UniProtKB:Q9Z2V5}. Note=It is mainly cytoplasmic, where it is associated with microtubules. {ECO:0000269|PubMed:12024216}.","SUBUNIT: Interacts with SIRT2 (via both phosphorylated, unphosphorylated, active or inactive forms); the interaction is necessary for the complex to interact with alpha-tubulin (PubMed:12620231, PubMed:17516032). Under proteasome impairment conditions, interacts with UBD via its histone deacetylase 1 and UBP-type zinc-finger regions (PubMed:19033385, PubMed:25422469). Interacts with BBIP10, CBFA2T3, CYLD, DDIT3/CHOP, ZMYND15, F-actin and HDAC11 (PubMed:19893491, PubMed:11533236, PubMed:11948178, PubMed:19081074, PubMed:17872950). Interacts with RIPOR2; this interaction occurs during early myogenic differentiation and prevents HDAC6 to deacetylate tubulin (PubMed:24687993). Interacts with DYSF; this interaction occurs during early myogenic differentiation (PubMed:24687993). Interacts with TPPP; inhibiting the tubulin deacetylase activity of HDAC6 (PubMed:20308065, PubMed:23093407). Interacts with DYNLL1 (PubMed:31505170). Interacts with ATP13A2; the interaction results in recruitment of HDAC6 to lysosomes to promote CTTN deacetylation (PubMed:30538141). {ECO:0000269|PubMed:11533236, ECO:0000269|PubMed:11948178, ECO:0000269|PubMed:12620231, ECO:0000269|PubMed:17516032, ECO:0000269|PubMed:17872950, ECO:0000269|PubMed:19033385, ECO:0000269|PubMed:19081074, ECO:0000269|PubMed:19893491, ECO:0000269|PubMed:20308065, ECO:0000269|PubMed:23093407, ECO:0000269|PubMed:24687993, ECO:0000269|PubMed:25422469, ECO:0000269|PubMed:30538141, ECO:0000269|PubMed:31505170}.",X,48801377,48824982,p11.23,1,0.072,0.33723,3.2915,41.161,0.5616769871923779,ENST00000334136,0.5877467105263158,0.1857035741064734,3648,,,,,,,0.21229859853350944,6.7315769957797444,Pituitary,broadly expressed,4.435208524641718,6.475340283529648,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,PMT
HGNC:14090,RAB9B,"RAB9B, member RAS oncogene family",Approved,,RAB9L,Xq22.2,gene with protein product,protein-coding gene,ENSG00000123570,51209,ENSG00000123570,Q9NP90,MGI:2442454,RGD:1562951,X,300285,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Involved in the transport of proteins between the endosomes and the trans Golgi network. {ECO:0000250|UniProtKB:P24408}.,"neutrophil degranulation [GO:0043312]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; retrograde transport, endosome to Golgi [GO:0042147]",GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802],"SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Lipid-anchor {ECO:0000305}; Cytoplasmic side {ECO:0000305}. Cytoplasmic vesicle, phagosome {ECO:0000269|PubMed:21255211}. Cytoplasmic vesicle, phagosome membrane {ECO:0000250}; Lipid-anchor {ECO:0000250}; Cytoplasmic side {ECO:0000250}. Note=Recruited to phagosomes containing S.aureus or M.tuberculosis.","SUBUNIT: Interacts (GTP-bound form) with SGSM1; the GDP-bound form has much lower affinity for SGSM1 (PubMed:22637480). The GTP-bound form but not the GDP-bound form interacts with HPS4 and the BLOC-3 complex (heterodimer of HPS1 and HPS4) but does not interact with HPS1 alone (PubMed:20048159). {ECO:0000269|PubMed:20048159, ECO:0000269|PubMed:22637480}.",X,103822327,103832257,q22.2,0.7343,0.683,-0.66844,1.8044,4.3785,0.4754025774276992,ENST00000243298,0.9656765676567657,0.18030492376905774,606,1,"RAB9A (76, 76, chrX)",TRUE,,,,0.5670801342127946,5.1437444165463475,Cerebellar_tissues,broadly expressed,3.0682202205207667,5.1437444165463475,TRUE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,no difference_Pre_Post2,Post2_higher_vs_Post1,no disorder
HGNC:14270,PCDH19,protocadherin 19,Approved,EFMR,"KIAA1313, EIEE9",Xq22.1,gene with protein product,protein-coding gene,ENSG00000165194,57526,ENSG00000165194,Q8TAB3,MGI:2685563,RGD:1565392,X,300460,TRUE,"Epileptic encephalopathy, early infantile, 9",300088,X-linked,,,,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,TRUE,confirmed,FUNCTION: Potential calcium-dependent cell-adhesion protein.,brain development [GO:0007420]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156],calcium ion binding [GO:0005509],SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Single-pass type I membrane protein {ECO:0000250}.,"",X,100291644,100410273,q22.1,0.99975,0.126,-0.22514,2.5929,23.729,0.8135800745378973,ENST00000373034,0.9060052219321149,0.3216695826043489,3447,,,,,,,0.6396047011987958,2.078889876154758,Nerve - Tibial,tissue-specific,2.0001947506851443,0.4193625213771581,FALSE,discordant,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:14281,CRLF2,cytokine receptor like factor 2,Approved,,"CRL2, TSLPR",Xp22.3 and Yp11.3,gene with protein product,protein-coding gene,ENSG00000205755,64109,ENSG00000205755,Q9HC73,MGI:1889506,RGD:621078,X,"300357, 400023",FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,TRUE,,no disorder,"FUNCTION: Receptor for thymic stromal lymphopoietin (TSLP). Forms a functional complex with TSLP and IL7R which is capable of stimulating cell proliferation through activation of STAT3 and STAT5. Also activates JAK2 (By similarity). Implicated in the development of the hematopoietic system. {ECO:0000250, ECO:0000269|PubMed:11418668}.",cytokine-mediated signaling pathway [GO:0019221]; interleukin-7-mediated signaling pathway [GO:0038111]; oncostatin-M-mediated signaling pathway [GO:0038165]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of mast cell activation [GO:0033005]; positive regulation of receptor signaling pathway via STAT [GO:1904894],ciliary neurotrophic factor receptor binding [GO:0005127]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; leukemia inhibitory factor receptor activity [GO:0004923],SUBCELLULAR LOCATION: [Isoform 1]: Cell membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}.; SUBCELLULAR LOCATION: [Isoform 2]: Secreted {ECO:0000305}.,SUBUNIT: Heterodimer of CRLF2 and IL7R.,X,1187549,1212723,p22.33,3.3104e-7,1.396,-1.0717,-0.85264,13.024,0.1570410328588731,ENST00000400841,0.1224910394265233,0.02860986547085202,1116,,,,,,,0.7237465293741726,0.6825382407804752,Lung,tissue-specific,0.015965213385799697,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:14287,NLGN4X,neuroligin 4 X-linked,Approved,NLGN4,"KIAA1260, NLGN, HLNX",Xp22.32-p22.31,gene with protein product,protein-coding gene,ENSG00000146938,57502,ENSG00000146938,Q8N0W4,,,X,300427,TRUE,"Mental retardation, X-linked",300495,"Multifactorial, X-linked, Isolated cases","{Asperger syndrome susceptibility, X-linked 2} // {Autism susceptibility, X-linked 2}",300497 // 300495,"X-linked // Multifactorial, X-linked, Isolated cases",TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,confirmed +CS,FALSE,TRUE,confirmed,FUNCTION: Putative neuronal cell surface protein involved in cell-cell-interactions.,adult behavior [GO:0030534]; brainstem development [GO:0003360]; cell-cell junction organization [GO:0045216]; cerebellum development [GO:0021549]; chemical synaptic transmission [GO:0007268]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of excitatory postsynaptic potential [GO:0090394]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; organ growth [GO:0035265]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; social behavior [GO:0035176]; synapse organization [GO:0050808]; synaptic vesicle endocytosis [GO:0048488]; vocalization behavior [GO:0071625],cell adhesion molecule binding [GO:0050839]; chloride ion binding [GO:0031404]; neurexin family protein binding [GO:0042043]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023],"SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane protein. Cell junction, synapse, postsynaptic density membrane.","SUBUNIT: Homodimer. Interacts with NRXN1 in a calcium-dependent manner. Interacts through its C-terminus with DLG4/PSD-95 third PDZ domain. {ECO:0000269|PubMed:11368788, ECO:0000269|PubMed:18093521, ECO:0000269|PubMed:9278515}.",X,5840637,6228867,p22.31,0.99267,0.249,-1.5137,2.7006,19.083,0.5588421889207246,ENST00000381095,0.8757649938800489,0.1327418145463634,2451,4,"NLGN4Y (97, 93, chrY); NLGN3 (72, 71, chrX); NLGN1 (71, 72, chr3); NLGN2 (63, 63, chr17)",TRUE,1,"NLGN4Y (97, 93, chrY)",TRUE,0.6889266521376558,4.236507925409285,Ovary,tissue-specific,2.6144177424074737,3.6559699940326618,FALSE,high confidence escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:14289,NLGN3,neuroligin 3,Approved,,"HNL3, KIAA1480, ASPGX1, AUTSX1",Xq13.1,gene with protein product,protein-coding gene,ENSG00000196338,54413,ENSG00000196338,Q9NZ94,MGI:2444609,RGD:621119,X,300336,TRUE,,,,"{Asperger syndrome susceptibility, X-linked 1} // {Autism susceptibility, X-linked 1}",300494 // 300425,"Multifactorial, X-linked, Isolated cases // X-linked",TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,PMT +CS,FALSE,,PMT,"FUNCTION: Cell surface protein involved in cell-cell-interactions via its interactions with neurexin family members. Plays a role in synapse function and synaptic signal transmission, and may mediate its effects by clustering other synaptic proteins. May promote the initial formation of synapses, but is not essential for this. May also play a role in glia-glia or glia-neuron interactions in the developing peripheral nervous system (By similarity). {ECO:0000250, ECO:0000269|PubMed:15620359}.","adult behavior [GO:0030534]; axon extension [GO:0048675]; chemical synaptic transmission [GO:0007268]; excitatory postsynaptic potential [GO:0060079]; inhibitory postsynaptic potential [GO:0060080]; learning [GO:0007612]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of excitatory postsynaptic potential [GO:0090394]; neuron cell-cell adhesion [GO:0007158]; oligodendrocyte differentiation [GO:0048709]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of synaptic vesicle clustering [GO:2000809]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; receptor-mediated endocytosis [GO:0006898]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of NMDA receptor activity [GO:2000310]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; regulation of terminal button organization [GO:2000331]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; synaptic vesicle endocytosis [GO:0048488]; visual learning [GO:0008542]; vocalization behavior [GO:0071625]",cell adhesion molecule binding [GO:0050839]; neurexin family protein binding [GO:0042043]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023],"SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Single-pass type I membrane protein {ECO:0000250}. Cell junction, synapse {ECO:0000250}. Note=Detected at both glutamatergic and GABAergic synapses. {ECO:0000250}.","SUBUNIT: Interacts with NRXN1, NRXN2 and NRXN3. Interacts (via its C-terminus) with DLG4/PSD-95 (via PDZ domain 3) (By similarity). Homodimer, and heterodimer with NLGN1 and NLGN2 (By similarity). {ECO:0000250}.",X,71144831,71171201,q13.1,0.97641,0.31,0.67378,4.206,20.325,0.3141764257718922,ENST00000358741,0.9234786022771888,0.3971757060734816,2547,4,"NLGN4X (71, 72, chrX); NLGN4Y (70, 68, chrY); NLGN1 (67, 69, chr3); NLGN2 (62, 63, chr17)",TRUE,,,,0.6279051757516293,5.180790357218108,Cerebellar_tissues,tissue-specific,4.7733264975982665,5.180790357218108,TRUE,high confidence non-escapee,Pre_higher_vs_Post,no difference_Pre_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,PMT
HGNC:14328,SPANXA2,SPANX family member A2,Approved,SPANX,,Xq27.2,gene with protein product,protein-coding gene,ENSG00000203926,728712,ENSG00000203926,Q9NS26,,,X,300493,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",spermatogenesis [GO:0007283],"",SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10906052}. Nucleus {ECO:0000269|PubMed:10906052}. Note=Associated with nuclear craters.,"",X,141589708,141590762,q27.2,,,,,,0.32666349230956626,ENST00000370518,0.26855123674911663,0.2586696986924389,294,4,"SPANXA1 (100, 100, chrX); SPANXC (94, 94, chrX); SPANXD (94, 94, chrX); SPANXB1 (85, 80, chrX)",TRUE,3,"SPANXA1 (100, 100, chrX); SPANXC (94, 94, chrX); SPANXD (94, 94, chrX)",TRUE,0.9767441860465116,0.5594692976868907,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:14329,SPANXB1,SPANX family member B1,Approved,"SPANXB2, SPANXF1, SPANXF2",CT11.2,Xq27.1,gene with protein product,protein-coding gene,ENSG00000227234,728695,ENSG00000227234,Q9NS25,,,X,300669,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",spermatid development [GO:0007286],"",SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10906052}. Nucleus {ECO:0000269|PubMed:10906052}. Note=Associated with nuclear craters.,"",X,141002594,141003706,q27.1,,,,,,0.35020574587570197,ENST00000449283,0.22852564102564102,0.21324668832791802,312,4,"SPANXA1 (80, 85, chrX); SPANXA2 (80, 85, chrX); SPANXC (76, 80, chrX); SPANXD (74, 78, chrX)",TRUE,,,,0.9731003526968082,6.927078663204347,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:14331,SPANXC,SPANX family member C,Approved,,"CTp11, CT11.3",Xq27.2,gene with protein product,protein-coding gene,ENSG00000198573,64663,ENSG00000198573,Q9NY87,,,X,300330,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","",SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10626816}. Nucleus {ECO:0000269|PubMed:10626816}. Note=Associated with nuclear craters.,"",X,141241463,141242517,q27.2,0.072819,1.924,-1.366,-2.4887,0.57203,0.3449014388509219,ENST00000358993,0.24489795918367346,0.15203100775193798,294,4,"SPANXD (98, 98, chrX); SPANXA1 (94, 94, chrX); SPANXA2 (94, 94, chrX); SPANXB1 (80, 76, chrX)",TRUE,3,"SPANXD (98, 98, chrX); SPANXA1 (94, 94, chrX); SPANXA2 (94, 94, chrX)",TRUE,0.9767441860465116,3.592337430648804,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:14332,SPANXD,SPANX family member D,Approved,SPANXE,CT11.4,Xq27.2,gene with protein product,protein-coding gene,ENSG00000196406,64648,ENSG00000196406,Q9BXN6,,,X,"300670, 300671",FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","",SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus {ECO:0000250}. Note=Associated with nuclear craters. {ECO:0000250}.,"",X,141697411,141698739,q27.2,0.077485,1.917,-1.8584,-3.5372,0.68574,0.33238050920694007,ENST00000370515,0.2554421768707483,0.16203449137715573,294,4,"SPANXC (98, 98, chrX); SPANXA1 (94, 94, chrX); SPANXA2 (94, 94, chrX); SPANXB1 (78, 74, chrX)",TRUE,3,"SPANXC (98, 98, chrX); SPANXA1 (94, 94, chrX); SPANXA2 (94, 94, chrX)",TRUE,0.9767441860465116,5.0090425472580264,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:14352,WDR13,WD repeat domain 13,Approved,,,Xp11.23,gene with protein product,protein-coding gene,ENSG00000101940,64743,ENSG00000101940,Q9H1Z4,MGI:1914661,RGD:1560982,X,300512,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",negative regulation of type B pancreatic cell proliferation [GO:1904691],promoter-specific chromatin binding [GO:1990841],SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12659815}.,"",X,48590042,48608869,p11.23,0.93514,0.362,0.15298,3.2948,13.097,0.5470304063654448,ENST00000376729,0.9396433470507545,0.2564858785303674,1458,,,,,,,0.14012371551734537,6.257568875417536,Ovary,broadly expressed,5.273154051623402,5.247194590085733,FALSE,high confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:1436,S100G,S100 calcium binding protein G,Approved,CALB3,"CABP9K, CABP1",Xp22.2,gene with protein product,protein-coding gene,ENSG00000169906,795,ENSG00000169906,P29377,MGI:104528,RGD:2253,X,302020,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","",calcium ion binding [GO:0005509]; transition metal ion binding [GO:0046914]; vitamin D binding [GO:0005499],"","",X,16650158,16654670,p22.2,0.11469,1.841,0.37396,0.37847,1.4581,0.21110283640116576,ENST00000380200,0.78625,0.12779305173706573,240,,,,,,,,0,,tissue-specific,0,0,FALSE,low confidence escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:14454,GABRQ,gamma-aminobutyric acid type A receptor subunit theta,Approved,,,Xq28,gene with protein product,protein-coding gene,ENSG00000268089,55879,ENSG00000268089,Q9UN88,MGI:1888498,RGD:68331,X,300349,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: GABA, the major inhibitory neurotransmitter in the vertebrate brain, mediates neuronal inhibition by binding to the GABA/benzodiazepine receptor and opening an integral chloride channel.",chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165],chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]; neurotransmitter receptor activity [GO:0030594]; neurotransmitter transmembrane transporter activity [GO:0005326]; transmembrane signaling receptor activity [GO:0004888],"SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell membrane; Multi-pass membrane protein. Cell membrane; Multi-pass membrane protein.","SUBUNIT: Generally pentameric. This subunit coassembles with alpha-2, beta-1 and gamma-1.",X,152637895,152657542,q28,0.0042977,0.736,1.7103,0.58136,17.874,0.45038894809356034,ENST00000598523,0.5549763033175356,0.09220194951262184,1899,,,,,,,0.8674418334199463,2.500689895726252,Cervix - Endocervix,tissue-specific,1.089335431696021,0.3008283492743659,FALSE,low confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,no difference_Post1_Post2,no disorder
HGNC:14455,H2AB3,H2A.B variant histone 3,Approved,"H2AFB, H2AFB3",,Xq28,gene with protein product,protein-coding gene,ENSG00000277745,83740,ENSG00000277745,P0C5Z0,"MGI:3642445, MGI:3644875, MGI:3644980",,X,300445,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Atypical histone H2A which can replace conventional H2A in some nucleosomes and is associated with active transcription and mRNA processing. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. Nucleosomes containing this histone are less rigid and organize less DNA than canonical nucleosomes in vivo. They are enriched in actively transcribed genes and associate with the elongating form of RNA polymerase. They associate with spliceosome components and are required for mRNA splicing. May participate in spermatogenesis. {ECO:0000269|PubMed:15257289, ECO:0000269|PubMed:16287874, ECO:0000269|PubMed:16957777, ECO:0000269|PubMed:17591702, ECO:0000269|PubMed:17726088, ECO:0000269|PubMed:18329190, ECO:0000269|PubMed:22795134}.",chromatin organization [GO:0006325]; chromatin silencing [GO:0006342]; mRNA processing [GO:0006397]; nucleosome assembly [GO:0006334],DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982],"SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:20008104}. Chromosome {ECO:0000269|PubMed:20008104, ECO:0000269|PubMed:22795134}. Note=Associated with the active X chromosome and with autosomes, while it is absent from the inactive X chromosome and excluded from Barr bodies. {ECO:0000269|PubMed:20008104}.","SUBUNIT: The nucleosome is a histone octamer containing two molecules each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and two H2A-H2B heterodimers. May be incorporated into a proportion of nucleosomes, replacing one or more H2A molecules.",X,155459415,155460005,q28,,,,,,0.6639835518460491,ENST00000615853,0.621551724137931,0.07565608597850537,348,2,"H2AB2 (100, 100, chrX); H2AB1 (99, 99, chrX)",TRUE,2,"H2AB2 (100, 100, chrX); H2AB1 (99, 99, chrX)",TRUE,0.9726785728728601,0.17878984098905976,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:14543,WNK3,WNK lysine deficient protein kinase 3,Approved,PRKWNK3,,Xp11.22,gene with protein product,protein-coding gene,ENSG00000196632,65267,ENSG00000196632,Q9BYP7,MGI:2652875,RGD:1563131,X,300358,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Serine/threonine kinase which plays an important role in the regulation of electrolyte homeostasis, cell signaling, survival and proliferation. Acts as an activator and inhibitor of sodium-coupled chloride cotransporters and potassium-coupled chloride cotransporters respectively (PubMed:16275913, PubMed:16275911, PubMed:16357011). Phosphorylates WNK4. Regulates the phosphorylation of SLC12A1 and SLC12A2. Increases Ca(2+) influx mediated by TRPV5 and TRPV6 by enhancing their membrane expression level via a kinase-dependent pathway (PubMed:18768590). Inhibits the activity of KCNJ1 by decreasing its expression at the cell membrane in a non-catalytic manner. {ECO:0000269|PubMed:16275911, ECO:0000269|PubMed:16275913, ECO:0000269|PubMed:16357011, ECO:0000269|PubMed:16501604, ECO:0000269|PubMed:17975670, ECO:0000269|PubMed:18768590, ECO:0000269|PubMed:20525693}.; FUNCTION: Isoform 1, isoform 2, isoform 3 and isoform 4 stimulate the activity of SLC12A1, SLC12A2 and SLC12A3 and inhibit the activity of SLC12A4, SLC12A5, SLC12A6 and SLC12A7. According to PubMed:19470686, isoform 1 inhibits the activity of SLC12A3. {ECO:0000269|PubMed:19470686, ECO:0000269|PubMed:21613606}.",cell volume homeostasis [GO:0006884]; intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of apoptotic process [GO:0043066]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of sodium ion transport [GO:0010766]; osmosensory signaling pathway [GO:0007231]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of ion transmembrane transporter activity [GO:0032414]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein autophosphorylation [GO:0046777]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of calcium ion import [GO:0090279]; regulation of cation transmembrane transport [GO:1904062],ATP binding [GO:0005524]; chloride channel inhibitor activity [GO:0019869]; potassium channel inhibitor activity [GO:0019870]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16501604}.,SUBUNIT: Interacts with WNK1 and WNK4. {ECO:0000269|PubMed:17975670}.,X,54192823,54358642,p11.22,0.99999,0.191,1.6824,2.552,55.132,0.6814349626469102,ENST00000375169,0.7743692660550459,0.38195451137215697,5232,,,,,,,0.7813413824866234,4.526907635190804,Testis,tissue-specific,1.1185922927730532,1.4643493752496362,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:14561,ARHGEF9,Cdc42 guanine nucleotide exchange factor 9,Approved,,"KIAA0424, PEM-2",Xq11.1,gene with protein product,protein-coding gene,ENSG00000131089,23229,ENSG00000131089,O43307,MGI:2442233,RGD:620719,X,300429,TRUE,Developmental and epileptic encephalopathy 8,300607,X-linked recessive,,,,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Acts as guanine nucleotide exchange factor (GEF) for CDC42. Promotes formation of GPHN clusters (By similarity). {ECO:0000250|UniProtKB:Q9QX73, ECO:0000269|PubMed:10559246}.",G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; regulation of small GTPase mediated signal transduction [GO:0051056],guanyl-nucleotide exchange factor activity [GO:0005085],"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10559246}. Cell junction, synapse, postsynaptic density {ECO:0000250|UniProtKB:Q3UTH8}.",SUBUNIT: Interacts with GPHN. {ECO:0000250|UniProtKB:Q9QX73}.,X,63634967,63809274,q11.2,0.9989,0.151,0.19219,3.0427,19.771,0.2527902683407,ENST00000671741,0.9718193384223919,0.2329667583104224,1572,,,,,,,0.43022127265353605,4.91723600916388,Cerebellar_tissues,broadly expressed,4.165397460122779,4.91723600916388,TRUE,low confidence non-escapee,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:14618,XAGE3,X antigen family member 3,Approved,"PLAC6, GAGED4","XAGE-3, pp9012, CT12.3a, CT12.3b",Xp11.22,gene with protein product,protein-coding gene,ENSG00000171402,170626,ENSG00000171402,Q8WTP9,,,X,300740,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,52862525,52868083,p11.22,0.094852,1.307,0.64951,-0.57851,4.7369,0.33006931455605676,ENST00000346279,0.01755952380952381,0.038215446138465385,336,3,"XAGE5 (73, 75, chrX); XAGE2 (72, 72, chrX); GAGE10 (58, 55, chrX)",TRUE,,,,0.9625957580106984,1.7513908775811493,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:14755,OR13H1,olfactory receptor family 13 subfamily H member 1,Approved,,,Xq26.2,gene with protein product,protein-coding gene,ENSG00000171054,347468,ENSG00000171054,Q8NG92,,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Odorant receptor. {ECO:0000305}.,"",G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984],SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.,"",X,131543976,131545056,q26.2,2.5456e-5,1.92,0.46503,-0.13429,4.2743,0.1618044431500089,ENST00000338616,0.17238403451995685,0.07145713571607099,927,,,,,,,,0,,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:1483,CAPN6,calpain 6,Approved,,"CAPNX, CalpM, CANPX",Xq23,gene with protein product,protein-coding gene,ENSG00000077274,827,ENSG00000077274,Q9Y6Q1,MGI:1100850,RGD:70960,X,300146,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Microtubule-stabilizing protein that may be involved in the regulation of microtubule dynamics and cytoskeletal organization. May act as a regulator of RAC1 activity through interaction with ARHGEF2 to control lamellipodial formation and cell mobility. Does not seem to have protease activity as it has lost the active site residues (By similarity). {ECO:0000250, ECO:0000269|PubMed:17210638}.",microtubule bundle formation [GO:0001578]; proteolysis [GO:0006508]; regulation of cytoskeleton organization [GO:0051493],calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; microtubule binding [GO:0008017],"SUBCELLULAR LOCATION: Cytoplasm, perinuclear region {ECO:0000269|PubMed:17210638}. Cytoplasm, cytoskeleton, spindle {ECO:0000269|PubMed:17210638}. Note=During mitose associated with the mitotic spindle. At telophase colocalized to the midbody spindle.",SUBUNIT: Interacts (via domain III) with microtubules. Interacts (via domain II) with ARHGEF2 (via the N-terminal zinc finger). {ECO:0000250}.,X,111245099,111270483,q23,0.81903,0.394,-0.99097,1.518,23.225,0.15330565314595976,ENST00000324068,0.8498961578400831,0.20782304423894027,1926,,,,,,,0.655281771346881,4.234401683486244,Kidney - Medulla,tissue-specific,0.008575392773241616,0,FALSE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:14865,ESX1,ESX homeobox 1,Approved,ESX1L,ESXR1,Xq22.2,gene with protein product,protein-coding gene,ENSG00000123576,80712,ENSG00000123576,Q8N693,MGI:1096388,RGD:1590738,X,300154,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: May coordinately regulate cell cycle progression and transcription during spermatogenesis. Inhibits degradation of polyubiquitinated cyclin A and cyclin B1 and thereby arrests the cell cycle at early M phase. ESXR1-N acts as a transcriptional repressor. Binds to the sequence 5'-TAATGTTATTA-3' which is present within the first intron of the KRAS gene and inhibits its expression. ESXR1-C has the ability to inhibit cyclin turnover. {ECO:0000269|PubMed:15235584, ECO:0000269|PubMed:15897875}.","negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cell cycle [GO:0051726]","DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15235584}. Nucleus {ECO:0000255|PROSITE-ProRule:PRU00108, ECO:0000269|PubMed:15235584}. Note=ESXR1-N localizes specifically to the nucleus while ESXR1-C localizes specifically to the cytoplasm.","",X,104250038,104254933,q22.2,0.52687,0.749,-2.7961,-0.038021,6.3311,0.8000927541157425,ENST00000372588,0.11564291564291564,0.038365408647838044,1221,,,,,,,0.9767441860465116,4.377325073658111,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:14944,PPP1R3F,protein phosphatase 1 regulatory subunit 3F,Approved,,Hb2E,Xp11.23,gene with protein product,protein-coding gene,ENSG00000049769,89801,ENSG00000049769,Q6ZSY5,MGI:1859617,RGD:1566398,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Glycogen-targeting subunit for protein phosphatase 1 (PP1). {ECO:0000269|PubMed:21668450}.,regulation of glycogen (starch) synthase activity [GO:2000465]; regulation of glycogen biosynthetic process [GO:0005979],glycogen binding [GO:2001069]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase binding [GO:0019903],SUBCELLULAR LOCATION: Membrane {ECO:0000250}; Single-pass membrane protein {ECO:0000250}.,"",X,49269793,49301461,p11.23,4.1516e-5,1.307,-0.42413,0.21346,11.031,0.5833554189128565,ENST00000055335,0.695375,0.35346163459135216,2400,,,,,,,0.497619141502517,5.51555319625369,Cerebellar_tissues,broadly expressed,4.447612255176555,5.51555319625369,TRUE,low confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:14963,GPR101,G protein-coupled receptor 101,Approved,,,Xq26.3,gene with protein product,protein-coding gene,ENSG00000165370,83550,ENSG00000165370,Q96P66,MGI:2685211,RGD:1564196,X,300393,TRUE,"Pituitary adenoma 2, GH-secreting",300943,X-linked,,,,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,FUNCTION: Orphan receptor.,adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188],G protein-coupled receptor activity [GO:0004930],SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.,"",X,137023929,137033995,q26.3,0.70375,0.571,0.98469,0.63524,8.3028,0.556113662456946,ENST00000651716,0.4802226588081205,0.10619845038740315,1527,,,,,,,0.9767441860465116,0.17169644063735567,Cerebellar_tissues,tissue-specific,0,0.17169644063735567,TRUE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:1497,CASK,calcium/calmodulin dependent serine protein kinase,Approved,TNRC8,"LIN2, CAGH39, FGS4",Xp11.4,gene with protein product,protein-coding gene,ENSG00000147044,8573,ENSG00000147044,O14936,MGI:1309489,RGD:62004,X,300172,TRUE,"FG syndrome 4 // Mental retardation and microcephaly with pontine and cerebellar hypoplasia // Mental retardation, with or without nystagmus",300422 // 300749 // 300422,// X-linked dominant //,,,,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Multidomain scaffolding protein with a role in synaptic transmembrane protein anchoring and ion channel trafficking. Contributes to neural development and regulation of gene expression via interaction with the transcription factor TBR1. Binds to cell-surface proteins, including amyloid precursor protein, neurexins and syndecans. May mediate a link between the extracellular matrix and the actin cytoskeleton via its interaction with syndecan and with the actin/spectrin-binding protein 4.1. Component of the LIN-10-LIN-2-LIN-7 complex, which associates with the motor protein KIF17 to transport vesicles containing N-methyl-D-aspartate (NMDA) receptor subunit NR2B along microtubules (By similarity). {ECO:0000250|UniProtKB:O70589}.",calcium ion import [GO:0070509]; cell adhesion [GO:0007155]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cellular response to growth factor stimulus [GO:0090288]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of wound healing [GO:0061045]; neurotransmitter secretion [GO:0007269]; positive regulation of calcium ion import [GO:0090280]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of synaptic vesicle exocytosis [GO:2000300],ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; guanylate kinase activity [GO:0004385]; neurexin family protein binding [GO:0042043]; protein serine/threonine kinase activity [GO:0004674],SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q62915}. Cytoplasm {ECO:0000250|UniProtKB:Q62915}. Cell membrane {ECO:0000250|UniProtKB:Q62915}; Peripheral membrane protein {ECO:0000250|UniProtKB:Q62915}.,"SUBUNIT: CASK and LIN7 form two mutually exclusive tripartite complexes with APBA1 or CASKIN1 (By similarity). Component of the brain-specific heterotrimeric complex (LIN-10-LIN-2-LIN-7 complex) composed of at least APBA1, CASK, and LIN7, which associates with the motor protein KIF17 to transport vesicles along microtubules (By similarity). Forms a heterotrimeric complex with DLG1 and LIN7B via their L27 domains (By similarity). Identified in a complex with ACTN4, IQGAP1, MAGI2, NPHS1, SPTAN1 and SPTBN1 (By similarity). Part of a complex containing CASK, TBR1 and TSPYL2 (By similarity). Interacts with WHRN (By similarity). Interacts (via the PDZ, SH3 and guanylate kinase-like domains) with NRXN1 (via C-terminus) (By similarity). Interacts with CASKIN1, APBA1, LIN7(A/B/C) and L27 domain of DLG1 and isoform 2 of DLG4 (By similarity). Interacts with FCHSD2 (By similarity). Interacts with KIRREL3 (PubMed:19012874). Interacts with TBR1 (By similarity). Interacts with TSPYL2 (By similarity). {ECO:0000250, ECO:0000250|UniProtKB:O70589, ECO:0000250|UniProtKB:Q62915, ECO:0000269|PubMed:18423203, ECO:0000269|PubMed:19012874, ECO:0000269|PubMed:9660868}.",X,41514934,41923517,p11.4,1,0.073,0.082769,4.2502,40.96,0.8043030211632232,ENST00000644347,0.9832219747587231,0.5430642339415146,2694,,,,,,,0.2369364205019021,3.611024797307352,Cerebellar_tissues,broadly expressed,2.6166470539685927,3.611024797307352,TRUE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:14976,SNX12,sorting nexin 12,Approved,,,Xq13.1,gene with protein product,protein-coding gene,ENSG00000147164,29934,ENSG00000147164,Q9UMY4,MGI:1919331,RGD:1565585,X,300883,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May be involved in several stages of intracellular trafficking. {ECO:0000250}.,endocytic recycling [GO:0032456]; late endosome to Golgi transport [GO:0034499]; negative regulation of early endosome to late endosome transport [GO:2000642]; negative regulation of gene expression [GO:0010629]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein processing [GO:0010955]; negative regulation of protein transport [GO:0051224]; protein transport [GO:0015031]; regulation of endocytosis [GO:0030100]; regulation of intracellular protein transport [GO:0033157],enzyme binding [GO:0019899]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol binding [GO:0035091],SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Peripheral membrane protein {ECO:0000305}; Cytoplasmic side {ECO:0000305}.,"",X,71056332,71073426,q13.1,0.78413,0.59,0.60472,2.1592,5.0755,0.5298905416783609,ENST00000374274,0.9568507157464212,0.22614346413396652,489,1,"SNX3 (73, 78, chr6)",TRUE,,,,0.1381258297195776,6.236366329203182,Cells - Cultured fibroblasts,broadly expressed,4.921288740277127,5.635126049565612,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,no disorder
HGNC:15455,MBTPS2,"membrane bound transcription factor peptidase, site 2",Approved,KFSD,S2P,Xp22.12,gene with protein product,protein-coding gene,ENSG00000012174,51360,ENSG00000012174,O43462,MGI:2444506,RGD:1566171,X,300294,TRUE,"IFAP syndrome with or without BRESHECK syndrome // Keratosis follicularis spinulosa decalvans, X-linked // Osteogenesis imperfecta, type XIX",308205 // 308800 // 301014,X-linked recessive // X-linked recessive // X-linked recessive,"?Olmsted syndrome, X-linked",300918,X-linked recessive,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Zinc metalloprotease that mediates intramembrane proteolysis of proteins such as ATF6, ATF6B, SREBF1/SREBP1 and SREBF2/SREBP2 (PubMed:11163209, PubMed:10805775). Catalyzes the second step in the proteolytic activation of the sterol regulatory element-binding proteins (SREBPs) SREBF1/SREBP1 and SREBF2/SREBP2: cleaves SREBPs within the first transmembrane segment, thereby releasing the N-terminal segment with a portion of the transmembrane segment attached (PubMed:10805775, PubMed:27380894, PubMed:9659902). Mature N-terminal SREBP fragments shuttle to the nucleus and activate gene transcription (PubMed:10805775, PubMed:27380894, PubMed:9659902). Also mediates the second step in the proteolytic activation of the cyclic AMP-dependent transcription factor ATF-6 (ATF6 and ATF6B) (PubMed:11163209). Involved in intramembrane proteolysis during bone formation (PubMed:27380894). {ECO:0000269|PubMed:10805775, ECO:0000269|PubMed:11163209, ECO:0000269|PubMed:27380894, ECO:0000269|PubMed:9659902}.",ATF6-mediated unfolded protein response [GO:0036500]; bone maturation [GO:0070977]; cholesterol metabolic process [GO:0008203]; endoplasmic reticulum unfolded protein response [GO:0030968]; membrane protein intracellular domain proteolysis [GO:0031293]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; regulation of cholesterol biosynthetic process [GO:0045540]; response to endoplasmic reticulum stress [GO:0034976],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],SUBCELLULAR LOCATION: Membrane {ECO:0000305|PubMed:19361614}; Multi-pass membrane protein {ECO:0000305|PubMed:19361614}. Cytoplasm {ECO:0000269|PubMed:19361614}.,"",X,21839617,21885423,p22.12,0.99752,0.17,0.13565,2.0915,17.583,0.49790113484381,ENST00000379484,0.9449358974358975,0.1005248687828043,1560,,,,,,,0.39985457565358185,4.135895990820972,Cells - Cultured fibroblasts,broadly expressed,1.7558233473486118,3.20365143872652,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:15524,P2RY8,P2Y receptor family member 8,Approved,,P2Y8,Xp22.33 and Yp11.3,gene with protein product,protein-coding gene,ENSG00000182162,286530,ENSG00000182162,Q86VZ1,,,X,300525,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,TRUE,,no disorder,FUNCTION: Probable receptor for purines coupled to G-proteins.,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of Rho protein signal transduction [GO:0035025],G protein-coupled purinergic nucleotide receptor activity [GO:0045028]; G protein-coupled receptor activity [GO:0004930],SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.,"",X,1462581,1537185,p22.33,0.0034012,1.644,0.045312,1.7332,5.2212,0.461133069828722,ENST00000381297,0.6824074074074075,0.018345413646588354,1080,,,,,,,0.7319498489675197,6.4050767744748125,Cells - EBV-transformed lymphocytes,tissue-specific,0.10902082574188551,0.09023734264583301,FALSE,low confidence escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:15588,SYTL4,synaptotagmin like 4,Approved,,,Xq22.1,gene with protein product,protein-coding gene,ENSG00000102362,94121,ENSG00000102362,Q96C24,MGI:1351606,RGD:620204,X,300723,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Modulates exocytosis of dense-core granules and secretion of hormones in the pancreas and the pituitary. Interacts with vesicles containing negatively charged phospholipids in a Ca(2+)-independent manner (By similarity). {ECO:0000250}.,exocytosis [GO:0006887]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; multivesicular body sorting pathway [GO:0071985]; negative regulation of insulin secretion [GO:0046676]; plasma membrane repair [GO:0001778]; platelet degranulation [GO:0002576]; positive regulation of exocytosis [GO:0045921]; positive regulation of protein secretion [GO:0050714]; regulation of plasma membrane repair [GO:1905684],metal ion binding [GO:0046872]; neurexin family protein binding [GO:0042043]; phospholipid binding [GO:0005543]; Rab GTPase binding [GO:0017137],"SUBCELLULAR LOCATION: Membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}. Cell membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}. Cytoplasmic vesicle, secretory vesicle membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}. Note=Detected close to the plasma membrane and on secretory granules. In pancreas, interacts with insulin-containing vesicles (By similarity). {ECO:0000250}.","SUBUNIT: Part of a ternary complex containing STX1A and RAB27A. Can bind both dominant negative and dominant active mutants of RAB27A. Binds STXBP1, RAB3A, RAB8A and RAB27B. Interacts with MYO5A (By similarity). {ECO:0000250}.",X,100674491,100732123,q22.1,0.014122,0.567,2.1506,0.81155,25.474,0.367022984814424,ENST00000276141,0.9128472222222223,0.1329917520619845,2016,,,,,,,0.5684376638123082,6.058387935803301,Ovary,broadly expressed,1.489455590349961,0.7360731555824612,FALSE,discordant,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,no difference_Post1_Post2,no disorder
HGNC:15589,SYTL5,synaptotagmin like 5,Approved,,,Xp11.4,gene with protein product,protein-coding gene,ENSG00000147041,94122,ENSG00000147041,Q8TDW5,MGI:2668451,RGD:631342,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May act as Rab effector protein and play a role in vesicle trafficking. Binds phospholipids.,exocytosis [GO:0006887]; intracellular protein transport [GO:0006886],metal ion binding [GO:0046872]; neurexin family protein binding [GO:0042043]; phospholipid binding [GO:0005543]; Rab GTPase binding [GO:0017137],SUBCELLULAR LOCATION: Membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}.,"SUBUNIT: Binds RAB27A that has been activated by GTP-binding, and possibly also RAB3A and RAB6A.",X,38006553,38128819,p11.4,2.6919e-4,0.648,-1.2443,-0.38888,28.077,0.09941615602913798,ENST00000297875,0.8314181486548108,0.08610347413146713,2193,,,,,,,0.7708775410716528,3.6451597969499825,Adrenal Gland,tissue-specific,2.6514903186273044,0.21329501711734952,FALSE,low confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:15631,TLR7,toll like receptor 7,Approved,,,Xp22.2,gene with protein product,protein-coding gene,ENSG00000196664,51284,ENSG00000196664,Q9NYK1,MGI:2176882,RGD:1563357,X,300365,TRUE,"Immunodeficiency 74, COVID19-related, X-linked",301051,X-linked recessive,,,,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,TRUE,confirmed,"FUNCTION: Endosomal receptor that plays a key role in innate and adaptive immunity (PubMed:14976261, PubMed:32433612). Controls host immune response against pathogens through recognition of uridine-containing single strand RNAs (ssRNAs) of viral origin or guanosine analogs (PubMed:31608988, PubMed:27742543, PubMed:12738885). Upon binding to agonists, undergoes dimerization that brings TIR domains from the two molecules into direct contact, leading to the recruitment of TIR-containing downstream adapter MYD88 through homotypic interaction (PubMed:27742543). In turn, the Myddosome signaling complex is formed involving IRAK4, IRAK1, TRAF6, TRAF3 leading to activation of downstream transcription factors NF-kappa-B and IRF7 to induce proinflammatory cytokines and interferons, respectively (PubMed:27742543). {ECO:0000269|PubMed:12738885, ECO:0000269|PubMed:14976261, ECO:0000269|PubMed:27742543, ECO:0000269|PubMed:31608988, ECO:0000269|PubMed:32433612}.",cellular response to mechanical stimulus [GO:0071260]; defense response to virus [GO:0051607]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; I-kappaB phosphorylation [GO:0007252]; immune response [GO:0006955]; innate immune response [GO:0045087]; microglial cell activation [GO:0001774]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; positive regulation of chemokine production [GO:0032722]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; regulation of protein phosphorylation [GO:0001932]; toll-like receptor 7 signaling pathway [GO:0034154]; toll-like receptor 9 signaling pathway [GO:0034162]; toll-like receptor signaling pathway [GO:0002224],double-stranded RNA binding [GO:0003725]; drug binding [GO:0008144]; pattern recognition receptor activity [GO:0038187]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; transmembrane signaling receptor activity [GO:0004888],"SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000250|UniProtKB:P58681}; Single-pass type I membrane protein {ECO:0000250|UniProtKB:P58681}. Endosome {ECO:0000250|UniProtKB:P58681}. Lysosome {ECO:0000250|UniProtKB:P58681}. Cytoplasmic vesicle, phagosome {ECO:0000250|UniProtKB:P58681}. Note=Relocalizes from endoplasmic reticulum to endosome and lysosome upon stimulation with agonist. {ECO:0000250|UniProtKB:P58681}.","SUBUNIT: Homodimer (PubMed:27742543). Interacts with MYD88 via their respective TIR domains (Probable). Interacts with UNC93B1 (By similarity). Interacts with SMPDL3B (By similarity). {ECO:0000250|UniProtKB:P58681, ECO:0000269|PubMed:27742543, ECO:0000305}.",X,12867072,12890361,p22.2,0.97912,0.305,-0.52686,3.0132,20.658,0.17308498622034613,ENST00000380659,0.7314285714285714,0.07073231692076981,3150,,,,,,,0.9015242990899005,5.375849199094899,Cells - EBV-transformed lymphocytes,tissue-specific,0.5771237601997375,0.15517119709015303,FALSE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:15632,TLR8,toll like receptor 8,Approved,,CD288,Xp22.2,gene with protein product,protein-coding gene,ENSG00000101916,51311,ENSG00000101916,Q9NR97,MGI:2176887,RGD:1590327,X,300366,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Endosomal receptor that plays a key role in innate and adaptive immunity (PubMed:25297876, PubMed:32433612). Controls host immune response against pathogens through recognition of RNA degradation products specific to microorganisms that are initially processed by RNASET2 (PubMed:31778653). Upon binding to agonists, undergoes dimerization that brings TIR domains from the two molecules into direct contact, leading to the recruitment of TIR-containing downstream adapter MYD88 through homotypic interaction (PubMed:23520111, PubMed:25599397, PubMed:26929371). In turn, the Myddosome signaling complex is formed involving IRAK4, IRAK1, TRAF6, TRAF3 leading to activation of downstream transcription factors NF-kappa-B and IRF7 to induce proinflammatory cytokines and interferons, respectively (PubMed:16737960, PubMed:17932028, PubMed:29155428). {ECO:0000269|PubMed:16737960, ECO:0000269|PubMed:17932028, ECO:0000269|PubMed:23520111, ECO:0000269|PubMed:25297876, ECO:0000269|PubMed:25599397, ECO:0000269|PubMed:26929371, ECO:0000269|PubMed:29155428, ECO:0000269|PubMed:31778653, ECO:0000269|PubMed:32433612}.",cellular response to mechanical stimulus [GO:0071260]; defense response to virus [GO:0051607]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immune response [GO:0006955]; immunoglobulin mediated immune response [GO:0016064]; innate immune response [GO:0045087]; microglial cell activation [GO:0001774]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of interleukin-12 production [GO:0032695]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; regulation of cytokine secretion [GO:0050707]; regulation of protein phosphorylation [GO:0001932]; response to virus [GO:0009615]; toll-like receptor 8 signaling pathway [GO:0034158]; toll-like receptor 9 signaling pathway [GO:0034162]; toll-like receptor signaling pathway [GO:0002224],DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; drug binding [GO:0008144]; identical protein binding [GO:0042802]; pattern recognition receptor activity [GO:0038187]; RNA binding [GO:0003723]; signaling receptor activity [GO:0038023]; single-stranded RNA binding [GO:0003727]; transmembrane signaling receptor activity [GO:0004888],SUBCELLULAR LOCATION: Endosome membrane {ECO:0000269|PubMed:25297876}; Single-pass type I membrane protein {ECO:0000250}. Note=Endosomal localization confers distinctive proteolytic processing. {ECO:0000269|PubMed:25297876}.,"SUBUNIT: Homodimer (PubMed:23520111, PubMed:25599397, PubMed:26929371, PubMed:29155428). Interacts with MYD88 via their respective TIR domains (Probable). Interacts with UNC93B1 (By similarity). Interacts with BTK (PubMed:17932028). Interacts with SMPDL3B (By similarity). {ECO:0000250|UniProtKB:P58682, ECO:0000269|PubMed:17932028, ECO:0000269|PubMed:23520111, ECO:0000269|PubMed:25599397, ECO:0000269|PubMed:26929371, ECO:0000269|PubMed:29155428, ECO:0000305}.",X,12906620,12923169,p22.2,0.32401,0.486,-0.018949,3.0832,21.632,0.36471392751310694,ENST00000218032,0.37485604606525913,0.049012746813296676,3126,,,,,,,0.8731995926847849,5.494204375163176,Whole Blood,tissue-specific,0.1199801363593891,0.042031061685791626,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:15805,GCNA,germ cell nuclear acidic peptidase,Approved,ACRC,NAAR1,Xq13.1,gene with protein product,protein-coding gene,ENSG00000147174,93953,ENSG00000147174,Q96QF7,,,X,300369,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:27718356, ECO:0000305|PubMed:11714101}.","",X,71578411,71613583,q13.1,0.98788,0.268,0.69124,0.7449,17.726,0.5019986985218927,ENST00000373696,0.22596339113680156,0.02791802049487628,2076,,,,,,,0.5660775093730588,4.096008785662773,Testis,broadly expressed,1.4540916457601079,2.7401785024996808,FALSE,high confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,no difference_Post1_Post2,no disorder
HGNC:15848,SEPTIN6,septin 6,Approved,SEPT6,"KIAA0128, SEP2, SEPT2, MGC16619, MGC20339",Xq24,gene with protein product,protein-coding gene,ENSG00000125354,23157,ENSG00000125354,Q14141,MGI:1888939,RGD:1585082,X,300683,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Filament-forming cytoskeletal GTPase. Required for normal organization of the actin cytoskeleton. Involved in cytokinesis. May play a role in HCV RNA replication. Forms a filamentous structure with SEPTIN12, SEPTIN6, SEPTIN2 and probably SEPTIN4 at the sperm annulus which is required for the structural integrity and motility of the sperm tail during postmeiotic differentiation (PubMed:25588830). {ECO:0000269|PubMed:17229681, ECO:0000269|PubMed:17803907, ECO:0000305|PubMed:25588830}.",cell differentiation [GO:0030154]; cellular protein localization [GO:0034613]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; mitotic cytokinesis [GO:0000281]; spermatogenesis [GO:0007283]; viral process [GO:0016032],GTPase activity [GO:0003924]; GTP binding [GO:0005525]; molecular adaptor activity [GO:0060090],"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15774761}. Cytoplasm, cytoskeleton, spindle {ECO:0000269|PubMed:15774761}. Chromosome, centromere, kinetochore {ECO:0000269|PubMed:15774761}. Cleavage furrow {ECO:0000269|PubMed:15774761}. Midbody {ECO:0000269|PubMed:15774761}. Cell projection, cilium, flagellum {ECO:0000269|PubMed:25588830}. Note=In metaphase cells, localized within the microtubule spindle. At the metaphase plate, in close apposition to the kinetochores of the congressed chromosomes. In cells undergoing cytokinesis, localized to the midbody, the ingressing cleavage furrow, and the central spindle. Found in the sperm annulus (PubMed:25588830). {ECO:0000269|PubMed:25588830}.","SUBUNIT: Septins polymerize into heterooligomeric protein complexes that form filaments, and associate with cellular membranes, actin filaments and microtubules. GTPase activity is required for filament formation. Filaments are assembled from asymmetrical heterotrimers, composed of SEPTIN2, SEPTIN6 and SEPTIN7 that associate head-to-head to form a hexameric unit. Within the trimer, directly interacts with SEPTIN2 and SEPTIN7. Also interacts with SEPTIN9 and SEPTIN12. Interaction with SEPTIN12 alters filament structure. Component of a septin core octomeric complex consisting of SEPTIN12, SEPTIN7, SEPTIN6 and SEPTIN2 or SEPTIN4 in the order 12-7-6-2-2-6-7-12 or 12-7-6-4-4-6-7-12 and located in the sperm annulus. Interacts with SOCS7. Interacts with HNRNPA1. {ECO:0000269|PubMed:16914550, ECO:0000269|PubMed:17229681, ECO:0000269|PubMed:17637674, ECO:0000269|PubMed:17803907, ECO:0000269|PubMed:18047794, ECO:0000269|PubMed:19145258, ECO:0000269|PubMed:25588830}.; SUBUNIT: (Microbial infection) Interacts with HCV NS5B. {ECO:0000269|PubMed:17229681}.",X,119615724,119693370,q24,0.93177,0.363,0.40225,1.7001,17.36,0.5302560902548598,ENST00000394610,0.9463395638629284,0.2300424893776556,1284,4,"SEPTIN11 (80, 79, chr4); SEPTIN8 (75, 67, chr5); SEPTIN10 (70, 56, chr2); SEPTIN14 (59, 60, chr7)",TRUE,,,,0.47037379245673633,7.527680298354842,Cells - EBV-transformed lymphocytes,broadly expressed,2.780639760242795,5.065195303976328,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:15975,SASH3,SAM and SH3 domain containing 3,Approved,CXorf9,"SLY, 753P9, SH3D6C, HACS2",Xq26.1,gene with protein product,protein-coding gene,ENSG00000122122,54440,ENSG00000122122,O75995,MGI:1921381,RGD:1560293,X,300441,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May function as a signaling adapter protein in lymphocytes. {ECO:0000250}.,"homeostasis of number of cells within a tissue [GO:0048873]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043372]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of organ growth [GO:0046622]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tumor necrosis factor production [GO:0032760]","","","",X,129779949,129795201,q26.1,0.38496,0.573,-1.302,1.8455,13.534,0.20646101530240468,ENST00000356892,0.7848643919510061,0.14523869032741815,1143,,,,,,,0.654354045156657,7.9414878326698535,Cells - EBV-transformed lymphocytes,tissue-specific,1.4043745456478052,0.7505061772343937,FALSE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:16090,PGRMC1,progesterone receptor membrane component 1,Approved,,HPR6.6,Xq24,gene with protein product,protein-coding gene,ENSG00000101856,10857,ENSG00000101856,O00264,MGI:1858305,RGD:70890,X,300435,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Component of a progesterone-binding protein complex (PubMed:28396637). Binds progesterone (PubMed:25675345). Has many reported cellular functions (heme homeostasis, interaction with CYPs). Required for the maintenance of uterine histoarchitecture and normal female reproductive lifespan (By similarity). Intracellular heme chaperone. Regulates heme synthesis via interactions with FECH and acts as a heme donor for at least some hemoproteins (PubMed:27599036). {ECO:0000250|UniProtKB:O55022, ECO:0000269|PubMed:25675345, ECO:0000269|PubMed:27599036, ECO:0000303|PubMed:28396637}.",heme biosynthetic process [GO:0006783]; neutrophil degranulation [GO:0043312],amyloid-beta binding [GO:0001540]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; steroid binding [GO:0005496],SUBCELLULAR LOCATION: Microsome membrane {ECO:0000250|UniProtKB:Q95250}; Single-pass membrane protein {ECO:0000255}. Smooth endoplasmic reticulum membrane {ECO:0000303|PubMed:28396637}; Single-pass membrane protein {ECO:0000255}. Mitochondrion outer membrane {ECO:0000250|UniProtKB:O55022}; Single-pass membrane protein {ECO:0000305}; Extracellular side {ECO:0000250|UniProtKB:O55022}.,"SUBUNIT: Homodimer. Forms stable homodimer through hydrophobic heme-heme stacking interactions (PubMed:26988023, PubMed:28396637). Interacts with FECH; the interaction results in decreased FECH activity (PubMed:27599036). Interacts with EGFR, CYP1A1 and CYP3A4; the interactions require PGRMC1 homodimerization (PubMed:28396637). {ECO:0000269|PubMed:26988023, ECO:0000269|PubMed:27599036, ECO:0000269|PubMed:28396637, ECO:0000303|PubMed:28396637}.",X,119236245,119244466,q24,0.6711,0.823,1.1456,0.079992,3.6205,0.6546019367514527,ENST00000217971,0.9064625850340136,0.24101474631342165,588,,,,,,,0.1543990790960429,7.91608844992387,Fallopian Tube,broadly expressed,6.960917086794509,7.018812185742817,FALSE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:16273,SYAP1,synapse associated protein 1,Approved,,"FLJ14495, PRO3113",Xp22.2,gene with protein product,protein-coding gene,ENSG00000169895,94056,ENSG00000169895,Q96A49,MGI:1914293,RGD:1303113,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Plays a role in adipocyte differentiation by promoting mTORC2-mediated phosphorylation of AKT1 at 'Ser-473' after growth factor stimulation (PubMed:23300339). {ECO:0000269|PubMed:23300339}.,cell differentiation [GO:0030154]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to insulin stimulus [GO:0032869]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; TORC2 signaling [GO:0038203],"","SUBCELLULAR LOCATION: Cytoplasm, perinuclear region {ECO:0000250|UniProtKB:Q9D5V6}. Golgi apparatus {ECO:0000250|UniProtKB:Q9D5V6}. Perikaryon {ECO:0000250|UniProtKB:Q9D5V6}. Cell projection, axon {ECO:0000250|UniProtKB:Q9D5V6}. Cell projection, dendrite {ECO:0000250|UniProtKB:Q9D5V6}. Cell projection, growth cone {ECO:0000250|UniProtKB:Q9D5V6}. Cell junction, synapse, presynaptic cell membrane {ECO:0000250|UniProtKB:Q9D5V6}. Cell junction, synapse, postsynaptic cell membrane {ECO:0000250|UniProtKB:Q9D5V6}. Membrane {ECO:0000269|PubMed:23300339}. Note=Localizes to cholinergic neuromuscular junctions and in actin-rich growth cone regions (By similarity). Membrane-associated in a epidermal growth factor (EGF)-dependent manner (PubMed:23300339). {ECO:0000250|UniProtKB:Q9D5V6, ECO:0000269|PubMed:23300339}.",SUBUNIT: Interacts (via phosphorylated form and BSD domain) with AKT1; this interaction is enhanced in a mTORC2-mediated manner in response to epidermal growth factor (EGF) stimulation and activates AKT1 (PubMed:23300339). {ECO:0000269|PubMed:23300339}.,X,16719612,16765340,p22.2,0.94312,0.352,0.33817,1.159,13.471,0.50358220450515645,ENST00000380155,0.8023607176581681,0.08490377405648587,1059,,,,,,,0.2006700147074735,5.001063595440027,Cells - Cultured fibroblasts,broadly expressed,3.1543563727572717,3.460827734007313,FALSE,high confidence escapee,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:16324,PPP1R2C,PPP1R2C family member C,Approved,PPP1R2P9,I-4,Xp11.3,gene with protein product,protein-coding gene,ENSG00000102055,80316,ENSG00000102055,O14990,,,X,301017,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Functions as a protein phosphatase inhibitor. It inhibits activity of the catalytic subunit of PP1 and weakly inhibits the activity of myosin-associated phosphates. {ECO:0000269|PubMed:11076525}.,regulation of phosphoprotein phosphatase activity [GO:0043666]; regulation of signal transduction [GO:0009966],protein phosphatase inhibitor activity [GO:0004864],"","",X,42777366,42778163,p11.3,,,,,,0.46638040559013205,ENST00000378131,0.2711001642036125,0.06328417895526119,609,,,,,,,0.9767441860465116,7.140226498459903,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:16353,MAGED2,MAGE family member D2,Approved,,"JCL-1, BCG1, 11B6, MAGE-D2, HCA10, MAGED, MGC8386",Xp11.21,gene with protein product,protein-coding gene,ENSG00000102316,10916,ENSG00000102316,Q9UNF1,MGI:1933391,RGD:70899,X,300470,TRUE,"Bartter syndrome, type 5, antenatal, transient",300971,X-linked recessive,,,,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Regulates the expression, localization to the plasma membrane and function of the sodium chloride cotransporters SLC12A1 and SLC12A3, two key components of salt reabsorption in the distal renal tubule. {ECO:0000269|PubMed:27120771}.",female pregnancy [GO:0007565]; platelet degranulation [GO:0002576]; renal sodium ion absorption [GO:0070294],"","",SUBUNIT: Interacts with GNAS. May interact with DNAJB1. {ECO:0000269|PubMed:27120771}.,X,54807599,54816015,p11.21,0.99538,0.233,0.53794,2.3381,20.324,0.40232353140609817,ENST00000375068,0.8241076331685887,0.35788552861784556,1821,,,,,,,0.19214461509658617,8.482065750783061,Ovary,broadly expressed,6.1284810678528885,6.928838116251303,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:16489,ATG4A,autophagy related 4A cysteine peptidase,Approved,"AUTL2, APG4A",,Xq22.3,gene with protein product,protein-coding gene,ENSG00000101844,115201,ENSG00000101844,Q8WYN0,MGI:2147903,RGD:1596915,X,300663,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Cysteine protease required for the cytoplasm to vacuole transport (Cvt) and autophagy. Cleaves the C-terminal amino acid of ATG8 family proteins to reveal a C-terminal glycine. Exposure of the glycine at the C-terminus is essential for ATG8 proteins conjugation to phosphatidylethanolamine (PE) and insertion to membranes, which is necessary for autophagy. Preferred substrate is GABARAPL2 followed by MAP1LC3A and GABARAP. Has also an activity of delipidating enzyme for the PE-conjugated forms. {ECO:0000269|PubMed:12473658, ECO:0000269|PubMed:15169837, ECO:0000269|PubMed:17347651, ECO:0000269|PubMed:21177865, ECO:0000269|PubMed:21245471, ECO:0000269|PubMed:22302004}.",autophagy [GO:0006914]; protein transport [GO:0015031]; proteolysis [GO:0006508],cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.,"",X,108091668,108154671,q22.3,0.98953,0.262,1.1869,1.3515,18.123,0.5375040531895315,ENST00000372232,0.9284043441938179,0.21494626343414147,1197,1,"ATG4B (54, 55, chr2)",TRUE,,,,0.17399626947668384,4.242099418366629,Lung,broadly expressed,2.4651229579112046,3.691433664086174,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:16499,RAB39B,"RAB39B, member RAS oncogene family",Approved,"MRX72, WSN",,Xq28,gene with protein product,protein-coding gene,ENSG00000155961,116442,ENSG00000155961,Q96DA2,MGI:1915040,,X,300774,TRUE,"Mental retardation, X-linked 72 // Waisman syndrome",300271 // 311510,X-linked recessive // X-linked recessive,,,,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Small GTPases Rab involved in autophagy (PubMed:27103069). The small GTPases Rab are key regulators of intracellular membrane trafficking, from the formation of transport vesicles to their fusion with membranes. Rabs cycle between an inactive GDP-bound form and an active GTP-bound form that is able to recruit to membranes different sets of downstream effectors directly responsible for vesicle formation, movement, tethering and fusion (PubMed:27103069). May regulate the homeostasis of SNCA/alpha-synuclein. Together with PICK1 proposed to ensure selectively GRIA2 exit from the endoplasmic reticulum to the Golgi and to regulate AMPAR compostion at the post-synapses and thus synaptic transmission (By similarity). {ECO:0000250|UniProtKB:Q8BHC1, ECO:0000269|PubMed:27103069}.",autophagy [GO:0006914]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of autophagy [GO:0010506]; synapse organization [GO:0050808]; vesicle-mediated transport [GO:0016192],GTPase activity [GO:0003924]; GTP binding [GO:0005525]; myosin V binding [GO:0031489],"SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Lipid-anchor {ECO:0000305}; Cytoplasmic side {ECO:0000305}. Cytoplasmic vesicle membrane {ECO:0000269|PubMed:26399558}; Lipid-anchor {ECO:0000305}; Cytoplasmic side {ECO:0000305}. Golgi apparatus {ECO:0000269|PubMed:20159109, ECO:0000269|PubMed:24349490}. Note=Partial colocalization with markers that cycle from the cell surface to the trans-Golgi network. {ECO:0000250|UniProtKB:Q8BHC1}.",SUBUNIT: Interacts (in GTP-bound form) with PICK1 (via PDZ domain); a PICK1 homodimer may allow simultaneous association of RAB39B and GRIA2 to PICK1 which is involved in GRIA2 trafficking. {ECO:0000269|PubMed:25784538}.,X,155258235,155264491,q28,0.82529,0.52,0.68649,1.9438,5.7551,0.518046499038849,ENST00000369454,0.9649532710280374,0.13101724568857787,642,1,"RAB39A (79, 77, chr11)",TRUE,,,,0.7836409448059838,4.340156320421238,Cerebellar_tissues,tissue-specific,3.2572777033377522,4.340156320421238,TRUE,low confidence non-escapee,no_difference_Pre_Post,Pre_higher_vs_Post1,no difference_Pre_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:16648,PJA1,praja ring finger ubiquitin ligase 1,Approved,,"FLJ11830, RNF70",Xq13.1,gene with protein product,protein-coding gene,ENSG00000181191,64219,ENSG00000181191,Q8NG27,MGI:1101765,RGD:1591532,X,300420,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Has E2-dependent E3 ubiquitin-protein ligase activity. Ubiquitinates MAGED1 antigen leading to its subsequent degradation by proteasome (By similarity). May be involved in protein sorting. {ECO:0000250, ECO:0000269|PubMed:12036302}.",protein catabolic process [GO:0030163],metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630],"","SUBUNIT: Binds ubiquitin-conjugating enzymes (E2s). In vitro, interacts with the ubiquitin-conjugating enzyme, UBE2D2. {ECO:0000269|PubMed:12036302}.",X,69160851,69165793,q13.1,0.92754,0.366,2.0169,1.0175,17.187,0.5063477822704536,ENST00000374571,0.6805885681946803,0.18222944263934016,1767,,,,,,,0.24798099507710158,5.686654593184207,Testis,broadly expressed,4.8620397007983795,5.468311238426087,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:16665,APLN,apelin,Approved,,"apelin, XNPEP2",Xq26.1,gene with protein product,protein-coding gene,ENSG00000171388,8862,ENSG00000171388,Q9ULZ1,MGI:1353624,RGD:620672,X,300297,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Endogenous ligand for the apelin receptor (APLNR) (PubMed:10525157). Drives internalization of the apelin receptor (By similarity). Apelin-36 dissociates more hardly than (pyroglu)apelin-13 from APLNR (By similarity). Hormone involved in the regulation of cardiac precursor cell movements during gastrulation and heart morphogenesis (By similarity). Has an inhibitory effect on cytokine production in response to T-cell receptor/CD3 cross-linking; the oral intake of apelin in the colostrum and the milk might therefore modulate immune responses in neonates (By similarity). Plays a role in early coronary blood vessels formation (By similarity). Mediates myocardial contractility in an ERK1/2-dependent manner (By similarity). May also have a role in the central control of body fluid homeostasis by influencing vasopressin release and drinking behavior (By similarity). {ECO:0000250|UniProtKB:Q4TTN8, ECO:0000250|UniProtKB:Q9R0R3, ECO:0000250|UniProtKB:Q9R0R4, ECO:0000269|PubMed:10525157}.; FUNCTION: (Microbial infection) Endogenous ligand for the apelin receptor (APLNR), an alternative coreceptor with CD4 for HIV-1 infection (PubMed:11090199). Inhibits HIV-1 entry in cells coexpressing CD4 and APLNR (PubMed:11090199). Apelin-36 has a greater inhibitory activity on HIV infection than other synthetic apelin derivatives (PubMed:11090199). {ECO:0000269|PubMed:11090199}.",angiogenesis [GO:0001525]; apelin receptor signaling pathway [GO:0060183]; coronary vasculature development [GO:0060976]; drinking behavior [GO:0042756]; gastrulation [GO:0007369]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; lactation [GO:0007595]; negative regulation of blood pressure [GO:0045776]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of gene expression [GO:0010629]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of corticotropin-releasing hormone secretion [GO:0051466]; positive regulation of corticotropin secretion [GO:0051461]; positive regulation of G protein-coupled receptor internalization [GO:1904022]; positive regulation of heart contraction [GO:0045823]; positive regulation of heat generation [GO:0031652]; positive regulation of phosphorylation [GO:0042327]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of respiratory gaseous exchange [GO:0043576]; regulation of the force of heart contraction [GO:0002026]; signal transduction [GO:0007165]; viral process [GO:0016032],apelin receptor binding [GO:0031704]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102],"SUBCELLULAR LOCATION: Secreted {ECO:0000250|UniProtKB:Q9TUI9}. Secreted, extracellular space {ECO:0000250|UniProtKB:Q9TUI9}. Note=Abundantly secreted in the colostrum. Lower level in milk. Decreases rapidly within several days after parturition in milk, but is still detectable even in commercial milk. {ECO:0000250|UniProtKB:Q9TUI9}.","",X,129645259,129654956,q26.1,0.45897,1.524,-0.39985,-0.23902,1.573,0.4808434350030275,ENST00000429967,0.7192307692307692,0.1656835791052237,234,,,,,,,0.6001642174960251,3.835408733994961,Other_Brain_tissues,tissue-specific,3.835408733994961,3.053371171985454,TRUE,low confidence non-escapee,no_difference_Pre_Post,Post1_higher_vs_Pre,no difference_Pre_Post2,Post1_higher_vs_Post2,no disorder
HGNC:16682,ZBTB33,zinc finger and BTB domain containing 33,Approved,,"ZNF-kaiso, kaiso, WUGSC:H_DJ525N14.1, KAISO, ZNF348",Xq24,gene with protein product,protein-coding gene,ENSG00000177485,10009,ENSG00000177485,Q86T24,MGI:1927290,RGD:1566309,X,300329,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Transcriptional regulator with bimodal DNA-binding specificity. Binds to methylated CpG dinucleotides in the consensus sequence 5'-CGCG-3' and also binds to the non-methylated consensus sequence 5'-CTGCNA-3' also known as the consensus kaiso binding site (KBS). Recruits the N-CoR repressor complex to promote histone deacetylation and the formation of repressive chromatin structures in target gene promoters. May contribute to the repression of target genes of the Wnt signaling pathway. May also activate transcription of a subset of target genes by the recruitment of CTNND2. Represses expression of MMP7 in conjunction with transcriptional corepressors CBFA2T3, CBFA2T2 and RUNX1T1 (PubMed:23251453). {ECO:0000269|PubMed:11445535, ECO:0000269|PubMed:14527417, ECO:0000269|PubMed:15548582, ECO:0000269|PubMed:15817151, ECO:0000269|PubMed:16354688, ECO:0000269|PubMed:23251453}.","intracellular signal transduction [GO:0035556]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; Wnt signaling pathway [GO:0016055]","DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; methyl-CpG binding [GO:0008327]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:15781635, ECO:0000269|PubMed:16354688}. Cytoplasm {ECO:0000269|PubMed:15781635}. Note=Also cytoplasmic in cells grown at high densities.","SUBUNIT: Self-associates. Interacts with CTNND2 (By similarity). Interacts with CTNND1, and this interaction inhibits binding to both methylated and non-methylated DNA. Interacts with NCOR1. Interacts with KPNA2/RCH1, which may mediate nuclear import of this protein. Interacts with CBFA2T3. {ECO:0000250|UniProtKB:Q8BN78, ECO:0000269|PubMed:10207085, ECO:0000269|PubMed:14527417, ECO:0000269|PubMed:15564377, ECO:0000269|PubMed:16354688, ECO:0000269|PubMed:23251453}.",X,120250752,120258398,q24,0.9127,0.388,1.7637,1.9378,12.239,0.6394980213821903,ENST00000557385,0.8771173848439822,0.2505623594101475,2019,,,,,,,0.3514958536056025,4.727168968628582,Cells - EBV-transformed lymphocytes,broadly expressed,2.8158377132085164,3.7841322683274687,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:16695,BCAP31,B cell receptor associated protein 31,Approved,,"DXS1357E, BAP31, 6C6-Ag, CDM",Xq28,gene with protein product,protein-coding gene,ENSG00000185825,10134,ENSG00000185825,P51572,MGI:1350933,RGD:1302944,X,300398,TRUE,"Deafness, dystonia, and cerebral hypomyelination",300475,X-linked recessive,,,,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Functions as a chaperone protein. Is one of the most abundant endoplasmic reticulum (ER) proteins. Plays a role in the export of secreted proteins in the ER, the recognition of abnormally folded protein and their targeting to the ER associated-degradation (ERAD). Also serves as a cargo receptor for the export of transmembrane proteins. May be involved in CASP8-mediated apoptosis. {ECO:0000269|PubMed:10958671, ECO:0000269|PubMed:18287538, ECO:0000269|PubMed:9396746}.","antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; apoptotic process [GO:0006915]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; positive regulation of retrograde protein transport, ER to cytosol [GO:1904154]; protein localization to endoplasmic reticulum exit site [GO:0070973]; spermatogenesis [GO:0007283]; viral process [GO:0016032]",MHC class I protein binding [GO:0042288]; protein-containing complex binding [GO:0044877],"SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:9334338, ECO:0000269|PubMed:9396746}; Multi-pass membrane protein {ECO:0000255}. Endoplasmic reticulum-Golgi intermediate compartment membrane {ECO:0000269|PubMed:11042173, ECO:0000269|PubMed:9396746}; Multi-pass membrane protein {ECO:0000255}. Note=May shuttle between the ER and the intermediate compartment/cis-Golgi complex. {ECO:0000269|PubMed:9396746}.","SUBUNIT: Homodimer and heterodimer with BCAP29. Binds CASP8 (isoform 9) as a complex containing BCAP31, BCAP29, BCL2 and/or BCL2L1. Interacts with VAMP3, VAMP1 and membrane IgD immunoglobulins. May interact with ACTG1 and non-muscle myosin II. Interacts with HACD2 (PubMed:15024066). {ECO:0000269|PubMed:11917123, ECO:0000269|PubMed:15024066, ECO:0000269|PubMed:23967155, ECO:0000269|PubMed:9334338}.; SUBUNIT: (Microbial infection) Interacts (via C-terminus) with HRSV membrane protein SH; this interaction is direct. {ECO:0000269|PubMed:25854864}.",X,153700492,153724565,q28,0.43366,0.65,0.13621,1.3006,9.6858,0.6509780945871172,ENST00000345046,0.8058029689608637,0.2427893026743314,741,,,,,,,0.10446850303230998,7.8428845759845816,Adipose - Subcutaneous,broadly expressed,6.6004585833652865,6.269449320404241,FALSE,low confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:16814,DACH2,dachshund family transcription factor 2,Approved,,,Xq21.2,gene with protein product,protein-coding gene,ENSG00000126733,117154,ENSG00000126733,Q96NX9,MGI:1890446,RGD:1561687,X,300608,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Transcription factor that is involved in regulation of organogenesis. Seems to be a regulator for SIX1 and SIX6. Seems to act as a corepressor of SIX6 in regulating proliferation by directly repressing cyclin-dependent kinase inhibitors, including the p27Kip1 promoter. Is recruited with SIX6 to the p27Kip1 promoter in embryonal retina. SIX6 corepression seems also to involve NCOR1, TBL1, HDAC1 and HDAC3. May be involved together with PAX3, SIX1, and EYA2 in regulation of myogenesis. In the developing somite, expression of DACH2 and PAX3 is regulated by the overlying ectoderm, and DACH2 and PAX3 positively regulate each other's expression (By similarity). Probably binds to DNA via its DACHbox-N domain. {ECO:0000250}.","development of primary female sexual characteristics [GO:0046545]; regulation of transcription, DNA-templated [GO:0006355]","DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]",SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.,SUBUNIT: Interacts with SIX6 and EYA2. {ECO:0000250}.,X,86148451,86832604,q21.2,0.16242,0.618,0.26586,0.47128,14.811,0.6012460825059937,ENST00000373125,0.9348888888888889,0.3147213196700825,1800,,,,,,,0.8891837456894357,1.8778580907803366,Other_Brain_tissues,tissue-specific,1.8778580907803366,0.07360617766844961,TRUE,discordant,no_difference_Pre_Post,Pre_higher_vs_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:16818,PUDP,pseudouridine 5'-phosphatase,Approved,"FAM16AX, HDHD1A, HDHD1","DXF68S1E, GS1",Xp22.31,gene with protein product,protein-coding gene,ENSG00000130021,8226,ENSG00000130021,Q08623,MGI:1914615,RGD:1305101,X,306480,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Dephosphorylates pseudouridine 5'-phosphate, a potential intermediate in rRNA degradation. Pseudouridine is then excreted intact in urine. {ECO:0000269|PubMed:20722631}.",nucleotide metabolic process [GO:0009117]; pyrimidine nucleoside salvage [GO:0043097],metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; pseudouridine 5'-phosphatase activity [GO:1990738],"","",X,6667865,7148158,p22.31,0.12667,1.143,-1.5403,0.080324,5.4812,0.6713847903699726,ENST00000381077,0.7331877729257642,0.03779055236190952,687,,,,,,,0.3779194889489199,4.941092222058879,Cells - EBV-transformed lymphocytes,broadly expressed,2.4587547047295297,2.6028380992454685,FALSE,high confidence escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,no difference_Pre_Post2,Post2_higher_vs_Post1,no disorder
HGNC:16825,MTMR8,myotubularin related protein 8,Approved,,FLJ20126,Xq11.2,gene with protein product,protein-coding gene,ENSG00000102043,55613,ENSG00000102043,Q96EF0,,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Phosphatase that acts on lipids with a phosphoinositol headgroup (PubMed:22647598, PubMed:26143924). Has phosphatase activity towards phosphatidylinositol 3-phosphate and phosphatidylinositol 3,5-bisphosphate (PubMed:22647598, PubMed:26143924). In complex with MTMR9, negatively regulates autophagy (PubMed:22647598). {ECO:0000269|PubMed:22647598, ECO:0000269|PubMed:26143924}.",negative regulation of autophagy [GO:0010507]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856],"phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3,5-bisphosphate phosphatase activity [GO:0106018]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein tyrosine phosphatase activity [GO:0004725]",SUBCELLULAR LOCATION: Nucleus envelope {ECO:0000269|PubMed:16787938}.,"SUBUNIT: Homodimer (PubMed:26143924). Heterodimer with MTMR9 (PubMed:16787938, PubMed:22647598). {ECO:0000269|PubMed:16787938, ECO:0000269|PubMed:22647598, ECO:0000269|PubMed:26143924}.",X,64268081,64395452,q11.2,7.0105e-19,1.84,-1.5897,-2.3426,17.578,0.3271503412671026,ENST00000374852,0.6183924349881796,0.07958010497375656,2115,,,,,,,0.46526896921136096,1.6258923275956565,Artery - Tibial,broadly expressed,0.21706316771291587,0.5106044916015734,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:16847,CSAG2,CSAG family member 2,Approved,CSAG3B,"TRAG3, CT24.2",Xq28,gene with protein product,protein-coding gene,ENSG00000268902,102723547,ENSG00000268902,Q9Y5P2,,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Drug-resistance related protein, its expression is associated with the chemotherapy resistant and neoplastic phenotype. May also be linked to the malignant phenotype.",response to drug [GO:0042493],"","","",X,152708261,152714549,q28,,,,,,0.17465069860279442,ENST00000638741,0.013281250000000001,0.04976255936015996,384,1,"CSAG3 (99, 99, chrX)",TRUE,1,"CSAG3 (99, 99, chrX)",TRUE,0.9650345865519799,0.10509686043263909,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:16849,MORF4L2,mortality factor 4 like 2,Approved,,"KIAA0026, MRGX",Xq22.2,gene with protein product,protein-coding gene,ENSG00000123562,9643,ENSG00000123562,Q15014,MGI:1927167,RGD:1359471,X,300409,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Component of the NuA4 histone acetyltransferase complex which is involved in transcriptional activation of select genes principally by acetylation of nucleosomal histone H4 and H2A. This modification may both alter nucleosome - DNA interactions and promote interaction of the modified histones with other proteins which positively regulate transcription. This complex may be required for the activation of transcriptional programs associated with oncogene and proto-oncogene mediated growth induction, tumor suppressor mediated growth arrest and replicative senescence, apoptosis, and DNA repair. The NuA4 complex ATPase and helicase activities seem to be, at least in part, contributed by the association of RUVBL1 and RUVBL2 with EP400. NuA4 may also play a direct role in DNA repair when directly recruited to sites of DNA damage. Also component of the MSIN3A complex which acts to repress transcription by deacetylation of nucleosomal histones.",chromatin silencing [GO:0006342]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone deacetylation [GO:0016575]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of striated muscle cell differentiation [GO:0051155]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of growth [GO:0040008],"",SUBCELLULAR LOCATION: Nucleus.,"SUBUNIT: Component of the NuA4 histone acetyltransferase complex which contains the catalytic subunit KAT5/TIP60 and the subunits EP400, TRRAP/PAF400, BRD8/SMAP, EPC1, DMAP1/DNMAP1, RUVBL1/TIP49, RUVBL2, ING3, actin, ACTL6A/BAF53A, MORF4L1/MRG15, MORF4L2/MRGX, MRGBP, YEATS4/GAS41 and VPS72/YL1. The NuA4 complex interacts with MYC and the adenovirus E1A protein. MORF4L1 may also participate in the formation of NuA4 related complexes which lack the KAT5/TIP60 catalytic subunit, but which include the SWI/SNF related protein SRCAP. Component of the MSIN3A histone deacetylase complex, which includes SIN3A, HDAC2, ARID4B, MORF4L1, RBBP4/RbAp48, and RBBP7/RbAp46. Interacts with MRFAP1 and RB1. May also interact with one or more as yet undefined members of the TLE (transducin-like enhancer of split) family of transcriptional repressors. {ECO:0000269|PubMed:12391155, ECO:0000269|PubMed:12963728, ECO:0000269|PubMed:14506250}.",X,103675496,103688158,q22.2,0.81082,0.544,0.70295,1.7645,5.5025,0.6419977198012021,ENST00000441076,0.9087658592848904,0.35571107223194204,867,1,"MORF4L1 (74, 59, chr15)",TRUE,,,,0.19300500410020593,9.261345107077576,Ovary,broadly expressed,7.134087426780997,7.965282139409515,FALSE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:16869,ARMCX2,armadillo repeat containing X-linked 2,Approved,,"ALEX2, KIAA0512, GASP9",Xq22.1,gene with protein product,protein-coding gene,ENSG00000184867,9823,ENSG00000184867,Q7L311,MGI:1914666,RGD:1359132,X,300363,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May regulate the dynamics and distribution of mitochondria in neural cells. {ECO:0000250|UniProtKB:Q6A058}.,"","",SUBCELLULAR LOCATION: Mitochondrion {ECO:0000250|UniProtKB:Q6A058}. Mitochondrion outer membrane {ECO:0000250|UniProtKB:Q8BHS6}; Single-pass membrane protein {ECO:0000255}.,"",X,101655281,101659850,q22.1,0.69249,0.581,-0.77547,1.514,8.1622,0.3465900549533147,ENST00000356824,0.5274881516587677,0.23104223944013996,1899,,,,,,,0.33862608554873325,6.826535776265396,Pituitary,broadly expressed,4.315725619318813,5.034427032142366,FALSE,high confidence non-escapee,no_difference_Pre_Post,Pre_higher_vs_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:16880,SSX4B,SSX family member 4B,Approved,,OTTHUMT00000056510,Xp11.23,gene with protein product,protein-coding gene,ENSG00000269791,548313,ENSG00000269791,O60224,MGI:2446771,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Could act as a modulator of transcription.,"regulation of transcription, DNA-templated [GO:0006355]",nucleic acid binding [GO:0003676],"","",X,48402078,48411910,p11.23,0.15282,1.722,0.88739,-0.075386,2.0974,0.3476340435973989,ENST00000595235,0.18077601410934743,0.12816795801049738,567,7,"SSX4 (100, 100, chrX); SSX7 (81, 81, chrX); SSX1 (79, 79, chrX); SSX5 (78, 64, chrX); SSX3 (67, 62, chrX); SSX2 (66, 56, chrX); SSX2B (66, 56, chrX)",TRUE,1,"SSX4 (100, 100, chrX)",TRUE,0.9767441860465116,0.04836454352459541,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:16949,FAM120C,family with sequence similarity 120C,Approved,CXorf17,"ORF34, FLJ20506",Xp11.22,gene with protein product,protein-coding gene,ENSG00000184083,54954,ENSG00000184083,Q9NX05,MGI:2387687,RGD:1564253,X,300741,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","",RNA binding [GO:0003723],"","",X,54068324,54183281,p11.22,0.99998,0.136,0.16023,3.6347,34.791,0.5308459409244304,ENST00000375180,0.9084168945609238,0.3495626093476631,3291,1,"FAM120A (56, 55, chr9)",TRUE,,,,0.35879090665408025,3.2636714554720783,Nerve - Tibial,broadly expressed,2.406615578187123,2.6568692950572657,FALSE,low confidence non-escapee,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,no difference_Post1_Post2,no disorder
HGNC:17032,VSIG4,V-set and immunoglobulin domain containing 4,Approved,,"Z39IG, CRIg",Xq12,gene with protein product,protein-coding gene,ENSG00000155659,11326,ENSG00000155659,Q9Y279,MGI:2679720,RGD:1564659,X,300353,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Phagocytic receptor, strong negative regulator of T-cell proliferation and IL2 production. Potent inhibitor of the alternative complement pathway convertases. {ECO:0000269|PubMed:17016562, ECO:0000269|PubMed:17051150}.","complement activation, alternative pathway [GO:0006957]; negative regulation of complement activation, alternative pathway [GO:0045957]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of macrophage activation [GO:0043031]; negative regulation of T cell proliferation [GO:0042130]",complement component C3b binding [GO:0001851],SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}.,"",X,66021738,66040125,q12,1.4953e-9,1.684,-1.6238,-1.4261,12.017,0.0820950660865282,ENST00000374737,0.391,0.062334416395901024,1200,,,,,,,0.4270188791985466,7.161071401924465,Lung,broadly expressed,2.1660566030514588,1.0159692084702199,FALSE,discordant,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:17123,SLC9A7,solute carrier family 9 member A7,Approved,,NHE7,Xp11.3,gene with protein product,protein-coding gene,ENSG00000065923,84679,ENSG00000065923,Q96T83,MGI:2444530,RGD:1561385,X,300368,TRUE,"Intellectual developmental disorder, X-linked 108",301024,X-linked recessive,,,,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Mediates electroneutral exchange of protons for Na(+) and K(+) across endomembranes. May contribute to the regulation of Golgi apparatus volume and pH. {ECO:0000269|PubMed:11279194, ECO:0000269|PubMed:30335141}.",ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; regulation of Golgi lumen acidification [GO:1905526]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; sodium ion import across plasma membrane [GO:0098719],potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385],"SUBCELLULAR LOCATION: Golgi apparatus, trans-Golgi network membrane {ECO:0000269|PubMed:15840657, ECO:0000269|PubMed:30335141}; Multi-pass membrane protein {ECO:0000269|PubMed:15840657}. Recycling endosome membrane {ECO:0000269|PubMed:15840657}; Multi-pass membrane protein {ECO:0000269|PubMed:15840657}. Cell membrane {ECO:0000269|PubMed:30335141}; Multi-pass membrane protein {ECO:0000305}.","SUBUNIT: Interacts with SCAMP1, SCAMP2 and SCAMP5; may participate in its shuttling from trans-Golgi network to recycling endosomes. {ECO:0000269|PubMed:15840657}.",X,46599251,46759118,p11.3,0.99352,0.264,0.1786,2.121,23.825,0.5566239083381256,ENST00000616978,0.9076111875286565,0.19897525618595352,2181,2,"SLC9A6 (68, 67, chrX); SLC9A9 (55, 62, chr3)",TRUE,,,,0.6171142694405433,5.240234177382753,Cells - EBV-transformed lymphocytes,tissue-specific,3.174864978207316,4.189626915884861,FALSE,high confidence non-escapee,no_difference_Pre_Post,Pre_higher_vs_Post1,no difference_Pre_Post2,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:17125,TMEM185A,transmembrane protein 185A,Approved,"CXorf13, FAM11A, FRAXF",,Xq28,gene with protein product,protein-coding gene,ENSG00000269556,84548,ENSG00000269556,Q8NFB2,MGI:2448555,RGD:1563037,X,300031,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","SUBCELLULAR LOCATION: Cell projection, dendrite {ECO:0000250}. Membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.",SUBUNIT: Interacts with MAP1B. {ECO:0000269|PubMed:15525354}.,X,149596556,149631912,q28,0.016569,1.074,0.73138,1.1509,8.5206,0.5242091813053901,ENST00000600449,0.9404558404558404,0.13819045238690328,1053,1,"TMEM185B (88, 88, chr2)",TRUE,1,"TMEM185B (88, 88, chr2)",TRUE,0.27632068296292,4.5000052920931335,Ovary,broadly expressed,2.3915257843442155,3.3291056522118034,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:17152,ACOT9,acyl-CoA thioesterase 9,Approved,,"CGI-16, MT-ACT48, ACATE2",Xp22.11,gene with protein product,protein-coding gene,ENSG00000123130,23597,ENSG00000123130,Q9Y305,"MGI:1928939, MGI:1928940",RGD:1359188,X,300862,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Acyl-CoA thioesterases are a group of enzymes that catalyze the hydrolysis of acyl-CoAs to the free fatty acid and coenzyme A (CoASH), providing the potential to regulate intracellular levels of acyl-CoAs, free fatty acids and CoASH. Active on long chain acyl-CoAs.",acyl-CoA metabolic process [GO:0006637],acetyl-CoA hydrolase activity [GO:0003986]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689],SUBCELLULAR LOCATION: Mitochondrion {ECO:0000250}.,"SUBUNIT: Interacts with NYAP1, NYAP2 and MYO16. {ECO:0000250}.",X,23701055,23766475,p22.11,6.8017e-9,1.18,1.1477,0.70195,19.569,0.5301349982201046,ENST00000379303,0.855902004454343,0.06538365408647838,1347,,,,,,,0.1937260237500877,5.279972660192287,Artery - Tibial,broadly expressed,2.6337101896734194,3.297652183510189,FALSE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:17169,PRDX4,peroxiredoxin 4,Approved,,AOE37-2,Xp22.11,gene with protein product,protein-coding gene,ENSG00000123131,10549,ENSG00000123131,Q13162,MGI:1859815,RGD:620043,X,300927,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Thiol-specific peroxidase that catalyzes the reduction of hydrogen peroxide and organic hydroperoxides to water and alcohols, respectively. Plays a role in cell protection against oxidative stress by detoxifying peroxides and as sensor of hydrogen peroxide-mediated signaling events. Regulates the activation of NF-kappa-B in the cytosol by a modulation of I-kappa-B-alpha phosphorylation. {ECO:0000269|PubMed:9388242}.",cell redox homeostasis [GO:0045454]; extracellular matrix organization [GO:0030198]; I-kappaB phosphorylation [GO:0007252]; male gonad development [GO:0008584]; negative regulation of male germ cell proliferation [GO:2000255]; neutrophil degranulation [GO:0043312]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; protein maturation by protein folding [GO:0022417]; reactive oxygen species metabolic process [GO:0072593]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283],thioredoxin peroxidase activity [GO:0008379],"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:18052930, ECO:0000269|PubMed:9388242}. Endoplasmic reticulum {ECO:0000269|PubMed:18052930}. Note=Cotranslationally translocated to and retained within the endoplasmic reticulum. A small fraction of the protein is cytoplasmic. {ECO:0000269|PubMed:18052930}.","SUBUNIT: Homodimer; disulfide-linked, upon oxidation (PubMed:9388242). 5 homodimers assemble to form a ring-like decamer (PubMed:21994946). Can form heterodimers with PRDX1 (PubMed:9388242). {ECO:0000269|PubMed:21994946, ECO:0000269|PubMed:9388242}.",X,23664262,23686397,p22.11,0.026755,0.942,-0.28442,1.0401,9.7139,0.5963506898086338,ENST00000379341,0.8321078431372549,0.1773056735816046,816,,,,,,,0.26015983544041255,7.621919993582331,Cells - Cultured fibroblasts,broadly expressed,3.576884882348737,4.1249608297947535,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:17184,ASB9,ankyrin repeat and SOCS box containing 9,Approved,,"DKFZP564L0862, MGC4954, FLJ20636",Xp22.2,gene with protein product,protein-coding gene,ENSG00000102048,140462,ENSG00000102048,Q96DX5,MGI:1916549,RGD:1560537,X,300890,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Substrate-recognition component of a SCF-like ECS (Elongin-Cullin-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. Recognizes at least two forms of creatine kinase, CKB and CKMT1A. {ECO:0000269|PubMed:22418839}.",intracellular signal transduction [GO:0035556]; positive regulation of protein catabolic process [GO:0045732]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567],"",SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:20302626}.,"",X,15235288,15270467,p22.2,0.69649,0.578,-0.29202,0.98518,8.2118,0.37646402677077523,ENST00000380488,0.628587570621469,0.1317,885,,,,,,,0.7509553773057599,5.397505221301016,Testis,tissue-specific,0.24796153027298426,0.13626069699539775,FALSE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:17186,ASB11,ankyrin repeat and SOCS box containing 11,Approved,,DKFZp779E2460,Xp22.2,gene with protein product,protein-coding gene,ENSG00000165192,140456,ENSG00000165192,Q8WXH4,MGI:1916104,RGD:1566298,X,300626,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May be a substrate-recognition component of a SCF-like ECS (Elongin-Cullin-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. {ECO:0000250}.,intracellular signal transduction [GO:0035556]; positive regulation of protein catabolic process [GO:0045732]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567],"","","",X,15281697,15315640,p22.2,1.961e-6,1.611,-0.73347,-0.0022245,9.5573,0.36226415094339626,ENST00000480796,0.8390946502057613,0.19380154961259685,972,1,"ASB5 (55, 54, chr4)",TRUE,,,,0.9202334040140437,4.580085169824785,Muscle - Skeletal,tissue-specific,0.004645765975437688,0.009466281061036424,FALSE,variable escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:17301,PCSK1N,proprotein convertase subtilisin/kexin type 1 inhibitor,Approved,,"SAAS, SgVIII, SCG8, proSAAS, PEN, BigLEN",Xp11.23,gene with protein product,protein-coding gene,ENSG00000102109,27344,ENSG00000102109,Q9UHG2,MGI:1353431,RGD:3617,X,300399,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: May function in the control of the neuroendocrine secretory pathway. Proposed be a specific endogenous inhibitor of PCSK1. ProSAAS and Big PEN-LEN, both containing the C-terminal inhibitory domain, but not the further processed peptides reduce PCSK1 activity in the endoplasmic reticulum and Golgi. It reduces the activity of the 84 kDa form but not the autocatalytically derived 66 kDa form of PCSK1. Subsequent processing of proSAAS may eliminate the inhibition. Slows down convertase-mediated processing of proopiomelanocortin and proenkephalin. May control the intracellular timing of PCSK1 rather than its total level of activity. The function of the processed secreted peptides is not known (By similarity). {ECO:0000250}.",neuropeptide signaling pathway [GO:0007218]; peptide hormone processing [GO:0016486]; response to cold [GO:0009409]; response to dietary excess [GO:0002021],endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]; signaling receptor binding [GO:0005102],"SUBCELLULAR LOCATION: Secreted {ECO:0000250|UniProtKB:Q9QXV0}. Golgi apparatus, trans-Golgi network {ECO:0000250|UniProtKB:Q9QXV0}. Note=A N-terminal processed peptide, probably Big SAAS or Little SAAS, is accumulated in cytoplasmic protein tau deposits in frontotemporal dementia and parkinsonism linked to chromosome 17 (Pick disease), Alzheimer disease and amyotrophic lateral sclerosis-parkinsonism/dementia complex 1 (Guam disease). {ECO:0000269|PubMed:12914799, ECO:0000269|PubMed:14746899}.",SUBUNIT: Interacts via the C-terminal inhibitory domain with PCSK1 66 kDa form. {ECO:0000250}.,X,48831096,48835610,p11.23,0.53242,1.254,1.3147,0.81314,2.2307,0.5465322817432055,ENST00000218230,0.5800766283524904,0.12706823294176456,783,,,,,,,0.7207789942668811,10.685966421062247,Pituitary,tissue-specific,8.56888715905062,7.736675898968873,FALSE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:17306,TAF9B,TATA-box binding protein associated factor 9b,Approved,TAF9L,"TAFII31L, DN-7, DN7, TFIID-31",Xq21.1,gene with protein product,protein-coding gene,ENSG00000187325,51616,ENSG00000187325,Q9HBM6,MGI:3039562,RGD:621116,X,300754,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Essential for cell viability. TAF9 and TAF9B are involved in transcriptional activation as well as repression of distinct but overlapping sets of genes. May have a role in gene regulation associated with apoptosis. TAFs are components of the transcription factor IID (TFIID) complex, the TBP-free TAFII complex (TFTC), the PCAF histone acetylase complex and the STAGA transcription coactivator-HAT complex. TFIID or TFTC are essential for the regulation of RNA polymerase II-mediated transcription. {ECO:0000269|PubMed:15899866}.",negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of signal transduction by p53 class mediator [GO:1901796]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367],protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976],SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.,SUBUNIT: Binds TAF5 and TAF6. Component of TFIID and the TATA-binding protein-free TAF complex (TFTC). TFIID is composed of TATA binding protein (TBP) and a number of TBP-associated factors (TAFs). Binds N-terminal domain of p53/TP53 which is essential for transcription. {ECO:0000269|PubMed:15899866}.,X,78129748,78139650,q21.1,1.085e-10,1.912,-1.612,-0.11315,9.0826,0.5290171179359021,ENST00000341864,0.9457671957671958,0.17930517370657337,756,1,"TAF9 (82, 78, chr5)",TRUE,,,,0.2116962917277306,5.442605169068243,Esophagus - Gastroesophageal Junction,broadly expressed,4.40158268539378,4.827633595909084,FALSE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,Post2_higher_vs_Post1,no disorder
HGNC:17310,TIMM17B,translocase of inner mitochondrial membrane 17B,Approved,,"DXS9822, JM3",Xp11.23,gene with protein product,protein-coding gene,ENSG00000126768,10245,ENSG00000126768,O60830,MGI:1343176,RGD:1561744,X,300249,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Essential component of the TIM23 complex, a complex that mediates the translocation of transit peptide-containing proteins across the mitochondrial inner membrane.",protein import into mitochondrial matrix [GO:0030150]; protein targeting to mitochondrion [GO:0006626],P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450],SUBCELLULAR LOCATION: Mitochondrion inner membrane; Multi-pass membrane protein.,"SUBUNIT: Component of the TIM23 complex at least composed of TIMM23, TIMM17 (TIMM17A or TIMM17B) and TIMM50. The complex interacts with the TIMM44 component of the PAM complex and with DNAJC15. {ECO:0000269|PubMed:23263864}.",X,48893447,48898143,p11.23,0.085414,0.906,0.58375,1.3146,8.5563,0.569496608251213,ENST00000376582,0.8797687861271676,0.11204698825293677,519,1,"TIMM17A (59, 77, chr1)",TRUE,,,,0.1020581256632042,5.519755751788401,Pituitary,broadly expressed,4.469853424123809,4.951823220600772,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:17342,BRWD3,bromodomain and WD repeat domain containing 3,Approved,,"FLJ38568, MRX93",Xq21.1,gene with protein product,protein-coding gene,ENSG00000165288,254065,ENSG00000165288,Q6RI45,MGI:3029414,RGD:1559445,X,300553,TRUE,"Mental retardation, X-linked 93",300659,X-linked recessive,,,,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,FUNCTION: Plays a role in the regulation of cell morphology and cytoskeletal organization. Required in the control of cell shape. {ECO:0000269|PubMed:21834987}.,cytoskeleton organization [GO:0007010]; regulation of cell shape [GO:0008360]; regulation of transcription by RNA polymerase II [GO:0006357],"","","",X,80669503,80809877,q21.1,1,0.084,-0.90397,4.269,75.372,0.540049263030335,ENST00000373275,0.9517655758920318,0.32479380154961257,5409,1,"PHIP (55, 54, chr6)",TRUE,,,,0.3032457013524189,3.685211330526517,Cells - EBV-transformed lymphocytes,broadly expressed,1.232881748465694,2.996305581178573,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:17402,EOLA2,endothelium and lymphocyte associated ASCH domain 2,Approved,CXorf40B,,Xq28,gene with protein product,protein-coding gene,ENSG00000197021,541578,ENSG00000197021,Q96DE9,MGI:1915868,RGD:1562747,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,149929527,149938700,q28,0.02439,1.882,-0.54296,-0.63949,1.9525,0.5710865625160442,ENST00000370406,0.6287211740041929,0.010297425643589103,477,1,"EOLA1 (99, 99, chrX)",TRUE,1,"EOLA1 (99, 99, chrX)",TRUE,0.15345583129216028,5.206424427815888,Ovary,broadly expressed,3.502954293717869,4.255462965768159,FALSE,high confidence non-escapee,no_difference_Pre_Post,Pre_higher_vs_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:17407,ZC3H12B,zinc finger CCCH-type containing 12B,Approved,CXorf32,MCPIP2,Xq11.2-q12,gene with protein product,protein-coding gene,ENSG00000102053,340554,ENSG00000102053,Q5HYM0,MGI:2442133,RGD:1560891,X,300889,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May function as RNase and regulate the levels of target RNA species. {ECO:0000305}.,"RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]",endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729],"","",X,65366638,65507887,q11.2,0.99835,0.206,0.95252,2.5427,23.083,0.2497792648357266,ENST00000338957,0.9024691358024691,0.1939515121219695,2511,,,,,,,0.4775928230727881,2.601595500524035,Cerebellar_tissues,broadly expressed,1.854869380370935,2.601595500524035,TRUE,discordant,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:17418,MAGEB17,MAGE family member B17,Approved,,,Xp22.2,gene with protein product,protein-coding gene,ENSG00000182798,645864,ENSG00000182798,A8MXT2,"MGI:3643982, MGI:3645128",,X,300763,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,16167481,16171464,p22.2,,,-0.40258,0.64444,,0.27031963470319637,ENST00000400004,0.19970326409495548,0.004423894026493376,1011,2,"MAGEB4 (56, 55, chrX); MAGEB1 (55, 53, chrX)",TRUE,,,,0.8782743679993662,2.124066705564117,Testis,tissue-specific,0.074733262804304,0.20898663678285903,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:17451,CYSLTR1,cysteinyl leukotriene receptor 1,Approved,,"CysLT1, CysLT(1), CYSLT1R",Xq21.1,gene with protein product,protein-coding gene,ENSG00000173198,10800,ENSG00000173198,Q9Y271,MGI:1926218,RGD:619796,X,300201,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Receptor for cysteinyl leukotrienes mediating bronchoconstriction of individuals with and without asthma. Stimulation by LTD4 results in the contraction and proliferation of smooth muscle, edema, eosinophil migration and damage to the mucus layer in the lung. This response is mediated via a G-protein that activates a phosphatidylinositol-calcium second messenger system. The rank order of affinities for the leukotrienes is LTD4 >> LTE4 = LTC4 >> LTB4.",calcium ion transport [GO:0006816]; cell surface receptor signaling pathway [GO:0007166]; chemotaxis [GO:0006935]; defense response [GO:0006952]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response to antigenic stimulus [GO:0002437]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; respiratory gaseous exchange by respiratory system [GO:0007585],cysteinyl leukotriene receptor activity [GO:0001631]; G protein-coupled peptide receptor activity [GO:0008528]; leukotriene receptor activity [GO:0004974],SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.,"",X,78271468,78327691,q21.1,0.01203,1.697,-2.662,-0.76762,4.0708,0.14242598935196174,ENST00000373304,0.8133136094674556,0.1699075231192202,1014,,,,,,,0.7433539300503011,3.706751553617117,Esophagus - Muscularis,tissue-specific,0.2363664822876657,0.10731995190621886,FALSE,high confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:17515,GAB3,GRB2 associated binding protein 3,Approved,,,Xq28,gene with protein product,protein-coding gene,ENSG00000160219,139716,ENSG00000160219,Q8WWW8,MGI:2387324,,X,300482,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",macrophage differentiation [GO:0030225],"","","SUBUNIT: Interacts with PIK3R/p85, SHP2 and GRAP2/MONA (By similarity). May interact with Grb2. {ECO:0000250}.",X,154675249,154751583,q28,0.9536,0.341,0.84975,1.4669,18.453,0.5554255758260529,ENST00000424127,0.7083900226757369,0.04486378405398651,1764,,,,,,,0.5138663801148713,5.164106436168906,Spleen,broadly expressed,1.1200665584762104,0.8855564037800933,FALSE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:17621,NUDT10,nudix hydrolase 10,Approved,,"DIPP3a, hDIPP3alpha",Xp11.22,gene with protein product,protein-coding gene,ENSG00000122824,170685,ENSG00000122824,Q8NFP7,"MGI:1930957, MGI:2147931",,X,300527,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Cleaves a beta-phosphate from the diphosphate groups in PP-InsP5 (diphosphoinositol pentakisphosphate), suggesting that it may play a role in signal transduction. Also able to catalyze the hydrolysis of dinucleoside oligophosphates, with Ap6A and Ap5A being the preferred substrates. The major reaction products are ADP and p4a from Ap6A and ADP and ATP from Ap5A. Also able to hydrolyze 5-phosphoribose 1-diphosphate. {ECO:0000269|PubMed:12105228}.",adenosine 5'-(hexahydrogen pentaphosphate) catabolic process [GO:1901911]; diadenosine hexaphosphate catabolic process [GO:1901909]; diadenosine pentaphosphate catabolic process [GO:1901907]; diphosphoinositol polyphosphate metabolic process [GO:0071543]; inositol phosphate metabolic process [GO:0043647],bis(5'-adenosyl)-hexaphosphatase activity [GO:0034431]; bis(5'-adenosyl)-pentaphosphatase activity [GO:0034432]; diphosphoinositol-polyphosphate diphosphatase activity [GO:0008486]; endopolyphosphatase activity [GO:0000298]; inositol diphosphate pentakisphosphate diphosphatase activity [GO:0052842]; inositol diphosphate tetrakisphosphate diphosphatase activity [GO:0052840]; m7G(5')pppN diphosphatase activity [GO:0050072]; metal ion binding [GO:0046872],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305|PubMed:12121577}.,"",X,51332231,51337525,p11.22,0.1065,1.239,-1.0947,0.97888,5.0271,0.6136459518543614,ENST00000356450,0.8832323232323233,0.18300424893776557,495,4,"NUDT11 (99, 99, chrX); NUDT4 (90, 82, chr12); NUDT4B (90, 82, chr1); NUDT3 (74, 70, chr6)",TRUE,1,"NUDT11 (99, 99, chrX)",TRUE,0.6714228812770002,5.57113675996099,Testis,tissue-specific,3.2951690525839483,3.6472903300980186,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,no disorder
HGNC:17625,ZNF674,zinc finger protein 674,Approved,MRX92,ZNF673B,Xp11.3,gene with protein product,protein-coding gene,ENSG00000251192,641339,ENSG00000251192,Q2M3X9,,,X,300573,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May be involved in transcriptional regulation.,"",DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565],SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.,"",X,46497727,46545457,p11.3,6.0351e-7,1.311,0.55045,1.057,13.884,0.33834531639662235,ENST00000523374,0.25441008018327604,0.010522369407648087,1746,,,,,,,0.3233578788350604,1.9898583585225151,Cerebellar_tissues,broadly expressed,1.13431952603045,1.9898583585225151,TRUE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:17652,PORCN,porcupine O-acyltransferase,Approved,DHOF,"MG61, PORC, PPN, por",Xp11.23,gene with protein product,protein-coding gene,ENSG00000102312,64840,ENSG00000102312,Q9H237,MGI:1890212,RGD:1564947,X,300651,TRUE,Focal dermal hypoplasia,305600,X-linked dominant,,,,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,TRUE,confirmed,"FUNCTION: Protein-serine O-palmitoleoyltransferase that acts as a key regulator of the Wnt signaling pathway by mediating the attachment of palmitoleate, a 16-carbon monounsaturated fatty acid (C16:1), to Wnt proteins. Serine palmitoleylation of WNT proteins is required for efficient binding to frizzled receptors. {ECO:0000250|UniProtKB:Q9JJJ7, ECO:0000269|PubMed:12034504, ECO:0000269|PubMed:20826466, ECO:0000269|PubMed:24292069}.",canonical Wnt signaling pathway [GO:0060070]; glycoprotein metabolic process [GO:0009100]; lipid modification [GO:0030258]; protein lipidation [GO:0006497]; protein palmitoleylation [GO:0045234]; protein palmitoylation [GO:0018345]; Wnt protein secretion [GO:0061355]; Wnt signaling pathway [GO:0016055],"palmitoleoyltransferase activity [GO:1990698]; transferase activity, transferring acyl groups [GO:0016746]; Wnt-protein binding [GO:0017147]",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000250|UniProtKB:Q9JJJ7}; Multi-pass membrane protein {ECO:0000250|UniProtKB:Q9JJJ7}.,"SUBUNIT: Interacts with WNT1, WNT3, WNT3A, WNT4, WNT5A, WNT5B, WNT6, WNT7A and WNT7B. {ECO:0000250|UniProtKB:Q9JJJ7}.",X,48508962,48520814,p11.23,0.99953,0.135,2.2732,2.3709,22.051,0.5249673101697941,ENST00000326194,0.943939393939394,0.1892026993251687,1386,,,,,,,0.362423173524219,5.967977821016742,Adrenal Gland,broadly expressed,3.70454001790255,5.613173586739642,FALSE,low confidence non-escapee,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:17756,EDA2R,ectodysplasin A2 receptor,Approved,,"XEDAR, EDA-A2R, EDAA2R, TNFRSF27",Xq12,gene with protein product,protein-coding gene,ENSG00000131080,60401,ENSG00000131080,Q9HAV5,MGI:2442860,RGD:1564025,X,300276,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Receptor for EDA isoform A2, but not for EDA isoform A1. Mediates the activation of the NF-kappa-B and JNK pathways. Activation seems to be mediated by binding to TRAF3 and TRAF6. {ECO:0000269|PubMed:12270937}.",ectodermal cell differentiation [GO:0010668]; epidermis development [GO:0008544]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; multicellular organism development [GO:0007275]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of JNK cascade [GO:0046330]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; tumor necrosis factor-mediated signaling pathway [GO:0033209],signaling receptor activity [GO:0038023]; tumor necrosis factor-activated receptor activity [GO:0005031],SUBCELLULAR LOCATION: Membrane; Single-pass type III membrane protein.,"SUBUNIT: Associates with TRAF1, TRAF3 and TRAF6.",X,66595637,66639298,q12,5.4689e-4,1.339,-1.9074,-0.20526,8.8105,0.2752977249965588,ENST00000374719,0.7363534675615212,0.09645088727818045,894,,,,,,,0.5597904574263202,5.145653002530088,Cells - Cultured fibroblasts,broadly expressed,0.6588366484495317,0.3321974944562882,FALSE,discordant,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:17757,TNMD,tenomodulin,Approved,,"myodulin, ChM1L, tendin, TEM, BRICD4",Xq22.1,gene with protein product,protein-coding gene,ENSG00000000005,64102,ENSG00000000005,Q9H2S6,MGI:1929885,RGD:620938,X,300459,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May be an angiogenesis inhibitor.,cellular response to BMP stimulus [GO:0071773]; endothelial cell morphogenesis [GO:0001886]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; tendon cell differentiation [GO:0035990],"",SUBCELLULAR LOCATION: [Isoform 1]: Membrane {ECO:0000305}; Single-pass type II membrane protein {ECO:0000305}. Nucleus envelope.; SUBCELLULAR LOCATION: [Isoform 2]: Membrane {ECO:0000305}; Single-pass type II membrane protein {ECO:0000305}. Nucleus envelope.; SUBCELLULAR LOCATION: [Isoform 3]: Cytoplasm.,"",X,100584936,100599885,q22.1,0.0035119,0.91,-0.46371,0.85895,13.013,0.07803729118373703,ENST00000373031,0.9560796645702306,0.33556610847288176,954,,,,,,,0.85541121318973945,4.820454707857023,Adipose - Subcutaneous,tissue-specific,0.18385107244716625,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:17778,GAGE12J,G antigen 12J,Approved,GAGE11,OTTHUMG00000024137,Xp11.23,gene with protein product,protein-coding gene,ENSG00000224659,729396,ENSG00000224659,A6NER3,,,X,300733,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,49322057,49329384,p11.23,0.0019883,1.953,-3.2775,-1.1798,1.2809,0.5404847859721505,ENST00000442437,0.08587570621468926,0.03084228942764309,354,11,"GAGE12G (98, 98, chrX); GAGE12F (98, 98, chrX); GAGE1 (98, 98, chrX); GAGE13 (98, 98, chrX); GAGE12E (97, 97, chrX); GAGE12D (97, 97, chrX); GAGE12C (97, 97, chrX); GAGE12H (97, 97, chrX); GAGE2A (95, 96, chrX); GAGE2E (92, 98, chrX); GAGE10 (91, 91, chrX)",TRUE,11,"GAGE12G (98, 98, chrX); GAGE12F (98, 98, chrX); GAGE1 (98, 98, chrX); GAGE13 (98, 98, chrX); GAGE12E (97, 97, chrX); GAGE12D (97, 97, chrX); GAGE12C (97, 97, chrX); GAGE12H (97, 97, chrX); GAGE2A (95, 96, chrX); GAGE2E (92, 98, chrX); GAGE10 (91, 91, chrX)",TRUE,0.9767441860465116,0.1875486028857759,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:17810,AMOT,angiomotin,Approved,,KIAA1071,Xq23,gene with protein product,protein-coding gene,ENSG00000126016,154796,ENSG00000126016,Q4VCS5,MGI:108440,RGD:1564027,X,300410,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Plays a central role in tight junction maintenance via the complex formed with ARHGAP17, which acts by regulating the uptake of polarity proteins at tight junctions. Appears to regulate endothelial cell migration and tube formation. May also play a role in the assembly of endothelial cell-cell junctions. {ECO:0000269|PubMed:11257124, ECO:0000269|PubMed:16678097}.",actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; cell-cell junction assembly [GO:0007043]; cell migration involved in gastrulation [GO:0042074]; cellular protein localization [GO:0034613]; chemotaxis [GO:0006935]; establishment of cell polarity involved in ameboidal cell migration [GO:0003365]; gastrulation with mouth forming second [GO:0001702]; hippo signaling [GO:0035329]; in utero embryonic development [GO:0001701]; negative regulation of angiogenesis [GO:0016525]; negative regulation of GTPase activity [GO:0034260]; negative regulation of vascular permeability [GO:0043116]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell size [GO:0045793]; positive regulation of embryonic development [GO:0040019]; positive regulation of stress fiber assembly [GO:0051496]; regulation of cell migration [GO:0030334]; regulation of small GTPase mediated signal transduction [GO:0051056]; vasculogenesis [GO:0001570],angiostatin binding [GO:0043532]; signaling receptor activity [GO:0038023],"SUBCELLULAR LOCATION: Cell junction, tight junction {ECO:0000269|PubMed:16043488}. Note=Localized on the cell surface. May act as a transmembrane protein.","SUBUNIT: Component of a complex whose core is composed of ARHGAP17, AMOT, MPP5/PALS1, PATJ and PARD3/PAR3. Interacts with MAGI1. Isoform 1 interacts with angiostatin. {ECO:0000269|PubMed:16043488, ECO:0000269|PubMed:16678097}.",X,112774503,112840815,q23,0.99666,0.266,0.32664,1.09,34.425,0.5207720866161574,ENST00000371959,0.85926267281106,0.4574606348412897,3255,,,,,,,0.4129588237140812,4.005139452661281,Other_Brain_tissues,broadly expressed,4.005139452661281,2.2564415770954422,TRUE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,Post2_higher_vs_Pre,no difference_Post1_Post2,no disorder
HGNC:17889,APEX2,apurinic/apyrimidinic endodeoxyribonuclease 2,Approved,,"APEXL2, APE2, XTH2, ZGRF2",Xp11.21,gene with protein product,protein-coding gene,ENSG00000169188,27301,ENSG00000169188,Q9UBZ4,MGI:1924872,RGD:1565983,X,300773,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Functions as a weak apurinic/apyrimidinic (AP) endodeoxyribonuclease in the DNA base excision repair (BER) pathway of DNA lesions induced by oxidative and alkylating agents. Initiates repair of AP sites in DNA by catalyzing hydrolytic incision of the phosphodiester backbone immediately adjacent to the damage, generating a single-strand break with 5'-deoxyribose phosphate and 3'-hydroxyl ends. Displays also double-stranded DNA 3'-5' exonuclease, 3'-phosphodiesterase activities. Shows robust 3'-5' exonuclease activity on 3'-recessed heteroduplex DNA and is able to remove mismatched nucleotides preferentially. Shows fairly strong 3'-phosphodiesterase activity involved in the removal of 3'-damaged termini formed in DNA by oxidative agents. In the nucleus functions in the PCNA-dependent BER pathway. Required for somatic hypermutation (SHM) and DNA cleavage step of class switch recombination (CSR) of immunoglobulin genes. Required for proper cell cycle progression during proliferation of peripheral lymphocytes. {ECO:0000269|PubMed:11376153, ECO:0000269|PubMed:16687656, ECO:0000269|PubMed:19443450}.",base-excision repair [GO:0006284]; cell cycle [GO:0007049]; DNA recombination [GO:0006310],DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; DNA binding [GO:0003677]; double-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008311]; endonuclease activity [GO:0004519]; phosphodiesterase I activity [GO:0004528]; zinc ion binding [GO:0008270],"SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Mitochondrion {ECO:0000305}. Note=Together with PCNA, is redistributed in discrete nuclear foci in presence of oxidative DNA damaging agents.",SUBUNIT: Interacts with PCNA; this interaction is triggered by reactive oxygen species and increased by misincorporation of uracil in nuclear DNA. {ECO:0000269|PubMed:11376153}.,X,55000363,55009057,p11.21,0.97302,0.268,-0.74585,0.56394,11.14,0.4070922550698473,ENST00000374987,0.6767501605651894,0.2505623594101475,1557,,,,,,,0.2821047241812975,5.354642570217958,Cells - EBV-transformed lymphocytes,broadly expressed,2.5781996708078037,2.871875182482519,FALSE,low confidence non-escapee,no_difference_Pre_Post,Pre_higher_vs_Post1,no difference_Pre_Post2,Post2_higher_vs_Post1,no disorder
HGNC:1798,CDR1,cerebellar degeneration related protein 1,Approved,CDR,"CDR62A, CDR34",Xq27.1,gene with protein product,protein-coding gene,ENSG00000288642,1038,ENSG00000288642,P51861,,RGD:6499092,X,302650,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,140783578,140784366,q27.1,,,-1.0765,0.53157,,0.2575821391152402,ENST00000674533,0.050190114068441066,0.11942014496375906,789,,,,,,,0.9016985856194487,5.793539585454506,Pituitary,tissue-specific,3.117158087345018,3.4163932208431413,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,no difference_Pre_Post2,Post2_higher_vs_Post1,no disorder
HGNC:18011,NUDT11,nudix hydrolase 11,Approved,,"DIPP3b, FLJ10628, hDIPP3beta",Xp11.22,gene with protein product,protein-coding gene,ENSG00000196368,55190,ENSG00000196368,Q96G61,"MGI:1930957, MGI:2147931",RGD:1594183,X,300528,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Cleaves a beta-phosphate from the diphosphate groups in PP-InsP5 (diphosphoinositol pentakisphosphate), suggesting that it may play a role in signal transduction. Also able to catalyze the hydrolysis of dinucleoside oligophosphates, with Ap6A and Ap5A being the preferred substrates. The major reaction products are ADP and p4a from Ap6A and ADP and ATP from Ap5A. Also able to hydrolyze 5-phosphoribose 1-diphosphate. {ECO:0000269|PubMed:12105228}.",adenosine 5'-(hexahydrogen pentaphosphate) catabolic process [GO:1901911]; diadenosine hexaphosphate catabolic process [GO:1901909]; diadenosine pentaphosphate catabolic process [GO:1901907]; diphosphoinositol polyphosphate metabolic process [GO:0071543]; inositol phosphate metabolic process [GO:0043647],bis(5'-adenosyl)-hexaphosphatase activity [GO:0034431]; bis(5'-adenosyl)-pentaphosphatase activity [GO:0034432]; diphosphoinositol-polyphosphate diphosphatase activity [GO:0008486]; endopolyphosphatase activity [GO:0000298]; inositol diphosphate pentakisphosphate diphosphatase activity [GO:0052842]; inositol diphosphate tetrakisphosphate diphosphatase activity [GO:0052840]; m7G(5')pppN diphosphatase activity [GO:0050072]; metal ion binding [GO:0046872],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12121577}.,"",X,51490011,51496592,p11.22,0.10316,1.257,-2.2978,1.4628,4.9464,0.7510806772510448,ENST00000375992,0.9345454545454546,0.23734066483379154,495,4,"NUDT10 (99, 99, chrX); NUDT4 (91, 82, chr12); NUDT4B (91, 82, chr1); NUDT3 (74, 71, chr6)",TRUE,1,"NUDT10 (99, 99, chrX)",TRUE,0.6808036935303368,6.082383260649495,Testis,tissue-specific,3.852398420286553,4.2603004646978455,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:18060,ARX,aristaless related homeobox,Approved,"MRXS1, PRTS, MRX76, MRX54, MRX43, MRX36, MRX29, MRX32, MRX33, MRX38, MRX87","ISSX, CT121, EIEE1",Xp21.3,gene with protein product,protein-coding gene,ENSG00000004848,170302,ENSG00000004848,Q96QS3,MGI:1097716,RGD:1562672,X,300382,TRUE,"Epileptic encephalopathy, early infantile, 1 // Hydranencephaly with abnormal genitalia // Lissencephaly, X-linked 2 // Mental retardation, X-linked 29 and others // Partington syndrome // Proud syndrome",308350 // 300215 // 300215 // 300419 // 309510 // 300004,X-linked recessive // X-linked // X-linked // X-linked recessive // X-linked recessive // X-linked,,,,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,confirmed +CS,FALSE,,confirmed,FUNCTION: Transcription factor required for normal brain development. May be important for maintenance of specific neuronal subtypes in the cerebral cortex and axonal guidance in the floor plate.,autonomic nervous system development [GO:0048483]; axon guidance [GO:0007411]; cell proliferation in forebrain [GO:0021846]; cerebral cortex GABAergic interneuron migration [GO:0021853]; cerebral cortex tangential migration [GO:0021800]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; enteric nervous system development [GO:0048484]; epithelial cell fate commitment [GO:0072148]; globus pallidus development [GO:0021759]; lipid digestion [GO:0044241]; nervous system development [GO:0007399]; positive regulation of gene expression [GO:0010628]; positive regulation of organ growth [GO:0046622]; regulation of cell population proliferation [GO:0042127],"chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]","SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00108, ECO:0000255|PROSITE-ProRule:PRU00138}.","",X,25003694,25016420,p21.3,0.90814,0.389,-0.65712,2.0538,7.6955,0.5887526954942686,ENST00000379044,0.7146832445233866,0.27825543614096476,1689,,,,,,,0.9332926984612182,7.130519083027338,Ovary,tissue-specific,2.7484140011432427,0.02525152657581595,FALSE,,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:18070,SLC38A5,solute carrier family 38 member 5,Approved,,"SN2, JM24",Xp11.23,gene with protein product,protein-coding gene,ENSG00000017483,92745,ENSG00000017483,Q8WUX1,MGI:2148066,RGD:620702,X,300649,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Functions as a sodium-dependent amino acid transporter which countertransport protons. Mediates the saturable, pH-sensitive, and electrogenic cotransport of several neutral amino acids including glycine, asparagine, alanine, serine, glutamine and histidine with sodium. {ECO:0000269|PubMed:11243884}.",amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; asparagine transmembrane transport [GO:1903713]; glutamine transport [GO:0006868]; glycine transport [GO:0015816]; L-alanine transmembrane transport [GO:1904557]; L-histidine transmembrane transport [GO:0089709]; L-serine transport [GO:0015825]; serine transport [GO:0032329]; transport across blood-brain barrier [GO:0150104],alanine transmembrane transporter activity [GO:0022858]; amino acid transmembrane transporter activity [GO:0015171]; glycine transmembrane transporter activity [GO:0015187]; L-asparagine transmembrane transporter activity [GO:0015182]; L-glutamine transmembrane transporter activity [GO:0015186]; L-histidine transmembrane transporter activity [GO:0005290]; L-serine transmembrane transporter activity [GO:0015194]; serine transmembrane transporter activity [GO:0022889],SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}.,"",X,48458537,48470260,p11.23,0.97676,0.297,0.29475,2.4433,15.956,0.3103802157643113,ENST00000620913,0.728752642706131,0.07958010497375656,1419,1,"SLC38A3 (60, 56, chr3)",TRUE,,,,0.5660369285009857,6.343848381095388,Pancreas,broadly expressed,3.4957207420966077,3.7875160481350303,FALSE,low confidence non-escapee,Pre_higher_vs_Post,no difference_Pre_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:18073,ARMCX1,armadillo repeat containing X-linked 1,Approved,,"ALEX1, GASP7",Xq22.1,gene with protein product,protein-coding gene,ENSG00000126947,51309,ENSG00000126947,Q9P291,MGI:1925498,RGD:1561629,X,300362,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Regulates mitochondrial transport during axon regeneration. Increases the proportion of motile mitochondria by recruiting stationary mitochondria into the motile pool. Enhances mitochondria movement and neurite growth in both adult axons and embryonic neurons. Promotes neuronal survival and axon regeneration after nerve injury. May link mitochondria to the Trak1-kinesin motor complex via its interaction with MIRO1. {ECO:0000250|UniProtKB:Q9CX83}.,"","",SUBCELLULAR LOCATION: Mitochondrion {ECO:0000250|UniProtKB:Q9CX83}. Mitochondrion outer membrane {ECO:0000250|UniProtKB:Q9CX83}; Single-pass membrane protein {ECO:0000255}.,SUBUNIT: Interacts with MIRO1. {ECO:0000250|UniProtKB:Q9CX83}.,X,101550547,101554700,q22.1,0.072672,0.955,0.46307,1.8257,8.1175,0.4456721450704877,ENST00000372829,0.8005139500734214,0.0902274431392152,1362,,,,,,,0.23907114737069535,6.3245694141794555,Ovary,broadly expressed,4.597572887232437,5.154611561082464,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:1808,CDX4,caudal type homeobox 4,Approved,,,Xq13.2,gene with protein product,protein-coding gene,ENSG00000131264,1046,ENSG00000131264,O14627,MGI:88362,RGD:1561529,X,300025,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",animal organ morphogenesis [GO:0009887]; anterior/posterior axis specification [GO:0009948]; blood vessel development [GO:0001568]; cell differentiation [GO:0030154]; labyrinthine layer development [GO:0060711]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]",SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00108}.,"",X,73447254,73455245,q13.2,0.0060181,1.432,0.44608,0.098388,6.2882,0.45016828224701927,ENST00000373514,0.7962573099415204,0.24071482129467633,855,,,,,,,0.952972419429772,1.0566875651228433,Skin - Not Sun Exposed (Suprapubic),tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:18145,PHF6,PHD finger protein 6,Approved,"BFLS, BORJ","KIAA1823, MGC14797, CENP-31",Xq26.2,gene with protein product,protein-coding gene,ENSG00000156531,84295,ENSG00000156531,Q8IWS0,MGI:1918248,RGD:2323526,X,300414,TRUE,Borjeson-Forssman-Lehmann syndrome,301900,X-linked recessive,,,,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,TRUE,confirmed,FUNCTION: Transcriptional regulator that associates with ribosomal RNA promoters and suppresses ribosomal RNA (rRNA) transcription. {ECO:0000269|PubMed:23229552}.,blastocyst hatching [GO:0001835]; negative regulation of transcription by RNA polymerase II [GO:0000122],"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; phosphoprotein binding [GO:0051219]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; scaffold protein binding [GO:0097110]; sequence-specific DNA binding [GO:0043565]; tubulin binding [GO:0015631]","SUBCELLULAR LOCATION: Nucleus. Nucleus, nucleolus. Chromosome, centromere, kinetochore {ECO:0000269|PubMed:20813266}. Note=Nuclear, it particularly localizes to the nucleolus.","SUBUNIT: Interacts with UBTF. Interacts with the NuRD complex component RBBP4 (via the nucleolar localization motif), the interaction mediates transcriptional repression activity. {ECO:0000269|PubMed:23229552, ECO:0000269|PubMed:24554700}.",X,134373312,134428791,q26.2,0.99784,0.166,-0.50192,2.2833,17.959,0.5646286767447559,ENST00000370803,0.9887067395264116,0.48645338665333665,1098,,,,,,,0.39921143120924407,4.803609361963602,Ovary,broadly expressed,2.32519354349244,3.6571900931449166,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:18151,NXT2,nuclear transport factor 2 like export factor 2,Approved,,P15-2,Xq23,gene with protein product,protein-coding gene,ENSG00000101888,55916,ENSG00000101888,Q9NPJ8,MGI:2147914,RGD:1560204,X,300320,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Regulator of protein export for NES-containing proteins. Also plays a role in mRNA nuclear export.,mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein import into nucleus [GO:0006606],"",SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Note=Shuttles between the nucleus and the cytoplasm.,"SUBUNIT: Associates with NXF1, NXF2, NXF3 and NXF5.",X,109535781,109544690,q23,0.83442,0.505,0.13498,1.1217,5.9234,0.5096984284298457,ENST00000372106,0.8696969696969697,0.0744063984003999,429,1,"NXT1 (53, 74, chr20)",TRUE,,,,0.48464138936324463,4.741547882920381,Testis,broadly expressed,2.162889966892024,1.6343957845943384,FALSE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:18158,VCX2,variable charge X-linked 2,Approved,,"VCX-2r, VCX-2R",Xp22.31,gene with protein product,protein-coding gene,ENSG00000177504,51480,ENSG00000177504,Q9H322,,,X,300532,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May mediate a process in spermatogenesis or may play a role in sex ratio distortion.,brain development [GO:0007420],"","","",X,8169944,8171267,p22.31,0.058136,1.943,-5.7221,-4.9949,0.17619,0.3285359265769138,ENST00000317103,0.002857142857142857,0.17375656085978505,420,4,"VCX3A (89, 67, chrX); VCX (89, 60, chrX); VCY1B (78, 86, chrY); VCY (78, 86, chrY)",TRUE,,,,0.976603561941963,4.8184466887939505,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:18159,VCX3A,variable charge X-linked 3A,Approved,VCX3,"VCX-8r, VCX-8R, VCX-A",Xp22.31,gene with protein product,protein-coding gene,ENSG00000169059,51481,ENSG00000169059,Q9NNX9,,,X,300533,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May mediate a process in spermatogenesis or may play a role in sex ratio distortion.,brain development [GO:0007420],"","","",X,6533618,6535118,p22.31,0.30958,1.87,-3.0186,-2.141,0.26767,0.35379119427501526,ENST00000381089,0.02602495543672014,0.12811797050737317,561,5,"VCX3B (99, 75, chrX); VCX (98, 89, chrX); VCX2 (67, 89, chrX); VCY1B (60, 89, chrY); VCY (60, 89, chrY)",TRUE,1,"VCX (98, 89, chrX)",TRUE,0.9662353434377469,5.690475763192908,Testis,tissue-specific,0.12166821370070062,0.08474924619168907,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:18174,STK26,serine/threonine kinase 26,Approved,,"MST4, MASK",Xq26.2,gene with protein product,protein-coding gene,ENSG00000134602,51765,ENSG00000134602,Q9P289,MGI:1917665,RGD:1563568,X,300547,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Mediator of cell growth (PubMed:11641781, PubMed:17360971). Modulates apoptosis (PubMed:11641781, PubMed:17360971). In association with STK24 negatively regulates Golgi reorientation in polarized cell migration upon RHO activation (PubMed:27807006). {ECO:0000269|PubMed:11641781, ECO:0000269|PubMed:17360971, ECO:0000269|PubMed:27807006}.",apoptotic process [GO:0006915]; cellular response to starvation [GO:0009267]; microvillus assembly [GO:0030033]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of hydrogen peroxide-induced cell death [GO:1903205]; response to hydrogen peroxide [GO:0042542],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674],"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17360971, ECO:0000269|PubMed:27807006}. Golgi apparatus {ECO:0000269|PubMed:15037601, ECO:0000269|PubMed:27807006}. Note=Colocalized with RIPOR1 in the Golgi of serum-starved cells and relocated to cytoplasmic punctae, probably vesicular compartments, along with RIPOR1 upon serum stimulation in a Rho- and PDCD10-dependent manner (PubMed:27807006). {ECO:0000269|PubMed:27807006}.","SUBUNIT: Homodimer (PubMed:20730082). Interacts with PDCD10 (PubMed:17360971, PubMed:19370760, PubMed:20332113). Interacts with GOLGA2 (PubMed:15037601, PubMed:20332113). Interacts with CTTNBP2NL (PubMed:18782753). Interacts with RIPOR1 (via C-terminus); this interaction occurs in a PDCD10-dependent and Rho-independent manner (PubMed:27807006). Interacts with PDCD10; this interaction is required for the association of STK26 with RIPOR1 (PubMed:27807006). {ECO:0000269|PubMed:15037601, ECO:0000269|PubMed:17360971, ECO:0000269|PubMed:18782753, ECO:0000269|PubMed:19370760, ECO:0000269|PubMed:20332113, ECO:0000269|PubMed:20730082, ECO:0000269|PubMed:27807006}.",X,132023302,132075943,q26.2,0.30798,0.538,1.1036,1.6978,17.026,0.5291214215202369,ENST00000394334,0.951558752997602,0.1546113471632092,1251,2,"STK24 (68, 68, chr13); STK25 (66, 68, chr2)",TRUE,,,,0.5542745492275819,6.554214316267771,Uterus,broadly expressed,0.696323279909956,2.674527315909279,FALSE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,no disorder
HGNC:18186,GPR173,G protein-coupled receptor 173,Approved,,SREB3,Xp11.22,gene with protein product,protein-coding gene,ENSG00000184194,54328,ENSG00000184194,Q9NS66,MGI:1918021,RGD:620748,X,300253,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Is a receptor for the SMIM20 derived peptides Phoenixin-14 and Phoenixin-20 (By similarity). It mediates the Phoenixin-14 and Phoenixin-20 augmentation of gonadotropin-releasing hormone (GNRH) signaling in the hypothalamus and pituitary gland (By similarity). In the ovary, it mediates the effects of Phoenixin-14 and Phoenixin-20 induced granulosa cell proliferation during follicular growth (PubMed:30933929). {ECO:0000250|UniProtKB:Q9JJH2, ECO:0000269|PubMed:30933929}.",negative regulation of neuron migration [GO:2001223]; signal transduction [GO:0007165],gonadotropin-releasing hormone receptor activity [GO:0004968]; G protein-coupled receptor activity [GO:0004930],SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000255}.,"",X,53048789,53080615,p11.22,0.87422,0.442,0.67795,2.2648,6.7655,0.25466748036032344,ENST00000332582,0.9422459893048128,0.37425643589102725,1122,2,"GPR85 (62, 62, chr7); GPR27 (53, 53, chr3)",TRUE,,,,0.5168174236074764,5.265436896049098,Pituitary,broadly expressed,3.405661590727819,5.102557357527064,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:18237,CD99L2,CD99 molecule like 2,Approved,MIC2L1,CD99B,Xq28,gene with protein product,protein-coding gene,ENSG00000102181,83692,ENSG00000102181,Q8TCZ2,MGI:2177151,RGD:620896,X,300846,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Plays a role in a late step of leukocyte extravasation helping cells to overcome the endothelial basement membrane. Acts at the same site as, but independently of, PECAM1 (By similarity). Homophilic adhesion molecule, but these interactions may not be required for cell aggregation (By similarity). {ECO:0000250}.",cell adhesion [GO:0007155]; diapedesis [GO:0050904]; positive regulation of neutrophil extravasation [GO:2000391]; positive regulation of T cell extravasation [GO:2000409],"",SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Single-pass type I membrane protein {ECO:0000250}; Extracellular side {ECO:0000250}. Cell junction {ECO:0000250}.,"",X,150766336,150898816,q28,1.7021e-4,1.037,0.62615,-0.16613,13.919,0.5977613836183493,ENST00000370377,0.5811153358681875,0.0709822544363909,789,,,,,,,0.2647901192280371,6.775498350276405,Nerve - Tibial,broadly expressed,5.632870182383029,6.478968570287072,FALSE,low confidence non-escapee,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:18283,RAB40A,"RAB40A, member RAS oncogene family",Approved,,"RAR2A, Rar-2",Xq22.2,gene with protein product,protein-coding gene,ENSG00000172476,142684,ENSG00000172476,Q8WXH6,,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May be a substrate-recognition component of a SCF-like ECS (Elongin-Cullin-SOCS-box protein) E3 ubiquitin ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. {ECO:0000250}.,intracellular signal transduction [GO:0035556]; protein localization to plasma membrane [GO:0072659]; protein ubiquitination [GO:0016567],GTPase activity [GO:0003924]; GTP binding [GO:0005525],SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Lipid-anchor {ECO:0000305}; Cytoplasmic side {ECO:0000305}.,"",X,103499130,103519489,q22.2,,,1.2197,0.7921,,0.1450735442272819,ENST00000304236,0.8390887290167865,0.10757310672331917,834,3,"RAB40AL (98, 98, chrX); RAB40B (88, 88, chr17); RAB40C (76, 75, chr16)",TRUE,2,"RAB40AL (98, 98, chrX); RAB40B (88, 88, chr17)",TRUE,0.5946507609699967,2.624910355229183,Ovary,broadly expressed,0.6718359230911642,0.8334815497065114,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:18293,RAB41,"RAB41, member RAS oncogene family",Approved,,,Xq13.1,gene with protein product,protein-coding gene,ENSG00000147127,347517,ENSG00000147127,Q5JT25,,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Required for normal Golgi ribbon organization and ER-to-Golgi trafficking. {ECO:0000269|PubMed:23936529}.,"intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",GTPase activity [GO:0003924]; GTP binding [GO:0005525],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:23936529}. Note=punctate localization concentrated in ruffled regions at the cell periphery.,"",X,70282093,70285002,q13.1,5.8306e-4,1.321,-0.479,0.27842,8.9333,0.2863304805954856,ENST00000374473,0.7068759342301943,0.2173956510872282,669,2,"RAB6B (62, 66, chr3); RAB6A (61, 65, chr11)",TRUE,,,,0.7924184132447012,3.050385023365407,Testis,tissue-specific,1.4283353807506587,1.4226070839162985,FALSE,low confidence non-escapee,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,no difference_Post1_Post2,no disorder
HGNC:18298,H2AB2,H2A.B variant histone 2,Approved,H2AFB2,,Xq28,gene with protein product,protein-coding gene,ENSG00000277858,474381,ENSG00000277858,P0C5Z0,"MGI:3642445, MGI:3644875, MGI:3644980",RGD:1561666,X,301038,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Atypical histone H2A which can replace conventional H2A in some nucleosomes and is associated with active transcription and mRNA processing. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. Nucleosomes containing this histone are less rigid and organize less DNA than canonical nucleosomes in vivo. They are enriched in actively transcribed genes and associate with the elongating form of RNA polymerase. They associate with spliceosome components and are required for mRNA splicing. May participate in spermatogenesis. {ECO:0000269|PubMed:15257289, ECO:0000269|PubMed:16287874, ECO:0000269|PubMed:16957777, ECO:0000269|PubMed:17591702, ECO:0000269|PubMed:17726088, ECO:0000269|PubMed:18329190, ECO:0000269|PubMed:22795134}.",chromatin organization [GO:0006325]; chromatin silencing [GO:0006342]; mRNA processing [GO:0006397]; nucleosome assembly [GO:0006334],DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982],"SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:20008104}. Chromosome {ECO:0000269|PubMed:20008104, ECO:0000269|PubMed:22795134}. Note=Associated with the active X chromosome and with autosomes, while it is absent from the inactive X chromosome and excluded from Barr bodies. {ECO:0000269|PubMed:20008104}.","SUBUNIT: The nucleosome is a histone octamer containing two molecules each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and two H2A-H2B heterodimers. May be incorporated into a proportion of nucleosomes, replacing one or more H2A molecules.",X,155380709,155381299,q28,,,,,,0.6634406380669435,ENST00000354514,0.6313218390804598,0.08252936765808548,348,2,"H2AB3 (100, 100, chrX); H2AB1 (99, 99, chrX)",TRUE,2,"H2AB3 (100, 100, chrX); H2AB1 (99, 99, chrX)",TRUE,,0,,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:18305,ATP6AP2,ATPase H+ transporting accessory protein 2,Approved,ATP6IP2,"M8-9, APT6M8-9, ATP6M8-9, PRR, RENR",Xp11.4,gene with protein product,protein-coding gene,ENSG00000182220,10159,ENSG00000182220,O75787,MGI:1917745,RGD:1561269,X,300556,TRUE,"Congenital disorder of glycosylation, type IIr // Mental retardation, X-linked, syndromic, Hedera type",301045 // 300423,X-linked recessive // X-linked recessive,"?Parkinsonism with spasticity, X-linked",300911,X-linked recessive,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Multifunctional protein which functions as a renin, prorenin cellular receptor and is involved in the assembly of the lysosomal proton-transporting V-type ATPase (v-ATPase) and the acidification of the endo-lysosomal system (PubMed:12045255, PubMed:29127204, PubMed:30374053, PubMed:32276428). May mediate renin-dependent cellular responses by activating ERK1 and ERK2 (PubMed:12045255). By increasing the catalytic efficiency of renin in AGT/angiotensinogen conversion to angiotensin I, may also play a role in the renin-angiotensin system (RAS) (PubMed:12045255). Involved in many neuronal processes including synapse morphology and synaptic transmission (By similarity). {ECO:0000250|UniProtKB:Q9CYN9, ECO:0000269|PubMed:12045255, ECO:0000269|PubMed:29127204, ECO:0000269|PubMed:30374053, ECO:0000269|PubMed:32276428}.",angiotensin maturation [GO:0002003]; eye pigmentation [GO:0048069]; head morphogenesis [GO:0060323]; lysosomal lumen acidification [GO:0007042]; neutrophil degranulation [GO:0043312]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transforming growth factor beta1 production [GO:0032914]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of MAPK cascade [GO:0043408]; rostrocaudal neural tube patterning [GO:0021903],signaling receptor activity [GO:0038023],"SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:29127204}; Single-pass type I membrane protein {ECO:0000255}. Lysosome membrane {ECO:0000269|PubMed:29127204}. Cytoplasmic vesicle, autophagosome membrane {ECO:0000250|UniProtKB:Q9CYN9}. Cell projection, dendritic spine membrane {ECO:0000250|UniProtKB:Q9CYN9}. Cell projection, axon {ECO:0000250|UniProtKB:Q9CYN9}.","SUBUNIT: Interacts with renin (PubMed:12045255). Interacts with VMA21 (via N-terminus); VMA21 is a v-ATPase accessory component (PubMed:29127204). Interacts with ATP6AP1 (via N-terminus) (PubMed:29127204). Interacts with ATP6V0D1; ATP6V0D1 is a v-ATPase complex subunit and the interaction promotes v-ATPase complex assembly (PubMed:30374053). Interacts with TMEM9; TMEM9 is a v-ATPase assembly regulator and the interaction induces the interaction with ATP6V0D1 (PubMed:30374053). {ECO:0000269|PubMed:12045255, ECO:0000269|PubMed:29127204, ECO:0000269|PubMed:30374053}.",X,40579372,40606848,p11.4,0.87089,0.429,0.68859,1.6643,11.071,0.6571099717484566,ENST00000636580,0.9010446343779677,0.1290427393151712,1053,,,,,,,0.20387596850171535,7.43095427138573,Cells - Cultured fibroblasts,broadly expressed,5.918312284888651,6.26095527725373,FALSE,low confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:18308,TMLHE,"trimethyllysine hydroxylase, epsilon",Approved,,"TMLH, FLJ10727, BBOX2, XAP130",Xq28,gene with protein product,protein-coding gene,ENSG00000185973,55217,ENSG00000185973,Q9NVH6,MGI:2180203,RGD:620629,X,300777,TRUE,,,,"{Autism, susceptibility to, X-linked 6}",300872,X-linked recessive,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,PMT +CS,FALSE,,PMT,"FUNCTION: Converts trimethyllysine (TML) into hydroxytrimethyllysine (HTML) (PubMed:11431483, PubMed:23092983). {ECO:0000269|PubMed:11431483, ECO:0000269|PubMed:23092983}.",carnitine biosynthetic process [GO:0045329]; negative regulation of oxidoreductase activity [GO:0051354]; oxidation-reduction process [GO:0055114],"iron ion binding [GO:0005506]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; trimethyllysine dioxygenase activity [GO:0050353]",SUBCELLULAR LOCATION: Mitochondrion matrix {ECO:0000269|PubMed:15754339}.,SUBUNIT: Homodimer. {ECO:0000250|UniProtKB:Q91ZW6}.,X,155489011,155719098,q28,7.9575e-5,1.177,-0.3478,0.63746,12.263,0.35851444650258296,ENST00000334398,0.8827014218009479,0.08307923019245189,1266,,,,,,,0.1975210163469633,3.0716185298645637,Cells - EBV-transformed lymphocytes,broadly expressed,1.6407319714881576,1.915025576479256,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,no difference_Pre_Post2,Post2_higher_vs_Post1,PMT
HGNC:18399,DHRSX,dehydrogenase/reductase X-linked,Approved,,"DHRS5X, DHRSXY, DHRSY, DHRS5Y, SDR46C1, SDR7C6",Xp22.33 and Yp11.2,gene with protein product,protein-coding gene,ENSG00000169084,207063,ENSG00000169084,Q8N5I4,MGI:2181510,RGD:1305017,X,301034,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,TRUE,,no disorder,FUNCTION: Involved in the positive regulation of starvation-induced autophagy (PubMed:25076851). {ECO:0000269|PubMed:25076851}.,positive regulation of autophagy [GO:0010508],oxidoreductase activity [GO:0016491],SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:25076851}. Note=Secreted in a non-classical form. A signal peptide sequence at position 1-31 is predicted.,"",X,2219506,2502805,p22.33,2.6081e-4,1.197,-1.1934,0.24276,10.981,0.44342128082100946,ENST00000334651,0.6418932527693857,0.013046738315421144,993,,,,,,,0.19071480223603174,4.300907107625737,Cervix - Endocervix,broadly expressed,2.1656675843755933,2.130482840161711,FALSE,low confidence escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:18403,FAM9A,family with sequence similarity 9 member A,Approved,,TEX39A,Xp22.31,gene with protein product,protein-coding gene,ENSG00000183304,171482,ENSG00000183304,Q8IZU1,,RGD:2324027,X,300477,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283],"","SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:12213195}.","",X,8790795,8801383,p22.31,3.0977e-12,1.907,-0.2884,-0.75174,10.482,0.36816836239707457,ENST00000381003,0.3596596596596597,0.027818045488627843,999,,,,,,,0.9758838872618305,3.4186851567524905,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:18404,FAM9B,family with sequence similarity 9 member B,Approved,,TEX39B,Xp22.31,gene with protein product,protein-coding gene,ENSG00000177138,171483,ENSG00000177138,Q8IZU0,,,X,300478,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283],"",SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12213195}.,"",X,9024232,9295682,p22.31,3.057e-5,1.693,0.011354,-0.63041,7.391,0.35676697764854887,ENST00000327220,0.5497326203208556,0.0514371407148213,561,,,,,,,0.945705875474529,2.3838756779201677,Testis,tissue-specific,0.018012100334576567,0,FALSE,discordant,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:18405,FAM9C,family with sequence similarity 9 member C,Approved,,TEX39C,Xp22.2,gene with protein product,protein-coding gene,ENSG00000187268,171484,ENSG00000187268,Q8IZT9,,RGD:1559891,X,300479,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283],"",SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12213195}.,"",X,13035617,13044682,p22.2,4.8778e-7,1.939,-0.55251,0.15913,5.1021,0.3989595135885611,ENST00000380625,0.631936127744511,0.10274931267183204,501,,,,,,,0.9464612605596148,1.993312057619879,Testis,tissue-specific,0.009662552632115379,0,FALSE,high confidence escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:18417,H2AP,H2A.P histone,Approved,"CXorf27, HYPM",HIP17,Xp11.4,gene with protein product,protein-coding gene,ENSG00000187516,25763,ENSG00000187516,O75409,MGI:1914584,RGD:1563155,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",chromatin organization [GO:0006325]; chromatin silencing [GO:0006342],DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982],"",SUBUNIT: May interact with the N-terminus of HD.,X,37990779,37991314,p11.4,,,0.13266,-0.39795,,0.20526315789473684,ENST00000341016,0.2423728813559322,0.044913771557110724,354,,,,,,,0.9760214574252039,6.249310698436271,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:18475,ZDHHC9,zinc finger DHHC-type palmitoyltransferase 9,Approved,"ZDHHC10, CXorf11","ZNF379, CGI-89, ZNF380, DHHC9",Xq26.1,gene with protein product,protein-coding gene,ENSG00000188706,51114,ENSG00000188706,Q9Y397,MGI:2444393,RGD:1561389,X,300646,TRUE,"Mental retardation, X-linked syndromic, Raymond type",300799,X-linked,,,,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Palmitoyltransferase that could catalyze the addition of palmitate onto various protein substrates (Probable). The ZDHHC9-GOLGA7 complex is a palmitoyltransferase specific for HRAS and NRAS (PubMed:16000296). May have a palmitoyltransferase activity toward the beta-2 adrenergic receptor/ADRB2 and therefore regulate G protein-coupled receptor signaling (PubMed:27481942). {ECO:0000269|PubMed:16000296, ECO:0000269|PubMed:27481942}.",peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612],palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; Ras palmitoyltransferase activity [GO:0043849],"SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:16000296}; Multi-pass membrane protein {ECO:0000255}. Golgi apparatus membrane {ECO:0000269|PubMed:16000296, ECO:0000269|PubMed:27481942}; Multi-pass membrane protein {ECO:0000255}.",SUBUNIT: Interacts with GOLGA7. {ECO:0000269|PubMed:16000296}.,X,129803288,129843909,q26.1,0.73749,0.479,-1.1679,2.5504,13.136,0.5372264605599312,ENST00000357166,0.9484018264840183,0.35983504123969007,1095,,,,,,,0.2740499713703768,5.527298710778335,Cells - Cultured fibroblasts,broadly expressed,4.351868569832657,4.2734599412914935,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,no difference_Pre_Post2,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:18515,TMEM47,transmembrane protein 47,Approved,TM4SF10,"BCMP1, DKFZP761J17121, DKFZp564E153, VAB-9",Xp21.1,gene with protein product,protein-coding gene,ENSG00000147027,83604,ENSG00000147027,Q9BQJ4,MGI:2177570,RGD:1564799,X,300698,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Regulates cell junction organization in epithelial cells. May play a role in the transition from adherens junction to tight junction assembly. May regulate F-actin polymerization required for tight junctional localization dynamics and affect the junctional localization of PARD6B. During podocyte differentiation may negatively regulate activity of FYN and subsequently the abundance of nephrin (By similarity). {ECO:0000250|UniProtKB:Q9JJG6, ECO:0000250|UniProtKB:Q9XSV3}.",cell-cell adhesion [GO:0098609],"","SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}. Cell junction, adherens junction {ECO:0000250|UniProtKB:Q9XSV3}. Note=Colocalizes with FYB1 at cell-cell contacts in podocytes. {ECO:0000250|UniProtKB:Q9JJG6}.","SUBUNIT: Interacts with CTNNB1, CTNNA1, PRKCI, PARD6B, FYB1. {ECO:0000250|UniProtKB:Q9JJG6, ECO:0000250|UniProtKB:Q9XSV3}.",X,34627075,34657285,p21.1,0.79685,0.567,-1.2339,1.0092,5.2734,0.6874040051047559,ENST00000275954,0.969047619047619,0.2226943264183954,546,,,,,,,0.4227453904205094,7.836807807844575,Artery - Aorta,broadly expressed,4.76317252198227,2.866883257317235,FALSE,low confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,no difference_Post1_Post2,no disorder
HGNC:18570,TGIF2LX,TGFB induced factor homeobox 2 like X-linked,Approved,,,Xq21.31,gene with protein product,protein-coding gene,ENSG00000153779,90316,ENSG00000153779,Q8IUE1,"MGI:2387796, MGI:3800824",RGD:1561826,X,300411,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May have a transcription role in testis.,"","DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]",SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00108}.,"",X,89921908,89922883,q21.31,,,-0.24854,0.87739,,0.4094393313270806,ENST00000283891,0.3210743801652893,0.10114971257185704,726,1,"TGIF2LY (63, 82, chrY)",TRUE,,,,0.9767441860465116,3.7686819025715375,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:18578,TXLNG,taxilin gamma,Approved,CXorf15,"FLJ11209, LSR5, FIAT, MGC126621, MGC126625, TXLNGX",Xp22.2,gene with protein product,protein-coding gene,ENSG00000086712,55787,ENSG00000086712,Q9NUQ3,MGI:3590652,RGD:1564371,X,300677,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: May be involved in intracellular vesicle traffic. Inhibits ATF4-mediated transcription, possibly by dimerizing with ATF4 to form inactive dimers that cannot bind DNA. May be involved in regulating bone mass density through an ATF4-dependent pathway. May be involved in cell cycle progression. {ECO:0000269|PubMed:15911876, ECO:0000269|PubMed:18068885}.",cell cycle [GO:0007049]; regulation of bone mineralization [GO:0030500]; regulation of cell cycle [GO:0051726]; regulation of cell cycle process [GO:0010564],activating transcription factor binding [GO:0033613]; syntaxin binding [GO:0019905]; transcription factor binding [GO:0008134],"SUBCELLULAR LOCATION: Nucleus membrane {ECO:0000269|PubMed:15911876}. Cytoplasm, cytosol {ECO:0000250|UniProtKB:Q8BHN1}.","SUBUNIT: Binds to the C-terminal coiled coil region of syntaxin family members STX1A, STX3A and STX4A. Forms a heterodimer with ATF4 in osteoblasts. {ECO:0000269|PubMed:15911876}.",X,16786432,16844519,p22.2,0.99845,0.158,-0.49667,0.086261,18.841,0.7126388233463954,ENST00000380122,0.8173913043478261,0.31044738815296175,1587,,,,,,,0.27892388299121995,5.314700150513644,Ovary,broadly expressed,3.1590494727671308,4.635736981337143,FALSE,high confidence escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,no disorder
HGNC:1867,CETN2,centrin 2,Approved,CALT,CEN2,Xq28,gene with protein product,protein-coding gene,ENSG00000147400,1069,ENSG00000147400,P41208,MGI:1347085,RGD:620247,X,300006,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Plays a fundamental role in microtubule organizing center structure and function. Required for centriole duplication and correct spindle formation. Has a role in regulating cytokinesis and genome stability via cooperation with CALM1 and CCP110.; FUNCTION: Involved in global genome nucleotide excision repair (GG-NER) by acting as component of the XPC complex. Cooperatively with RAD23B appears to stabilize XPC. In vitro, stimulates DNA binding of the XPC:RAD23B dimer.; FUNCTION: The XPC complex is proposed to represent the first factor bound at the sites of DNA damage and together with other core recognition factors, XPA, RPA and the TFIIH complex, is part of the pre-incision (or initial recognition) complex. The XPC complex recognizes a wide spectrum of damaged DNA characterized by distortions of the DNA helix such as single-stranded loops, mismatched bubbles or single-stranded overhangs. The orientation of XPC complex binding appears to be crucial for inducing a productive NER. XPC complex is proposed to recognize and to interact with unpaired bases on the undamaged DNA strand which is followed by recruitment of the TFIIH complex and subsequent scanning for lesions in the opposite strand in a 5'-to-3' direction by the NER machinery. Cyclobutane pyrimidine dimers (CPDs) which are formed upon UV-induced DNA damage esacpe detection by the XPC complex due to a low degree of structural perurbation. Instead they are detected by the UV-DDB complex which in turn recruits and cooperates with the XPC complex in the respective DNA repair.; FUNCTION: As a component of the TREX-2 complex, involved in the export of mRNAs to the cytoplasm through the nuclear pores. {ECO:0000269|PubMed:22307388, ECO:0000305|PubMed:23591820}.","cell division [GO:0051301]; centriole replication [GO:0007099]; ciliary basal body-plasma membrane docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; global genome nucleotide-excision repair [GO:0070911]; mitotic cell cycle [GO:0000278]; mRNA transport [GO:0051028]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; spermatogenesis [GO:0007283]",calcium ion binding [GO:0005509]; G-protein beta/gamma-subunit complex binding [GO:0031683]; heterotrimeric G-protein binding [GO:0032795]; microtubule binding [GO:0008017],"SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000269|PubMed:14654843}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriole {ECO:0000269|PubMed:23591820}. Nucleus envelope {ECO:0000269|PubMed:23591820}. Nucleus, nuclear pore complex {ECO:0000269|PubMed:23591820}. Nucleus {ECO:0000305}.","SUBUNIT: Monomer. Homooligomer (PubMed:15356003). Interacts with SFI1 (PubMed:16956364). Interacts with CCP110 (PubMed:16760425). Component of the XPC complex composed of XPC, RAD23B and CETN2 (PubMed:11279143, PubMed:15964821, PubMed:16533048, PubMed:16627479). Component of the nuclear pore complex (NPC)-associated TREX-2 complex (transcription and export complex 2), composed of at least GANP, 2 copies of ENY2, PCID2, SEM1/DSS1, and either centrin CETN2 or centrin CETN3. The TREX-2 complex also associates with ALYREF/ALY and with the nucleoporin NUP153 (PubMed:22307388, PubMed:23591820). {ECO:0000269|PubMed:11279143, ECO:0000269|PubMed:15356003, ECO:0000269|PubMed:15964821, ECO:0000269|PubMed:16533048, ECO:0000269|PubMed:16627479, ECO:0000269|PubMed:16760425, ECO:0000269|PubMed:16956364, ECO:0000269|PubMed:22307388, ECO:0000269|PubMed:23591820}.",X,152826994,152830757,q28,0.50331,0.779,0.98864,1.4951,6.0902,0.449502832724949,ENST00000370277,0.8566473988439306,0.0994501374656336,519,1,"CETN1 (83, 83, chr18)",TRUE,1,"CETN1 (83, 83, chr18)",TRUE,0.20383587741123407,6.714135593856333,Pituitary,broadly expressed,5.5974358256762935,4.865010659984563,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:18704,NAA10,"N-alpha-acetyltransferase 10, NatA catalytic subunit",Approved,"ARD1, ARD1A","DXS707, TE2",Xq28,gene with protein product,protein-coding gene,ENSG00000102030,8260,ENSG00000102030,P41227,MGI:1915255,RGD:1565315,X,300013,TRUE,"Microphthalmia, syndromic 1 // Ogden syndrome",309800 // 300855,"X-linked // X-linked dominant, X-linked recessive",,,,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Catalytic subunit of the N-terminal acetyltransferase A (NatA) complex which displays alpha (N-terminal) acetyltransferase activity (PubMed:15496142, PubMed:19826488, PubMed:19420222, PubMed:20145209, PubMed:27708256, PubMed:25489052, PubMed:29754825). Acetylates amino termini that are devoid of initiator methionine (PubMed:19420222). The alpha (N-terminal) acetyltransferase activity may be important for vascular, hematopoietic and neuronal growth and development. Without NAA15, displays epsilon (internal) acetyltransferase activity towards HIF1A, thereby promoting its degradation (PubMed:12464182). Represses MYLK kinase activity by acetylation, and thus represses tumor cell migration (PubMed:19826488). Acetylates, and stabilizes TSC2, thereby repressing mTOR activity and suppressing cancer development (PubMed:20145209). Acetylates HSPA1A and HSPA1B at 'Lys-77' which enhances its chaperone activity and leads to preferential binding to co-chaperone HOPX (PubMed:27708256). Acetylates HIST1H4A (PubMed:29754825). Acts as a negative regulator of sister chromatid cohesion during mitosis (PubMed:27422821). {ECO:0000269|PubMed:12464182, ECO:0000269|PubMed:15496142, ECO:0000269|PubMed:19420222, ECO:0000269|PubMed:19826488, ECO:0000269|PubMed:20145209, ECO:0000269|PubMed:25489052, ECO:0000269|PubMed:27422821, ECO:0000269|PubMed:27708256, ECO:0000269|PubMed:29754825}.","DNA packaging [GO:0006323]; internal protein amino acid acetylation [GO:0006475]; negative regulation of maintenance of mitotic sister chromatid cohesion, centromeric [GO:2000719]; N-terminal peptidyl-glutamic acid acetylation [GO:0018002]; N-terminal peptidyl-serine acetylation [GO:0017198]; N-terminal protein amino acid acetylation [GO:0006474]; protein acetylation [GO:0006473]",N-acetyltransferase activity [GO:0008080]; peptide alpha-N-acetyltransferase activity [GO:0004596]; peptide-glutamate-N-acetyltransferase activity [GO:1990190]; peptide-serine-N-acetyltransferase activity [GO:1990189],"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12464182, ECO:0000269|PubMed:25489052, ECO:0000269|PubMed:25732826}. Nucleus {ECO:0000269|PubMed:12464182, ECO:0000269|PubMed:15496142, ECO:0000269|PubMed:25732826}. Note=Also present in the free cytosolic and cytoskeleton-bound polysomes. {ECO:0000269|PubMed:15496142}.","SUBUNIT: Component of the N-terminal acetyltransferase A (NatA) complex composed of NAA10 and NAA15 or NAA16 (PubMed:20154145). Interacts with HIF1A (via its ODD domain); the interaction increases HIF1A protein stability during normoxia, an down-regulates it when induced by hypoxia (PubMed:12464182). Interacts with NAA50 and with the ribosome (PubMed:16507339). Binds to MYLK (PubMed:19826488). Interacts with NAA15 (PubMed:15496142, PubMed:29754825). Associates with HYPK when in complex with NAA15 (PubMed:15496142, PubMed:29754825). Interacts with NAA16 (PubMed:19480662). Interacts (via its C-terminal domain) with TSC2, leading to its acetylation (PubMed:20145209). Interacts with IKBKB (PubMed:19716809). Interacts with HSPA1A and HSPA1B leading to its acetylation (PubMed:27708256). {ECO:0000269|PubMed:12464182, ECO:0000269|PubMed:15496142, ECO:0000269|PubMed:16507339, ECO:0000269|PubMed:19480662, ECO:0000269|PubMed:19716809, ECO:0000269|PubMed:19826488, ECO:0000269|PubMed:20145209, ECO:0000269|PubMed:20154145, ECO:0000269|PubMed:27708256, ECO:0000269|PubMed:29754825}.",X,153929225,153935080,q28,0.76179,0.522,-0.30793,2.408,9.0877,0.6485280836904278,ENST00000464845,0.8809322033898305,0.11417145713571607,708,1,"NAA11 (81, 83, chr4)",TRUE,,,,0.10255405689371548,6.318924164030077,Uterus,broadly expressed,5.130482016449638,6.086982216455425,FALSE,variable escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:18706,GRIPAP1,GRIP1 associated protein 1,Approved,,"GRASP-1, GRASP1, KIAA1167, MPMGp800B12492Q3, DKFZp434P0630",Xp11.23,gene with protein product,protein-coding gene,ENSG00000068400,56850,ENSG00000068400,Q4V328,MGI:1859616,RGD:621249,X,300408,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Regulates the endosomal recycling back to the neuronal plasma membrane, possibly by connecting early and late recycling endosomal domains and promoting segregation of recycling endosomes from early endosomal membranes. Involved in the localization of recycling endosomes to dendritic spines, thereby playing a role in the maintenance of dendritic spine morphology. Required for the activity-induced AMPA receptor recycling to dendrite membranes and for long-term potentiation and synaptic plasticity (By similarity). {ECO:0000250|UniProtKB:Q9JHZ4}.; FUNCTION: [GRASP-1 C-terminal chain]: Functions as a scaffold protein to facilitate MAP3K1/MEKK1-mediated activation of the JNK1 kinase by phosphorylation, possibly by bringing MAP3K1/MEKK1 and JNK1 in close proximity. {ECO:0000269|PubMed:17761173}.","neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; regulation of modification of synaptic structure [GO:1905244]; regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0099152]; regulation of recycling endosome localization within postsynapse [GO:0099158]",identical protein binding [GO:0042802],"SUBCELLULAR LOCATION: Early endosome membrane {ECO:0000269|PubMed:15897011}; Peripheral membrane protein {ECO:0000305}. Recycling endosome membrane {ECO:0000250|UniProtKB:Q9JHZ4}; Peripheral membrane protein {ECO:0000250|UniProtKB:Q9JHZ4}. Cell projection, axon {ECO:0000250|UniProtKB:Q9JHZ4}. Cell projection, dendrite {ECO:0000250|UniProtKB:Q9JHZ4}. Cell junction, synapse {ECO:0000250|UniProtKB:Q9JHZ4}. Note=Localizes to recycling endosomal tubules that are emanating from early endosomes. {ECO:0000250|UniProtKB:Q9JHZ4}.","SUBUNIT: Interacts with GRIP1, GRIP2 and AMPA receptors (By similarity). Interacts (via C-terminus) with MAPK8/JNK1 and MAP3K1/MEKK1; the interaction promotes MAP3K1-mediated phosphorylation of MAPK8 (PubMed:17761173). Interacts (via N-terminus) with RAB4A (in GTP-bound form) (PubMed:20098723). Interacts (via C-terminus) with STX12 (By similarity). {ECO:0000250|UniProtKB:Q9JHZ4, ECO:0000269|PubMed:17761173, ECO:0000269|PubMed:20098723}.",X,48973720,49002264,p11.23,0.99998,0.159,1.6091,2.6163,39.532,0.4593741027849555,ENST00000376423,0.8722486144101346,0.13079230192451888,2526,,,,,,,0.28703994208820094,7.507965058393309,Cerebellar_tissues,broadly expressed,5.374681320424787,7.507965058393309,TRUE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:18709,CCNB3,cyclin B3,Approved,,,Xp11.22,gene with protein product,protein-coding gene,ENSG00000147082,85417,ENSG00000147082,Q8WWL7,MGI:2183443,RGD:1564367,X,300456,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Cyclins are positive regulatory subunits of the cyclin-dependent kinases (CDKs), and thereby play an essential role in the control of the cell cycle, notably via their destruction during cell division. Its tissue specificity suggest that it may be required during early meiotic prophase I. {ECO:0000269|PubMed:12185076}.",cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of G2/M transition of mitotic cell cycle [GO:0010389],cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901],SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12185076}.,SUBUNIT: Interacts with CDK2 kinase. {ECO:0000269|PubMed:12185076}.,X,50202713,50351914,p11.22,0.8585,0.361,1.3309,0.84006,32.827,0.4051730468759892,ENST00000376042,0.2000238777459408,0.13099225193701575,4188,,,,,,,0.8991260553328361,3.5901348971980696,Testis,tissue-specific,0.3233839050312789,0.3497111885041126,FALSE,high confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:18742,PNMA3,PNMA family member 3,Approved,,"MA5, MA3, MGC132756, MGC132758",Xq28,gene with protein product,protein-coding gene,ENSG00000183837,29944,ENSG00000183837,Q9UL41,MGI:2180565,RGD:1563752,X,300675,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",positive regulation of apoptotic process [GO:0043065],nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270],"SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}.","",X,153056409,153060467,q28,,,1.0637,0.74742,,0.4719674633788209,ENST00000619635,0.11564327485380117,0.05596100974756311,1368,,,,,,,0.740429889646475,5.417707394401919,Testis,tissue-specific,4.266066887343431,5.06278227767597,FALSE,discordant,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:18743,PNMA5,PNMA family member 5,Approved,,KIAA1934,Xq28,gene with protein product,protein-coding gene,ENSG00000198883,114824,ENSG00000198883,Q96PV4,MGI:2180566,RGD:1565857,X,300916,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",positive regulation of apoptotic process [GO:0043065],identical protein binding [GO:0042802],"","",X,152988824,152994116,q28,,,1.2016,0.48031,,0.3567022873534177,ENST00000535214,0.1730512249443207,0.03596600849787553,1347,,,,,,,0.9253798243785316,4.39283944652829,Testis,tissue-specific,2.7563849902299817,0.07082165942034956,FALSE,discordant,no_difference_Pre_Post,no difference_Pre_Post1,Post2_higher_vs_Pre,no difference_Post1_Post2,no disorder
HGNC:18783,AKAP17A,A-kinase anchoring protein 17A,Approved,"CXYorf3, SFRS17A","XE7, XE7Y, DXYS155E, MGC39904, 721P, CCDC133",Xp22.33 and Yp11.32,gene with protein product,protein-coding gene,ENSG00000197976,8227,ENSG00000197976,Q02040,,RGD:1564640,X,"312095, 465000",FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,TRUE,,no disorder,"FUNCTION: Splice factor regulating alternative splice site selection for certain mRNA precursors. Mediates regulation of pre-mRNA splicing in a PKA-dependent manner. {ECO:0000269|PubMed:16982639, ECO:0000269|PubMed:19840947}.","B cell activation [GO:0042113]; mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]; signal transduction [GO:0007165]",protein kinase A binding [GO:0051018]; RNA binding [GO:0003723],"SUBCELLULAR LOCATION: Nucleus speckle {ECO:0000269|PubMed:16982639, ECO:0000269|PubMed:19840947}.","SUBUNIT: Monomer. Component of the spliceosome. Interacts with ZRANB2 and SFRS1/ASF through its Arg/Ser-rich domain. Interacts with RI and RII subunits of PKA. {ECO:0000269|PubMed:12176931, ECO:0000269|PubMed:16982639, ECO:0000269|PubMed:19840947}.",X,1591604,1602520,p22.33,0.50167,0.524,-2.8164,0.27913,14.801,0.6068697657482705,ENST00000313871,0.6870210727969349,0.055711072231942015,2088,,,,,,,0.18527770313064795,7.189083257994877,Ovary,broadly expressed,3.971451586395384,5.485070939970254,FALSE,low confidence escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:18786,FAM50A,family with sequence similarity 50 member A,Approved,,"DXS9928E, XAP5, HXC-26, 9F",Xq28,gene with protein product,protein-coding gene,ENSG00000071859,9130,ENSG00000071859,Q14320,MGI:1351626,RGD:1560964,X,300453,TRUE,"Intellectual developmental disorder, X-linked, syndromic, Armfield type",300261,X-linked recessive,,,,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,FUNCTION: May be a DNA-binding protein or transcriptional factor. {ECO:0000269|PubMed:9339379}.,chromatin organization [GO:0006325]; spermatogenesis [GO:0007283],RNA binding [GO:0003723],SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.,"",X,154444141,154450654,q28,0.97913,0.292,0.26592,3.0177,16.25,0.46955796986611725,ENST00000393600,0.9050980392156863,0.26203449137715573,1020,1,"FAM50B (74, 78, chr6)",TRUE,,,,0.11126374179654189,7.178585183161768,Pituitary,broadly expressed,5.736258500344033,7.000157786141325,FALSE,high confidence non-escapee,Pre_higher_vs_Post,no difference_Pre_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:18992,ADGRG4,adhesion G protein-coupled receptor G4,Approved,GPR112,"RP1-299I16, PGR17",Xq26.3,gene with protein product,protein-coding gene,ENSG00000156920,139378,ENSG00000156920,Q8IZF6,MGI:2685213,RGD:1564057,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Orphan receptor.,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186],G protein-coupled receptor activity [GO:0004930],SUBCELLULAR LOCATION: Membrane {ECO:0000255}; Multi-pass membrane protein {ECO:0000255}.,"",X,136300963,136416890,q26.3,1.2147e-34,1.146,-1.6602,-0.8278,60.06,0.3202571373670205,ENST00000394143,0.3200367845937466,0.15421144713821544,9243,,,,,,,0.9252334823916241,2.1018685478500383,Fallopian Tube,tissue-specific,0,0,FALSE,high confidence escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:19060,GPR119,G protein-coupled receptor 119,Approved,,"hGPCR2, GPCR2",Xq26.1,gene with protein product,protein-coding gene,ENSG00000147262,139760,ENSG00000147262,Q8TDV5,MGI:2668412,RGD:727808,X,300513,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Receptor for the endogenous fatty-acid ethanolamide oleoylethanolamide (OEA) and lysophosphatidylcholine (LPC). Functions as a glucose-dependent insulinotropic receptor. The activity of this receptor is mediated by G proteins which activate adenylate cyclase. Seems to act through a G(s) mediated pathway. {ECO:0000269|PubMed:16517404}.,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; insulin secretion [GO:0030073]; regulation of metabolic process [GO:0019222],G protein-coupled receptor activity [GO:0004930]; phosphatidylcholine binding [GO:0031210],SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.,"",X,130384345,130385660,q26.1,0.0086183,1.295,-0.53871,1.2388,7.03,0.23865478254240266,ENST00000276218,0.7140873015873016,0.3303924018995251,1008,,,,,,,0.9567850244101878,0.3117158420826739,Pancreas,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:19073,THOC2,THO complex 2,Approved,"CXorf3, MRX12, MRX35","THO2, dJ506G2.1",Xq25,gene with protein product,protein-coding gene,ENSG00000125676,57187,ENSG00000125676,Q8NI27,MGI:2442413,RGD:1561623,X,300395,TRUE,"Mental retardation, X-linked 12/35",300957,X-linked recessive,,,,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Required for efficient export of polyadenylated RNA and spliced mRNA. Acts as component of the THO subcomplex of the TREX complex which is thought to couple mRNA transcription, processing and nuclear export, and which specifically associates with spliced mRNA and not with unspliced pre-mRNA. TREX is recruited to spliced mRNAs by a transcription-independent mechanism, binds to mRNA upstream of the exon-junction complex (EJC) and is recruited in a splicing- and cap-dependent manner to a region near the 5' end of the mRNA where it functions in mRNA export to the cytoplasm via the TAP/NFX1 pathway. The TREX complex is essential for the export of Kaposi's sarcoma-associated herpesvirus (KSHV) intronless mRNAs and infectious virus production. THOC2 (and probably the THO complex) is involved in releasing mRNA from nuclear speckle domains. Required for NXF1 localization to the nuclear rim. Plays a role for proper neuronal development. {ECO:0000269|PubMed:11979277, ECO:0000269|PubMed:15833825, ECO:0000269|PubMed:15998806, ECO:0000269|PubMed:17190602, ECO:0000269|PubMed:18974867, ECO:0000269|PubMed:22893130, ECO:0000269|PubMed:23222130, ECO:0000269|PubMed:26166480}.",blastocyst development [GO:0001824]; cell morphogenesis [GO:0000902]; generation of neurons [GO:0048699]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; negative regulation of neuron projection development [GO:0010977]; neuron development [GO:0048666]; poly(A)+ mRNA export from nucleus [GO:0016973]; regulation of mRNA export from nucleus [GO:0010793]; RNA export from nucleus [GO:0006405]; RNA splicing [GO:0008380]; stem cell division [GO:0017145]; viral mRNA export from host cell nucleus [GO:0046784],mRNA binding [GO:0003729],SUBCELLULAR LOCATION: Nucleus {ECO:0000305}. Nucleus speckle {ECO:0000305}.,"SUBUNIT: Component of the THO complex, which is composed of THOC1, THOC2, THOC3, THOC5, THOC6 and THOC7; together with at least ALYREF/THOC4, DDX39B, SARNP/CIP29 and CHTOP, THO forms the transcription/export (TREX) complex which seems to have a dynamic structure involving ATP-dependent remodeling. Interacts with THOC1, POLDIP3 and ZC3H11A. {ECO:0000269|PubMed:11979277, ECO:0000269|PubMed:15833825, ECO:0000269|PubMed:15870275, ECO:0000269|PubMed:15998806, ECO:0000269|PubMed:22928037}.",X,123600561,123733056,q25,1,0.081,0.20091,5.5258,58.925,0.6955312119631368,ENST00000245838,0.9749058971141782,0.3219685438863521,4782,,,,,,,0.23064052726963338,5.525229500145002,Cells - EBV-transformed lymphocytes,broadly expressed,3.0751749079797377,4.3023848591557945,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:19133,HS6ST2,heparan sulfate 6-O-sulfotransferase 2,Approved,,,Xq26.2,gene with protein product,protein-coding gene,ENSG00000171004,90161,ENSG00000171004,Q96MM7,MGI:1354959,RGD:1564397,X,300545,TRUE,,,,?Paganini-Miozzo syndrome,301025,X-linked recessive,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,PMT +CS,FALSE,,PMT,"FUNCTION: 6-O-sulfation enzyme which catalyzes the transfer of sulfate from 3'-phosphoadenosine 5'-phosphosulfate (PAPS) to position 6 of the N-sulfoglucosamine residue (GlcNS) of heparan sulfate. {ECO:0000269|PubMed:12492399, ECO:0000269|PubMed:30471091}.","glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]",heparan sulfate 6-O-sulfotransferase activity [GO:0017095],SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type II membrane protein {ECO:0000305}.,"",X,132626016,132961395,q26.2,0.0010077,0.933,0.75215,1.3955,14.099,0.17373930417408678,ENST00000370836,0.8692519251925193,0.09382654336415897,1818,,,,,,,0.800594166589255,4.3171086660540565,Ovary,tissue-specific,2.0935094713687543,2.1039541271636053,FALSE,low confidence escapee,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,no difference_Post1_Post2,PMT
HGNC:19142,SPACA5B,sperm acrosome associated 5B,Approved,,LYZL5B,Xp11.23,gene with protein product,protein-coding gene,ENSG00000171478,729201,ENSG00000171478,Q96QH8,MGI:2685564,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; metabolic process [GO:0008152],lysozyme activity [GO:0003796],SUBCELLULAR LOCATION: Secreted {ECO:0000305}.,"",X,48130657,48132613,p11.23,0.3121,1.867,0.021499,0.62929,0.29023,0.1765040071925383,ENST00000304270,0.536875,0.18605348662834292,480,1,"SPACA5 (100, 100, chrX)",TRUE,1,"SPACA5 (100, 100, chrX)",TRUE,0.9767441860465116,0.08602934643221226,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:19161,STARD8,StAR related lipid transfer domain containing 8,Approved,,"KIAA0189, ARHGAP38",Xq13.1,gene with protein product,protein-coding gene,ENSG00000130052,9754,ENSG00000130052,Q92502,MGI:2448556,RGD:1560770,X,300689,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Accelerates GTPase activity of RHOA and CDC42, but not RAC1. Stimulates the hydrolysis of phosphatidylinositol 4,5-bisphosphate by PLCD1. {ECO:0000269|PubMed:17976533}.",actin cytoskeleton organization [GO:0030036]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165],GTPase activator activity [GO:0005096]; lipid binding [GO:0008289],"SUBCELLULAR LOCATION: Cell junction, focal adhesion {ECO:0000269|PubMed:17976533}.",SUBUNIT: Binds both the SH2 and PTB domains of TNS1.,X,68647666,68725842,q13.1,0.024522,0.5,-0.33829,0.37365,31.386,0.2617418147945712,ENST00000374599,0.6017210144927536,0.16180954761309674,3312,,,,,,,0.4185252636747436,5.391396552110296,Lung,broadly expressed,1.9713577734487844,1.6273897171989393,FALSE,high confidence non-escapee,no_difference_Pre_Post,Post1_higher_vs_Pre,no difference_Pre_Post2,Post1_higher_vs_Post2,no disorder
HGNC:1934,CHIC1,cysteine rich hydrophobic domain 1,Approved,,BRX,Xq13.2,gene with protein product,protein-coding gene,ENSG00000204116,53344,ENSG00000204116,Q5VXU3,MGI:1344694,RGD:1589722,X,300922,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","",SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}. Cytoplasmic vesicle {ECO:0000250}. Note=Also present at a Golgi-like vesicular compartment and at scattered vesicles. {ECO:0000250}.,"",X,73563200,73687102,q13.2,0.85254,0.476,-1.1489,0.58777,6.2824,0.5185492886674677,ENST00000373504,0.9700813008130081,0.271056622851365,615,1,"CHIC2 (60, 81, chr4)",TRUE,,,,0.28662731969031097,3.9430586388903976,Cerebellar_tissues,broadly expressed,3.044892418853075,3.9430586388903976,TRUE,high confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:19340,MAGEA2B,MAGE family member A2B,Approved,,"MAGE2, MGC16973, MAGEA2",Xq28,gene with protein product,protein-coding gene,ENSG00000183305,266740,ENSG00000183305,P43356,,,X,300549,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Reduces p53/TP53 transactivation function through recruitment of HDAC3 to p53/TP53 transcription sites. Also represses p73/TP73 activity. Proposed to enhance ubiquitin ligase activity of RING-type zinc finger-containing E3 ubiquitin-protein ligases. In vitro enhances ubiquitin ligase activity of TRIM28 and stimulates p53/TP53 ubiquitination by TRIM28 potentially in presence of Ubl-conjugating enzyme UBE2H. Proposed to act through recruitment and/or stabilization of the Ubl-conjugating enzyme (E2) at the E3:substrate complex. May play a role in embryonal development and tumor transformation or aspects of tumor progression. In vitro promotes cell viability in melanoma cell lines. Antigen recognized on a melanoma by autologous cytolytic T-lymphocytes. Negatively regulates acetylation and sumoylation of PML and represses PML-induced p53/TP53 acetylation and activation. {ECO:0000269|PubMed:16847267, ECO:0000269|PubMed:17942928, ECO:0000269|PubMed:20864041, ECO:0000269|PubMed:22117195}.",cellular protein catabolic process [GO:0044257]; cellular senescence [GO:0090398]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; signal transduction by p53 class mediator [GO:0072331],histone deacetylase binding [GO:0042826]; repressing transcription factor binding [GO:0070491]; ubiquitin protein ligase binding [GO:0031625],"SUBCELLULAR LOCATION: Nucleus. Nucleus, PML body.","SUBUNIT: Interacts with TRIM28 and UBE2H. Interacts with HDAC3. Interacts with PML (isoform PML-1, isoform PML-2, isoform PML-3, isoform PML-4 and isoform PML-5). {ECO:0000269|PubMed:16847267, ECO:0000269|PubMed:20864041, ECO:0000269|PubMed:22117195}.",X,152714586,152718607,q28,,,,,,0.316321939380718,ENST00000331220,0.03492063492063492,0.0024743814046488378,945,9,"MAGEA2 (100, 100, chrX); MAGEA12 (88, 88, chrX); MAGEA3 (84, 84, chrX); MAGEA6 (84, 84, chrX); MAGEA4 (68, 67, chrX); MAGEA1 (67, 68, chrX); MAGEA8 (63, 63, chrX); MAGEA9B (59, 59, chrX); MAGEA9 (59, 59, chrX)",TRUE,4,"MAGEA2 (100, 100, chrX); MAGEA12 (88, 88, chrX); MAGEA3 (84, 84, chrX); MAGEA6 (84, 84, chrX)",TRUE,0.9767441860465116,0.030561241303148537,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:19374,NKRF,NFKB repressing factor,Approved,,"ITBA4, NRF",Xq24,gene with protein product,protein-coding gene,ENSG00000186416,55922,ENSG00000186416,O15226,MGI:1924536,RGD:6500424,X,300440,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Interacts with a specific negative regulatory element (NRE) 5'-AATTCCTCTGA-3' to mediate transcriptional repression of certain NK-kappa-B responsive genes. Involved in the constitutive silencing of the interferon beta promoter, independently of the virus-induced signals, and in the inhibition of the basal and cytokine-induced iNOS promoter activity. Also involved in the regulation of IL-8 transcription. {ECO:0000269|PubMed:12381793}.","negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]","DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]","SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:12429849}.",SUBUNIT: Interacts with NF-kappa-B. Interacts with XRN2 (PubMed:24462208). {ECO:0000269|PubMed:24462208}.,X,119588337,119606443,q24,0.99661,0.178,1.2066,2.7407,16.747,0.6278181036118414,ENST00000304449,0.9013989387361312,0.24373906523369157,2073,,,,,,,0.32872616347161476,4.472559254581194,Cells - EBV-transformed lymphocytes,broadly expressed,3.2011743209813983,4.223766191710063,FALSE,high confidence non-escapee,no_difference_Pre_Post,Pre_higher_vs_Post1,no difference_Pre_Post2,Post2_higher_vs_Post1,no disorder
HGNC:1940,CHM,CHM Rab escort protein,Approved,"TCD, DXS540",REP-1,Xq21.2,gene with protein product,protein-coding gene,ENSG00000188419,1121,ENSG00000188419,P24386,MGI:892979,RGD:2340,X,300390,TRUE,Choroideremia,303100,X-linked dominant,,,,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,TRUE,confirmed,"FUNCTION: Substrate-binding subunit of the Rab geranylgeranyltransferase (GGTase) complex. Binds unprenylated Rab proteins and presents the substrate peptide to the catalytic component B composed of RABGGTA and RABGGTB, and remains bound to it after the geranylgeranyl transfer reaction. The component A is thought to be regenerated by transferring its prenylated Rab back to the donor membrane. Besides, a pre-formed complex consisting of CHM and the Rab GGTase dimer (RGGT or component B) can bind to and prenylate Rab proteins; this alternative pathway is proposed to be the predominant pathway for Rab protein geranylgeranylation. {ECO:0000269|PubMed:18532927, ECO:0000269|PubMed:7957092}.",post-translational protein modification [GO:0043687]; protein geranylgeranylation [GO:0018344]; protein targeting to membrane [GO:0006612]; regulation of apoptotic process [GO:0042981]; small GTPase mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192]; visual perception [GO:0007601],GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; Rab geranylgeranyltransferase activity [GO:0004663]; Rab GTPase binding [GO:0017137],"SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:7957092}.","SUBUNIT: Monomer (By similarity). Heterotrimer composed of RABGGTA, RABGGTB and CHM; within this trimer, RABGGTA and RABGGTB form the catalytic component B, while CHM (component A) mediates Rab protein binding (PubMed:21905166). Can associate with the Rab GGTase dimer (RGGT or component B) prior to Rab protein binding; the association is stabilized by geranylgeranyl pyrophosphate (GGpp). The CHM:RGGT:Rab complex is destabilized by GGpp (PubMed:18532927). Interacts with RAB1A, RAB1B, RAB5A, RAB7A and RAB27A and mediates their prenylation (PubMed:7957092). Interacts with the non-phosphorylated forms of RAB3A, RAB3B, RAB3C, RAB3D, RAB5B, RAB5C, RAB8A, RAB8B, RAB10, RAB12, RAB35, and RAB43 (PubMed:26824392, PubMed:29125462). {ECO:0000250|UniProtKB:P37727, ECO:0000269|PubMed:18532927, ECO:0000269|PubMed:21905166, ECO:0000269|PubMed:26824392, ECO:0000269|PubMed:29125462, ECO:0000269|PubMed:7957092}.",X,85861180,86047561,q21.2,0.99899,0.194,-1.1986,0.79323,24.391,0.4627633947815503,ENST00000357749,0.7854230377166157,0.1852786803299175,1962,1,"CHML (72, 72, chr1)",TRUE,,,,0.2850866536593038,3.694167024413976,Cells - Cultured fibroblasts,broadly expressed,2.3094556170825045,3.353493383633109,FALSE,low confidence non-escapee,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:19653,SSX7,SSX family member 7,Approved,,,Xp11.22,gene with protein product,protein-coding gene,ENSG00000187754,280658,ENSG00000187754,Q7RTT5,,,X,300542,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Could act as a modulator of transcription.,"regulation of transcription, DNA-templated [GO:0006355]",nucleic acid binding [GO:0003676],"","",X,52644061,52654900,p11.22,2.6848e-6,1.818,-0.22103,-1.9689,7.113,0.328698973926176,ENST00000298181,0.1908289241622575,0.16268432891777057,567,7,"SSX5 (82, 68, chrX); SSX4 (81, 81, chrX); SSX4B (81, 81, chrX); SSX1 (78, 78, chrX); SSX2 (72, 61, chrX); SSX2B (72, 61, chrX); SSX3 (71, 66, chrX)",TRUE,,,,0.9767441860465116,0.06611303133465317,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:19701,CNKSR2,connector enhancer of kinase suppressor of Ras 2,Approved,,"KIAA0902, CNK2, KSR2",Xp22.12,gene with protein product,protein-coding gene,ENSG00000149970,22866,ENSG00000149970,Q8WXI2,MGI:2661175,RGD:708454,X,300724,TRUE,"Mental retardation, X-linked, syndromic, Houge type",301008,X-linked,,,,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,confirmed +CS,FALSE,TRUE,confirmed,FUNCTION: May function as an adapter protein or regulator of Ras signaling pathways. {ECO:0000269|PubMed:14597674}.,intracellular signal transduction [GO:0035556]; postsynapse organization [GO:0099173]; regulation of signal transduction [GO:0009966],identical protein binding [GO:0042802]; protein kinase binding [GO:0019901],SUBCELLULAR LOCATION: Cytoplasm. Membrane; Peripheral membrane protein.,"SUBUNIT: Interacts with RAF1, RAB2L and RAL GTPase proteins. {ECO:0000269|PubMed:14597674}.",X,21372801,21654695,p22.12,0.99996,0.185,1.5186,3.6053,41.859,0.7738700770236884,ENST00000379510,0.9642834138486313,0.22951762059485128,3105,,,,,,,0.7985803862677372,6.133892270197556,Cerebellar_tissues,tissue-specific,3.650753072645691,6.133892270197556,TRUE,discordant,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:19763,ASB12,ankyrin repeat and SOCS box containing 12,Approved,,FLJ39577,Xq11.2,gene with protein product,protein-coding gene,ENSG00000198881,142689,ENSG00000198881,Q8WXK4,MGI:1917642,RGD:1561142,X,300891,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Probable substrate-recognition component of a SCF-like ECS (Elongin-Cullin-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. {ECO:0000250, ECO:0000269|PubMed:16325183}.",post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567],"","",SUBUNIT: Interacts with CUL5 and RNF7. {ECO:0000269|PubMed:16325183}.,X,64224194,64230607,q11.2,6.9764e-4,1.68,0.58351,-0.92733,5.8626,0.1690117040605062,ENST00000362002,0.7856844305120168,0.09622594351412148,957,,,,,,,0.84865534877179,5.369298962164133,Muscle - Skeletal,tissue-specific,0.23535209418647315,0.577562728092362,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:1986,CITED1,Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1,Approved,MSG1,,Xq13.1,gene with protein product,protein-coding gene,ENSG00000125931,4435,ENSG00000125931,Q99966,MGI:108023,RGD:620781,X,300149,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Transcriptional coactivator of the p300/CBP-mediated transcription complex. Enhances SMAD-mediated transcription by strengthening the functional link between the DNA-binding SMAD transcription factors and the p300/CBP transcription coactivator complex. Stimulates estrogen-dependent transactivation activity mediated by estrogen receptors signaling; stabilizes the interaction of estrogen receptor ESR1 and histone acetyltransferase EP300. Positively regulates TGF-beta signaling through its association with the SMAD/p300/CBP-mediated transcriptional coactivator complex. Induces transcription from estrogen-responsive promoters and protection against cell death. Potentiates EGR2-mediated transcriptional activation activity from the ERBB2 promoter. Acts as an inhibitor of osteoblastic mineralization through a cAMP-dependent parathyroid hormone receptor signaling. May play a role in pigmentation of melanocytes. Associates with chromatin to the estrogen-responsive TGF-alpha promoter region in a estrogen-dependent manner. {ECO:0000269|PubMed:10722728, ECO:0000269|PubMed:11581164, ECO:0000269|PubMed:21172805}.","apoptotic process [GO:0006915]; brain development [GO:0007420]; branching involved in ureteric bud morphogenesis [GO:0001658]; embryonic axis specification [GO:0000578]; labyrinthine layer development [GO:0060711]; melanin biosynthetic process [GO:0042438]; melanocyte differentiation [GO:0030318]; mesenchymal to epithelial transition [GO:0060231]; metanephros development [GO:0001656]; negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003340]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of Wnt signaling pathway [GO:0030178]; nucleocytoplasmic transport [GO:0006913]; pigmentation [GO:0043473]; placenta development [GO:0001890]; positive regulation of gene expression [GO:0010628]; positive regulation of mesenchymal stem cell proliferation [GO:1902462]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of apoptotic process [GO:0042981]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cAMP [GO:0051591]; response to cytokine [GO:0034097]; response to estrogen [GO:0043627]; response to insulin [GO:0032868]; response to interferon-gamma [GO:0034341]; response to interleukin-1 [GO:0070555]; response to interleukin-11 [GO:0071105]; response to interleukin-2 [GO:0070669]; response to interleukin-4 [GO:0070670]; response to interleukin-6 [GO:0070741]; response to interleukin-9 [GO:0071104]; response to lipopolysaccharide [GO:0032496]; response to parathyroid hormone [GO:0071107]; response to transforming growth factor beta [GO:0071559]; SMAD protein signal transduction [GO:0060395]; spongiotrophoblast layer development [GO:0060712]; transforming growth factor beta receptor signaling pathway [GO:0007179]; vasculogenesis [GO:0001570]",chromatin binding [GO:0003682]; co-SMAD binding [GO:0070410]; LBD domain binding [GO:0050693]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; transcription coactivator activity [GO:0003713],SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:16864582}. Cytoplasm {ECO:0000269|PubMed:16864582}. Note=Shuttles between the nucleus and the cytoplasm by a nuclear export signal and (NES) in a CRM1-dependent manner.,"SUBUNIT: Interacts (via C-terminus) with CREBBP. Interacts with EGR2 (By similarity). Homodimer. Binds to RBM14. Interacts (via N-terminus) with HSPA8; the interaction suppresses the association of CITED1 with p300/CBP and SMAD-mediated transcription transactivation. Interacts (via C-terminus) with TOX3 (via HGM box); the interaction increases estrogen-response element (ERE)-dependent transcription and protection against cell death. Interacts with ESR1; the interaction occurs in a estrogen-dependent manner (By similarity). Interacts (unphosphorylated form preferentially and via C-terminus) with EP300. {ECO:0000250, ECO:0000269|PubMed:10722728, ECO:0000269|PubMed:11443112, ECO:0000269|PubMed:11581164, ECO:0000269|PubMed:16864582, ECO:0000269|PubMed:21172805, ECO:0000269|PubMed:9707553}.",X,72301638,72307187,q13.1,0.024446,1.389,0.64433,0.87881,5.4817,0.744582130856173,ENST00000651998,0.6756013745704468,0.24976255936015995,582,,,,,,,0.8600330830475567,7.343878575763815,Testis,tissue-specific,1.9324240678466307,2.0553345017510996,FALSE,discordant,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:19901,RRAGB,Ras related GTP binding B,Approved,,,Xp11.21,gene with protein product,protein-coding gene,ENSG00000083750,10325,ENSG00000083750,Q5VZM2,MGI:3038613,RGD:619805,X,300725,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Guanine nucleotide-binding protein that plays a crucial role in the cellular response to amino acid availability through regulation of the mTORC1 signaling cascade (PubMed:18497260, PubMed:20381137, PubMed:24095279, PubMed:23723238). Forms heterodimeric Rag complexes with RRAGC or RRAGD and cycles between an inactive GDP-bound and an active GTP-bound form (PubMed:18497260, PubMed:20381137, PubMed:24095279, PubMed:23723238). In its active form participates in the relocalization of mTORC1 to the lysosomes and its subsequent activation by the GTPase RHEB (PubMed:18497260, PubMed:20381137, PubMed:23723238). Involved in the RCC1/Ran-GTPase pathway (PubMed:9394008). {ECO:0000269|PubMed:18497260, ECO:0000269|PubMed:20381137, ECO:0000269|PubMed:23723238, ECO:0000269|PubMed:24095279, ECO:0000269|PubMed:9394008}.",cell cycle arrest [GO:0007050]; cellular protein localization [GO:0034613]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine starvation [GO:1990253]; cellular response to starvation [GO:0009267]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TOR signaling [GO:0032008]; regulation of autophagy [GO:0010506]; regulation of macroautophagy [GO:0016241]; regulation of TOR signaling [GO:0032006],GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; GTP binding [GO:0005525]; guanyl ribonucleotide binding [GO:0032561],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:9394008}. Lysosome {ECO:0000269|PubMed:20381137}.,"SUBUNIT: Interacts with RRAGC and RRAGD; heterodimerization stabilizes RRAG proteins (PubMed:11073942). In complex with RRAGC, but not with RRAGA, interacts with RPTOR; this interaction is particularly efficient with GTP-loaded RRAGB and GDP-loaded RRAGC (PubMed:18497260). Component of the lysosomal folliculin complex (LFC), composed of FLCN, FNIP1 (or FNIP2), RRAGA/RagA or RRAGB/RagB GDP-bound, RRAGC/RagC or RRAGD/RagD GTP-bound, and Ragulator (By similarity). Interacts with SH3BP4; the interaction with this negative regulator is most probably direct, preferentially occurs with the inactive GDP-bound form of RRAGB, is negatively regulated by amino acids and prevents interaction with RPTOR (PubMed:22575674). Interacts with the GATOR1 complex; inactivates RRAGB (PubMed:23723238). The Rag heterodimer interacts with SLC38A9; the probable amino acid sensor (PubMed:25561175, PubMed:25567906). Interacts with SESN1, SESN2 and SESN3 (PubMed:25259925). {ECO:0000250|UniProtKB:Q7L523, ECO:0000269|PubMed:11073942, ECO:0000269|PubMed:18497260, ECO:0000269|PubMed:22575674, ECO:0000269|PubMed:23723238, ECO:0000269|PubMed:25259925, ECO:0000269|PubMed:25561175, ECO:0000269|PubMed:25567906}.",X,55717749,55758774,p11.21,0.8363,0.427,-0.38455,1.9423,14.732,0.38149295204659367,ENST00000374941,0.9789625360230547,0.2274181454636341,1041,1,"RRAGA (82, 98, chr9)",TRUE,1,"RRAGA (82, 98, chr9)",TRUE,0.2043700024116037,4.983714171987633,Cervix - Ectocervix,broadly expressed,3.8154832081923633,4.672405540138961,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:19906,P2RY10,P2Y receptor family member 10,Approved,,P2Y10,Xq21.1,gene with protein product,protein-coding gene,ENSG00000078589,27334,ENSG00000078589,O00398,MGI:1926076,RGD:1561912,X,300529,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Putative receptor for purines coupled to G-proteins.,G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of Rho protein signal transduction [GO:0035025],G protein-coupled purinergic nucleotide receptor activity [GO:0045028]; G protein-coupled receptor activity [GO:0004930],SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.,"",X,78945332,78963727,q21.1,0.15542,1.039,-0.19642,1.36,6.0481,0.15184395502888198,ENST00000171757,0.6400980392156863,0.08980254936265934,1020,,,,,,,0.8922448656695754,6.630386540645576,Cells - EBV-transformed lymphocytes,tissue-specific,0,0,FALSE,variable escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:20083,DDX53,DEAD-box helicase 53,Approved,,"CAGE, CT26",Xp22.11,gene with protein product,protein-coding gene,ENSG00000184735,168400,ENSG00000184735,Q86TM3,,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","",ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11922625}.,"",X,22999960,23003589,p22.11,0.66167,0.847,-1.0699,0.0051921,3.5162,0.4066634714536767,ENST00000327968,0.4774789029535865,0.25003749062734315,1896,1,"DDX43 (61, 59, chr6)",TRUE,,,,0.976285524399465,3.65483648835314,Testis,tissue-specific,0,0.07208233290767524,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:20145,GPR143,G protein-coupled receptor 143,Approved,OA1,,Xp22.2,gene with protein product,protein-coding gene,ENSG00000101850,4935,ENSG00000101850,P51810,MGI:107193,RGD:1565799,X,300808,TRUE,"Nystagmus 6, congenital, X-linked // Ocular albinism, type I, Nettleship-Falls type",300814 // 300500,X-linked recessive // X-linked,,,,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Receptor for tyrosine, L-DOPA and dopamine. After binding to L-DOPA, stimulates Ca(2+) influx into the cytoplasm, increases secretion of the neurotrophic factor SERPINF1 and relocalizes beta arrestin at the plasma membrane; this ligand-dependent signaling occurs through a G(q)-mediated pathway in melanocytic cells. Its activity is mediated by G proteins which activate the phosphoinositide signaling pathway. Plays also a role as an intracellular G protein-coupled receptor involved in melanosome biogenesis, organization and transport. {ECO:0000269|PubMed:10471510, ECO:0000269|PubMed:16524428, ECO:0000269|PubMed:18697795, ECO:0000269|PubMed:18828673, ECO:0000269|PubMed:19717472}.",calcium-mediated signaling using intracellular calcium source [GO:0035584]; eye pigment biosynthetic process [GO:0006726]; G protein-coupled receptor signaling pathway [GO:0007186]; melanosome localization [GO:0032400]; melanosome organization [GO:0032438]; melanosome transport [GO:0032402]; phosphatidylinositol-mediated signaling [GO:0048015]; regulation of calcium-mediated signaling [GO:0050848]; regulation of melanosome organization [GO:1903056]; regulation of melanosome transport [GO:1902908]; signal transduction [GO:0007165]; visual perception [GO:0007601],dopamine binding [GO:0035240]; G protein-coupled receptor activity [GO:0004930]; L-DOPA binding [GO:0072544]; L-DOPA receptor activity [GO:0035643]; tyrosine binding [GO:0072545],"SUBCELLULAR LOCATION: Melanosome membrane {ECO:0000269|PubMed:10471510, ECO:0000269|PubMed:12643545, ECO:0000269|PubMed:16524428, ECO:0000269|PubMed:16621890, ECO:0000269|PubMed:17081065}; Multi-pass membrane protein {ECO:0000255}. Lysosome membrane {ECO:0000269|PubMed:16524428, ECO:0000269|PubMed:16621890}; Multi-pass membrane protein {ECO:0000255}. Apical cell membrane {ECO:0000269|PubMed:18828673}; Multi-pass membrane protein {ECO:0000255}. Note=Distributed throughout the endo-melanosomal system but most of endogenous protein is localized in unpigmented stage II melanosomes. Its expression on the apical cell membrane is sensitive to tyrosine (PubMed:18828673). {ECO:0000269|PubMed:18828673}.","SUBUNIT: Interacts with heterotrimeric G(i) proteins. Interacts with ARRB1 and ARRB2. Interacts with MLANA. {ECO:0000269|PubMed:10471510, ECO:0000269|PubMed:16524428, ECO:0000269|PubMed:19717472}.",X,9725346,9786297,p22.2,0.92526,0.374,-0.16082,0.87866,12.69,0.5676442762535477,ENST00000467482,0.7367078189300411,0.06630842289427644,1215,,,,,,,0.624632376165107,2.468945574341701,Other_Brain_tissues,tissue-specific,2.468945574341701,1.2713360277997179,TRUE,discordant,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:2022,CLCN4,chloride voltage-gated channel 4,Approved,,"CLC4, ClC-4",Xp22.2,gene with protein product,protein-coding gene,ENSG00000073464,1183,ENSG00000073464,P51793,MGI:104571,RGD:708381,X,302910,TRUE,Raynaud-Claes syndrome,300114,X-linked dominant,,,,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,confirmed +CS,FALSE,TRUE,confirmed,"FUNCTION: Strongly outwardly rectifying, electrogenic H(+)/Cl(-)exchanger which mediates the exchange of chloride ions against protons (PubMed:18063579, PubMed:28972156, PubMed:23647072, PubMed:27550844, PubMed:25644381). The CLC channel family contains both chloride channels and proton-coupled anion transporters that exchange chloride or another anion for protons (PubMed:29845874). The presence of conserved gating glutamate residues is typical for family members that function as antiporters (PubMed:29845874). {ECO:0000269|PubMed:18063579, ECO:0000269|PubMed:23647072, ECO:0000269|PubMed:25644381, ECO:0000269|PubMed:27550844, ECO:0000269|PubMed:28972156, ECO:0000303|PubMed:29845874}.",chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220],antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride channel activity [GO:0005254]; chloride ion binding [GO:0031404]; solute:proton antiporter activity [GO:0015299]; voltage-gated chloride channel activity [GO:0005247],"SUBCELLULAR LOCATION: Early endosome membrane {ECO:0000250|UniProtKB:P51794}; Multi-pass membrane protein {ECO:0000255}. Late endosome membrane {ECO:0000269|PubMed:28972156}; Multi-pass membrane protein {ECO:0000255}. Endoplasmic reticulum membrane {ECO:0000269|PubMed:17023393, ECO:0000269|PubMed:28972156}; Multi-pass membrane protein {ECO:0000255}. Lysosome membrane {ECO:0000269|PubMed:28972156}; Multi-pass membrane protein {ECO:0000255}. Recycling endosome membrane {ECO:0000269|PubMed:28972156}; Multi-pass membrane protein {ECO:0000255}. Note=Localizes to late endosome membrane, lysosome membrane and recycling endosome membrane in the presence of CLCN3. {ECO:0000269|PubMed:28972156}.",SUBUNIT: Monomer (PubMed:28972156). Forms heterodimers with CLCN3 (PubMed:28972156). {ECO:0000269|PubMed:28972156}.,X,10156975,10237660,p22.2,0.99893,0.151,0.040381,4.5166,19.829,0.5859846265209747,ENST00000380833,0.8905825667980727,0.11267183204198951,2283,2,"CLCN5 (77, 72, chrX); CLCN3 (76, 67, chr4)",TRUE,,,,0.7004247454241752,5.613714335576204,Cerebellar_tissues,tissue-specific,4.172071416568149,5.613714335576204,TRUE,low confidence non-escapee,no_difference_Pre_Post,Pre_higher_vs_Post1,no difference_Pre_Post2,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:2023,CLCN5,chloride voltage-gated channel 5,Approved,"NPHL2, NPHL1","DENTS, XLRH, hClC-K2, hCIC-K2, CLC5, XRN, ClC-5",Xp11.23,gene with protein product,protein-coding gene,ENSG00000171365,1184,ENSG00000171365,P51795,MGI:99486,RGD:2362,X,300008,TRUE,"Dent disease // Hypophosphatemic rickets // Nephrolithiasis, type I // Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis",300009 // 300554 // 310468 // 308990,X-linked recessive // X-linked recessive // X-linked recessive // X-linked recessive,,,,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,FUNCTION: Proton-coupled chloride transporter. Functions as antiport system and exchanges chloride ions against protons. Important for normal acidification of the endosome lumen. May play an important role in renal tubular function.,excretion [GO:0007588]; ion transmembrane transport [GO:0034220],ATP binding [GO:0005524]; chloride channel activity [GO:0005254]; chloride ion binding [GO:0031404]; identical protein binding [GO:0042802]; solute:proton antiporter activity [GO:0015299]; voltage-gated chloride channel activity [GO:0005247],SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000269|PubMed:19019917}; Multi-pass membrane protein {ECO:0000269|PubMed:19019917}. Endosome membrane {ECO:0000269|PubMed:19019917}; Multi-pass membrane protein {ECO:0000269|PubMed:19019917}. Cell membrane {ECO:0000269|PubMed:19019917}; Multi-pass membrane protein {ECO:0000269|PubMed:19019917}.,SUBUNIT: Interacts with NEDD4 and NEDD4L. {ECO:0000269|PubMed:15489223}.,X,49922596,50099235,p11.23,0.99242,0.279,1.5863,2.5341,27.812,0.6370207031728531,ENST00000376091,0.8397388820889433,0.20072481879530119,2451,2,"CLCN4 (72, 77, chrX); CLCN3 (72, 68, chr4)",TRUE,,,,0.49966942878531945,4.487499212121445,Kidney - Medulla,broadly expressed,1.0594106583208633,3.081746095195617,FALSE,high confidence non-escapee,no_difference_Pre_Post,Pre_higher_vs_Post1,no difference_Pre_Post2,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:20342,ZDHHC15,zinc finger DHHC-type palmitoyltransferase 15,Approved,,"FLJ31812, MRX91, DHHC15",Xq13.3,gene with protein product,protein-coding gene,ENSG00000102383,158866,ENSG00000102383,Q96MV8,MGI:1915336,RGD:1562075,X,300576,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Palmitoyltransferase that catalyzes the addition of palmitate onto various protein substrates (PubMed:18817523, PubMed:23034182). Has no stringent fatty acid selectivity and in addition to palmitate can also transfer onto target proteins myristate from tetradecanoyl-CoA and stearate from octadecanoyl-CoA (By similarity). Palmitoylates IGF2R and SORT1, promoting their partitioning to an endosomal membrane subdomain where they can interact with the retromer cargo-selective complex (PubMed:18817523). Thereby, regulates retrograde transport from endosomes to the Golgi apparatus of these lysosomal sorting receptors and plays a role in trafficking of lysosomal proteins (PubMed:18817523). In the nervous system, catalyzes the palmitoylation of DLG4/PSD95 and regulates its synaptic clustering and function in synaptogenesis (By similarity). Could be involved in the differentiation of dopaminergic neurons and the development of the diencephalon (By similarity). Could also catalyze the palmitoylation of GAP43 (By similarity). Could also palmitoylate DNAJC5 and regulate its localization to the Golgi membrane (By similarity). Could also palmitoylate FYN as shown in vitro (PubMed:19956733). {ECO:0000250|UniProtKB:F1QXD3, ECO:0000250|UniProtKB:Q8BGJ0, ECO:0000269|PubMed:18817523, ECO:0000269|PubMed:19956733, ECO:0000269|PubMed:23034182}.",peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of dendrite development [GO:1900006]; protein localization to membrane [GO:0072657]; protein localization to postsynapse [GO:0062237]; protein palmitoylation [GO:0018345]; protein targeting to Golgi apparatus [GO:0140450]; protein targeting to membrane [GO:0006612]; regulation of dendritic spine morphogenesis [GO:0061001]; synaptic vesicle maturation [GO:0016188],palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; zinc ion binding [GO:0008270],"SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000269|PubMed:16647879}; Multi-pass membrane protein {ECO:0000250|UniProtKB:F1QXD3}. Cell junction, synapse, postsynaptic density {ECO:0000250|UniProtKB:Q2TGJ4}.","",X,75368427,75523502,q13.3,0.83968,0.425,-0.039883,1.0264,14.799,0.35442936871636666,ENST00000373367,0.951577909270217,0.1871032241939515,1014,1,"ZDHHC2 (58, 53, chr8)",TRUE,,,,0.4510392506714147,2.141020720356236,Cervix - Ectocervix,broadly expressed,1.1670174475058865,1.8727105817221401,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:20372,NDUFB11,NADH:ubiquinone oxidoreductase subunit B11,Approved,,"ESSS, NP17.3, Np15",Xp11.3,gene with protein product,protein-coding gene,ENSG00000147123,54539,ENSG00000147123,Q9NX14,MGI:1349919,RGD:1563698,X,300403,TRUE,Linear skin defects with multiple congenital anomalies 3,300952,X-linked dominant,"?Mitochondrial complex I deficiency, nuclear type 30",301021,X-linked,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone. {ECO:0000269|PubMed:27626371}.","mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]","",SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000305|PubMed:12611891}; Single-pass membrane protein {ECO:0000305}.,"SUBUNIT: Complex I is composed of 45 different subunits. {ECO:0000269|PubMed:12611891, ECO:0000269|PubMed:27626371}.",X,47142216,47145038,p11.3,0.80382,0.556,-0.29215,0.51342,5.3861,0.5430916032607219,ENST00000377811,0.6961038961038961,0.2247938015496126,462,,,,,,,0.11765430906023992,8.350651939545411,Muscle - Skeletal,broadly expressed,6.923303712699484,7.4565433393124705,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:2041,CLDN2,claudin 2,Approved,,,Xq22.3,gene with protein product,protein-coding gene,ENSG00000165376,9075,ENSG00000165376,P57739,MGI:1276110,RGD:1560247,X,300520,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Plays a major role in tight junction-specific obliteration of the intercellular space, through calcium-independent cell-adhesion activity. {ECO:0000250}.",bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155],identical protein binding [GO:0042802]; structural molecule activity [GO:0005198],"SUBCELLULAR LOCATION: Cell junction, tight junction {ECO:0000250}. Cell membrane {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}.","SUBUNIT: Can form homo- and heteropolymers with other CLDN. Homopolymers interact with CLDN3, but not CLDN1, homopolymers. Directly interacts with TJP1/ZO-1, TJP2/ZO-2 and TJP3/ZO-3 (By similarity). {ECO:0000250}.",X,106900164,106930861,q22.3,0.70328,0.748,0.83142,1.6148,3.9924,0.11855130307640631,ENST00000541806,0.7380952380952381,0.15031242189452637,693,,,,,,,0.8627956133604983,5.388740604787264,Kidney - Cortex,tissue-specific,0.04846373401366767,0.05630737843118674,FALSE,high confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:20439,UPF3B,UPF3B regulator of nonsense mediated mRNA decay,Approved,"MRX62, UPF3BP1, UPF3BP2, UPF3BP3","RENT3B, UPF3X, HUPF3B, MRX82",Xq24,gene with protein product,protein-coding gene,ENSG00000125351,65109,ENSG00000125351,Q9BZI7,MGI:1915384,RGD:1560264,X,300298,TRUE,"Mental retardation, X-linked, syndromic 14",300676,X-linked recessive,,,,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Involved in nonsense-mediated decay (NMD) of mRNAs containing premature stop codons by associating with the nuclear exon junction complex (EJC) and serving as link between the EJC core and NMD machinery. Recruits UPF2 at the cytoplasmic side of the nuclear envelope and the subsequent formation of an UPF1-UPF2-UPF3 surveillance complex (including UPF1 bound to release factors at the stalled ribosome) is believed to activate NMD. In cooperation with UPF2 stimulates both ATPase and RNA helicase activities of UPF1. Binds spliced mRNA upstream of exon-exon junctions. In vitro, stimulates translation; the function is independent of association with UPF2 and components of the EJC core. {ECO:0000269|PubMed:11163187, ECO:0000269|PubMed:12718880, ECO:0000269|PubMed:16209946, ECO:0000269|PubMed:16601204, ECO:0000269|PubMed:18066079}.","mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of translation [GO:0045727]; RNA export from nucleus [GO:0006405]",mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of nuclear pore [GO:0017056],SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Note=Shuttling between the nucleus and the cytoplasm.,"SUBUNIT: Found in a post-splicing messenger ribonucleoprotein (mRNP) complex. Core component of the mRNA splicing-dependent exon junction complex (EJC); the core complex contains CASC3, EIF4A3, MAGOH or MAGOHB, and RBM8A. The EJC core components EIF4A3 and the MAGOH-RBM8A dimer form a composite binding site for UPF3B which overlaps with the EJC binding site for WIBG (PubMed:16601204, PubMed:18066079, PubMed:23917022, PubMed:20479275). Interacts with EST1A, UPF2 and RBM8A (PubMed:12554878, PubMed:18066079, PubMed:15004547). Interacts with CPSF6 (PubMed:19864460). {ECO:0000269|PubMed:11113196, ECO:0000269|PubMed:11163187, ECO:0000269|PubMed:11546873, ECO:0000269|PubMed:11546874, ECO:0000269|PubMed:12554878, ECO:0000269|PubMed:12718880, ECO:0000269|PubMed:15004547, ECO:0000269|PubMed:16209946, ECO:0000269|PubMed:16601204, ECO:0000269|PubMed:18066079, ECO:0000269|PubMed:19864460, ECO:0000269|PubMed:20479275, ECO:0000269|PubMed:23917022}.",X,119805311,119852998,q24,0.98497,0.292,-0.4498,1.8439,21.553,0.5505050505050505,ENST00000276201,0.8978650137741047,0.17558110472381905,1452,,,,,,,0.25760593086484607,5.294470039117663,Cerebellar_tissues,broadly expressed,3.6887958070246314,5.294470039117663,TRUE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:20476,DUSP21,dual specificity phosphatase 21,Approved,,,Xp11.3,gene with protein product,protein-coding gene,ENSG00000189037,63904,ENSG00000189037,Q9H596,MGI:1920797,RGD:1560427,X,300678,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Can dephosphorylate single and diphosphorylated synthetic MAPK peptides, with preference for the phosphotyrosine and diphosphorylated forms over phosphothreonine.",peptidyl-tyrosine dephosphorylation [GO:0035335],MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; protein tyrosine phosphatase activity [GO:0004725],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12408986}. Nucleus {ECO:0000269|PubMed:12408986}. Mitochondrion inner membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}; Matrix side {ECO:0000250}.,"",X,44844021,44844888,p11.3,3.235e-4,1.957,1.7525,0.52005,1.8005,0.4264753989120031,ENST00000339042,0.6006980802792321,0.18132966758310423,573,1,"DUSP18 (68, 69, chr22)",TRUE,,,,0.9767441860465116,4.420489139250487,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:20564,MBNL3,muscleblind like splicing regulator 3,Approved,,"CHCR, FLJ11316, MBLX39, MBXL",Xq26.2,gene with protein product,protein-coding gene,ENSG00000076770,55796,ENSG00000076770,Q9NUK0,MGI:2444912,RGD:1565834,X,300413,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Mediates pre-mRNA alternative splicing regulation. Acts either as activator or repressor of splicing on specific pre-mRNA targets. Inhibits cardiac troponin-T (TNNT2) pre-mRNA exon inclusion but induces insulin receptor (IR) pre-mRNA exon inclusion in muscle. Antagonizes the alternative splicing activity pattern of CELF proteins. May play a role in myotonic dystrophy pathophysiology (DM). Could inhibit terminal muscle differentiation, acting at approximately the time of myogenin induction. {ECO:0000269|PubMed:12297108, ECO:0000269|PubMed:15257297}.","mRNA processing [GO:0006397]; multicellular organism development [GO:0007275]; negative regulation of myoblast differentiation [GO:0045662]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]",metal ion binding [GO:0046872]; RNA binding [GO:0003723],"SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11929853}. Cytoplasm {ECO:0000269|PubMed:11929853}. Note=Greater concentration in the nucleus. In both DM1 and DM2 patients, colocalizes with nuclear foci of retained expanded-repeat transcripts.","",X,132369317,132489968,q26.2,0.68597,0.505,1.9557,1.3888,12.465,0.2297809348107069,ENST00000370857,0.9109815354713314,0.272831792051987,1029,2,"MBNL1 (67, 60, chr3); MBNL2 (63, 60, chr13)",TRUE,,,,0.5354308728383269,4.313746499103899,Testis,broadly expressed,0.5575581141393582,0.11589746875890046,FALSE,low confidence non-escapee,no_difference_Pre_Post,Pre_higher_vs_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:2063,CLIC2,chloride intracellular channel 2,Approved,,"XAP121, CLCNL2",Xq28,gene with protein product,protein-coding gene,ENSG00000155962,1193,ENSG00000155962,O15247,,RGD:1306580,X,300138,TRUE,,,,"?Mental retardation, X-linked, syndromic 32",300886,X-linked recessive,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,PMT +CS,FALSE,,PMT,"FUNCTION: Can insert into membranes and form chloride ion channels. Channel activity depends on the pH. Membrane insertion seems to be redox-regulated and may occur only under oxydizing conditions. Modulates the activity of RYR2 and inhibits calcium influx. {ECO:0000269|PubMed:15147738, ECO:0000269|PubMed:15916532, ECO:0000269|PubMed:17945253}.",negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; positive regulation of binding [GO:0051099]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; signal transduction [GO:0007165],chloride channel activity [GO:0005254]; glutathione peroxidase activity [GO:0004602]; voltage-gated ion channel activity [GO:0005244],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15916532}. Membrane {ECO:0000305|PubMed:15916532}; Single-pass membrane protein {ECO:0000305|PubMed:15916532}. Note=Exists both as soluble cytoplasmic protein and as membrane protein with probably a single transmembrane domain.,"SUBUNIT: Monomer. Interacts with TRAPPC2 and RYR2. {ECO:0000269|PubMed:12681486, ECO:0000269|PubMed:15147738, ECO:0000269|PubMed:15916532, ECO:0000269|PubMed:17945253}.",X,155276211,155334657,q28,0.049547,1.086,0.11811,1.2706,7.1263,0.11198134522531306,ENST00000369449,0.7935483870967742,0.18110472381904524,744,2,"CLIC4 (62, 60, chr1); CLIC1 (59, 60, chr6)",TRUE,,,,0.3762004255083259,5.496411216475492,Lung,broadly expressed,2.1742849636798853,1.8383104266253605,FALSE,high confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,no difference_Post1_Post2,PMT
HGNC:20672,PHF8,PHD finger protein 8,Approved,,"ZNF422, KIAA1111, JHDM1F, KDM7B",Xp11.22,gene with protein product,protein-coding gene,ENSG00000172943,23133,ENSG00000172943,Q9UPP1,MGI:2444341,RGD:1561065,X,300560,TRUE,"Mental retardation syndrome, X-linked, Siderius type",300263,X-linked recessive,,,,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Histone lysine demethylase with selectivity for the di- and monomethyl states that plays a key role cell cycle progression, rDNA transcription and brain development. Demethylates mono- and dimethylated histone H3 'Lys-9' residue (H3K9Me1 and H3K9Me2), dimethylated H3 'Lys-27' (H3K27Me2) and monomethylated histone H4 'Lys-20' residue (H4K20Me1). Acts as a transcription activator as H3K9Me1, H3K9Me2, H3K27Me2 and H4K20Me1 are epigenetic repressive marks. Involved in cell cycle progression by being required to control G1-S transition. Acts as a coactivator of rDNA transcription, by activating polymerase I (pol I) mediated transcription of rRNA genes. Required for brain development, probably by regulating expression of neuron-specific genes. Only has activity toward H4K20Me1 when nucleosome is used as a substrate and when not histone octamer is used as substrate. May also have weak activity toward dimethylated H3 'Lys-36' (H3K36Me2), however, the relevance of this result remains unsure in vivo. Specifically binds trimethylated 'Lys-4' of histone H3 (H3K4me3), affecting histone demethylase specificity: has weak activity toward H3K9Me2 in absence of H3K4me3, while it has high activity toward H3K9me2 when binding H3K4me3. {ECO:0000269|PubMed:19843542, ECO:0000269|PubMed:20023638, ECO:0000269|PubMed:20101266, ECO:0000269|PubMed:20208542, ECO:0000269|PubMed:20346720, ECO:0000269|PubMed:20421419, ECO:0000269|PubMed:20531378, ECO:0000269|PubMed:20548336, ECO:0000269|PubMed:20622853, ECO:0000269|PubMed:20622854}.","brain development [GO:0007420]; G1/S transition of mitotic cell cycle [GO:0000082]; histone H3-K27 demethylation [GO:0071557]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; histone H4-K20 demethylation [GO:0035574]; negative regulation of ribosomal DNA heterochromatin assembly [GO:0061188]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase I [GO:0045943]",2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; chromatin binding [GO:0003682]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K27 specific) [GO:0071558]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K9 specific) [GO:0032454]; histone demethylase activity (H4-K20 specific) [GO:0035575]; iron ion binding [GO:0005506]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270],"SUBCELLULAR LOCATION: Nucleus. Nucleus, nucleolus. Note=Recruited to H3K4me3 sites on chromatin during interphase. Dissociates from chromatin when cells enter mitosis.","SUBUNIT: Interacts with POLR1B, UBTF, SETD1A, HCFC1, E2F1 and ZNF711. {ECO:0000269|PubMed:20023638, ECO:0000269|PubMed:20101266, ECO:0000269|PubMed:20208542, ECO:0000269|PubMed:20346720, ECO:0000269|PubMed:20622854}.",X,53936676,54048958,p11.22,0.99785,0.263,0.43027,3.9759,40.013,0.6492463916377065,ENST00000338154,0.9165528455284553,0.19442639340164958,3075,,,,,,,0.3296849003137215,5.916756079824044,Testis,broadly expressed,2.4289650983435753,4.114579415342483,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:20686,PASD1,PAS domain containing repressor 1,Approved,,CT63,Xq28,gene with protein product,protein-coding gene,ENSG00000166049,139135,ENSG00000166049,Q8IV76,,RGD:7496877,X,300993,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Functions as a suppressor of the biological clock that drives the daily circadian rhythms of cells throughout the body (PubMed:25936801). Acts as a nuclear repressor of the CLOCK-ARNTL/BMAL1 heterodimer-mediated transcriptional activation of the core clock components (PubMed:25936801). Inhibits circadian clock function in cancer cells, when overexpressed (PubMed:25936801). {ECO:0000269|PubMed:25936801}.","negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; rhythmic process [GO:0048511]",DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription factor inhibitor activity [GO:0140416],SUBCELLULAR LOCATION: [Isoform 1]: Nucleus {ECO:0000269|PubMed:25936801}. Note=Associates preferentially at the periphery of the nucleus with heterochromatin (PubMed:25936801). {ECO:0000269|PubMed:25936801}.; SUBCELLULAR LOCATION: [Isoform 2]: Nucleus {ECO:0000269|PubMed:25936801}. Note=Associates preferentially at the periphery of the nucleus with heterochromatin (PubMed:25936801). {ECO:0000269|PubMed:25936801}.,SUBUNIT: Interacts with the CLOCK-ARNTL/BMAL1 heterodimer; this interaction inhibits CLOCK-ARNTL/BMAL1 transcriptional activation and suppress circadian timekeeping (PubMed:25936801). Interacts with ARNTL/BMAL1 (PubMed:25936801). {ECO:0000269|PubMed:25936801}.,X,151563675,151676739,q28,0.82307,0.379,-1.0515,-0.81232,27.708,0.4603863152725487,ENST00000370357,0.09242032730404824,0.06224799779066556,2322,,,,,,,0.9767441860465116,4.974781670268907,Testis,tissue-specific,0,0,FALSE,low confidence escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:20694,SPIN2A,spindlin family member 2A,Approved,SPIN2,"DXF34, TDRD25",Xp11.21,gene with protein product,protein-coding gene,ENSG00000147059,54466,ENSG00000147059,Q99865,"MGI:1922101, MGI:3645574, MGI:3645924, MGI:3647272, MGI:3650966, MGI:3705652, MGI:3781026, MGI:3781070, MGI:3781932, MGI:3805546, MGI:5434821, MGI:5434847, MGI:5434992",RGD:1560898,X,300621,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: May be involved in the regulation of cell cycle progression (By similarity). Exhibits H3K4me3-binding activity (PubMed:29061846). {ECO:0000250|UniProtKB:Q9BPZ2, ECO:0000269|PubMed:29061846}.","cell cycle [GO:0007049]; gamete generation [GO:0007276]; regulation of cell cycle [GO:0051726]; regulation of transcription, DNA-templated [GO:0006355]",methylated histone binding [GO:0035064],SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q9BPZ2}.,SUBUNIT: Interacts with C11orf84/SPINDOC (PubMed:29061846). {ECO:0000269|PubMed:29061846}.,X,57134530,57137625,p11.21,0.0011466,1.881,-0.62415,-1.0334,3.4956,0.292516029617248,ENST00000374908,0.9404118404118404,0.29792551862034494,777,4,"SPIN2B (100, 100, chrX); SPIN1 (78, 77, chr9); SPIN3 (74, 74, chrX); SPIN4 (64, 66, chrX)",TRUE,1,"SPIN2B (100, 100, chrX)",TRUE,0.6858776500292642,0.9280299110655523,Cerebellar_tissues,tissue-specific,0.1817640982131741,0.9280299110655523,TRUE,high confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:20715,MID1IP1,MID1 interacting protein 1,Approved,,"STRAIT11499, FLJ10386, MIG12, THRSPL, G12-like",Xp11.4,gene with protein product,protein-coding gene,ENSG00000165175,58526,ENSG00000165175,Q9NPA3,MGI:1915291,RGD:1303258,X,300961,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Plays a role in the regulation of lipogenesis in liver. Up-regulates ACACA enzyme activity. Required for efficient lipid biosynthesis, including triacylglycerol, diacylglycerol and phospholipid. Involved in stabilization of microtubules (By similarity). {ECO:0000250}.",carnitine shuttle [GO:0006853]; lipid metabolic process [GO:0006629]; negative regulation of microtubule depolymerization [GO:0007026]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of ligase activity [GO:0051351]; protein polymerization [GO:0051258]; regulation of lipid biosynthetic process [GO:0046890],identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022],"SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q9CQ20}. Cytoplasm {ECO:0000250|UniProtKB:Q9CQ20}. Cytoplasm, cytoskeleton {ECO:0000250|UniProtKB:Q9CQ20}. Note=Associated with microtubules. {ECO:0000250|UniProtKB:Q9CQ20}.",SUBUNIT: Homodimer in the absence of THRSP. Heterodimer with THRSP. The homodimer interacts with ACACA and ACACB. Promotes polymerization of Acetyl-CoA carboxylase to form complexes that contain MID1IP1 and ACACA and/or ACACB. Interaction with THRSP interferes with ACACA binding (By similarity). {ECO:0000250}.,X,38801432,38806537,p11.4,0.57733,1.095,-1.9401,0.23495,2.653,0.3941530636045797,ENST00000614558,0.8795289855072463,0.1552111972006998,552,,,,,,,0.17479981445829196,6.047582010958266,Nerve - Tibial,broadly expressed,5.8277377437338425,4.141915025643036,FALSE,low confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:20794,ERCC6L,"ERCC excision repair 6 like, spindle assembly checkpoint helicase",Approved,,"FLJ20105, PICH, RAD26L",Xq13.1,gene with protein product,protein-coding gene,ENSG00000186871,54821,ENSG00000186871,Q2NKX8,MGI:2654144,RGD:1565734,X,300687,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: DNA helicase that acts as an essential component of the spindle assembly checkpoint. Contributes to the mitotic checkpoint by recruiting MAD2 to kinetochores and monitoring tension on centromeric chromatin (PubMed:17218258). Acts as a tension sensor that associates with catenated DNA which is stretched under tension until it is resolved during anaphase (PubMed:17218258, PubMed:23973328). Functions as ATP-dependent DNA translocase (PubMed:23973328, PubMed:28977671). Can promote Holliday junction branch migration (in vitro) (PubMed:23973328). {ECO:0000269|PubMed:17218258, ECO:0000269|PubMed:23973328, ECO:0000269|PubMed:28977671}.",cell cycle [GO:0007049]; cell division [GO:0051301],ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616],"SUBCELLULAR LOCATION: Chromosome, centromere {ECO:0000269|PubMed:17218258, ECO:0000269|PubMed:17989990}. Chromosome, centromere, kinetochore {ECO:0000269|PubMed:17218258}. Chromosome {ECO:0000269|PubMed:17218258, ECO:0000269|PubMed:17671160, ECO:0000269|PubMed:17989990}. Note=Localizes to kinetochores, inner centromeres and thin threads connecting separating chromosomes even during anaphase. In prometaphase cells, it mostly concentrates in between kinetochores. In metaphase, it localizes to numerous thin threads that stretch between sister kinetochores of the aligned chromosomes and are composed of catenated centromeric DNA. Evolution from inner centromeres to thin threads takes place in response to tension. Resolution of thin threads requires topoisomerase 2-alpha (TOP2A) after anaphase onset. {ECO:0000269|PubMed:17218258, ECO:0000269|PubMed:17671160, ECO:0000269|PubMed:17956945, ECO:0000269|PubMed:17989990}.","SUBUNIT: Interacts with PLK1, which phosphorylates it (PubMed:17218258, PubMed:17671160, PubMed:28977671). Both proteins are mutually dependent on each other for correct subcellular localization (PubMed:17218258, PubMed:17671160). Interacts (via N-terminal TPR repeat) with BEND3 (via BEN domains 1 and 3); the interaction is direct (PubMed:28977671). {ECO:0000269|PubMed:17218258, ECO:0000269|PubMed:17671160, ECO:0000269|PubMed:28977671}.",X,72204657,72239027,q13.1,0.99932,0.211,1.4104,2.8905,29.852,0.5622901748060926,ENST00000334463,0.6279776179056754,0.06503374156460885,3753,,,,,,,0.8404120311052019,3.36676282471395,Cells - EBV-transformed lymphocytes,tissue-specific,0.07744974761526177,0.48897766660285386,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:20893,BCOR,BCL6 corepressor,Approved,,"FLJ20285, KIAA1575",Xp11.4,gene with protein product,protein-coding gene,ENSG00000183337,54880,ENSG00000183337,Q6W2J9,MGI:1918708,RGD:1562735,X,300485,TRUE,"Microphthalmia, syndromic 2",300166,X-linked dominant,,,,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Transcriptional corepressor. May specifically inhibit gene expression when recruited to promoter regions by sequence-specific DNA-binding proteins such as BCL6 and MLLT3. This repression may be mediated at least in part by histone deacetylase activities which can associate with this corepressor. Involved in the repression of TFAP2A; impairs binding of BCL6 and KDM2B to TFAP2A promoter regions. Via repression of TFAP2A acts as a negative regulator of osteo-dentiogenic capacity in adult stem cells; the function implies inhibition of methylation on histone H3 'Lys-4' (H3K4me3) and 'Lys-36' (H3K36me2). {ECO:0000269|PubMed:10898795, ECO:0000269|PubMed:15004558, ECO:0000269|PubMed:18280243, ECO:0000269|PubMed:19578371, ECO:0000269|PubMed:23911289}.","blastocyst hatching [GO:0001835]; heart development [GO:0007507]; histone H2A monoubiquitination [GO:0035518]; negative regulation of bone mineralization [GO:0030502]; negative regulation of histone H3-K36 methylation [GO:0000415]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of tooth mineralization [GO:0070171]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; odontogenesis [GO:0042476]; roof of mouth development [GO:0060021]; specification of axis polarity [GO:0065001]",heat shock protein binding [GO:0031072]; histone deacetylase binding [GO:0042826]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976],SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10898795}.,"SUBUNIT: Interacts with BCL6; the interaction is direct (PubMed:10898795). Forms ternary complexes with BCL6 and SMRT/NCOR2 on selected target genes promoters; potently repress expression (PubMed:23911289, PubMed:18280243). Can interact with HDAC1, HDAC3 and HDAC5 (PubMed:10898795). Interacts with PCGF1; the interaction is direct (PubMed:16943429, PubMed:23523425, PubMed:26687479). Interacts with KDM2B. Component of an approximately 800 kDa repressive BCOR complex at least composed of BCOR, RYBP, PCGF1, RING1, RNF2/RING2, KDM2B and SKP1 (PubMed:16943429). Interacts with CPNE4 (via VWFA domain) (By similarity). Isoform 1 may interact with MLLT3/AF9 (By similarity). {ECO:0000250|UniProtKB:Q8CGN4, ECO:0000269|PubMed:10898795, ECO:0000269|PubMed:16943429, ECO:0000269|PubMed:18280243, ECO:0000269|PubMed:23523425, ECO:0000269|PubMed:23911289, ECO:0000269|PubMed:26687479}.",X,40049815,40177329,p11.4,1,0.141,-0.59791,1.8797,44.56,0.8760154932238815,ENST00000378444,0.8388382687927107,0.538815296175956,5268,,,,,,,0.28034665427678795,4.804858962785817,Artery - Tibial,broadly expressed,1.8289118077306312,2.9814371338094725,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:20985,VGLL1,vestigial like family member 1,Approved,,"TONDU, TDU",Xq26.3,gene with protein product,protein-coding gene,ENSG00000102243,51442,ENSG00000102243,Q99990,MGI:2655768,RGD:1564038,X,300583,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May act as a specific coactivator for the mammalian TEFs. {ECO:0000269|PubMed:10518497}.,"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]",transcription coactivator activity [GO:0003713],SUBCELLULAR LOCATION: Nucleus.,SUBUNIT: Interacts with TEFs. {ECO:0000269|PubMed:10518497}.,X,136532215,136556807,q26.3,0.81365,0.539,-0.59235,0.49389,5.5506,0.12363327280454352,ENST00000370634,0.29382239382239383,0.11144713821544613,777,,,,,,,0.8773500712386447,2.527866051188997,Kidney - Medulla,tissue-specific,0,0,FALSE,high confidence escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:21039,ZNF449,zinc finger protein 449,Approved,,"ZSCAN19, FLJ23614",Xq26.3,gene with protein product,protein-coding gene,ENSG00000173275,203523,ENSG00000173275,Q6P9G9,MGI:1925869,RGD:1584453,X,300627,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May be involved in transcriptional regulation.,spermatogonial cell division [GO:0007284],metal ion binding [GO:0046872]; sequence-specific double-stranded DNA binding [GO:1990837],SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00187}.,"",X,135344796,135363413,q26.3,0.66997,0.465,0.57863,2.3285,16.673,0.5354664568512386,ENST00000339249,0.46229929351316634,0.05816045988502874,1557,,,,,,,0.26721771751620493,3.5715069283917313,Nerve - Tibial,broadly expressed,1.6607598013616385,2.694789951908762,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:21152,LONRF3,LON peptidase N-terminal domain and ring finger 3,Approved,RNF127,FLJ22612,Xq24,gene with protein product,protein-coding gene,ENSG00000175556,79836,ENSG00000175556,Q496Y0,MGI:1921615,RGD:1565451,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","",metal ion binding [GO:0046872],"","",X,118974614,119018355,q24,0.41779,0.463,-0.51753,1.2729,22.711,0.6748971193415638,ENST00000371628,0.6904385964912281,0.24766308422894276,2280,,,,,,,0.5541752933621226,3.7183177828878287,Thyroid,broadly expressed,0.6153437840057341,2.9521639372133563,FALSE,high confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:21153,RNF128,ring finger protein 128,Approved,,"FLJ23516, GRAIL",Xq22.3,gene with protein product,protein-coding gene,ENSG00000133135,79589,ENSG00000133135,Q8TEB7,MGI:1914139,RGD:1566282,X,300439,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: E3 ubiquitin-protein ligase that catalyzes 'Lys-48'- and 'Lys-63'-linked polyubiquitin chains formation. Functions as an inhibitor of cytokine gene transcription. Inhibits IL2 and IL4 transcription, thereby playing an important role in the induction of the anergic phenotype, a long-term stable state of T-lymphocyte unresponsiveness to antigenic stimulation associated with the blockade of interleukin production. Ubiquitinates ARPC5 with 'Lys-48' linkages and COR1A with 'Lys-63' linkages leading to their degradation, down-regulation of these cytosleletal components results in impaired lamellipodium formation and reduced accumulation of F-actin at the immunological synapse. Functions in the patterning of the dorsal ectoderm; sensitizes ectoderm to respond to neural-inducing signals. {ECO:0000269|PubMed:12705856, ECO:0000269|PubMed:22016387}.",negative regulation of cytokine biosynthetic process [GO:0042036]; positive regulation of protein catabolic process in the vacuole [GO:1904352]; protein deubiquitination [GO:0016579]; protein localization to lysosome [GO:0061462]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511],metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630],"SUBCELLULAR LOCATION: Endomembrane system {ECO:0000250}; Single-pass membrane protein {ECO:0000250}. Cytoplasm, cytoskeleton {ECO:0000269|PubMed:12705856, ECO:0000269|PubMed:22016387}. Cytoplasm, perinuclear region {ECO:0000250}. Note=Localized in an asymmetric perinuclear punctate manner. Localizes to the internal pool of the transferrin recycling endosomal pathway. Partially colocalized with the endoplasmic reticulum resident HSPA5, with Golgi resident STX5, and with the late endosomal GTPase RAB7A (By similarity). {ECO:0000250}.","",X,106693794,106797016,q22.3,0.22826,0.672,0.70743,0.66552,11.546,0.5182740496271849,ENST00000255499,0.8015540015540016,0.2596600849787553,1287,,,,,,,0.6809069736751103,5.1563642543001755,Adrenal Gland,tissue-specific,1.7118340653097877,0.8598173219531188,FALSE,low confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:21165,RAP2C,"RAP2C, member of RAS oncogene family",Approved,,DKFZp313B211,Xq26.2,gene with protein product,protein-coding gene,ENSG00000123728,57826,ENSG00000123728,Q9Y3L5,MGI:1919315,RGD:1588562,X,301016,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Small GTP-binding protein which cycles between a GDP-bound inactive and a GTP-bound active form. May play a role in cytoskeletal rearrangements and regulate cell spreading through activation of the effector TNIK. May play a role in SRE-mediated gene transcription. {ECO:0000269|PubMed:17447155}.,establishment of endothelial intestinal barrier [GO:0090557]; negative regulation of cell migration [GO:0030336]; neutrophil degranulation [GO:0043312]; positive regulation of protein autophosphorylation [GO:0031954]; Rap protein signal transduction [GO:0032486]; regulation of protein tyrosine kinase activity [GO:0061097],GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; transcription coactivator activity [GO:0003713],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17447155}. Recycling endosome membrane {ECO:0000250}; Lipid-anchor {ECO:0000250}; Cytoplasmic side {ECO:0000250}.,"",X,132203024,132219480,q26.2,0.29631,1.186,-1.0685,1.7292,3.9372,0.5761334565857643,ENST00000370874,0.9856884057971015,0.19090227443139215,552,4,"RAP2A (91, 91, chr13); RAP2B (86, 86, chr3); RAP1A (62, 61, chr1); RAP1B (61, 61, chr12)",TRUE,2,"RAP2A (91, 91, chr13); RAP2B (86, 86, chr3)",TRUE,0.4286407965587989,7.690074819955942,Uterus,broadly expressed,3.273432339276342,3.1666190478679828,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,no difference_Pre_Post2,Post2_higher_vs_Post1,no disorder
HGNC:21167,PDZD4,PDZ domain containing 4,Approved,PDZK4,"KIAA1444, LU1, FLJ34125, PDZRN4L, LNX5",Xq28,gene with protein product,protein-coding gene,ENSG00000067840,57595,ENSG00000067840,Q76G19,MGI:2443483,RGD:1561214,X,300634,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","SUBCELLULAR LOCATION: Cytoplasm, cell cortex {ECO:0000269|PubMed:15077175}. Note=Mainly localized under the plasma membrane.","",X,153802166,153830565,q28,0.84853,0.4,0.48506,2.704,19.386,0.7026885474860335,ENST00000393758,0.7517611683848797,0.07763059235191203,2328,,,,,,,0.5936437064542578,8.636020954757242,Cerebellar_tissues,broadly expressed,7.524416343013338,8.636020954757242,TRUE,discordant,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:21188,MAGEB16,MAGE family member B16,Approved,,,Xp21.1,gene with protein product,protein-coding gene,ENSG00000189023,139604,ENSG00000189023,A2A368,MGI:1919217,RGD:1562365,X,300762,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,35798342,35803735,p21.1,0.37021,1.774,-0.14913,0.57724,0.80152,0.3412218675232757,ENST00000399988,0.10287179487179487,0.013196700824793801,975,,,,,,,0.9767441860465116,2.468617201045285,Testis,tissue-specific,0,0,FALSE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:2149,CNGA2,cyclic nucleotide gated channel subunit alpha 2,Approved,"CNCA1, CNCA","CNG2, OCNC1, OCNCa, OCNCALPHA, OCNCalpha, FLJ46312",Xq28,gene with protein product,protein-coding gene,ENSG00000183862,1260,ENSG00000183862,Q16280,MGI:108040,RGD:2367,X,300338,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Odorant signal transduction is probably mediated by a G-protein coupled cascade using cAMP as second messenger. The olfactory channel can be shown to be activated by cyclic nucleotides which leads to a depolarization of olfactory sensory neurons.,response to stimulus [GO:0050896]; sensory perception of smell [GO:0007608],calmodulin binding [GO:0005516]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; intracellular cAMP-activated cation channel activity [GO:0005222]; intracellular cGMP-activated cation channel activity [GO:0005223],SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.,"SUBUNIT: Heterotetramer composed of two subunits of CNGA2, one of CNGA4 and one of CNGB1b. The complex forms the cyclic nucleotide-gated (CNG) channel of olfactory sensory neurons (By similarity). {ECO:0000250}.",X,151738451,151745304,q28,9.8232e-4,0.787,-0.29378,-0.028456,18.34,0.12845081375326334,ENST00000329903,0.8643107769423559,0.1277180704823794,1995,2,"CNGA3 (62, 59, chr2); CNGA1 (58, 56, chr4)",TRUE,,,,0.9767441860465116,0.5322800498085875,Testis,tissue-specific,0,0,FALSE,low confidence escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:21731,PGAM4,phosphoglycerate mutase family member 4,Approved,,"dJ1000K24.1, PGAM3, PGAM-B, PGAM1",Xq21.1,gene with protein product,protein-coding gene,ENSG00000226784,441531,ENSG00000226784,Q8N0Y7,,,X,300567,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",glycolytic process [GO:0006096]; positive regulation of flagellated sperm motility [GO:1902093],bisphosphoglycerate mutase activity [GO:0004082]; hydrolase activity [GO:0016787]; phosphoglycerate mutase activity [GO:0004619],"","",X,77967949,77969638,q21.1,,,1.0011,0.19946,,0.29922626793906615,ENST00000458128,0.8916339869281046,0.33519120219945014,765,2,"PGAM1 (96, 96, chr10); PGAM2 (78, 78, chr7)",TRUE,1,"PGAM1 (96, 96, chr10)",TRUE,0.7733864006510456,0.9252041985332038,Cells - EBV-transformed lymphocytes,tissue-specific,0.12616686219529885,0.1876569123970733,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:2207,COL4A5,collagen type IV alpha 5 chain,Approved,"ASLN, ATS",,Xq22.3,gene with protein product,protein-coding gene,ENSG00000188153,1287,ENSG00000188153,P29400,MGI:88456,RGD:1565499,X,303630,TRUE,"Alport syndrome 1, X-linked",301050,X-linked dominant,,,,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,TRUE,confirmed,"FUNCTION: Type IV collagen is the major structural component of glomerular basement membranes (GBM), forming a 'chicken-wire' meshwork together with laminins, proteoglycans and entactin/nidogen.",collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; extracellular matrix organization [GO:0030198]; neuromuscular junction development [GO:0007528],extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020],"SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular matrix, basement membrane.","SUBUNIT: There are six type IV collagen isoforms, alpha 1(IV)-alpha 6(IV), each of which can form a triple helix structure with 2 other chains to generate type IV collagen network.",X,108439838,108697545,q22.3,1,0.191,-0.35551,2.4995,61.945,0.38662486938349006,ENST00000328300,0.8379038613081167,0.3556360909772557,5076,1,"COL4A1 (53, 54, chr13)",TRUE,,,,0.4877287686420515,7.381015092125051,Esophagus - Gastroesophageal Junction,broadly expressed,3.1237506105136497,1.6345351877661503,FALSE,low confidence non-escapee,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:2208,COL4A6,collagen type IV alpha 6 chain,Approved,,,Xq22.3,gene with protein product,protein-coding gene,ENSG00000197565,1288,ENSG00000197565,Q14031,MGI:2152695,RGD:1589724,X,303631,TRUE,,,,"?Deafness, X-linked 6",300914,X-linked recessive,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PMT +CS,FALSE,,PMT,"FUNCTION: Type IV collagen is the major structural component of glomerular basement membranes (GBM), forming a 'chicken-wire' meshwork together with laminins, proteoglycans and entactin/nidogen.",cell adhesion [GO:0007155]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; extracellular matrix organization [GO:0030198],extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020],"SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular matrix, basement membrane.","SUBUNIT: There are six type IV collagen isoforms, alpha 1(IV)-alpha 6(IV), each of which can form a triple helix structure with 2 other chains to generate type IV collagen network.",X,108155607,108439497,q22.3,0.89901,0.322,-0.22956,1.4821,60.309,0.4157209016154914,ENST00000334504,0.6581707076680465,0.34948762809297673,5073,,,,,,,0.6899652835546304,7.545860286447113,Esophagus - Gastroesophageal Junction,tissue-specific,0.1919668518775649,0.14773312636822103,FALSE,variable escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,PMT
HGNC:22082,VMA21,vacuolar ATPase assembly factor VMA21,Approved,MEAX,XMEA,Xq28,gene with protein product,protein-coding gene,ENSG00000160131,203547,ENSG00000160131,Q3ZAQ7,MGI:1914298,RGD:1566155,X,300913,TRUE,"Myopathy, X-linked, with excessive autophagy",310440,X-linked recessive,,,,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Required for the assembly of the V0 complex of the vacuolar ATPase (V-ATPase) in the endoplasmic reticulum. {ECO:0000255|HAMAP-Rule:MF_03058, ECO:0000269|PubMed:19379691}.",regulation of ATPase activity [GO:0043462]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072],"","SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000255|HAMAP-Rule:MF_03058, ECO:0000269|PubMed:19379691, ECO:0000269|PubMed:23315026}; Multi-pass membrane protein {ECO:0000255|HAMAP-Rule:MF_03058}. Endoplasmic reticulum-Golgi intermediate compartment membrane {ECO:0000255|HAMAP-Rule:MF_03058, ECO:0000269|PubMed:19379691, ECO:0000269|PubMed:23315026}; Multi-pass membrane protein {ECO:0000255|HAMAP-Rule:MF_03058}. Cytoplasmic vesicle, COPII-coated vesicle membrane {ECO:0000255|HAMAP-Rule:MF_03058, ECO:0000269|PubMed:19379691, ECO:0000269|PubMed:23315026}; Multi-pass membrane protein {ECO:0000255|HAMAP-Rule:MF_03058}.",SUBUNIT: Associates with the V0 complex of the vacuolar ATPase (V-ATPase) (PubMed:29127204). Interacts with ATP6AP2 (PubMed:29127204). {ECO:0000269|PubMed:29127204}.,X,151396515,151409364,q28,0.57236,1.112,-1.2595,0.77586,2.6052,0.6111797528019733,ENST00000330374,0.9,0.1438140464883779,306,,,,,,,0.20268695207198154,4.73687542290827,Cells - Cultured fibroblasts,broadly expressed,3.980262987065218,4.663982133755994,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:22263,SSX2B,SSX family member 2B,Approved,,CT5.2b,Xp11.22,gene with protein product,protein-coding gene,ENSG00000268447,727837,ENSG00000268447,Q16385,,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Could act as a modulator of transcription.,"regulation of transcription, DNA-templated [GO:0006355]",nucleic acid binding [GO:0003676],SUBCELLULAR LOCATION: Nucleus.,SUBUNIT: Interacts via its N-terminal region with RAB3IP and SSX2IP. {ECO:0000269|PubMed:12007189}.,X,52751132,52790305,p11.22,,,,,,0.44354525724112837,ENST00000596480,0.09664902998236331,0.09775056235941015,567,7,"SSX2 (100, 100, chrX); SSX3 (64, 70, chrX); SSX7 (61, 72, chrX); SSX5 (61, 59, chrX); SSX4 (56, 66, chrX); SSX4B (56, 66, chrX); SSX1 (54, 64, chrX)",TRUE,1,"SSX2 (100, 100, chrX)",TRUE,0.9767441860465116,0.16571774474011017,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:22282,TCEAL5,transcription elongation factor A like 5,Approved,,WEX4,Xq22.1,gene with protein product,protein-coding gene,ENSG00000204065,340543,ENSG00000204065,Q5H9L2,MGI:3036236,RGD:1594149,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May be involved in transcriptional regulation.,"",WW domain binding [GO:0050699],SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.,"",X,103273691,103276750,q22.1,0.72911,0.694,-1.2375,1.1208,4.3116,0.28607699047006024,ENST00000372680,0.1426731078904992,0.11202199450137466,621,2,"TCEAL3 (88, 90, chrX); TCEAL6 (78, 87, chrX)",TRUE,1,"TCEAL3 (88, 90, chrX)",TRUE,0.7451459769713821,7.360004260250156,Cerebellar_tissues,tissue-specific,6.057523921402164,7.360004260250156,TRUE,,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,no difference_Post1_Post2,no disorder
HGNC:22516,H2AB1,H2A.B variant histone 1,Approved,H2AFB1,,Xq28,gene with protein product,protein-coding gene,ENSG00000274183,474382,ENSG00000274183,P0C5Y9,"MGI:3642445, MGI:3644875, MGI:3644980",,X,301037,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Atypical histone H2A which can replace conventional H2A in some nucleosomes and is associated with active transcription and mRNA processing (PubMed:22795134). Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability (PubMed:15257289, PubMed:16287874, PubMed:16957777, PubMed:17591702, PubMed:17726088, PubMed:18329190, PubMed:22795134). Nucleosomes containing this histone are less rigid and organize less DNA than canonical nucleosomes in vivo (PubMed:15257289, PubMed:16957777, PubMed:17591702, PubMed:24336483). They are enriched in actively transcribed genes and associate with the elongating form of RNA polymerase (PubMed:17591702, PubMed:24753410). They associate with spliceosome components and are required for mRNA splicing (PubMed:22795134). {ECO:0000269|PubMed:15257289, ECO:0000269|PubMed:16287874, ECO:0000269|PubMed:16957777, ECO:0000269|PubMed:17591702, ECO:0000269|PubMed:17726088, ECO:0000269|PubMed:18329190, ECO:0000269|PubMed:22795134, ECO:0000269|PubMed:24336483, ECO:0000269|PubMed:24753410}.",chromatin organization [GO:0006325]; chromatin silencing [GO:0006342]; mRNA processing [GO:0006397]; nucleosome assembly [GO:0006334],DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982],"SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:20008104, ECO:0000269|PubMed:24336483}. Chromosome {ECO:0000269|PubMed:20008104, ECO:0000269|PubMed:22795134, ECO:0000269|PubMed:24336483}. Note=Associated with the active X chromosome and with autosomes, while it is absent from the inactive X chromosome and excluded from Barr bodies. {ECO:0000269|PubMed:20008104}.","SUBUNIT: The nucleosome is a histone octamer containing two molecules each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and two H2A-H2B heterodimers. May be incorporated into a proportion of nucleosomes, replacing one or more H2A molecules. {ECO:0000269|PubMed:15257289, ECO:0000269|PubMed:16957777}.",X,154884972,154885558,q28,,,0.84338,0.07184,,0.670453270135825,ENST00000620016,0.6663793103448276,0.10514871282179455,348,2,"H2AB3 (99, 99, chrX); H2AB2 (99, 99, chrX)",TRUE,2,"H2AB3 (99, 99, chrX); H2AB2 (99, 99, chrX)",TRUE,0.9747898290257442,2.5563018787591707,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:2259,ENOX2,ecto-NOX disulfide-thiol exchanger 2,Approved,COVA1,"APK1, tNOX",Xq26.1,gene with protein product,protein-coding gene,ENSG00000165675,10495,ENSG00000165675,Q16206,MGI:2384799,RGD:1563643,X,300282,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: May be involved in cell growth. Probably acts as a terminal oxidase of plasma electron transport from cytosolic NAD(P)H via hydroquinones to acceptors at the cell surface. Hydroquinone oxidase activity alternates with a protein disulfide-thiol interchange/oxidoreductase activity which may control physical membrane displacements associated with vesicle budding or cell enlargement. The activities oscillate with a period length of 22 minutes and play a role in control of the ultradian cellular biological clock. {ECO:0000269|PubMed:12356293, ECO:0000269|PubMed:9932650}.",oxidation-reduction process [GO:0055114]; regulation of growth [GO:0040008]; ultradian rhythm [GO:0007624],nucleic acid binding [GO:0003676]; protein disulfide oxidoreductase activity [GO:0015035],"SUBCELLULAR LOCATION: Cell membrane. Secreted, extracellular space. Note=Extracellular and plasma membrane-associated.","",X,130623369,130903317,q26.1,1.5327e-6,0.892,-0.44069,0.82752,23.175,0.4268999683777801,ENST00000338144,0.920949263502455,0.19717570607348164,1833,1,"ENOX1 (67, 63, chr13)",TRUE,,,,0.31990397971257,4.358002336680233,Artery - Tibial,broadly expressed,2.4638604452865285,2.4519469459375194,FALSE,low confidence non-escapee,no_difference_Pre_Post,Pre_higher_vs_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:22880,MAGED4B,MAGE family member D4B,Approved,,,Xp11.22,gene with protein product,protein-coding gene,ENSG00000187243,81557,ENSG00000187243,Q96JG8,,,X,300765,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May enhance ubiquitin ligase activity of RING-type zinc finger-containing E3 ubiquitin-protein ligases. Proposed to act through recruitment and/or stabilization of the Ubl-conjugating enzyme (E2) at the E3:substrate complex. {ECO:0000269|PubMed:20864041}.,"","","",SUBUNIT: Interacts with TRIM27. {ECO:0000269|PubMed:20864041}.,X,52061827,52069248,p11.22,,,,,,0.45656153556863127,ENST00000335504,0.5703953279424978,0.16425893526618346,2226,1,"MAGED4 (100, 100, chrX)",TRUE,1,"MAGED4 (100, 100, chrX)",TRUE,0.8836311973003127,0.372083991658433,Pituitary,tissue-specific,0.10604768762896723,0.08267452530106822,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:2291,COX7B,cytochrome c oxidase subunit 7B,Approved,,,Xq21.1,gene with protein product,protein-coding gene,ENSG00000131174,1349,ENSG00000131174,P24311,MGI:1913392,RGD:727789,X,300885,TRUE,Linear skin defects with multiple congenital anomalies 2,300887,X-linked dominant,,,,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Component of the cytochrome c oxidase, the last enzyme in the mitochondrial electron transport chain which drives oxidative phosphorylation. The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular oxygen, creating an electrochemical gradient over the inner membrane that drives transmembrane transport and the ATP synthase. Cytochrome c oxidase is the component of the respiratory chain that catalyzes the reduction of oxygen to water. Electrons originating from reduced cytochrome c in the intermembrane space (IMS) are transferred via the dinuclear copper A center (CU(A)) of subunit 2 and heme A of subunit 1 to the active site in subunit 1, a binuclear center (BNC) formed by heme A3 and copper B (CU(B)). The BNC reduces molecular oxygen to 2 water molecules using 4 electrons from cytochrome c in the IMS and 4 protons from the mitochondrial matrix (By similarity). Plays a role in proper central nervous system (CNS) development in vertebrates (PubMed:23122588). {ECO:0000250|UniProtKB:P13183, ECO:0000269|PubMed:23122588}.","central nervous system development [GO:0007417]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]",cytochrome-c oxidase activity [GO:0004129],SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000269|PubMed:30030519}; Single-pass membrane protein {ECO:0000269|PubMed:30030519}.,"SUBUNIT: Component of the cytochrome c oxidase (complex IV, CIV), a multisubunit enzyme composed of 14 subunits. The complex is composed of a catalytic core of 3 subunits MT-CO1, MT-CO2 and MT-CO3, encoded in the mitochondrial DNA, and 11 supernumerary subunits COX4I1 (or COX4I2), COX5A, COX5B, COX6A1 (or COX6A2), COX6B1 (or COX6B2), COX6C, COX7A2 (or COX7A1), COX7B, COX7C, COX8A and NDUFA4, which are encoded in the nuclear genome (PubMed:30030519). The complex exists as a monomer or a dimer and forms supercomplexes (SCs) in the inner mitochondrial membrane with NADH-ubiquinone oxidoreductase (complex I, CI) and ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII), resulting in different assemblies (supercomplex SCI(1)III(2)IV(1) and megacomplex MCI(2)III(2)IV(2)) (PubMed:28844695). {ECO:0000269|PubMed:28844695, ECO:0000269|PubMed:30030519}.",X,77899440,77907376,q21.1,0.67459,0.815,-0.76307,0.42394,3.6597,0.5787716860306863,ENST00000650309,0.8683127572016461,0.10337415646088478,243,1,"COX7B2 (70, 69, chr4)",TRUE,,,,0.2239225334687651,7.185539523797542,Heart - Left Ventricle,broadly expressed,5.592448067115587,5.905992238302835,FALSE,variable escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:22931,KLHL13,kelch like family member 13,Approved,"BKLHD2, KIAA1309",FLJ10262,Xq24,gene with protein product,protein-coding gene,ENSG00000003096,90293,ENSG00000003096,Q9P2N7,MGI:1914705,RGD:1559646,X,300655,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Substrate-specific adapter of a BCR (BTB-CUL3-RBX1) E3 ubiquitin-protein ligase complex required for mitotic progression and cytokinesis. The BCR(KLHL9-KLHL13) E3 ubiquitin ligase complex mediates the ubiquitination of AURKB and controls the dynamic behavior of AURKB on mitotic chromosomes and thereby coordinates faithful mitotic progression and completion of cytokinesis. {ECO:0000269|PubMed:14528312, ECO:0000269|PubMed:17543862, ECO:0000269|PubMed:19995937}.",cell cycle [GO:0007049]; cell division [GO:0051301]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; regulation of cytokinesis [GO:0032465],cullin family protein binding [GO:0097602]; protein N-terminus binding [GO:0047485],"","SUBUNIT: Component of the BCR(KLHL9-KLHL13) E3 ubiquitin ligase complex, at least composed of CUL3, KLHL9, KLHL13 and RBX1. Interacts with AURKB. {ECO:0000269|PubMed:14528312, ECO:0000269|PubMed:17543862}.",X,117897813,118117340,q24,0.035016,0.619,0.73281,2.2048,19.144,0.5016158244255833,ENST00000541812,0.9575,0.1799300174956261,1920,1,"KLHL9 (86, 92, chr9)",TRUE,1,"KLHL9 (86, 92, chr9)",TRUE,0.6094582763770543,4.564359875612561,Uterus,tissue-specific,1.413204112129496,1.729537544040735,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:22979,SLC10A3,solute carrier family 10 member 3,Approved,,"P3, DXS253E",Xq28,gene with protein product,protein-coding gene,ENSG00000126903,8273,ENSG00000126903,P09131,MGI:95048,RGD:1563513,X,312090,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: The ubiquitous expression and the conservation of the sequence in distant animal species suggest that the gene codes for a protein with housekeeping functions.,bile acid and bile salt transport [GO:0015721]; response to retinoic acid [GO:0032526],bile acid:sodium symporter activity [GO:0008508],SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.,"",X,154487306,154490690,q28,0.8071,0.55,-0.96826,1.2169,5.4403,0.5138581109291197,ENST00000651600,0.7213389121338912,0.06880779805048738,1434,,,,,,,0.18841018621632744,6.095770439942458,Artery - Aorta,broadly expressed,2.6010427585983504,3.548017319055603,FALSE,high confidence non-escapee,no_difference_Pre_Post,Pre_higher_vs_Post1,no difference_Pre_Post2,Post2_higher_vs_Post1,no disorder
HGNC:22982,JADE3,jade family PHD finger 3,Approved,PHF16,"KIAA0215, JADE-3",Xp11.3,gene with protein product,protein-coding gene,ENSG00000102221,9767,ENSG00000102221,Q92613,MGI:2148019,RGD:1563945,X,300618,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Scaffold subunit of some HBO1 complexes, which have a histone H4 acetyltransferase activity. {ECO:0000269|PubMed:16387653}.",histone H3 acetylation [GO:0043966]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982],metal ion binding [GO:0046872],"","SUBUNIT: Component of the HBO1 complex composed at least of ING4 or ING5, KAT7/HBO1, MEAF6, and one of JADE1, JADE2 and JADE3. {ECO:0000269|PubMed:16387653}.",X,46912276,47061242,p11.3,0.99978,0.124,0.61302,1.8969,24.024,0.7876834944504117,ENST00000614628,0.8489077669902912,0.2519370157460635,2472,,,,,,,0.395827986131011,4.282143228781498,Testis,broadly expressed,1.445276452927393,2.0119696608881186,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:22997,RTL3,retrotransposon Gag like 3,Approved,ZCCHC5,"FLJ38865, Mar3, Mart3, ZHC5, SIRH9",Xq21.1,gene with protein product,protein-coding gene,ENSG00000179300,203430,ENSG00000179300,Q8N8U3,MGI:2685221,RGD:1564805,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: May function as a transcriptional regulator. Plays a role in postnatal myogenesis, may be involved in the regulation of satellite cells self-renewal. {ECO:0000250|UniProtKB:Q6P1Y1}.","",nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270],SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q6P1Y1}.,"",X,78656068,78659328,q21.1,4.4007e-11,1.858,-1.865,-1.9273,10.749,0.10544132745081718,ENST00000321110,0.16785714285714287,0.27160709822544365,1428,,,,,,,0.7954420291207065,1.8224405603018108,Esophagus - Gastroesophageal Junction,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:23019,ZRSR2,"zinc finger CCCH-type, RNA binding motif and serine/arginine rich 2",Approved,U2AF1L2,"U2AF1-RS2, URP, ZC3H22",Xp22.2,gene with protein product,protein-coding gene,ENSG00000169249,8233,ENSG00000169249,Q15696,MGI:103287,RGD:1559763,X,300028,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Pre-mRNA-binding protein required for splicing of both U2- and U12-type introns. Selectively interacts with the 3'-splice site of U2- and U12-type pre-mRNAs and promotes different steps in U2 and U12 intron splicing. Recruited to U12 pre-mRNAs in an ATP-dependent manner and is required for assembly of the prespliceosome, a precursor to other spliceosomal complexes. For U2-type introns, it is selectively and specifically required for the second step of splicing. {ECO:0000269|PubMed:21041408, ECO:0000269|PubMed:9237760}.","mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]",identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; pre-mRNA 3'-splice site binding [GO:0030628],SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:15146077}.,"SUBUNIT: Component of the U11/U12 snRNPs that are part of the U12-type spliceosome. Interacts (via RS domain) with SRSF1 and SRSF2. Interacts with U2AF2/U2AF65. {ECO:0000269|PubMed:15146077, ECO:0000269|PubMed:21041408, ECO:0000269|PubMed:9237760}.",X,15790472,15823260,p22.2,0.99963,0.132,0.2755,1.4554,22.686,0.5119709633378843,ENST00000307771,0.7971704623878537,0.07428142964258935,1449,,,,,,,0.1752972158293394,5.317488590688024,Uterus,broadly expressed,3.9394052577044287,4.884798145743497,FALSE,high confidence escapee,no_difference_Pre_Post,Pre_higher_vs_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:23068,TRAPPC2,trafficking protein particle complex 2,Approved,SEDL,"TRS20, SEDT, MIP-2A, ZNF547L, hYP38334",Xp22.2,gene with protein product,protein-coding gene,ENSG00000196459,6399,ENSG00000196459,P0DI81,MGI:1913476,RGD:1306925,X,300202,TRUE,Spondyloepiphyseal dysplasia tarda,313400,X-linked recessive,,,,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,TRUE,confirmed,FUNCTION: Prevents transcriptional repression and induction of cell death by ENO1 (By similarity). May play a role in vesicular transport from endoplasmic reticulum to Golgi. {ECO:0000250}.,"COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; regulation of transcription, DNA-templated [GO:0006355]; skeletal system development [GO:0001501]",ion channel binding [GO:0044325]; transcription factor binding [GO:0008134],"SUBCELLULAR LOCATION: Cytoplasm, perinuclear region {ECO:0000269|PubMed:11031107}. Endoplasmic reticulum-Golgi intermediate compartment {ECO:0000269|PubMed:11031107}. Nucleus {ECO:0000269|PubMed:20498720, ECO:0000269|PubMed:25918224}. Cytoplasm {ECO:0000269|PubMed:20498720}. Note=Localized in perinuclear granular structures. {ECO:0000269|PubMed:11031107}.","SUBUNIT: Can homodimerize. Component of the multisubunit TRAPP (transport protein particle) complex, which includes TRAPPC2, TRAPPC2L, TRAPPC3, TRAPPC3L, TRAPPC4, TRAPPC5, TRAPPC8, TRAPPC9, TRAPPC10, TRAPPC11 and TRAPPC12. Interacts with ENO1, PITX1 and SF1. {ECO:0000269|PubMed:11805826, ECO:0000269|PubMed:19416478, ECO:0000269|PubMed:20498720, ECO:0000269|PubMed:21525244}.",X,13712244,13734635,p22.2,0.002414,1.746,-0.42884,1.5318,4.6392,0.5596838542552991,ENST00000380579,0.9638297872340426,0.07538115471132217,423,1,"TRAPPC2B (80, 100, chr19)",TRUE,,,,0.27391883430235264,4.941068740273871,Cerebellar_tissues,broadly expressed,3.5643903637378727,4.941068740273871,TRUE,high confidence escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:23086,USP51,ubiquitin specific peptidase 51,Approved,,,Xp11.21,gene with protein product,protein-coding gene,ENSG00000247746,158880,ENSG00000247746,Q70EK9,MGI:3588217,RGD:1562211,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Specifically deubiquitinates 'Lys-14' (H2AK13Ub) and 'Lys-16'(H2AK15Ub) of histone H2A regulating the DNA damage response at double-strand breaks (DSBs) (PubMed:27083998). USP51 is recruited to chromatin after DNA damage and regulates the dynamic assembly/disassembly of TP53BP1 and BRCA1. Exhibits also activity for 'Lys-27' or 'Lys-63'-linked di-ubiquitin (PubMed:27083998). {ECO:0000269|PubMed:27083998}.,DNA repair [GO:0006281]; histone deubiquitination [GO:0016578]; protein deubiquitination [GO:0016579]; regulation of cell cycle process [GO:0010564]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; regulation of response to DNA damage stimulus [GO:2001020]; ubiquitin-dependent protein catabolic process [GO:0006511],chromatin binding [GO:0003682]; histone binding [GO:0042393]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; zinc ion binding [GO:0008270],"SUBCELLULAR LOCATION: Chromosome {ECO:0000305|PubMed:27083998}. Note=Upon DNA damage, chromatin-bound USP51 disassociates from chromatin immediately following DNA damage and reassociates with chromatin following DNA repair. {ECO:0000269|PubMed:27083998}.",SUBUNIT: Interacts with H2A (PubMed:27083998). {ECO:0000269|PubMed:27083998}.,X,55484616,55489202,p11.21,0.12613,0.653,-1.4765,1.1345,14.026,0.49151415271633847,ENST00000500968,0.7579588014981273,0.4297425643589103,2136,,,,,,,0.46635815848183293,2.5028957545067163,Ovary,broadly expressed,1.4680984274406828,2.080862286427745,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,no disorder
HGNC:23148,PLCXD1,phosphatidylinositol specific phospholipase C X domain containing 1,Approved,,FLJ11323,Xp22.33 and Yp11.32,gene with protein product,protein-coding gene,ENSG00000182378,55344,ENSG00000182378,Q9NUJ7,MGI:2685422,RGD:1560935,X,300974,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,TRUE,,no disorder,"",lipid metabolic process [GO:0006629],phosphoric diester hydrolase activity [GO:0008081],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:22732399}.,"",X,276322,303356,p22.33,4.3087e-10,1.627,-2.3946,-1.5257,13.301,0.521196982957842,ENST00000381657,0.5353909465020577,0.03861187672262591,972,,,,,,,0.36156299679387394,5.127323743867532,Cerebellar_tissues,broadly expressed,3.0148747839120995,5.127323743867532,TRUE,low confidence escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:23250,DGAT2L6,diacylglycerol O-acyltransferase 2 like 6,Approved,,"DC3, FLJ25989",Xq13.1,gene with protein product,protein-coding gene,ENSG00000184210,347516,ENSG00000184210,Q6ZPD8,MGI:3045268,RGD:1596935,X,300926,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Diglyceride acyltransferase that uses fatty acyl-CoA as substrate (PubMed:15671038). Particularly active with oleate as a substrate (PubMed:15671038). Has no wax synthase activity to produce wax esters (PubMed:15671038). Able to use 1-monoalkylglycerol (1-MAkG) as an acyl acceptor for the synthesis of monoalkyl-monoacylglycerol (MAMAG) (PubMed:28420705). {ECO:0000269|PubMed:15671038, ECO:0000269|PubMed:28420705}.",acylglycerol acyl-chain remodeling [GO:0036155]; lipid metabolic process [GO:0006629]; monoacylglycerol biosynthetic process [GO:0006640],O-acyltransferase activity [GO:0008374],SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Multi-pass membrane protein {ECO:0000255}.,"",X,70177483,70205704,q13.1,5.5267e-11,1.665,-0.73812,-0.48618,13.675,0.20445036135412706,ENST00000333026,0.5900394477317554,0.08980254936265934,1014,,,,,,,0.9452640253130203,0.7976671280384576,Skin - Not Sun Exposed (Suprapubic),tissue-specific,0,0,FALSE,variable escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:23251,AWAT2,acyl-CoA wax alcohol acyltransferase 2,Approved,DGAT2L4,MFAT,Xq13.1,gene with protein product,protein-coding gene,ENSG00000147160,158835,ENSG00000147160,Q6E213,MGI:3045345,RGD:1565111,X,300925,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Acyltransferase that catalyzes the formation of ester bonds between fatty alcohols and fatty acyl-CoAs to form wax monoesters (PubMed:15220349, PubMed:15671038, PubMed:16106050, PubMed:28420705). Shows a preference for medium chain acyl-CoAs from C12 to C16 in length and fatty alcohols shorter than C20, as the acyl donors and acceptors, respectively (PubMed:15220349, PubMed:15671038). Also possesses acyl-CoA retinol acyltransferase (ARAT) activity that catalyzes 11-cis-specific retinyl ester synthesis (PubMed:16106050, PubMed:24799687). Shows higher catalytic efficiency toward 11-cis-retinol versus 9-cis-retinol, 13-cis-retinol, and all-trans-retinol substrates (PubMed:24799687). {ECO:0000269|PubMed:15220349, ECO:0000269|PubMed:15671038, ECO:0000269|PubMed:16106050, ECO:0000269|PubMed:24799687, ECO:0000269|PubMed:28420705}.",acylglycerol acyl-chain remodeling [GO:0036155]; lipid metabolic process [GO:0006629]; monoacylglycerol biosynthetic process [GO:0006640]; retinoid metabolic process [GO:0001523]; wax biosynthetic process [GO:0010025],2-acylglycerol O-acyltransferase activity [GO:0003846]; arachidoyl-CoA:1-dodecanol O-acyltransferase activity [GO:0102966]; long-chain-alcohol O-fatty-acyltransferase activity [GO:0047196]; O-acyltransferase activity [GO:0008374]; retinol O-fatty-acyltransferase activity [GO:0050252],SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000250|UniProtKB:Q6E1M8}; Multi-pass membrane protein {ECO:0000255}.,SUBUNIT: Monomer. {ECO:0000250|UniProtKB:Q6E1M8}.,X,70040542,70049938,q13.1,0.18858,0.711,-0.40383,1.2812,10.911,0.19257357298044636,ENST00000276101,0.5867265469061876,0.03524118970257436,1002,,,,,,,0.9534596440963704,2.2454256864583115,Skin - Not Sun Exposed (Suprapubic),tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:23252,AWAT1,acyl-CoA wax alcohol acyltransferase 1,Approved,DGAT2L3,,Xq13.1,gene with protein product,protein-coding gene,ENSG00000204195,158833,ENSG00000204195,Q58HT5,MGI:3588200,RGD:1587163,X,300924,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Acyltransferase that catalyzes the formation of ester bonds between fatty alcohols and fatty acyl-CoAs to form wax monoesters (PubMed:15671038). Shows a strong preference for decyl alcohol (C10), with less activity towards C16 and C18 alcohols (PubMed:15671038). Shows a strong preference for saturated acyl-CoAs (PubMed:15671038). {ECO:0000269|PubMed:15671038}.",arachidonic acid metabolic process [GO:0019369]; lipid metabolic process [GO:0006629]; wax biosynthetic process [GO:0010025],arachidoyl-CoA:1-dodecanol O-acyltransferase activity [GO:0102966]; long-chain-alcohol O-fatty-acyltransferase activity [GO:0047196]; O-acyltransferase activity [GO:0008374],SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000250|UniProtKB:Q6E213}; Multi-pass membrane protein {ECO:0000255}.,"",X,70234655,70240659,q13.1,2.6614e-4,1.192,-0.22164,0.2557,11.023,0.14095646794414993,ENST00000374521,0.5843971631205673,0.11347163209197701,987,,,,,,,0.9404605492522253,0.36563319345691425,Skin - Not Sun Exposed (Suprapubic),tissue-specific,0,0,FALSE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:2332,CPXCR1,CPX chromosome region candidate 1,Approved,,CT77,Xq21.31,gene with protein product,protein-coding gene,ENSG00000147183,53336,ENSG00000147183,Q8N123,MGI:2685989,RGD:2321886,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,88747225,88754785,q21.31,,,-0.19044,-0.56313,,0.3733048061600865,ENST00000276127,0.08443708609271523,0.042364408897775555,906,,,,,,,0.9767441860465116,3.4085216627056063,Testis,tissue-specific,0,0,FALSE,low confidence escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:23357,MCTS1,MCTS1 re-initiation and release factor,Approved,,MCT-1,Xq24,gene with protein product,protein-coding gene,ENSG00000232119,28985,ENSG00000232119,Q9ULC4,MGI:1916245,RGD:1566390,X,300587,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Anti-oncogene that plays a role in cell cycle regulation; decreases cell doubling time and anchorage-dependent growth; shortens the duration of G1 transit time and G1/S transition. When constitutively expressed, increases CDK4 and CDK6 kinases activity and CCND1/cyclin D1 protein level, as well as G1 cyclin/CDK complex formation. Involved in translation initiation; promotes recruitment of aminoacetyled initiator tRNA to P site of 40S ribosomes. Can promote release of deacylated tRNA and mRNA from recycled 40S subunits following ABCE1-mediated dissociation of post-termination ribosomal complexes into subunits. Plays a role as translation enhancer; recruits the density-regulated protein/DENR and binds to the cap complex of the 5'-terminus of mRNAs, subsequently altering the mRNA translation profile; up-regulates protein levels of BCL2L2, TFDP1, MRE11, CCND1 and E2F1, while mRNA levels remains constant. Hyperactivates DNA damage signaling pathway; increased gamma-irradiation-induced phosphorylation of histone H2AX, and induces damage foci formation. Increases the overall number of chromosomal abnormalities such as larger chromosomes formation and multiples chromosomal fusions when overexpressed in gamma-irradiated cells. May play a role in promoting lymphoid tumor development: lymphoid cell lines overexpressing MCTS1 exhibit increased growth rates and display increased protection against apoptosis. May contribute to the pathogenesis and progression of breast cancer via promotion of angiogenesis through the decline of inhibitory THBS1/thrombospondin-1, and inhibition of apoptosis. Involved in the process of proteasome degradation to down-regulate Tumor suppressor p53/TP53 in breast cancer cell; Positively regulates phosphorylation of MAPK1 and MAPK3. Involved in translation initiation; promotes aminoacetyled initiator tRNA to P site of 40S ribosomes. Can promote release of deacylated tRNA and mRNA from recycled 40S subunits following ABCE1-mediated dissociation of post-termination ribosomal complexes into subunits. {ECO:0000269|PubMed:10440924, ECO:0000269|PubMed:11709712, ECO:0000269|PubMed:12637315, ECO:0000269|PubMed:15897892, ECO:0000269|PubMed:16322206, ECO:0000269|PubMed:16982740, ECO:0000269|PubMed:17016429, ECO:0000269|PubMed:17416211, ECO:0000269|PubMed:20713520, ECO:0000269|PubMed:9766643}.",cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; formation of translation preinitiation complex [GO:0001731]; IRES-dependent viral translational initiation [GO:0075522]; positive regulation of cell population proliferation [GO:0008284]; regulation of growth [GO:0040008]; ribosome disassembly [GO:0032790]; translation reinitiation [GO:0002188],translation initiation factor activity [GO:0003743],"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:11709712, ECO:0000269|PubMed:16982740}. Note=Nuclear relocalization after DNA damage.",SUBUNIT: Interacts (via PUA domain) with DENR. {ECO:0000269|PubMed:16982740}.,X,120594010,120621159,q24,0.87474,0.441,0.86037,2.0473,6.7781,0.37811608163706256,ENST00000371317,0.9787545787545787,0.35028742814296426,546,1,"MCTS2P (93, 94, chr20)",TRUE,1,"MCTS2P (93, 94, chr20)",TRUE,0.24952378629167563,5.391644007950662,Cells - EBV-transformed lymphocytes,broadly expressed,3.5955872026345386,3.9909231026094494,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,no disorder
HGNC:23483,DOCK11,dedicator of cytokinesis 11,Approved,,"FLJ32122, FLJ43653, ZIZ2, ACG",Xq24,gene with protein product,protein-coding gene,ENSG00000147251,139818,ENSG00000147251,Q5JSL3,MGI:1923224,RGD:1564707,X,300681,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Guanine nucleotide-exchange factor (GEF) that activates CDC42 by exchanging bound GDP for free GTP. Required for marginal zone (MZ) B-cell development, is associated with early bone marrow B-cell development, MZ B-cell formation, MZ B-cell number and marginal metallophilic macrophages morphology. Facilitates filopodia formation through the activation of CDC42. {ECO:0000250|UniProtKB:A2AF47}.",B cell homeostasis [GO:0001782]; blood coagulation [GO:0007596]; marginal zone B cell differentiation [GO:0002315]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264],guanyl-nucleotide exchange factor activity [GO:0005085]; Rho guanyl-nucleotide exchange factor activity [GO:0005089],"",SUBUNIT: Interacts with CDC42. {ECO:0000250|UniProtKB:A2AF47}.,X,118495898,118686163,q24,0.012097,0.373,0.73053,2.6842,77.966,0.5868338717959348,ENST00000276204,0.8816811036252807,0.315296175956011,6234,1,"DOCK9 (59, 58, chr13)",TRUE,,,,0.4026224443455888,5.536814467053337,Adipose - Subcutaneous,broadly expressed,1.4824301248053535,1.0934384816637348,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:23485,MORC4,MORC family CW-type zinc finger 4,Approved,ZCWCC2,"ZCW4, FLJ11565",Xq22.3,gene with protein product,protein-coding gene,ENSG00000133131,79710,ENSG00000133131,Q8TE76,MGI:1922996,RGD:1559905,X,300970,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","",zinc ion binding [GO:0008270],SUBCELLULAR LOCATION: Nucleus {ECO:0000305|PubMed:17608765}.,"",X,106813871,107000212,q22.3,0.99783,0.249,-0.89781,1.3623,31.168,0.7229852470085918,ENST00000355610,0.7860341151385928,0.23894026493376655,2814,,,,,,,0.29991146134522906,4.681741597901612,Adrenal Gland,broadly expressed,1.7167407324364143,2.5869220323673043,FALSE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:23502,SLITRK4,SLIT and NTRK like family member 4,Approved,,DKFZp547M2010,Xq27.3,gene with protein product,protein-coding gene,ENSG00000179542,139065,ENSG00000179542,Q8IW52,MGI:2442509,RGD:1588563,X,300562,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: It is involved in synaptogenesis and promotes synapse differentiation (PubMed:27812321). Suppresses neurite outgrowth (By similarity). {ECO:0000250|UniProtKB:Q810B8, ECO:0000269|PubMed:27812321}.",axonogenesis [GO:0007409]; positive regulation of synapse assembly [GO:0051965]; regulation of presynapse assembly [GO:1905606]; regulation of synapse organization [GO:0050807],"",SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}. Cell membrane {ECO:0000269|PubMed:27812321}.,SUBUNIT: Interacts (via LRR 1 and 2 repeats) with PTPRD (via extracellular domain). {ECO:0000250|UniProtKB:Q810B8}.,X,143622790,143636101,q27.3,0.79447,0.422,1.087,1.9674,18.395,0.6093308448869578,ENST00000356928,0.9248210023866349,0.37395651087228193,2514,,,,,,,0.7705960141887781,4.015386058803707,Cerebellar_tissues,tissue-specific,2.1666222612083716,4.015386058803707,TRUE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:2370,MED14,mediator complex subunit 14,Approved,"CXorf4, CRSP2","EXLM1, CRSP150, TRAP170, RGR1, CSRP",Xp11.4,gene with protein product,protein-coding gene,ENSG00000180182,9282,ENSG00000180182,O60244,MGI:1349442,RGD:1560170,X,300182,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. {ECO:0000269|PubMed:15340088, ECO:0000269|PubMed:15625066, ECO:0000269|PubMed:16595664}.","positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell population maintenance [GO:0019827]; transcription initiation from RNA polymerase II promoter [GO:0006367]",nuclear receptor transcription coactivator activity [GO:0030374]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; vitamin D receptor binding [GO:0042809],SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.,"SUBUNIT: Interacts with GATA1 (By similarity). Component of the Mediator complex, which is composed of MED1, MED4, MED6, MED7, MED8, MED9, MED10, MED11, MED12, MED13, MED13L, MED14, MED15, MED16, MED17, MED18, MED19, MED20, MED21, MED22, MED23, MED24, MED25, MED26, MED27, MED29, MED30, MED31, CCNC, CDK8 and CDC2L6/CDK11. The MED12, MED13, CCNC and CDK8 subunits form a distinct module termed the CDK8 module. Mediator containing the CDK8 module is less active than Mediator lacking this module in supporting transcriptional activation. Individual preparations of the Mediator complex lacking one or more distinct subunits have been variously termed ARC, CRSP, DRIP, PC2, SMCC and TRAP. Interacts with AR, ESR1, SREBF1 and STAT2. {ECO:0000250, ECO:0000269|PubMed:10024883, ECO:0000269|PubMed:10235266, ECO:0000269|PubMed:10235267, ECO:0000269|PubMed:11867769, ECO:0000269|PubMed:12218053, ECO:0000269|PubMed:12509459, ECO:0000269|PubMed:15175163, ECO:0000269|PubMed:15340088, ECO:0000269|PubMed:15625066, ECO:0000269|PubMed:15989967, ECO:0000269|PubMed:16595664, ECO:0000269|PubMed:9734358}.",X,40648305,40735858,p11.4,1,0.092,1.5661,4.1329,51.732,0.6889952153110048,ENST00000324817,0.9627262313860252,0.15736065983504124,4365,,,,,,,0.2134079644635194,4.629158418055764,Cells - EBV-transformed lymphocytes,broadly expressed,2.4895506423261677,3.913612298460948,FALSE,variable escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,no disorder
HGNC:23793,MAGED4,MAGE family member D4,Approved,,"MAGE1, MGC3210, KIAA1859, MAGE-E1",Xp11.22,gene with protein product,protein-coding gene,ENSG00000154545,728239,ENSG00000154545,Q96JG8,,,X,300702,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May enhance ubiquitin ligase activity of RING-type zinc finger-containing E3 ubiquitin-protein ligases. Proposed to act through recruitment and/or stabilization of the Ubl-conjugating enzyme (E2) at the E3:substrate complex. {ECO:0000269|PubMed:20864041}.,"","","",SUBUNIT: Interacts with TRIM27. {ECO:0000269|PubMed:20864041}.,X,52184823,52192268,p11.22,0.32367,1.852,1.4248,0.84201,0.39332,0.4572292785009914,ENST00000599522,0.6238786279683377,0.18880279930017496,2274,1,"MAGED4B (100, 100, chrX)",TRUE,1,"MAGED4B (100, 100, chrX)",TRUE,0.8862808661624708,0.20860715232553262,Pituitary,tissue-specific,0.058338386979734695,0.04193395038312125,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:23795,MAGEB5,MAGE family member B5,Approved,,"MAGE-B5, CT3.3",Xp21.3,gene with protein product,protein-coding gene,ENSG00000188408,347541,ENSG00000188408,Q9BZ81,"MGI:2148169, MGI:3712084",RGD:1563078,X,300466,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,26216169,26218270,p21.3,,,0.57116,0.2494,,0.12924167447501783,ENST00000602297,0.07270531400966183,0.017895526118470385,828,,,,,,,0.9759645927698682,1.5487719814860978,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:23796,MAGEB6,MAGE family member B6,Approved,,"FLJ40242, MAGE-B6, MAGEB6A, CT3.4",Xp21.3,gene with protein product,protein-coding gene,ENSG00000176746,158809,ENSG00000176746,Q8N7X4,,RGD:1565662,X,300467,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,26192440,26195646,p21.3,,,-1.8614,-0.50716,,0.3169941495932685,ENST00000379034,0.04852941176470588,0.009597600599850037,1224,1,"MAGEB6B (80, 80, chrX)",TRUE,,,,0.9767441860465116,3.0835248546118206,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:23798,MAGEC3,MAGE family member C3,Approved,,"HCA2, MAGE-C3, CT7.2",Xq27.2,gene with protein product,protein-coding gene,ENSG00000165509,139081,ENSG00000165509,Q8TD91,,,X,300469,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,141838316,141897832,q27.2,7.6566e-16,1.722,-1.6667,-0.94908,17.294,0.15525664190590913,ENST00000298296,0.03814699792960662,0.1294926268432892,1932,,,,,,,0.8395007396417747,1.7368775870844688,Artery - Aorta,tissue-specific,0.9814442580088681,0.8270417919358155,FALSE,low confidence escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:23984,NXF2B,nuclear RNA export factor 2B,Approved,,bA353J17.1,Xq22.1,gene with protein product,protein-coding gene,ENSG00000269437,728343,ENSG00000269437,Q9GZY0,MGI:1933192,RGD:1559530,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Involved in the export of mRNA from the nucleus to the cytoplasm.,mRNA export from nucleus [GO:0006406]; multicellular organism development [GO:0007275]; poly(A)+ mRNA export from nucleus [GO:0016973]; RNA transport [GO:0050658],RNA binding [GO:0003723],"SUBCELLULAR LOCATION: Nucleus, nucleoplasm. Cytoplasm. Note=Localized in the nucleoplasm and at the nuclear envelope. Shuttles between the nucleus and the cytoplasm.","SUBUNIT: Interacts with NXT1, NXT2, E1B-AP5, the REF proteins and with nucleoporins, Nup62, Nup153 and Nup214. Interacts with LUZP4. {ECO:0000269|PubMed:10567585, ECO:0000269|PubMed:25662211}.",X,102360396,102439932,q22.1,0.71333,0.563,-0.33858,1.3814,8.425,0.3399857205997348,ENST00000602195,0.518341307814992,0.028542864283929017,1881,2,"NXF2 (100, 100, chrX); NXF1 (57, 57, chr11)",TRUE,1,"NXF2 (100, 100, chrX)",TRUE,0.9632956141760436,0.35313242494727154,Testis,tissue-specific,0,0.01971251670006859,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:24009,APOOL,apolipoprotein O like,Approved,"CXorf33, FAM121A","UNQ8193, AAIR8193, Mic27, MICOS27",Xq21.1,gene with protein product,protein-coding gene,ENSG00000155008,139322,ENSG00000155008,Q6UXV4,MGI:1915367,RGD:1549725,X,300955,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Component of the MICOS complex, a large protein complex of the mitochondrial inner membrane that plays crucial roles in the maintenance of crista junctions, inner membrane architecture, and formation of contact sites to the outer membrane. Specifically binds to cardiolipin (in vitro) but not to the precursor lipid phosphatidylglycerol. Plays a crucial role in crista junction formation and mitochondrial function (PubMed:23704930), (PubMed:25764979). {ECO:0000269|PubMed:23704930, ECO:0000269|PubMed:25764979}.",cristae formation [GO:0042407]; inner mitochondrial membrane organization [GO:0007007]; platelet degranulation [GO:0002576],"","SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000269|PubMed:23704930, ECO:0000269|PubMed:25764979}; Multi-pass membrane protein {ECO:0000269|PubMed:23704930}. Mitochondrion {ECO:0000269|PubMed:25781180, ECO:0000269|PubMed:25997101}.","SUBUNIT: Component of the mitochondrial contact site and cristae organizing system (MICOS) complex, composed of at least MICOS10/MIC10, CHCHD3/MIC19, CHCHD6/MIC25, APOOL/MIC27, IMMT/MIC60, APOO/MIC23/MIC26 and MICOS13/MIC13. This complex was also known under the names MINOS or MitOS complex (PubMed:25764979, PubMed:25781180, PubMed:23704930, PubMed:25764979, PubMed:25781180, PubMed:25997101).The MICOS complex associates with mitochondrial outer membrane proteins SAMM50, MTX1 and MTX2 (together described as components of the mitochondrial outer membrane sorting assembly machinery (SAM) complex) and DNAJC11, mitochondrial inner membrane protein TMEM11 and with HSPA9. The MICOS and SAM complexes together with DNAJC11 are part of a large protein complex spanning both membranes termed the mitochondrial intermembrane space bridging (MIB) complex. Interacts with MICOS10/MIC10, IMMT/MIC60 and APOO/MIC23/MIC26 (PubMed:25764979, PubMed:25781180, PubMed:23704930, PubMed:25764979, PubMed:25781180, PubMed:25997101). {ECO:0000269|PubMed:23704930, ECO:0000269|PubMed:25764979, ECO:0000269|PubMed:25781180, ECO:0000269|PubMed:25997101}.",X,85003877,85093316,q21.1,0.021234,1.002,-0.62663,0.25874,9.129,0.5220169144828486,ENST00000373173,0.7861214374225527,0.06765808547863034,807,,,,,,,0.26890462541986904,4.143989248207134,Artery - Tibial,broadly expressed,2.2936588766634376,2.5175818396719887,FALSE,high confidence non-escapee,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:24027,ACTRT1,actin related protein T1,Approved,,"AIP1, KIAA0705, ARIP1, Arp-T1",Xq25,gene with protein product,protein-coding gene,ENSG00000123165,139741,ENSG00000123165,Q8TDG2,MGI:1920610,RGD:1359559,X,300487,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Negatively regulates the Hedgehog (SHH) signaling. Binds to the promoter of the SHH signaling mediator, GLI1, and inhibits its expression. {ECO:0000269|PubMed:28869610}.","negative regulation of transcription, DNA-templated [GO:0045892]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription, DNA-templated [GO:0006355]",chromatin binding [GO:0003682],"SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000305|PubMed:28869610}. Cytoplasm {ECO:0000269|PubMed:28869610}. Nucleus {ECO:0000269|PubMed:28869610}. Note=Both detected in the nucleus and cytoplasm, localizes to the nucleus where it binds chromatin upon stimulation of the Hedgehog pathway. {ECO:0000269|PubMed:28869610}.","",X,128050962,128052398,q25,0.0037403,1.611,-0.34416,-1.2444,5.3899,0.18004594275780716,ENST00000371124,0.6146772767462423,0.1970757310672332,1131,1,"ACTRT2 (76, 75, chr1)",TRUE,,,,0.9767441860465116,3.2349810150795992,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:24061,AKAP14,A-kinase anchoring protein 14,Approved,,AKAP28,Xq24,gene with protein product,protein-coding gene,ENSG00000186471,158798,ENSG00000186471,Q86UN6,MGI:3618288,RGD:708510,X,300462,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Binds to type II regulatory subunits of protein kinase A and anchors/targets them.,"",protein kinase A regulatory subunit binding [GO:0034237],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}.,SUBUNIT: Binds to type II regulatory subunits (RII). {ECO:0000269|PubMed:12475942}.,X,119895837,119920716,q24,0.65829,0.612,0.51062,0.66976,7.7525,0.2305237347019774,ENST00000371431,0.2696969696969697,0.08790302424393902,594,,,,,,,0.9598132280680669,6.067939820509075,Testis,tissue-specific,0.35673654593831416,0.5924589508933938,FALSE,discordant,Pre_higher_vs_Post,no difference_Pre_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:24065,ARMCX3,armadillo repeat containing X-linked 3,Approved,,"ALEX3, GASP6",Xq22.1,gene with protein product,protein-coding gene,ENSG00000102401,51566,ENSG00000102401,Q9UH62,MGI:1918953,RGD:1549739,X,300364,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Regulates mitochondrial aggregation and transport in axons in living neurons. May link mitochondria to the TRAK2-kinesin motor complex via its interaction with Miro and TRAK2. Mitochondrial distribution and dynamics is regulated through ARMCX3 protein degradation, which is promoted by PCK and negatively regulated by WNT1. Enhances the SOX10-mediated transactivation of the neuronal acetylcholine receptor subunit alpha-3 and beta-4 subunit gene promoters. {ECO:0000250|UniProtKB:Q8BHS6}.",cellular protein localization [GO:0034613]; positive regulation of transcription by RNA polymerase II [GO:0045944],"",SUBCELLULAR LOCATION: Mitochondrion outer membrane {ECO:0000250|UniProtKB:Q8BHS6}; Single-pass membrane protein {ECO:0000255}. Cytoplasm {ECO:0000250|UniProtKB:Q8BHS6}. Nucleus {ECO:0000250|UniProtKB:Q8BHS6}.,"SUBUNIT: Interacts (via ARM domain) with MIRO1, MIRO2 and TRAK2. The interaction with Miro is calcium-dependent. Interacts with SOX10. {ECO:0000250|UniProtKB:Q8BHS6}.",X,101622797,101627843,q22.1,0.45882,0.841,0.40256,1.7428,5.6387,0.36891131635462915,ENST00000471229,0.9546491228070175,0.45163709072731817,1140,,,,,,,0.16246870346379072,6.368798026684038,Pituitary,broadly expressed,5.119322973089321,5.531008651146138,FALSE,low confidence non-escapee,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:24092,MAGEH1,MAGE family member H1,Approved,,APR1,Xp11.21,gene with protein product,protein-coding gene,ENSG00000187601,28986,ENSG00000187601,Q9H213,MGI:1922875,RGD:1359316,X,300548,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",apoptotic process [GO:0006915],"","","",X,55452127,55453566,p11.21,0.2292,1.419,-1.0141,0.61707,3.1481,0.44862496448385697,ENST00000342972,0.43681818181818183,0.1282179455136216,660,,,,,,,0.24915010568484536,6.670004676513003,Pituitary,broadly expressed,5.660771778788514,6.3681344994388605,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:24173,ATXN3L,ataxin 3 like,Approved,,MJDL,Xp22.2,gene with protein product,protein-coding gene,ENSG00000123594,92552,ENSG00000123594,Q9H3M9,,,X,300920,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Deubiquitinating enzyme that cleaves both 'Lys-48'-linked and 'Lys-63'-linked poly-ubiquitin chains (in vitro).,protein deubiquitination [GO:0016579],thiol-dependent ubiquitin-specific protease activity [GO:0004843],SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.,"",X,13318236,13320399,p22.2,,,0.1546,-0.020323,,0.24978776478768885,ENST00000380622,0.6876404494382022,0.22154461384653837,1068,1,"ATXN3 (71, 68, chr14)",TRUE,,,,0.9767441860465116,1.965337326217723,Testis,tissue-specific,0,0,FALSE,discordant,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:24185,BRCC3,BRCA1/BRCA2-containing complex subunit 3,Approved,CXorf53,"C6.1A, BRCC36",Xq28,gene with protein product,protein-coding gene,ENSG00000185515,79184,ENSG00000185515,P46736,MGI:2389572,RGD:1588543,X,300617,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Metalloprotease that specifically cleaves 'Lys-63'-linked polyubiquitin chains (PubMed:19214193, PubMed:20656690, PubMed:24075985, PubMed:26344097). Does not have activity toward 'Lys-48'-linked polyubiquitin chains. Component of the BRCA1-A complex, a complex that specifically recognizes 'Lys-63'-linked ubiquitinated histones H2A and H2AX at DNA lesions sites, leading to target the BRCA1-BARD1 heterodimer to sites of DNA damage at double-strand breaks (DSBs). In the BRCA1-A complex, it specifically removes 'Lys-63'-linked ubiquitin on histones H2A and H2AX, antagonizing the RNF8-dependent ubiquitination at double-strand breaks (DSBs) (PubMed:20656690). Catalytic subunit of the BRISC complex, a multiprotein complex that specifically cleaves 'Lys-63'-linked ubiquitin in various substrates (PubMed:20656690, PubMed:24075985, PubMed:26344097, PubMed:26195665). Mediates the specific 'Lys-63'-specific deubiquitination associated with the COP9 signalosome complex (CSN), via the interaction of the BRISC complex with the CSN complex (PubMed:19214193). The BRISC complex is required for normal mitotic spindle assembly and microtubule attachment to kinetochores via its role in deubiquitinating NUMA1 (PubMed:26195665). Plays a role in interferon signaling via its role in the deubiquitination of the interferon receptor IFNAR1; deubiquitination increases IFNAR1 activity by enhancing its stability and cell surface expression (PubMed:24075985, PubMed:26344097). Down-regulates the response to bacterial lipopolysaccharide (LPS) via its role in IFNAR1 deubiquitination (PubMed:24075985). {ECO:0000269|PubMed:14636569, ECO:0000269|PubMed:16707425, ECO:0000269|PubMed:17525341, ECO:0000269|PubMed:19202061, ECO:0000269|PubMed:19214193, ECO:0000269|PubMed:19261746, ECO:0000269|PubMed:19261748, ECO:0000269|PubMed:19261749, ECO:0000269|PubMed:20656690, ECO:0000269|PubMed:24075985, ECO:0000269|PubMed:26195665, ECO:0000269|PubMed:26344097}.",cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; histone H2A K63-linked deubiquitination [GO:0070537]; positive regulation of DNA repair [GO:0045739]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; response to ionizing radiation [GO:0010212]; response to X-ray [GO:0010165]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425],enzyme regulator activity [GO:0030234]; isopeptidase activity [GO:0070122]; Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; polyubiquitin modification-dependent protein binding [GO:0031593]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459],"SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:18077395, ECO:0000269|PubMed:19202061, ECO:0000269|PubMed:19261748, ECO:0000269|PubMed:19261749, ECO:0000269|PubMed:20656690, ECO:0000269|PubMed:24075985, ECO:0000269|PubMed:26344097}. Cytoplasm {ECO:0000269|PubMed:20656690, ECO:0000269|PubMed:24075985}. Cytoplasm, cytoskeleton, spindle pole {ECO:0000305|PubMed:26195665}. Note=Localizes at sites of DNA damage at double-strand breaks (DSBs) (PubMed:20656690, PubMed:26344097). Interaction with ABRAXAS2 retains BRCC3 in the cytoplasm (PubMed:20656690). {ECO:0000269|PubMed:20656690, ECO:0000269|PubMed:26344097}.","SUBUNIT: Component of the ARISC complex, at least composed of UIMC1/RAP80, ABRAXAS1, BRCC3/BRCC36, BABAM2 and BABAM1/NBA1 (PubMed:20656690, PubMed:24075985). Component of the BRCA1-A complex, at least composed of BRCA1, BARD1, UIMC1/RAP80, ABRAXAS1, BRCC3/BRCC36, babam2 and BABAM1/NBA1. In the BRCA1-A complex, interacts directly with ABRAXAS1 and babam2 (PubMed:18077395, PubMed:19261748). Component of the BRISC complex, at least composed of ABRAXAS2, BRCC3/BRCC36, BABAM2 and BABAM1/NBA1 (PubMed:24075985, PubMed:25283148, PubMed:26344097). Identified in a complex with SHMT2 and the other subunits of the BRISC complex (PubMed:24075985). In the BRISC complex, interacts directly with ABRAXAS2 (PubMed:20656690, PubMed:26344097). Identified in a complex with ABRAXAS2 and NUMA1 (PubMed:26195665). The BRISC complex interacts with the CSN complex. Component of the BRCA1/BRCA2 containing complex (BRCC), which also contains BRCA1, BRCA2, BARD1, BABAM2 and RAD51. BRCC is a ubiquitin E3 ligase complex that enhances cellular survival following DNA damage. Interacts with BRCA1. Binds polyubiquitin. {ECO:0000269|PubMed:14636569, ECO:0000269|PubMed:17525341, ECO:0000269|PubMed:18077395, ECO:0000269|PubMed:19214193, ECO:0000269|PubMed:19261746, ECO:0000269|PubMed:19261748, ECO:0000269|PubMed:19261749, ECO:0000269|PubMed:20656690, ECO:0000269|PubMed:26195665, ECO:0000269|PubMed:26344097}.",X,155071420,155123074,q28,0.0063932,0.813,0.61611,2.6703,14.562,0.6815968841285297,ENST00000330045,0.9490867579908676,0.189952511872032,876,,,,,,,0.2801487224987162,4.8634924936150075,Cells - EBV-transformed lymphocytes,broadly expressed,2.9603059668397824,4.464648665035484,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:24198,CTAG1A,cancer/testis antigen 1A,Approved,,"LAGE2A, ESO1",Xq28,gene with protein product,protein-coding gene,ENSG00000268651,246100,ENSG00000268651,P78358,,,X,300657,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",positive regulation of transcription by RNA polymerase II [GO:0045944]; tRNA threonylcarbamoyladenosine metabolic process [GO:0070525],identical protein binding [GO:0042802],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12065688}.,"",X,154585133,154586821,q28,,,,,,0.41435913781425554,ENST00000599837,0.002946593001841621,0.028342914271432144,543,2,"CTAG2 (82, 82, chrX); CTAG1B (68, 79, chrX)",TRUE,,,,0.8422743370179968,0.07278125590800558,Fallopian Tube,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:24282,RBMX2,RNA binding motif protein X-linked 2,Approved,,"CGI-79, Snu17",Xq26.1,gene with protein product,protein-coding gene,ENSG00000134597,51634,ENSG00000134597,Q9Y388,MGI:1919414,RGD:1562693,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Involved in pre-mRNA splicing as component of the activated spliceosome. {ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316}.","mRNA splicing, via spliceosome [GO:0000398]",RNA binding [GO:0003723],"SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316}.","SUBUNIT: Part of the activated spliceosome B/catalytic step 1 spliceosome, one of the forms of the spliceosome which has a well-formed active site but still cannot catalyze the branching reaction and is composed of at least 52 proteins, the U2, U5 and U6 snRNAs and the pre-mRNA. {ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316}.",X,130401987,130413656,q26.1,0.93892,0.337,0.79734,0.91703,8.8673,0.406945198046663,ENST00000305536,0.6298245614035087,0.13236690827293177,969,,,,,,,0.23217439859613384,5.162411470955436,Cervix - Ectocervix,broadly expressed,3.434544165268571,4.249160870013067,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:24294,CSAG1,chondrosarcoma associated gene 1,Approved,,"CSAGE, CT24.1",Xq28,gene with protein product,protein-coding gene,ENSG00000198930,158511,ENSG00000198930,Q6PB30,,,X,300944,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,152727484,152733735,q28,0.003607,1.923,-2.0877,-1.0377,2.1134,0.3123999645175349,ENST00000452779,0,0.012646838290427393,237,,,,,,,0.9491812932871087,1.764269712128176,Testis,tissue-specific,1.0389698941355812,0.5846335287476032,FALSE,low confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:24338,C1GALT1C1,C1GALT1 specific chaperone 1,Approved,,"COSMC, C1GALT2",Xq24,gene with protein product,protein-coding gene,ENSG00000171155,29071,ENSG00000171155,Q96EU7,MGI:1913493,RGD:1311230,X,300611,TRUE,"Tn polyagglutination syndrome, somatic",300622,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed -CS,FALSE,,confirmed,"FUNCTION: Probable chaperone required for the generation of 1 O-glycan Gal-beta1-3GalNAc-alpha1-Ser/Thr (T antigen), which is a precursor for many extended O-glycans in glycoproteins. Probably acts as a specific molecular chaperone assisting the folding/stability of core 1 beta-3-galactosyltransferase (C1GALT1). {ECO:0000269|PubMed:12464682}.","O-glycan processing [GO:0016266]; O-glycan processing, core 1 [GO:0016267]; platelet activation [GO:0030168]; platelet morphogenesis [GO:0036344]; protein O-linked glycosylation [GO:0006493]",glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263],SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type II membrane protein {ECO:0000305}.,"SUBUNIT: Associates with core 1 beta-3-galactosyltransferase (C1GALT1), probably not with the soluble active form.",X,120625674,120630054,q24,0.85158,0.478,0.056312,1.0293,6.2625,0.6075882850410123,ENST00000304661,0.8961337513061651,0.09217695576105973,957,1,"C1GALT1C1L (64, 64, chr2)",TRUE,,,,0.28294683728558073,5.96082212304708,Cells - Cultured fibroblasts,broadly expressed,2.947471665029255,3.0412797852073785,FALSE,high confidence non-escapee,no_difference_Pre_Post,Pre_higher_vs_Post1,no difference_Pre_Post2,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:2435,CSF2RA,colony stimulating factor 2 receptor subunit alpha,Approved,CSF2R,"CD116, alphaGMR",Xp22.32 and Yp11.3,gene with protein product,protein-coding gene,ENSG00000198223,1438,ENSG00000198223,P15509,MGI:1339754,RGD:1594330,X,"306250, 425000",TRUE,"Surfactant metabolism dysfunction, pulmonary, 4",300770,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed -CS,TRUE,,confirmed,"FUNCTION: Low affinity receptor for granulocyte-macrophage colony-stimulating factor. Transduces a signal that results in the proliferation, differentiation, and functional activation of hematopoietic cells.",cellular protein metabolic process [GO:0044267]; cytokine-mediated signaling pathway [GO:0019221]; MAPK cascade [GO:0000165],cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; signaling receptor activity [GO:0038023],SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane protein.; SUBCELLULAR LOCATION: [Isoform 3]: Secreted {ECO:0000305}.; SUBCELLULAR LOCATION: [Isoform 4]: Secreted {ECO:0000305}.; SUBCELLULAR LOCATION: [Isoform 6]: Secreted {ECO:0000305}.,"SUBUNIT: Heterodimer of an alpha and a beta subunit. The beta subunit is common to the IL3, IL5 and GM-CSF receptors. The signaling GM-CSF receptor complex is a dodecamer of two head-to-head hexamers of two alpha, two beta, and two ligand subunits. {ECO:0000269|PubMed:18692472}.",X,1268800,1310381,p22.33,2.3956e-10,1.119,-3.4021,-0.83694,23.859,0.3698482316903369,ENST00000381529,0.058187863674147966,0.04707129605088789,1203,,,,,,,0.7307503437064208,5.600180533956041,Whole Blood,tissue-specific,1.2697513220483745,0.47544862458100523,FALSE,low confidence escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:24358,TSPYL2,TSPY like 2,Approved,,"SE20-4, HRIHFB2216, CTCL, DENTT, CDA1, CINAP, TSPX",Xp11.22,gene with protein product,protein-coding gene,ENSG00000184205,64061,ENSG00000184205,Q9H2G4,MGI:106244,RGD:1563283,X,300564,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Part of the CASK/TBR1/TSPYL2 transcriptional complex which modulates gene expression in response to neuronal synaptic activity, probably by facilitating nucleosome assembly. May inhibit cell proliferation by inducing p53-dependent CDKN1A expression. {ECO:0000269|PubMed:11395479, ECO:0000269|PubMed:17317670}.",cell cycle [GO:0007049]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell growth [GO:0030308]; negative regulation of DNA replication [GO:0008156]; nucleosome assembly [GO:0006334]; regulation of protein kinase activity [GO:0045859]; regulation of signal transduction [GO:0009966],chromatin binding [GO:0003682]; histone binding [GO:0042393]; rDNA binding [GO:0000182],"SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11318608, ECO:0000269|PubMed:11395479}. Cytoplasm {ECO:0000250}. Note=Enriched in transcriptionally active regions of chromatin in neurons. {ECO:0000250}.","SUBUNIT: Interacts with histones. Interacts with CASK. Part of a complex containing CASK, TBR1 and TSPYL2 (By similarity). {ECO:0000250}.",X,53082367,53088540,p11.22,0.87393,0.405,-3.2663,0.32982,15.548,0.5253400819328473,ENST00000375442,0.40561959654178675,0.24066483379155212,2082,,,,,,,0.26315500445361906,9.686400725652021,Ovary,broadly expressed,7.22881869049588,9.135146204568944,FALSE,low confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:24514,RTL8A,retrotransposon Gag like 8A,Approved,FAM127B,"DKFZP564B147, MAR8A, CXX1b, SIRH6",Xq26.3,gene with protein product,protein-coding gene,ENSG00000203950,26071,ENSG00000203950,Q9BWD3,"MGI:1913408, MGI:1920115, MGI:3576504",RGD:1593086,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,135050932,135052196,q26.3,0.44642,1.567,-1.675,-0.0048829,1.4632,0.5588895505978285,ENST00000370775,0.856140350877193,0.14658835291177205,342,2,"RTL8B (96, 96, chrX); RTL8C (91, 91, chrX)",TRUE,2,"RTL8B (96, 96, chrX); RTL8C (91, 91, chrX)",TRUE,0.13356216874415702,7.104126950527225,Cervix - Ectocervix,broadly expressed,5.944158006617022,6.900311354021404,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,no disorder
HGNC:24553,TCEAL6,transcription elongation factor A like 6,Approved,,WEX2,Xq22.1,gene with protein product,protein-coding gene,ENSG00000204071,158931,ENSG00000204071,Q6IPX3,"MGI:1913354, MGI:1923939",,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May be involved in transcriptional regulation.,"",WW domain binding [GO:0050699],SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.,"",X,102140476,102142970,q22.1,0.016648,1.925,-0.14369,-0.62043,1.3245,0.47130471489138476,ENST00000372773,0.126268115942029,0.03401649587603099,552,2,"TCEAL3 (93, 86, chrX); TCEAL5 (87, 78, chrX)",TRUE,1,"TCEAL3 (93, 86, chrX)",TRUE,0.8192301737387054,7.094769168789307,Cerebellar_tissues,tissue-specific,5.105158426391872,7.094769168789307,TRUE,,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:24603,TFDP3,transcription factor Dp family member 3,Approved,,"HCA661, E2F-like, CT30",Xq26.2,gene with protein product,protein-coding gene,ENSG00000183434,51270,ENSG00000183434,Q5H9I0,,,X,300772,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Competitive inhibitor of E2F-mediated transactivation activity. Impairs E2F-mediated cell-cycle progression from G(1) to S phase. {ECO:0000269|PubMed:16418725, ECO:0000269|PubMed:17062573, ECO:0000269|PubMed:20559320}.",cellular response to DNA damage stimulus [GO:0006974]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; regulation of transcription by RNA polymerase II [GO:0006357],"activating transcription factor binding [GO:0033613]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; transcription factor binding [GO:0008134]",SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Note=Translocates to the nucleus on heterodimerization with E2F family members.,"SUBUNIT: Heterodimer: with E2F family members. TFDP3/E2F heterodimers do not bind DNA and repress E2F-dependent transcriptional activity. {ECO:0000269|PubMed:17062573, ECO:0000269|PubMed:20559320}.",X,133216662,133218354,q26.2,,,-1.0904,0.15026,,0.4599961216013277,ENST00000310125,0.8746305418719211,0.45631092226943265,1218,1,"TFDP1 (76, 75, chr13)",TRUE,,,,0.9760846111278146,3.401285041203023,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:24683,FATE1,fetal and adult testis expressed 1,Approved,,"FATE, CT43",Xq28,gene with protein product,protein-coding gene,ENSG00000147378,89885,ENSG00000147378,Q969F0,MGI:1925155,,X,300450,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Involved in the regulation of endoplasmic reticulum (ER)-mitochondria coupling. Negatively regulates the ER-mitochondria distance and Ca(2+) transfer from ER to mitochondria possibly implicating it in the regulation of apoptosis (PubMed:27402544). May collaborate with RNF183 to restrain BIK protein levels thus regulating apoptotic signaling (PubMed:26567849). {ECO:0000269|PubMed:27402544, ECO:0000305|PubMed:26567849}.",apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitochondrial calcium ion concentration [GO:0051562],identical protein binding [GO:0042802]; ubiquitin protein ligase binding [GO:0031625],"SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:26567849, ECO:0000269|PubMed:27402544}. Mitochondrion outer membrane {ECO:0000269|PubMed:27402544}. Endoplasmic reticulum membrane {ECO:0000269|PubMed:27402544}; Single-pass membrane protein {ECO:0000305}; Cytoplasmic side {ECO:0000305|PubMed:27402544}. Note=Localized to specific membrane structures termed mitochondria-associated membranes (MAMs) which connect the endoplasmic reticulum (ER) and the mitochondria. Also associated with the outer surface of mitochondria at sites that are not in close contact with the ER. {ECO:0000269|PubMed:27402544}.","SUBUNIT: Interacts with BIK and RNF183 (PubMed:26567849). Interacts with IMMT/MIC60and EMD (PubMed:27402544). {ECO:0000269|PubMed:26567849, ECO:0000269|PubMed:27402544}.",X,151716035,151723194,q28,0.0071681,1.364,0.13455,-0.33804,6.6424,0.159416033896883,ENST00000370350,0.22735507246376813,0.044763809047738065,552,,,,,,,0.9550218232541727,9.020893846737302,Testis,tissue-specific,0.0628658069092001,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:24715,TBC1D8B,TBC1 domain family member 8B,Approved,,"FLJ20298, RP11-321G1.1, GRAMD8B",Xq22.3,gene with protein product,protein-coding gene,ENSG00000133138,54885,ENSG00000133138,Q0IIM8,MGI:1918101,RGD:1563084,X,301027,TRUE,"Nephrotic syndrome, type 20",301028,X-linked,,,,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,TRUE,confirmed,"FUNCTION: Involved in vesicular recycling, probably as a RAB11B GTPase-activating protein. {ECO:0000269|PubMed:30661770}.",activation of GTPase activity [GO:0090630]; glomerular filtration [GO:0003094]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192],calcium ion binding [GO:0005509]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137],"SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:30661770}.",SUBUNIT: Interacts (via domain Rab-GAP TBC) with RAB11B (in GTP-bound form). {ECO:0000269|PubMed:30661770}.,X,106802673,106876150,q22.3,5.953e-9,0.743,0.83778,0.05699,39.102,0.4713034452811405,ENST00000357242,0.9071067499256616,0.1720069982504374,3363,1,"TBC1D8 (54, 53, chr2)",TRUE,,,,0.5236809288480265,3.670738383037959,Adrenal Gland,broadly expressed,0.7025174777185129,0.21100907751013623,FALSE,high confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:24767,LANCL3,LanC like 3,Approved,,FLJ42925,Xp21.1,gene with protein product,protein-coding gene,ENSG00000147036,347404,ENSG00000147036,Q6ZV70,MGI:2443335,RGD:1563642,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","",catalytic activity [GO:0003824],"","",X,37571569,37684463,p21.1,0.042661,0.837,-1.6669,0.14199,10.941,0.6451663975174947,ENST00000378619,0.9471100554235946,0.30992251937015747,1263,,,,,,,0.6873313598265796,1.3075334446527414,Colon - Sigmoid,tissue-specific,0.4375686605286957,0.5769390443571257,FALSE,discordant,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,no difference_Post1_Post2,no disorder
HGNC:24834,GPRASP1,G protein-coupled receptor associated sorting protein 1,Approved,,"GASP, GASP1",Xq22.1,gene with protein product,protein-coding gene,ENSG00000198932,9737,ENSG00000198932,Q5JY77,MGI:1917418,RGD:621343,X,300417,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Modulates lysosomal sorting and functional down-regulation of a variety of G-protein coupled receptors. Targets receptors for degradation in lysosomes via its interaction with BECN2. {ECO:0000269|PubMed:12142540, ECO:0000269|PubMed:15452121, ECO:0000269|PubMed:23954414}.",endosome to lysosome transport [GO:0008333]; G protein-coupled receptor catabolic process [GO:1990172],"",SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15452121}.,"SUBUNIT: Interacts with cytoplasmic tails of a variety of G-protein coupled receptors such as D2 dopamine receptor/DRD2 (By similarity), delta opioid receptor/OPRD1, beta-2 adrenergic receptor/ADRB2 and D4 dopamine receptor/DRD4. Interacts with PER1. Interacts with BECN2; the interaction is direct. {ECO:0000250, ECO:0000269|PubMed:12142540, ECO:0000269|PubMed:15086532, ECO:0000269|PubMed:15452121, ECO:0000269|PubMed:23954414}.",X,102651092,102659083,q22.1,0.31099,0.416,1.7226,0.72845,34.698,0.43618976585599745,ENST00000537097,0.20685291308500478,0.07005748562859285,4188,,,,,,,0.4036929069255197,7.190461773136801,Cerebellar_tissues,broadly expressed,4.898987062170336,7.190461773136801,TRUE,low confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:2484,CSTF2,cleavage stimulation factor subunit 2,Approved,,CstF-64,Xq22.1,gene with protein product,protein-coding gene,ENSG00000101811,1478,ENSG00000101811,P33240,MGI:1343054,RGD:1596566,X,300907,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: One of the multiple factors required for polyadenylation and 3'-end cleavage of mammalian pre-mRNAs. This subunit is directly involved in the binding to pre-mRNAs (By similarity). {ECO:0000250, ECO:0000269|PubMed:9199325}.","mRNA 3'-end processing [GO:0031124]; mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; termination of RNA polymerase II transcription [GO:0006369]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]",mRNA binding [GO:0003729]; RNA binding [GO:0003723],SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11598190}. Note=Localized with DDX1 in cleavage bodies.,"SUBUNIT: The CSTF complex is composed of CSTF1 (50 kDa subunit), CSTF2 (64 kDa subunit) and CSTF3 (77 kDa subunit). CSTF2 directly interacts with CSTF3, SYMPK and RPO2TC1. Interacts with HSF1 in heat-stressed cells. Interacts with CPSF2, CPSF3 and FIP1L1. Interacts with DDX1. {ECO:0000269|PubMed:10669729, ECO:0000269|PubMed:11389848, ECO:0000269|PubMed:11598190, ECO:0000269|PubMed:14707147, ECO:0000269|PubMed:14749727, ECO:0000269|PubMed:18688255, ECO:0000269|PubMed:21102410}.",X,100820359,100841520,q22.1,0.99959,0.133,1.088,3.4292,22.434,0.5259251613410599,ENST00000372972,0.9464244521337947,0.1435391152211947,1734,1,"CSTF2T (72, 69, chr10)",TRUE,,,,0.3486983549420514,5.191381039084524,Cells - EBV-transformed lymphocytes,broadly expressed,2.757985433658874,4.227167302595019,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:24887,PNPLA4,patatin like phospholipase domain containing 4,Approved,,"DXS1283E, GS2, iPLA2eta",Xp22.31,gene with protein product,protein-coding gene,ENSG00000006757,8228,ENSG00000006757,P41247,,RGD:1562200,X,300102,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Has abundant triacylglycerol lipase activity (PubMed:15364929). Transfers fatty acid from triglyceride to retinol, hydrolyzes retinylesters, and generates 1,3-diacylglycerol from triglycerides (PubMed:17603008). {ECO:0000269|PubMed:15364929, ECO:0000269|PubMed:17603008}.",lipid homeostasis [GO:0055088]; triglyceride catabolic process [GO:0019433],retinyl-palmitate esterase activity [GO:0050253]; triglyceride lipase activity [GO:0004806],SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:26741492}.,"",X,7898247,7927739,p22.31,0.0025724,1.271,-0.040987,-0.14555,8.2486,0.49299014958729676,ENST00000381042,0.7846456692913386,0.057110722319420146,762,,,,,,,0.23517851010678065,4.047922218818466,Ovary,broadly expressed,3.303066163260212,2.8336976972574752,FALSE,high confidence escapee,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:2491,CTAG1B,cancer/testis antigen 1B,Approved,"CTAG, CTAG1","NY-ESO-1, LAGE2B, LAGE2A, ESO1, CT6.1",Xq28,gene with protein product,protein-coding gene,ENSG00000184033,1485,ENSG00000184033,P78358,,,X,300156,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",positive regulation of transcription by RNA polymerase II [GO:0045944]; tRNA threonylcarbamoyladenosine metabolic process [GO:0070525],identical protein binding [GO:0042802],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12065688}.,"",X,154617609,154619282,q28,,,,,,0.41459069316374736,ENST00000328435,3.683241252302026e-4,0.0469632591852037,543,2,"CTAG1A (79, 68, chrX); CTAG2 (64, 55, chrX)",TRUE,,,,0.9767441860465116,0.11557491785891688,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:2492,CTAG2,cancer/testis antigen 2,Approved,,"LAGE-1, CAMEL, LAGE1, ESO2, MGC3803, MGC138724, CT6.2a, CT6.2b, LAGE-1a, LAGE-1b",Xq28,gene with protein product,protein-coding gene,ENSG00000126890,30848,ENSG00000126890,O75638,,RGD:1561702,X,300396,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",positive regulation of transcription by RNA polymerase II [GO:0045944]; tRNA threonylcarbamoyladenosine metabolic process [GO:0070525],"","","",X,154651972,154653579,q28,0.10495,1.865,0.33846,-0.48964,1.2742,0.4400332469564367,ENST00000369585,0.009023941068139963,0.04516370907273182,543,2,"CTAG1A (82, 82, chrX); CTAG1B (55, 64, chrX)",TRUE,,,,0.9759006720724955,3.8853303154761663,Testis,tissue-specific,0,0,FALSE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:24925,FUNDC2,FUN14 domain containing 2,Approved,,"HCBP6, DC44",Xq28,gene with protein product,protein-coding gene,ENSG00000165775,65991,ENSG00000165775,Q9BWH2,MGI:1914641,RGD:1560916,X,301042,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",autophagy of mitochondrion [GO:0000422],"","","",X,155025980,155060304,q28,0.059823,1.019,0.77346,0.36308,7.6054,0.7731192387749033,ENST00000369498,0.8122807017543859,0.09860034991252187,570,,,,,,,0.19101481790124789,5.557523437700543,Muscle - Skeletal,broadly expressed,3.8305595725342574,4.710657680384571,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:24931,ZC4H2,zinc finger C4H2-type containing,Approved,"KIAA1166, WWS, MCS, MRXS4",HCA127,Xq11.2,gene with protein product,protein-coding gene,ENSG00000126970,55906,ENSG00000126970,Q9NQZ6,MGI:2679294,RGD:1561708,X,300897,TRUE,"Wieacker-Wolff syndrome // Wieacker-Wolff syndrome, female-restricted",314580 // 301041,X-linked recessive // X-linked dominant,,,,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Plays a role in interneurons differentiation (PubMed:26056227). Involved in neuronal development and in neuromuscular junction formation. {ECO:0000269|PubMed:23623388, ECO:0000269|PubMed:26056227}.",nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; positive regulation of neuron differentiation [GO:0045666]; spinal cord motor neuron differentiation [GO:0021522],metal ion binding [GO:0046872],"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:23623388}. Nucleus {ECO:0000269|PubMed:23623388, ECO:0000269|PubMed:26056227}. Cell junction, synapse, postsynaptic cell membrane {ECO:0000269|PubMed:23623388}. Note=Upon transfection into mouse primary hippocampal neurons, localizes at excitatory, but not inhibitory, postsynaptic sites.","",X,64915802,65034713,q11.2,0.90752,0.39,-1.4204,1.5121,7.676,0.32552954292084724,ENST00000374839,0.9705185185185186,0.12484378905273681,675,,,,,,,0.28089728536459707,3.3504406696986524,Pituitary,broadly expressed,2.19386319002012,2.9008822610331535,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:24934,MAGEE1,MAGE family member E1,Approved,,"KIAA1587, DAMAGE",Xq13.3,gene with protein product,protein-coding gene,ENSG00000198934,57692,ENSG00000198934,Q9HCI5,MGI:2148149,RGD:1560259,X,300759,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May enhance ubiquitin ligase activity of RING-type zinc finger-containing E3 ubiquitin-protein ligases. Proposed to act through recruitment and/or stabilization of the Ubl-conjugating enzyme (E2) at the E3:substrate complex. {ECO:0000269|PubMed:20864041}.,"","","SUBCELLULAR LOCATION: Cytoplasm, perinuclear region {ECO:0000250}. Nucleus {ECO:0000250}. Cell membrane {ECO:0000250}. Note=In the skeletal muscle, found at the postsynaptic membrane and is associated with a subset of myonuclei. May reside within nuclei and/or in perinuclear compartments. In peripheral nerves, colocalizes with DTNA in the Schwann cell membrane (By similarity). {ECO:0000250}.","SUBUNIT: Interacts with DTNA (By similarity). Interacts with TRIM28. {ECO:0000250, ECO:0000269|PubMed:20864041}.",X,76427710,76431342,q13.3,0.97046,0.31,-1.8684,1.4379,15.298,0.4720758693361433,ENST00000361470,0.3998608211551844,0.11657085728567858,2874,,,,,,,0.6017635250113211,5.510026711872982,Cerebellar_tissues,tissue-specific,4.280355065628609,5.510026711872982,TRUE,discordant,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:24935,MAGEE2,MAGE family member E2,Approved,,HCA3,Xq13.3,gene with protein product,protein-coding gene,ENSG00000186675,139599,ENSG00000186675,Q8TD90,MGI:2148316,RGD:1564872,X,300760,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,75782987,75785254,q13.3,1.9687e-12,1.82,-1.2505,-1.7411,12.643,0.3115628772831717,ENST00000373359,0.8257633587786259,0.40244938765308674,1572,,,,,,,0.8747862363797666,3.182294230370876,Cerebellar_tissues,tissue-specific,1.248905177479447,3.182294230370876,TRUE,,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,no disorder
HGNC:24971,LUZP4,leucine zipper protein 4,Approved,,"HOM-TES-85, CT-8, CT28",Xq23,gene with protein product,protein-coding gene,ENSG00000102021,51213,ENSG00000102021,Q9P127,,RGD:1584898,X,300616,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Export adapter involved in mRNA nuclear export in cancer cells. Binds and enhances the RNA-binding activity of the nuclear RNA export factor NXF1. Can restore mRNA export function in cells compromised by loss of mRNA export adapters (PubMed:25662211). {ECO:0000269|PubMed:25662211}.,mRNA transport [GO:0051028],RNA binding [GO:0003723],"SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12032826, ECO:0000269|PubMed:25662211}. Cytoplasm {ECO:0000269|PubMed:25662211}. Note=In nuclear speckles. Relocalizes to the cytoplasm during cell division. {ECO:0000269|PubMed:12032826, ECO:0000269|PubMed:25662211}.","SUBUNIT: Interacts NXF1, NXF2, THOC1, THOC5, DDX39B/UAP56 and SRRT. {ECO:0000269|PubMed:25662211}.",X,115289715,115307563,q23,0.0013873,1.857,0.35268,-0.66868,3.7749,0.3653293533224923,ENST00000371920,0.05753715498938429,0.04093976505873532,942,,,,,,,0.9764415039727483,3.4178106676859894,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:25085,FAM104B,family with sequence similarity 104 member B,Approved,CXorf44,FLJ20434,Xp11.21,gene with protein product,protein-coding gene,ENSG00000182518,90736,ENSG00000182518,Q5XKR9,,RGD:2323310,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,55143102,55161310,p11.21,0.017574,1.921,0.46865,-0.21785,1.4105,0.48134318577702373,ENST00000425133,0.5367521367521367,0.04181454636340915,351,,,,,,,0.1954023231804555,3.9356483230674217,Uterus,broadly expressed,3.1839977588156776,3.5617843530818414,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,no disorder
HGNC:25117,RIPPLY1,ripply transcriptional repressor 1,Approved,,,Xq22.3,gene with protein product,protein-coding gene,ENSG00000147223,92129,ENSG00000147223,Q0D2K3,MGI:3614797,RGD:1588264,X,300575,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Plays a role in somitogenesis. Essential for transcriptional repression of the segmental patterning genes, thus terminating the segmentation program in the presomitic mesoderm, and also required for the maintenance of rostrocaudal polarity in somites (By similarity). {ECO:0000250|UniProtKB:Q2WG80}.","embryonic pattern specification [GO:0009880]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; somite rostral/caudal axis specification [GO:0032525]; somite specification [GO:0001757]","",SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q2WG80}.,"",X,106900063,106903341,q22.3,0.0094433,1.774,-0.043571,0.11192,3.6387,0.09529729507291326,ENST00000276173,0.4517543859649123,0.19850037490627342,456,,,,,,,0.8571940580207179,1.8088216032277273,Kidney - Medulla,tissue-specific,0.06381905806733575,0,FALSE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:25169,GPRASP2,G protein-coupled receptor associated sorting protein 2,Approved,,"GASP2, FLJ37327",Xq22.1,gene with protein product,protein-coding gene,ENSG00000158301,114928,ENSG00000158301,Q96D09,MGI:2442071,RGD:1561019,X,300969,TRUE,,,,"?Deafness, X-linked 7",301018,X-linked recessive,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PMT +CS,FALSE,,PMT,FUNCTION: May play a role in regulation of a variety of G-protein coupled receptors. {ECO:0000269|PubMed:15086532}.,"",amyloid-beta binding [GO:0001540]; G protein-coupled receptor binding [GO:0001664],"",SUBUNIT: Interacts with cytoplasmic tails of a variety of G-protein coupled receptors such as muscarinic acetylcholine receptor M1/CHRM1 and calcitonin receptor/CALCR. {ECO:0000269|PubMed:15086532}.,X,102712176,102717733,q22.1,0.98751,0.269,1.1744,0.71345,17.647,0.46793640047391005,ENST00000332262,0.5063965037743345,0.08222944263934016,2517,,,,,,,0.400654065221396,5.744467904800177,Cerebellar_tissues,broadly expressed,4.2194938163588604,5.744467904800177,TRUE,high confidence non-escapee,no_difference_Pre_Post,Pre_higher_vs_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,PMT
HGNC:25195,FAM199X,"family with sequence similarity 199, X-linked",Approved,CXorf39,,Xq22.2,gene with protein product,protein-coding gene,ENSG00000123575,139231,ENSG00000123575,Q6PEV8,MGI:2384304,RGD:1591830,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,104166453,104195902,q22.2,0.57269,0.564,0.98934,2.4989,11.166,0.5560747963376058,ENST00000493442,0.9730934018851757,0.18465383654086479,1167,,,,,,,0.1724678712295217,4.758932060199517,Nerve - Tibial,broadly expressed,4.110229592423189,4.636343303833558,FALSE,high confidence non-escapee,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,no difference_Post1_Post2,no disorder
HGNC:2520,CTPS2,CTP synthase 2,Approved,,,Xp22.2,gene with protein product,protein-coding gene,ENSG00000047230,56474,ENSG00000047230,Q9NRF8,MGI:1933185,RGD:1563369,X,300380,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Catalyzes the ATP-dependent amination of UTP to CTP with either L-glutamine or ammonia as the source of nitrogen. Constitutes the rate-limiting enzyme in the synthesis of cytosine nucleotides. {ECO:0000269|PubMed:10899599, ECO:0000269|PubMed:16179339}.",'de novo' CTP biosynthetic process [GO:0044210]; CTP biosynthetic process [GO:0006241]; glutamine metabolic process [GO:0006541]; nucleobase-containing small molecule interconversion [GO:0015949]; pyrimidine nucleobase biosynthetic process [GO:0019856]; pyrimidine nucleotide metabolic process [GO:0006220],ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]; identical protein binding [GO:0042802],"","",X,16587999,16712936,p22.2,0.81923,0.394,0.60378,2.5903,23.229,0.5334971263107094,ENST00000359276,0.8763770584894947,0.05236190952261935,1761,1,"CTPS1 (75, 74, chr1)",TRUE,,,,0.2660400404580995,4.371823680873609,Ovary,broadly expressed,2.3483174144794723,3.816768642478704,FALSE,variable escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:25202,PABIR3,PABIR family member 3,Approved,FAM122C,RP3-473B4.1,Xq26.3,gene with protein product,protein-coding gene,ENSG00000156500,159091,ENSG00000156500,Q6P4D5,MGI:1921116,RGD:1590266,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,134796395,134854835,q26.3,2.0902e-4,1.604,-0.063561,-0.053389,7.1493,,,,,,1,"FAM122A (56, 53, chr9)",TRUE,,,,0.6257136795021829,3.4351244960802596,Ovary,tissue-specific,0.9224391655891127,0.618131036870093,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:25214,RTL4,retrotransposon Gag like 4,Approved,ZCCHC16,"Mart4, Mar4, FLJ46608, SIRH11",Xq23,gene with protein product,protein-coding gene,ENSG00000187823,340595,ENSG00000187823,Q6ZR62,MGI:3588192,RGD:1588188,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Involved in cognitive function in the brain, possibly via the noradrenergic system. {ECO:0000250|UniProtKB:Q3URY0}.",cognition [GO:0050890]; norepinephrine metabolic process [GO:0042415],nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270],"","",X,112454500,112457112,q23,3.4473e-6,1.786,0.20689,-0.52864,7.4225,0.18972966233540953,ENST00000340433,0.3157556270096463,0.14448887778055486,933,,,,,,,0.9165711056771967,0.35390138265361826,Liver,tissue-specific,0.0990225984429221,0.18860728043828281,FALSE,high confidence escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:25235,MOSPD1,motile sperm domain containing 1,Approved,,dJ473B4,Xq26.3,gene with protein product,protein-coding gene,ENSG00000101928,56180,ENSG00000101928,Q9UJG1,MGI:1917630,RGD:1359486,X,300674,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Plays a role in differentiation and/or proliferation of mesenchymal stem cells. Proposed to be involved in epithelial-to-mesenchymal transition (EMT). However, another study suggests that it is not required for EMT or stem cell self-renewal and acts during later stages of differentiation. {ECO:0000250|UniProtKB:Q8VEL0}.",cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944],"",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000250|UniProtKB:Q8VEL0}; Multi-pass membrane protein {ECO:0000255}. Golgi apparatus membrane {ECO:0000250|UniProtKB:Q8VEL0}; Multi-pass membrane protein {ECO:0000255}.,"",X,134887632,134915257,q26.3,0.92491,0.361,-0.17706,1.3283,8.2785,0.47841167324482714,ENST00000370783,0.9669781931464174,0.1989002749312672,642,,,,,,,0.22714397029630262,4.064417279743771,Esophagus - Mucosa,broadly expressed,2.219546476415304,2.688868524495346,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:25301,FAM47C,family with sequence similarity 47 member C,Approved,,,Xp21.1,gene with protein product,protein-coding gene,ENSG00000198173,442444,ENSG00000198173,Q5HY64,MGI:1918114,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,37008366,37011664,p21.1,,,-1.0875,-0.53441,,0.5096118456442343,ENST00000358047,0.021525096525096526,0.015071232191952012,3108,,,,,,,0.9704434353454886,2.927054477993013,Testis,tissue-specific,0.021014720904270055,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:25377,MAGEB10,MAGE family member B10,Approved,,FLJ32965,Xp21.3,gene with protein product,protein-coding gene,ENSG00000177689,139422,ENSG00000177689,Q96LZ2,,,X,300761,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,27807990,27823014,p21.3,,,-0.052033,1.3681,,0.49044940973805545,ENST00000356790,0.1331417624521073,0.050148849797023005,1044,,,,,,,0.9762939917206525,1.7745572641182246,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:25391,NRK,Nik related kinase,Approved,,DKFZp686A17109,Xq22.3,gene with protein product,protein-coding gene,ENSG00000123572,203447,ENSG00000123572,Q7Z2Y5,MGI:1351326,RGD:1566163,X,300791,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: May phosphorylate cofilin-1 and induce actin polymerization through this process, during the late stages of embryogenesis. Involved in the TNF-alpha-induced signaling pathway (By similarity). {ECO:0000250}.",actin cytoskeleton reorganization [GO:0031532]; activation of JNKK activity [GO:0007256]; activation of protein kinase activity [GO:0032147]; negative regulation of cell population proliferation [GO:0008285]; neuron projection morphogenesis [GO:0048812]; parturition [GO:0007567]; regulation of spongiotrophoblast cell proliferation [GO:0060721]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674],"","",X,105822539,105958610,q22.3,0.99274,0.289,0.89232,0.66035,54.383,0.6618302150948199,ENST00000243300,0.7526216045483259,0.31644588852786804,4749,,,,,,,0.8083720446754868,5.443742560737058,Ovary,tissue-specific,0.023841538782542557,2.2338159849609447,FALSE,low confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,no difference_Post1_Post2,no disorder
HGNC:25400,XAGE1B,X antigen family member 1B,Approved,"XAGE1C, XAGE1D, XAGE1E","CT12.1b, CT12.1c, CT12.1d",Xp11.22,gene with protein product,protein-coding gene,ENSG00000204382,653067,ENSG00000204382,Q9HD64,,,X,"300744, 300745, 300289",FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,52512077,52520803,p11.22,,,,,,0.2577499129223267,ENST00000518075,0.06666666666666667,0.004473881529617596,246,1,"XAGE1A (100, 100, chrX)",TRUE,1,"XAGE1A (100, 100, chrX)",TRUE,0.9767441860465116,0.13039189950862573,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:25402,OTUD5,OTU deubiquitinase 5,Approved,,"DKFZp761A052, DUBA",Xp11.23,gene with protein product,protein-coding gene,ENSG00000068308,55593,ENSG00000068308,Q96G74,MGI:1859615,RGD:1563027,X,300713,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Deubiquitinating enzyme that functions as negative regulator of the innate immune system. Acts via TRAF3 deubiquitination and subsequent suppression of type I interferon (IFN) production. Has peptidase activity towards 'Lys-48'- and 'Lys-63'-linked polyubiquitin chains. Can also cleave 'Lys-11'-linked ubiquitin chains (in vitro). {ECO:0000269|PubMed:17991829, ECO:0000269|PubMed:22245969, ECO:0000269|PubMed:23827681}.",negative regulation of type I interferon production [GO:0032480]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; response to lipopolysaccharide [GO:0032496],Lys48-specific deubiquitinase activity [GO:1990380]; Lys63-specific deubiquitinase activity [GO:0061578]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitinyl hydrolase activity [GO:0101005],"","SUBUNIT: Interacts with TRAF3. {ECO:0000269|PubMed:17991829, ECO:0000269|PubMed:22245969}.",X,48922028,48958386,p11.23,0.99717,0.173,0.05417,3.994,17.234,0.7213607237348223,ENST00000376488,0.9339212228101117,0.263009247688078,1701,,,,,,,0.1238733266010835,6.532507103235601,Cerebellar_tissues,broadly expressed,5.367821837419386,6.532507103235601,TRUE,high confidence non-escapee,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:25410,RAB40AL,RAB40A like,Approved,,"RAR2, RLGP",Xq22.1,gene with protein product,protein-coding gene,ENSG00000102128,282808,ENSG00000102128,P0C0E4,,,X,300405,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May be a substrate-recognition component of a SCF-like ECS (Elongin-Cullin-SOCS-box protein) E3 ubiquitin ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. {ECO:0000250}.,intracellular signal transduction [GO:0035556]; protein localization to plasma membrane [GO:0072659]; protein ubiquitination [GO:0016567],GTPase activity [GO:0003924]; GTP binding [GO:0005525],"SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Lipid-anchor {ECO:0000305}; Cytoplasmic side {ECO:0000305}. Cytoplasm {ECO:0000269|PubMed:22581972}. Mitochondrion {ECO:0000269|PubMed:12145744, ECO:0000269|PubMed:22581972}.","",X,102937272,102938300,q22.1,0.31342,1.865,0.47415,-0.23263,0.30207,0.4329281752219825,ENST00000218249,0.7821983273596177,0.33469132716820793,837,3,"RAB40A (98, 98, chrX); RAB40B (89, 89, chr17); RAB40C (75, 74, chr16)",TRUE,2,"RAB40A (98, 98, chrX); RAB40B (89, 89, chr17)",TRUE,0.5862015413738725,0.46431277660507336,Cerebellar_tissues,broadly expressed,0.0772116832215574,0.46431277660507336,TRUE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:25455,TSR2,TSR2 ribosome maturation factor,Approved,,"DT1P1A10, RP1-112K5.2, WGG1",Xp11.22,gene with protein product,protein-coding gene,ENSG00000158526,90121,ENSG00000158526,Q969E8,MGI:1916749,RGD:1562416,X,300945,TRUE,,,,?Diamond-Blackfan anemia 14 with mandibulofacial dysostosis,300946,X-linked recessive,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PMT +CS,FALSE,,PMT,FUNCTION: May be involved in 20S pre-rRNA processing. {ECO:0000305}.,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]","","","",X,54440404,54448032,p11.22,0.80082,0.561,-0.6348,0.9894,5.3372,0.3737419578739422,ENST00000375151,0.7527777777777778,0.1965508622844289,576,,,,,,,0.1438977035835426,7.020035421292245,Other_Brain_tissues,broadly expressed,7.020035421292245,6.940977157660271,TRUE,low confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,Post2_higher_vs_Post1,PMT
HGNC:25475,BEX4,brain expressed X-linked 4,Approved,BEXL1,FLJ10097,Xq22.1,gene with protein product,protein-coding gene,ENSG00000102409,56271,ENSG00000102409,Q9NWD9,MGI:3606746,RGD:1564749,X,300692,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May play a role in microtubule deacetylation by negatively regulating the SIRT2 deacetylase activity toward alpha-tubulin and thereby participate in the control of cell cycle progression and genomic stability. {ECO:0000269|PubMed:27512957}.,chromosome segregation [GO:0007059]; negative regulation of tubulin deacetylation [GO:1904428]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127],alpha-tubulin binding [GO:0043014]; histone deacetylase binding [GO:0042826],"SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, spindle pole {ECO:0000269|PubMed:27512957}. Nucleus {ECO:0000269|PubMed:27512957}. Cytoplasm {ECO:0000269|PubMed:27512957}. Note=Also localizes to microtubules. {ECO:0000269|PubMed:27512957}.",SUBUNIT: Interacts with alpha-tubulin (PubMed:27512957). Interacts with SIRT2 (PubMed:27512957). {ECO:0000269|PubMed:27512957}.,X,103215108,103217246,q22.1,0.67195,0.821,-0.30483,0.24036,3.6301,0.5661288090910147,ENST00000372695,0.2275482093663912,0.05981004748812797,363,,,,,,,0.2800450468583309,8.28634521121353,Cerebellar_tissues,broadly expressed,7.791247558917003,8.28634521121353,TRUE,high confidence non-escapee,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:25486,RADX,"RPA1 related single stranded DNA binding protein, X-linked",Approved,CXorf57,"FLJ14191, FLJ10178",Xq22.3,gene with protein product,protein-coding gene,ENSG00000147231,55086,ENSG00000147231,Q6NSI4,MGI:2147848,RGD:1589413,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Single-stranded DNA-binding protein recruited to replication forks to maintain genome stability (PubMed:28735897). Prevents fork collapse by antagonizing the accumulation of RAD51 at forks to ensure the proper balance of fork remodeling and protection without interfering with the capacity of cells to complete homologous recombination of double-strand breaks (PubMed:28735897). {ECO:0000269|PubMed:28735897}.,negative regulation of double-strand break repair via homologous recombination [GO:2000042]; regulation of DNA repair [GO:0006282],RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697],SUBCELLULAR LOCATION: Chromosome {ECO:0000269|PubMed:28735897}. Note=Recruited to replication forks. {ECO:0000269|PubMed:28735897}.,"",X,106611930,106679439,q22.3,2.712e-4,0.648,-0.20912,1.9524,28.097,0.4651581973956956,ENST00000372548,0.6271028037383177,0.1400899775056236,2568,,,,,,,0.6522970042892176,4.944919337495001,Pituitary,tissue-specific,1.927509661031108,0.8741036763283648,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,no difference_Pre_Post2,Post2_higher_vs_Post1,no disorder
HGNC:2555,CUL4B,cullin 4B,Approved,,,Xq24,gene with protein product,protein-coding gene,ENSG00000158290,8450,ENSG00000158290,Q13620,MGI:1919834,RGD:1564494,X,300304,TRUE,"Mental retardation, X-linked, syndromic 15 (Cabezas type)",300354,X-linked recessive,,,,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Core component of multiple cullin-RING-based E3 ubiquitin-protein ligase complexes which mediate the ubiquitination and subsequent proteasomal degradation of target proteins. The functional specificity of the E3 ubiquitin-protein ligase complex depends on the variable substrate recognition subunit. CUL4B may act within the complex as a scaffold protein, contributing to catalysis through positioning of the substrate and the ubiquitin-conjugating enzyme. Plays a role as part of the E3 ubiquitin-protein ligase complex in polyubiquitination of CDT1, histone H2A, histone H3 and histone H4 in response to radiation-induced DNA damage. Targeted to UV damaged chromatin by DDB2 and may be important for DNA repair and DNA replication. Required for ubiquitination of cyclin E, and consequently, normal G1 cell cycle progression. Regulates the mammalian target-of-rapamycin (mTOR) pathway involved in control of cell growth, size and metabolism. Specific CUL4B regulation of the mTORC1-mediated pathway is dependent upon 26S proteasome function and requires interaction between CUL4B and MLST8. With CUL4A, contributes to ribosome biogenesis (PubMed:26711351). {ECO:0000269|PubMed:14578910, ECO:0000269|PubMed:16322693, ECO:0000269|PubMed:16678110, ECO:0000269|PubMed:18235224, ECO:0000269|PubMed:18593899, ECO:0000269|PubMed:19801544, ECO:0000269|PubMed:22118460, ECO:0000269|PubMed:26711351}.","cellular response to DNA damage stimulus [GO:0006974]; DNA damage response, detection of DNA damage [GO:0042769]; G1/S transition of mitotic cell cycle [GO:0000082]; global genome nucleotide-excision repair [GO:0070911]; histone H2A monoubiquitination [GO:0035518]; neuron projection development [GO:0031175]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein catabolic process [GO:0045732]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; ribosome biogenesis [GO:0042254]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; transcription-coupled nucleotide-excision repair [GO:0006283]; ubiquitin-dependent protein catabolic process [GO:0006511]; UV-damage excision repair [GO:0070914]",ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842],"SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:18593899, ECO:0000269|PubMed:19801544}.","SUBUNIT: Component of multiple DCX (DDB1-CUL4-X-box) E3 ubiquitin-protein ligase complexes that seem to be formed of DDB1, CUL4A or CUL4B, RBX1 and a variable substrate recognition component which seems to belong to a protein family described as DCAF (Ddb1- and Cul4-associated factor) or CDW (CUL4-DDB1-associated WD40-repeat) proteins. Component of the DCX(DTL) complex with the putative substrate recognition component DTL. Component of the DCX(DDB2) complex with the putative substrate recognition component DDB2. Part of a complex with RBX1 and TIP120A/CAND1. Interacts with RBX1 GRWD1, MLST8, SMU1, TLE2, TLE3, DCAF1, DDA1, DCAF6, DCAF17, DDB2, DCAF8, TIP120A/CAND1 and TMEM113. Interacts with cyclin E and with importins alpha-1 (KPNA2), alpha-3 (KPNA4), alpha-5 (KPNA1) and beta-1 (KPNB1). May interact with WDR26, WDR51B, SNRNP40, WDR61, WDR76 and WDR5. {ECO:0000269|PubMed:10230407, ECO:0000269|PubMed:12609982, ECO:0000269|PubMed:14578910, ECO:0000269|PubMed:16322693, ECO:0000269|PubMed:16678110, ECO:0000269|PubMed:16949367, ECO:0000269|PubMed:17041588, ECO:0000269|PubMed:18235224, ECO:0000269|PubMed:18593899, ECO:0000269|PubMed:19801544, ECO:0000269|PubMed:22118460}.",X,120523858,120575794,q24,1,0.085,-0.52201,3.7714,35.017,0.45384491740968014,ENST00000371322,0.9836681547619047,0.5166958260434892,2688,1,"CUL4A (68, 82, chr13)",TRUE,,,,0.30766481910033516,6.5982609778004555,Cells - Cultured fibroblasts,broadly expressed,3.803537037877417,4.833127912678638,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:25553,GNL3L,G protein nucleolar 3 like,Approved,,"FLJ10613, GNL3B",Xp11.22,gene with protein product,protein-coding gene,ENSG00000130119,54552,ENSG00000130119,Q9NVN8,MGI:2448557,RGD:1600217,X,300873,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Stabilizes TERF1 telomeric association by preventing TERF1 recruitment by PML. Stabilizes TERF1 protein by preventing its ubiquitination and hence proteasomal degradation. Does so by interfering with TERF1-binding to FBXO4 E3 ubiquitin-protein ligase. Required for cell proliferation. By stabilizing TRF1 protein during mitosis, promotes metaphase-to-anaphase transition. Stabilizes MDM2 protein by preventing its ubiquitination, and hence proteasomal degradation. By acting on MDM2, may affect TP53 activity. Required for normal processing of ribosomal pre-rRNA. Binds GTP. {ECO:0000269|PubMed:16251348, ECO:0000269|PubMed:17034816, ECO:0000269|PubMed:19487455, ECO:0000269|PubMed:21132010}.","negative regulation of protein binding [GO:0032091]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of protein localization to chromosome, telomeric region [GO:1904816]; regulation of protein stability [GO:0031647]; ribosome biogenesis [GO:0042254]",GTP binding [GO:0005525]; RNA binding [GO:0003723],"SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:17034816}.","SUBUNIT: Interacts with MDM2; this interaction, which occurs in the nucleoplasm, stabilizes MDM2. Indirectly interacts with TP53, via MDM2-binding. Interacts with TERF1; this interaction probably occurs in the nucleoplasm and is increased during mitosis, when the nucleolus is disassembled. This binding may promote TERF1 homodimerization. Interacts with TERT. {ECO:0000269|PubMed:19487455, ECO:0000269|PubMed:21132010}.",X,54530183,54621521,p11.22,0.99558,0.232,0.11827,1.3581,20.443,0.3915300347937,ENST00000360845,0.8232132647226987,0.08432891777055736,1749,,,,,,,0.4104919541653198,4.4486961584682545,Cells - EBV-transformed lymphocytes,broadly expressed,1.2492329413234071,1.7048387732377204,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,no disorder
HGNC:25617,RBM41,RNA binding motif protein 41,Approved,,FLJ11016,Xq22.3,gene with protein product,protein-coding gene,ENSG00000089682,55285,ENSG00000089682,Q96IZ5,MGI:2444923,RGD:1590579,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May bind RNA. {ECO:0000305}.,"mRNA splicing, via spliceosome [GO:0000398]",pre-mRNA intronic binding [GO:0097157]; U12 snRNA binding [GO:0030626],"","",X,107064420,107118823,q22.3,0.96551,0.319,-0.58115000000000006,0.68319,14.87,0.38218357247610973,ENST00000372479,0.9169082125603865,0.09172706823294177,1242,,,,,,,0.3659717026867209,3.459602108886086,Testis,broadly expressed,1.191246789716267,2.6165541367141434,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:2563,TEX28,testis expressed 28,Approved,CXorf2,fTEX,Xq28,gene with protein product,protein-coding gene,ENSG00000278057,1527,ENSG00000278057,O15482,MGI:2686384,RGD:1582832,X,300092,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","",SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass membrane protein {ECO:0000305}.,"",X,154271265,154295853,q28,,,,,,0.5446537326843185,ENST00000619903,0.3573398215733982,0.04031492126968258,1233,,,,,,,0.9767441860465116,1.2410164227204061,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:25657,BCORL1,BCL6 corepressor like 1,Approved,CXorf10,FLJ11362,Xq26.1,gene with protein product,protein-coding gene,ENSG00000085185,63035,ENSG00000085185,Q5H9F3,MGI:2443910,RGD:1566108,X,300688,TRUE,Shukla-Vernon syndrome,301029,X-linked recessive,,,,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,confirmed +CS,FALSE,TRUE,confirmed,FUNCTION: Transcriptional corepressor. May specifically inhibit gene expression when recruited to promoter regions by sequence-specific DNA-binding proteins such as BCL6. This repression may be mediated at least in part by histone deacetylase activities which can associate with this corepressor. {ECO:0000269|PubMed:17379597}.,chromatin organization [GO:0006325],"",SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:17379597}.,"SUBUNIT: Interacts with PCGF1, forming heterodimers (PubMed:23523425, PubMed:27568929). The PCGF1-BCORL1 heterodimeric complex interacts with the KDM2B-SKP1 heterodimeric complex to form a homotetrameric polycomb repression complex 1 (PRC1.1) (PubMed:27568929). Interacts with CTBP1, HDAC4, HDAC5 and HDAC7 (PubMed:17379597). {ECO:0000269|PubMed:17379597, ECO:0000269|PubMed:23523425, ECO:0000269|PubMed:27568929}.",X,129981107,130058083,q26.1,0.99999,0.152,1.0188,2.0631,41.383,0.7278670294769298,ENST00000218147,0.7194314641744548,0.7294176455886029,5136,,,,,,,0.2644696094226801,3.883767424185893,Testis,broadly expressed,1.6642825785739557,3.199553783800906,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:25667,TASL,TLR adaptor interacting with endolysosomal SLC15A4,Approved,CXorf21,FLJ11577,Xp21.2,gene with protein product,protein-coding gene,ENSG00000120280,80231,ENSG00000120280,Q9HAI6,MGI:1918648,RGD:1565785,X,301049,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Innate immune adapter that mediates the recruitment and activation of IRF5 downstream of endolysosomal toll-like receptors TLR7, TLR8 and TLR9 (PubMed:32433612). Following recruitment to endolysosome by SLC15A4 downstream of TLR7, TLR8 and TLR9, specifically recruits IRF5 transcription factor via its pLxIS motif, leading to IRF5 activation and subsequent expression of type I interferons (PubMed:32433612). Plays a role in the regulation of endolysosomal pH in immune cells such as B-cells, dendritic cells and monocytes (PubMed:31001245). {ECO:0000269|PubMed:31001245, ECO:0000269|PubMed:32433612}.",regulation of lysosomal lumen pH [GO:0035751],"","SUBCELLULAR LOCATION: Lysosome membrane {ECO:0000269|PubMed:31092820, ECO:0000269|PubMed:32433612}. Endosome membrane {ECO:0000269|PubMed:32433612}. Nucleus {ECO:0000269|PubMed:31092820}. Cytoplasm {ECO:0000269|PubMed:31092820}. Note=Recruited to endolysosome following interaction with SLC15A4 (PubMed:32433612). May colocalize with TLR7 in the endosomal pathway (PubMed:31092820). {ECO:0000269|PubMed:31092820, ECO:0000269|PubMed:32433612}.",SUBUNIT: Interacts (via pLxIS motif) with IRF5; leading to IRF5 activation (PubMed:32433612). Interacts with SLC15A4; leading to its recruitment to endolysosome (PubMed:32433612). {ECO:0000269|PubMed:32433612}.,X,30558809,30577766,p21.2,0.84298,0.492,0.21796,0.92949,6.0886,,,,,,,,,,,,0.8188224296779295,5.59319538855615,Cells - EBV-transformed lymphocytes,tissue-specific,0.44645739902508336,0.14877287800662314,FALSE,variable escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:2567,OFD1,OFD1 centriole and centriolar satellite protein,Approved,"CXorf5, RP23","71-7A, JBTS10",Xp22.2,gene with protein product,protein-coding gene,ENSG00000046651,8481,ENSG00000046651,O75665,MGI:1350328,RGD:1562231,X,300170,TRUE,"Joubert syndrome 10 // Orofaciodigital syndrome I // Simpson-Golabi-Behmel syndrome, type 2",300804 // 311200 // 300209,X-linked recessive // X-linked dominant // X-linked recessive,?Retinitis pigmentosa 23,300424,X-linked recessive,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Component of the centrioles controlling mother and daughter centrioles length. Recruits to the centriole IFT88 and centriole distal appendage-specific proteins including CEP164. Involved in the biogenesis of the cilium, a centriole-associated function. The cilium is a cell surface projection found in many vertebrate cells required to transduce signals important for development and tissue homeostasis. Plays an important role in development by regulating Wnt signaling and the specification of the left-right axis. Only OFD1 localized at the centriolar satellites is removed by autophagy, which is an important step in the ciliogenesis regulation (By similarity). {ECO:0000250}.",ciliary basal body-plasma membrane docking [GO:0097711]; cilium assembly [GO:0060271]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of G2/M transition of mitotic cell cycle [GO:0010389],alpha-tubulin binding [GO:0043014]; gamma-tubulin binding [GO:0043015]; identical protein binding [GO:0042802],"SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriole {ECO:0000269|PubMed:12595504, ECO:0000269|PubMed:14654843, ECO:0000269|PubMed:20230748, ECO:0000269|PubMed:26643951}. Cytoplasm, cytoskeleton, cilium basal body {ECO:0000269|PubMed:17761535}. Nucleus {ECO:0000269|PubMed:17761535}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriolar satellite {ECO:0000269|PubMed:24121310, ECO:0000269|PubMed:26643951}. Note=Localizes to centriole distal ends and to centriolar satellites (PubMed:20230748, PubMed:24121310). Localization to centrioles and pericentriolar satellites may be mediated by KIAA0753/OFIP (PubMed:26643951). {ECO:0000269|PubMed:26643951}.","SUBUNIT: Homooligomer. Interacts with LCA5. Interacts with RUVBL1; the interaction is direct and may mediate interaction with the NuA4 histone acetyltransferase complex. Interacts with SDCCAG8; the interaction is direct. Interacts with MAP1LC3B. Interacts with C2CD3; OFD1 may act as a egative regulator of C2CD3. Forms a complex with KIAA0753/OFIP and CEP20/FOR20; the interaction with CEP20 is detected only in the presence of KIAA0753. Interacts with PCM1; this interaction may be mediated by KIAA0753/OFIP (PubMed:26643951). {ECO:0000269|PubMed:17761535, ECO:0000269|PubMed:19800048, ECO:0000269|PubMed:20835237, ECO:0000269|PubMed:24089205, ECO:0000269|PubMed:24997988, ECO:0000269|PubMed:26643951}.",X,13734745,13769357,p22.2,0.95968,0.322,-0.50839,0.31954,40.891,0.5673868611256182,ENST00000340096,0.5782823297137216,0.08900274931267182,3039,,,,,,,0.23574193616403522,5.58854974672662,Ovary,broadly expressed,3.283043149415033,4.3521264308039385,FALSE,high confidence escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:2568,MAMLD1,mastermind like domain containing 1,Approved,CXorf6,"CG1, F18",Xq28,gene with protein product,protein-coding gene,ENSG00000013619,10046,ENSG00000013619,Q13495,MGI:3045303,,X,300120,TRUE,"Hypospadias 2, X-linked",300758,X-linked recessive,,,,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,FUNCTION: Transactivates the HES3 promoter independently of NOTCH proteins. HES3 is a non-canonical NOTCH target gene which lacks binding sites for RBPJ. {ECO:0000269|PubMed:18162467}.,male gonad development [GO:0008584]; regulation of transcription by RNA polymerase II [GO:0006357],"",SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:18162467}. Note=Punctate nuclear localization.,"",X,150361422,150514178,q28,0.62647,0.445,-0.8965,0.59856,20.571,0.7270549995723207,ENST00000432680,0.5331664998331666,0.20042489377655587,2997,,,,,,,0.45878112609969096,5.2263119954635275,Testis,broadly expressed,3.275781840881083,3.509841497380845,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,no difference_Pre_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:2569,RTL8C,retrotransposon Gag like 8C,Approved,"CXX1, FAM127A","Mart8, Mar8, MAR8C, SIRH5",Xq26.3,gene with protein product,protein-coding gene,ENSG00000134590,8933,ENSG00000134590,"A6ZKI3, O15255","MGI:1913408, MGI:1920115, MGI:3576504",,X,300213,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","",SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Lipid-anchor {ECO:0000305}.,"",X,135032355,135033546,q26.3,0.45663,1.532,-0.50901,1.526,1.5525,0.5104584155849335,ENST00000257013,0.8172514619883041,0.17420644838790303,342,2,"RTL8A (91, 91, chrX); RTL8B (90, 90, chrX)",TRUE,2,"RTL8A (91, 91, chrX); RTL8B (90, 90, chrX)",TRUE,0.13017163585743338,9.00454352640474,Artery - Aorta,broadly expressed,8.55597716114862,8.54536029879857,FALSE,high confidence non-escapee,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:25726,LAS1L,LAS1 like ribosome biogenesis factor,Approved,,"FLJ12525, Las1",Xq12,gene with protein product,protein-coding gene,ENSG00000001497,81887,ENSG00000001497,Q9Y4W2,MGI:1923380,RGD:1565755,X,300964,TRUE,Wilson-Turner syndrome,309585,X-linked recessive,,,,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Involved in the biogenesis of the 60S ribosomal subunit. Required for maturation of the 28S rRNA. Functions as a component of the Five Friends of Methylated CHTOP (5FMC) complex; the 5FMC complex is recruited to ZNF148 by methylated CHTOP, leading to desumoylation of ZNF148 and subsequent transactivation of ZNF148 target genes. {ECO:0000269|PubMed:20647540, ECO:0000269|PubMed:22872859}.",maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]; rRNA processing [GO:0006364],endonuclease activity [GO:0004519]; RNA binding [GO:0003723],"SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:12429849, ECO:0000269|PubMed:20647540}. Nucleus, nucleoplasm {ECO:0000250}. Cytoplasm {ECO:0000250}. Note=Mainly found in the nucleoplasm, with low levels detected in the cytoplasmic and chromatin fractions (By similarity). Localizes mainly to the granular component, the region implicated in the later steps of rRNA processing and subunit assembly and export. {ECO:0000250}.","SUBUNIT: Component of some MLL1/MLL complex, at least composed of the core components KMT2A/MLL1, ASH2L, HCFC1/HCF1, WDR5 and RBBP5, as well as the facultative components BAP18, CHD8, E2F6, HSP70, INO80C, KANSL1, LAS1L, MAX, MCRS1, MGA, KAT8/MOF, PELP1, PHF20, PRP31, RING2, RUVB1/TIP49A, RUVB2/TIP49B, SENP3, TAF1, TAF4, TAF6, TAF7, TAF9 and TEX10. Component of the 5FMC complex, at least composed of PELP1, LAS1L, TEX10, WDR18 and SENP3; the complex interacts with methylated CHTOP and ZNF148. {ECO:0000269|PubMed:15960975, ECO:0000269|PubMed:22872859}.",X,65512582,65534787,q12,0.99955,0.179,0.3162,2.6661,26.564,0.4210640549119618,ENST00000374811,0.7208616780045352,0.14531367158210448,2205,,,,,,,0.31900638055528485,6.600282392499493,Cerebellar_tissues,broadly expressed,4.399034338993341,6.600282392499493,TRUE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,no difference_Pre_Post2,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:25742,MAP7D3,MAP7 domain containing 3,Approved,,FLJ12649,Xq26.3,gene with protein product,protein-coding gene,ENSG00000129680,79649,ENSG00000129680,Q8IWC1,MGI:2445051,RGD:1565514,X,300930,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Promotes the assembly and stability of microtubules. {ECO:0000269|PubMed:22142902, ECO:0000269|PubMed:24927501}.",microtubule cytoskeleton organization [GO:0000226]; microtubule polymerization [GO:0046785],microtubule binding [GO:0008017]; tubulin binding [GO:0015631],"SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, spindle {ECO:0000269|PubMed:15561729}. Note=Localizes to the microtubules throughout mitosis. {ECO:0000269|PubMed:22142902}.","SUBUNIT: Interacts (via N-terminus coiled coil domains) with tubulin and microtubules. {ECO:0000269|PubMed:22142902, ECO:0000269|PubMed:24927501}.",X,136213220,136256482,q26.3,4.6062e-10,0.981,1.2856,-0.11114,28.41,0.6560867519992077,ENST00000316077,0.20611934625617637,0.047313171707073234,2631,,,,,,,0.41590140653467145,5.214781486324231,Artery - Tibial,broadly expressed,0.7678666321766285,0.44134324025912275,FALSE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:25748,TRMT2B,tRNA methyltransferase 2 homolog B,Approved,CXorf34,FLJ12687,Xq22.1,gene with protein product,protein-coding gene,ENSG00000188917,79979,ENSG00000188917,Q96GJ1,MGI:2442530,RGD:1565132,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Probable S-adenosyl-L-methionine-dependent methyltransferase that catalyzes the formation of 5-methyl-uridine at position 54 (m5U54) in all tRNA. May also have a role in tRNA stabilization or maturation (By similarity). {ECO:0000250}.,"",S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity [GO:0030697],"","",X,101009346,101052116,q22.1,4.5938e-7,1.018,-0.1878,1.0304,20.296,0.45253590356152346,ENST00000372936,0.7033663366336633,0.1316420894776306,1515,,,,,,,0.21238167006888692,4.141359215530043,Spleen,broadly expressed,2.0929921806571308,1.93769843051765,FALSE,low confidence non-escapee,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:25772,ARMCX5,armadillo repeat containing X-linked 5,Approved,,"FLJ12969, GASP5",Xq22.1,gene with protein product,protein-coding gene,ENSG00000125962,64860,ENSG00000125962,Q6P1M9,MGI:2148026,RGD:7586448,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,102599168,102604159,q22.1,0.033415,0.889,0.0013212,1.0357,10.291,0.4040817645981272,ENST00000246174,0.5174716756112105,0.17945513621594603,1677,,,,,,,0.2635318028665357,3.635220390838109,Thyroid,broadly expressed,1.7244800193076046,2.1801956106453972,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,no disorder
HGNC:2578,CYBB,cytochrome b-245 beta chain,Approved,CGD,"GP91-PHOX, NOX2",Xp21.1-p11.4,gene with protein product,protein-coding gene,ENSG00000165168,1536,ENSG00000165168,P04839,MGI:88574,RGD:620574,X,300481,TRUE,"Chronic granulomatous disease, X-linked // Immunodeficiency 34, mycobacteriosis, X-linked",306400 // 300645,X-linked recessive // X-linked recessive,,,,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,FUNCTION: Critical component of the membrane-bound oxidase of phagocytes that generates superoxide. It is the terminal component of a respiratory chain that transfers single electrons from cytoplasmic NADPH across the plasma membrane to molecular oxygen on the exterior. Also functions as a voltage-gated proton channel that mediates the H(+) currents of resting phagocytes. It participates in the regulation of cellular pH and is blocked by zinc.,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; cell redox homeostasis [GO:0045454]; cellular response to cadmium ion [GO:0071276]; cellular response to ethanol [GO:0071361]; cellular response to L-glutamine [GO:1904845]; cellular response to oxidative stress [GO:0034599]; defense response [GO:0006952]; electron transport chain [GO:0022900]; hydrogen peroxide biosynthetic process [GO:0050665]; hypoxia-inducible factor-1alpha signaling pathway [GO:0097411]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; neutrophil degranulation [GO:0043312]; oxidation-reduction process [GO:0055114]; positive regulation of angiogenesis [GO:0045766]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of ion transmembrane transport [GO:0034765]; respiratory burst [GO:0045730]; response to aldosterone [GO:1904044]; response to angiotensin [GO:1990776]; response to drug [GO:0042493]; response to nutrient [GO:0007584]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]",flavin adenine dinucleotide binding [GO:0050660]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; superoxide-generating NADPH oxidase activity [GO:0016175]; voltage-gated ion channel activity [GO:0005244],SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein. Note=As unassembled monomer may localize to the endoplasmic reticulum. {ECO:0000305|PubMed:28351984}.,"SUBUNIT: Composed of a heavy chain (beta) and a light chain (alpha). Component of an NADPH oxidase complex composed of a heterodimer formed by the membrane proteins CYBA and CYBB and the cytosolic subunits NCF1, NCF2 and NCF4. Interacts with NCF1. Interacts with calprotectin (S100A8/9). Interacts with NRROS; the interaction is direct and impairs formation of a stable NADPH oxidase complex (PubMed:19028840, PubMed:3600769, PubMed:9224653). Interacts with CYBC1; CYBC1 may act as a chaperone stabilizing Cytochrome b-245 heterodimer (PubMed:28351984). {ECO:0000269|PubMed:19028840, ECO:0000269|PubMed:28351984, ECO:0000269|PubMed:3600769, ECO:0000269|PubMed:9224653}.",X,37780059,37813461,p21.1,0.99904,0.193,-0.4819,2.1906,24.539,0.15455154293957035,ENST00000378588,0.8351430239346176,0.10772306923269183,1713,2,"NOX3 (59, 59, chr6); NOX1 (58, 59, chrX)",TRUE,,,,0.5552211238815806,6.562138607509336,Whole Blood,broadly expressed,1.8311273312050222,1.8483375026763667,FALSE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:2582,CYLC1,cylicin 1,Approved,,,Xq21.1,gene with protein product,protein-coding gene,ENSG00000183035,1538,ENSG00000183035,P35663,MGI:1914657,RGD:2323810,X,300768,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Possible architectural role during spermatogenesis. May be involved in spermatid differentiation.,cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283],structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198],"SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, perinuclear theca, calyx. Note=Sperm head cytoskeletal structure.","",X,83861126,83886699,q21.1,0.93145,0.367,-1.6266,-1.5283,12.939,0.27056277056277056,ENST00000329312,0.21150306748466258,0.03954011497125719,1956,,,,,,,0.9767441860465116,6.036070284408476,Testis,tissue-specific,0,0,FALSE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:25864,TMEM35A,transmembrane protein 35A,Approved,TMEM35,"FLJ14084, TUF-1, NACHO",Xq22.1,gene with protein product,protein-coding gene,ENSG00000126950,59353,ENSG00000126950,Q53FP2,MGI:1914814,RGD:1303093,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: A soluble peptide released by shedding may interact with NGFR and modulate neurite outgrowth. {ECO:0000250}.,"","",SUBCELLULAR LOCATION: Peroxisome membrane {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}. Cytoplasmic vesicle {ECO:0000250}. Note=Shedding may lead to a soluble peptide. {ECO:0000250}.,SUBUNIT: May interact with NGFR. {ECO:0000250}.,X,101078879,101096367,q22.1,0.65922,0.853,0.59176,1.0684,3.4894,0.2467686076294046,ENST00000372930,0.9212301587301587,0.29997500624843787,504,,,,,,,0.6498038376785824,5.947137788700611,Colon - Sigmoid,tissue-specific,4.281891091045805,5.921680298168225,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:25866,DIPK2B,divergent protein kinase domain 2B,Approved,CXorf36,"FLJ14103, DIA1R",Xp11.3,gene with protein product,protein-coding gene,ENSG00000147113,79742,ENSG00000147113,Q9H7Y0,MGI:1923155,RGD:1559731,X,300959,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","",SUBCELLULAR LOCATION: Secreted {ECO:0000305}.,"",X,45148373,45200901,p11.3,3.2801e-5,1.355,-0.2625,0.53934,10.624,0.16380435617209696,ENST00000398000,0.7774193548387097,0.20244938765308673,1302,,,,,,,0.4343939285792368,5.495151491587075,Adipose - Subcutaneous,broadly expressed,2.103712475324157,1.5662160372572769,FALSE,low confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,no difference_Post1_Post2,no disorder
HGNC:25899,MAP7D2,MAP7 domain containing 2,Approved,,FLJ14503,Xp22.12,gene with protein product,protein-coding gene,ENSG00000184368,256714,ENSG00000184368,Q96T17,MGI:1917474,RGD:1564852,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",microtubule cytoskeleton organization [GO:0000226],"","","",X,20006713,20116907,p22.12,0.041409,0.478,-0.35367,-0.24603,32.834,0.8003793266951162,ENST00000379643,0.7623600344530577,0.06883279180204949,2322,,,,,,,0.8176919912045192,5.4282780896064,Cerebellar_tissues,tissue-specific,4.077148981381797,5.4282780896064,TRUE,discordant,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:25955,ZNF280C,zinc finger protein 280C,Approved,SUHW3,"FLJ20095, ZNF633, ZPET",Xq26.1,gene with protein product,protein-coding gene,ENSG00000056277,55609,ENSG00000056277,Q8ND82,MGI:2387585,RGD:1564669,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May function as a transcription factor.,"regulation of transcription, DNA-templated [GO:0006355]",DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872],SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.,"",X,130202707,130268899,q26.1,0.99899,0.194,0.089249,1.5458,24.394,0.5758643724230069,ENST00000370978,0.7008581752484192,0.074656335916021,2214,1,"AC090517.4 (65, 64, chr15)",TRUE,,,,0.47066369521333057,3.561790461653818,Testis,broadly expressed,1.0998136060221575,2.0020939941515232,FALSE,discordant,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,no disorder
HGNC:25960,NUP62CL,nucleoporin 62 C-terminal like,Approved,,FLJ20130,Xq22.3,gene with protein product,protein-coding gene,ENSG00000198088,54830,ENSG00000198088,Q9H1M0,MGI:2685565,RGD:1564353,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",protein import into nucleus [GO:0006606]; RNA export from nucleus [GO:0006405],phospholipid binding [GO:0005543]; structural constituent of nuclear pore [GO:0017056],"","",X,107123427,107206433,q22.3,0.0013073,1.49,0.78271,0.26804,6.9302,0.6396633573339254,ENST00000372466,0.7162162162162162,0.10007498125468633,555,,,,,,,0.7544486610356347,4.182390380400666,Testis,tissue-specific,0.392697694550205,0.1773909927769812,FALSE,discordant,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:25974,GDPD2,glycerophosphodiester phosphodiesterase domain containing 2,Approved,,"OBDPF, FLJ20207, GDE3",Xq13.1,gene with protein product,protein-coding gene,ENSG00000130055,54857,ENSG00000130055,Q9HCC8,MGI:1918834,RGD:1560780,X,300940,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Has glycerophosphoinositol inositolphosphodiesterase activity and specifically hydrolyzes glycerophosphoinositol, with no activity for other substrates such as glycerophosphoinositol 4-phosphate, glycerophosphocholine, glycerophosphoethanolamine, and glycerophosphoserine. Accelerates the program of osteoblast differentiation and growth. May play a role in remodeling of the actin cytoskeleton (By similarity). {ECO:0000250}.",actin filament reorganization [GO:0090527]; lipid metabolic process [GO:0006629]; positive regulation of osteoblast differentiation [GO:0045669],glycerophosphoinositol inositolphosphodiesterase activity [GO:0047394]; metal ion binding [GO:0046872],"SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein. Cytoplasm. Cytoplasm, cytoskeleton {ECO:0000250}. Note=Colocalizes with the actin cytoskeleton. {ECO:0000250}.","",X,70423031,70433390,q13.1,0.31473,0.457,0.72945,2.0028,25.926,0.19484947877764427,ENST00000374382,0.7057407407407408,0.24973756560859786,1620,,,,,,,0.8750762862780567,7.0143999301281355,Spleen,tissue-specific,2.6556884181881713,1.2604894123893575,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:26007,KRBOX4,KRAB box domain containing 4,Approved,ZNF673,FLJ20344,Xp11.3,gene with protein product,protein-coding gene,ENSG00000147121,55634,ENSG00000147121,Q5JUW0,,,X,300585,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","regulation of transcription, DNA-templated [GO:0006355]",nucleic acid binding [GO:0003676],"","",X,46447292,46497422,p11.3,0.64798,0.882,-0.52771,0.25919,3.368,0.36549230508164837,ENST00000344302,0.1994186046511628,0.019195201199700074,516,,,,,,,0.21939958460322856,4.12607254243185,Cerebellar_tissues,broadly expressed,3.110154408329599,4.12607254243185,TRUE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,no disorder
HGNC:26044,GEMIN8,gem nuclear organelle associated protein 8,Approved,FAM51A1,FLJ20514,Xp22.2,gene with protein product,protein-coding gene,ENSG00000046647,54960,ENSG00000046647,Q9NWZ8,MGI:2384300,RGD:1359160,X,300962,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: The SMN complex plays a catalyst role in the assembly of small nuclear ribonucleoproteins (snRNPs), the building blocks of the spliceosome. Thereby, plays an important role in the splicing of cellular pre-mRNAs. Most spliceosomal snRNPs contain a common set of Sm proteins SNRPB, SNRPD1, SNRPD2, SNRPD3, SNRPE, SNRPF and SNRPG that assemble in a heptameric protein ring on the Sm site of the small nuclear RNA to form the core snRNP. In the cytosol, the Sm proteins SNRPD1, SNRPD2, SNRPE, SNRPF and SNRPG are trapped in an inactive 6S pICln-Sm complex by the chaperone CLNS1A that controls the assembly of the core snRNP. Dissociation by the SMN complex of CLNS1A from the trapped Sm proteins and their transfer to an SMN-Sm complex triggers the assembly of core snRNPs and their transport to the nucleus. {ECO:0000269|PubMed:17023415, ECO:0000269|PubMed:18984161}.",import into nucleus [GO:0051170]; spliceosomal snRNP assembly [GO:0000387],"","SUBCELLULAR LOCATION: Nucleus, gem {ECO:0000269|PubMed:16434402}. Cytoplasm {ECO:0000269|PubMed:16434402}. Note=Found in nuclear bodies called gems (Gemini of Cajal bodies) that are often in proximity to Cajal (coiled) bodies. Also found in the cytoplasm.","SUBUNIT: Part of the core SMN complex that contains SMN1, GEMIN2/SIP1, DDX20/GEMIN3, GEMIN4, GEMIN5, GEMIN6, GEMIN7, GEMIN8 and STRAP/UNRIP. Part of the SMN-Sm complex that contains SMN1, GEMIN2/SIP1, DDX20/GEMIN3, GEMIN4, GEMIN5, GEMIN6, GEMIN7, GEMIN8, STRAP/UNRIP and the Sm proteins SNRPB, SNRPD1, SNRPD2, SNRPD3, SNRPE, SNRPF and SNRPG. Interacts directly with SMN1 and with the GEMIN6-GEMIN7 heterodimer, mediating their interaction. {ECO:0000269|PubMed:16434402, ECO:0000269|PubMed:17023415, ECO:0000269|PubMed:18984161}.",X,14008279,14029893,p22.2,0.94464,0.327,0.30538,0.59997,9.1451,0.5230386388054229,ENST00000380523,0.527846364883402,0.04358910272431892,729,,,,,,,0.2132745361308826,5.031562818666648,Nerve - Tibial,broadly expressed,3.4266069348036683,3.95448016761311,FALSE,high confidence escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,no disorder
HGNC:26047,CT55,cancer/testis antigen 55,Approved,CXorf48,FLJ20527,Xq26.3,gene with protein product,protein-coding gene,ENSG00000169551,54967,ENSG00000169551,Q8WUE5,,RGD:1560456,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,135156540,135171398,q26.3,0.48549,0.802,-0.42557,0.84162,5.909,0.3319273172675837,ENST00000276241,0.3593710691823899,0.03171707073231692,795,,,,,,,0.9736149517626409,2.339887049392734,Testis,tissue-specific,0.06728502051070778,0.012199496566878387,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:26058,LAGE3,L antigen family member 3,Approved,,"ITBA2, CVG5, DXS9951E, DXS9879E, ESO3, Pcc1",Xq28,gene with protein product,protein-coding gene,ENSG00000196976,8270,ENSG00000196976,Q14657,MGI:1913442,RGD:1562476,X,300060,TRUE,"Galloway-Mowat syndrome 2, X-linked",301006,X-linked recessive,,,,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Component of the EKC/KEOPS complex that is required for the formation of a threonylcarbamoyl group on adenosine at position 37 (t(6)A37) in tRNAs that read codons beginning with adenine. The complex is probably involved in the transfer of the threonylcarbamoyl moiety of threonylcarbamoyl-AMP (TC-AMP) to the N6 group of A37. LAGE3 functions as a dimerization module for the complex. {ECO:0000305|PubMed:22912744, ECO:0000305|PubMed:27903914}.",positive regulation of transcription by RNA polymerase II [GO:0045944]; tRNA processing [GO:0008033]; tRNA threonylcarbamoyladenosine metabolic process [GO:0070525],"","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:28805828}. Nucleus {ECO:0000269|PubMed:22912744, ECO:0000269|PubMed:27903914, ECO:0000269|PubMed:28805828}.","SUBUNIT: Component of the EKC/KEOPS complex composed of at least GON7, TP53RK, TPRKB, OSGEP and LAGE3; the whole complex dimerizes. {ECO:0000269|PubMed:22912744, ECO:0000269|PubMed:27903914, ECO:0000269|PubMed:28805828}.",X,154477769,154479257,q28,0.12721,1.806,0.56517,0.40929,1.6806,0.5595806599252166,ENST00000357360,0.26064814814814813,0.059885028742814296,432,,,,,,,0.2347239124585825,5.942369055580617,Pituitary,broadly expressed,5.25819477185704,5.463037125989462,FALSE,high confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:26086,TMEM255A,transmembrane protein 255A,Approved,FAM70A,FLJ20716,Xq24,gene with protein product,protein-coding gene,ENSG00000125355,55026,ENSG00000125355,Q5JRV8,MGI:3045722,RGD:727788,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",response to bacterium [GO:0009617],"",SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.,"",X,120258650,120311556,q24,0.0024035,0.982,0.67801,0.27418,12.065,0.46548966876591596,ENST00000371369,0.9383435582822086,0.33444138965258685,978,,,,,,,0.6439660210735922,4.475448105756687,Cervix - Ectocervix,tissue-specific,2.2922929166723747,2.0980337678588605,FALSE,low confidence non-escapee,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,no difference_Post1_Post2,no disorder
HGNC:26094,ARMCX6,armadillo repeat containing X-linked 6,Approved,,"FLJ20811, GASP10",Xq22.1,gene with protein product,protein-coding gene,ENSG00000198960,54470,ENSG00000198960,Q7L4S7,MGI:2147993,RGD:1359303,X,301048,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May regulate the dynamics and distribution of mitochondria in neural cells. {ECO:0000250|UniProtKB:Q8K3A6}.,"","",SUBCELLULAR LOCATION: Mitochondrion {ECO:0000250|UniProtKB:Q8K3A6}. Mitochondrion outer membrane {ECO:0000250|UniProtKB:Q8BHS6}; Single-pass membrane protein {ECO:0000255}.,"",X,101615118,101618001,q22.1,0.11709,1.186,-1.841,-0.9364,5.2724,0.2966350179920547,ENST00000361910,0.5761904761904761,0.28395401149712574,903,,,,,,,0.21622220817441548,4.108624814681649,Cells - Cultured fibroblasts,broadly expressed,2.253444750262485,2.74425045376449,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:26121,TCEAL4,transcription elongation factor A like 4,Approved,,"FLJ21174, WEX7",Xq22.2,gene with protein product,protein-coding gene,ENSG00000133142,79921,ENSG00000133142,Q96EI5,,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May be involved in transcriptional regulation.,"",WW domain binding [GO:0050699],SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.,"",X,103576231,103587736,q22.2,0.74827,0.656,-0.30604,0.9526,4.5631,0.4384378459548628,ENST00000472484,0.27901234567901234,0.16635841039740065,648,,,,,,,0.2664536757997662,9.534129709743937,Ovary,broadly expressed,6.505467012287542,6.729134665467333,FALSE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:26217,TMEM164,transmembrane protein 164,Approved,,"FLJ22679, RP13-360B22.2",Xq23,gene with protein product,protein-coding gene,ENSG00000157600,84187,ENSG00000157600,Q5U3C3,MGI:2148020,RGD:1563286,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","",SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.,"",X,110002631,110182734,q23,0.94373,0.329,0.1771,2.3633,9.0987,0.5004160084889848,ENST00000372068,0.9757270693512304,0.3865533616595851,894,,,,,,,0.2504303478794038,4.824722036412368,Skin - Sun Exposed (Lower leg),broadly expressed,2.934395721536855,2.6277982509866065,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:26233,EFHC2,EF-hand domain containing 2,Approved,MRX74,FLJ22843,Xp11.3,gene with protein product,protein-coding gene,ENSG00000183690,80258,ENSG00000183690,Q5JST6,MGI:1921655,RGD:1563388,X,300817,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",cellular response to leukemia inhibitory factor [GO:1990830]; cilium-dependent cell motility [GO:0060285]; mitotic cytokinesis [GO:0000281]; mitotic spindle organization [GO:0007052]; regulation of neuron projection development [GO:0010975],alpha-tubulin binding [GO:0043014]; calcium ion binding [GO:0005509],"","",X,44147872,44343672,p11.3,0.9991,0.147,0.28069,0.62188,20.308,0.47091052134096295,ENST00000420999,0.6813777777777777,0.08902774306423394,2250,,,,,,,0.634999108803792,3.723984426745611,Testis,tissue-specific,1.4324196315001572,0.6931073184583071,FALSE,discordant,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,no difference_Post1_Post2,no disorder
HGNC:26237,CSAG3,CSAG family member 3,Approved,CSAG3A,,Xq28,gene with protein product,protein-coding gene,ENSG00000268916,389903,ENSG00000268916,Q9Y5P2,,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Drug-resistance related protein, its expression is associated with the chemotherapy resistant and neoplastic phenotype. May also be linked to the malignant phenotype.",response to drug [GO:0042493],"","","",X,152753921,152760222,q28,,,,,,0.18585633305454885,ENST00000599845,0.015104166666666667,0.055486128467883034,384,1,"CSAG2 (99, 99, chrX)",TRUE,1,"CSAG2 (99, 99, chrX)",TRUE,0.9601700049573908,1.4787699429952879,Testis,tissue-specific,0.03822629429673628,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:26239,CXorf56,chromosome X open reading frame 56,Approved,,FLJ22965,Xq24,gene with protein product,protein-coding gene,ENSG00000018610,63932,ENSG00000018610,Q9H5V9,MGI:1924894,RGD:1564541,X,301012,TRUE,,,,"?Mental retardation, X-linked 107",301013,X-linked,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,PMT +CS,FALSE,,PMT,"","","",SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:29374277}. Cytoplasm {ECO:0000250|UniProtKB:Q8VDP2}. Note=Detected in the nucleus and cell soma of various neuronal types. {ECO:0000250|UniProtKB:Q8VDP2}.,"",X,119538149,119565409,q24,0.95204,0.313,1.5337,2.2384,9.5476,0.4167850715165293,ENST00000644802,0.9491778774289985,0.1274431392151962,669,,,,,,,0.14280217609294815,4.585058677184702,Artery - Tibial,broadly expressed,3.5244523885857086,4.5044805649629085,FALSE,low confidence non-escapee,no_difference_Pre_Post,Pre_higher_vs_Post1,no difference_Pre_Post2,Post2_higher_vs_Post1,PMT
HGNC:26356,CXorf58,chromosome X open reading frame 58,Approved,,FLJ25444,Xp22.11,gene with protein product,protein-coding gene,ENSG00000165182,254158,ENSG00000165182,Q96LI9,MGI:1921682,RGD:1590267,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,23908006,23939509,p22.11,3.0653e-7,1.407,-0.10773,0.40424,12.919,0.5360505551126977,ENST00000379211,0.5363363363363364,0.1250687328167958,999,,,,,,,0.9440953882006657,2.883591492917732,Testis,tissue-specific,0.09880625493364685,0.08098279584336757,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:26371,CBLL2,Cbl proto-oncogene like 2,Approved,ZNF645,"FLJ25735, HAKAIL, CT138",Xp22.11,gene with protein product,protein-coding gene,ENSG00000175809,158506,ENSG00000175809,Q8N7E2,,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: E3 ubiquitin ligase catalyzing the covalent attachment of ubiquitin moieties onto substrate proteins (PubMed:20657603). May operate on tyrosine-phosphorylated SRC substrates (PubMed:22252131). {ECO:0000269|PubMed:20657603, ECO:0000269|PubMed:22252131}.",protein ubiquitination [GO:0016567]; regulation of cell adhesion [GO:0030155],metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:20657603}. Note=Localized over the postacrosomal perinuclear theca region and the entire length of sperm tail. {ECO:0000269|PubMed:20657603}.,SUBUNIT: Homodimer. {ECO:0000250|UniProtKB:Q9JIY2}.,X,22272913,22274461,p22.11,,,0.21446,0.31007,,0.4508180350040231,ENST00000323684,0.5320031298904538,0.291327168207948,1278,,,,,,,0.9765025704464042,4.365265599771611,Testis,tissue-specific,0,0.04535279950323021,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:26372,FMR1NB,FMR1 neighbor,Approved,,"FLJ25736, NY-SAR-35, CT37",Xq27.3-q28,gene with protein product,protein-coding gene,ENSG00000176988,158521,ENSG00000176988,Q8N0W7,MGI:2672032,RGD:1564059,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","",SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.,"",X,147981337,148026665,q27.3,0.081815,0.919,-0.82438,-0.31996,8.4381,0.47819984325671805,ENST00000370467,0.12486979166666667,0.057085728567858034,768,,,,,,,0.9735081601752876,6.805408547633624,Testis,tissue-specific,0,0.09952736360354608,FALSE,discordant,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:26388,ARHGAP36,Rho GTPase activating protein 36,Approved,,FLJ30058,Xq26.1,gene with protein product,protein-coding gene,ENSG00000147256,158763,ENSG00000147256,Q6ZRI8,MGI:1922654,RGD:1565967,X,300937,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: GTPase activator for the Rho-type GTPases by converting them to an inactive GDP-bound state. {ECO:0000250}.,regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165],GTPase activator activity [GO:0005096],"","",X,131058346,131089885,q26.1,0.87324,0.405,1.4182,1.1879,15.531,0.3726231161831349,ENST00000276211,0.7962895377128953,0.33331667083229194,1644,,,,,,,0.9571183564041001,8.17229748520911,Pituitary,tissue-specific,1.1978591023468268,0.4596487934710665,FALSE,low confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,no difference_Post1_Post2,no disorder
HGNC:26392,PTCHD1,patched domain containing 1,Approved,,FLJ30296,Xp22.11,gene with protein product,protein-coding gene,ENSG00000165186,139411,ENSG00000165186,Q96NR3,MGI:2685233,RGD:1564527,X,300828,TRUE,,,,"{Autism, susceptibility to, X-linked 4}",300830,X-linked recessive,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,PMT +CS,FALSE,,PMT,"FUNCTION: Required for the development and function of the thalamic reticular nucleus (TRN), a part of the thalamus that is critical for thalamocortical transmission, generation of sleep rhythms, sensorimotor processing and attention. {ECO:0000250|UniProtKB:Q14B62}.",chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; excitatory chemical synaptic transmission [GO:0098976]; inhibitory chemical synaptic transmission [GO:0098977]; long-term memory [GO:0007616]; short-term memory [GO:0007614]; smoothened signaling pathway [GO:0007224]; social behavior [GO:0035176]; thalamus development [GO:0021794],"",SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:20844286}; Multi-pass membrane protein {ECO:0000269|PubMed:20844286}.,"",X,23334849,23404374,p22.11,0.98224,0.284,-0.22546,2.004,16.691,0.7515316173811961,ENST00000379361,0.9756280464941882,0.46820794801299676,2667,,,,,,,0.7904625649864888,4.577459041228091,Cerebellar_tissues,tissue-specific,1.385270882251988,4.577459041228091,TRUE,discordant,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,no difference_Post1_Post2,PMT
HGNC:26411,HDX,highly divergent homeobox,Approved,CXorf43,FLJ30678,Xq21.1,gene with protein product,protein-coding gene,ENSG00000165259,139324,ENSG00000165259,Q7Z353,MGI:2685226,RGD:1563666,X,300994,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",cell differentiation [GO:0030154]; positive regulation of transcription by RNA polymerase II [GO:0045944],"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]",SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00108}.,"",X,84317874,84502479,q21.1,0.075851,0.555,0.043547,0.12931,21.323,0.3424580376253239,ENST00000373177,0.9609744331886155,0.15153711572106973,2073,,,,,,,0.4826465833353202,2.4495006282800036,Artery - Tibial,broadly expressed,0.9030837875806415,2.120439866431402,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:26440,FAAH2,fatty acid amide hydrolase 2,Approved,AMDD,"RP11-479E16.1, FLJ31204, FAAH-2",Xp11.21,gene with protein product,protein-coding gene,ENSG00000165591,158584,ENSG00000165591,Q6GMR7,,,X,300654,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Catalyzes the hydrolysis of endogenous amidated lipids like the sleep-inducing lipid oleamide ((9Z)-octadecenamide), the endocannabinoid anandamide (N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-ethanolamine), as well as other fatty amides, to their corresponding fatty acids, thereby regulating the signaling functions of these molecules (PubMed:17015445, PubMed:19926788). Hydrolyzes monounsaturated substrate anandamide preferentially as compared to polyunsaturated substrates. {ECO:0000269|PubMed:17015445, ECO:0000269|PubMed:19926788}.",arachidonic acid metabolic process [GO:0019369]; lipid catabolic process [GO:0016042],anandamide amidohydrolase activity [GO:0103073]; fatty acid amide hydrolase activity [GO:0017064]; oleamide hydrolase activity [GO:0102077],SUBCELLULAR LOCATION: Membrane {ECO:0000305|PubMed:17015445}; Single-pass membrane protein {ECO:0000305}. Lipid droplet {ECO:0000269|PubMed:19926788}.,SUBUNIT: Homodimer. {ECO:0000250}.,X,57286706,57489196,p11.21,1.8917e-21,1.935,-4.6632,-3.6273,16.396,0.3438422593993431,ENST00000374900,0.7525953721075672,0.0667583104223944,1599,,,,,,,0.5656795785291017,4.339864251654171,Pituitary,broadly expressed,1.1646961873261463,3.3006362662693434,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:26537,RIBC1,RIB43A domain with coiled-coils 1,Approved,,FLJ32783,Xp11.22,gene with protein product,protein-coding gene,ENSG00000158423,158787,ENSG00000158423,Q8N443,MGI:1913861,RGD:1359621,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,53422690,53431120,p11.22,0.983,0.282,1.3406,1.0128,16.809,0.4919636617749826,ENST00000375327,0.5278947368421053,0.1561859535116221,1140,,,,,,,0.7923086596674571,5.522184465774006,Testis,tissue-specific,0.8606791955157771,0.7750269354690741,FALSE,low confidence escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:26583,PWWP3B,PWWP domain containing 3B,Approved,MUM1L1,FLJ33516,Xq22.3,gene with protein product,protein-coding gene,ENSG00000157502,139221,ENSG00000157502,Q5H9M0,MGI:2445062,RGD:1565148,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,106168305,106208956,q22.3,0.48293,0.531,-1.5383,0.11631,14.601,0.31761081931914514,ENST00000357175,0.49684361549497846,0.05946013496625844,2091,,,,,,,0.7925088040798717,7.7433197267701654,Ovary,tissue-specific,1.3662074935699728,0.21369442005585948,FALSE,high confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:26634,KLHL34,kelch like family member 34,Approved,,"FLJ34960, RP11-450P7.3",Xp22.12,gene with protein product,protein-coding gene,ENSG00000185915,257240,ENSG00000185915,Q8N239,MGI:2685234,RGD:1560439,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,21654690,21658330,p22.12,3.0037e-5,1.374,2.4734,1.4595,10.477,0.7243395990199059,ENST00000379499,0.6780878552971576,0.39427643089227693,1935,,,,,,,0.9175111811590212,3.2515888276453357,Muscle - Skeletal,tissue-specific,0.4121257289868039,1.678245468919006,FALSE,,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,no difference_Post1_Post2,no disorder
HGNC:26659,FAM47B,family with sequence similarity 47 member B,Approved,,FLJ35782,Xp21.1,gene with protein product,protein-coding gene,ENSG00000189132,170062,ENSG00000189132,Q8NA70,,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,34942796,34944915,p21.1,,,-1.4602,-0.71373,,0.621807683766378,ENST00000329357,0.08952528379772962,0.13186703324168958,1938,1,"FAM47A (67, 55, chrX)",TRUE,,,,0.9767441860465116,4.50373670943915,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:26708,CFAP47,cilia and flagella associated protein 47,Approved,"CXorf59, CXorf22, CXorf30, CHDC2","FLJ36601, RP13-11B7.1, MGC34831",Xp21.1,gene with protein product,protein-coding gene,ENSG00000165164,286464,ENSG00000165164,Q6ZTR5,MGI:3781475,RGD:1587070,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,35919734,36385317,p21.1,0.98906,0.289,-1.4232,0.10109,26.822,0.39528432732316227,ENST00000378653,0.47478042659974906,0.059335166208447886,9564,,,,,,,0.9426956309526816,2.1794441688187085,Pituitary,tissue-specific,0.12135577050600665,0.012627660110756767,FALSE,low confidence escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:26748,FAM133A,family with sequence similarity 133 member A,Approved,,"RP1-32F7.2, FLJ37659, CT115",Xq21.32,gene with protein product,protein-coding gene,ENSG00000179083,286499,ENSG00000179083,Q8N9E0,,RGD:9153529,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,93674013,93712274,q21.32,0.39581,0.947,-0.19006,0.071696,4.9971,0.5361186855848777,ENST00000322139,0.7536813922356091,0.40702324418895275,747,1,"FAM133B (80, 80, chr7)",TRUE,,,,0.8721539894754188,4.130239000852395,Testis,tissue-specific,2.0279042277472943,2.3015130225159495,FALSE,high confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:26779,GAGE12B,G antigen 12B,Approved,,OTTHUMG00000024142,Xp11.23,gene with protein product,protein-coding gene,ENSG00000236737,729428,ENSG00000236737,A1L429,,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,49529869,49529985,p11.23,,,,,,0.5516084903578836,ENST00000361446,0.15217391304347827,0.0923453237410072,23,,,,,,,,0,,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:26837,AMER1,APC membrane recruitment protein 1,Approved,FAM123B,"RP11-403E24.2, FLJ39827, WTX",Xq11.2,gene with protein product,protein-coding gene,ENSG00000184675,139285,ENSG00000184675,Q5JTC6,MGI:1919595,RGD:1560322,X,300647,TRUE,Osteopathia striata with cranial sclerosis,300373,X-linked dominant,,,,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,confirmed +CS,FALSE,TRUE,confirmed,"FUNCTION: Regulator of the canonical Wnt signaling pathway. Acts by specifically binding phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2), translocating to the cell membrane and interacting with key regulators of the canonical Wnt signaling pathway, such as components of the beta-catenin destruction complex. Acts both as a positive and negative regulator of the Wnt signaling pathway, depending on the context: acts as a positive regulator by promoting LRP6 phosphorylation. Also acts as a negative regulator by acting as a scaffold protein for the beta-catenin destruction complex and promoting stabilization of Axin at the cell membrane. Promotes CTNNB1 ubiquitination and degradation. Involved in kidney development. {ECO:0000269|PubMed:17510365, ECO:0000269|PubMed:17925383, ECO:0000269|PubMed:19416806, ECO:0000269|PubMed:21304492, ECO:0000269|PubMed:21498506}.",adipose tissue development [GO:0060612]; beta-catenin destruction complex assembly [GO:1904885]; beta-catenin destruction complex disassembly [GO:1904886]; bone development [GO:0060348]; mesenchymal cell differentiation involved in kidney development [GO:0072161]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of protein ubiquitination [GO:0031398]; regulation of canonical Wnt signaling pathway [GO:0060828]; Wnt signaling pathway [GO:0016055],"beta-catenin binding [GO:0008013]; beta-catenin destruction complex binding [GO:1904713]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]","SUBCELLULAR LOCATION: Cytoplasm. Cell membrane; Peripheral membrane protein; Cytoplasmic side. Nucleus. Note=Shuttles between nucleus and cytoplasm. Detected in nuclear paraspeckles that are found close to splicing speckles. Translocates to the cell membrane following binding to PtdIns(4,5)P2.","SUBUNIT: Interacts with CTNNB1, AXIN1, LRP6, KEAP1, APC and BTRC. Interacts with SCF (SKP1-CUL1-F-box protein) E3 ubiquitin-protein ligase complexes containing BTRC and/or FBXW11. Identified in the beta-catenin destruction complex containing CTNNB1, APC, AXIN1 and AXIN2. Interacts with WT1. {ECO:0000269|PubMed:17510365, ECO:0000269|PubMed:17925383, ECO:0000269|PubMed:19416806, ECO:0000269|PubMed:21304492, ECO:0000269|PubMed:21498506}.",X,64185117,64205708,q11.2,0.8538,0.371,-1.1469,-0.56916,28.316,0.4588282053679978,ENST00000374869,0.5681631455399061,0.15026243439140216,3408,,,,,,,0.4438966462822767,3.350608980902566,Ovary,broadly expressed,0.9253151151167963,2.509648975749417,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:26859,RBMXL3,RBMX like 3,Approved,CXorf55,FLJ40249,Xq23,gene with protein product,protein-coding gene,ENSG00000175718,139804,ENSG00000175718,Q8N7X1,,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","mRNA splicing, via spliceosome [GO:0000398]",mRNA binding [GO:0003729]; snRNA binding [GO:0017069],"","",X,115189410,115192868,q23,,,-1.2294,-0.83889,,0.6579729970855885,ENST00000424776,0.24057428214731585,0.19270182454386403,3204,,,,,,,0.9757069669585472,2.9599184966892484,Testis,tissue-specific,0,0.01427901381681745,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:26952,OPN1MW2,"opsin 1, medium wave sensitive 2",Approved,,,Xq28,gene with protein product,protein-coding gene,ENSG00000166160,728458,ENSG00000166160,P0DN77,,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Visual pigments are the light-absorbing molecules that mediate vision. They consist of an apoprotein, opsin, covalently linked to cis-retinal. {ECO:0000250|UniProtKB:P04001}.",cellular response to light stimulus [GO:0071482]; G protein-coupled receptor signaling pathway [GO:0007186]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; visual perception [GO:0007601],G protein-coupled photoreceptor activity [GO:0008020],SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:P04001}; Multi-pass membrane protein {ECO:0000255}.,"",X,154219756,154233286,q28,0.24464,1.36,0.034677,0.35244,3.3377,0.3730399281699712,ENST00000369929,0.6746118721461187,0.13471632091977007,1095,3,"OPN1MW3 (100, 100, chrX); OPN1MW (100, 100, chrX); OPN1LW (96, 96, chrX)",TRUE,3,"OPN1MW3 (100, 100, chrX); OPN1MW (100, 100, chrX); OPN1LW (96, 96, chrX)",TRUE,,0,,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:27040,SPIN4,spindlin family member 4,Approved,,"FLJ44984, TDRD28",Xq11.1,gene with protein product,protein-coding gene,ENSG00000186767,139886,ENSG00000186767,Q56A73,MGI:2444925,RGD:1564004,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Exhibits H3K4me3-binding activity. {ECO:0000269|PubMed:29061846}.,"gamete generation [GO:0007276]; regulation of transcription, DNA-templated [GO:0006355]",methylated histone binding [GO:0035064],"",SUBUNIT: Interacts with C11orf84/SPINDOC (PubMed:29061846). {ECO:0000269|PubMed:29061846}.,X,63347228,63351332,q11.1,0.75843,0.636,0.56465,1.5809,4.7022,0.56921707539615,ENST00000374884,0.9550666666666666,0.3300674831292177,750,4,"SPIN1 (75, 71, chr9); SPIN3 (69, 67, chrX); SPIN2B (66, 64, chrX); SPIN2A (66, 64, chrX)",TRUE,,,,0.36099012331099795,3.309481810833304,Cells - EBV-transformed lymphocytes,broadly expressed,1.3820585089760682,1.4146524286546596,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:2714,DCX,doublecortin,Approved,,"SCLH, DC, LISX, DBCN, XLIS",Xq23,gene with protein product,protein-coding gene,ENSG00000077279,1641,ENSG00000077279,O43602,MGI:1277171,RGD:620670,X,300121,TRUE,"Lissencephaly, X-linked // Subcortical laminal heterotopia, X-linked",300067 // 300067,X-linked // X-linked,,,,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Microtubule-associated protein required for initial steps of neuronal dispersion and cortex lamination during cerebral cortex development. May act by competing with the putative neuronal protein kinase DCLK1 in binding to a target protein. May in that way participate in a signaling pathway that is crucial for neuronal interaction before and during migration, possibly as part of a calcium ion-dependent signal transduction pathway. May be part with PAFAH1B1/LIS-1 of overlapping, but distinct, signaling pathways that promote neuronal migration. {ECO:0000269|PubMed:22359282}.",axoneme assembly [GO:0035082]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; nervous system development [GO:0007399]; neuron migration [GO:0001764]; photoreceptor cell development [GO:0042461]; retina development in camera-type eye [GO:0060041],microtubule binding [GO:0008017]; protein kinase binding [GO:0019901],"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}. Cell projection, neuron projection {ECO:0000250|UniProtKB:Q9ESI7}. Note=Localizes at neurite tips. {ECO:0000250|UniProtKB:Q9ESI7}.","SUBUNIT: Interacts with tubulin (PubMed:27292316). Interacts with USP9X (PubMed:24607389). {ECO:0000269|PubMed:24607389, ECO:0000269|PubMed:27292316}.",X,111293779,111412429,q23,0.3042,0.616,1.4242,2.7035,12.58,0.1602285927923838,ENST00000636035,0.9639418710263397,0.47375656085978507,1101,,,,,,,0.9360958164446452,1.5418567637543894,Other_Brain_tissues,tissue-specific,1.5418567637543894,0.40029582067019154,TRUE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:27252,H2BW1,H2B.W histone 1,Approved,H2BFWT,,Xq22.2,gene with protein product,protein-coding gene,ENSG00000123569,158983,ENSG00000123569,Q7Z2G1,,,X,300507,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Atypical histone H2B. Nucleosomes containing it are structurally and dynamically indistinguishable from those containing conventional H2B. However, unlike conventional H2B, does not recruit chromosome condensation factors and does not participate in the assembly of mitotic chromosomes. May be important for telomere function. {ECO:0000269|PubMed:16449661}.",nucleosome assembly [GO:0006334],DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982],SUBCELLULAR LOCATION: Nucleus membrane {ECO:0000269|PubMed:15475252}. Chromosome {ECO:0000269|PubMed:15475252}.,"SUBUNIT: The nucleosome is a histone octamer containing two molecules each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and two H2A-H2B heterodimers. The octamer wraps approximately 147 bp of DNA.",X,104011147,104013687,q22.2,0.0024619,1.741,0.96543,-0.60212,4.6715,0.45264335553385665,ENST00000217926,0.47234848484848485,0.07488127968007999,528,1,"H2BW2 (63, 72, chrX)",TRUE,,,,0.9767441860465116,1.1687190456942216,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:27272,SPIN3,spindlin family member 3,Approved,,TDRD27,Xp11.21,gene with protein product,protein-coding gene,ENSG00000204271,169981,ENSG00000204271,Q5JUX0,,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Exhibits H3K4me3-binding activity. {ECO:0000269|PubMed:29061846}.,"gamete generation [GO:0007276]; regulation of transcription, DNA-templated [GO:0006355]",methylated histone binding [GO:0035064],"",SUBUNIT: Interacts with C11orf84/SPINDOC (PubMed:29061846). {ECO:0000269|PubMed:29061846}.,X,56818298,56995827,p11.21,0.77837,0.6,0.57017,1.0903,4.9891,0.4512338425381904,ENST00000374919,0.8846846846846846,0.2702574356410897,777,4,"SPIN1 (84, 83, chr9); SPIN2B (74, 74, chrX); SPIN2A (74, 74, chrX); SPIN4 (67, 69, chrX)",TRUE,1,"SPIN1 (84, 83, chr9)",TRUE,0.42837504183292785,3.830731951465187,Cerebellar_tissues,broadly expressed,2.0186911402420336,3.830731951465187,TRUE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,no disorder
HGNC:27273,ZCCHC12,zinc finger CCHC-type containing 12,Approved,,"FLJ16123, SIZN, SIZN1, PNMA7A",Xq24,gene with protein product,protein-coding gene,ENSG00000174460,170261,ENSG00000174460,Q6PEW1,MGI:1919943,RGD:1359439,X,300701,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Transcriptional coactivator in the bone morphogenetic protein (BMP)-signaling pathway. It positively modulates BMP signaling by interacting with SMAD1 and associating with CBP in the transcription complex. It contributes to the BMP-induced enhancement of cholinergic-neuron-specific gene expression (By similarity). {ECO:0000250}.,BMP signaling pathway [GO:0030509],nuclear receptor transcription coactivator activity [GO:0030374]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270],"",SUBUNIT: Interacts with SMAD1 and CREB-binding protein (CBP). Forms a protein-DNA complex through its association with SMAD1 (By similarity). {ECO:0000250}.,X,118823824,118826968,q24,0.04647,1.111,-0.58718,0.68264,6.9671,0.4601932811780948,ENST00000310164,0.6909015715467328,0.21872031992002,1209,1,"ZCCHC18 (84, 84, chrX)",TRUE,1,"ZCCHC18 (84, 84, chrX)",TRUE,0.8301410272818949,8.157417678744183,Fallopian Tube,tissue-specific,4.629385765139578,6.973863793925568,FALSE,low confidence non-escapee,no_difference_Pre_Post,Pre_higher_vs_Post1,no difference_Pre_Post2,Post2_higher_vs_Post1,no disorder
HGNC:27334,INTS6L,integrator complex subunit 6 like,Approved,DDX26B,FLJ41215,Xq26.3,gene with protein product,protein-coding gene,ENSG00000165359,203522,ENSG00000165359,Q5JSJ4,MGI:2442593,RGD:1592872,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",snRNA 3'-end processing [GO:0034472],"","","",X,135520643,135582510,q26.3,0.99992,0.152,-0.13758,1.7066,31.119,0.6117850694599878,ENST00000639893,0.9030404152762328,0.3402149462634341,2697,1,"INTS6 (67, 68, chr13)",TRUE,,,,0.3102268026880029,5.403351240783088,Cerebellar_tissues,broadly expressed,2.4297766266289655,5.403351240783088,TRUE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,no disorder
HGNC:27397,CT47A11,cancer/testis antigen family 47 member A11,Approved,,CT47.11,Xq24,gene with protein product,protein-coding gene,ENSG00000226929,255313,ENSG00000226929,Q5JQC4,,,X,300592,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,120933840,120937158,q24,,,,,,0.5192026920464393,ENST00000457020,0.017531718569780853,0.07798050487378155,867,13,"CT47A8 (100, 100, chrX); CT47A2 (100, 100, chrX); CT47A9 (100, 100, chrX); CT47A4 (100, 100, chrX); CT47A6 (100, 100, chrX); CT47A5 (100, 100, chrX); CT47A12 (100, 100, chrX); CT47A10 (100, 100, chrX); CT47A7 (100, 100, chrX); CT47A1 (100, 100, chrX); CT47A3 (100, 100, chrX); CT47B1 (86, 83, chrX); AL772284.1 (67, 60, chrX)",TRUE,11,"CT47A8 (100, 100, chrX); CT47A2 (100, 100, chrX); CT47A9 (100, 100, chrX); CT47A4 (100, 100, chrX); CT47A6 (100, 100, chrX); CT47A5 (100, 100, chrX); CT47A12 (100, 100, chrX); CT47A10 (100, 100, chrX); CT47A7 (100, 100, chrX); CT47A1 (100, 100, chrX); CT47A3 (100, 100, chrX)",TRUE,,0,,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:27413,BCLAF3,BCLAF1 and THRAP3 family member 3,Approved,CXorf23,,Xp22.12,gene with protein product,protein-coding gene,ENSG00000173681,256643,ENSG00000173681,A2AJT9,MGI:2685992,RGD:1562161,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",positive regulation of transcription by RNA polymerase II [GO:0045944],DNA binding [GO:0003677]; transcription coregulator activity [GO:0003712],SUBCELLULAR LOCATION: Mitochondrion {ECO:0000305}.,"",X,19912860,19970298,p22.12,0.62532,0.421,0.5024,1.2624,24.967,0.3057298324015078,ENST00000379682,0.7236891385767791,0.130592351912022,2136,,,,,,,0.2846906044781104,3.6123053125340476,Nerve - Tibial,broadly expressed,1.9288516148675343,3.4932431844342235,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:2745,DDX3X,DEAD-box helicase 3 X-linked,Approved,DDX3,"DBX, HLP2, DDX14",Xp11.4,gene with protein product,protein-coding gene,ENSG00000215301,1654,ENSG00000215301,O00571,MGI:103064,RGD:1564771,X,300160,TRUE,"Intellectual developmental disorder, X-linked, syndrome, Snijders Blok type",300958,"X-linked dominant, X-linked recessive",,,,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Multifunctional ATP-dependent RNA helicase (PubMed:17357160, PubMed:21589879, PubMed:31575075). The ATPase activity can be stimulated by various ribo-and deoxynucleic acids indicative for a relaxed substrate specificity (PubMed:29222110). In vitro can unwind partially double-stranded DNA with a preference for 5'-single-stranded DNA overhangs (PubMed:17357160, PubMed:21589879). Binds RNA G-quadruplex (rG4s) structures, including those located in the 5'-UTR of NRAS mRNA (PubMed:30256975). Involved in many cellular processes, which do not necessarily require its ATPase/helicase catalytic activities (Probable). Involved in transcription regulation (PubMed:16818630, PubMed:18264132). Positively regulates CDKN1A/WAF1/CIP1 transcription in an SP1-dependent manner, hence inhibits cell growth. This function requires its ATPase, but not helicase activity (PubMed:16818630, PubMed:18264132). CDKN1A up-regulation may be cell-type specific (PubMed:18264132). Binds CDH1/E-cadherin promoter and represses its transcription (PubMed:18264132). Potentiates HNF4A-mediated MTTP transcriptional activation; this function requires ATPase, but not helicase activity. Facilitates HNF4A acetylation, possibly catalyzed by CREBBP/EP300, thereby increasing the DNA-binding affinity of HNF4 to its response element. In addition, disrupts the interaction between HNF4 and SHP that forms inactive heterodimers and enhances the formation of active HNF4 homodimers. By promoting HNF4A-induced MTTP expression, may play a role in lipid homeostasis (PubMed:28128295). May positively regulate TP53 transcription (PubMed:28842590). Associates with mRNPs, predominantly with spliced mRNAs carrying an exon junction complex (EJC) (PubMed:17095540, PubMed:18596238). Involved in the regulation of translation initiation (PubMed:18628297, PubMed:17667941, PubMed:22872150). Not involved in the general process of translation, but promotes efficient translation of selected complex mRNAs, containing highly structured 5'-untranslated regions (UTR) (PubMed:20837705, PubMed:22872150). This function depends on helicase activity (PubMed:20837705, PubMed:22872150). Might facilitate translation by resolving secondary structures of 5'-UTRs during ribosome scanning (PubMed:20837705). Alternatively, may act prior to 43S ribosomal scanning and promote 43S pre-initiation complex entry to mRNAs exhibiting specific RNA motifs, by performing local remodeling of transcript structures located close to the cap moiety (PubMed:22872150). Independently of its ATPase activity, promotes the assembly of functional 80S ribosomes and disassembles from ribosomes prior to the translation elongation process (PubMed:22323517). Positively regulates the translation of cyclin E1/CCNE1 mRNA and consequently promotes G1/S-phase transition during the cell cycle (PubMed:20837705). May activate TP53 translation (PubMed:28842590). Required for endoplasmic reticulum stress-induced ATF4 mRNA translation (PubMed:29062139). Independently of its ATPase/helicase activity, enhances IRES-mediated translation; this activity requires interaction with EIF4E (PubMed:17667941, PubMed:22323517). Independently of its ATPase/helicase activity, has also been shown specifically repress cap-dependent translation, possibly by acting on translation initiation factor EIF4E (PubMed:17667941). Involved in innate immunity, acting as a viral RNA sensor. Binds viral RNAs and promotes the production of type I interferon (IFN-alpha and IFN-beta) (PubMed:31575075, PubMed:20127681, PubMed:21170385). Potentiate MAVS/DDX58-mediated induction of IFNB in early stages of infection (PubMed:20127681, PubMed:21170385). Enhances IFNB1 expression via IRF3/IRF7 pathway and participates in NFKB activation in the presence of MAVS and TBK1 (PubMed:18583960, PubMed:18636090, PubMed:21170385, PubMed:27980081, PubMed:19913487). Involved in TBK1 and IKBKE-dependent IRF3 activation leading to IFNB induction, acts as a scaffolding adapter that links IKBKE and IRF3 and coordinates their activation (PubMed:23478265). Involved in the TLR7/TLR8 signaling pathway leading to type I interferon induction, including IFNA4 production. In this context, acts as an upstream regulator of IRF7 activation by MAP3K14/NIK and CHUK/IKKA. Stimulates CHUK autophosphorylation and activation following physiological activation of the TLR7 and TLR8 pathways, leading to MAP3K14/CHUK-mediated activatory phosphorylation of IRF7 (PubMed:30341167). Also stimulates MAP3K14/CHUK-dependent NF-kappa-B signaling (PubMed:30341167). Negatively regulates TNF-induced IL6 and IL8 expression, via the NF-kappa-B pathway. May act by interacting with RELA/p65 and trapping it in the cytoplasm (PubMed:27736973). May also bind IFNB promoter; the function is independent of IRF3 (PubMed:18583960). Involved in both stress and inflammatory responses (By similarity). Independently of its ATPase/helicase activity, required for efficient stress granule assembly through its interaction with EIF4E, hence promotes survival in stressed cells (PubMed:21883093). Independently of its helicase activity, regulates NLRP3 inflammasome assembly through interaction with NLRP3 and hence promotes cell death by pyroptosis during inflammation. This function is independent of helicase activity (By similarity). Therefore DDX3X availability may be used to interpret stress signals and choose between pro-survival stress granules and pyroptotic NLRP3 inflammasomes and serve as a live-or-die checkpoint in stressed cells (By similarity). In association with GSK3A/B, negatively regulates extrinsic apoptotic signaling pathway via death domain receptors, including TNFRSF10B, slowing down the rate of CASP3 activation following death receptor stimulation (PubMed:18846110). Cleavage by caspases may inactivate DDX3X and relieve the inhibition (PubMed:18846110). Independently of its ATPase/helicase activity, allosteric activator of CSNK1E. Stimulates CSNK1E-mediated phosphorylation of DVL2, thereby involved in the positive regulation of Wnt/beta-catenin signaling pathway. Also activates CSNK1A1 and CSNK1D in vitro, but it is uncertain if these targets are physiologically relevant (PubMed:23413191, PubMed:29222110). ATPase and casein kinase-activating functions are mutually exclusive (PubMed:29222110). May be involved in mitotic chromosome segregation (PubMed:21730191). {ECO:0000250|UniProtKB:Q62167, ECO:0000269|PubMed:16818630, ECO:0000269|PubMed:17095540, ECO:0000269|PubMed:17357160, ECO:0000269|PubMed:17667941, ECO:0000269|PubMed:18264132, ECO:0000269|PubMed:18583960, ECO:0000269|PubMed:18596238, ECO:0000269|PubMed:18628297, ECO:0000269|PubMed:18636090, ECO:0000269|PubMed:18846110, ECO:0000269|PubMed:19913487, ECO:0000269|PubMed:20127681, ECO:0000269|PubMed:20837705, ECO:0000269|PubMed:21170385, ECO:0000269|PubMed:21589879, ECO:0000269|PubMed:21730191, ECO:0000269|PubMed:21883093, ECO:0000269|PubMed:22323517, ECO:0000269|PubMed:22872150, ECO:0000269|PubMed:23413191, ECO:0000269|PubMed:23478265, ECO:0000269|PubMed:27736973, ECO:0000269|PubMed:27980081, ECO:0000269|PubMed:28128295, ECO:0000269|PubMed:28842590, ECO:0000269|PubMed:29062139, ECO:0000269|PubMed:29222110, ECO:0000269|PubMed:30256975, ECO:0000269|PubMed:30341167, ECO:0000269|PubMed:31575075, ECO:0000305}.; FUNCTION: (Microbial infection) Facilitates hepatitis C virus (HCV) replication (PubMed:29899501). During infection, HCV core protein inhibits the interaction between MAVS and DDX3X and therefore impairs MAVS-dependent INFB induction and might recruit DDX3X to HCV replication complex (PubMed:21170385). {ECO:0000269|PubMed:21170385, ECO:0000269|PubMed:29899501}.; FUNCTION: (Microbial infection) Facilitates HIV-1 replication (PubMed:15507209, PubMed:18583960, PubMed:21589879, PubMed:22872150, PubMed:29899501). Acts as a cofactor for XPO1-mediated nuclear export of HIV-1 Rev RNAs (PubMed:15507209, PubMed:18583960, PubMed:29899501). This function is strongly stimulated in the presence of TBK1 and requires DDX3X ATPase activity (PubMed:18583960). {ECO:0000269|PubMed:15507209, ECO:0000269|PubMed:18583960, ECO:0000269|PubMed:21589879, ECO:0000269|PubMed:22872150, ECO:0000269|PubMed:29899501}.; FUNCTION: (Microbial infection) Facilitates Zika virus (ZIKV) replication. {ECO:0000269|PubMed:29899501}.; FUNCTION: (Microbial infection) Facilitates Dengue virus (DENV) replication. {ECO:0000269|PubMed:29899501}.; FUNCTION: (Microbial infection) Facilitates Venezuelan equine encephalitis virus (VEEV) replication. {ECO:0000269|PubMed:27105836}.",cell differentiation [GO:0030154]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to osmotic stress [GO:0071470]; cellular response to virus [GO:0098586]; chromosome segregation [GO:0007059]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; gamete generation [GO:0007276]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway [GO:0097193]; lipid homeostasis [GO:0055088]; mature ribosome assembly [GO:0042256]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of translation [GO:0017148]; neutrophil degranulation [GO:0043312]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of chemokine (C-C motif) ligand 5 production [GO:0071651]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of protein acetylation [GO:1901985]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 8 signaling pathway [GO:0034161]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; positive regulation of viral genome replication [GO:0045070]; protein localization to cytoplasmic stress granule [GO:1903608]; response to virus [GO:0009615]; RNA secondary structure unwinding [GO:0010501]; stress granule assembly [GO:0034063]; translational initiation [GO:0006413]; viral process [GO:0016032]; Wnt signaling pathway [GO:0016055],ATPase activity [GO:0016887]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; CTPase activity [GO:0043273]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; eukaryotic initiation factor 4E binding [GO:0008190]; gamma-tubulin binding [GO:0043015]; GTPase activity [GO:0003924]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; nucleoside-triphosphatase activity [GO:0017111]; poly(A) binding [GO:0008143]; protein serine/threonine kinase activator activity [GO:0043539]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA stem-loop binding [GO:0035613]; RNA strand annealing activity [GO:0033592]; transcription factor binding [GO:0008134]; translation initiation factor binding [GO:0031369],"SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:23413191, ECO:0000269|PubMed:29899501}. Nucleus {ECO:0000269|PubMed:10329544, ECO:0000269|PubMed:15507209, ECO:0000269|PubMed:16818630, ECO:0000269|PubMed:18596238, ECO:0000269|PubMed:18636090, ECO:0000269|PubMed:22034099, ECO:0000269|PubMed:29899501, ECO:0000269|PubMed:30131165, ECO:0000269|PubMed:31575075}. Cytoplasm {ECO:0000269|PubMed:10329544, ECO:0000269|PubMed:15507209, ECO:0000269|PubMed:16818630, ECO:0000269|PubMed:18596238, ECO:0000269|PubMed:18636090, ECO:0000269|PubMed:20127681, ECO:0000269|PubMed:21170385, ECO:0000269|PubMed:21730191, ECO:0000269|PubMed:21883093, ECO:0000269|PubMed:22034099, ECO:0000269|PubMed:23413191, ECO:0000269|PubMed:27105836, ECO:0000269|PubMed:27736973, ECO:0000269|PubMed:28733330, ECO:0000269|PubMed:29062139, ECO:0000269|PubMed:29222110, ECO:0000269|PubMed:30131165, ECO:0000269|PubMed:30341167, ECO:0000269|PubMed:31575075}. Cytoplasm, Stress granule {ECO:0000269|PubMed:18596238, ECO:0000269|PubMed:18632687, ECO:0000269|PubMed:22872150, ECO:0000269|PubMed:29062139}. Inflammasome {ECO:0000250|UniProtKB:Q62167}. Cell projection, lamellipodium {ECO:0000269|PubMed:28733330}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000269|PubMed:28842590}. Note=Shuttles between the nucleus and the cytosol (PubMed:15507209, PubMed:18636090, PubMed:29899501, PubMed:31575075, PubMed:30131165). Exported from the nucleus partly through the XPO1/CRM1 system and partly through NXF1/TAP (PubMed:15507209, PubMed:18636090, PubMed:18596238, PubMed:31575075, PubMed:30131165). Localizes to nuclear pores on the outer side of the nuclear membrane (PubMed:15507209). In the cytosol, partly colocalizes with mitochondria (PubMed:20127681). At G0, predominantly located in nucleus. In G1/S phase, predominantly cytoplasmic (PubMed:22034099). During prophase/prometaphase, localizes in close proximity to the condensing chromosomes (PubMed:30131165, PubMed:21730191). During telophase, localizes around the newly synthesized nuclear membrane and in the cytoplasm (PubMed:22034099). Colocalizes with TRPV4 at the plasma membrane. When TRPV4 channel is activated, intracellular Ca(2+) levels increase and the calmodulin/CAMKII pathway is activated, relocalizes to the nucleus (PubMed:29899501). WNT3A stimulation promotes DDX3 recruitment to the plasma membrane (PubMed:23413191). At the leading edge of migrating fibroblasts, colocalizes with CAPRIN1 and PABPC1 (PubMed:28733330). Localizes to centrosome throughout the cell cycle and associates with TP53 at centrosome during mitosis (PubMed:28842590). Translocates to the nucleus in response to HPIV-3 virus-mediated infection (PubMed:31575075). {ECO:0000269|PubMed:15507209, ECO:0000269|PubMed:18596238, ECO:0000269|PubMed:18636090, ECO:0000269|PubMed:20127681, ECO:0000269|PubMed:21730191, ECO:0000269|PubMed:22034099, ECO:0000269|PubMed:23413191, ECO:0000269|PubMed:28733330, ECO:0000269|PubMed:28842590, ECO:0000269|PubMed:29899501, ECO:0000269|PubMed:30131165, ECO:0000269|PubMed:31575075}.","SUBUNIT: Homodimer; can bind RNA as a monomer and as a dimer/oligomer (PubMed:27546789, PubMed:31300642). Interacts with TDRD3 (PubMed:18632687). Interacts (when phosphorylated at Ser-102) with IRF3; the interaction facilitates the phosphorylation and activation of IRF3 by IKBKE (PubMed:23478265, PubMed:27980081). Directly interacts with XPO1/CRM1 (PubMed:15507209, PubMed:30131165, PubMed:31575075). The interaction with XPO1/CMR1 is dependent on the DDX3X nuclear export signal motif and XPO1 interaction with GTPase RAN in its active GTP-bound form (PubMed:31575075, PubMed:30131165). Weakly interacts with TBKBP1/SINTBAD (PubMed:27980081). Directly interacts with TRAF3; this interaction stimulates TRAF3 'Lys-63' ubiquitination (PubMed:27980081). Interacts with CSNK1E in a Wnt-dependent manner; this interaction greatly enhances CSNK1E affinity for ATP, stimulates its kinase activity and promotes CSNK1E-mediated DVL2 phosphorylation (PubMed:23413191, PubMed:29222110). In the presence of RNA, the interaction is decreased (PubMed:29222110). Also interacts with CSNK1D and stimulates its kinase activity (PubMed:23413191, PubMed:29222110). Interacts with TRPV4; this interaction is decreased when the TRPV4 channel is activated, leading to DDX3X relocalization to the nucleus (PubMed:29899501). Interacts with MAP3K14/NIK (PubMed:30341167). Directly interacts with CHUK/IKKA after physiological activation of the TLR7 and TLR8 pathways; this interaction enhances CHUK autophosphorylation (PubMed:30341167). May associate with EIF4F complex, composed of at least EIF4A, EIF4E and EIF4G1/EIF4G3 (Probable). Directly interacts with EIF4E in an RNA-independent manner; this interaction enhances EIF4E cap-binding ability (PubMed:17667941, PubMed:21883093, PubMed:28733330). Directly interacts with EIF4G1 in an RNA-independent manner (PubMed:22872150). DDX3X competes with EIF4G1 for interaction with EIF4E (PubMed:17667941, PubMed:21883093). Interacts with EIF4A1 and EIF2S1 in an RNA-independent manner (PubMed:18596238, PubMed:22323517). Associates with the eukaryotic translation initiation factor 3 (eIF-3) complex, including with EIF3B and EIF3C subunits (PubMed:18628297, PubMed:22323517). Directly interacts with IKBKE/IKKE; this interaction stimulates IKBKE activating autophosphorylation and is induced upon viral infection (PubMed:18636090, PubMed:20657822, PubMed:23478265, PubMed:27980081). Interacts with TBK1 (PubMed:20375222). Interacts with SP1; this interaction potentiates SP1-induced CDKN1A/WAF1/CIP1 transcription (PubMed:16818630). Interacts with GSK3A and GSK3B (PubMed:18846110). Interacts with several death receptors, inclusing FAS, TNFRSF10A and TNFRSF10B (PubMed:18846110). Recruited to TNFRSF10B in the absence of receptor stimulation. When TNFRSF10B is stimulated, further recruited to the receptor and cleaved by caspases. A large proteolytic fragment remains associated with TNFRSF10B (PubMed:18846110). Interacts (via C-terminus) with NXF1/TAP; this interaction may be partly involved in DDX3X nuclear export and in NXF1 localization to stress granules (PubMed:18596238). Identified in an mRNP complex, composed of at least DHX9, DDX3X, ELAVL1, HNRNPU, IGF2BP1/2, ILF3, PABPC1, PCBP2, PTBP2, STAU1, STAU2, SYNCRIP and YBX1 (PubMed:19029303). The interaction with IGF2BP1/2 is RNA-dependent (PubMed:22323517). Directly interacts with PABPC1/PABP1 in an RNA-independent manner (PubMed:18596238, PubMed:21883093, PubMed:22872150, PubMed:28733330). This interaction increases in stressed cells and decreases during cell recovery (PubMed:21883093). Interacts (via C-terminus) with MAVS/IPS-1; this interaction occurs rapidly, but transiently after Sendai virus infection (PubMed:20127681, PubMed:21170385, PubMed:27980081). The interaction potentiates MAVS-mediated IFNB induction (PubMed:20127681, PubMed:21170385). Interacts with ERCC6/CBS (PubMed:26030138). Interacts with DHX33 in an RNA-independent manner (PubMed:26100019). Interacts with DDX5 in the cytoplasm; this interaction may be more efficient when both proteins are unphosphorylated (PubMed:22034099). Interacts with DDX58/RIG-1 (PubMed:20127681). Interacts with IFIH1/MDA5 (PubMed:20127681). Interacts with NCAPH; this interaction may be important for the NCAPH localization at condensing chromosomes during mitosis (PubMed:21730191). Interacts with NLRP3 (via NACHT domain) under inflammasome-activating conditions (By similarity). Interacts with CAPRIN1 (PubMed:28733330). Interacts with HNF4A and NR0B2/SHP in an RNA-independent manner; this interaction disrupts the interaction between HNF4 and NR0B2 that forms inactive heterodimers and enhances the formation of active HNF4 homodimers (PubMed:28128295). Interacts with CREBBP/CBP (PubMed:28128295). Interacts with EP300/p300 (PubMed:28128295). Interacts with gamma-tubulin (PubMed:28842590). Interacts with phosphorylated TP53 (PubMed:28842590). Directly interacts with RELA/p65; this interaction may trap RELA in the cytoplasm, impairing nuclear relocalization upon TNF activating signals (PubMed:27736973). {ECO:0000250|UniProtKB:Q62167, ECO:0000269|PubMed:15507209, ECO:0000269|PubMed:16818630, ECO:0000269|PubMed:17667941, ECO:0000269|PubMed:18596238, ECO:0000269|PubMed:18628297, ECO:0000269|PubMed:18632687, ECO:0000269|PubMed:18636090, ECO:0000269|PubMed:18846110, ECO:0000269|PubMed:19029303, ECO:0000269|PubMed:20127681, ECO:0000269|PubMed:20375222, ECO:0000269|PubMed:20657822, ECO:0000269|PubMed:21170385, ECO:0000269|PubMed:21730191, ECO:0000269|PubMed:21883093, ECO:0000269|PubMed:22034099, ECO:0000269|PubMed:22323517, ECO:0000269|PubMed:22872150, ECO:0000269|PubMed:23413191, ECO:0000269|PubMed:23478265, ECO:0000269|PubMed:26030138, ECO:0000269|PubMed:26100019, ECO:0000269|PubMed:27546789, ECO:0000269|PubMed:27736973, ECO:0000269|PubMed:27980081, ECO:0000269|PubMed:28128295, ECO:0000269|PubMed:28733330, ECO:0000269|PubMed:28842590, ECO:0000269|PubMed:29222110, ECO:0000269|PubMed:29899501, ECO:0000269|PubMed:30131165, ECO:0000269|PubMed:30341167, ECO:0000269|PubMed:31300642, ECO:0000269|PubMed:31575075, ECO:0000305|PubMed:17667941, ECO:0000305|PubMed:21883093, ECO:0000305|PubMed:22872150, ECO:0000305|PubMed:28733330, ECO:0000305|PubMed:29062139}.; SUBUNIT: (Microbial infection) Interacts with hepatitis B virus (HBV) polymerase in the cytoplasm; this interaction may inhibit DDX3X interaction with the IKBKE/TBK1 complex, and hence impair IKBKE/TBK1-mediated increase in IFNB production. {ECO:0000269|PubMed:20375222, ECO:0000269|PubMed:20657822}.; SUBUNIT: (Microbial infection) Directly interacts with hepatitis C virus (HCV) core protein in the cytoplasm. {ECO:0000269|PubMed:10329544}.; SUBUNIT: (Microbial infection) Interacts with vaccinia virus (VACV) protein K7. {ECO:0000269|PubMed:18636090, ECO:0000269|PubMed:19913487}.; SUBUNIT: (Microbial infection) Interacts with HIV-1 protein Rev. {ECO:0000269|PubMed:15507209}.; SUBUNIT: (Microbial infection) Interacts with Venezuelan equine encephalitis virus non-structural protein 3. {ECO:0000269|PubMed:27105836}.",X,41333348,41364472,p11.4,0.99986,0.118,-0.67543,4.3295,25.22,0.8040194299135263,ENST00000644876,0.9613373554550025,0.1575606098475381,1989,1,"DDX3Y (81, 90, chrY)",TRUE,,,,0.1293624206699899,7.518897026246697,Fallopian Tube,broadly expressed,5.015515410290167,6.150241818119248,FALSE,high confidence escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:27867,H2BW2,H2B.W histone 2,Approved,"H2BFM, H2BM",,Xq22.2,gene with protein product,protein-coding gene,ENSG00000101812,286436,ENSG00000101812,P0C1H6,MGI:1916639,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling.",nucleosome assembly [GO:0006334],DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982],SUBCELLULAR LOCATION: Nucleus. Chromosome.,"SUBUNIT: The nucleosome is a histone octamer containing two molecules each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and two H2A-H2B heterodimers. The octamer wraps approximately 147 bp of DNA.",X,104039916,104042454,q22.2,0.014026,1.639,-2.0541,-1.0409,4.357,0.35190761186077346,ENST00000675318,0.5382795698924732,0.07798050487378155,465,1,"H2BW1 (72, 63, chrX)",TRUE,,,,0.9763451021537187,1.761025650009867,Testis,tissue-specific,0.017202732312587836,0.013017537471123284,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:27989,PABPC1L2A,poly(A) binding protein cytoplasmic 1 like 2A,Approved,RBM32A,,Xq13.2,gene with protein product,protein-coding gene,ENSG00000186288,340529,ENSG00000186288,Q5JQF8,MGI:3644774,RGD:1566367,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","",RNA binding [GO:0003723],"","",X,73077276,73079512,q13.2,0.35004,1.812,-0.19648,1.0268,0.62559,0.618209067066317,ENST00000373519,0.8983416252072969,0.3979005248687828,603,1,"PABPC1L2B (100, 100, chrX)",TRUE,1,"PABPC1L2B (100, 100, chrX)",TRUE,0.9240627779214877,3.152048717954284,Cerebellar_tissues,tissue-specific,1.726042095508598,3.152048717954284,TRUE,,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:27990,BEX5,brain expressed X-linked 5,Approved,NGFRAP1L1,,Xq22.1,gene with protein product,protein-coding gene,ENSG00000184515,340542,ENSG00000184515,Q5H9J7,,RGD:6488322,X,300693,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",signal transduction [GO:0007165],signaling receptor binding [GO:0005102],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15958283}.,"",X,102153708,102155977,q22.1,0.0025394,1.943,-0.020981,0.31347,1.6151,0.4067492961866111,ENST00000333643,0.6708333333333333,0.14681329667583104,336,1,"BEX3 (59, 59, chrX)",TRUE,,,,0.5835513946992956,6.712045448553693,Pituitary,broadly expressed,5.863958267527438,6.084106796444582,FALSE,,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,no difference_Post1_Post2,no disorder
HGNC:27992,SATL1,spermidine/spermine N1-acetyl transferase like 1,Approved,,,Xq21.1,gene with protein product,protein-coding gene,ENSG00000184788,340562,ENSG00000184788,Q86VE3,MGI:1921059,RGD:1565932,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","",N-acetyltransferase activity [GO:0008080],"","",X,85092284,85243911,q21.1,4.9995e-20,1.638,0.094399,-0.17094,22.646,0.6332517598718995,ENST00000644105,0.14875478927203065,0.2537615596100975,2088,,,,,,,0.9641155243612947,1.4935499897615834,Testis,tissue-specific,0.2546387864436724,0.10959411332714598,FALSE,high confidence non-escapee,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:28034,PDZD11,PDZ domain containing 11,Approved,PDZK11,,Xq13.1,gene with protein product,protein-coding gene,ENSG00000120509,51248,ENSG00000120509,Q5EBL8,MGI:1919871,RGD:1560007,X,300632,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Mediates docking of ADAM10 to zonula adherens by interacting with PLEKHA7 which is required for PLEKHA7 to interact with the ADAM10-binding protein TSPAN33. {ECO:0000269|PubMed:30463011}.,antimicrobial humoral response [GO:0019730]; biotin metabolic process [GO:0006768]; ion transmembrane transport [GO:0034220]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; neurotransmitter secretion [GO:0007269]; pantothenate metabolic process [GO:0015939]; pore complex assembly [GO:0046931]; protein localization to basolateral plasma membrane [GO:1903361]; transmembrane transport [GO:0055085],protein C-terminus binding [GO:0008022],"SUBCELLULAR LOCATION: [Isoform 2]: Secreted {ECO:0000305}.; SUBCELLULAR LOCATION: [Isoform 1]: Cytoplasm {ECO:0000269|PubMed:12763866}. Cell junction, adherens junction {ECO:0000269|PubMed:30463011}. Cell membrane {ECO:0000269|PubMed:30463011}.","SUBUNIT: Interacts with ATP2B1, ATP2B2, ATP2B3, ATP2B4 and ATP7A (PubMed:12763866, PubMed:16051599). Interacts with PLEKHA7 (via WW domains) at zonula adherens; this interaction is essential for the interaction between PLEKHA7 and the ADAM10-binding protein TSPAN33 (PubMed:30463011). {ECO:0000269|PubMed:12763866, ECO:0000269|PubMed:16051599, ECO:0000269|PubMed:30463011}.",X,70286595,70290514,q13.1,0.1986,0.928,0.2371,1.7507,6.7793,0.4505268041145141,ENST00000239666,0.9645390070921985,0.20807298175456135,423,,,,,,,0.21080017628312356,6.3589605835006555,Cells - Cultured fibroblasts,broadly expressed,5.573671421537188,4.975130310218417,FALSE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:28089,EOLA1,endothelium and lymphocyte associated ASCH domain 1,Approved,"CXorf40, CXorf40A",,Xq28,gene with protein product,protein-coding gene,ENSG00000197620,91966,ENSG00000197620,Q8TE69,MGI:1915868,,X,300954,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: May have an important role of cell protection in inflammation reaction. In epithelial cells, regulates negatively IL6 production and apoptosis through the regulation of MT2A expession (PubMed:24916366). {ECO:0000269|PubMed:24916366}.",regulation of gene expression [GO:0010468]; regulation of interleukin-6 production [GO:0032675],"","",SUBUNIT: Interacts with MT2A. {ECO:0000269|PubMed:15541360}.,X,149540355,149550510,q28,0.59015,1.053,-0.47211,0.44701,2.7775,0.49638250236993275,ENST00000393985,0.6111111111111112,0.00569857535616096,477,1,"EOLA2 (99, 99, chrX)",TRUE,1,"EOLA2 (99, 99, chrX)",TRUE,0.20753279340036188,4.017636903049499,Pituitary,broadly expressed,2.6277912485247548,3.25265937784852,FALSE,low confidence non-escapee,no_difference_Pre_Post,Pre_higher_vs_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:28100,MMGT1,membrane magnesium transporter 1,Approved,TMEM32,EMC5,Xq26.3,gene with protein product,protein-coding gene,ENSG00000169446,93380,ENSG00000169446,Q8N4V1,MGI:2384305,RGD:1566339,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Mediates Mg(2+) transport. {ECO:0000250|UniProtKB:Q8K273}.,copper ion transport [GO:0006825]; magnesium ion transport [GO:0015693],cobalt ion transmembrane transporter activity [GO:0015087]; ferrous iron transmembrane transporter activity [GO:0015093]; inorganic cation transmembrane transporter activity [GO:0022890]; magnesium ion transmembrane transporter activity [GO:0015095],SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:22119785}; Multi-pass membrane protein {ECO:0000255}. Golgi apparatus membrane {ECO:0000250|UniProtKB:Q8K273}; Multi-pass membrane protein {ECO:0000255}. Early endosome membrane {ECO:0000250|UniProtKB:Q8K273}; Multi-pass membrane protein {ECO:0000255}.,SUBUNIT: Component of the ER membrane protein complex (EMC). {ECO:0000269|PubMed:22119785}.,X,135962070,135974063,q26.3,0.79834,0.565,0.52057,1.22,5.2972,0.5088490083649813,ENST00000305963,0.9734848484848485,0.14498875281179704,396,,,,,,,0.23211968113210082,5.604267070817687,Artery - Tibial,broadly expressed,3.4879236193037473,4.114121279406065,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,no disorder
HGNC:28247,TCEAL3,transcription elongation factor A like 3,Approved,,"MGC15737, WEX8",Xq22.2,gene with protein product,protein-coding gene,ENSG00000196507,85012,ENSG00000196507,Q969E4,MGI:1913354,RGD:1562504,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May be involved in transcriptional regulation.,"",WW domain binding [GO:0050699],SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.,"",X,103607451,103629690,q22.2,0.73954,0.673,0.86881,1.0927,4.4468,0.4571642310549584,ENST00000372627,0.46733001658374795,0.215071232191952,603,2,"TCEAL5 (90, 88, chrX); TCEAL6 (86, 93, chrX)",TRUE,2,"TCEAL5 (90, 88, chrX); TCEAL6 (86, 93, chrX)",TRUE,0.2657006468899881,7.608358330016473,Uterus,broadly expressed,6.1449559272781755,6.758807504499052,FALSE,,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:28248,PNMA6A,PNMA family member 6A,Approved,PNMA6C,MGC15827,Xq28,gene with protein product,protein-coding gene,ENSG00000235961,84968,ENSG00000235961,P0CW24,,,X,300917,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,153072454,153075019,q28,,,,,,0.5840945596819072,ENST00000421798,0.04108333333333333,0.022544363909022744,1200,,,,,,,0.6860238407219751,4.291286755036938,Cerebellar_tissues,tissue-specific,3.4193366303679213,4.291286755036938,TRUE,high confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:28277,TCEANC,transcription elongation factor A N-terminal and central domain containing,Approved,,MGC17403,Xp22.2,gene with protein product,protein-coding gene,ENSG00000176896,170082,ENSG00000176896,Q8N8B7,MGI:2685236,RGD:1584894,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","transcription, DNA-templated [GO:0006351]","","","",X,13653189,13681964,p22.2,0.051926,1.069,0.50293,0.28,7.2439,0.252437238508727,ENST00000380600,0.5464962121212121,0.030242439390152462,1056,,,,,,,0.37048353788773,2.2268028958789854,Cerebellar_tissues,broadly expressed,1.0088669106725892,2.2268028958789854,TRUE,high confidence escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,no disorder
HGNC:28304,YIPF6,Yip1 domain family member 6,Approved,,"MGC21416, FinGER6",Xq12-q13.1,gene with protein product,protein-coding gene,ENSG00000181704,286451,ENSG00000181704,Q96EC8,MGI:1925179,RGD:1566154,X,300996,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May be required for stable YIPF1 and YIPF2 protein expression. {ECO:0000269|PubMed:28286305}.,intestinal epithelial cell development [GO:0060576],identical protein binding [GO:0042802],"SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000269|PubMed:27999994}; Multi-pass membrane protein {ECO:0000305}. Note=Evenly distributed between cis- and trans-Golgi apparatus (PubMed:27999994). Mainly localizes within medial-/trans-Golgi and trans-Golgi network (TGN), while less so within cis-Golgi (PubMed:28286305). {ECO:0000269|PubMed:27999994, ECO:0000269|PubMed:28286305}.","SUBUNIT: Predominantly interacts with YIPF1 or YIPF2, but may also form a ternary complex with YIPF1 and YIPF2. This interaction may stabilize YIPF1 and YIPF2. {ECO:0000269|PubMed:28286305}.",X,68498562,68537282,q12,0.89735,0.406,0.71566,1.2122,7.3703,0.531632110579479,ENST00000462683,0.8890295358649789,0.08742814296425894,711,,,,,,,0.19871887318850376,4.609861316831502,Pituitary,broadly expressed,3.352700624019048,3.7722287850449696,FALSE,high confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:28334,UPRT,uracil phosphoribosyltransferase homolog,Approved,,"DKFZp781E1243, MGC23937, FUR1, RP11-311P8.3",Xq13.3,gene with protein product,protein-coding gene,ENSG00000094841,139596,ENSG00000094841,Q96BW1,MGI:2685620,RGD:1564806,X,300656,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",female pregnancy [GO:0007565]; lactation [GO:0007595]; nucleoside metabolic process [GO:0009116]; response to insulin [GO:0032868]; UMP biosynthetic process [GO:0006222],GTP binding [GO:0005525]; kinase activity [GO:0016301],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17384901}. Nucleus {ECO:0000269|PubMed:17384901}.,"",X,75156388,75304885,q13.3,0.5784,0.561,0.19275,1.4488,11.228,0.3235805471592967,ENST00000373383,0.7348387096774194,0.14113971507123219,930,,,,,,,0.24634343453570048,3.9570509512558134,Cells - EBV-transformed lymphocytes,broadly expressed,2.7345665628081157,3.054991697733424,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:28336,TCEAL7,transcription elongation factor A like 7,Approved,,"MGC23947, WEX5",Xq22.2,gene with protein product,protein-coding gene,ENSG00000182916,56849,ENSG00000182916,Q9BRU2,MGI:1915746,RGD:1593009,X,300771,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Plays a role in the negative regulation of NF-kappa-B signaling at the basal level by modulating transcriptional activity of NF-kappa-B on its target gene promoters. Associates with cyclin D1 promoter containing Myc E-box sequence and transcriptionally represses cyclin D1 expression. Regulates telomerase reverse transcriptase expression and telomerase activity in both ALT (alternative lengthening of telomeres)and telomerase-positive cell lines. {ECO:0000269|PubMed:18806825, ECO:0000269|PubMed:19966855, ECO:0000269|PubMed:20454512}.","negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription, DNA-templated [GO:0045892]",WW domain binding [GO:0050699],SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:18806825}.,"",X,103330229,103332326,q22.2,0.4847,1.432,0.41192,0.38334,1.7999,0.309683308069695,ENST00000332431,0.8567656765676568,0.23079230192451888,303,,,,,,,0.516192678855256,7.051382978452046,Cerebellar_tissues,broadly expressed,6.273446886350145,7.051382978452046,TRUE,high confidence non-escapee,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:28381,MOSPD2,motile sperm domain containing 2,Approved,,MGC26706,Xp22.2,gene with protein product,protein-coding gene,ENSG00000130150,158747,ENSG00000130150,Q8NHP6,MGI:1924013,RGD:1563952,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Endoplasmic reticulum-anchored receptor which modulates interorganelle contacts by interacting with other organelle-bound proteins via their FFAT motif (PubMed:29858488). Might have a more important role in endoplasmic reticulum and endosomes contacts (PubMed:29858488). Promotes migration of primary monocytes and neutrophils, in response to various chemokines (PubMed:28137892). {ECO:0000269|PubMed:28137892, ECO:0000269|PubMed:29858488}.",chemotaxis [GO:0006935]; neutrophil degranulation [GO:0043312]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of neutrophil chemotaxis [GO:0090023],"","SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:28137892, ECO:0000269|PubMed:29858488}; Single-pass type IV membrane protein {ECO:0000269|PubMed:29858488}. Note=Localization to contact sites involving the endoplasmic reticulum and several organelles is regulated by interaction with proteins containing FFAT motif. {ECO:0000269|PubMed:29858488}.","SUBUNIT: Interacts (via MSP domain) with STARD3 (via FFAT motif), STARD3NL (via FFAT motif), RMDN3 (via FFAT motif), OSBPL1A (via FFAT motif) and CERT1 (via FFAT motif). {ECO:0000269|PubMed:29858488}.",X,14873421,14922327,p22.2,0.99105,0.256,2.3186,1.6602,18.545,0.543205321362318,ENST00000380492,0.8980089916506101,0.12421894526368409,1557,,,,,,,0.27460401745022683,4.181038924431668,Nerve - Tibial,broadly expressed,2.6506979363108134,3.0757901711725117,FALSE,high confidence non-escapee,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:28399,TENT5D,terminal nucleotidyltransferase 5D,Approved,FAM46D,"MGC26999, CT1.26, CT112",Xq21.1,gene with protein product,protein-coding gene,ENSG00000174016,169966,ENSG00000174016,Q8NEK8,MGI:2685223,RGD:1559589,X,300976,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Nucleotidyltransferase that act as a non-canonical poly(A) RNA polymerase. {ECO:0000269|PubMed:27060136, ECO:0000269|PubMed:28931820}.",mRNA stabilization [GO:0048255],RNA adenylyltransferase activity [GO:1990817],"","",X,80335504,80445311,q21.1,0.83028,0.512,-0.45545,0.95716,5.8461,0.48044774861826456,ENST00000538312,0.7798290598290598,0.05891027243189203,1170,1,"TENT5C (58, 58, chr1)",TRUE,,,,0.9745490935286908,2.176795082191463,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:28400,CT45A2,cancer/testis antigen family 45 member A2,Approved,,"CT45-2, CT45.2",Xq26.3,gene with protein product,protein-coding gene,ENSG00000271449,728911,ENSG00000271449,Q5DJT8,,,X,300793,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",snRNA 3'-end processing [GO:0034472],"","","",X,135811668,135820012,q26.3,,,,,,0.42636706688028975,ENST00000612907,0.1987719298245614,0.01234691327168208,570,8,"CT45A9 (100, 100, chrX); CT45A8 (100, 100, chrX); CT45A3 (98, 98, chrX); CT45A1 (98, 98, chrX); CT45A5 (98, 98, chrX); CT45A7 (98, 98, chrX); CT45A6 (98, 98, chrX); CT45A10 (95, 95, chrX)",TRUE,8,"CT45A9 (100, 100, chrX); CT45A8 (100, 100, chrX); CT45A3 (98, 98, chrX); CT45A1 (98, 98, chrX); CT45A5 (98, 98, chrX); CT45A7 (98, 98, chrX); CT45A6 (98, 98, chrX); CT45A10 (95, 95, chrX)",TRUE,,0,,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:28402,GAGE12C,G antigen 12C,Approved,,OTTHUMG00000024144,Xp11.23,gene with protein product,protein-coding gene,ENSG00000237671,729422,ENSG00000237671,A1L429,,,X,300727,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,49532211,49539538,p11.23,,,,,,0.5639507839739184,ENST00000420398,0.05508474576271186,0.03476630842289428,354,11,"GAGE12E (100, 100, chrX); GAGE12D (100, 100, chrX); GAGE12H (99, 99, chrX); GAGE12G (99, 99, chrX); GAGE12F (99, 99, chrX); GAGE1 (97, 97, chrX); GAGE12J (97, 97, chrX); GAGE13 (97, 97, chrX); GAGE2A (96, 97, chrX); GAGE2E (93, 99, chrX); GAGE10 (90, 91, chrX)",TRUE,11,"GAGE12E (100, 100, chrX); GAGE12D (100, 100, chrX); GAGE12H (99, 99, chrX); GAGE12G (99, 99, chrX); GAGE12F (99, 99, chrX); GAGE1 (97, 97, chrX); GAGE12J (97, 97, chrX); GAGE13 (97, 97, chrX); GAGE2A (96, 97, chrX); GAGE2E (93, 99, chrX); GAGE10 (90, 91, chrX)",TRUE,,0,,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:28434,CCNQ,cyclin Q,Approved,FAM58A,CycM,Xq28,gene with protein product,protein-coding gene,ENSG00000262919,92002,ENSG00000262919,Q8N1B3,MGI:1916359,RGD:1305651,X,300708,TRUE,STAR syndrome,300707,X-linked dominant,,,,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Activating cyclin for the cyclin-associated kinase CDK10. {ECO:0000269|PubMed:18297069, ECO:0000269|PubMed:24218572}.",regulation of transcription by RNA polymerase II [GO:0006357],cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538],"","SUBUNIT: Associates with CDK10 to promote its kinase activity. Interacts with SALL1. {ECO:0000269|PubMed:18297069, ECO:0000269|PubMed:24218572}.",X,153587925,153600045,q28,0.90384,0.396,-0.082147,1.1412,7.5619,0.642100929663834,ENST00000576892,0.770281124497992,0.020094976255936016,747,,,,,,,0.18606376356592555,5.407852372843468,Pituitary,broadly expressed,4.552340179341881,4.612638532168042,FALSE,high confidence non-escapee,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:28509,BEND2,BEN domain containing 2,Approved,CXorf20,MGC33653,Xp22.13,gene with protein product,protein-coding gene,ENSG00000177324,139105,ENSG00000177324,Q8NDZ0,,RGD:7741042,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,18162931,18220886,p22.13,0.088486,0.544,-0.30818,0.71344,21.772,0.613379336783592,ENST00000380033,0.146875,0.024343914021494627,2400,,,,,,,0.9682077479739489,3.0039799502717046,Testis,tissue-specific,0,0,FALSE,variable escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:28515,MAGEB18,MAGE family member B18,Approved,,MGC33889,Xp21.3,gene with protein product,protein-coding gene,ENSG00000176774,286514,ENSG00000176774,Q96M61,MGI:3045344,RGD:1560369,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May enhance ubiquitin ligase activity of RING-type zinc finger-containing E3 ubiquitin-protein ligases. Proposed to act through recruitment and/or stabilization of the Ubl-conjugating enzyme (E2) at the E3:substrate complex. {ECO:0000269|PubMed:20864041}.,"","",SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q8BQR7}.,SUBUNIT: Interacts with LNX1. {ECO:0000269|PubMed:20864041}.,X,26138343,26140736,p21.3,5.6883e-5,1.853,1.1563,0.82007,5.2938,0.2450379808870375,ENST00000325250,0.30281007751937983,0.1129467633091727,1032,,,,,,,0.9767441860465116,1.244570483708395,Testis,tissue-specific,0,0,FALSE,low confidence escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:28570,DNAAF6,dynein axonemal assembly factor 6,Approved,"CXorf41, PIH1D3","MGC35261, NYSAR97, TWISTER",Xq22.3,gene with protein product,protein-coding gene,ENSG00000080572,139212,ENSG00000080572,Q9NQM4,"MGI:1921958, MGI:3607720",RGD:1566312,X,300933,TRUE,"Ciliary dyskinesia, primary, 36, X-linked",300991,X-linked recessive,,,,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Plays a role in cytoplasmic pre-assembly of axonemal dynein. {ECO:0000269|PubMed:28041644, ECO:0000269|PubMed:28176794}.",axonemal dynein complex assembly [GO:0070286]; cilium movement [GO:0003341]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159]; outer dynein arm assembly [GO:0036158],chaperone binding [GO:0051087]; dynein intermediate chain binding [GO:0045505],"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:28176794}. Golgi apparatus, trans-Golgi network {ECO:0000269|PubMed:28176794}. Note=Localized to the cytoplasm of spermatogenic cells. {ECO:0000250|UniProtKB:Q3KNI6}.","SUBUNIT: Interacts with HSPA1A/B and HSP90AA1 (By similarity). Interacts with DNAAF2 and DNAAF4 (PubMed:28041644). Interacts wuth DNAI2 (PubMed:28176794). {ECO:0000250|UniProtKB:Q3KNI6, ECO:0000269|PubMed:28041644, ECO:0000269|PubMed:28176794}.",X,107206611,107244247,q22.3,0.85529,0.472,-0.80444,0.47523,6.3401,0.6664127951256664,ENST00000372453,0.6176744186046511,0.10282429392651837,645,,,,,,,0.9716359882628725,4.105074594101117,Testis,tissue-specific,0,0,FALSE,discordant,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:28589,CXorf38,chromosome X open reading frame 38,Approved,,MGC39350,Xp11.4,gene with protein product,protein-coding gene,ENSG00000185753,159013,ENSG00000185753,Q8TB03,MGI:1916405,RGD:1565685,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,40626921,40647561,p11.4,1.3652e-4,1.076,0.16979,0.50352,13.416,0.5754691872217067,ENST00000327877,0.7419791666666666,0.1752061984503874,960,,,,,,,0.3187388734286162,4.720946022430367,Cells - EBV-transformed lymphocytes,broadly expressed,2.1558528336288267,3.202204553708443,FALSE,high confidence escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:28601,TMEM31,transmembrane protein 31,Approved,,MGC39655,Xq22.2,gene with protein product,protein-coding gene,ENSG00000179363,203562,ENSG00000179363,Q5JXX7,,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","",SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.,"",X,103710909,103714032,q22.2,0.0012864,1.867,0.50117,0.27255,3.6633,0.24146869784453676,ENST00000319560,0.27889546351084815,0.12751812046988253,507,,,,,,,0.8934003245728944,7.224686671070603,Testis,tissue-specific,0.9592270952925313,1.0653269015989857,FALSE,,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:28612,TMSB15B,thymosin beta 15B,Approved,,MGC39900,Xq22.2,gene with protein product,protein-coding gene,ENSG00000158427,286527,ENSG00000158427,P0CG35,"MGI:3843059, MGI:3843061",,X,301011,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Plays an important role in the organization of the cytoskeleton. Binds to and sequesters actin monomers (G actin) and therefore inhibits actin polymerization (By similarity). May be involved in cell migration. {ECO:0000250, ECO:0000269|PubMed:19296525}.",actin filament organization [GO:0007015]; positive regulation of cell migration [GO:0030335]; regulation of cell migration [GO:0030334]; sequestering of actin monomers [GO:0042989],actin monomer binding [GO:0003785],"SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000250}.","",X,103918896,103966712,q22.2,0.38882,1.733,1.251,-0.72487,0.96308,0.5415571799763745,ENST00000540220,0.8695652173913043,0.16315921019745064,138,1,"TMSB15A (100, 100, chrX)",TRUE,1,"TMSB15A (100, 100, chrX)",TRUE,0.8450918017529551,1.5061195076664793,Cells - EBV-transformed lymphocytes,tissue-specific,0.10936443779124763,0.6916833399135848,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:28615,ARMCX4,armadillo repeat containing X-linked 4,Approved,CXorf35,"MGC40053, GASP4",Xq22.1,gene with protein product,protein-coding gene,ENSG00000196440,100131755,ENSG00000196440,Q5H9R4,MGI:2147887,RGD:2325053,X,301046,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","",SUBCELLULAR LOCATION: Membrane {ECO:0000255}; Single-pass membrane protein {ECO:0000255}.,"",X,101418287,101533459,q22.1,1,0.122,3.4923,2.6373,38.746,0.10102607351184202,ENST00000423738,0.192681507347592,0.22106973256685827,6873,,,,,,,0.42658932874766614,4.718860249358379,Ovary,broadly expressed,2.0314551896849147,3.5898174073036153,FALSE,low confidence non-escapee,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:28675,VSIG1,V-set and immunoglobulin domain containing 1,Approved,,"MGC44287, GPA34",Xq22.3,gene with protein product,protein-coding gene,ENSG00000101842,340547,ENSG00000101842,Q86XK7,MGI:1926039,RGD:1565570,X,300620,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",epithelial cell morphogenesis [GO:0003382]; maintenance of gastrointestinal epithelium [GO:0030277],"",SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}.,"",X,108044970,108079184,q22.3,0.0023894,0.983,-0.43873,0.45554,12.051,0.2347146527734559,ENST00000217957,0.5047250859106529,0.18055486128467882,1164,,,,,,,0.9197058496045506,6.386959208181552,Stomach,tissue-specific,0.4469496157142353,0.05369288606214183,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:28683,TCEAL8,transcription elongation factor A like 8,Approved,,"MGC45400, WEX3",Xq22.1,gene with protein product,protein-coding gene,ENSG00000180964,90843,ENSG00000180964,Q8IYN2,MGI:1913934,RGD:1359631,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May be involved in transcriptional regulation.,"",WW domain binding [GO:0050699],SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.,"",X,103252995,103255192,q22.1,0.54338,1.213,0.37838,0.35945,2.332,0.32544182865211924,ENST00000372685,0.8641242937853107,0.35236190952261937,354,,,,,,,0.18597305487639493,7.139745745016443,Cells - Cultured fibroblasts,broadly expressed,5.6713584847993825,6.2766018117955005,FALSE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:28727,APOO,apolipoprotein O,Approved,FAM121B,"MGC4825, My025, Mic23, MIC26, MICOS26",Xp22.11,gene with protein product,protein-coding gene,ENSG00000184831,79135,ENSG00000184831,Q9BUR5,MGI:1915566,RGD:1565289,X,300753,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Component of the MICOS complex, a large protein complex of the mitochondrial inner membrane that plays crucial roles in the maintenance of crista junctions, inner membrane architecture, and formation of contact sites to the outer membrane. Plays a crucial role in crista junction formation and mitochondrial function (PubMed:25764979). Can promote cardiac lipotoxicity by enhancing mitochondrial respiration and fatty acid metabolism in cardiac myoblasts (PubMed:24743151). Promotes cholesterol efflux from macrophage cells. Detected in HDL, LDL and VLDL. Secreted by a microsomal triglyceride transfer protein (MTTP)-dependent mechanism, probably as a VLDL-associated protein that is subsequently transferred to HDL (PubMed:16956892). {ECO:0000269|PubMed:16956892, ECO:0000269|PubMed:24743151, ECO:0000269|PubMed:25764979}.",cristae formation [GO:0042407]; inner mitochondrial membrane organization [GO:0007007]; lipid transport [GO:0006869],"","SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000269|PubMed:25764979}; Single-pass membrane protein {ECO:0000255}. Secreted {ECO:0000269|PubMed:16956892, ECO:0000269|PubMed:25764979}. Mitochondrion {ECO:0000269|PubMed:25781180}. Golgi apparatus membrane {ECO:0000269|PubMed:25764979}. Endoplasmic reticulum membrane {ECO:0000269|PubMed:25764979}. Note=Exists in three distinct forms: a glycosylated and secreted form, an ER/Golgi-resident form and a non-glycosylated mitochondrial form. {ECO:0000269|PubMed:25764979}.","SUBUNIT: Component of the mitochondrial contact site and cristae organizing system (MICOS) complex, composed of at least MICOS10/MIC10, CHCHD3/MIC19, CHCHD6/MIC25, APOOL/MIC27, IMMT/MIC60, APOO/MIC23/MIC26 and MICOS13/MIC13. This complex was also known under the names MINOS or MitOS complex. he MICOS complex associates with mitochondrial outer membrane proteins SAMM50, MTX1 and MTX2 (together described as components of the mitochondrial outer membrane sorting assembly machinery (SAM) complex) and DNAJC11, mitochondrial inner membrane protein TMEM11 and with HSPA9 (PubMed:25764979, PubMed:25781180, PubMed:25997101). The MICOS and SAM complexes together with DNAJC11 are part of a large protein complex spanning both membranes termed the mitochondrial intermembrane space bridging (MIB) complex. Interacts with IMMT/MIC60 (PubMed:25764979, PubMed:25781180). Interacts with MICOS10/MIC10 and APOOL/MIC27 (PubMed:25764979). {ECO:0000269|PubMed:25764979, ECO:0000269|PubMed:25781180, ECO:0000269|PubMed:25997101, ECO:0000305}.",X,23833353,23907938,p22.11,0.60201,0.548,-0.23262,-0.040572,11.488,0.5405780026335852,ENST00000379226,0.8676716917922949,0.1277680579855036,597,,,,,,,0.31360653506447916,4.77044586185115,Cerebellar_tissues,broadly expressed,4.298563012439471,4.77044586185115,TRUE,low confidence non-escapee,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:28746,FUNDC1,FUN14 domain containing 1,Approved,,MGC51029,Xp11.3,gene with protein product,protein-coding gene,ENSG00000069509,139341,ENSG00000069509,Q8IVP5,MGI:1919268,RGD:1563372,X,300871,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Acts as an activator of hypoxia-induced mitophagy, an important mechanism for mitochondrial quality control. {ECO:0000269|PubMed:22267086}.",autophagy of mitochondrion [GO:0000422]; macroautophagy [GO:0016236]; response to hypoxia [GO:0001666]; response to organonitrogen compound [GO:0010243],"",SUBCELLULAR LOCATION: Mitochondrion outer membrane {ECO:0000269|PubMed:22267086}; Multi-pass membrane protein {ECO:0000269|PubMed:22267086}.,"SUBUNIT: Interacts (via YXXL motif) with MAP1 LC3 family proteins MAP1LC3A, MAP1LC3B and GABARAP. {ECO:0000269|PubMed:22267086}.",X,44523639,44542859,p11.3,0.042053,1.15,0.74579,0.25884,6.723,0.36820083682008364,ENST00000378045,0.9623931623931624,0.1672581854536366,468,,,,,,,0.18699417220268638,5.033528721880512,Pituitary,broadly expressed,4.848798181244189,4.971757355858755,FALSE,high confidence escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:2877,DIAPH2,diaphanous related formin 2,Approved,,"POF, DIA, POF2, DIA2",Xq21.33,gene with protein product,protein-coding gene,ENSG00000147202,1730,ENSG00000147202,O60879,MGI:1858500,RGD:1564399,X,300108,TRUE,,,,?Premature ovarian failure 2A,300511,X-linked dominant,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PMT +CS,FALSE,,PMT,"FUNCTION: Could be involved in oogenesis. Involved in the regulation of endosome dynamics. Implicated in a novel signal transduction pathway, in which isoform 3 and CSK are sequentially activated by RHOD to regulate the motility of early endosomes through interactions with the actin cytoskeleton. {ECO:0000269|PubMed:12577064}.",actin filament organization [GO:0007015]; female gamete generation [GO:0007292]; multicellular organism development [GO:0007275]; oogenesis [GO:0048477],actin binding [GO:0003779]; Rho GTPase binding [GO:0017048]; signaling receptor binding [GO:0005102],"SUBCELLULAR LOCATION: [Isoform 3]: Cytoplasm, cytosol. Early endosome. Note=Isoform 3 is cytosolic but when coexpressed with RHOD, the 2 proteins colocalize to early endosomes.",SUBUNIT: Isoform 3 interacts with RHOD in the GTP-bound form. {ECO:0000269|PubMed:12577064}.,X,96684663,97604997,q21.33,0.99443,0.283,-1.328,1.8331,41.868,0.5447161996682763,ENST00000324765,0.8967332123411978,0.3416895776055986,3306,1,"DIAPH3 (57, 53, chr13)",TRUE,,,,0.3507880612064683,4.504988963435565,Artery - Tibial,broadly expressed,1.3145747251546505,0.5185985859553118,FALSE,discordant,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,no difference_Post1_Post2,PMT
HGNC:28790,PBDC1,polysaccharide biosynthesis domain containing 1,Approved,CXorf26,MGC874,Xq13.3,gene with protein product,protein-coding gene,ENSG00000102390,51260,ENSG00000102390,Q9BVG4,MGI:1914933,RGD:1562502,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,76173040,76178314,q13.3,0.57162,0.698,-1.4368,0.68048,6.7965,0.3812075005151453,ENST00000373358,0.6998575498575499,0.09875031242189453,702,,,,,,,0.17233827407125601,6.099337289343565,Cells - EBV-transformed lymphocytes,broadly expressed,3.818277949242396,4.313075301800325,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:28855,ZNF630,zinc finger protein 630,Approved,,"BC037316, dJ54B20.2, FLJ20573, MGC138344",Xp11.23,gene with protein product,protein-coding gene,ENSG00000221994,57232,ENSG00000221994,Q2M218,,,X,300819,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May be involved in transcriptional regulation.,"regulation of transcription, DNA-templated [GO:0006355]",DNA binding [GO:0003677]; metal ion binding [GO:0046872],SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.,"",X,47983356,48071658,p11.23,1.19e-4,1.101,0.72157,-0.14471,13.111,0.3895997375328084,ENST00000276054,0.2209726443768997,0.08010497375656087,1974,,,,,,,0.3717537827516495,2.960048282971392,Ovary,broadly expressed,1.4145414876016462,2.6012222743575624,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,no disorder
HGNC:28880,MAGT1,magnesium transporter 1,Approved,,"DKFZp564K142, IAP, OST3B, MRX95, SLC58A1",Xq21.1,gene with protein product,protein-coding gene,ENSG00000102158,84061,ENSG00000102158,Q9H0U3,MGI:1914325,RGD:620094,X,300715,TRUE,"Congenital disorder of glycosylation, type Icc // Immunodeficiency, X-linked, with magnesium defect, Epstein-Barr virus infection and neoplasia",301031 // 300853,X-linked recessive // X-linked recessive,,,,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Acts as accessory component of the N-oligosaccharyl transferase (OST) complex which catalyzes the transfer of a high mannose oligosaccharide from a lipid-linked oligosaccharide donor to an asparagine residue within an Asn-X-Ser/Thr consensus motif in nascent polypeptide chains. Involved in N-glycosylation of STT3B-dependent substrates. Specifically required for the glycosylation of a subset of acceptor sites that are near cysteine residues; in this function seems to act redundantly with TUSC3. In its oxidized form proposed to form transient mixed disulfides with a glycoprotein substrate to facilitate access of STT3B to the unmodified acceptor site. Has also oxidoreductase-independent functions in the STT3B-containing OST complex possibly involving substrate recognition. {ECO:0000269|PubMed:25135935, ECO:0000269|PubMed:26864433, ECO:0000269|PubMed:31036665, ECO:0000305}.; FUNCTION: May be involved in Mg(2+) transport in epithelial cells. {ECO:0000305|PubMed:15804357, ECO:0000305|PubMed:19717468}.",cognition [GO:0050890]; magnesium ion transport [GO:0015693]; neutrophil degranulation [GO:0043312]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; transmembrane transport [GO:0055085],magnesium ion transmembrane transporter activity [GO:0015095],SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:19717468}; Multi-pass membrane protein {ECO:0000269|PubMed:19717468}. Endoplasmic reticulum {ECO:0000269|PubMed:25135935}. Endoplasmic reticulum membrane {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}.,"SUBUNIT: Accessory component of the STT3B-containing form of the oligosaccharyltransferase (OST) complex. OST exists in two different complex forms which contain common core subunits RPN1, RPN2, OST48, OST4, DAD1 and TMEM258, either STT3A or STT3B as catalytic subunits, and form-specific accessory subunits. OST can form stable complexes with the Sec61 complex or with both the Sec61 and TRAP complexes. The association of TUSC3 or MAGT1 with the STT3B-containing complex seems to be mutually exclusvice. {ECO:0000269|PubMed:25135935, ECO:0000305}.",X,77825747,77895593,q21.1,0.96138,0.326,-0.45572,1.0616,14.557,0.5670091401873398,ENST00000618282,0.9241071428571429,0.08637840539865034,1008,1,"TUSC3 (61, 64, chr8)",TRUE,,,,0.1696708076336769,5.7512708918944115,Cells - EBV-transformed lymphocytes,broadly expressed,3.405408358308586,2.616080047948021,FALSE,high confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:2890,DKC1,dyskerin pseudouridine synthase 1,Approved,DKC,"XAP101, dyskerin, NAP57, NOLA4, Cbf5",Xq28,gene with protein product,protein-coding gene,ENSG00000130826,1736,ENSG00000130826,O60832,MGI:1861727,RGD:621780,X,300126,TRUE,"Dyskeratosis congenita, X-linked",305000,X-linked recessive,,,,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,confirmed +CS,FALSE,,confirmed,"FUNCTION: [Isoform 1]: Catalytic subunit of H/ACA small nucleolar ribonucleoprotein (H/ACA snoRNP) complex, which catalyzes pseudouridylation of rRNA (PubMed:25219674). This involves the isomerization of uridine such that the ribose is subsequently attached to C5, instead of the normal N1 (PubMed:25219674). Each rRNA can contain up to 100 pseudouridine ('psi') residues, which may serve to stabilize the conformation of rRNAs. Required for ribosome biogenesis and telomere maintenance (PubMed:19179534, PubMed:25219674). Also required for correct processing or intranuclear trafficking of TERC, the RNA component of the telomerase reverse transcriptase (TERT) holoenzyme (PubMed:19179534). {ECO:0000269|PubMed:19179534, ECO:0000269|PubMed:25219674}.; FUNCTION: [Isoform 3]: Promotes cell to cell and cell to substratum adhesion, increases the cell proliferation rate and leads to cytokeratin hyper-expression. {ECO:0000269|PubMed:21820037}.",box H/ACA snoRNA 3'-end processing [GO:0000495]; enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; mRNA pseudouridine synthesis [GO:1990481]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of telomerase RNA localization to Cajal body [GO:1904872]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]; rRNA pseudouridine synthesis [GO:0031118]; scaRNA localization to Cajal body [GO:0090666]; snRNA pseudouridine synthesis [GO:0031120]; telomerase RNA stabilization [GO:0090669]; telomere maintenance via telomerase [GO:0007004],box H/ACA snoRNA binding [GO:0034513]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034],"SUBCELLULAR LOCATION: [Isoform 1]: Nucleus, nucleolus {ECO:0000269|PubMed:10556300, ECO:0000269|PubMed:10591218, ECO:0000269|PubMed:12429849}. Nucleus, Cajal body {ECO:0000250|UniProtKB:P40615}. Note=Also localized to Cajal bodies (coiled bodies). {ECO:0000250|UniProtKB:P40615}.; SUBCELLULAR LOCATION: [Isoform 3]: Cytoplasm {ECO:0000269|PubMed:21820037}.","SUBUNIT: Part of the H/ACA small nucleolar ribonucleoprotein (H/ACA snoRNP) complex, which contains NHP2/NOLA2, GAR1/NOLA1, NOP10/NOLA3, and DKC1/NOLA4, which is presumed to be the catalytic subunit (PubMed:15044956). The complex contains a stable core formed by binding of one or two NOP10-DKC1 heterodimers to NHP2; GAR1 subsequently binds to this core via DKC1 (PubMed:15044956). The complex binds a box H/ACA small nucleolar RNA (snoRNA), which may target the specific site of modification within the RNA substrate (PubMed:15044956). During assembly, the complex contains NAF1 instead of GAR1/NOLA1 (PubMed:16601202, PubMed:16618814). The complex also interacts with TERC, which contains a 3'-terminal domain related to the box H/ACA snoRNAs. Specific interactions with snoRNAs or TERC are mediated by GAR1 and NHP2. Associates with NOLC1/NOPP140 (PubMed:15044956). H/ACA snoRNPs interact with the SMN complex, consisting of SMN1 or SMN2, GEMIN2/SIP1, DDX20/GEMIN3, and GEMIN4. This is mediated by interaction between GAR1 and SMN1 or SMN2. The SMN complex may be required for correct assembly of the H/ACA snoRNP complex (PubMed:15044956). Component of the telomerase holoenzyme complex composed of one molecule of TERT, one molecule of WRAP53/TCAB1, two molecules of H/ACA ribonucleoprotein complex subunits DKC1, NOP10, NHP2 and GAR1, and a telomerase RNA template component (TERC) (PubMed:11074001, PubMed:19179534, PubMed:20351177, PubMed:29695869). The telomerase holoenzyme complex is associated with TEP1, SMG6/EST1A and POT1 (PubMed:19179534). Interacts with SHQ1; this interaction may lead to the stabilization of DKC1, from the time of its synthesis until its association with NOP10, NHP2, and NAF1 at the nascent H/ACA RNA (PubMed:19734544, PubMed:19383767). Interacts with HMBOX1 (PubMed:23685356). Interacts with DHX36 (PubMed:21846770). {ECO:0000269|PubMed:11074001, ECO:0000269|PubMed:15044956, ECO:0000269|PubMed:16601202, ECO:0000269|PubMed:16618814, ECO:0000269|PubMed:19179534, ECO:0000269|PubMed:19383767, ECO:0000269|PubMed:19734544, ECO:0000269|PubMed:20351177, ECO:0000269|PubMed:21846770, ECO:0000269|PubMed:23685356, ECO:0000269|PubMed:29695869}.",X,154762742,154777689,q28,0.99916,0.191,-0.5691,3.3994,24.889,0.6183767005359265,ENST00000369550,0.8083495145631068,0.08522869282679331,1545,,,,,,,0.28063939294219864,6.741561365232585,Cells - EBV-transformed lymphocytes,broadly expressed,3.791876569232241,5.004058628157764,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:28907,ITIH6,inter-alpha-trypsin inhibitor heavy chain family member 6,Approved,ITIH5L,UNQ6369,Xp11.22,gene with protein product,protein-coding gene,ENSG00000102313,347365,ENSG00000102313,Q6UXX5,MGI:2685232,RGD:6485811,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",hyaluronan metabolic process [GO:0030212],serine-type endopeptidase inhibitor activity [GO:0004867],SUBCELLULAR LOCATION: Secreted {ECO:0000250}.,"",X,54748918,54798255,p11.22,1.5096e-24,1.518,-1.7085,-2.3032,29.81,0.1596199051009783,ENST00000218436,0.4332825976661593,0.17518120469882528,3942,,,,,,,0.9522475537112797,1.223774685189259,Muscle - Skeletal,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:28909,CCDC22,coiled-coil domain containing 22,Approved,CXorf37,JM1,Xp11.23,gene with protein product,protein-coding gene,ENSG00000101997,28952,ENSG00000101997,O60826,MGI:1859608,RGD:1560910,X,300859,TRUE,Ritscher-Schinzel syndrome 2,300963,X-linked recessive,,,,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Involved in regulation of NF-kappa-B signaling. Promotes ubiquitination of I-kappa-B-kinase subunit IKBKB and its subsequent proteasomal degradation leading to NF-kappa-B activation; the function may involve association with COMMD8 and a CUL1-dependent E3 ubiquitin ligase complex. May down-regulate NF-kappa-B activity via association with COMMD1 and involving a CUL2-dependent E3 ubiquitin ligase complex. Regulates the cellular localization of COMM domain-containing proteins, such as COMMD1 and COMMD10 (PubMed:23563313). Component of the CCC complex, which is involved in the regulation of endosomal recycling of surface proteins, including integrins, signaling receptor and channels. The CCC complex associates with SNX17, retriever and WASH complexes to prevent lysosomal degradation and promote cell surface recycling of numerous cargos such as integrins ITGA5:ITGB1 (PubMed:28892079, PubMed:25355947). Plays a role in copper ion homeostasis. Involved in copper-dependent ATP7A trafficking between the trans-Golgi network and vesicles in the cell periphery; the function is proposed to depend on its association within the CCC complex and cooperation with the WASH complex on early endosomes (PubMed:25355947). {ECO:0000269|PubMed:23563313, ECO:0000269|PubMed:25355947, ECO:0000269|PubMed:28892079}.; FUNCTION: (Microbial infection) The CCC complex, in collaboration with the heterotrimeric retriever complex, mediates the exit of human papillomavirus to the cell surface. {ECO:0000269|PubMed:28892079}.","cellular copper ion homeostasis [GO:0006878]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; endocytic recycling [GO:0032456]; Golgi to plasma membrane transport [GO:0006893]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; post-translational protein modification [GO:0043687]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; retrograde transport, endosome to plasma membrane [GO:1990126]",cullin family protein binding [GO:0097602],SUBCELLULAR LOCATION: Endosome {ECO:0000305|PubMed:28892079}.,"SUBUNIT: Interacts with CPNE1 and CPNE4 (By similarity). Interacts with COMMD1, COMMD2 COMMD3, COMMD4, COMMD5, COMMD6, COMMD7, COMMD8, COMMD9, COMMD10 (PubMed:25355947). Interacts with CUL1, CUL2, CUL3, SKP1, BTRC (PubMed:23563313). Interacts with CCDC93; proposed to be a component of the CCC (COMMD/CCDC22/CCDC93) complex which contains at least COMMD1 (and possibly other COMM domain-containing proteins), CCDC22 and CCDC93; in the complex interacts directly with CCDC93 (PubMed:25355947). Interacts with VPS35L; associates with the retriever complex (PubMed:25355947, PubMed:28892079). Interacts with SNX17 and SNX31 (PubMed:28892079). {ECO:0000250|UniProtKB:Q9JIG7, ECO:0000269|PubMed:23563313, ECO:0000269|PubMed:25355947, ECO:0000269|PubMed:28892079}.",X,49235470,49250520,p11.23,0.99979,0.123,-0.088284,1.2892,24.202,0.5232575158806826,ENST00000376227,0.7309978768577494,0.24576355911022243,1884,,,,,,,0.16525638590337607,5.219373775222014,Spleen,broadly expressed,3.361091762062717,5.123384780577181,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:28910,CCDC120,coiled-coil domain containing 120,Approved,,JM11,Xp11.23,gene with protein product,protein-coding gene,ENSG00000147144,90060,ENSG00000147144,Q96HB5,MGI:1859619,RGD:1561596,X,300947,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Centriolar protein required for centriole subdistal appendage assembly and microtubule anchoring in interphase cells (PubMed:28422092). Together with CCDC68, cooperate with subdistal appendage components ODF2, NIN and CEP170 for hierarchical subdistal appendage assembly (PubMed:28422092). Recruits NIN and CEP170 to centrosomes (PubMed:28422092). Also required for neurite growth. Localizes CYTH2 to vesicles to allow its transport along neurites, and subsequent ARF6 activation and neurite growth. {ECO:0000269|PubMed:25326380}.",microtubule anchoring at centrosome [GO:0034454]; multicellular organism development [GO:0007275]; protein localization [GO:0008104],"","SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriole {ECO:0000269|PubMed:28422092}. Cytoplasm {ECO:0000269|PubMed:25326380}. Cell projection, neuron projection {ECO:0000269|PubMed:25326380}. Cell projection, growth cone {ECO:0000269|PubMed:25326380}. Endosome {ECO:0000269|PubMed:25326380}. Note=Localizes to the subdistal appendages of mother centrioles and proximal ends of both centrioles in interphase cells (PubMed:28422092). Recruited to subdistal appendages by ODF2 (PubMed:28422092). In differentiating neuroblastoma cells, colocalizes with CYTH2 in both neurite shaft and growth cone areas (PubMed:25326380). Partially colocalizes with endosomes along neurites in differentiating neuroblastoma cells (PubMed:25326380). {ECO:0000269|PubMed:25326380, ECO:0000269|PubMed:28422092}.","SUBUNIT: Interacts with NIN and CEP170; leading to recruit them to centrosomes (PubMed:28422092). Directly interacts with CYTH2; this interaction stabilizes CCDC120, possibly by preventing ubiquitination. {ECO:0000269|PubMed:25326380, ECO:0000269|PubMed:28422092}.",X,49053572,49069857,p11.23,0.43409,0.551,-0.20867,0.074511,14.076,0.14821841465583682,ENST00000603986,0.7579626972740315,0.1513,2091,,,,,,,0.4270483451798231,5.719495607227801,Esophagus - Mucosa,broadly expressed,2.0596667664292516,4.664952095038055,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:28911,PRAF2,PRA1 domain family member 2,Approved,,"JM4, Yip6a",Xp11.23,gene with protein product,protein-coding gene,ENSG00000243279,11230,ENSG00000243279,O60831,MGI:1859607,RGD:1566287,X,300840,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: May be involved in ER/Golgi transport and vesicular traffic. Plays a proapoptotic role in cerulenin-induced neuroblastoma apoptosis. {ECO:0000269|PubMed:17975142, ECO:0000269|PubMed:18395978}.",L-glutamate transmembrane transport [GO:0015813]; protein transport [GO:0015031],"",SUBCELLULAR LOCATION: Endosome membrane {ECO:0000305|PubMed:17975142}; Multi-pass membrane protein {ECO:0000305|PubMed:17975142}.,"SUBUNIT: Interacts with CCR5 and GDE1. {ECO:0000269|PubMed:15757671, ECO:0000269|PubMed:16472945}.",X,49071161,49074002,p11.23,0.74236,0.667,1.9694,1.174,4.484,0.46208770950454925,ENST00000553851,0.7385474860335196,0.30222444388902775,537,,,,,,,0.2705958589785259,6.311568506086282,Pituitary,broadly expressed,5.164862690051987,5.450741128903349,FALSE,high confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,Post2_higher_vs_Pre,no difference_Post1_Post2,no disorder
HGNC:28912,WDR45,WD repeat domain 45,Approved,WDRX1,"JM5, WIPI4, NBIA5",Xp11.23,gene with protein product,protein-coding gene,ENSG00000196998,11152,ENSG00000196998,Q9Y484,MGI:1859606,RGD:1359718,X,300526,TRUE,Neurodegeneration with brain iron accumulation 5,300894,X-linked dominant,,,,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,confirmed +CS,FALSE,TRUE,confirmed,"FUNCTION: Component of the autophagy machinery that controls the major intracellular degradation process by which cytoplasmic materials are packaged into autophagosomes and delivered to lysosomes for degradation (PubMed:23435086, PubMed:28561066). Activated by the STK11/AMPK signaling pathway upon starvation, WDR45 is involved in autophagosome assembly downstream of WIPI2, regulating the size of forming autophagosomes (PubMed:28561066). Probably recruited to membranes through its PtdIns3P activity (PubMed:28561066). {ECO:0000269|PubMed:23435086, ECO:0000269|PubMed:28561066}.",autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; cellular response to starvation [GO:0009267]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497],"phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol phosphate binding [GO:1901981]; protein kinase binding [GO:0019901]","SUBCELLULAR LOCATION: Preautophagosomal structure {ECO:0000269|PubMed:21802374, ECO:0000269|PubMed:28561066}. Cytoplasm {ECO:0000269|PubMed:21802374}. Note=Diffusely localized in the cytoplasm under nutrient-rich conditions. Localizes to autophagic structures during starvation-induced autophagy. {ECO:0000269|PubMed:21802374}.","SUBUNIT: Interacts with WIPI1 (PubMed:28561066). Interacts with WIPI2 (PubMed:28561066). Interacts with ATG2A and probably ATG2B (PubMed:28561066). Interacts with ULK1 (PubMed:28561066). May interact with the PRKAA1, PRKAA2, PRKAB1 and PRKAG1 subunits of the AMPK kinase (PubMed:28561066). May interact with NUDC (PubMed:28561066). {ECO:0000269|PubMed:28561066}.",X,49074433,49101170,p11.23,0.99145,0.21,1.7837,2.0155,14.262,0.4209491224052696,ENST00000376372,0.9500461680517083,0.08357910522369408,1083,,,,,,,0.13572928701653314,6.222541835585436,Cervix - Endocervix,broadly expressed,4.396570532821856,5.102378886586651,FALSE,high confidence non-escapee,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:29007,FRMPD4,FERM and PDZ domain containing 4,Approved,"PDZK10, PDZD10",KIAA0316,Xp22.2,gene with protein product,protein-coding gene,ENSG00000169933,9758,ENSG00000169933,Q14CM0,MGI:3042378,RGD:1566031,X,300838,TRUE,"Mental retardation, X-linked 104",300983,X-linked,,,,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,confirmed +CS,FALSE,TRUE,confirmed,"FUNCTION: Positive regulator of dendritic spine morphogenesis and density. Required for the maintenance of excitatory synaptic transmission. Binds phosphatidylinositol 4,5-bisphosphate. {ECO:0000269|PubMed:19118189}.",positive regulation of synapse structural plasticity [GO:0051835],"phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]","SUBCELLULAR LOCATION: Cell projection, dendritic spine {ECO:0000269|PubMed:19118189}.","SUBUNIT: Interacts (via C-terminus) with DLG1, DLG2, DLG3 and DLG4/PSD95. Interacts (via N-terminus) with ARHGEF7; the interaction is mediated by the PDZ domain (PubMed:19118189). Interacts with GPSM2 (via TPR repeat region) (PubMed:25664792). {ECO:0000269|PubMed:19118189, ECO:0000269|PubMed:25664792}.",X,11822423,12724523,p22.2,1,0.083,-1.6077,1.9503,35.69,0.5286110744020087,ENST00000675598,0.8710531291359426,0.30752311922019493,5289,,,,,,,0.8855484392198374,2.231012995118689,Cerebellar_tissues,tissue-specific,1.8031402240928147,2.231012995118689,TRUE,discordant,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:2902,DLG3,discs large MAGUK scaffold protein 3,Approved,,"NE-Dlg, SAP102, SAP-102, NEDLG, KIAA1232, MRX90, PPP1R82",Xq13.1,gene with protein product,protein-coding gene,ENSG00000082458,1741,ENSG00000082458,Q92796,MGI:1888986,RGD:68423,X,300189,TRUE,"Mental retardation, X-linked 90",300850,X-linked recessive,,,,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,confirmed +CS,FALSE,TRUE,confirmed,FUNCTION: Required for learning most likely through its role in synaptic plasticity following NMDA receptor signaling.,cell-cell adhesion [GO:0098609]; establishment of planar polarity [GO:0001736]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; MAPK cascade [GO:0000165]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of phosphatase activity [GO:0010923]; positive regulation of protein tyrosine kinase activity [GO:0061098]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of NMDA receptor activity [GO:2000310]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072],ionotropic glutamate receptor binding [GO:0035255]; kinase binding [GO:0019900]; PDZ domain binding [GO:0030165]; phosphatase binding [GO:0019902]; protein C-terminus binding [GO:0008022]; protein phosphatase binding [GO:0019903]; structural constituent of postsynaptic density [GO:0098919]; ubiquitin protein ligase binding [GO:0031625],"","SUBUNIT: Interacts through its PDZ domains with NETO1, GRIN2B and SYNGAP1. Interacts through its guanylate kinase-like domain with DLGAP1, DLGAP2, DLGAP3 and DLGAP4. Interacts with FLTP/C1orf192 (By similarity). Interacts through its PDZ domains with APC. Interacts through its first two PDZ domains with ERBB4. Interacts through its third PDZ domain with NLGN1, and probably with NLGN2 and NLGN3. Interacts with FRMPD4 (via C-terminus). Interacts with LRFN1, LRFN2 and LRFN4. {ECO:0000250|UniProtKB:P70175, ECO:0000269|PubMed:10725395, ECO:0000269|PubMed:16630835, ECO:0000269|PubMed:19118189, ECO:0000269|PubMed:9188857, ECO:0000269|PubMed:9278515}.",X,70444835,70505490,q13.1,0.99999,0.09,0.69663,2.8769,33.275,0.4113466378941664,ENST00000374360,0.9484922575387124,0.49132716820794803,2454,3,"DLG1 (66, 60, chr3); DLG2 (65, 55, chr11); DLG4 (58, 64, chr17)",TRUE,,,,0.29248861808439225,4.93766453698789,Cerebellar_tissues,broadly expressed,3.5675697843993563,4.93766453698789,TRUE,high confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:29059,IQSEC2,IQ motif and Sec7 domain ArfGEF 2,Approved,"MRX1, MRX78, MRX18","KIAA0522, BRAG1, IQ-ArfGEF",Xp11.22,gene with protein product,protein-coding gene,ENSG00000124313,23096,ENSG00000124313,Q5JU85,MGI:3528396,RGD:1596452,X,300522,TRUE,"Mental retardation, X-linked 1/78",309530,X-linked dominant,,,,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,confirmed +CS,FALSE,TRUE,confirmed,FUNCTION: Is a guanine nucleotide exchange factor for the ARF GTP-binding proteins. {ECO:0000269|PubMed:26793055}.,actin cytoskeleton organization [GO:0030036]; modulation of chemical synaptic transmission [GO:0050804]; regulation of ARF protein signal transduction [GO:0032012]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696],ARF guanyl-nucleotide exchange factor activity [GO:0005086],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}.,"",X,53225828,53321350,p11.22,0.99998,0.133,1.9145,5.1894,35.58,0.529071104450961,ENST00000642864,0.8458920976046563,0.40384903774056485,4467,,,,,,,0.5258093801208656,5.199179585244375,Cerebellar_tissues,broadly expressed,3.6926392122581144,5.199179585244375,TRUE,high confidence escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:29081,GAGE13,G antigen 13,Approved,GAGE12A,OTTHUMG00000024138,Xp11.23,gene with protein product,protein-coding gene,ENSG00000274274,645051,ENSG00000274274,Q4V321,,,X,300734,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,49331616,49338952,p11.23,0.32958,1.844,-0.99282,-0.5011,0.44566,0.5735730322348044,ENST00000612958,0.0692090395480226,0.04448887778055486,354,11,"GAGE12G (98, 98, chrX); GAGE12F (98, 98, chrX); GAGE1 (98, 98, chrX); GAGE12J (98, 98, chrX); GAGE12E (97, 97, chrX); GAGE12D (97, 97, chrX); GAGE12C (97, 97, chrX); GAGE12H (97, 97, chrX); GAGE2A (97, 97, chrX); GAGE2E (92, 98, chrX); GAGE10 (92, 93, chrX)",TRUE,11,"GAGE12G (98, 98, chrX); GAGE12F (98, 98, chrX); GAGE1 (98, 98, chrX); GAGE12J (98, 98, chrX); GAGE12E (97, 97, chrX); GAGE12D (97, 97, chrX); GAGE12C (97, 97, chrX); GAGE12H (97, 97, chrX); GAGE2A (97, 97, chrX); GAGE2E (92, 98, chrX); GAGE10 (92, 93, chrX)",TRUE,,0,,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:29215,SHROOM4,shroom family member 4,Approved,,KIAA1202,Xp11.22,gene with protein product,protein-coding gene,ENSG00000158352,57477,ENSG00000158352,Q9ULL8,MGI:2685570,RGD:1563434,X,300579,TRUE,Stocco dos Santos X-linked mental retardation syndrome,300434,X-linked,,,,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Probable regulator of cytoskeletal architecture that plays an important role in development. May regulate cellular and cytoskeletal architecture by modulating the spatial distribution of myosin II (By similarity). {ECO:0000250, ECO:0000269|PubMed:16684770}.",actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; brain development [GO:0007420]; cognition [GO:0050890],actin filament binding [GO:0051015]; myosin II binding [GO:0045159],"SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000269|PubMed:16249884, ECO:0000269|PubMed:16684770}. Note=Shows partial colocalization with the cytoplasmic pool of F-actin.",SUBUNIT: Interacts directly with F-actin. {ECO:0000250}.,X,50591647,50814302,p11.22,0.99965,0.226,0.33025,0.95131,40.469,0.5042260673994269,ENST00000289292,0.5656180276662205,0.35793551612096974,4482,,,,,,,0.5574377594928887,4.639839912345208,Lung,broadly expressed,1.815825419694942,1.0506141832239124,FALSE,high confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:29218,KIAA1210,KIAA1210,Approved,,,Xq24,gene with protein product,protein-coding gene,ENSG00000250423,57481,ENSG00000250423,Q9ULL0,MGI:3705243,RGD:1561445,X,300995,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","SUBCELLULAR LOCATION: Cytoplasmic vesicle, secretory vesicle, acrosome {ECO:0000250|UniProtKB:E9Q0C6}. Note=Localizes to the sex body in spermatocyte, acrosome, and near the ectoplasmic specialization. {ECO:0000250|UniProtKB:E9Q0C6}.",SUBUNIT: Interacts with TOP2B. {ECO:0000250|UniProtKB:E9Q0C6}.,X,119078635,119150579,q24,0.0091034,0.446,-0.32766,-0.23529,46.332,0.332081018913121,ENST00000402510,0.0810916179337232,0.06943264183954012,5130,,,,,,,0.951597912895029,5.761463471367204,Testis,tissue-specific,0.01598747157240112,0.02543269255988026,FALSE,variable escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:29237,WWC3,WWC family member 3,Approved,,"KIAA1280, BM042",Xp22.2,gene with protein product,protein-coding gene,ENSG00000047644,55841,ENSG00000047644,Q9ULE0,,RGD:1560666,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",negative regulation of hippo signaling [GO:0035331]; negative regulation of organ growth [GO:0046621]; negative regulation of transcription by RNA polymerase II [GO:0000122],kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090],"","",X,10015254,10144474,p22.2,0.99996,0.185,-0.38482,1.5132,42.012,0.831422018348624,ENST00000380861,0.8212259835315645,0.16823294176455886,3279,,,,,,,0.23137661217035374,5.590086978672099,Lung,broadly expressed,3.103667161097713,4.725059450192119,FALSE,low confidence non-escapee,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:29245,RTL9,retrotransposon Gag like 9,Approved,RGAG1,"KIAA1318, Mart9, Mar9, SIRH10",Xq23,gene with protein product,protein-coding gene,ENSG00000243978,57529,ENSG00000243978,Q8NET4,MGI:2685231,RGD:6486824,X,300965,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,110358816,110456334,q23,0.99731,0.218,-0.28616,-0.66854,21.778,0.23410066328521265,ENST00000465301,0.36124310055195585,0.42284428892776804,4167,,,,,,,0.9260925806256093,4.144454313926194,Testis,tissue-specific,0.352415039132759,0.8974936979879765,FALSE,variable escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:2928,DMD,dystrophin,Approved,MRX85,"BMD, DXS142, DXS164, DXS206, DXS230, DXS239, DXS268, DXS269, DXS270, DXS272",Xp21.2-p21.1,gene with protein product,protein-coding gene,ENSG00000198947,1756,ENSG00000198947,P11532,MGI:94909,RGD:2507,X,300377,TRUE,"Becker muscular dystrophy // Cardiomyopathy, dilated, 3B // Duchenne muscular dystrophy",300376 // 302045 // 310200,X-linked recessive // X-linked // X-linked recessive,,,,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Anchors the extracellular matrix to the cytoskeleton via F-actin. Ligand for dystroglycan. Component of the dystrophin-associated glycoprotein complex which accumulates at the neuromuscular junction (NMJ) and at a variety of synapses in the peripheral and central nervous systems and has a structural function in stabilizing the sarcolemma. Also implicated in signaling events and synaptic transmission. {ECO:0000250|UniProtKB:P11531, ECO:0000269|PubMed:16710609}.",cardiac muscle cell action potential [GO:0086001]; cardiac muscle contraction [GO:0060048]; cellular protein-containing complex assembly [GO:0034622]; cellular protein localization [GO:0034613]; maintenance of blood-brain barrier [GO:0035633]; motile cilium assembly [GO:0044458]; muscle cell cellular homeostasis [GO:0046716]; muscle fiber development [GO:0048747]; muscle filament sliding [GO:0030049]; muscle organ development [GO:0007517]; negative regulation of peptidyl-cysteine S-nitrosylation [GO:1902083]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; peptide biosynthetic process [GO:0043043]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cellular response to growth factor stimulus [GO:0090287]; regulation of heart rate [GO:0002027]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of skeletal muscle contraction [GO:0014819]; regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [GO:0014809]; regulation of voltage-gated calcium channel activity [GO:1901385]; response to muscle stretch [GO:0035994],actin binding [GO:0003779]; dystroglycan binding [GO:0002162]; myosin binding [GO:0017022]; nitric-oxide synthase binding [GO:0050998]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; vinculin binding [GO:0017166]; zinc ion binding [GO:0008270],"SUBCELLULAR LOCATION: Cell membrane, sarcolemma {ECO:0000250|UniProtKB:P11531}; Peripheral membrane protein {ECO:0000250|UniProtKB:P11531}; Cytoplasmic side {ECO:0000250|UniProtKB:P11531}. Cytoplasm, cytoskeleton {ECO:0000250|UniProtKB:P11531}. Cell junction, synapse, postsynaptic cell membrane {ECO:0000250|UniProtKB:P11531}. Note=In muscle cells, sarcolemma localization requires the presence of ANK2, while localization to costameres requires the presence of ANK3. Localizes to neuromuscular junctions (NMJs). In adult muscle, NMJ localization depends upon ANK2 presence, but not in newborn animals. {ECO:0000250|UniProtKB:P11531}.","SUBUNIT: Interacts with SYNM (By similarity). Interacts with the syntrophins SNTA1, SNTB1, SNTB2, SNTG1 and SNTG2 (PubMed:7844150, PubMed:8576247). Interacts with KRT19 (PubMed:16000376). Component of the dystrophin-associated glycoprotein complex which is composed of three subcomplexes: a cytoplasmic complex comprised of DMD (or UTRN), DTNA and a number of syntrophins, such as SNTB1, SNTB2, SNTG1 and SNTG2, the transmembrane dystroglycan complex, and the sarcoglycan-sarcospan complex. Interacts with DAG1 (betaDAG1) with DMD; the interaction is inhibited by phosphorylation on the PPXY motif of DAG1 (PubMed:7592992, PubMed:11495720, PubMed:10932245). Interacts with CMYA5 (By similarity). Directly interacts with ANK2 and ANK3; these interactions do not interfere with betaDAG1-binding and are necessary for proper localization in muscle cells (By similarity). Identified in a dystroglycan complex that contains at least PRX, DRP2, UTRN, DMD and DAG1 (By similarity). {ECO:0000250|UniProtKB:P11531, ECO:0000269|PubMed:10932245, ECO:0000269|PubMed:11495720, ECO:0000269|PubMed:16000376, ECO:0000269|PubMed:7592992, ECO:0000269|PubMed:7844150, ECO:0000269|PubMed:8576247}.",X,31097677,33339441,p21.1,1,0.154,-3.4421,-2.4322,165.44,0.2631578947368421,ENST00000357033,0.9435160065111232,0.1873281679580105,11058,,,,,,,0.48573541843371154,5.5064337432078405,Nerve - Tibial,broadly expressed,2.1269728562577654,2.3779038987066823,FALSE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:29292,LRCH2,leucine rich repeats and calponin homology domain containing 2,Approved,,KIAA1495,Xq23,gene with protein product,protein-coding gene,ENSG00000130224,57631,ENSG00000130224,Q5VUJ6,MGI:2147870,RGD:1590569,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: May play a role in the organization of the cytoskeleton. {ECO:0000250|UniProtKB:Q960C5, ECO:0000250|UniProtKB:Q96II8}.","","","","",X,115110616,115234096,q23,0.99713,0.242,1.235,1.9411,26.012,0.45542940161130924,ENST00000317135,0.9412967798085291,0.2952511872031992,2298,,,,,,,0.4622762968139408,4.151818236300272,Cervix - Ectocervix,broadly expressed,2.242288477905227,3.0027943171437568,FALSE,discordant,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:29347,KLHL15,kelch like family member 15,Approved,,KIAA1677,Xp22.11,gene with protein product,protein-coding gene,ENSG00000174010,80311,ENSG00000174010,Q96M94,MGI:1923400,RGD:1563101,X,300980,TRUE,"Mental retardation, X-linked 103",300982,X-linked recessive,,,,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,confirmed +CS,FALSE,TRUE,confirmed,"FUNCTION: Substrate-specific adapter for CUL3 E3 ubiquitin-protein ligase complex (PubMed:14528312). Acts as an adapter for CUL3 to target the serine/threonine-protein phosphatase 2A (PP2A) subunit PPP2R5B for ubiquitination and subsequent proteasomal degradation, thus promoting exchange with other regulatory subunits (PubMed:23135275). Acts as an adapter for CUL3 to target the DNA-end resection factor RBBP8/CtIP for ubiquitination and subsequent proteasomal degradation. Through the regulation of RBBP8/CtIP protein turnover, plays a key role in DNA damage response, favoring DNA double-strand repair through error-prone non-homologous end joining (NHEJ) over error-free, RBBP8-mediated homologous recombination (HR) (PubMed:27561354). {ECO:0000269|PubMed:14528312, ECO:0000269|PubMed:23135275, ECO:0000269|PubMed:27561354}.",negative regulation of double-strand break repair via homologous recombination [GO:2000042]; nuclear protein quality control by the ubiquitin-proteasome system [GO:0071630]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],"",SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:27561354}.,"SUBUNIT: Homodimer. Dimerization does not affect PPP2R5B-binding, but is required for its proteasomal degradation (PubMed:23135275). Interacts with CUL3 (PubMed:27561354, PubMed:14528312, PubMed:23135275). Directly interacts with PPP2R5B; this interaction leads to PPP2R5B proteasomal degradation (PubMed:23135275). Interacts with RBBP8/CtIP; this interaction leads to RBBP8 proteasomal degradation (PubMed:27561354). {ECO:0000269|PubMed:14528312, ECO:0000269|PubMed:23135275, ECO:0000269|PubMed:27561354}.",X,23983720,24027186,p22.11,0.99422,0.195,-0.10462,3.6857,15.314,0.6815768361243837,ENST00000328046,0.9755922865013774,0.20229942514371407,1815,,,,,,,0.4479967607452825,4.537258787667568,Testis,broadly expressed,1.8368774735286788,2.7805410797579277,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:29353,BHLHB9,basic helix-loop-helix family member b9,Approved,,"p60TRP, KIAA1701, GASP3",Xq22.1,gene with protein product,protein-coding gene,ENSG00000198908,80823,ENSG00000198908,Q6PI77,MGI:1917487,RGD:1303224,X,300921,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May play a role in the control of cellular aging and survival.,learning or memory [GO:0007611]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of neurogenesis [GO:0050769]; positive regulation of synapse assembly [GO:0051965],protein homodimerization activity [GO:0042803],"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15034937}. Nucleus {ECO:0000269|PubMed:15034937}. Note=Mainly cytoplasmic, and nuclear at lower level.","",X,102720688,102753540,q22.1,0.02025,1.016,1.9661,0.47379,9.011,0.3048012339533826,ENST00000457056,0.6060827250608273,0.047088227943014246,1644,1,"ARMCX5-GPRASP2 (100, 100, chrX)",TRUE,1,"ARMCX5-GPRASP2 (100, 100, chrX)",TRUE,0.5147045057864964,4.0371054299604365,Cerebellar_tissues,broadly expressed,2.7990748689941807,4.0371054299604365,TRUE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,no disorder
HGNC:29377,ZMAT1,zinc finger matrin-type 1,Approved,,KIAA1789,Xq22.1,gene with protein product,protein-coding gene,ENSG00000166432,84460,ENSG00000166432,Q5H9K5,MGI:2442284,RGD:1565344,X,301007,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","",DNA binding [GO:0003677]; zinc ion binding [GO:0008270],SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.,"",X,101882288,101932079,q22.1,0.0010485,0.78,0.53525,0.44326,18.512,0.5455766325331544,ENST00000651725,0.585632183908046,0.18912771807048237,2088,,,,,,,0.4108429464883597,6.213325893912574,Pituitary,broadly expressed,3.326498519102573,3.995425724464661,FALSE,discordant,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,Post2_higher_vs_Post1,no disorder
HGNC:29382,FRMPD3,FERM and PDZ domain containing 3,Approved,,"RP5-1070B1.1, KIAA1817",Xq22.3,gene with protein product,protein-coding gene,ENSG00000147234,84443,ENSG00000147234,Q5JV73,MGI:3646547,RGD:1563753,X,301005,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",neutrophil degranulation [GO:0043312],"","","",X,107522450,107605251,q22.3,1.9028e-4,0.476,1.6777,1.0211,53.604,0.15621206843777377,ENST00000276185,0.8421314191054666,0.20979755061234692,5433,,,,,,,0.8644851135658312,3.6998680757151665,Cerebellar_tissues,tissue-specific,1.6044746524116327,3.6998680757151665,TRUE,variable escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:29395,DCAF12L1,DDB1 and CUL4 associated factor 12 like 1,Approved,WDR40B,KIAA1892L,Xq25,gene with protein product,protein-coding gene,ENSG00000198889,139170,ENSG00000198889,Q5VU92,MGI:2444462,RGD:1563873,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,126549383,126552814,q25,0.95405,0.309,0.11344,2.4087,9.6672,0.58614277629557765,ENST00000371126,0.7591235632183908,0.28217945513621595,1392,2,"DCAF12L2 (87, 87, chrX); DCAF12 (60, 61, chr9)",TRUE,1,"DCAF12L2 (87, 87, chrX)",TRUE,0.9203489766626278,3.680020481114138,Testis,tissue-specific,0.010197631432430541,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:29430,RTL5,retrotransposon Gag like 5,Approved,RGAG4,"KIAA2001, Mar5, Mart5, SIRH8",Xq13.1,gene with protein product,protein-coding gene,ENSG00000242732,340526,ENSG00000242732,Q5HYW3,MGI:3045324,RGD:6490575,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,72127110,72131901,q13.1,1.8633e-4,1.021,0.049852,0.20307,14.131,0.5751829953878279,ENST00000609883,0.5332748538011696,0.3287928017995501,1710,,,,,,,0.4544684764020002,6.290470482667477,Cerebellar_tissues,broadly expressed,3.8500993041969647,6.290470482667477,TRUE,high confidence non-escapee,no_difference_Pre_Post,Pre_higher_vs_Post1,no difference_Pre_Post2,Post2_higher_vs_Post1,no disorder
HGNC:29433,NEXMIF,neurite extension and migration factor,Approved,KIAA2022,"XPN, MRX98, KIDLIA",Xq13.3,gene with protein product,protein-coding gene,ENSG00000050030,340533,ENSG00000050030,Q5QGS0,MGI:2148050,RGD:1561931,X,300524,TRUE,"Mental retardation, X-linked 98",300912,X-linked dominant,,,,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,confirmed +CS,FALSE,TRUE,confirmed,"FUNCTION: Involved in neurite outgrowth by regulating cell-cell adhesion via the N-cadherin signaling pathway. May act by regulating expression of protein-coding genes, such as N-cadherins and integrin beta-1 (ITGB1). {ECO:0000250|UniProtKB:D3ZGX1}.",negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of neuron migration [GO:2001223],"",SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:24071057}. Cytoplasm {ECO:0000250|UniProtKB:Q5DTT1}.,"",X,74732856,74925472,q13.3,0.99968,0.198,-0.3865,1.2725,31.876,0.6997126180318798,ENST00000055682,0.9235772357723577,0.35156210947263183,4551,,,,,,,0.6718102592782542,2.257187171544543,Cerebellar_tissues,tissue-specific,1.129335777398848,2.257187171544543,TRUE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:29437,CLTRN,"collectrin, amino acid transport regulator",Approved,TMEM27,NX17,Xp22.2,gene with protein product,protein-coding gene,ENSG00000147003,57393,ENSG00000147003,Q9HBJ8,MGI:1926234,RGD:708489,X,300631,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Plays an important role in amino acid transport by acting as binding partner of amino acid transporters SLC6A18 and SLC6A19, regulating their trafficking on the cell surface and their amino acid transporter activity (By similarity). May also play a role in trafficking of amino acid transporters SLC3A1 and SLC7A9 to the renal cortical cell membrane (By similarity). Regulator of SNARE complex function (PubMed:16330323). Stimulator of beta cell replication (PubMed:16330323). {ECO:0000250|UniProtKB:Q9ESG4, ECO:0000269|PubMed:16330323}.",positive regulation of amino acid transport [GO:0051957]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of L-proline import across plasma membrane [GO:1905737]; positive regulation of SNARE complex assembly [GO:0035543]; regulation of transmembrane transporter activity [GO:0022898],protein homodimerization activity [GO:0042803],SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:22628310}; Single-pass type I membrane protein {ECO:0000255}. Note=Localizes to the brush border membranes of cells in the proximal tubules of kidney (By similarity). Colocalizes with SLC6A19 in the early proximal S1 tubule (By similarity). {ECO:0000250|UniProtKB:Q9ESG4}.,"SUBUNIT: Monomer (PubMed:22628310). Homodimer; dimerization prevents CLTRN cleavage by BACE2 (PubMed:22628310). Interacts with SLC6A18; this interaction regulates the trafficking of SLC6A18 to the cell membrane and its amino acid transporter activity (By similarity). Interacts with SLC6A19; this interaction regulates the trafficking of SLC6A19 to the cell membrane and its amino acid transporter activity (By similarity). Interacts with SNAPIN (PubMed:16330323). {ECO:0000250|UniProtKB:Q9ESG4, ECO:0000269|PubMed:16330323, ECO:0000269|PubMed:22628310}.",X,15627318,15675012,p22.2,1.1309e-4,1.746,0.82405,-0.27881,6.2319,0.21498045213460235,ENST00000380342,0.8434977578475337,0.1042239440139965,669,1,"AC097625.1 (54, 94, chrX)",TRUE,,,,0.7958397839190643,5.920667266139611,Kidney - Cortex,tissue-specific,0.6508160173853527,0.6005404713392989,FALSE,high confidence escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:2957,DNASE1L1,deoxyribonuclease 1 like 1,Approved,DNL1L,"DNAS1L1, XIB, DNASEX",Xq28,gene with protein product,protein-coding gene,ENSG00000013563,1774,ENSG00000013563,P49184,MGI:109628,RGD:1359588,X,300081,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","DNA catabolic process [GO:0006308]; DNA catabolic process, endonucleolytic [GO:0000737]; DNA metabolic process [GO:0006259]; neutrophil degranulation [GO:0043312]",deoxyribonuclease activity [GO:0004536]; deoxyribonuclease I activity [GO:0004530]; DNA binding [GO:0003677],SUBCELLULAR LOCATION: Endoplasmic reticulum {ECO:0000269|PubMed:16107205}.,"",X,154401236,154412112,q28,0.38833,0.685,-1.4614,0.6932,9.1937,0.367628359851057,ENST00000369807,0.4603960396039604,0.029967508122969257,909,,,,,,,0.30686785125296046,5.47218880367726,Muscle - Skeletal,broadly expressed,2.6789034692708245,2.9035030207885866,FALSE,low confidence non-escapee,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:29603,HSFX1,"heat shock transcription factor family, X-linked 1",Approved,,LW-1,Xq28,gene with protein product,protein-coding gene,ENSG00000171116,100506164,ENSG00000171116,Q9UBD0,,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",cellular response to heat [GO:0034605]; positive regulation of transcription from RNA polymerase II promoter in response to heat stress [GO:0061408]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]",SUBCELLULAR LOCATION: Nucleus {ECO:0000305}. Cytoplasm {ECO:0000269|PubMed:15044259}.,"",X,149774068,149776867,q28,,,,,,0.41266200582525203,ENST00000370416,0.09284591194968554,0.041614596350912275,1272,1,"HSFX2 (100, 100, chrX)",TRUE,1,"HSFX2 (100, 100, chrX)",TRUE,0.7933068787795217,0.9357531602518877,Testis,tissue-specific,0.0912531302948483,0.5523323089791483,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:29818,TCEAL2,transcription elongation factor A like 2,Approved,,"my048, MY0876G05, WEX1",Xq22.1,gene with protein product,protein-coding gene,ENSG00000184905,140597,ENSG00000184905,Q9H3H9,,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May be involved in transcriptional regulation.,"",WW domain binding [GO:0050699],SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.,"",X,102125679,102140426,q22.1,0.35082,1.81,-1.7133,0.11532,0.63246,0.4546552434536749,ENST00000372780,0.1570175438596491,0.09380154961259685,684,,,,,,,0.520777832389246,7.931626922273066,Cerebellar_tissues,broadly expressed,7.041560596048044,7.931626922273066,TRUE,high confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:29845,XKRX,XK related X-linked,Approved,,"XPLAC, XKR2",Xq22.1,gene with protein product,protein-coding gene,ENSG00000182489,402415,ENSG00000182489,Q6PP77,MGI:3584011,RGD:1359223,X,300684,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","",SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:16431037}; Multi-pass membrane protein {ECO:0000269|PubMed:16431037}.,"",X,100913445,100929433,q22.1,3.1303e-4,1.157,0.63093,0.48171,11.363,0.3909351902754871,ENST00000372956,0.8538518518518519,0.2612596850787303,1350,,,,,,,0.8476343884605392,3.7771777117305123,Skin - Sun Exposed (Lower leg),tissue-specific,0.12526849210858962,0.09873182041601775,FALSE,discordant,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:29861,CHRDL1,chordin like 1,Approved,MGC1,"NRLN1, CHL",Xq23,gene with protein product,protein-coding gene,ENSG00000101938,91851,ENSG00000101938,Q9BU40,MGI:1933172,RGD:735215,X,300350,TRUE,"Megalocornea 1, X-linked",309300,X-linked recessive,,,,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,TRUE,confirmed,"FUNCTION: Antagonizes the function of BMP4 by binding to it and preventing its interaction with receptors. Alters the fate commitment of neural stem cells from gliogenesis to neurogenesis. Contributes to neuronal differentiation of neural stem cells in the brain by preventing the adoption of a glial fate. May play a crucial role in dorsoventral axis formation. May play a role in embryonic bone formation (By similarity). May also play an important role in regulating retinal angiogenesis through modulation of BMP4 actions in endothelial cells. Plays a role during anterior segment eye development. {ECO:0000250, ECO:0000269|PubMed:18587495, ECO:0000269|PubMed:22284829}.",BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; cellular protein metabolic process [GO:0044267]; eye development [GO:0001654]; negative regulation of BMP signaling pathway [GO:0030514]; nervous system development [GO:0007399]; ossification [GO:0001503]; post-translational protein modification [GO:0043687],"",SUBCELLULAR LOCATION: Secreted {ECO:0000305}.,"",X,110673856,110795819,q23,0.2164,0.522,-0.19853,0.45009,20.158,0.38855595953040234,ENST00000372042,0.9707334785766158,0.3688827793051737,1377,,,,,,,0.41927004827804376,7.617210310224668,Nerve - Tibial,broadly expressed,3.8274328996296028,3.1100349410995856,FALSE,high confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:29873,NKAP,NFKB activating protein,Approved,,FLJ22626,Xq24,gene with protein product,protein-coding gene,ENSG00000101882,79576,ENSG00000101882,Q8N5F7,MGI:1914300,RGD:1565955,X,300766,TRUE,"Intellectual developmental disorder, X-linked, syndromic, Hackman-Di Donato type",301039,X-linked recessive,,,,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Acts as a transcriptional repressor. Plays a role as a transcriptional corepressor of the Notch-mediated signaling required for T-cell development. Also involved in the TNF and IL-1 induced NF-kappa-B activation. Associates with chromatin at the Notch-regulated SKP2 promoter. {ECO:0000269|PubMed:14550261, ECO:0000269|PubMed:19409814}.","granulocyte differentiation [GO:0030851]; hematopoietic stem cell proliferation [GO:0071425]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; stem cell population maintenance [GO:0019827]; T cell differentiation in thymus [GO:0033077]",chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; RNA binding [GO:0003723],SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:14550261}.,SUBUNIT: Component of the Notch corepressor complex. Interacts with CIR1 and HDAC3. {ECO:0000269|PubMed:19409814}.,X,119920672,119943751,q24,0.99735,0.172,0.50187,1.5082,17.405,0.5318054478403318,ENST00000371410,0.8501602564102564,0.13181704573856537,1248,1,"NKAPL (62, 64, chr6)",TRUE,,,,0.24129650503833464,3.358795704890871,Ovary,broadly expressed,2.2657219261871986,2.858542044642988,FALSE,high confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:29887,NLRP2B,NLR family pyrin domain containing 2B,Approved,NLRP2P,"NOD24, NALP2P, CLRX.1, POP4",Xp11.21,gene with protein product,protein-coding gene,ENSG00000215174,286430,ENSG00000215174,P0DMW2,,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: May function as a negative regulator of NF-kappa-B by preventing RELA/p65 phosphorylation at 'Ser-536', thereby inhibiting its transcriptional activity. Through NF-kappa-B regulation may control cytokine release upon Toll-like receptors activation and therefore play a role in modulation of innate immunity. May also play a role in cell cycle progression and apoptotic process. {ECO:0000269|PubMed:24871464}.",innate immune response [GO:0045087]; negative regulation of cell cycle [GO:0045786]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; positive regulation of apoptotic process [GO:0043065]; positive regulation of interleukin-1 beta production [GO:0032731],"",SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:24871464}. Nucleus {ECO:0000269|PubMed:24871464}. Note=Targeted to the nucleus upon TNF-alpha treatment. {ECO:0000269|PubMed:24871464}.,"",X,57677067,57680260,p11.21,,,,,,0.36601713875252206,ENST00000434992,0.034057971014492754,0.14741314671332167,138,,,,,,,0.8034946131076474,0.5609941745265448,Cerebellar_tissues,tissue-specific,0.09251489155657983,0.5609941745265448,TRUE,,,,,,no disorder
HGNC:29962,FAM47A,family with sequence similarity 47 member A,Approved,,MGC27003,Xp21.1,gene with protein product,protein-coding gene,ENSG00000185448,158724,ENSG00000185448,Q5JRC9,MGI:1918114,RGD:2324262,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,34129756,34132314,p21.1,,,-0.78747,0.079064,,0.5948527739384503,ENST00000613251,0.09691912708600771,0.07365658585353661,2337,1,"FAM47B (55, 67, chrX)",TRUE,,,,0.9767441860465116,2.6922240816127005,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:29992,PAGE5,PAGE family member 5,Approved,,"PAGE-5, CT16.1, CT16.2",Xp11.21,gene with protein product,protein-coding gene,ENSG00000158639,90737,ENSG00000158639,Q96GU1,,,X,301009,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,55220355,55224108,p11.21,0.020689,1.467,-0.58644,0.38658,5.1286,0.45169265880562953,ENST00000374955,0.052552552552552555,0.022094476380904775,333,2,"PAGE2B (75, 88, chrX); PAGE2 (70, 82, chrX)",TRUE,,,,0.9735663408286747,5.040041989155826,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:29993,RHOXF1,Rhox homeobox family member 1,Approved,,"OTEX, PEPP1",Xq24,gene with protein product,protein-coding gene,ENSG00000101883,158800,ENSG00000101883,Q8NHV9,,RGD:1563291,X,300446,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Transcription factor maybe involved in reproductive processes. Modulates expression of target genes encoding proteins involved in processes relevant to spermatogenesis. {ECO:0000269|PubMed:28171660}.,"autonomic nervous system development [GO:0048483]; enteric nervous system development [GO:0048484]; gamete generation [GO:0007276]; intracellular steroid hormone receptor signaling pathway [GO:0030518]; multicellular organism development [GO:0007275]; nervous system development [GO:0007399]; positive regulation of gene expression [GO:0010628]; regulation of transcription, DNA-templated [GO:0006355]; sexual reproduction [GO:0019953]","DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]","SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00108, ECO:0000269|PubMed:11980563}.",SUBUNIT: Does not interact with itself.,X,120109051,120115913,q24,0.77494,0.606,0.22687,-0.078911,4.9383,0.31458344504620445,ENST00000217999,0.06486486486486487,0.045838540364908774,555,,,,,,,0.7234651104987307,4.934195657335297,Testis,tissue-specific,1.2703495287331028,4.470260273225182,FALSE,,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:30006,MAGIX,"MAGI family member, X-linked",Approved,,"PDZX, JM10, FLJ21687",Xp11.23,gene with protein product,protein-coding gene,ENSG00000269313,79917,ENSG00000269313,Q9H6Y5,MGI:1859644,RGD:1549729,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,49162564,49168483,p11.23,6.6022e-5,1.835,1.0885,0.22342,5.491,0.5239847794897387,ENST00000616266,0.33466183574879227,0.12476880779805048,828,,,,,,,0.6110269536909734,4.127567250981914,Cerebellar_tissues,tissue-specific,1.6782116594254834,4.127567250981914,TRUE,high confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,no difference_Post1_Post2,no disorder
HGNC:30011,RHOXF2,Rhox homeobox family member 2,Approved,,"THG1, PEPP-2, PEPP2, CT107",Xq24,gene with protein product,protein-coding gene,ENSG00000131721,84528,ENSG00000131721,Q9BQY4,,,X,300447,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Transcription factor maybe involved in reproductive processes. Modulates expression of target genes encoding proteins involved in processes relevant to spermatogenesis. {ECO:0000269|PubMed:28171660}.,positive regulation of gene expression [GO:0010628],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]",SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00108}.,"",X,120158613,120165630,q24,2.1767e-4,1.886,-1.5361,0.12468,4.1646,0.42713607222910166,ENST00000371388,0.03667820069204152,0.009872531867033242,867,1,"RHOXF2B (99, 99, chrX)",TRUE,1,"RHOXF2B (99, 99, chrX)",TRUE,0.974311951108804,2.6895161076634797,Testis,tissue-specific,0,0.06543720339064807,FALSE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:30048,PIR,pirin,Approved,,,Xp22.2,gene with protein product,protein-coding gene,ENSG00000087842,8544,ENSG00000087842,O00625,MGI:1916906,RGD:1359212,X,300931,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Transcriptional coregulator of NF-kappa-B which facilitates binding of NF-kappa-B proteins to target kappa-B genes in a redox-state-dependent manner. May be required for efficient terminal myeloid maturation of hematopoietic cells. Has quercetin 2,3-dioxygenase activity (in vitro). {ECO:0000269|PubMed:17288615, ECO:0000269|PubMed:20010624, ECO:0000269|PubMed:20711196, ECO:0000269|PubMed:23716661}.",digestion [GO:0007586]; monocyte differentiation [GO:0030224]; transcription by RNA polymerase II [GO:0006366],"metal ion binding [GO:0046872]; quercetin 2,3-dioxygenase activity [GO:0008127]; transcription coregulator activity [GO:0003712]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:20089166, ECO:0000269|PubMed:9079676}. Cytoplasm {ECO:0000269|PubMed:20089166}. Note=Predominantly localized in dot-like subnuclear structures. Cytoplasmic localization of PIR seems to positively correlate with melanoma progression. {ECO:0000269|PubMed:20089166, ECO:0000269|PubMed:9079676}.","SUBUNIT: May interact with NF1/CTF1. Interacts with BCL3. Identified in a complex comprised of PIR, BLC3, NFKB1 and target DNA. {ECO:0000269|PubMed:10362352, ECO:0000269|PubMed:14573596, ECO:0000269|PubMed:20711196, ECO:0000269|PubMed:9079676}.",X,15384799,15493564,p22.2,5.3402e-10,1.799,-0.066046,-0.39802,10.855,0.3919846969174324,ENST00000380420,0.9072164948453608,0.024293926518370406,873,,,,,,,0.29238887452684514,4.942125042406451,Bladder,broadly expressed,3.390355397973663,2.7294918638367927,FALSE,variable escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:30084,TCEAL9,transcription elongation factor A like 9,Approved,WBP5,"DKFZp313K1940, WEX6",Xq22.2,gene with protein product,protein-coding gene,ENSG00000185222,51186,ENSG00000185222,Q9UHQ7,MGI:109567,RGD:1592975,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May be involved in transcriptional regulation. {ECO:0000305}.,"",WW domain binding [GO:0050699],SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.,"",X,103356489,103358462,q22.2,0.12214,1.821,0.17962,0.24118,1.5923,0.27867978481074007,ENST00000372661,0.9384126984126984,0.23646588352911774,315,,,,,,,0.2948834939454694,8.95809155929962,Ovary,broadly expressed,5.288532059097003,6.093207318359128,FALSE,variable escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:30114,FAM156A,family with sequence similarity 156 member A,Approved,TMEM29,PRO0659,Xp11.22,gene with protein product,protein-coding gene,ENSG00000268350,29057,ENSG00000268350,Q8NDB6,,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","",methylated histone binding [GO:0035064],SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass membrane protein {ECO:0000305}.,"",X,52926402,52995472,p11.22,,,,,,0.30725627044066656,ENST00000623782,0.2263239875389408,0.03884028992751812,642,1,"FAM156B (100, 100, chrX)",TRUE,1,"FAM156B (100, 100, chrX)",TRUE,0.7590955374518572,1.2546545067720023,Cerebellar_tissues,tissue-specific,0.324653942998398,1.2546545067720023,TRUE,high confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:30189,GTPBP6,GTP binding protein 6 (putative),Approved,,"PGPL, FLJ20977",Xp22.33 and Yp11.32,gene with protein product,protein-coding gene,ENSG00000178605,8225,ENSG00000178605,O43824,MGI:1306825,RGD:1305954,X,300124,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,TRUE,,no disorder,"","",GTP binding [GO:0005525]; metal ion binding [GO:0046872]; ribosome binding [GO:0043022],"","",X,304529,318819,p22.33,1.1591e-7,1.549,-2.5242,-1.7654,11.657,0.6608638580709703,ENST00000326153,0.6106382978723405,0.050162459385153714,1551,,,,,,,0.1129053315444322,6.8143966098211814,Nerve - Tibial,broadly expressed,5.380327720570453,6.405553359729593,FALSE,low confidence escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:30245,GPR174,G protein-coupled receptor 174,Approved,,FKSG79,Xq21.1,gene with protein product,protein-coding gene,ENSG00000147138,84636,ENSG00000147138,Q9BXC1,MGI:2685222,RGD:1564689,X,300903,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Putative receptor for purines coupled to G-proteins. {ECO:0000250}.,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of Rho protein signal transduction [GO:0035025]; T cell homeostasis [GO:0043029],bioactive lipid receptor activity [GO:0045125]; G protein-coupled receptor activity [GO:0004930],SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.,"",X,79144663,79175315,q21.1,0.39757,0.677,-0.29216,0.65289,9.2953,0.13475248981820825,ENST00000645147,0.6872255489021956,0.10724818795301175,1002,,,,,,,0.8577646427042684,4.334325136466724,Cells - EBV-transformed lymphocytes,tissue-specific,0,0,FALSE,variable escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:30305,RPA4,replication protein A4,Approved,,HSU24186,Xq21.33,gene with protein product,protein-coding gene,ENSG00000204086,29935,ENSG00000204086,Q13156,,,X,300767,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: As part of the alternative replication protein A complex, aRPA, binds single-stranded DNA and probably plays a role in DNA repair. Compared to the RPA2-containing, canonical RPA complex, may not support chromosomal DNA replication and cell cycle progression through S-phase. The aRPA may not promote efficient priming by DNA polymerase alpha but could support DNA polymerase delta synthesis in the presence of PCNA and replication factor C (RFC), the dual incision/excision reaction of nucleotide excision repair and RAD51-dependent strand exchange. {ECO:0000269|PubMed:19116208, ECO:0000269|PubMed:19942684, ECO:0000269|PubMed:19996105, ECO:0000269|PubMed:20545304}.",DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; double-strand break repair via homologous recombination [GO:0000724]; G1/S transition of mitotic cell cycle [GO:0000082]; nucleotide-excision repair [GO:0006289],single-stranded DNA binding [GO:0003697],SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:19942684}. Note=Localizes to DNA repair foci after DNA damage.,"SUBUNIT: Component of the aRPA, the alternative replication protein A complex, a trimeric complex similar to the replication protein A complex/RPA but where RPA1 and RPA3 are associated with RPA4 instead of RPA2. Interacts with RPA1 and RPA3. {ECO:0000269|PubMed:19116208, ECO:0000269|PubMed:7760808}.",X,96883908,96885467,q21.33,,,1.5125,0.25103,,0.519235877991644,ENST00000373040,0.15152671755725192,0.08517870532366908,786,,,,,,,0.8321177203756722,2.2537533345436254,Testis,tissue-specific,0.06113511846270152,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:3032,DRP2,dystrophin related protein 2,Approved,,,Xq22.1,gene with protein product,protein-coding gene,ENSG00000102385,1821,ENSG00000102385,Q13474,MGI:107432,RGD:621750,X,300052,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Required for normal myelination and for normal organization of the cytoplasm and the formation of Cajal bands in myelinating Schwann cells. Required for normal PRX location at appositions between the abaxonal surface of the myelin sheath and the Schwann cell plasma membrane. Possibly involved in membrane-cytoskeleton interactions of the central nervous system. {ECO:0000250, ECO:0000250|UniProtKB:Q05AA6}.",central nervous system development [GO:0007417]; synapse organization [GO:0050808]; synaptic signaling [GO:0099536],zinc ion binding [GO:0008270],"SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic density {ECO:0000250|UniProtKB:Q9EPA0}. Cell projection, dendrite {ECO:0000250|UniProtKB:Q9EPA0}. Perikaryon {ECO:0000250|UniProtKB:Q9EPA0}. Cell membrane {ECO:0000250|UniProtKB:Q05AA6}; Peripheral membrane protein {ECO:0000250|UniProtKB:Q05AA6}. Note=Detected in Schwann cells at periaxonal myelin membranes. {ECO:0000250|UniProtKB:Q05AA6}.","SUBUNIT: Interacts with PRX; this enhances phosphorylation. Identified in a dystroglycan complex that contains at least PRX, DRP2, UTRN, DMD and DAG1. {ECO:0000250|UniProtKB:Q05AA6}.",X,101219769,101264497,q22.1,3.7475e-6,0.628,1.1456,1.6995,38.693,0.20625298100011602,ENST00000402866,0.9201461377870563,0.21619595101224695,2874,,,,,,,0.8945082348463305,7.942602471867171,Nerve - Tibial,tissue-specific,2.5386325192559944,0.6524318837184024,FALSE,high confidence non-escapee,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:30369,SAGE1,sarcoma antigen 1,Approved,,"SAGE, CT14",Xq26.3,gene with protein product,protein-coding gene,ENSG00000181433,55511,ENSG00000181433,Q9NXZ1,,,X,300359,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",snRNA 3'-end processing [GO:0034472],"","","",X,135889205,135913061,q26.3,8.5732e-18,1.316,-0.098995,-0.39048,28.302,0.43886951831760523,ENST00000324447,0.2251197053406998,0.061134716320919776,2715,,,,,,,0.9739907873237317,3.24457961666462,Testis,tissue-specific,0.02559385162642439,0,FALSE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:30469,FOXR2,forkhead box R2,Approved,,"MGC21658, FOXN6",Xp11.21,gene with protein product,protein-coding gene,ENSG00000189299,139628,ENSG00000189299,Q6PJQ5,MGI:3511682,RGD:1564437,X,300949,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]",SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00089}.,"",X,55623400,55626192,p11.21,0.076682,1.918,-1.1476,-0.21158,0.66652,0.153482880755608,ENST00000339140,0.4511752136752137,0.18542864283929017,936,1,"FOXR1 (53, 57, chr11)",TRUE,,,,0.9767441860465116,1.8355239436761477,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:30490,PABIR2,PABIR family member 2,Approved,FAM122B,"DKFZp686L20116, RP11-308B5.5",Xq26.3,gene with protein product,protein-coding gene,ENSG00000156504,159090,ENSG00000156504,Q7Z309,MGI:1926005,RGD:1560129,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,134769566,134797232,q26.3,0.83835,0.457,-0.55632,1.2604,10.371,,,,,,1,"FAM122A (70, 65, chr9)",TRUE,,,,0.19900032416133936,5.739591612780696,Ovary,broadly expressed,4.185097431441536,4.867562925730291,FALSE,,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:3051,TSC22D3,TSC22 domain family member 3,Approved,DSIPI,"DIP, GILZ, TSC-22R, hDIP",Xq22.3,gene with protein product,protein-coding gene,ENSG00000157514,1831,ENSG00000157514,Q99576,MGI:1196284,RGD:621654,X,300506,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Protects T-cells from IL2 deprivation-induced apoptosis through the inhibition of FOXO3A transcriptional activity that leads to the down-regulation of the pro-apoptotic factor BCL2L11. In macrophages, plays a role in the anti-inflammatory and immunosuppressive effects of glucocorticoids and IL10. In T-cells, inhibits anti-CD3-induced NFKB1 nuclear translocation. In vitro, suppresses AP1 and NFKB1 DNA-binding activities (By similarity). Isoform 1 inhibits myogenic differentiation and mediates anti-myogenic effects of glucocorticoids by binding and regulating MYOD1 and HDAC1 transcriptional activity resulting in reduced expression of MYOG (By similarity). {ECO:0000250, ECO:0000269|PubMed:15031210}.","ion transmembrane transport [GO:0034220]; negative regulation of activation-induced cell death of T cells [GO:0070236]; regulation of transcription, DNA-templated [GO:0006355]; response to osmotic stress [GO:0006970]","DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]","SUBCELLULAR LOCATION: [Isoform 1]: Cytoplasm {ECO:0000250}. Nucleus {ECO:0000250}. Note=Localization depends on differentiation status of myoblasts. In undifferentiated myoblasts, isoform 1 localizes to the cytoplasm, but in differentiating myoblasts, isoform 1 is localized to the nucleus (By similarity). {ECO:0000250}.","SUBUNIT: Can form homodimers, however it is likely to function as a monomer. Interacts with AP1 (By similarity). Interacts with NFKB1. Isoform 1 interacts with MYOD1 (By similarity). Isoform 1 interacts with HDAC1; this interaction affects HDAC1 activity on MYOG promoter and thus inhibits MYOD1 transcriptional activity (By similarity). {ECO:0000250}.",X,107713221,107777342,q22.3,0.4339,0.88,-0.049815,1.0337,5.386,0.4931317978595732,ENST00000315660,0.9039800995024876,0.19200199950012498,603,,,,,,,0.24725014945475704,9.821606587752159,Nerve - Tibial,broadly expressed,5.133164822582035,6.759302333428369,FALSE,low confidence non-escapee,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:30512,WDR44,WD repeat domain 44,Approved,,"DKFZp686L20145, RPH11, RAB11BP, SYM-4",Xq24,gene with protein product,protein-coding gene,ENSG00000131725,54521,ENSG00000131725,Q5JSH3,MGI:1919654,RGD:727965,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Downstream effector for RAB11. May be involved in vesicle recycling (By similarity). {ECO:0000250}.,"",Rab GTPase binding [GO:0017137],"SUBCELLULAR LOCATION: Cytoplasm, cytosol. Cytoplasm, perinuclear region. Endosome membrane. Golgi apparatus, trans-Golgi network. Note=Colocalized with RAB11 along microtubules oriented toward lamellipodia. {ECO:0000250}.",SUBUNIT: Interacts with the GTP-bound form of RAB11 when membrane-associated. Does not bind to other Rab and Rho small G proteins (By similarity). {ECO:0000250}.,X,118346073,118449961,q24,0.99972,0.195,1.0363,2.9519,32.217,0.6672376250370843,ENST00000254029,0.8983223924142961,0.2334666333416646,2742,,,,,,,0.21138992993456548,4.4745463665899115,Artery - Tibial,broadly expressed,2.9249074927446674,3.769009998281471,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:30533,CXorf51A,chromosome X open reading frame 51A,Approved,CXorf51,,Xq27.3,gene with protein product,protein-coding gene,ENSG00000224440,100129239,ENSG00000224440,A0A1B0GTR3,,RGD:9476443,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,146814106,146814726,q27.3,,,,,,0.2405348736005064,ENST00000458472,0.014067278287461774,0.05658585353661585,327,1,"CXorf51B (100, 100, chrX)",TRUE,1,"CXorf51B (100, 100, chrX)",TRUE,0.9767441860465116,0.17705159636320142,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:30557,SLC25A43,solute carrier family 25 member 43,Approved,,,Xq24,gene with protein product,protein-coding gene,ENSG00000077713,203427,ENSG00000077713,Q8WUT9,MGI:2684854,RGD:1559928,X,300641,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","",ATP transmembrane transporter activity [GO:0005347],SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}.,"",X,119399336,119454478,q24,0.089593,0.892,0.58223,1.2453,8.6884,0.49545829892650695,ENST00000217909,0.8696881091617934,0.09709742554265523,1026,,,,,,,0.30317354640685945,5.100616087931007,Esophagus - Mucosa,broadly expressed,2.0756421554590347,3.24372619666906,FALSE,low confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,no difference_Post1_Post2,no disorder
HGNC:30668,SRPX2,sushi repeat containing protein X-linked 2,Approved,,SRPUL,Xq22.1,gene with protein product,protein-coding gene,ENSG00000102359,27286,ENSG00000102359,O60687,MGI:1916042,RGD:1562444,X,300642,TRUE,,,,"?Rolandic epilepsy, mental retardation, and speech dyspraxia",300643,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PMT -CS,FALSE,,PMT,"FUNCTION: Acts as a ligand for the urokinase plasminogen activator surface receptor. Plays a role in angiogenesis by inducing endothelial cell migration and the formation of vascular network (cords). Involved in cellular migration and adhesion. Increases the phosphorylation levels of FAK. Interacts with and increases the mitogenic activity of HGF. Promotes synapse formation. May have a role in the perisylvian region, critical for language and cognitive development. {ECO:0000269|PubMed:16497722, ECO:0000269|PubMed:18718938, ECO:0000269|PubMed:19065654, ECO:0000269|PubMed:24179158}.",angiogenesis [GO:0001525]; cell-cell adhesion [GO:0098609]; cell motility [GO:0048870]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of synapse assembly [GO:0051965]; regulation of phosphorylation [GO:0042325]; vocalization behavior [GO:0071625],hepatocyte growth factor binding [GO:0036458]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102],"SUBCELLULAR LOCATION: Secreted. Cytoplasm. Cell surface. Cell junction, synapse {ECO:0000250}.","SUBUNIT: Forms homooligomers (By similarity). Interacts with PLAUR (via the UPAR/Ly6 domains), ADAMTS4 and CTSB. Interacts with HGF; the interaction increases the mitogenic activity of HGF. {ECO:0000250, ECO:0000269|PubMed:18718938, ECO:0000269|PubMed:22242148, ECO:0000269|PubMed:24179158}.",X,100644195,100675788,q22.1,0.04812,0.538,1.2071,0.22618,24.436,0.23570915062207573,ENST00000373004,0.8081545064377682,0.14653836540864784,1398,,,,,,,0.4592837119940528,5.375605968989983,Adipose - Subcutaneous,broadly expressed,0.36451976596219526,0.1928285590499045,FALSE,variable escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,no difference_Pre_Post2,no difference_Post1_Post2,PMT
HGNC:30677,GPKOW,G-patch domain and KOW motifs,Approved,,"T54, GPATC5, GPATCH5, Spp2, Mos2",Xp11.23,gene with protein product,protein-coding gene,ENSG00000068394,27238,ENSG00000068394,Q92917,MGI:1859610,RGD:1583600,X,301003,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: RNA-binding protein involved in pre-mRNA splicing. {ECO:0000269|PubMed:25296192}.,"mRNA splicing, via spliceosome [GO:0000398]",RNA binding [GO:0003723],"SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:21880142, ECO:0000269|PubMed:25296192}.","SUBUNIT: Interacts with PRKX (PubMed:16491121). Interacts with DHX16 (PubMed:25296192). Interacts with PRKACB (PubMed:21880142). {ECO:0000269|PubMed:16491121, ECO:0000269|PubMed:21880142, ECO:0000269|PubMed:25296192}.",X,49113407,49123735,p11.23,0.99553,0.187,-0.22801,0.92073,16.007,0.4644839696386088,ENST00000156109,0.6666666666666666,0.11859535116220946,1431,,,,,,,0.12158943347243391,5.4535109945585685,Artery - Tibial,broadly expressed,4.60360260893422,5.21404124166293,FALSE,high confidence non-escapee,no_difference_Pre_Post,Pre_higher_vs_Post1,no difference_Pre_Post2,Post2_higher_vs_Post1,no disorder
HGNC:30681,TAB3,TGF-beta activated kinase 1 (MAP3K7) binding protein 3,Approved,MAP3K7IP3,,Xp21.2,gene with protein product,protein-coding gene,ENSG00000157625,257397,ENSG00000157625,Q8N5C8,MGI:1913974,RGD:1594527,X,300480,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Adapter linking MAP3K7/TAK1 and TRAF6 or TRAF2. Mediator of MAP3K7 activation, respectively in the IL1 and TNF signaling pathways. Plays a role in activation of NF-kappa-B and AP1 transcription factor. Isoform 2 may be an oncogenic factor. {ECO:0000269|PubMed:14633987, ECO:0000269|PubMed:14766965}.",activation of MAPK activity [GO:0000187]; Fc-epsilon receptor signaling pathway [GO:0038095]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; interleukin-1-mediated signaling pathway [GO:0070498]; JNK cascade [GO:0007254]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of autophagy [GO:0010507]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; stimulatory C-type lectin receptor signaling pathway [GO:0002223],metal ion binding [GO:0046872],"","SUBUNIT: Interacts with TAB1, TAB2, MAP3K7, TRAF2 and TRAF6. The minimal TAB3-containing complex (TAB1-MAP3K7-TAB3) appears not to contain TAB2. However, it seems sensible to consider that TAB2 may also join this complex and may act in a cooperative manner with TAB3. Interacts with DYNC2I2 (via the WD domains). Interacts with RBCK1. Binds 'Lys-63'-linked polyubiquitin chains. Interacts with TRIM5. {ECO:0000269|PubMed:14633987, ECO:0000269|PubMed:14670075, ECO:0000269|PubMed:14766965, ECO:0000269|PubMed:17449468, ECO:0000269|PubMed:19521662, ECO:0000269|PubMed:21512573}.; SUBUNIT: (Microbial infection) Interacts with M.tuberculosis PtpA, which blocks the NF-kappa-B signaling pathway. {ECO:0000269|PubMed:25642820}.",X,30827442,30975084,p21.2,0.61714,0.423,1.2763,1.759,24.874,0.2136346706582618,ENST00000378933,0.9720897615708275,0.13354161459635092,2139,,,,,,,0.34790772742815895,4.459884029321245,Uterus,broadly expressed,1.895081546284569,2.9672377888202166,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,no disorder
HGNC:30701,FAM155B,family with sequence similarity 155 member B,Approved,"TMEM28, CXorf63",TED,Xq13.1,gene with protein product,protein-coding gene,ENSG00000130054,27112,ENSG00000130054,O75949,MGI:3648377,RGD:1584125,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",calcium ion import across plasma membrane [GO:0098703],"",SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.,"",X,69504326,69532508,q13.1,0.81284,0.479,-1.4419,-0.37939,9.8992,0.7448246613830943,ENST00000252338,0.8465116279069768,0.38435391152211945,1419,,,,,,,0.82891096798717,5.417626390574548,Heart - Atrial Appendage,tissue-specific,1.80912628806282,3.713415385734139,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post1_higher_vs_Post2,no disorder
HGNC:30744,TMSB15A,thymosin beta 15A,Approved,TMSL8,TMSNB,Xq22.1,gene with protein product,protein-coding gene,ENSG00000158164,11013,ENSG00000158164,P0CG34,MGI:1925728,RGD:708373,X,300939,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Plays an important role in the organization of the cytoskeleton. Binds to and sequesters actin monomers (G actin) and therefore inhibits actin polymerization (By similarity). {ECO:0000250}.,actin filament organization [GO:0007015]; regulation of cell migration [GO:0030334]; sequestering of actin monomers [GO:0042989],actin monomer binding [GO:0003785],"SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000250}.","",X,102513682,102516739,q22.1,0.39053,1.728,0.28095,-0.12559,0.97788,0.4769536019536019,ENST00000289373,0.9079710144927536,0.10609847538115472,138,1,"TMSB15B (100, 100, chrX)",TRUE,1,"TMSB15B (100, 100, chrX)",TRUE,0.5850466870687359,3.086146842799026,Prostate,broadly expressed,0.6702575216235898,1.2646685343821038,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post1_higher_vs_Post2,no disorder
HGNC:3076,DUSP9,dual specificity phosphatase 9,Approved,,"MKP-4, MKP4",Xq28,gene with protein product,protein-coding gene,ENSG00000130829,1852,ENSG00000130829,Q99956,MGI:2387107,RGD:1565535,X,300134,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Inactivates MAP kinases. Has a specificity for the ERK family.,activation of MAPK activity [GO:0000187]; inactivation of MAPK activity [GO:0000188]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; peptidyl-threonine dephosphorylation [GO:0035970]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of apoptotic process [GO:0043065]; protein dephosphorylation [GO:0006470]; regulation of heart growth [GO:0060420],MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; mitogen-activated protein kinase binding [GO:0051019]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine/threonine phosphatase activity [GO:0008330]; protein tyrosine phosphatase activity [GO:0004725],SUBCELLULAR LOCATION: Cytoplasm.,"",X,153642492,153651326,q28,0.81981,0.529,0.016791,1.323,5.6575,0.5013169569794054,ENST00000342782,0.706060606060606,0.11749562609347663,1155,1,"DUSP6 (54, 54, chr12)",TRUE,,,,0.9198837940347152,6.239375126914423,Kidney - Medulla,tissue-specific,1.9317435620050694,0.3495928747922525,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:30798,PRRG3,proline rich and Gla domain 3,Approved,,TMG3,Xq28,gene with protein product,protein-coding gene,ENSG00000130032,79057,ENSG00000130032,Q9BZD7,MGI:2685214,RGD:1560309,X,300685,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","",calcium ion binding [GO:0005509],SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.,"",X,151694607,151705924,q28,7.9468e-7,1.756,-2.567,-0.75622,8.4189,0.4910606010701528,ENST00000674457,0.7870689655172414,0.15116220944763809,696,,,,,,,0.7827087330871915,4.659205314370372,Nerve - Tibial,tissue-specific,2.1105169266332955,0.39950417433576096,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,no difference_Pre_Post2,Post2_higher_vs_Post1,no disorder
HGNC:30881,ALG13,ALG13 UDP-N-acetylglucosaminyltransferase subunit,Approved,"GLT28D1, CXorf45","MDS031, YGL047W, FLJ23018, TDRD13, CDG1S",Xq23,gene with protein product,protein-coding gene,ENSG00000101901,79868,ENSG00000101901,Q9NP73,MGI:1914824,RGD:1359416,X,300776,TRUE,Developmental and epileptic encephalopathy 36,300884,X-linked,"?Congenital disorder of glycosylation, type Is",300884,X-linked,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,confirmed +CS,FALSE,TRUE,confirmed,"FUNCTION: [Isoform 1]: Possible multifunctional enzyme with both glycosyltransferase and deubiquitinase activities.; FUNCTION: [Isoform 2]: May be involved in protein N-glycosylation, second step of the dolichol-linked oligosaccharide pathway.",dolichol-linked oligosaccharide biosynthetic process [GO:0006488],N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity [GO:0004577]; RNA binding [GO:0003723]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459],SUBCELLULAR LOCATION: [Isoform 2]: Endoplasmic reticulum {ECO:0000305}. Note=Could be recruited to the cytosolic face of the endoplasmic reticulum membrane through its interaction with ALG14.,SUBUNIT: Isoform 2 may interact with ALG14. {ECO:0000250}.,X,111665811,111760649,q23,0.99998,0.16,-0.722,1.1475,39.232,0.5798983014172887,ENST00000394780,0.7807850029291155,0.09795051237190702,3414,,,,,,,0.212071094775318,4.667159808555583,Fallopian Tube,broadly expressed,2.5784074137536206,3.4993420514549363,FALSE,variable escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:30891,CXorf49,chromosome X open reading frame 49,Approved,,,Xq13.1,gene with protein product,protein-coding gene,ENSG00000215115,100130361,ENSG00000215115,A8MYA2,"MGI:2685988, MGI:3646776",RGD:2320498,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,71714371,71718151,q13.1,,,,,,0.5150259441209292,ENST00000535490,0.021359223300970873,0.016370907273181703,1545,2,"CXorf49B (100, 100, chrX); BX276092.9 (73, 72, chrX)",TRUE,1,"CXorf49B (100, 100, chrX)",TRUE,0.9767441860465116,0.04045468247064922,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:30892,HUWE1,"HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1",Approved,,"Ib772, KIAA0312, UREB1",Xp11.22,gene with protein product,protein-coding gene,ENSG00000086758,10075,ENSG00000086758,Q7Z6Z7,MGI:1926884,RGD:1561763,X,300697,TRUE,"Mental retardation, X-linked syndromic, Turner type",309590,X-linked,,,,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,confirmed +CS,FALSE,TRUE,confirmed,"FUNCTION: E3 ubiquitin-protein ligase which mediates ubiquitination and subsequent proteasomal degradation of target proteins (PubMed:15989957, PubMed:19713937, PubMed:15567145, PubMed:15767685, PubMed:18488021, PubMed:17567951, PubMed:19037095, PubMed:20534529). Regulates apoptosis by catalyzing the polyubiquitination and degradation of MCL1 (PubMed:15989957). Mediates monoubiquitination of DNA polymerase beta (POLB) at 'Lys-41', 'Lys-61' and 'Lys-81', thereby playing a role in base-excision repair (PubMed:19713937). Also ubiquitinates the p53/TP53 tumor suppressor and core histones including H1, H2A, H2B, H3 and H4 (PubMed:15567145, PubMed:15767685, PubMed:15989956). Ubiquitinates MFN2 to negatively regulate mitochondrial fusion in response to decreased stearoylation of TFRC (PubMed:26214738). Binds to an upstream initiator-like sequence in the preprodynorphin gene. Regulates neural differentiation and proliferation by catalyzing the polyubiquitination and degradation of MYCN (PubMed:18488021). May regulate abundance of CDC6 after DNA damage by polyubiquitinating and targeting CDC6 to degradation (PubMed:17567951). Mediates polyubiquitination of isoform 2 of PA2G4 (PubMed:19037095). Acts in concert with MYCBP2 to regulate the circadian clock gene expression by promoting the lithium-induced ubiquination and degradation of NR1D1 (PubMed:20534529). {ECO:0000269|PubMed:15567145, ECO:0000269|PubMed:15767685, ECO:0000269|PubMed:15989956, ECO:0000269|PubMed:15989957, ECO:0000269|PubMed:17567951, ECO:0000269|PubMed:18488021, ECO:0000269|PubMed:19037095, ECO:0000269|PubMed:19713937, ECO:0000269|PubMed:20534529, ECO:0000269|PubMed:26214738}.",base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; histone ubiquitination [GO:0016574]; membrane fusion [GO:0061025]; negative regulation of mitochondrial fusion [GO:0010637]; neutrophil degranulation [GO:0043312]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],DNA binding [GO:0003677]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842],"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19713937}. Nucleus {ECO:0000269|PubMed:19713937}. Note=Mainly expressed in the cytoplasm of most tissues, except in the nucleus of spermatogonia, primary spermatocytes and neuronal cells (By similarity). Predominantly cytosolic or perinuclear in some colorectal carcinoma cells. {ECO:0000250|UniProtKB:Q7TMY8}.","SUBUNIT: Interacts with isoform p14ARF of CDKN2A which strongly inhibits HUWE1 ubiquitin ligase activity. Interacts with MYCN, POLB and CDC6. Interacts with isoform 2 of PA2G4. Interacts with NR1D1 (PubMed:20534529). {ECO:0000269|PubMed:15989956, ECO:0000269|PubMed:17567951, ECO:0000269|PubMed:18488021, ECO:0000269|PubMed:19037095, ECO:0000269|PubMed:19713937, ECO:0000269|PubMed:20534529}.",X,53532096,53686728,p11.22,1,0.06,0.68398,8.8732,153.33,0.6386288021589774,ENST00000262854,0.9537904761904762,0.38137965508622845,13125,,,,,,,0.21463142463080517,6.6691968846114005,Cells - EBV-transformed lymphocytes,broadly expressed,4.449812256283443,5.804378872328573,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:30930,XAGE5,X antigen family member 5,Approved,GAGED5,"XAGE-5, CT12.5",Xp11.22,gene with protein product,protein-coding gene,ENSG00000171405,170627,ENSG00000171405,Q8WWM1,,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,52812204,52818301,p11.22,1.7076e-6,1.866,0.22789,-1.1374,6.5647,0.4025764895330113,ENST00000351072,0.05045871559633028,0.004773806548362909,327,2,"XAGE3 (75, 73, chrX); XAGE2 (69, 68, chrX)",TRUE,,,,0.9767441860465116,1.891823551423644,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:30933,BEX2,brain expressed X-linked 2,Approved,,DJ79P11.1,Xq22.2,gene with protein product,protein-coding gene,ENSG00000133134,84707,ENSG00000133134,Q9BXY8,MGI:1328321,RGD:1564466,X,300691,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Regulator of mitochondrial apoptosis and G1 cell cycle in breast cancer. Protects the breast cancer cells against mitochondrial apoptosis and this effect is mediated through the modulation of BCL2 protein family, which involves the positive regulation of anti-apoptotic member BCL2 and the negative regulation of pro-apoptotic members BAD, BAK1 and PUMA. Required for the normal cell cycle progression during G1 in breast cancer cells through the regulation of CCND1 and CDKN1A. Regulates the level of PP2A regulatory subunit B and PP2A phosphatase activity. {ECO:0000269|PubMed:19711341}.",apoptotic process [GO:0006915]; cell cycle [GO:0007049]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; signal transduction [GO:0007165],signaling receptor binding [GO:0005102],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus {ECO:0000269|PubMed:16314316}.,"SUBUNIT: Interacts with OMP (By similarity). Interacts with LMO2, possibly leading to regulate the transcriptional activity of a DNA-binding complex containing LMO2. {ECO:0000250, ECO:0000269|PubMed:16314316}.",X,103309346,103311007,q22.2,0.10078,1.271,0.38336,-0.013765,4.8876,0.5361679090492649,ENST00000372677,0.6529715762273902,0.19280179955011248,387,1,"BEX1 (71, 91, chrX)",TRUE,,,,0.5038740010420535,7.980059584409334,Pituitary,broadly expressed,7.193830869031036,7.91137700650876,FALSE,high confidence non-escapee,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,no difference_Post1_Post2,no disorder
HGNC:30968,GAGE10,G antigen 10,Approved,,OTTHUMG00000024136,Xp11.23,gene with protein product,protein-coding gene,ENSG00000215274,102724473,ENSG00000215274,A6NGK3,,,X,300737,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,49303669,49319844,p11.23,0.0016612,1.828,-0.98967,-0.92758,4.047,0.4282714412024757,ENST00000407599,0.08632478632478632,0.03849037740564859,351,12,"GAGE13 (93, 92, chrX); GAGE2A (92, 92, chrX); GAGE12G (91, 91, chrX); GAGE12F (91, 91, chrX); GAGE1 (91, 91, chrX); GAGE12J (91, 91, chrX); GAGE12E (91, 90, chrX); GAGE12D (91, 90, chrX); GAGE12C (91, 90, chrX); GAGE12H (90, 89, chrX); GAGE2E (85, 90, chrX); XAGE3 (55, 58, chrX)",TRUE,11,"GAGE13 (93, 92, chrX); GAGE2A (92, 92, chrX); GAGE12G (91, 91, chrX); GAGE12F (91, 91, chrX); GAGE1 (91, 91, chrX); GAGE12J (91, 91, chrX); GAGE12E (91, 90, chrX); GAGE12D (91, 90, chrX); GAGE12C (91, 90, chrX); GAGE12H (90, 89, chrX); GAGE2E (85, 90, chrX)",TRUE,0.8379879031358701,1.8339142171093095,Pituitary,tissue-specific,0.3213589837271362,0.5846229465324234,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:3133,EBP,EBP cholestenol delta-isomerase,Approved,CDPX2,"CPX, CPXD, CHO2",Xp11.23,gene with protein product,protein-coding gene,ENSG00000147155,10682,ENSG00000147155,Q15125,MGI:107822,RGD:620957,X,300205,TRUE,"Chondrodysplasia punctata, X-linked dominant // MEND syndrome",302960 // 300960,X-linked dominant // X-linked recessive,,,,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Catalyzes the conversion of Delta(8)-sterols to their corresponding Delta(7)-isomers. {ECO:0000269|PubMed:12760743, ECO:0000269|PubMed:8798407, ECO:0000269|PubMed:9894009}.",cholesterol biosynthetic process [GO:0006695]; cholesterol biosynthetic process via desmosterol [GO:0033489]; cholesterol biosynthetic process via lathosterol [GO:0033490]; cholesterol metabolic process [GO:0008203]; skeletal system development [GO:0001501]; sterol biosynthetic process [GO:0016126],C-8 sterol isomerase activity [GO:0000247]; cholestenol delta-isomerase activity [GO:0047750]; identical protein binding [GO:0042802]; steroid delta-isomerase activity [GO:0004769]; transmembrane signaling receptor activity [GO:0004888]; xenobiotic transmembrane transporter activity [GO:0042910],"SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:10406945}; Multi-pass membrane protein {ECO:0000305}. Nucleus envelope {ECO:0000269|PubMed:10406945}. Cytoplasmic vesicle {ECO:0000269|PubMed:10406945}. Note=During interphase, detected on the endoplasmic reticulum and the nuclear envelope. During mitosis, detected on cytoplasmic vesicles. {ECO:0000269|PubMed:10406945}.","",X,48521799,48528716,p11.23,0.93645,0.342,0.059806,1.4942,8.7549,0.45741623565184625,ENST00000495186,0.7226551226551227,0.1551112221944514,693,1,"AF196969.1 (73, 59, chrX)",TRUE,,,,0.3304282319528156,6.610661679511525,Liver,broadly expressed,3.635522241459754,5.273968991881412,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:31353,SPACA5,sperm acrosome associated 5,Approved,,"SLLP2, LYZL5, LYC5, UNQ6288, dJ54B20.3, PNPK6288",Xp11.23,gene with protein product,protein-coding gene,ENSG00000171489,389852,ENSG00000171489,Q96QH8,MGI:2685564,RGD:1584964,X,300593,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; metabolic process [GO:0008152],lysozyme activity [GO:0003796],SUBCELLULAR LOCATION: Secreted {ECO:0000305}.,"",X,48004336,48009729,p11.23,0.39716,1.712,0.77507,0.85041,1.0353,0.3852343937266719,ENST00000304355,0.5795833333333333,0.15641089727568108,480,1,"SPACA5B (100, 100, chrX)",TRUE,1,"SPACA5B (100, 100, chrX)",TRUE,0.9767441860465116,0.06335769909254779,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:3157,EDA,ectodysplasin A,Approved,"ED1, EDA2, ODT1","EDA1, XLHED, HED, XHED, ED1-A1, ED1-A2, EDA-A1, EDA-A2",Xq13.1,gene with protein product,protein-coding gene,ENSG00000158813,1896,ENSG00000158813,Q92838,MGI:1195272,RGD:1563178,X,300451,TRUE,"Ectodermal dysplasia 1, hypohidrotic, X-linked // Tooth agenesis, selective, X-linked 1",305100 // 313500,X-linked recessive // X-linked dominant,,,,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Cytokine which is involved in epithelial-mesenchymal signaling during morphogenesis of ectodermal organs. Functions as a ligand activating the DEATH-domain containing receptors EDAR and EDA2R (PubMed:8696334, PubMed:11039935, PubMed:27144394). May also play a role in cell adhesion (By similarity). {ECO:0000250|UniProtKB:O54693, ECO:0000269|PubMed:11039935, ECO:0000269|PubMed:27144394, ECO:0000269|PubMed:8696334}.; FUNCTION: [Isoform 1]: Binds only to the receptor EDAR, while isoform 3 binds exclusively to the receptor EDA2R. {ECO:0000269|PubMed:11039935, ECO:0000269|PubMed:27144394}.; FUNCTION: [Isoform 3]: Binds only to the receptor EDA2R. {ECO:0000269|PubMed:11039935, ECO:0000269|PubMed:27144394}.",cell differentiation [GO:0030154]; cell-matrix adhesion [GO:0007160]; cytokine-mediated signaling pathway [GO:0019221]; gene expression [GO:0010467]; hair follicle placode formation [GO:0060789]; immune response [GO:0006955]; odontogenesis of dentin-containing tooth [GO:0042475]; pigmentation [GO:0043473]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; regulation of NIK/NF-kappaB signaling [GO:1901222]; salivary gland cavitation [GO:0060662]; trachea gland development [GO:0061153]; tumor necrosis factor-mediated signaling pathway [GO:0033209],death receptor agonist activity [GO:0038177]; death receptor binding [GO:0005123]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164],"SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:O54693}; Single-pass type II membrane protein {ECO:0000250|UniProtKB:O54693}.; SUBCELLULAR LOCATION: [Ectodysplasin-A, secreted form]: Secreted {ECO:0000269|PubMed:11309369}.",SUBUNIT: Homotrimer. The homotrimers may then dimerize and form higher-order oligomers. {ECO:0000269|PubMed:14656435}.,X,69616067,70039472,q13.1,0.97391,0.266,0.72508,1.7843,11.232,0.5536648353137499,ENST00000374552,0.8758503401360545,0.5178705323669083,1176,,,,,,,0.39374308064763924,3.1827018307118355,Adrenal Gland,broadly expressed,0.7681614532467271,0.6405556860214701,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:31684,YY2,YY2 transcription factor,Approved,,ZNF631,Xp22.12,gene with protein product,protein-coding gene,ENSG00000230797,404281,ENSG00000230797,O15391,MGI:3837947,RGD:2324567,X,300570,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Functions as a multifunctional transcription factor that may exhibit positive and negative control on a large number of genes. May antagonize YY1 and function in development and differentiation. {ECO:0000269|PubMed:16260628}.,positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]",SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.,"",X,21855987,21858740,p22.12,0.40781,0.925,-0.64789,1.3477,5.1202,0.6292501987105891,ENST00000429584,0.5079535299374441,0.24338915271182204,1119,1,"YY1 (61, 55, chr14)",TRUE,,,,0.5259288057795247,2.19206788447965,Testis,broadly expressed,0.38539569418353065,1.0087529146707888,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:31686,DMRTC1B,DMRT like family C1B,Approved,,,Xq13.1,gene with protein product,protein-coding gene,ENSG00000184911,728656,ENSG00000184911,Q5HYR2,MGI:3639121,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]","","",X,72777009,72848802,q13.1,,,,,,0.4901163305525753,ENST00000334036,0.17236614853195165,0.17208197950512372,579,1,"DMRTC1 (100, 100, chrX)",TRUE,1,"DMRTC1 (100, 100, chrX)",TRUE,0.9176572325303597,0.7422166694106279,Pituitary,tissue-specific,0.09628182662136056,0.38644126022840153,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:31689,MAP3K15,mitogen-activated protein kinase kinase kinase 15,Approved,,"bA723P2.3, FLJ16518, ASK3",Xp22.12,gene with protein product,protein-coding gene,ENSG00000180815,389840,ENSG00000180815,Q6ZN16,MGI:2448588,RGD:1560603,X,300820,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May function in a signal transduction pathway that is activated by various cell stresses and leads to apoptosis. {ECO:0000269|PubMed:20362554}.,activation of MAPKK activity [GO:0000186],ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672],"","",X,19360056,19515261,p22.12,2.9348e-32,1.337,-1.5277,-0.7833,44.84,0.6034574562493343,ENST00000338883,0.7747082699137494,0.11717070732316921,3942,1,"MAP3K5 (58, 56, chr6)",TRUE,,,,0.9149407132313797,4.872681035756315,Adrenal Gland,tissue-specific,0.08598802675425528,0.2496273731396907,FALSE,discordant,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:31709,ARL13A,ADP ribosylation factor like GTPase 13A,Approved,ARL13,,Xq22.1,gene with protein product,protein-coding gene,ENSG00000174225,392509,ENSG00000174225,Q5H913,MGI:1921698,RGD:1562947,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",non-motile cilium assembly [GO:1905515]; receptor localization to non-motile cilium [GO:0097500],GTP binding [GO:0005525],"","",X,100969708,100990831,q22.1,5.9177e-4,1.317,0.20856,1.0495,8.962,0.14946472943770125,ENST00000450049,0.36770428015564205,0.07028071079062581,771,,,,,,,0.9298740897378515,4.141097583717768,Testis,tissue-specific,0.053830488412769724,0.13704546094059208,FALSE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:31710,UBE2NL,ubiquitin conjugating enzyme E2 N like (gene/pseudogene),Approved,,,Xq27.3,gene with protein product,protein-coding gene,ENSG00000276380,389898,ENSG00000276380,Q5JXB2,,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",protein polyubiquitination [GO:0000209],ubiquitin conjugating enzyme activity [GO:0061631],"","",X,143884071,143885255,q27.3,0.015382,1.931,-0.81104,0.18975,1.2004,0.35567715458276333,ENST00000618570,0.9958874458874459,0.3068232941764559,462,1,"UBE2N (91, 91, chr12)",TRUE,1,"UBE2N (91, 91, chr12)",TRUE,0.9651806886015083,0.07807200266983884,Testis,tissue-specific,0,0,FALSE,,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:31749,ZCCHC13,zinc finger CCHC-type containing 13,Approved,,"4930513O09RIK, Cnbp2, ZNF9L",Xq13.2,gene with protein product,protein-coding gene,ENSG00000187969,389874,ENSG00000187969,Q8WW36,MGI:1922314,RGD:1589760,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",positive regulation of cytoplasmic translation [GO:2000767],mRNA binding [GO:0003729]; single-stranded RNA binding [GO:0003727]; translation regulator activity [GO:0045182]; zinc ion binding [GO:0008270],"","",X,74304180,74305034,q13.2,0.0013939,1.856,0.58897,0.71154,3.7821,0.43896229313901935,ENST00000339534,0.8295409181636727,0.3049987503124219,501,1,"CNBP (61, 56, chr3)",TRUE,,,,0.9767441860465116,5.651149303063519,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:31795,NCBP2L,nuclear cap binding protein subunit 2 like,Approved,,,Xq22.3,gene with protein product,protein-coding gene,ENSG00000170935,392517,ENSG00000170935,A6PVI3,,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]",RNA cap binding [GO:0000339],"","",X,107774899,107795829,q22.3,,,-0.84846,-0.062166,,0.45662969234574474,ENST00000509000,0.45995670995670995,0.21462134466383403,462,1,"NCBP2 (65, 63, chr3)",TRUE,,,,0.8492369200667657,1.6049395268263003,Testis,tissue-specific,0.1347818714675875,0.32200195898255124,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:31804,PAGE2,PAGE family member 2,Approved,GAGEC2,"MGC62094, PAGE-2, CT16.4",Xp11.21,gene with protein product,protein-coding gene,ENSG00000234068,203569,ENSG00000234068,Q7Z2X7,,,X,300738,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,55089018,55092842,p11.21,0.057156,1.602,-0.39025,-0.44175,3.5762,0.3813421974208556,ENST00000374968,0.0380952380952381,0.00807298175456136,336,2,"PAGE2B (94, 94, chrX); PAGE5 (82, 70, chrX)",TRUE,1,"PAGE2B (94, 94, chrX)",TRUE,0.970336109204628,5.0241645137520905,Testis,tissue-specific,0,0.20245345545847093,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:31805,PAGE2B,PAGE family member 2B,Approved,,CT16.5,Xp11.21,gene with protein product,protein-coding gene,ENSG00000238269,389860,ENSG00000238269,Q5JRK9,,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,55075030,55078909,p11.21,0.0012072,1.875,-0.22916,-0.10687,3.5704,0.42784842906441933,ENST00000374971,0.0494047619047619,0.04788802799300175,336,2,"PAGE2 (94, 94, chrX); PAGE5 (88, 75, chrX)",TRUE,1,"PAGE2 (94, 94, chrX)",TRUE,0.9345954063931957,5.973204857645652,Testis,tissue-specific,0.10257321307733284,0.29938827530609496,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:31810,DCAF8L1,DDB1 and CUL4 associated factor 8 like 1,Approved,WDR42B,,Xp21.3,gene with protein product,protein-coding gene,ENSG00000226372,139425,ENSG00000226372,A6NGE4,,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,27977992,27981449,p21.3,,,-1.485,0.33872,,0.3875968992248062,ENST00000441525,0.7921242373821409,0.3994001499625094,1803,2,"DCAF8L2 (80, 76, chrX); DCAF8 (67, 67, chr1)",TRUE,,,,0.9758709627070111,1.281229390750027,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:31811,DCAF8L2,DDB1 and CUL4 associated factor 8 like 2,Approved,WDR42C,,Xp21.3,gene with protein product,protein-coding gene,ENSG00000189186,347442,ENSG00000189186,P0C7V8,,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,27590382,27748821,p21.3,0.81931,0.474,-0.67396,1.3449,10.014,0.21697778870702936,ENST00000451261,0.5424050632911392,0.20039990002499375,1896,2,"DCAF8L1 (76, 80, chrX); DCAF8 (66, 70, chr1)",TRUE,,,,0.9758224983219997,4.003179439902569,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:31838,VCX3B,variable charge X-linked 3B,Approved,,VCX-C,Xp22.31,gene with protein product,protein-coding gene,ENSG00000205642,425054,ENSG00000205642,Q9H321,,,X,300981,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May mediate a process in spermatogenesis or may play a role in sex ratio distortion.,brain development [GO:0007420],"","","",X,8464830,8466510,p22.31,0.33685,1.833,-1.6127,-1.6366,0.5098,0.37882508102647566,ENST00000381032,0.02186234817813765,0.11859535116220944,741,2,"VCX (81, 97, chrX); VCX3A (75, 99, chrX)",TRUE,,,,0.9543819114236117,4.734032139564932,Testis,tissue-specific,0.1841177638430252,0.15244408676614585,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:31849,F8A2,coagulation factor VIII associated 2,Approved,,,Xq28,gene with protein product,protein-coding gene,ENSG00000274791,474383,ENSG00000274791,P23610,MGI:95474,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: RAB5A effector molecule that is involved in vesicular trafficking of early endosomes (PubMed:16476778). Mediates the recruitment of HTT by RAB5A onto early endosomes. The HTT-F8A1/F8A2/F8A3-RAB5A complex stimulates early endosomal interaction with actin filaments and inhibits interaction with microtubules, leading to the reduction of endosome motility (PubMed:16476778). {ECO:0000269|PubMed:16476778}.",negative regulation of proteasomal protein catabolic process [GO:1901799]; vesicle cytoskeletal trafficking [GO:0099518],"","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16476778}. Nucleus {ECO:0000269|PubMed:16476778}. Early endosome {ECO:0000269|PubMed:16476778}. Nucleus, nuclear body {ECO:0000250|UniProtKB:Q00558}. Note=Diffuse presence in the cytoplasm and accumulation in the nucleus (PubMed:16476778). In absence of HTT, F8A1/F8A2/F8A3 is concentred in cytoplasm (By similarity). Colocalized with HTT in endosomes (PubMed:16476778). In neuron found in intranuclear structures, the intranuclear rodlets (INRs), also known as rodlets of Roncoroni, in association with ubiquitin (By similarity). {ECO:0000250|UniProtKB:Q00558, ECO:0000269|PubMed:16476778}.","SUBUNIT: Interacts with HTT (via C-terminus) (PubMed:29466333). Interacts with RAB5A (By similarity). Found in a complex with F8A1/F8A2/F8A3, HTT and RAB5A; mediates the recruitment of HTT by RAB5A onto early endosomes (By similarity). {ECO:0000250|UniProtKB:M0RDU0, ECO:0000269|PubMed:29466333}.",X,155382115,155383230,q28,,,,,,0.7167278345923389,ENST00000369505,0.2538530465949821,0.13051737065733568,1116,2,"F8A1 (100, 100, chrX); F8A3 (100, 100, chrX)",TRUE,2,"F8A1 (100, 100, chrX); F8A3 (100, 100, chrX)",TRUE,0.937587596986313,0.04723306627314833,Fallopian Tube,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:31850,F8A3,coagulation factor VIII associated 3,Approved,,,Xq28,gene with protein product,protein-coding gene,ENSG00000277150,474384,ENSG00000277150,P23610,MGI:95474,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: RAB5A effector molecule that is involved in vesicular trafficking of early endosomes (PubMed:16476778). Mediates the recruitment of HTT by RAB5A onto early endosomes. The HTT-F8A1/F8A2/F8A3-RAB5A complex stimulates early endosomal interaction with actin filaments and inhibits interaction with microtubules, leading to the reduction of endosome motility (PubMed:16476778). {ECO:0000269|PubMed:16476778}.",negative regulation of proteasomal protein catabolic process [GO:1901799]; vesicle cytoskeletal trafficking [GO:0099518],"","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16476778}. Nucleus {ECO:0000269|PubMed:16476778}. Early endosome {ECO:0000269|PubMed:16476778}. Nucleus, nuclear body {ECO:0000250|UniProtKB:Q00558}. Note=Diffuse presence in the cytoplasm and accumulation in the nucleus (PubMed:16476778). In absence of HTT, F8A1/F8A2/F8A3 is concentred in cytoplasm (By similarity). Colocalized with HTT in endosomes (PubMed:16476778). In neuron found in intranuclear structures, the intranuclear rodlets (INRs), also known as rodlets of Roncoroni, in association with ubiquitin (By similarity). {ECO:0000250|UniProtKB:Q00558, ECO:0000269|PubMed:16476778}.","SUBUNIT: Interacts with HTT (via C-terminus) (PubMed:29466333). Interacts with RAB5A (By similarity). Found in a complex with F8A1/F8A2/F8A3, HTT and RAB5A; mediates the recruitment of HTT by RAB5A onto early endosomes (By similarity). {ECO:0000250|UniProtKB:M0RDU0, ECO:0000269|PubMed:29466333}.",X,155456914,155458620,q28,,,,,,0.7189217179715347,ENST00000622749,0.17383512544802868,0.10937265683579105,1116,2,"F8A2 (100, 100, chrX); F8A1 (100, 100, chrX)",TRUE,2,"F8A2 (100, 100, chrX); F8A1 (100, 100, chrX)",TRUE,0.39599868115654185,0.09930597821617114,Thyroid,broadly expressed,0.042327329875999443,0.05617500749895131,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:31851,CENPVL1,centromere protein V like 1,Approved,CENPVP1,PRR6L1,Xp11.22,gene with protein product,protein-coding gene,ENSG00000223591,389857,ENSG00000223591,A0A0U1RR11,,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","",carbon-sulfur lyase activity [GO:0016846]; metal ion binding [GO:0046872],"","",X,51710512,51712131,p11.22,,,,,,0.6893730493015363,ENST00000602548,0.17655677655677657,0.04848787803049238,819,2,"CENPVL2 (100, 100, chrX); CENPVL3 (96, 91, chrX)",TRUE,2,"CENPVL2 (100, 100, chrX); CENPVL3 (96, 91, chrX)",TRUE,,0,,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:31852,PABPC1L2B,poly(A) binding protein cytoplasmic 1 like 2B,Approved,RBM32B,,Xq13.2,gene with protein product,protein-coding gene,ENSG00000184388,645974,ENSG00000184388,Q5JQF8,,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","",RNA binding [GO:0003723],"","",X,73002939,73006106,q13.2,0.32142,1.855,-0.16929,0.85942,0.37339,0.5880812470997947,ENST00000373521,0.8849087893864013,0.3010247438140465,603,1,"PABPC1L2A (100, 100, chrX)",TRUE,1,"PABPC1L2A (100, 100, chrX)",TRUE,0.9287878247143199,2.9877365132576474,Cerebellar_tissues,tissue-specific,1.6023048394967625,2.9877365132576474,TRUE,,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:31894,SLC25A53,solute carrier family 25 member 53,Approved,MCART6,,Xq22.2,gene with protein product,protein-coding gene,ENSG00000269743,401612,ENSG00000269743,Q5H9E4,MGI:1914312,RGD:1591860,X,300941,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","",SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.,"",X,104099214,104157009,q22.2,0.056834,1.037,-0.35796,0.66753,7.4734,0.4249904132909646,ENST00000594199,0.706926406926407,0.08117970507373157,924,,,,,,,0.4873839491779968,1.811787484476038,Spleen,broadly expressed,0.9315121168784886,1.0397595667838018,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:31904,GAGE12D,G antigen 12D,Approved,,OTTHUMG00000024145,Xp11.23,gene with protein product,protein-coding gene,ENSG00000227488,100132399,ENSG00000227488,A1L429,,,X,300728,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,49541767,49549094,p11.23,,,,,,0.5674202116724094,ENST00000405679,0.08107344632768361,0.030892276930767307,354,11,"GAGE12E (100, 100, chrX); GAGE12C (100, 100, chrX); GAGE12H (99, 99, chrX); GAGE12G (99, 99, chrX); GAGE12F (99, 99, chrX); GAGE1 (97, 97, chrX); GAGE12J (97, 97, chrX); GAGE13 (97, 97, chrX); GAGE2A (96, 97, chrX); GAGE2E (93, 99, chrX); GAGE10 (90, 91, chrX)",TRUE,11,"GAGE12E (100, 100, chrX); GAGE12C (100, 100, chrX); GAGE12H (99, 99, chrX); GAGE12G (99, 99, chrX); GAGE12F (99, 99, chrX); GAGE1 (97, 97, chrX); GAGE12J (97, 97, chrX); GAGE13 (97, 97, chrX); GAGE2A (96, 97, chrX); GAGE2E (93, 99, chrX); GAGE10 (90, 91, chrX)",TRUE,,0,,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:31905,GAGE12E,G antigen 12E,Approved,,OTTHUMG00000024146,Xp11.23,gene with protein product,protein-coding gene,ENSG00000216649,729431,ENSG00000216649,A1L429,,,X,300729,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,49551333,49558649,p11.23,,,,,,0.5665106025743392,ENST00000381698,0.07090395480225989,0.03254186453386653,354,11,"GAGE12D (100, 100, chrX); GAGE12C (100, 100, chrX); GAGE12H (99, 99, chrX); GAGE12G (99, 99, chrX); GAGE12F (99, 99, chrX); GAGE1 (97, 97, chrX); GAGE12J (97, 97, chrX); GAGE13 (97, 97, chrX); GAGE2A (96, 97, chrX); GAGE2E (93, 99, chrX); GAGE10 (90, 91, chrX)",TRUE,11,"GAGE12D (100, 100, chrX); GAGE12C (100, 100, chrX); GAGE12H (99, 99, chrX); GAGE12G (99, 99, chrX); GAGE12F (99, 99, chrX); GAGE1 (97, 97, chrX); GAGE12J (97, 97, chrX); GAGE13 (97, 97, chrX); GAGE2A (96, 97, chrX); GAGE2E (93, 99, chrX); GAGE10 (90, 91, chrX)",TRUE,,0,,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:31906,GAGE12F,G antigen 12F,Approved,,OTTHUMG00000024147,Xp11.23,gene with protein product,protein-coding gene,ENSG00000236362,100008586,ENSG00000236362,P0CL80,,,X,300730,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","",SUBUNIT: Forms tetramers. {ECO:0000250}.,X,49551278,49568218,p11.23,,,,,,0.5714227819373664,ENST00000639028,0.07316384180790961,0.03319170207448138,354,11,"GAGE12G (100, 100, chrX); GAGE12E (99, 99, chrX); GAGE12D (99, 99, chrX); GAGE12C (99, 99, chrX); GAGE12H (98, 98, chrX); GAGE1 (98, 98, chrX); GAGE12J (98, 98, chrX); GAGE13 (98, 98, chrX); GAGE2A (97, 97, chrX); GAGE2E (94, 100, chrX); GAGE10 (91, 91, chrX)",TRUE,11,"GAGE12G (100, 100, chrX); GAGE12E (99, 99, chrX); GAGE12D (99, 99, chrX); GAGE12C (99, 99, chrX); GAGE12H (98, 98, chrX); GAGE1 (98, 98, chrX); GAGE12J (98, 98, chrX); GAGE13 (98, 98, chrX); GAGE2A (97, 97, chrX); GAGE2E (94, 100, chrX); GAGE10 (91, 91, chrX)",TRUE,,0,,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:31907,GAGE12G,G antigen 12G,Approved,,OTTHUMG00000024148,Xp11.23,gene with protein product,protein-coding gene,ENSG00000215269,645073,ENSG00000215269,P0CL81,,,X,300731,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","",SUBUNIT: Forms tetramers. {ECO:0000250}.,X,49570434,49577754,p11.23,,,,,,0.567154364622719,ENST00000445148,0.07203389830508475,0.030492376905773555,354,11,"GAGE12F (100, 100, chrX); GAGE12E (99, 99, chrX); GAGE12D (99, 99, chrX); GAGE12C (99, 99, chrX); GAGE12H (98, 98, chrX); GAGE1 (98, 98, chrX); GAGE12J (98, 98, chrX); GAGE13 (98, 98, chrX); GAGE2A (97, 97, chrX); GAGE2E (94, 100, chrX); GAGE10 (91, 91, chrX)",TRUE,11,"GAGE12F (100, 100, chrX); GAGE12E (99, 99, chrX); GAGE12D (99, 99, chrX); GAGE12C (99, 99, chrX); GAGE12H (98, 98, chrX); GAGE1 (98, 98, chrX); GAGE12J (98, 98, chrX); GAGE13 (98, 98, chrX); GAGE2A (97, 97, chrX); GAGE2E (94, 100, chrX); GAGE10 (91, 91, chrX)",TRUE,,0,,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:31908,GAGE12H,G antigen 12H,Approved,,OTTHUMG00000024149,Xp11.23,gene with protein product,protein-coding gene,ENSG00000224902,729442,ENSG00000224902,A6NDE8,,,X,300732,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,49579983,49587301,p11.23,0.34494,1.82,0.047582,-2.0531,0.58092,0.5679327863893673,ENST00000381722,0.07146892655367232,0.03881529617595601,354,11,"GAGE12E (99, 99, chrX); GAGE12D (99, 99, chrX); GAGE12C (99, 99, chrX); GAGE12G (98, 98, chrX); GAGE12F (98, 98, chrX); GAGE1 (97, 97, chrX); GAGE12J (97, 97, chrX); GAGE13 (97, 97, chrX); GAGE2A (95, 96, chrX); GAGE2E (92, 98, chrX); GAGE10 (89, 90, chrX)",TRUE,11,"GAGE12E (99, 99, chrX); GAGE12D (99, 99, chrX); GAGE12C (99, 99, chrX); GAGE12G (98, 98, chrX); GAGE12F (98, 98, chrX); GAGE1 (97, 97, chrX); GAGE12J (97, 97, chrX); GAGE13 (97, 97, chrX); GAGE2A (95, 96, chrX); GAGE2E (92, 98, chrX); GAGE10 (89, 90, chrX)",TRUE,,0,,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:31909,MAGEA9B,MAGE family member A9B,Approved,,,Xq28,gene with protein product,protein-coding gene,ENSG00000267978,728269,ENSG00000267978,P43362,,,X,300764,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Not known, though may play a role in embryonal development and tumor transformation or aspects of tumor progression.","","","","",X,149581653,149587453,q28,,,0.81094,0.49858,,0.3057851807568355,ENST00000595065,0.04715189873417722,0.0017745563609097726,948,9,"MAGEA9 (100, 100, chrX); MAGEA8 (68, 67, chrX); MAGEA4 (65, 65, chrX); MAGEA1 (61, 62, chrX); MAGEA3 (60, 60, chrX); MAGEA12 (59, 60, chrX); MAGEA2 (59, 59, chrX); MAGEA2B (59, 59, chrX); MAGEA6 (58, 58, chrX)",TRUE,1,"MAGEA9 (100, 100, chrX)",TRUE,0.9767441860465116,2.0729255535447675,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:31960,GAGE2E,G antigen 2E,Approved,,GAGE8,Xp11.23,gene with protein product,protein-coding gene,ENSG00000275113,26749,ENSG00000275113,Q4V326,,,X,300736,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,49341192,49345922,p11.23,,,,,,0.5725572093808762,ENST00000621907,0.07583081570996979,0.038440389902524366,331,11,"GAGE12G (100, 94, chrX); GAGE12F (100, 94, chrX); GAGE12E (99, 93, chrX); GAGE12D (99, 93, chrX); GAGE12C (99, 93, chrX); GAGE1 (99, 93, chrX); GAGE12H (98, 92, chrX); GAGE12J (98, 92, chrX); GAGE13 (98, 92, chrX); GAGE2A (96, 91, chrX); GAGE10 (90, 85, chrX)",TRUE,11,"GAGE12G (100, 94, chrX); GAGE12F (100, 94, chrX); GAGE12E (99, 93, chrX); GAGE12D (99, 93, chrX); GAGE12C (99, 93, chrX); GAGE1 (99, 93, chrX); GAGE12H (98, 92, chrX); GAGE12J (98, 92, chrX); GAGE13 (98, 92, chrX); GAGE2A (96, 91, chrX); GAGE10 (90, 85, chrX)",TRUE,,0,,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:31962,FAM156B,family with sequence similarity 156 member B,Approved,TMEM29B,,Xp11.22,gene with protein product,protein-coding gene,ENSG00000179304,727866,ENSG00000179304,Q8NDB6,,RGD:1584469,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","",methylated histone binding [GO:0035064],SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass membrane protein {ECO:0000305}.,"",X,52891306,52908560,p11.22,,,,,,0.6361981412283224,ENST00000416841,0.3,0.047613096725818545,642,1,"FAM156A (100, 100, chrX)",TRUE,1,"FAM156A (100, 100, chrX)",TRUE,0.5712827379340771,0.17006349351872438,Pituitary,broadly expressed,0.033849077690239475,0.1457073846941648,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:3226,EFNB1,ephrin B1,Approved,"EPLG2, CFNS","LERK2, Elk-L",Xq13.1,gene with protein product,protein-coding gene,ENSG00000090776,1947,ENSG00000090776,P98172,MGI:102708,RGD:2540,X,300035,TRUE,Craniofrontonasal dysplasia,304110,X-linked dominant,,,,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,TRUE,confirmed,"FUNCTION: Cell surface transmembrane ligand for Eph receptors, a family of receptor tyrosine kinases which are crucial for migration, repulsion and adhesion during neuronal, vascular and epithelial development (PubMed:8070404, PubMed:7973638). Binding to Eph receptors residing on adjacent cells leads to contact-dependent bidirectional signaling into neighboring cells (PubMed:8070404, PubMed:7973638). Shows high affinity for the receptor tyrosine kinase EPHB1/ELK (PubMed:8070404, PubMed:7973638). Can also bind EPHB2 and EPHB3 (PubMed:8070404). Binds to, and induces collapse of, commissural axons/growth cones in vitro (By similarity). May play a role in constraining the orientation of longitudinally projecting axons (By similarity). {ECO:0000250|UniProtKB:P52795, ECO:0000269|PubMed:7973638, ECO:0000269|PubMed:8070404}.",axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; embryonic pattern specification [GO:0009880]; ephrin receptor signaling pathway [GO:0048013]; neural crest cell migration [GO:0001755]; positive regulation of T cell proliferation [GO:0042102]; T cell costimulation [GO:0031295],ephrin receptor binding [GO:0046875],"SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10197531, ECO:0000269|PubMed:7973638}; Single-pass type I membrane protein {ECO:0000255}. Membrane raft {ECO:0000269|PubMed:10197531}. Note=May recruit GRIP1 and GRIP2 to membrane raft domains. {ECO:0000269|PubMed:10197531}.; SUBCELLULAR LOCATION: [Ephrin-B1 C-terminal fragment]: Cell membrane {ECO:0000269|PubMed:16930449}; Single-pass type I membrane protein {ECO:0000305}.; SUBCELLULAR LOCATION: [Ephrin-B1 intracellular domain]: Nucleus {ECO:0000269|PubMed:16930449}. Note=Colocalizes with ZHX2 in the nucleus. {ECO:0000250|UniProtKB:P52795}.","SUBUNIT: Interacts (via PDZ-binding motif) with GRIP1 and GRIP2 (via PDZ domain 6) (PubMed:10197531). Interacts with TLE1 (PubMed:21429299). The intracellular domain peptide interacts with ZHX2; the interaction enhances ZHX2 transcriptional repression activity (By similarity). {ECO:0000250|UniProtKB:P52795, ECO:0000269|PubMed:10197531, ECO:0000269|PubMed:21429299}.",X,68829021,68842160,q13.1,0.93251,0.349,0.26288,1.5909,8.5834,0.5924012931819934,ENST00000204961,0.8670509125840538,0.2937265683579105,1041,,,,,,,0.2676890544560149,6.538935408773331,Nerve - Tibial,broadly expressed,2.5137181226844043,2.521979141627847,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post1_higher_vs_Post2,confirmed monogenic disorder
HGNC:32312,OTUD6A,OTU deubiquitinase 6A,Approved,,"FLJ25831, HSHIN6, DUBA2",Xq13.1,gene with protein product,protein-coding gene,ENSG00000189401,139562,ENSG00000189401,Q7L8S5,MGI:3644685,RGD:1560855,X,300714,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Deubiquitinating enzyme that hydrolyzes 'Lys-27'-, 'Lys-29'- and 'Lys-33'-linked polyubiquitin chains. Also able to hydrolyze 'Lys-11'-linked ubiquitin chains. {ECO:0000269|PubMed:23827681}.",protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K27-linked deubiquitination [GO:1990167]; protein K29-linked deubiquitination [GO:0035523]; protein K33-linked deubiquitination [GO:1990168],thiol-dependent ubiquitin-specific protease activity [GO:0004843],"","",X,70062457,70064179,q13.1,0.28466,1.895,0.81924,1.8218,0.041864,0.570948420735123,ENST00000338352,0.5118800461361015,0.17985503624093976,867,,,,,,,0.9767441860465116,3.4242153438154745,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:3235,EGFL6,EGF like domain multiple 6,Approved,MAEG,,Xp22.2,gene with protein product,protein-coding gene,ENSG00000198759,25975,ENSG00000198759,Q8IUX8,MGI:1858599,RGD:1563321,X,300239,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May bind integrin alpha-8/beta-1 and play a role in hair follicle morphogenesis. Promotes matrix assembly (By similarity). {ECO:0000250}.,cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; extracellular matrix organization [GO:0030198]; multicellular organism development [GO:0007275]; positive regulation of cell-substrate adhesion [GO:0010811],calcium ion binding [GO:0005509]; integrin binding [GO:0005178],"SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular matrix, basement membrane {ECO:0000250}.","",X,13569601,13633575,p22.2,9.9818e-13,1.286,-0.93617,0.6372,22.601,0.41251694266014494,ENST00000361306,0.7762936221419976,0.09940014996250937,1662,,,,,,,0.8733356578504701,5.471337055813598,Lung,tissue-specific,0.22005377308610422,0.04730950766517185,FALSE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:32395,DGKK,diacylglycerol kinase kappa,Approved,,,Xp11.22,gene with protein product,protein-coding gene,ENSG00000274588,139189,ENSG00000274588,Q5KSL6,MGI:3580254,RGD:1561510,X,300837,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Phosphorylates diacylglycerol (DAG) to generate phosphatidic acid (PA). {ECO:0000269|PubMed:16210324}.,diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; platelet activation [GO:0030168]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; response to oxidative stress [GO:0006979],ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16210324}. Membrane {ECO:0000269|PubMed:16210324}; Peripheral membrane protein {ECO:0000269|PubMed:16210324}.,SUBUNIT: Does not form homooligomers.,X,50365409,50470825,p11.22,,,,,,0.5479358230167292,ENST00000611977,0.7173218029350105,0.25903524118970256,3816,,,,,,,0.969094819042212,3.499782120147312,Pituitary,tissue-specific,0.07625615893600143,0.11765229305430014,FALSE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:32459,ZCCHC18,zinc finger CCHC-type containing 18,Approved,,"SIZN2, PNMA7B",Xq22.2,gene with protein product,protein-coding gene,ENSG00000166707,644353,ENSG00000166707,P0CG32,MGI:1914245,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",BMP signaling pathway [GO:0030509],metal ion binding [GO:0046872]; nuclear receptor transcription coactivator activity [GO:0030374],"","",X,104112131,104115842,q22.2,0.41342,0.915,1.009,0.74716,5.1775,0.49200036992509016,ENST00000650639,0.37557755775577556,0.18847788052986753,1212,1,"ZCCHC12 (84, 84, chrX)",TRUE,1,"ZCCHC12 (84, 84, chrX)",TRUE,0.5949313669635699,3.646272122676534,Cerebellar_tissues,broadly expressed,2.0789445120530208,3.646272122676534,TRUE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:32488,ARSH,arylsulfatase family member H,Approved,,,Xp22.33,gene with protein product,protein-coding gene,ENSG00000205667,347527,ENSG00000205667,Q5FYA8,,,X,300586,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","",arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872],SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.,"",X,3006546,3034111,p22.33,7.3193e-8,1.394,0.87624,0.31437,13.925,0.26574541589157585,ENST00000381130,0.5269982238010658,0.07044349070100143,1689,3,"ARSD (64, 60, chrX); ARSL (59, 54, chrX); ARSF (59, 56, chrX)",TRUE,,,,0.9135575549304064,0.39530633660291703,Esophagus - Mucosa,tissue-specific,0,0,FALSE,high confidence escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:3250,EIF1AX,eukaryotic translation initiation factor 1A X-linked,Approved,"EIF4C, EIF1A","eIF-1A, eIF-4C",Xp22.12,gene with protein product,protein-coding gene,ENSG00000173674,1964,ENSG00000173674,P47813,"MGI:95298, MGI:1913485",RGD:1560198,X,300186,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Seems to be required for maximal rate of protein biosynthesis. Enhances ribosome dissociation into subunits and stabilizes the binding of the initiator Met-tRNA(I) to 40 S ribosomal subunits.,translational initiation [GO:0006413],"RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]","","",X,20124525,20141838,p22.12,0.91015,0.386,0.47863,2.3908,7.7601,0.6314414597542568,ENST00000379607,0.975632183908046,0.11532116970757311,435,1,"EIF1AY (99, 99, chrY)",TRUE,1,"EIF1AY (99, 99, chrY)",TRUE,0.1728112285067583,6.190439055606399,Ovary,broadly expressed,4.732822723452745,6.1214350895452325,FALSE,high confidence escapee,no_difference_Pre_Post,Pre_higher_vs_Post1,no difference_Pre_Post2,Post2_higher_vs_Post1,no disorder
HGNC:3267,EIF2S3,eukaryotic translation initiation factor 2 subunit gamma,Approved,EIF2G,"EIF2gamma, EIF2",Xp22.11,gene with protein product,protein-coding gene,ENSG00000130741,1968,ENSG00000130741,P41091,MGI:1349431,RGD:1561279,X,300161,TRUE,MEHMO syndrome,300148,X-linked recessive,,,,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,confirmed +CS,FALSE,TRUE,confirmed,"FUNCTION: As a subunit of eukaryotic initiation factor 2 (eIF-2), involved in the early steps of protein synthesis. In the presence of GTP, eIF-2 forms a ternary complex with initiator tRNA Met-tRNAi and then recruits the 40S ribosomal complex and initiation factors eIF-1, eIF-1A and eIF-3 to form the 43S pre-initiation complex (43S PIC), a step that determines the rate of protein translation. The 43S PIC binds to mRNA and scans downstream to the initiation codon, where it forms a 48S initiation complex by codon-anticodon base pairing. This leads to the displacement of eIF-1 to allow GTPase-activating protein (GAP) eIF-5-mediated hydrolysis of eIF2-bound GTP. Hydrolysis of GTP and release of Pi, which makes GTP hydrolysis irreversible, causes the release of the eIF-2-GDP binary complex from the 40S subunit, an event that is essential for the subsequent joining of the 60S ribosomal subunit to form an elongation-competent 80S ribosome. In order for eIF-2 to recycle and catalyze another round of initiation, the GDP bound to eIF-2 must be exchanged with GTP by way of a reaction catalyzed by GDP-GTP exchange factor (GEF) eIF-2B (By similarity). Along with its paralog on chromosome Y, may contribute to spermatogenesis up to the round spermatid stage (By similarity). {ECO:0000250|UniProtKB:P32481, ECO:0000250|UniProtKB:Q9Z0N1}.",formation of translation preinitiation complex [GO:0001731]; positive regulation of translational fidelity [GO:0045903]; translational initiation [GO:0006413]; transmembrane transport [GO:0055085],"cadherin binding [GO:0045296]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]","","SUBUNIT: The eukaryotic translation initiation factor 2 complex/eIF2 is a heterotrimer composed of an alpha subunit, also called subunit 1 (encoded by EIF2S1), a beta subunit, also called subunit 2 (encoded by EIF2S2) and a gamma subunit, also called subunit 3 (encoded by EIF2S3). {ECO:0000269|PubMed:23063529}.",X,24054946,24078810,p22.11,0.96388,0.322,-0.12973,3.6078,14.742,0.5709391949757351,ENST00000253039,0.9649753347427766,0.11707073231692076,1419,1,"EIF2S3B (99, 99, chr12)",TRUE,1,"EIF2S3B (99, 99, chr12)",TRUE,0.2103270562980921,7.950864960806056,Cells - EBV-transformed lymphocytes,broadly expressed,4.745672979614748,5.973858055361702,FALSE,high confidence escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:32701,HSFX2,"heat shock transcription factor family, X-linked 2",Approved,,,Xq28,gene with protein product,protein-coding gene,ENSG00000268738,100130086,ENSG00000268738,Q9UBD0,,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",cellular response to heat [GO:0034605]; positive regulation of transcription from RNA polymerase II promoter in response to heat stress [GO:0061408]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]",SUBCELLULAR LOCATION: Nucleus {ECO:0000305}. Cytoplasm {ECO:0000269|PubMed:15044259}.,"",X,149592512,149595314,q28,,,,,,0.41058277092047524,ENST00000598963,0.07374213836477987,0.03221694576355911,1272,1,"HSFX1 (100, 100, chrX)",TRUE,1,"HSFX1 (100, 100, chrX)",TRUE,0.9618273456085771,0.8743539600251514,Testis,tissue-specific,0,0.055437309720840544,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:32950,DCAF12L2,DDB1 and CUL4 associated factor 12 like 2,Approved,WDR40C,,Xq25,gene with protein product,protein-coding gene,ENSG00000198354,340578,ENSG00000198354,Q5VW00,MGI:2445178,RGD:1560768,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,126163499,126166289,q25,0.0058713,1.04,0.724,0.93714,10.108,0.6070867587360519,ENST00000360028,0.7851293103448276,0.29387653086728316,1392,2,"DCAF12L1 (87, 87, chrX); DCAF12 (64, 65, chr9)",TRUE,1,"DCAF12L1 (87, 87, chrX)",TRUE,0.8033200822581176,3.8429285627926624,Testis,tissue-specific,1.0802824456327744,0.39100658554749274,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:32960,SOWAHD,sosondowah ankyrin repeat domain family member D,Approved,ANKRD58,,Xq24,gene with protein product,protein-coding gene,ENSG00000187808,347454,ENSG00000187808,A6NJG2,MGI:3045274,RGD:1563086,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,119758588,119760202,q24,0.53135,1.257,0.94376,0.77982,2.2209,0.5727451039647489,ENST00000343905,0.37774261603375525,0.16745813546613347,948,,,,,,,0.772371292139338,3.7051153433965864,Testis,tissue-specific,0.36406922215946597,0.4070035250053133,FALSE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:32979,HAUS7,HAUS augmin like complex subunit 7,Approved,UCHL5IP,UIP1,Xq28,gene with protein product,protein-coding gene,ENSG00000213397,55559,ENSG00000213397,Q99871,MGI:1920988,RGD:1562991,X,300540,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Contributes to mitotic spindle assembly, maintenance of centrosome integrity and completion of cytokinesis as part of the HAUS augmin-like complex. {ECO:0000269|PubMed:19369198, ECO:0000269|PubMed:19427217}.",cell division [GO:0051301]; centrosome cycle [GO:0007098]; ciliary basal body-plasma membrane docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; spindle assembly [GO:0051225],microtubule minus-end binding [GO:0051011]; thioesterase binding [GO:0031996],"SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000269|PubMed:19369198, ECO:0000269|PubMed:19427217}. Cytoplasm, cytoskeleton, spindle {ECO:0000269|PubMed:19369198, ECO:0000269|PubMed:19427217}. Note=Localizes to interphase centrosomes and to mitotic spindle microtubules. {ECO:0000269|PubMed:19369198, ECO:0000269|PubMed:19427217}.","SUBUNIT: Component of the HAUS augmin-like complex. The complex interacts with the gamma-tubulin ring complex and this interaction is required for spindle assembly. Binds UCHL5. {ECO:0000269|PubMed:11163772, ECO:0000269|PubMed:19369198, ECO:0000269|PubMed:19427217}.",X,153447666,153495516,q28,0.98913,0.22,-0.60937,0.37552,13.612,0.31443523902958354,ENST00000370210,0.46458333333333335,0.02714321419645089,384,,,,,,,0.5737257391272851,4.256338914483355,Artery - Aorta,broadly expressed,1.0621631680662145,1.2801248919757295,FALSE,low confidence non-escapee,no_difference_Pre_Post,Pre_higher_vs_Post1,no difference_Pre_Post2,Post2_higher_vs_Post1,no disorder
HGNC:33146,PPP4R3C,protein phosphatase 4 regulatory subunit 3C,Approved,"SMEK3P, PPP4R3CP","FLJ32867, FLFL3P, smk1",Xp21.3,gene with protein product,protein-coding gene,ENSG00000224960,139420,ENSG00000224960,Q6ZMV5,,RGD:1559817,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,27460207,27463341,p21.3,,,,,,0.352051801907995,ENST00000412172,0.5569027611044418,0.3929517620594851,2499,2,"PPP4R3B (62, 60, chr2); PPP4R3A (53, 53, chr14)",TRUE,,,,0.9767441860465116,2.0360742417928708,Testis,tissue-specific,0,0,FALSE,low confidence escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:33147,SPIN2B,spindlin family member 2B,Approved,,"SPIN-2, TDRD26",Xp11.21,gene with protein product,protein-coding gene,ENSG00000186787,474343,ENSG00000186787,Q9BPZ2,"MGI:1922101, MGI:3645574, MGI:3645924, MGI:3647272, MGI:3650966, MGI:3705652, MGI:3781026, MGI:3781070, MGI:3781932, MGI:3805546, MGI:5434821, MGI:5434847, MGI:5434992",RGD:6503238,X,300517,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Involved in the regulation of cell cycle progression, this activity is related to the inhibition of apoptosis following the removal of essential growth factors (PubMed:12145692). Exhibits H3K4me3-binding activity (PubMed:29061846). {ECO:0000269|PubMed:12145692, ECO:0000269|PubMed:29061846}.","apoptotic process [GO:0006915]; cell cycle [GO:0007049]; gamete generation [GO:0007276]; regulation of cell cycle [GO:0051726]; regulation of transcription, DNA-templated [GO:0006355]",methylated histone binding [GO:0035064],SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12145692}.,SUBUNIT: Interacts with C11orf84/SPINDOC (PubMed:29061846). {ECO:0000269|PubMed:29061846}.,X,57118551,57121546,p11.21,0.056895,1.605,-0.19853,1.73,3.5664,0.4411780925665168,ENST00000333933,0.9671814671814671,0.2994251437140715,777,4,"SPIN2A (100, 100, chrX); SPIN1 (79, 77, chr9); SPIN3 (74, 74, chrX); SPIN4 (64, 66, chrX)",TRUE,1,"SPIN2A (100, 100, chrX)",TRUE,0.2609967743084972,3.4144806016907556,Cervix - Endocervix,broadly expressed,2.424330918858611,3.1098736864230307,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:33156,RTL8B,retrotransposon Gag like 8B,Approved,FAM127C,"MAR8B, CXX1c, SIRH4",Xq26.3,gene with protein product,protein-coding gene,ENSG00000212747,441518,ENSG00000212747,Q17RB0,"MGI:1913408, MGI:1920115, MGI:3576504",RGD:1595540,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,135020513,135022542,q26.3,0.014256,1.936,-0.69123,-0.033433,1.0828,0.4722929133136163,ENST00000391440,0.8926900584795322,0.15863534116470882,342,2,"RTL8A (96, 96, chrX); RTL8C (90, 90, chrX)",TRUE,2,"RTL8A (96, 96, chrX); RTL8C (90, 90, chrX)",TRUE,0.2654434197012083,5.919931151646513,Artery - Tibial,broadly expressed,3.380205794795797,3.981934829780736,FALSE,,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,no disorder
HGNC:33174,SPANXN1,SPANX family member N1,Approved,,"SPANX-N1, CT11.6",Xq27.3,gene with protein product,protein-coding gene,ENSG00000203923,494118,ENSG00000203923,Q5VSR9,,,X,300664,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,145247503,145256208,q27.3,0.39191,1.725,-1.2254,-0.79891,0.98984,0.17222375310002758,ENST00000370493,0.005479452054794521,0.06155961009747563,219,1,"SPANXN5 (86, 86, chrX)",TRUE,1,"SPANXN5 (86, 86, chrX)",TRUE,0.9767441860465116,1.8832493429126986,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:33175,SPANXN2,SPANX family member N2,Approved,,"SPANX-N2, CT11.7",Xq27.3,gene with protein product,protein-coding gene,ENSG00000268988,494119,ENSG00000268988,Q5MJ10,,,X,300665,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,143711955,143721423,q27.3,0.090812,1.894,0.19596,-0.3199,0.98628,0.17164067025681737,ENST00000598475,0.015469613259668509,0.05396150962259435,543,1,"SPANXN3 (60, 77, chrX)",TRUE,,,,0.9767441860465116,2.3023249006887876,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:33176,SPANXN3,SPANX family member N3,Approved,,"SPANX-N3, CT11.8",Xq27.3,gene with protein product,protein-coding gene,ENSG00000189252,139067,ENSG00000189252,Q5MJ09,,,X,300666,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,143508735,143517475,q27.3,0.38315,1.746,-1.9785,-0.19147,0.91389,0.20048529233998766,ENST00000370503,0.004929577464788733,0.03991502124468883,426,1,"SPANXN2 (77, 60, chrX)",TRUE,,,,0.9767441860465116,6.376019435772348,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:33177,SPANXN4,SPANX family member N4,Approved,,"SPANX-N4, CT11.9",Xq27.3,gene with protein product,protein-coding gene,ENSG00000189326,441525,ENSG00000189326,Q5MJ08,,,X,300667,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,143025918,143034702,q27.3,0.35242,1.807,0.16937,-1.2989,0.64643,0.20213337337499207,ENST00000370504,0.010403397027600849,0.06693326668332916,471,,,,,,,0.9767441860465116,4.583982337454421,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:33178,SPANXN5,SPANX family member N5,Approved,,"SPANX-N5, CT11.10",Xp11.22,gene with protein product,protein-coding gene,ENSG00000204363,494197,ENSG00000204363,Q5MJ07,,,X,300668,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,52796144,52797427,p11.22,0.085244,1.904,0.043468,-0.17888,0.86466,0.17617022447940323,ENST00000375511,0.05707762557077626,0.10482379405148713,219,1,"SPANXN1 (86, 86, chrX)",TRUE,1,"SPANXN1 (86, 86, chrX)",TRUE,0.9767441860465116,5.078626911951365,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:3319,ELF4,E74 like ETS transcription factor 4,Approved,,"MEF, ELFR",Xq26.1,gene with protein product,protein-coding gene,ENSG00000102034,2000,ENSG00000102034,Q99607,MGI:1928377,RGD:1560743,X,300775,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Transcriptional activator that binds to DNA sequences containing the consensus 5'-WGGA-3'. Transactivates promoters of the hematopoietic growth factor genes CSF2, IL3, IL8, and of the bovine lysozyme gene. Acts synergistically with RUNX1 to transactivate the IL3 promoter (By similarity). Also transactivates the PRF1 promoter in natural killer (NK) cells. Plays a role in the development and function of NK and NK T-cells and in innate immunity. Controls the proliferation and homing of CD8+ T-cells via the Kruppel-like factors KLF4 and KLF2 (By similarity). Controls cell senescence in a p53-dependent manner. Can also promote cellular transformation through inhibition of the p16 pathway. {ECO:0000250, ECO:0000269|PubMed:10207087, ECO:0000269|PubMed:14625302, ECO:0000269|PubMed:14976184, ECO:0000269|PubMed:19380490, ECO:0000269|PubMed:8895518, ECO:0000269|PubMed:9524226}.","cell differentiation [GO:0030154]; innate immune response [GO:0045087]; natural killer cell proliferation [GO:0001787]; NK T cell proliferation [GO:0001866]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]","DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]","SUBCELLULAR LOCATION: Nucleus, PML body {ECO:0000269|PubMed:14976184}. Note=Accumulation into PML nuclear bodies is mediated by PML.","SUBUNIT: Interacts with RUNX1 (via the Runt domain); the interaction transactivates the IL3 promoter. Interacts (via its C-terminus) with PML; the interaction translocates ELF4 to PML nuclear bodies and enhances transactivation of LYZ. {ECO:0000269|PubMed:10207087, ECO:0000269|PubMed:14976184}.",X,130063955,130110716,q26.1,0.06139,0.644,0.62896,1.1663,16.314,0.6531388869034562,ENST00000308167,0.7119477911646587,0.2398400399900025,1992,,,,,,,0.3537787715311512,5.618505905369949,Cells - EBV-transformed lymphocytes,broadly expressed,0.6830972465605923,0.4294595689215266,FALSE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:3321,ELK1,ETS transcription factor ELK1,Approved,,,Xp11.23,gene with protein product,protein-coding gene,ENSG00000126767,2002,ENSG00000126767,P19419,MGI:101833,RGD:1598663,X,311040,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Transcription factor that binds to purine-rich DNA sequences. Forms a ternary complex with SRF and the ETS and SRF motifs of the serum response element (SRE) on the promoter region of immediate early genes such as FOS and IER2. Induces target gene transcription upon JNK-signaling pathway stimulation (By similarity). {ECO:0000250|UniProtKB:A4GTP4, ECO:0000269|PubMed:1630903, ECO:0000269|PubMed:7889942}.","cell differentiation [GO:0030154]; cellular response to gamma radiation [GO:0071480]; cellular response to testosterone stimulus [GO:0071394]; positive regulation of neuron death [GO:1901216]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to fibroblast growth factor [GO:0071774]; response to light stimulus [GO:0009416]","chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor binding [GO:0001085]; sequence-specific double-stranded DNA binding [GO:1990837]",SUBCELLULAR LOCATION: Nucleus.,"SUBUNIT: Interacts in its sumoylated form with PIAS2/PIASX which enhances its transcriptional activator activity (PubMed:15920481). Interacts with MAD2L2; the interaction is direct and promotes phosphorylation by the kinases MAPK8 and/or MAPK9 (PubMed:17296730). Interacts with POU1F1 (PubMed:26612202). {ECO:0000269|PubMed:15920481, ECO:0000269|PubMed:17296730, ECO:0000269|PubMed:26612202}.",X,47635521,47650604,p11.23,0.93711,0.341,0.65616,2.1894,8.7843,0.4293227433723302,ENST00000376983,0.6743589743589744,0.24051487128217947,1287,,,,,,,0.29984920140968613,6.341729624783781,Ovary,broadly expressed,5.06057489152057,6.253287785628892,FALSE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:33267,CT45A1,cancer/testis antigen family 45 member A1,Approved,,"CT45-1, CT45.1",Xq26.3,gene with protein product,protein-coding gene,ENSG00000268940,541466,ENSG00000268940,Q5HYN5,,,X,300648,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",snRNA 3'-end processing [GO:0034472],"","","",X,135713453,135723539,q26.3,0.30048,1.88,1.0356,0.70361,0.18585,0.43690073540819807,ENST00000594565,0.12912280701754386,0.05603513174404015,570,8,"CT45A3 (99, 99, chrX); CT45A5 (99, 99, chrX); CT45A7 (99, 99, chrX); CT45A6 (99, 99, chrX); CT45A8 (98, 98, chrX); CT45A2 (98, 98, chrX); CT45A9 (98, 98, chrX); CT45A10 (94, 94, chrX)",TRUE,8,"CT45A3 (99, 99, chrX); CT45A5 (99, 99, chrX); CT45A7 (99, 99, chrX); CT45A6 (99, 99, chrX); CT45A8 (98, 98, chrX); CT45A2 (98, 98, chrX); CT45A9 (98, 98, chrX); CT45A10 (94, 94, chrX)",TRUE,0.9760135129093999,2.234700574072767,Testis,tissue-specific,0.07021193419542024,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:33268,CT45A3,cancer/testis antigen family 45 member A3,Approved,CT45A4,"CT45-3, CT45.3, CT45-4, CT45.4",Xq26.3,gene with protein product,protein-coding gene,ENSG00000269096,441519,ENSG00000269096,Q8NHU0,,,X,300794,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",snRNA 3'-end processing [GO:0034472],"","","",X,135759846,135768191,q26.3,,,,,,0.42996739783287563,ENST00000598716,0.20526315789473684,0.018645338665333668,570,8,"CT45A1 (99, 99, chrX); CT45A5 (99, 99, chrX); CT45A7 (99, 99, chrX); CT45A6 (99, 99, chrX); CT45A8 (98, 98, chrX); CT45A2 (98, 98, chrX); CT45A9 (98, 98, chrX); CT45A10 (94, 94, chrX)",TRUE,8,"CT45A1 (99, 99, chrX); CT45A5 (99, 99, chrX); CT45A7 (99, 99, chrX); CT45A6 (99, 99, chrX); CT45A8 (98, 98, chrX); CT45A2 (98, 98, chrX); CT45A9 (98, 98, chrX); CT45A10 (94, 94, chrX)",TRUE,0.9767441860465116,1.0796341123687059,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:33270,CT45A5,cancer/testis antigen family 45 member A5,Approved,,"CT45-5, CT45.5",Xq26.3,gene with protein product,protein-coding gene,ENSG00000228836,441521,ENSG00000228836,P0DMU8,,,X,300796,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",snRNA 3'-end processing [GO:0034472],"","","",X,135777130,135785298,q26.3,1.3301e-8,1.973,-4.1954,-3.8594,3.7428,0.4405502516261648,ENST00000487941,0.18596491228070175,0.016070982254436393,570,8,"CT45A7 (100, 100, chrX); CT45A6 (100, 100, chrX); CT45A3 (99, 99, chrX); CT45A1 (99, 99, chrX); CT45A8 (98, 98, chrX); CT45A2 (98, 98, chrX); CT45A9 (98, 98, chrX); CT45A10 (95, 95, chrX)",TRUE,8,"CT45A7 (100, 100, chrX); CT45A6 (100, 100, chrX); CT45A3 (99, 99, chrX); CT45A1 (99, 99, chrX); CT45A8 (98, 98, chrX); CT45A2 (98, 98, chrX); CT45A9 (98, 98, chrX); CT45A10 (95, 95, chrX)",TRUE,0.9767441860465116,0.2445327335426222,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:33271,CT45A6,cancer/testis antigen family 45 member A6,Approved,,"CT45-6, CT45.6",Xq26.3,gene with protein product,protein-coding gene,ENSG00000278289,541465,ENSG00000278289,P0DMU7,,,X,300797,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",snRNA 3'-end processing [GO:0034472],"","","",X,135794685,135802787,q26.3,0.30472,1.875,0.90156,0.50962,0.22407,0.4323818726105938,ENST00000620654,0.17473684210526316,0.012996750812296927,570,8,"CT45A5 (100, 100, chrX); CT45A7 (100, 100, chrX); CT45A3 (99, 99, chrX); CT45A1 (99, 99, chrX); CT45A8 (98, 98, chrX); CT45A2 (98, 98, chrX); CT45A9 (98, 98, chrX); CT45A10 (95, 95, chrX)",TRUE,8,"CT45A5 (100, 100, chrX); CT45A7 (100, 100, chrX); CT45A3 (99, 99, chrX); CT45A1 (99, 99, chrX); CT45A8 (98, 98, chrX); CT45A2 (98, 98, chrX); CT45A9 (98, 98, chrX); CT45A10 (95, 95, chrX)",TRUE,,0,,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:33282,CT47A1,cancer/testis antigen family 47 member A1,Approved,,CT47.1,Xq24,gene with protein product,protein-coding gene,ENSG00000236371,728096,ENSG00000236371,Q5JQC4,,,X,300780,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,120982476,120985788,q24,,,,,,0.48982574646579863,ENST00000433030,0.009573241061130335,0.07768057985503624,867,13,"CT47A9 (100, 100, chrX); CT47A6 (100, 100, chrX); CT47A12 (100, 100, chrX); CT47A7 (100, 100, chrX); CT47A3 (100, 100, chrX); CT47A5 (100, 100, chrX); CT47A2 (100, 100, chrX); CT47A4 (100, 100, chrX); CT47A10 (100, 100, chrX); CT47A8 (100, 100, chrX); CT47A11 (100, 100, chrX); CT47B1 (86, 83, chrX); AL772284.1 (67, 60, chrX)",TRUE,11,"CT47A9 (100, 100, chrX); CT47A6 (100, 100, chrX); CT47A12 (100, 100, chrX); CT47A7 (100, 100, chrX); CT47A3 (100, 100, chrX); CT47A5 (100, 100, chrX); CT47A2 (100, 100, chrX); CT47A4 (100, 100, chrX); CT47A10 (100, 100, chrX); CT47A8 (100, 100, chrX); CT47A11 (100, 100, chrX)",TRUE,,0,,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:33283,CT47A2,cancer/testis antigen family 47 member A2,Approved,,CT47.2,Xq24,gene with protein product,protein-coding gene,ENSG00000242362,728090,ENSG00000242362,Q5JQC4,,,X,300781,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,120977606,120980928,q24,,,,,,0.5119207187210579,ENST00000458218,0.016724336793540948,0.07398150462384404,867,13,"CT47A4 (100, 100, chrX); CT47A9 (100, 100, chrX); CT47A6 (100, 100, chrX); CT47A5 (100, 100, chrX); CT47A12 (100, 100, chrX); CT47A7 (100, 100, chrX); CT47A1 (100, 100, chrX); CT47A3 (100, 100, chrX); CT47A10 (100, 100, chrX); CT47A8 (100, 100, chrX); CT47A11 (100, 100, chrX); CT47B1 (86, 83, chrX); AL772284.1 (67, 60, chrX)",TRUE,11,"CT47A4 (100, 100, chrX); CT47A9 (100, 100, chrX); CT47A6 (100, 100, chrX); CT47A5 (100, 100, chrX); CT47A12 (100, 100, chrX); CT47A7 (100, 100, chrX); CT47A1 (100, 100, chrX); CT47A3 (100, 100, chrX); CT47A10 (100, 100, chrX); CT47A8 (100, 100, chrX); CT47A11 (100, 100, chrX)",TRUE,,0,,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:33284,CT47A3,cancer/testis antigen family 47 member A3,Approved,,CT47.3,Xq24,gene with protein product,protein-coding gene,ENSG00000236126,728082,ENSG00000236126,Q5JQC4,,,X,300782,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,120972746,120976068,q24,,,,,,0.5119207187210579,ENST00000441330,0.01649365628604383,0.08797800549862535,867,13,"CT47A9 (100, 100, chrX); CT47A12 (100, 100, chrX); CT47A6 (100, 100, chrX); CT47A7 (100, 100, chrX); CT47A1 (100, 100, chrX); CT47A5 (100, 100, chrX); CT47A2 (100, 100, chrX); CT47A4 (100, 100, chrX); CT47A10 (100, 100, chrX); CT47A8 (100, 100, chrX); CT47A11 (100, 100, chrX); CT47B1 (86, 83, chrX); AL772284.1 (67, 60, chrX)",TRUE,11,"CT47A9 (100, 100, chrX); CT47A12 (100, 100, chrX); CT47A6 (100, 100, chrX); CT47A7 (100, 100, chrX); CT47A1 (100, 100, chrX); CT47A5 (100, 100, chrX); CT47A2 (100, 100, chrX); CT47A4 (100, 100, chrX); CT47A10 (100, 100, chrX); CT47A8 (100, 100, chrX); CT47A11 (100, 100, chrX)",TRUE,,0,,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:33285,CT47A4,cancer/testis antigen family 47 member A4,Approved,,CT47.4,Xq24,gene with protein product,protein-coding gene,ENSG00000230594,728075,ENSG00000230594,Q5JQC4,,,X,300783,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,120967886,120971208,q24,,,,,,0.5119207187210579,ENST00000415858,0.023414071510957323,0.08557860534866284,867,13,"CT47A2 (100, 100, chrX); CT47A9 (100, 100, chrX); CT47A6 (100, 100, chrX); CT47A5 (100, 100, chrX); CT47A12 (100, 100, chrX); CT47A7 (100, 100, chrX); CT47A1 (100, 100, chrX); CT47A3 (100, 100, chrX); CT47A10 (100, 100, chrX); CT47A8 (100, 100, chrX); CT47A11 (100, 100, chrX); CT47B1 (86, 83, chrX); AL772284.1 (67, 60, chrX)",TRUE,11,"CT47A2 (100, 100, chrX); CT47A9 (100, 100, chrX); CT47A6 (100, 100, chrX); CT47A5 (100, 100, chrX); CT47A12 (100, 100, chrX); CT47A7 (100, 100, chrX); CT47A1 (100, 100, chrX); CT47A3 (100, 100, chrX); CT47A10 (100, 100, chrX); CT47A8 (100, 100, chrX); CT47A11 (100, 100, chrX)",TRUE,,0,,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:33286,CT47A5,cancer/testis antigen family 47 member A5,Approved,,CT47.5,Xq24,gene with protein product,protein-coding gene,ENSG00000237957,728072,ENSG00000237957,Q5JQC4,,,X,300784,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,120963026,120966348,q24,,,,,,0.5119207187210579,ENST00000439466,0.018223760092272202,0.08062984253936516,867,13,"CT47A9 (100, 100, chrX); CT47A6 (100, 100, chrX); CT47A12 (100, 100, chrX); CT47A7 (100, 100, chrX); CT47A1 (100, 100, chrX); CT47A3 (100, 100, chrX); CT47A2 (100, 100, chrX); CT47A4 (100, 100, chrX); CT47A10 (100, 100, chrX); CT47A8 (100, 100, chrX); CT47A11 (100, 100, chrX); CT47B1 (86, 83, chrX); AL772284.1 (67, 60, chrX)",TRUE,11,"CT47A9 (100, 100, chrX); CT47A6 (100, 100, chrX); CT47A12 (100, 100, chrX); CT47A7 (100, 100, chrX); CT47A1 (100, 100, chrX); CT47A3 (100, 100, chrX); CT47A2 (100, 100, chrX); CT47A4 (100, 100, chrX); CT47A10 (100, 100, chrX); CT47A8 (100, 100, chrX); CT47A11 (100, 100, chrX)",TRUE,,0,,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:33287,CT47A6,cancer/testis antigen family 47 member A6,Approved,,CT47.6,Xq24,gene with protein product,protein-coding gene,ENSG00000226023,728062,ENSG00000226023,Q5JQC4,,,X,300785,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,120958165,120961487,q24,,,,,,0.5050653354867127,ENST00000419194,0.03298731257208766,0.09150212446888278,867,13,"CT47A9 (100, 100, chrX); CT47A12 (100, 100, chrX); CT47A3 (100, 100, chrX); CT47A7 (100, 100, chrX); CT47A1 (100, 100, chrX); CT47A5 (100, 100, chrX); CT47A2 (100, 100, chrX); CT47A4 (100, 100, chrX); CT47A10 (100, 100, chrX); CT47A8 (100, 100, chrX); CT47A11 (100, 100, chrX); CT47B1 (86, 83, chrX); AL772284.1 (67, 60, chrX)",TRUE,11,"CT47A9 (100, 100, chrX); CT47A12 (100, 100, chrX); CT47A3 (100, 100, chrX); CT47A7 (100, 100, chrX); CT47A1 (100, 100, chrX); CT47A5 (100, 100, chrX); CT47A2 (100, 100, chrX); CT47A4 (100, 100, chrX); CT47A10 (100, 100, chrX); CT47A8 (100, 100, chrX); CT47A11 (100, 100, chrX)",TRUE,,0,,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:33288,CT47A7,cancer/testis antigen family 47 member A7,Approved,,CT47.7,Xq24,gene with protein product,protein-coding gene,ENSG00000228517,653282,ENSG00000228517,Q5JQC4,,,X,300786,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,120953282,120956600,q24,,,,,,0.5225699522277469,ENST00000434883,0.007612456747404844,0.05801049737565609,867,13,"CT47A9 (100, 100, chrX); CT47A6 (100, 100, chrX); CT47A12 (100, 100, chrX); CT47A3 (100, 100, chrX); CT47A1 (100, 100, chrX); CT47A5 (100, 100, chrX); CT47A2 (100, 100, chrX); CT47A4 (100, 100, chrX); CT47A10 (100, 100, chrX); CT47A8 (100, 100, chrX); CT47A11 (100, 100, chrX); CT47B1 (86, 83, chrX); AL772284.1 (67, 60, chrX)",TRUE,11,"CT47A9 (100, 100, chrX); CT47A6 (100, 100, chrX); CT47A12 (100, 100, chrX); CT47A3 (100, 100, chrX); CT47A1 (100, 100, chrX); CT47A5 (100, 100, chrX); CT47A2 (100, 100, chrX); CT47A4 (100, 100, chrX); CT47A10 (100, 100, chrX); CT47A8 (100, 100, chrX); CT47A11 (100, 100, chrX)",TRUE,,0,,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:33289,CT47A8,cancer/testis antigen family 47 member A8,Approved,,CT47.8,Xq24,gene with protein product,protein-coding gene,ENSG00000230347,728049,ENSG00000230347,Q5JQC4,,,X,300787,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,120948422,120951744,q24,,,,,,0.5158285104670202,ENST00000457977,0.015340253748558248,0.09677580604848789,867,13,"CT47A11 (100, 100, chrX); CT47A2 (100, 100, chrX); CT47A9 (100, 100, chrX); CT47A4 (100, 100, chrX); CT47A6 (100, 100, chrX); CT47A5 (100, 100, chrX); CT47A12 (100, 100, chrX); CT47A10 (100, 100, chrX); CT47A7 (100, 100, chrX); CT47A1 (100, 100, chrX); CT47A3 (100, 100, chrX); CT47B1 (86, 83, chrX); AL772284.1 (67, 60, chrX)",TRUE,11,"CT47A11 (100, 100, chrX); CT47A2 (100, 100, chrX); CT47A9 (100, 100, chrX); CT47A4 (100, 100, chrX); CT47A6 (100, 100, chrX); CT47A5 (100, 100, chrX); CT47A12 (100, 100, chrX); CT47A10 (100, 100, chrX); CT47A7 (100, 100, chrX); CT47A1 (100, 100, chrX); CT47A3 (100, 100, chrX)",TRUE,,0,,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:33290,CT47A9,cancer/testis antigen family 47 member A9,Approved,,CT47.9,Xq24,gene with protein product,protein-coding gene,ENSG00000226600,728042,ENSG00000226600,Q5JQC4,,,X,300788,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,120943561,120946883,q24,,,,,,0.5153386448350478,ENST00000417256,0.016839677047289503,0.08475381154711323,867,13,"CT47A12 (100, 100, chrX); CT47A3 (100, 100, chrX); CT47A6 (100, 100, chrX); CT47A7 (100, 100, chrX); CT47A1 (100, 100, chrX); CT47A5 (100, 100, chrX); CT47A2 (100, 100, chrX); CT47A4 (100, 100, chrX); CT47A10 (100, 100, chrX); CT47A8 (100, 100, chrX); CT47A11 (100, 100, chrX); CT47B1 (86, 83, chrX); AL772284.1 (67, 60, chrX)",TRUE,11,"CT47A12 (100, 100, chrX); CT47A3 (100, 100, chrX); CT47A6 (100, 100, chrX); CT47A7 (100, 100, chrX); CT47A1 (100, 100, chrX); CT47A5 (100, 100, chrX); CT47A2 (100, 100, chrX); CT47A4 (100, 100, chrX); CT47A10 (100, 100, chrX); CT47A8 (100, 100, chrX); CT47A11 (100, 100, chrX)",TRUE,,0,,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:33291,CT47A10,cancer/testis antigen family 47 member A10,Approved,,CT47.10,Xq24,gene with protein product,protein-coding gene,ENSG00000224089,728036,ENSG00000224089,Q5JQC4,,,X,300789,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,120938701,120942023,q24,,,,,,0.5148497087393787,ENST00000430448,0.02837370242214533,0.09057735566108473,867,13,"CT47A2 (100, 100, chrX); CT47A9 (100, 100, chrX); CT47A4 (100, 100, chrX); CT47A6 (100, 100, chrX); CT47A5 (100, 100, chrX); CT47A12 (100, 100, chrX); CT47A7 (100, 100, chrX); CT47A1 (100, 100, chrX); CT47A3 (100, 100, chrX); CT47A8 (100, 100, chrX); CT47A11 (100, 100, chrX); CT47B1 (86, 83, chrX); AL772284.1 (67, 60, chrX)",TRUE,11,"CT47A2 (100, 100, chrX); CT47A9 (100, 100, chrX); CT47A4 (100, 100, chrX); CT47A6 (100, 100, chrX); CT47A5 (100, 100, chrX); CT47A12 (100, 100, chrX); CT47A7 (100, 100, chrX); CT47A1 (100, 100, chrX); CT47A3 (100, 100, chrX); CT47A8 (100, 100, chrX); CT47A11 (100, 100, chrX)",TRUE,,0,,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:33292,CT47A12,cancer/testis antigen family 47 member A12,Approved,,CT47.12,Xq24,gene with protein product,protein-coding gene,ENSG00000226685,100507170,ENSG00000226685,Q5JQC4,,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,120930250,120932301,q24,,,,,,0.5119607314394694,ENST00000419982,0.020876585928489042,0.09085228692826794,867,13,"CT47A9 (100, 100, chrX); CT47A3 (100, 100, chrX); CT47A6 (100, 100, chrX); CT47A7 (100, 100, chrX); CT47A1 (100, 100, chrX); CT47A5 (100, 100, chrX); CT47A2 (100, 100, chrX); CT47A4 (100, 100, chrX); CT47A10 (100, 100, chrX); CT47A8 (100, 100, chrX); CT47A11 (100, 100, chrX); CT47B1 (86, 83, chrX); AL772284.1 (67, 60, chrX)",TRUE,11,"CT47A9 (100, 100, chrX); CT47A3 (100, 100, chrX); CT47A6 (100, 100, chrX); CT47A7 (100, 100, chrX); CT47A1 (100, 100, chrX); CT47A5 (100, 100, chrX); CT47A2 (100, 100, chrX); CT47A4 (100, 100, chrX); CT47A10 (100, 100, chrX); CT47A8 (100, 100, chrX); CT47A11 (100, 100, chrX)",TRUE,,0,,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:33293,CT47B1,cancer/testis antigen family 47 member B1,Approved,,CT47.13,Xq24,gene with protein product,protein-coding gene,ENSG00000236446,643311,ENSG00000236446,P0C2W7,,RGD:7519078,X,300790,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,120872603,120875929,q24,7.6299e-9,1.953,-5.6175,-6.0585,5.7952,0.47871860371124636,ENST00000371311,0.005333333333333333,0.052636840789802554,900,13,"CT47A2 (83, 86, chrX); CT47A8 (83, 86, chrX); CT47A9 (83, 86, chrX); CT47A4 (83, 86, chrX); CT47A6 (83, 86, chrX); CT47A5 (83, 86, chrX); CT47A12 (83, 86, chrX); CT47A10 (83, 86, chrX); CT47A11 (83, 86, chrX); CT47A7 (83, 86, chrX); CT47A1 (83, 86, chrX); CT47A3 (83, 86, chrX); AL772284.1 (69, 63, chrX)",TRUE,12,"CT47A2 (83, 86, chrX); CT47A8 (83, 86, chrX); CT47A9 (83, 86, chrX); CT47A4 (83, 86, chrX); CT47A6 (83, 86, chrX); CT47A5 (83, 86, chrX); CT47A12 (83, 86, chrX); CT47A10 (83, 86, chrX); CT47A11 (83, 86, chrX); CT47A7 (83, 86, chrX); CT47A1 (83, 86, chrX); CT47A3 (83, 86, chrX)",TRUE,0.9767441860465116,3.8357523146207546,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:3331,EMD,emerin,Approved,,"STA, LEMD5",Xq28,gene with protein product,protein-coding gene,ENSG00000102119,2010,ENSG00000102119,P50402,MGI:108117,RGD:2551,X,300384,TRUE,"Emery-Dreifuss muscular dystrophy 1, X-linked",310300,X-linked recessive,,,,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,TRUE,confirmed,"FUNCTION: Stabilizes and promotes the formation of a nuclear actin cortical network. Stimulates actin polymerization in vitro by binding and stabilizing the pointed end of growing filaments. Inhibits beta-catenin activity by preventing its accumulation in the nucleus. Acts by influencing the nuclear accumulation of beta-catenin through a CRM1-dependent export pathway. Links centrosomes to the nuclear envelope via a microtubule association. EMD and BAF are cooperative cofactors of HIV-1 infection. Association of EMD with the viral DNA requires the presence of BAF and viral integrase. The association of viral DNA with chromatin requires the presence of BAF and EMD. Required for proper localization of non-farnesylated prelamin-A/C. {ECO:0000269|PubMed:15328537, ECO:0000269|PubMed:16680152, ECO:0000269|PubMed:16858403, ECO:0000269|PubMed:17785515, ECO:0000269|PubMed:19323649}.",cellular response to growth factor stimulus [GO:0071363]; mitotic nuclear envelope reassembly [GO:0007084]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of fibroblast proliferation [GO:0048147]; positive regulation of protein export from nucleus [GO:0046827]; regulation of canonical Wnt signaling pathway [GO:0060828]; skeletal muscle cell differentiation [GO:0035914],actin binding [GO:0003779]; beta-tubulin binding [GO:0048487]; cadherin binding [GO:0045296],"SUBCELLULAR LOCATION: Nucleus inner membrane {ECO:0000269|PubMed:19167377}; Single-pass membrane protein; Nucleoplasmic side {ECO:0000269|PubMed:19167377}. Nucleus outer membrane. Note=Colocalized with BANF1 at the central region of the assembling nuclear rim, near spindle-attachment sites. The accumulation of different intermediates of prelamin-A/C (non-farnesylated or carboxymethylated farnesylated prelamin-A/C) in fibroblasts modify its localization in the nucleus.","SUBUNIT: Interacts with lamins A and C, BANF1, GMCL, BCLAF1 and YTHDC1/YT521. Interacts with TMEM43; the interaction retains emerin in the nuclear inner membrane. Interacts with SUN1 and SUN2 (By similarity). Interacts with ACTB, SPTAN1, F-actin, CTNNB1 and beta-tubulin. Interacts with TMEM201. {ECO:0000250, ECO:0000269|PubMed:11792822, ECO:0000269|PubMed:12493765, ECO:0000269|PubMed:12755701, ECO:0000269|PubMed:15009215, ECO:0000269|PubMed:15328537, ECO:0000269|PubMed:16858403, ECO:0000269|PubMed:16972941, ECO:0000269|PubMed:17785515, ECO:0000269|PubMed:19323649, ECO:0000269|PubMed:21610090}.",X,154379273,154381523,q28,0.93178,0.35,-2.4209,-0.16471,8.5531,0.665321239271695,ENST00000369842,0.4503267973856209,0.11299675081229693,765,,,,,,,0.15092436768491682,7.892646025226911,Ovary,broadly expressed,5.502101422635511,6.708987284921797,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:33358,GLOD5,glyoxalase domain containing 5,Approved,,,Xp11.23,gene with protein product,protein-coding gene,ENSG00000171433,392465,ENSG00000171433,A6NK44,MGI:1917074,RGD:1564596,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,48761747,48773648,p11.23,0.053308,1.638,0.19841,-0.61047,3.4291,0.23147652013631395,ENST00000303227,0.7542443064182195,0.048537865533616595,483,,,,,,,0.8231867923503924,2.0932863491036247,Small Intestine - Terminal Ileum,tissue-specific,0,0.07094589470715294,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:33494,CT83,cancer/testis antigen 83,Approved,CXorf61,"KK-LC-1, FLJ20611, FLJ22913",Xq23,gene with protein product,protein-coding gene,ENSG00000204019,203413,ENSG00000204019,Q5H943,,,X,300625,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","",SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:16651449}; Single-pass type II membrane protein {ECO:0000269|PubMed:16651449}.,"",X,116461686,116462976,q23,0.083699,1.907,1.0189,-0.013165,0.82995,0.3364065473124271,ENST00000371894,0.07543859649122807,0.04081479630092477,342,,,,,,,0.9729667181917898,6.718334224262915,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:33519,RHOXF2B,Rhox homeobox family member 2B,Approved,,,Xq24,gene with protein product,protein-coding gene,ENSG00000203989,727940,ENSG00000203989,P0C7M4,,RGD:2321855,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Transcription factor maybe involved in reproductive processes. Modulates expression of target genes encoding proteins involved in processes relevant to spermatogenesis. {ECO:0000269|PubMed:28171660}.,positive regulation of gene expression [GO:0010628],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]",SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00108}.,"",X,120072264,120077690,q24,0.25146,1.335,-0.33055,-0.073437,3.4197,0.427075823590258,ENST00000371402,0.022837370242214532,0.009222694326418396,867,1,"RHOXF2 (99, 99, chrX)",TRUE,1,"RHOXF2 (99, 99, chrX)",TRUE,0.9763559384458517,1.825716441558501,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:33713,CXorf65,chromosome X open reading frame 65,Approved,,,Xq13.1,gene with protein product,protein-coding gene,ENSG00000204165,158830,ENSG00000204165,A6NEN9,MGI:2685460,RGD:9078783,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,71103889,71106788,q13.1,0.88329,0.428,-1.2548,0.19697,6.9898,0.21106615807840498,ENST00000374251,0.48478260869565215,0.21339665083729067,552,,,,,,,0.8710307411960724,6.111206629258355,Testis,tissue-specific,0.07099499525663547,0.024199023989747732,FALSE,high confidence escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:33737,NHSL2,NHS like 2,Approved,,,Xq13.1,gene with protein product,protein-coding gene,ENSG00000204131,340527,ENSG00000204131,Q5HYW2,MGI:3645090,RGD:1564117,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",cell differentiation [GO:0030154],"","","",X,71910818,72161750,q13.1,0.11655,0.524,0.72412,0.73661,22.592,0.6210405483482613,ENST00000633930,0.6747145187601957,0.24196450887278181,3678,,,,,,,0.5267032044943096,4.4237630338513885,Cerebellar_tissues,broadly expressed,1.6735157204210696,4.4237630338513885,TRUE,discordant,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:33738,EZHIP,EZH inhibitory protein,Approved,CXorf67,CATACOMB,Xp11.22,gene with protein product,protein-coding gene,ENSG00000187690,340602,ENSG00000187690,Q86X51,MGI:2147968,RGD:7681336,X,301036,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Inhibits PRC2/EED-EZH1 and PRC2/EED-EZH2 complex function by inhibiting EZH1/EZH2 methyltransferase activity, thereby causing down-regulation of histone H3 trimethylation on 'Lys-27' (H3K27me3) (PubMed:29909548, PubMed:31086175, PubMed:31451685, PubMed:30923826). Probably inhibits methyltransferase activity by limiting the stimulatory effect of cofactors such as AEBP2 and JARID2 (PubMed:30923826). Inhibits H3K27me3 deposition during spermatogenesis and oogenesis (By similarity). {ECO:0000250|UniProtKB:B1B0V2, ECO:0000269|PubMed:29909548, ECO:0000269|PubMed:30923826, ECO:0000269|PubMed:31086175, ECO:0000269|PubMed:31451685}.",negative regulation of histone H3-K27 methylation [GO:0061086],"","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:29909548, ECO:0000269|PubMed:30923826, ECO:0000269|PubMed:31086175}. Cytoplasm {ECO:0000269|PubMed:30923826}.","SUBUNIT: Interacts with PRC2/EED-EZH1 complex member EZH1 and with PRC2/EED-EZH2 complex member EZH2; the interaction blocks EZH1/EZH2 methyltransferase activity (PubMed:29909548, PubMed:31086175, PubMed:31451685, PubMed:30923826). Interacts (via C-terminus) with SUZ12 which is a member of the PRC2/EED-EZH1 and PRC2/EED-EZH2 complexes (PubMed:29909548, PubMed:30923826). {ECO:0000269|PubMed:29909548, ECO:0000269|PubMed:30923826, ECO:0000269|PubMed:31086175, ECO:0000269|PubMed:31451685}.",X,51406948,51408843,p11.22,,,-1.0003,-0.69017,,0.5554784057769754,ENST00000342995,0.020105820105820106,0.03089227693076731,1512,,,,,,,0.8921047712986713,3.8916524879339742,Testis,tissue-specific,0.39238996790541125,1.8583948399974977,FALSE,high confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:33743,CXorf66,chromosome X open reading frame 66,Approved,,"RP11-35F15.2, SGPX",Xq27.1,gene with protein product,protein-coding gene,ENSG00000203933,347487,ENSG00000203933,Q5JRM2,MGI:3779666,RGD:1584124,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","",SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}.,"",X,139955728,139965521,q27.1,0.029379,1.847,-0.56034,0.20468,2.2783,0.1791514194432372,ENST00000370540,0.05230202578268877,0.10822294426393402,1086,,,,,,,0.9763831954393623,4.9524640367656385,Testis,tissue-specific,0,0,FALSE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:338,AGTR2,angiotensin II receptor type 2,Approved,,"AT2, MRX88",Xq23,gene with protein product,protein-coding gene,ENSG00000180772,186,ENSG00000180772,P50052,MGI:87966,RGD:2072,X,300034,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Receptor for angiotensin II. Cooperates with MTUS1 to inhibit ERK2 activation and cell proliferation. {ECO:0000269|PubMed:15123706}.,"aldosterone secretion [GO:0035932]; angiotensin-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0002033]; blood vessel remodeling [GO:0001974]; brain development [GO:0007420]; brain renin-angiotensin system [GO:0002035]; cell growth involved in cardiac muscle cell development [GO:0061049]; cell surface receptor signaling pathway [GO:0007166]; cellular response to dexamethasone stimulus [GO:0071549]; cellular sodium ion homeostasis [GO:0006883]; cerebellar cortex development [GO:0021695]; dopamine biosynthetic process [GO:0042416]; exploration behavior [GO:0035640]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway coupled to cGMP nucleotide second messenger [GO:0007199]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell growth [GO:0030308]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of heart rate [GO:0010459]; negative regulation of icosanoid secretion [GO:0032304]; negative regulation of neurotrophin TRK receptor signaling pathway [GO:0051387]; negative regulation of norepinephrine secretion [GO:0010700]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of blood pressure [GO:0008217]; regulation of metanephros size [GO:0035566]; regulation of protein import into nucleus [GO:0042306]; regulation of systemic arterial blood pressure by circulatory renin-angiotensin [GO:0001991]; renin-angiotensin regulation of aldosterone production [GO:0002018]; vasodilation [GO:0042311]",angiotensin type II receptor activity [GO:0004945]; G protein-coupled receptor activity [GO:0004930]; receptor antagonist activity [GO:0048019]; transcription factor binding [GO:0008134],SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.,SUBUNIT: Interacts with MTUS1. {ECO:0000269|PubMed:15123706}.,X,116170744,116174974,q23,0.0082345,1.312,-0.28707,-0.072329,6.9328,0.171344734897568,ENST00000371906,0.6212454212454213,0.2472881779555111,1092,,,,,,,0.8864634255614758,1.1225799593297847,Cervix - Endocervix,tissue-specific,0,0.35920572210163343,FALSE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:34229,CXorf49B,chromosome X open reading frame 49B,Approved,,,Xq13.1,gene with protein product,protein-coding gene,ENSG00000215113,100132994,ENSG00000215113,A8MYA2,"MGI:2685988, MGI:3646776",,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,71763424,71767204,q13.1,,,,,,0.5129545935581867,ENST00000542739,0.02686084142394822,0.014646338415396152,1545,2,"CXorf49 (100, 100, chrX); BX276092.9 (73, 72, chrX)",TRUE,1,"CXorf49 (100, 100, chrX)",TRUE,0.9767441860465116,0.06690933829201037,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:34498,PRR32,proline rich 32,Approved,CXorf64,,Xq25,gene with protein product,protein-coding gene,ENSG00000183631,100130613,ENSG00000183631,B1ATL7,MGI:1916050,RGD:1583341,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,126819729,126821786,q25,0.0045812,1.902,0.85139,0.13756,2.4682,0.18041667230468766,ENST00000371125,0.21003344481605352,0.10622344413896526,897,,,,,,,0.9608842574483953,1.4630521709850177,Heart - Atrial Appendage,tissue-specific,0,0,FALSE,low confidence escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:34499,SMIM10L2A,small integral membrane protein 10 like 2A,Approved,"NCRNA00086, LINC00086","MGC39606, LED, LINC0086",Xq26.3,gene with protein product,protein-coding gene,ENSG00000178947,399668,ENSG00000178947,P0DMW4,MGI:2443645,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,135421944,135428075,q26.3,,,,,,0.5665487400159479,ENST00000417443,0.7721518987341772,0.07663084228942764,237,4,"SMIM10L2B (100, 100, chrX); AC009412.1 (76, 87, chr7); SMIM10 (72, 67, chrX); SMIM10L1 (62, 71, chr12)",TRUE,1,"SMIM10L2B (100, 100, chrX)",TRUE,0.6629895930123969,5.48667254585093,Adrenal Gland,tissue-specific,4.845720863686391,4.026034254159413,FALSE,low confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,no difference_Post1_Post2,no disorder
HGNC:34500,SMIM10L2B,small integral membrane protein 10 like 2B,Approved,"NCRNA00087, LINC00087",RP11-85L21.2,Xq26.3,gene with protein product,protein-coding gene,ENSG00000196972,644596,ENSG00000196972,P0DMW5,,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,135094985,135098712,q26.3,,,,,,0.5687784037732181,ENST00000433425,0.7835443037974683,0.11367158210447388,237,4,"SMIM10L2A (100, 100, chrX); AC009412.1 (76, 87, chr7); SMIM10 (72, 67, chrX); SMIM10L1 (62, 71, chr12)",TRUE,1,"SMIM10L2A (100, 100, chrX)",TRUE,0.541280113710218,4.755149300841728,Cerebellar_tissues,broadly expressed,4.681584195407886,4.755149300841728,TRUE,low confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:35428,CMC4,C-X9-C motif containing 4,Approved,"MTCP1, MTCP1NB","P8MTCP1, p8",Xq28,gene with protein product,protein-coding gene,ENSG00000182712,100272147,ENSG00000182712,P56277,"MGI:102699, MGI:5637812",RGD:7647017,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","",SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:7784073}.,"",X,155061622,155071136,q28,0.1581,1.703,-0.76262,0.17006,2.1782,0.7037927767540161,ENST00000369484,0.8613526570048309,0.16698325418645338,207,,,,,,,,,,tissue-specific,,,FALSE,low confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,no difference_Post1_Post2,no disorder
HGNC:3546,F8,coagulation factor VIII,Approved,F8C,"FVIII, DXS1253E, HEMA",Xq28,gene with protein product,protein-coding gene,ENSG00000185010,2157,ENSG00000185010,P00451,MGI:88383,RGD:727845,X,300841,TRUE,Hemophilia A,306700,X-linked recessive,,,,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Factor VIII, along with calcium and phospholipid, acts as a cofactor for F9/factor IXa when it converts F10/factor X to the activated form, factor Xa.","acute-phase response [GO:0006953]; blood coagulation [GO:0007596]; blood coagulation, intrinsic pathway [GO:0007597]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; platelet activation [GO:0030168]; platelet degranulation [GO:0002576]",copper ion binding [GO:0005507]; oxidoreductase activity [GO:0016491],"SUBCELLULAR LOCATION: Secreted, extracellular space.","SUBUNIT: Interacts with VWF/vWF. vWF binding is essential for the stabilization of F8 in circulation. {ECO:0000269|PubMed:1554716, ECO:0000269|PubMed:9218428}.",X,154835788,155026940,q28,1,0.089,1.3712,2.4669,70.383,0.13018460176530322,ENST00000360256,0.4871740362811791,0.08315421144713822,7056,,,,,,,0.4102373482097607,4.368412170339042,Adipose - Visceral (Omentum),broadly expressed,1.9570899658349468,1.314490618806497,FALSE,high confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:3547,F8A1,coagulation factor VIII associated 1,Approved,F8A,DXS522E,Xq28,gene with protein product,protein-coding gene,ENSG00000277203,8263,ENSG00000277203,P23610,MGI:95474,RGD:1566014,X,305423,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: RAB5A effector molecule that is involved in vesicular trafficking of early endosomes (PubMed:16476778). Mediates the recruitment of HTT by RAB5A onto early endosomes. The HTT-F8A1/F8A2/F8A3-RAB5A complex stimulates early endosomal interaction with actin filaments and inhibits interaction with microtubules, leading to the reduction of endosome motility (PubMed:16476778). {ECO:0000269|PubMed:16476778}.",negative regulation of proteasomal protein catabolic process [GO:1901799]; vesicle cytoskeletal trafficking [GO:0099518],"","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16476778}. Nucleus {ECO:0000269|PubMed:16476778}. Early endosome {ECO:0000269|PubMed:16476778}. Nucleus, nuclear body {ECO:0000250|UniProtKB:Q00558}. Note=Diffuse presence in the cytoplasm and accumulation in the nucleus (PubMed:16476778). In absence of HTT, F8A1/F8A2/F8A3 is concentred in cytoplasm (By similarity). Colocalized with HTT in endosomes (PubMed:16476778). In neuron found in intranuclear structures, the intranuclear rodlets (INRs), also known as rodlets of Roncoroni, in association with ubiquitin (By similarity). {ECO:0000250|UniProtKB:Q00558, ECO:0000269|PubMed:16476778}.","SUBUNIT: Interacts with HTT (via C-terminus) (PubMed:29466333). Interacts with RAB5A (By similarity). Found in a complex with F8A1/F8A2/F8A3, HTT and RAB5A; mediates the recruitment of HTT by RAB5A onto early endosomes (By similarity). {ECO:0000250|UniProtKB:M0RDU0, ECO:0000269|PubMed:29466333}.",X,154886349,154888061,q28,,,0.94049,0.67285,,0.7223635938851669,ENST00000610495,0.27804659498207884,0.13804048987753062,1116,2,"F8A2 (100, 100, chrX); F8A3 (100, 100, chrX)",TRUE,2,"F8A2 (100, 100, chrX); F8A3 (100, 100, chrX)",TRUE,0.1757350992343559,4.152702630915754,Cells - EBV-transformed lymphocytes,broadly expressed,3.6349765422993054,3.5299152494860015,FALSE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:3551,F9,coagulation factor IX,Approved,,FIX,Xq27.1,gene with protein product,protein-coding gene,ENSG00000101981,2158,ENSG00000101981,P00740,MGI:88384,RGD:2589,X,300746,TRUE,"Hemophilia B // Thrombophilia, X-linked, due to factor IX defect",306900 // 300807,X-linked recessive // X-linked recessive,"{Deep venous thrombosis, protection against} // {Warfarin sensitivity}",300807 // 301052,X-linked recessive // X-linked,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Factor IX is a vitamin K-dependent plasma protein that participates in the intrinsic pathway of blood coagulation by converting factor X to its active form in the presence of Ca(2+) ions, phospholipids, and factor VIIIa. {ECO:0000269|PubMed:1730085, ECO:0000269|PubMed:19846852, ECO:0000269|PubMed:20121197, ECO:0000269|PubMed:20121198, ECO:0000269|PubMed:2592373, ECO:0000269|PubMed:8295821}.","blood coagulation [GO:0007596]; blood coagulation, intrinsic pathway [GO:0007597]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; proteolysis [GO:0006508]; zymogen activation [GO:0031638]",calcium ion binding [GO:0005509]; endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252],"SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:19846852, ECO:0000269|PubMed:2592373, ECO:0000269|PubMed:3857619, ECO:0000269|PubMed:8295821, ECO:0000269|PubMed:9169594}.","SUBUNIT: Heterodimer of a light chain and a heavy chain; disulfide-linked (PubMed:20121198, PubMed:20121197, PubMed:20080729). Interacts with SERPINC1. {ECO:0000269|PubMed:20004170, ECO:0000269|PubMed:20080729, ECO:0000269|PubMed:20121197, ECO:0000269|PubMed:20121198, ECO:0000269|PubMed:2592373}.",X,139530739,139563459,q27.1,0.99776,0.167,-1.2451,2.1809,17.862,0.17808550953825988,ENST00000218099,0.6105339105339105,0.12114471382154461,1386,,,,,,,0.9762345712157333,7.884231584272817,Liver,tissue-specific,0,0,FALSE,discordant,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:3571,ACSL4,acyl-CoA synthetase long chain family member 4,Approved,"FACL4, MRX63, MRX68","ACS4, LACS4",Xq23,gene with protein product,protein-coding gene,ENSG00000068366,2182,ENSG00000068366,O60488,MGI:1354713,RGD:69401,X,300157,TRUE,"Mental retardation, X-linked 63",300387,X-linked dominant,,,,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Catalyzes the conversion of long-chain fatty acids to their active form acyl-CoA for both synthesis of cellular lipids, and degradation via beta-oxidation (PubMed:24269233, PubMed:22633490, PubMed:21242590). Preferentially activates arachidonate and eicosapentaenoate as substrates (PubMed:21242590). Preferentially activates 8,9-EET > 14,15-EET > 5,6-EET > 11,12-EET. Modulates glucose-stimulated insulin secretion by regulating the levels of unesterified EETs (By similarity). Modulates prostaglandin E2 secretion (PubMed:21242590). {ECO:0000250|UniProtKB:O35547, ECO:0000269|PubMed:21242590, ECO:0000269|PubMed:22633490, ECO:0000269|PubMed:24269233}.",dendritic spine development [GO:0060996]; embryonic process involved in female pregnancy [GO:0060136]; fatty acid transport [GO:0015908]; lipid biosynthetic process [GO:0008610]; lipid metabolic process [GO:0006629]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; negative regulation of prostaglandin secretion [GO:0032307]; neuron differentiation [GO:0030182]; positive regulation of cell growth [GO:0030307]; positive regulation of insulin secretion [GO:0032024]; response to interleukin-15 [GO:0070672]; response to nutrient [GO:0007584]; triglyceride biosynthetic process [GO:0019432],acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957],SUBCELLULAR LOCATION: Mitochondrion outer membrane {ECO:0000250}; Single-pass type III membrane protein {ECO:0000250}. Peroxisome membrane {ECO:0000250}; Single-pass type III membrane protein {ECO:0000250}. Microsome membrane {ECO:0000250}; Single-pass type III membrane protein {ECO:0000250}. Endoplasmic reticulum membrane {ECO:0000269|PubMed:24269233}; Single-pass type III membrane protein {ECO:0000250}. Cell membrane {ECO:0000269|PubMed:24269233}.,"",X,109624244,109733403,q23,0.98103,0.306,0.069346,2.5909,25.329,0.6746207428516863,ENST00000672401,0.9100844510680576,0.2221944513871532,2013,1,"ACSL3 (65, 64, chr2)",TRUE,,,,0.25915275337813615,5.743969979651253,Cells - EBV-transformed lymphocytes,broadly expressed,3.5909732138658743,4.210088791326982,FALSE,high confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:3583,FANCB,FA complementation group B,Approved,,"FAB, FLJ34064, FAAP95",Xp22.2,gene with protein product,protein-coding gene,ENSG00000181544,2187,ENSG00000181544,Q8NB91,MGI:2448558,RGD:1561555,X,300515,TRUE,"Fanconi anemia, complementation group B",300514,X-linked recessive,,,,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,FUNCTION: DNA repair protein required for FANCD2 ubiquitination. {ECO:0000269|PubMed:15502827}.,interstrand cross-link repair [GO:0036297]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414],"",SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:15502827}.,"SUBUNIT: Belongs to the multisubunit FA complex composed of FANCA, FANCB, FANCC, FANCE, FANCF, FANCG, FANCL/PHF9 and FANCM. The complex is not found in FA patients. {ECO:0000269|PubMed:15502827, ECO:0000269|PubMed:16116422}.",X,14835961,14873069,p22.2,0.99631,0.227,0.42722,-0.041747,20.93,0.5676769016513031,ENST00000650831,0.5615116279069767,0.11904523869032742,2580,,,,,,,0.7891523954141896,2.7087302141353833,Cells - EBV-transformed lymphocytes,tissue-specific,0.23161058380016425,0.6359340495939827,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:3663,FGD1,"FYVE, RhoGEF and PH domain containing 1",Approved,FGDY,ZFYVE3,Xp11.22,gene with protein product,protein-coding gene,ENSG00000102302,2245,ENSG00000102302,P98174,MGI:104566,RGD:1565188,X,300546,TRUE,"Aarskog-Scott syndrome // Mental retardation, X-linked syndromic 16",305400 // 305400,X-linked recessive // X-linked recessive,,,,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Activates CDC42, a member of the Ras-like family of Rho- and Rac proteins, by exchanging bound GDP for free GTP. Plays a role in regulating the actin cytoskeleton and cell shape. {ECO:0000269|PubMed:8969170}.",actin cytoskeleton organization [GO:0030036]; animal organ morphogenesis [GO:0009887]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; G protein-coupled receptor signaling pathway [GO:0007186]; multicellular organism development [GO:0007275]; positive regulation of apoptotic process [GO:0043065]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165],guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; small GTPase binding [GO:0031267],"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cell projection, lamellipodium {ECO:0000250}. Cell projection, ruffle {ECO:0000250}. Cytoplasm, cytoskeleton {ECO:0000250}. Note=Associated with membrane ruffles and lamellipodia. {ECO:0000250}.",SUBUNIT: Interacts with DBNL/ABP1 and CTTN. May interact with CCPG1 (By similarity). Binds CDC42. {ECO:0000250}.,X,54445454,54496234,p11.22,0.9997,0.196,0.35263,3.5183,32.05,0.5594121484629839,ENST00000375135,0.8488911988911989,0.32029492626843287,2886,,,,,,,0.28566158487923204,4.291529889123515,Uterus,broadly expressed,2.959480845451449,3.9975408152640446,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:3670,FGF13,fibroblast growth factor 13,Approved,LINC00889,"FHF2, FGF2, FLJ30672",Xq26.3-q27.1,gene with protein product,protein-coding gene,ENSG00000129682,2258,ENSG00000129682,Q92913,MGI:109178,RGD:620164,X,300070,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Microtubule-binding protein which directly binds tubulin and is involved in both polymerization and stabilization of microtubules (By similarity). Through its action on microtubules, may participate in the refinement of axons by negatively regulating axonal and leading processes branching (By similarity). Plays a crucial role in neuron polarization and migration in the cerebral cortex and the hippocampus (By similarity). May regulate voltage-gated sodium channels transport and function (PubMed:15282281). May also play a role in MAPK signaling (By similarity). Required for the development of axonal initial segment-targeting inhibitory GABAergic synapses made by chandelier neurons (By similarity). {ECO:0000250|UniProtKB:P70377, ECO:0000269|PubMed:15282281}.",cell-cell signaling [GO:0007267]; cerebral cortex cell migration [GO:0021795]; establishment of neuroblast polarity [GO:0045200]; hippocampus development [GO:0021766]; inhibitory synapse assembly [GO:1904862]; learning [GO:0007612]; MAPK cascade [GO:0000165]; memory [GO:0007613]; microtubule polymerization [GO:0046785]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; neuron migration [GO:0001764]; protein localization to plasma membrane [GO:0072659]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; signal transduction [GO:0007165]; sodium ion transport [GO:0006814],beta-tubulin binding [GO:0048487]; growth factor activity [GO:0008083]; ion channel binding [GO:0044325]; microtubule binding [GO:0008017]; protein kinase activator activity [GO:0030295]; sodium channel regulator activity [GO:0017080],"SUBCELLULAR LOCATION: Cell projection, filopodium {ECO:0000250}. Cell projection, growth cone {ECO:0000250}. Cell projection, dendrite {ECO:0000250}. Nucleus {ECO:0000269|PubMed:10644718}. Cytoplasm {ECO:0000269|PubMed:10644718}. Note=Not secreted. {ECO:0000250}.; SUBCELLULAR LOCATION: [Isoform 1]: Nucleus, nucleolus.; SUBCELLULAR LOCATION: [Isoform 2]: Cytoplasm. Nucleus.","SUBUNIT: Interacts with SCN8A; may regulate SCN8A activity. Interacts with SCN1A; may regulate SCN1A activity. Interacts with SCN5A; the interaction is direct and may regulate SNC5A density at membranes and function. May also interact with SCN2A and SCN11A. Interacts with MAPK8IP2; may regulate the MAPK8IP2 scaffolding activity. {ECO:0000269|PubMed:11378392, ECO:0000269|PubMed:15282281, ECO:0000269|PubMed:19406745, ECO:0000269|PubMed:21566136, ECO:0000269|PubMed:21817159}.",X,138614727,139222777,q27.1,0.89489,0.406,0.42011,1.5915,11.691,0.584042464160626,ENST00000315930,0.975609756097561,0.22039490127468134,738,2,"FGF12 (56, 58, chr3); FGF14 (55, 56, chr13)",TRUE,,,,0.6648092109902183,2.6801240311445795,Other_Brain_tissues,tissue-specific,2.6801240311445795,0.1863668042328822,TRUE,discordant,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:3672,FGF16,fibroblast growth factor 16,Approved,MF4,,Xq21.1,gene with protein product,protein-coding gene,ENSG00000196468,8823,ENSG00000196468,O43320,MGI:1931627,RGD:71052,X,300827,TRUE,Metacarpal 4-5 fusion,309630,X-linked recessive,,,,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Plays an important role in the regulation of embryonic development, cell proliferation and cell differentiation, and is required for normal cardiomyocyte proliferation and heart development. {ECO:0000269|PubMed:16597617}.",animal organ morphogenesis [GO:0009887]; cell-cell signaling [GO:0007267]; fibroblast growth factor receptor signaling pathway [GO:0008543]; MAPK cascade [GO:0000165]; positive regulation of brown fat cell proliferation [GO:0070349]; positive regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000546]; positive regulation of protein kinase B signaling [GO:0051897]; response to temperature stimulus [GO:0009266]; signal transduction [GO:0007165],fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083],SUBCELLULAR LOCATION: Secreted {ECO:0000250|UniProtKB:O54769}.,SUBUNIT: Interacts with FGFR1 and FGFR2. {ECO:0000269|PubMed:16597617}.,X,77447389,77457278,q21.1,0.75107,0.65,0.99648,0.88352,4.601,0.5740632896481125,ENST00000439435,0.9016025641025641,0.3628092976755811,624,2,"FGF9 (70, 69, chr13); FGF20 (63, 62, chr8)",TRUE,,,,0.8231401785975968,0.7186698065880179,Adipose - Subcutaneous,tissue-specific,0.03159704652885189,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,Post1_higher_vs_Post2,confirmed monogenic disorder
HGNC:3702,FHL1,four and a half LIM domains 1,Approved,,"SLIM1, KYO-T, bA535K18.1, FHL1B, XMPMA, FLH1A, MGC111107",Xq26.3,gene with protein product,protein-coding gene,ENSG00000022267,2273,ENSG00000022267,Q13642,MGI:1298387,RGD:2615,X,300163,TRUE,"Emery-Dreifuss muscular dystrophy 6, X-linked // Myopathy, X-linked, with postural muscle atrophy // Reducing body myopathy, X-linked 1a, severe, infantile or early childhood onset // Reducing body myopathy, X-linked 1b, with late childhood or adult onset // Scapuloperoneal myopathy, X-linked dominant",300696 // 300696 // 300717 // 300718 // 300695,X-linked recessive // X-linked recessive // X-linked dominant // X-linked // X-linked dominant,?Uruguay faciocardiomusculoskeletal syndrome,300280,X-linked recessive,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,FUNCTION: May have an involvement in muscle development or hypertrophy.,animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; muscle organ development [GO:0007517]; negative regulation of cell growth [GO:0030308]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; positive regulation of potassium ion transport [GO:0043268]; regulation of membrane depolarization [GO:0003254]; regulation of potassium ion transmembrane transporter activity [GO:1901016],ion channel binding [GO:0044325]; metal ion binding [GO:0046872],"SUBCELLULAR LOCATION: [Isoform 1]: Cytoplasm.; SUBCELLULAR LOCATION: [Isoform 3]: Cytoplasm. Nucleus.; SUBCELLULAR LOCATION: [Isoform 2]: Nucleus. Cytoplasm, cytosol. Note=Predominantly nuclear in myoblasts but is cytosolic in differentiated myotubes.","",X,136146702,136211359,q26.3,0.96979,0.276,1.3223,0.88988,10.829,0.17011169092595887,ENST00000370683,0.9234567901234568,0.1316670832291927,891,,,,,,,0.3746616156757828,10.98428315529087,Muscle - Skeletal,broadly expressed,5.791996349633396,6.546329615226371,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:3708,VEGFD,vascular endothelial growth factor D,Approved,FIGF,VEGF-D,Xp22.2,gene with protein product,protein-coding gene,ENSG00000165197,2277,ENSG00000165197,O43915,MGI:108037,RGD:620695,X,300091,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Growth factor active in angiogenesis, lymphangiogenesis and endothelial cell growth, stimulating their proliferation and migration and also has effects on the permeability of blood vessels. May function in the formation of the venous and lymphatic vascular systems during embryogenesis, and also in the maintenance of differentiated lymphatic endothelium in adults. Binds and activates VEGFR-2 (KDR/FLK1) and VEGFR-3 (FLT4) receptors. {ECO:0000269|PubMed:21148085}.",angiogenesis [GO:0001525]; cell population proliferation [GO:0008283]; dopaminergic neuron differentiation [GO:0071542]; induction of positive chemotaxis [GO:0050930]; platelet degranulation [GO:0002576]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of mast cell chemotaxis [GO:0060754]; positive regulation of protein phosphorylation [GO:0001934]; response to bacterium [GO:0009617]; response to hypoxia [GO:0001666]; sprouting angiogenesis [GO:0002040]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084],chemoattractant activity [GO:0042056]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; platelet-derived growth factor receptor binding [GO:0005161]; vascular endothelial growth factor receptor 3 binding [GO:0043185]; vascular endothelial growth factor receptor binding [GO:0005172],SUBCELLULAR LOCATION: Secreted.,SUBUNIT: Homodimer; non-covalent and antiparallel. {ECO:0000269|PubMed:21148085}.,X,15345596,15384413,p22.2,2.498e-5,1.154,-0.66157,0.49937,13.604,0.22055266228407183,ENST00000297904,0.8872300469483568,0.195201199700075,1065,,,,,,,0.6147061799641486,6.119870740572551,Lung,tissue-specific,1.4077714934486147,2.216110253469129,FALSE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:37167,MTRNR2L10,MT-RNR2 like 10,Approved,,,Xp11.21,gene with protein product,protein-coding gene,ENSG00000256045,100463488,ENSG00000256045,P0CJ77,,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Plays a role as a neuroprotective and antiapoptotic factor. {ECO:0000250|UniProtKB:Q8IVG9}.,negative regulation of execution phase of apoptosis [GO:1900118],receptor antagonist activity [GO:0048019],SUBCELLULAR LOCATION: Secreted {ECO:0000250|UniProtKB:Q8IVG9}. Cytoplasm {ECO:0000250|UniProtKB:Q8IVG9}.,"",X,55181392,55182442,p11.21,,,-0.22999,-0.33245,,0.4533723931087396,ENST00000545075,0.8853333333333333,0.6054486378405398,75,,,,,,,0.7534315803196779,0.7288521890655072,Other_Brain_tissues,tissue-specific,0.7288521890655072,0.44436227724653465,TRUE,,no_difference_Pre_Post,Post1_higher_vs_Pre,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:37286,CCDC160,coiled-coil domain containing 160,Approved,,,Xq26.2,gene with protein product,protein-coding gene,ENSG00000203952,347475,ENSG00000203952,A6NGH7,MGI:3588225,RGD:1597791,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",cell differentiation [GO:0030154]; positive regulation of transcription by RNA polymerase II [GO:0045944],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]","","",X,134237047,134246207,q26.2,0.016983,1.558,-1.278,-0.13853,4.7282,0.4965146237240161,ENST00000517294,0.39386503067484663,0.11014746313421644,978,,,,,,,0.7983562547726943,3.2686739245483585,Kidney - Medulla,tissue-specific,1.3312523329149921,0.8811269831191736,FALSE,low confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,no difference_Post1_Post2,no disorder
HGNC:374,AKAP4,A-kinase anchoring protein 4,Approved,,"p82, hAKAP82, AKAP82, Fsc1, HI, CT99",Xp11.22,gene with protein product,protein-coding gene,ENSG00000147081,8852,ENSG00000147081,Q5JQC9,MGI:102794,RGD:620828,X,300185,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Major structural component of sperm fibrous sheath. Plays a role in sperm motility. {ECO:0000269|PubMed:9822690}.,establishment of protein localization [GO:0045184]; flagellated sperm motility [GO:0030317]; motile cilium assembly [GO:0044458]; protein localization [GO:0008104]; signal transduction [GO:0007165]; single fertilization [GO:0007338]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178],protein kinase A binding [GO:0051018],"SUBCELLULAR LOCATION: Cell projection, cilium, flagellum {ECO:0000269|PubMed:9822690}. Note=Localizes to the principle piece of the sperm flagellum.",SUBUNIT: Interacts with PRKAR1A and PRKAR2A. Interacts with ENO4. {ECO:0000250|UniProtKB:Q60662}.,X,50190777,50201007,p11.22,0.99323,0.246,-0.2037,0.78353,19.297,0.10680697730632803,ENST00000358526,0.6744249512670565,0.17245688577855536,2565,,,,,,,0.9745166880676916,8.903930035162363,Testis,tissue-specific,0,0.01776459222787742,FALSE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:3754,FLNA,filamin A,Approved,"FLN1, FLN, OPD2, OPD1",ABP-280,Xq28,gene with protein product,protein-coding gene,ENSG00000196924,2316,ENSG00000196924,P21333,MGI:95556,RGD:1560614,X,300017,TRUE,"Cardiac valvular dysplasia, X-linked // Congenital short bowel syndrome // Frontometaphyseal dysplasia 1 // Heterotopia, periventricular, 1 // Intestinal pseudoobstruction, neuronal // Melnick-Needles syndrome // Otopalatodigital syndrome, type I // Otopalatodigital syndrome, type II // Terminal osseous dysplasia",314400 // 300048 // 305620 // 300049 // 300048 // 309350 // 311300 // 304120 // 300244,X-linked // X-linked recessive // X-linked recessive // X-linked dominant // X-linked recessive // X-linked dominant // X-linked dominant // X-linked dominant // X-linked dominant,?FG syndrome 2,300321,X-linked,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Promotes orthogonal branching of actin filaments and links actin filaments to membrane glycoproteins. Anchors various transmembrane proteins to the actin cytoskeleton and serves as a scaffold for a wide range of cytoplasmic signaling proteins. Interaction with FLNB may allow neuroblast migration from the ventricular zone into the cortical plate. Tethers cell surface-localized furin, modulates its rate of internalization and directs its intracellular trafficking (By similarity). Involved in ciliogenesis. Plays a role in cell-cell contacts and adherens junctions during the development of blood vessels, heart and brain organs. Plays a role in platelets morphology through interaction with SYK that regulates ITAM- and ITAM-like-containing receptor signaling, resulting in by platelet cytoskeleton organization maintenance (By similarity). During the axon guidance process, required for growth cone collapse induced by SEMA3A-mediated stimulation of neurons (PubMed:25358863). {ECO:0000250, ECO:0000250|UniProtKB:Q8BTM8, ECO:0000269|PubMed:22121117, ECO:0000269|PubMed:25358863}.","actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; cell junction assembly [GO:0034329]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; cytoplasmic sequestering of protein [GO:0051220]; defense response to virus [GO:0051607]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319]",actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; mu-type opioid receptor binding [GO:0031852]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; Rac GTPase binding [GO:0048365]; Ral GTPase binding [GO:0017160]; Rho GTPase binding [GO:0017048]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transcription factor binding [GO:0008134],"SUBCELLULAR LOCATION: Cytoplasm, cell cortex {ECO:0000269|PubMed:16291724}. Cytoplasm, cytoskeleton {ECO:0000250|UniProtKB:Q8BTM8}. Perikaryon {ECO:0000250|UniProtKB:Q8BTM8}. Cell projection, growth cone {ECO:0000250|UniProtKB:Q8BTM8}. Note=Colocalizes with CPMR1 in the central region of DRG neuron growth cone (By similarity). Following SEMA3A stimulation of DRG neurons, colocalizes with F-actin (By similarity). {ECO:0000250|UniProtKB:Q8BTM8}.","SUBUNIT: Homodimer. Interacts with PDLIM2 (By similarity). Interacts with RFLNA and RFLNB (By similarity). Interacts with FCGR1A, FLNB, FURIN, HSPB7, INPPL1, KCND2, MYOT, MYOZ1, ARHGAP24, PSEN1, PSEN2 and ECSCR. Interacts also with various other binding partners in addition to filamentous actin. Interacts (via N-terminus) with MIS18BP1 (via N-terminus). Interacts (via N-terminus) with TAF1B. Interacts with TMEM67 (via C-terminus) and MKS1. Interacts (via actin-binding domain) with MICALL2 (via CH domain). Interacts (via filamin repeat 5) with SYK; docks SYK to the plasma membrane (PubMed:20713593). Interacts (via filamin repeats 19 and 21) with DRD3; increased PKA-mediated phosphorylation at Ser-2152. Interacts (via filamin repeat 21) with MAS1, AGTR1 and ADRA1D; increases PKA-mediated phosphorylation of FLNA at Ser-2152 (PubMed:26460884). Interacts (via filamin repeats 4, 9, 12, 17, 19, 21, and 23) with GP1BA (high affinity), ITGB7, ITGB2 and FBLIM1 (PubMed:19828450, PubMed:21524097, PubMed:25666618). Interacts with CEACAM1 (via cytoplasmic domain); inhibits cell migration and cell scattering by interfering with the interaction between FLNA and RALA (PubMed:16291724). Interacts with FOXC1 (PubMed:15684392). Interacts (via calponin-homology (CH) domain 1 and filamin repeat 24) with CRMP1; the interaction alters FLNA ternary structure and thus promotes FLNA dissociation from F-actin (PubMed:25358863). Interacts with DPYSL3/CRMP3 and DPYSL4/CRMP4 (PubMed:25358863). {ECO:0000250, ECO:0000250|UniProtKB:Q8BTM8, ECO:0000269|PubMed:11102480, ECO:0000269|PubMed:11739414, ECO:0000269|PubMed:12393796, ECO:0000269|PubMed:15684392, ECO:0000269|PubMed:16076904, ECO:0000269|PubMed:16291724, ECO:0000269|PubMed:16862148, ECO:0000269|PubMed:18322202, ECO:0000269|PubMed:18556573, ECO:0000269|PubMed:19828450, ECO:0000269|PubMed:19923718, ECO:0000269|PubMed:20713593, ECO:0000269|PubMed:21228480, ECO:0000269|PubMed:21524097, ECO:0000269|PubMed:22121117, ECO:0000269|PubMed:23890175, ECO:0000269|PubMed:25358863, ECO:0000269|PubMed:25666618, ECO:0000269|PubMed:26460884, ECO:0000269|PubMed:9437013}.",X,154348524,154374638,q28,1,0.082,-2.9839,3.7802,76.51,0.5139755786894369,ENST00000369850,0.7759063444108761,0.09122719320169957,7944,2,"FLNC (73, 71, chr7); FLNB (69, 69, chr3)",TRUE,,,,0.29806572939704284,12.273754811621197,Artery - Tibial,broadly expressed,4.737129691394254,5.552778208006447,FALSE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:3775,FMR1,FMRP translational regulator 1,Approved,"POF1, POF","FMRP, FRAXA, MGC87458",Xq27.3,gene with protein product,protein-coding gene,ENSG00000102081,2332,ENSG00000102081,Q06787,MGI:95564,RGD:2623,X,309550,TRUE,Fragile X syndrome // Fragile X tremor/ataxia syndrome // Premature ovarian failure 1,300624 // 300623 // 311360,X-linked dominant // X-linked dominant // X-linked,,,,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Multifunctional polyribosome-associated RNA-binding protein that plays a central role in neuronal development and synaptic plasticity through the regulation of alternative mRNA splicing, mRNA stability, mRNA dendritic transport and postsynaptic local protein synthesis of a subset of mRNAs (PubMed:16631377, PubMed:18653529, PubMed:19166269, PubMed:23235829, PubMed:25464849). Plays a role in the alternative splicing of its own mRNA (PubMed:18653529). Plays a role in mRNA nuclear export (By similarity). Together with export factor NXF2, is involved in the regulation of the NXF1 mRNA stability in neurons (By similarity). Stabilizes the scaffolding postsynaptic density protein DLG4/PSD-95 and the myelin basic protein (MBP) mRNAs in hippocampal neurons and glial cells, respectively; this stabilization is further increased in response to metabotropic glutamate receptor (mGluR) stimulation (By similarity). Plays a role in selective delivery of a subset of dendritic mRNAs to synaptic sites in response to mGluR activation in a kinesin-dependent manner (By similarity). Plays a role as a repressor of mRNA translation during the transport of dendritic mRNAs to postsynaptic dendritic spines (PubMed:11532944, PubMed:11157796, PubMed:12594214, PubMed:23235829). Component of the CYFIP1-EIF4E-FMR1 complex which blocks cap-dependent mRNA translation initiation (By similarity). Represses mRNA translation by stalling ribosomal translocation during elongation (By similarity). Reports are contradictory with regards to its ability to mediate translation inhibition of MBP mRNA in oligodendrocytes (PubMed:23891804). Also involved in the recruitment of the RNA helicase MOV10 to a subset of mRNAs and hence regulates microRNA (miRNA)-mediated translational repression by AGO2 (PubMed:14703574, PubMed:17057366, PubMed:25464849). Facilitates the assembly of miRNAs on specific target mRNAs (PubMed:17057366). Plays also a role as an activator of mRNA translation of a subset of dendritic mRNAs at synapses (PubMed:19097999, PubMed:19166269). In response to mGluR stimulation, FMR1-target mRNAs are rapidly derepressed, allowing for local translation at synapses (By similarity). Binds to a large subset of dendritic mRNAs that encode a myriad of proteins involved in pre- and postsynaptic functions (PubMed:7692601, PubMed:11719189, PubMed:11157796, PubMed:12594214, PubMed:17417632, PubMed:23235829, PubMed:24448548). Binds to 5'-ACU[GU]-3' and/or 5'-[AU]GGA-3' RNA consensus sequences within mRNA targets, mainly at coding sequence (CDS) and 3'-untranslated region (UTR) and less frequently at 5'-UTR (PubMed:23235829). Binds to intramolecular G-quadruplex structures in the 5'- or 3'-UTRs of mRNA targets (PubMed:11719189, PubMed:18579868, PubMed:25464849, PubMed:25692235). Binds to G-quadruplex structures in the 3'-UTR of its own mRNA (PubMed:7692601, PubMed:11532944, PubMed:12594214, PubMed:15282548, PubMed:18653529). Binds also to RNA ligands harboring a kissing complex (kc) structure; this binding may mediate the association of FMR1 with polyribosomes (PubMed:15805463). Binds mRNAs containing U-rich target sequences (PubMed:12927206). Binds to a triple stem-loop RNA structure, called Sod1 stem loop interacting with FMRP (SoSLIP), in the 5'-UTR region of superoxide dismutase SOD1 mRNA (PubMed:19166269). Binds to the dendritic, small non-coding brain cytoplasmic RNA 1 (BC1); which may increase the association of the CYFIP1-EIF4E-FMR1 complex to FMR1 target mRNAs at synapses (By similarity). Associates with export factor NXF1 mRNA-containing ribonucleoprotein particles (mRNPs) in a NXF2-dependent manner (By similarity). Binds to a subset of miRNAs in the brain (PubMed:14703574, PubMed:17057366). May associate with nascent transcripts in a nuclear protein NXF1-dependent manner (PubMed:18936162). In vitro, binds to RNA homopolymer; preferentially on poly(G) and to a lesser extent on poly(U), but not on poly(A) or poly(C) (PubMed:7688265, PubMed:7781595, PubMed:12950170, PubMed:15381419, PubMed:8156595). Moreover, plays a role in the modulation of the sodium-activated potassium channel KCNT1 gating activity (PubMed:20512134). Negatively regulates the voltage-dependent calcium channel current density in soma and presynaptic terminals of dorsal root ganglion (DRG) neurons, and hence regulates synaptic vesicle exocytosis (By similarity). Modulates the voltage-dependent calcium channel CACNA1B expression at the plasma membrane by targeting the channels for proteosomal degradation (By similarity). Plays a role in regulation of MAP1B-dependent microtubule dynamics during neuronal development (By similarity). Recently, has been shown to play a translation-independent role in the modulation of presynaptic action potential (AP) duration and neurotransmitter release via large-conductance calcium-activated potassium (BK) channels in hippocampal and cortical excitatory neurons (PubMed:25561520). Finally, FMR1 may be involved in the control of DNA damage response (DDR) mechanisms through the regulation of ATR-dependent signaling pathways such as histone H2AX/H2A.x and BRCA1 phosphorylations (PubMed:24813610). {ECO:0000250|UniProtKB:P35922, ECO:0000250|UniProtKB:Q80WE1, ECO:0000269|PubMed:11157796, ECO:0000269|PubMed:11532944, ECO:0000269|PubMed:11719189, ECO:0000269|PubMed:12594214, ECO:0000269|PubMed:12927206, ECO:0000269|PubMed:12950170, ECO:0000269|PubMed:14703574, ECO:0000269|PubMed:15282548, ECO:0000269|PubMed:15381419, ECO:0000269|PubMed:15805463, ECO:0000269|PubMed:16631377, ECO:0000269|PubMed:17057366, ECO:0000269|PubMed:17417632, ECO:0000269|PubMed:18579868, ECO:0000269|PubMed:18653529, ECO:0000269|PubMed:18936162, ECO:0000269|PubMed:19097999, ECO:0000269|PubMed:19166269, ECO:0000269|PubMed:20512134, ECO:0000269|PubMed:23235829, ECO:0000269|PubMed:23891804, ECO:0000269|PubMed:24448548, ECO:0000269|PubMed:24813610, ECO:0000269|PubMed:25464849, ECO:0000269|PubMed:25561520, ECO:0000269|PubMed:25692235, ECO:0000269|PubMed:7688265, ECO:0000269|PubMed:7692601, ECO:0000269|PubMed:7781595, ECO:0000269|PubMed:8156595}.; FUNCTION: [Isoform 10]: binds to RNA homopolymer; preferentially on poly(G) and to a lesser extent on poly(U), but not on poly(A) or poly(C) (PubMed:24204304). May bind to RNA in Cajal bodies (PubMed:24204304). {ECO:0000269|PubMed:24204304}.; FUNCTION: [Isoform 6]: binds to RNA homopolymer; preferentially on poly(G) and to a lesser extent on poly(U), but not on poly(A) or poly(C) (PubMed:24204304). May bind to RNA in Cajal bodies (PubMed:24204304). {ECO:0000269|PubMed:24204304}.; FUNCTION: (Microbial infection) Acts as a positive regulator of influenza A virus (IAV) replication. Required for the assembly and nuclear export of the viral ribonucleoprotein (vRNP) components. {ECO:0000269|PubMed:24514761}.","cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; cellular response to UV [GO:0034644]; cellular response to virus [GO:0098586]; gene silencing by RNA [GO:0031047]; glutamate receptor signaling pathway [GO:0007215]; modulation by host of viral RNA genome replication [GO:0044830]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of cytoplasmic translation [GO:2000766]; negative regulation of long-term synaptic depression [GO:1900453]; negative regulation of mRNA catabolic process [GO:1902373]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of intracellular transport of viral material [GO:1901254]; positive regulation of mRNA binding [GO:1902416]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor internalization [GO:0002092]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of dendritic spine development [GO:0060998]; regulation of filopodium assembly [GO:0051489]; regulation of gene silencing by miRNA [GO:0060964]; regulation of mRNA stability [GO:0043488]; regulation of neuronal action potential [GO:0098908]; regulation of neurotransmitter secretion [GO:0046928]; RNA splicing [GO:0008380]; viral process [GO:0016032]",chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; G-quadruplex RNA binding [GO:0002151]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; methylated histone binding [GO:0035064]; microtubule binding [GO:0008017]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; RNA strand annealing activity [GO:0033592]; sequence-specific mRNA binding [GO:1990825]; siRNA binding [GO:0035197]; translation initiation factor binding [GO:0031369]; translation regulator activity [GO:0045182]; translation repressor activity [GO:0030371],"SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10196376, ECO:0000269|PubMed:16571602, ECO:0000269|PubMed:18936162}. Nucleus, nucleolus {ECO:0000269|PubMed:12837692, ECO:0000269|PubMed:16407062, ECO:0000269|PubMed:16571602, ECO:0000269|PubMed:24658146}. Chromosome, centromere {ECO:0000250|UniProtKB:P35922}. Chromosome {ECO:0000250|UniProtKB:P35922}. Cytoplasm {ECO:0000269|PubMed:10196376, ECO:0000269|PubMed:12837692, ECO:0000269|PubMed:18664458, ECO:0000269|PubMed:18936162, ECO:0000269|PubMed:7781595, ECO:0000269|PubMed:8401578, ECO:0000269|PubMed:8515814}. Cytoplasm, perinuclear region {ECO:0000269|PubMed:24658146}. Cytoplasm, Cytoplasmic ribonucleoprotein granule {ECO:0000269|PubMed:12417734, ECO:0000269|PubMed:14532325, ECO:0000269|PubMed:15380484, ECO:0000269|PubMed:16636078, ECO:0000269|PubMed:18093976, ECO:0000269|PubMed:9659908}. Perikaryon {ECO:0000269|PubMed:12417734, ECO:0000269|PubMed:15380484, ECO:0000269|PubMed:18093976}. Cell projection, neuron projection {ECO:0000269|PubMed:12417734, ECO:0000269|PubMed:15380484, ECO:0000269|PubMed:18093976}. Cell projection, axon {ECO:0000250|UniProtKB:P35922}. Cell projection, dendrite {ECO:0000250|UniProtKB:P35922}. Cell projection, dendritic spine {ECO:0000250|UniProtKB:P35922}. Cell junction, synapse, synaptosome {ECO:0000250|UniProtKB:P35922}. Cell projection, growth cone {ECO:0000269|PubMed:15380484}. Cell projection, filopodium tip {ECO:0000250|UniProtKB:P35922}. Cell junction, synapse {ECO:0000250|UniProtKB:P35922}. Cell junction, synapse, postsynaptic cell membrane {ECO:0000250|UniProtKB:P35922}. Cell junction, synapse, presynaptic cell membrane {ECO:0000250|UniProtKB:P35922}. Cell membrane {ECO:0000250|UniProtKB:P35922}. Cytoplasm, Stress granule {ECO:0000269|PubMed:16636078, ECO:0000269|PubMed:18632687, ECO:0000269|PubMed:18664458}. Note=Colocalizes with H2AX/H2A.x in pericentromeric heterochromatin in response to DNA damaging agents (By similarity). Localizes on meiotic pachytene-stage chromosomes (By similarity). Forms nuclear foci representing sites of ongoing DNA replication in response to DNA damaging agents (By similarity). Shuttles between nucleus and cytoplasm in a XPO1/CRM1-dependent manner (PubMed:10196376). Localizes to cytoplasmic ribonucleoprotein granules, also referred to as messenger ribonucleoprotein particles or mRNPs, along dendrites and dendritic spines (PubMed:9659908, PubMed:14532325). FMR1-containing cytoplasmic granules colocalize to F-actin-rich structures, including filopodium, spines and growth cone during the development of hippocampal neurons (By similarity). FMR1-containing cytoplasmic granules are transported out of the soma along axon and dendrite to synaptic contacts in a microtubule- and kinesin-dependent manner (PubMed:12417734, PubMed:15380484). Colocalizes with CACNA1B in the cytoplasm and at the cell membrane of neurons (By similarity). Colocalizes with CYFIP1, CYFIP2, NXF2 and ribosomes in the perinuclear region (By similarity). Colocalizes with CYFIP1 and EIF4E in dendrites and probably at synapses (By similarity). Colocalizes with FXR1, kinesin, 60S acidic ribosomal protein RPLP0 and SMN in cytoplasmic granules in the soma and neurite cell processes (PubMed:12417734, PubMed:18093976, PubMed:16636078). Colocalizes with FXR1 and FXR2 in discrete granules, called fragile X granules (FXGs), along axon and presynaptic compartments (By similarity). Colocalizes with TDRD3 in cytoplasmic stress granules (SGs) in response to various cellular stress (PubMed:18632687, PubMed:18664458, PubMed:16636078). {ECO:0000250|UniProtKB:P35922, ECO:0000250|UniProtKB:Q80WE1, ECO:0000269|PubMed:10196376, ECO:0000269|PubMed:12417734, ECO:0000269|PubMed:14532325, ECO:0000269|PubMed:15380484, ECO:0000269|PubMed:16636078, ECO:0000269|PubMed:18093976, ECO:0000269|PubMed:18632687, ECO:0000269|PubMed:18664458, ECO:0000269|PubMed:9659908}.; SUBCELLULAR LOCATION: [Isoform 6]: Cytoplasm {ECO:0000269|PubMed:24204304, ECO:0000269|PubMed:8789445}. Cytoplasm, perinuclear region {ECO:0000269|PubMed:24204304}.; SUBCELLULAR LOCATION: [Isoform 9]: Cytoplasm {ECO:0000269|PubMed:24204304, ECO:0000269|PubMed:8789445}.; SUBCELLULAR LOCATION: [Isoform 10]: Nucleus {ECO:0000269|PubMed:8789445}. Nucleus, Cajal body {ECO:0000269|PubMed:24204304}. Note=Colocalizes with Colin and SMN in Cajal bodies (PubMed:24204304).; SUBCELLULAR LOCATION: [Isoform 11]: Nucleus {ECO:0000269|PubMed:8789445}. Nucleus, Cajal body {ECO:0000269|PubMed:24204304}.","SUBUNIT: Homodimer (PubMed:7489725, PubMed:12950170, PubMed:16636078). Forms heterodimer with FXR1; heterodimerization occurs in a methylation-dependent manner (PubMed:7489725, PubMed:11157796, PubMed:16636078). Forms heterodimer with FXR2 (PubMed:7489725, PubMed:11157796). Homooligomer (PubMed:11157796, PubMed:18664458). Component of the CYFIP1-EIF4E-FMR1 complex at least composed of CYFIP, EIF4E and FMR1; this mRNA cap binding complex formation increases in presence of the brain cytoplasmic RNA BC1 and is dynamically regulated in an activity-dependent manner to repress and then possibly release dendritic mRNAs for translation in response to mGluR stimulation (By similarity). Associates with the SMN core complex that contains SMN, GEMIN2/SIP1, DDX20/GEMIN3, GEMIN4, GEMIN5, GEMIN6, GEMIN7, GEMIN8 and STRAP/UNRIP (PubMed:18093976). Part of a ribonucleoprotein complex with AGO2/EIF2C2 and miRNAs (PubMed:14703574). Interacts with AGO2/EIF2C2 (PubMed:14703574). Interacts (via C-terminus) with CACNA1B; this interaction induces a decrease in the number of presynaptic functional CACNA1B channels at the cell surface (By similarity). Interacts with CYFIP1; this interaction recruits CYFIP1 to capped mRNA (By similarity). Interacts with CYFIP2 (By similarity). Interacts with EIF5; this interaction occurs in a RNA-dependent manner (By similarity). Interacts with dynein (By similarity). Interacts with FXR1 and FXR2 (PubMed:8668200, PubMed:14532325, PubMed:15380484). Interacts with methylated histone H3 (PubMed:24813610). Interacts with IGF2BP1; this interaction allows to recruit IGF2BP1 to mRNA in a FMR1-dependent manner (PubMed:15282548). Interacts (via N-terminus) with KCNMB4 (PubMed:25561520). Interacts with KCNT1 (via C-terminus); this interaction alters gating properties of KCNT1 (PubMed:20512134). Interacts (via phosphorylated form) with MCRS1 (via N-terminus) (PubMed:16571602). Interacts with MOV10; this interaction is direct, occurs in an RNA-dependent manner on polysomes and induces association of MOV10 with RNAs (PubMed:25464849). Interacts with MYO5A and PURA; these interactions occur in association with polyribosome (By similarity). Interacts with NCL (By similarity). Interacts with NUFIP1 (PubMed:10556305). Interacts (via N-terminus) with NUFIP2 (PubMed:12837692, PubMed:16407062). Interacts with NXF1; this interaction occurs in a mRNA-dependent and polyribosome-independent manner in the nucleus (PubMed:18936162). Interacts with NXF2 (via N-terminus); this interaction is direct and occurs in a NXF1 mRNA-containing mRNP complexes (By similarity). Interacts with RANBP9 (via C-terminus); this interaction is direct and inhibits binding of FMR1 to RNA homopolymer (PubMed:15381419). Interacts with RPLP0 (PubMed:15380484). Interacts (via C-terminus) with SMN (via C-terminus); this interaction is direct and occurs in a RNA-independent manner (PubMed:18093976). Interacts with TDRD3 (via C-terminus); this interaction is direct (PubMed:18632687, PubMed:18664458). Interacts with YBX1; this interaction occurs in association with polyribosome (By similarity). Interacts with nucleosome (PubMed:24813610). Associates with polyribosome; this association occurs in a mRNA-dependent manner (PubMed:9659908, PubMed:11719188, PubMed:12594214, PubMed:19097999, PubMed:24448548). Associates with cytoplasmic messenger ribonucleoprotein particles (mRNPs) (PubMed:7692601, PubMed:9659908, PubMed:12575950, PubMed:19097999). Associates with microtubules in a kinesin- and dynein-dependent manner (By similarity). Isoform 6 interacts (via N-terminus) with NCL (via C-terminus) (PubMed:24658146). Isoform 6 interacts with CYFIP2; this interaction occurs in a RNA-dependent manner (PubMed:24658146). Isoform 6 interacts with EIF5; this interaction occurs in a RNA-dependent manner (PubMed:24658146). Isoform 6 interacts with RPLP0 (PubMed:24658146). Interacts with HABP4 (PubMed:21771594). Interacts with SND1 (PubMed:14508492). {ECO:0000250|UniProtKB:P35922, ECO:0000269|PubMed:10556305, ECO:0000269|PubMed:11157796, ECO:0000269|PubMed:11719188, ECO:0000269|PubMed:12575950, ECO:0000269|PubMed:12594214, ECO:0000269|PubMed:12837692, ECO:0000269|PubMed:12950170, ECO:0000269|PubMed:14508492, ECO:0000269|PubMed:14532325, ECO:0000269|PubMed:14703574, ECO:0000269|PubMed:15282548, ECO:0000269|PubMed:15380484, ECO:0000269|PubMed:15381419, ECO:0000269|PubMed:16407062, ECO:0000269|PubMed:16571602, ECO:0000269|PubMed:16636078, ECO:0000269|PubMed:18093976, ECO:0000269|PubMed:18632687, ECO:0000269|PubMed:18664458, ECO:0000269|PubMed:18936162, ECO:0000269|PubMed:19097999, ECO:0000269|PubMed:20512134, ECO:0000269|PubMed:21771594, ECO:0000269|PubMed:24448548, ECO:0000269|PubMed:24658146, ECO:0000269|PubMed:24813610, ECO:0000269|PubMed:25464849, ECO:0000269|PubMed:25561520, ECO:0000269|PubMed:7489725, ECO:0000269|PubMed:7692601, ECO:0000269|PubMed:8668200, ECO:0000269|PubMed:9659908}.; SUBUNIT: (Microbial infection) Interacts (via KH 2 domain) with influenza A nucleoprotein (NP); this interaction occurs in a RNA-dependent manner and stimulates viral ribonucleoprotein (vRNP) assembly and subsequent RNA synthesis. {ECO:0000269|PubMed:24514761}.; SUBUNIT: (Microbial infection) Interacts with Sindbis virus non-structural protein 3 (via C-terminus); this interaction inhibits the formation of host stress granules on viral mRNAs and the nsp3-FMR1 complexes bind viral RNAs and probably orchestrate the assembly of viral replication complexes. {ECO:0000269|PubMed:27509095}.",X,147911919,147951125,q27.3,0.64718,0.417,1.3993,2.9736,25.22,0.7021556177464817,ENST00000370475,0.978725645076356,0.15666083479130216,1899,1,"FXR1 (57, 58, chr3)",TRUE,,,,0.19821713387463202,5.1517025758213855,Cerebellar_tissues,broadly expressed,3.8805288085305696,5.1517025758213855,TRUE,high confidence non-escapee,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:3776,AFF2,AF4/FMR2 family member 2,Approved,FMR2,FRAXE,Xq28,gene with protein product,protein-coding gene,ENSG00000155966,2334,ENSG00000155966,P51816,MGI:1202294,RGD:1565592,X,300806,TRUE,"Mental retardation, X-linked, FRAXE type",309548,X-linked recessive,,,,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,confirmed +CS,FALSE,TRUE,confirmed,FUNCTION: RNA-binding protein. Might be involved in alternative splicing regulation through an interaction with G-quartet RNA structure. {ECO:0000269|PubMed:19136466}.,brain development [GO:0007420]; learning or memory [GO:0007611]; mRNA processing [GO:0006397]; negative regulation of gene expression [GO:0010629]; nuclear speck organization [GO:0035063]; regulation of gene expression [GO:0010468]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380],G-quadruplex RNA binding [GO:0002151],"SUBCELLULAR LOCATION: Nucleus speckle {ECO:0000269|PubMed:19136466}. Note=When splicing is inhibited, accumulates in enlarged speckles.","",X,148500617,149000663,q28,0.99577,0.275,-1.0512,1.4119,38.198,0.6958394055168249,ENST00000370460,0.8494918699186992,0.23679080229942515,3936,,,,,,,0.8103522349249465,3.3268055275838986,Cerebellar_tissues,tissue-specific,1.1036386291878886,3.3268055275838986,TRUE,discordant,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:3968,CENPI,centromere protein I,Approved,FSHPRH1,"LRPR1, CENP-I, Mis6",Xq22.1,gene with protein product,protein-coding gene,ENSG00000102384,2491,ENSG00000102384,Q92674,MGI:2147897,RGD:2631,X,300065,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Component of the CENPA-CAD (nucleosome distal) complex, a complex recruited to centromeres which is involved in assembly of kinetochore proteins, mitotic progression and chromosome segregation. May be involved in incorporation of newly synthesized CENPA into centromeres via its interaction with the CENPA-NAC complex. Required for the localization of CENPF, MAD1L1 and MAD2 (MAD2L1 or MAD2L2) to kinetochores. Involved in the response of gonadal tissues to follicle-stimulating hormone. {ECO:0000269|PubMed:12640463, ECO:0000269|PubMed:16622420}.",CENP-A containing nucleosome assembly [GO:0034080]; sex differentiation [GO:0007548],"","SUBCELLULAR LOCATION: Nucleus. Chromosome, centromere. Note=Localizes exclusively in the centromeres. The CENPA-CAD complex is probably recruited on centromeres by the CENPA-NAC complex.","SUBUNIT: Component of the CENPA-CAD complex, composed of CENPI, CENPK, CENPL, CENPO, CENPP, CENPQ, CENPR and CENPS. The CENPA-CAD complex interacts with the CENPA-NAC complex, at least composed of CENPA, CENPC, CENPH, CENPM, CENPN, CENPT and CENPU. Interacts with SENP6. {ECO:0000269|PubMed:16622419, ECO:0000269|PubMed:16622420, ECO:0000269|PubMed:20212317}.",X,101098218,101163681,q22.1,0.99974,0.169,0.82642,1.4621,28.053,0.24663677130044842,ENST00000372927,0.7084103918978424,0.11679580104973757,2271,,,,,,,0.7980736676734552,3.529333720485082,Cells - EBV-transformed lymphocytes,tissue-specific,0.21189934948891936,0.22428790737819052,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:397,ALAS2,5'-aminolevulinate synthase 2,Approved,ASB,,Xp11.21,gene with protein product,protein-coding gene,ENSG00000158578,212,ENSG00000158578,P22557,MGI:87990,RGD:2084,X,301300,TRUE,"Anemia, sideroblastic, 1 // Protoporphyria, erythropoietic, X-linked",300751 // 300752,X-linked recessive // X-linked,,,,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"",cellular iron ion homeostasis [GO:0006879]; erythrocyte development [GO:0048821]; erythrocyte differentiation [GO:0030218]; heme biosynthetic process [GO:0006783]; hemoglobin biosynthetic process [GO:0042541]; oxygen homeostasis [GO:0032364]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to hypoxia [GO:0001666],5-aminolevulinate synthase activity [GO:0003870]; glycine binding [GO:0016594]; pyridoxal phosphate binding [GO:0030170],SUBCELLULAR LOCATION: Mitochondrion matrix {ECO:0000269|PubMed:14643893}.,SUBUNIT: Homodimer. Interacts with SUCLA2. {ECO:0000269|PubMed:14643893}.,X,55009055,55030977,p11.21,0.99586,0.184,-0.81511,2.3698,16.209,0.09441607591052503,ENST00000650242,0.8284013605442176,0.09722569357660585,1764,1,"ALAS1 (61, 56, chr3)",TRUE,,,,0.9273590555134983,9.231873966533058,Whole Blood,tissue-specific,0.37669379249305535,0.3454985697674875,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:3987,FTHL17,ferritin heavy chain like 17,Approved,,CT38,Xp21.2,gene with protein product,protein-coding gene,ENSG00000132446,53940,ENSG00000132446,Q9BXU8,MGI:1919246,RGD:1584678,X,300308,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",intracellular sequestering of iron ion [GO:0006880]; iron ion transport [GO:0006826],ferric iron binding [GO:0008199]; ferrous iron binding [GO:0008198]; ferroxidase activity [GO:0004322]; iron ion binding [GO:0005506],"","",X,31071233,31072041,p21.2,,,1.043,0.75966,,0.4217397467452821,ENST00000359202,0.49039855072463767,0.12034491377155711,552,1,"FTH1 (65, 65, chr11)",TRUE,,,,0.9750772089382238,3.1217912627357953,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:4057,G6PD,glucose-6-phosphate dehydrogenase,Approved,,G6PD1,Xq28,gene with protein product,protein-coding gene,ENSG00000160211,2539,ENSG00000160211,P11413,MGI:105979,RGD:2645,X,305900,TRUE,"Hemolytic anemia, G6PD deficient (favism)",300908,X-linked dominant,{Resistance to malaria due to G6PD deficiency},611162,,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Cytosolic glucose-6-phosphate dehydrogenase that catalyzes the first and rate-limiting step of the oxidative branch within the pentose phosphate pathway/shunt, an alternative route to glycolysis for the dissimilation of carbohydrates and a major source of reducing power and metabolic intermediates for fatty acid and nucleic acid biosynthetic processes. {ECO:0000269|PubMed:15858258, ECO:0000269|PubMed:24769394, ECO:0000269|PubMed:26479991, ECO:0000269|PubMed:743300}.","cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; lipid metabolic process [GO:0006629]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; oxidation-reduction process [GO:0055114]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]",glucose-6-phosphate dehydrogenase activity [GO:0004345]; glucose binding [GO:0005536]; identical protein binding [GO:0042802]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803],"SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:743300}. Membrane; Peripheral membrane protein {ECO:0000269|PubMed:743300}.","SUBUNIT: Homotetramer; dimer of dimers (PubMed:24769394, PubMed:10745013, PubMed:15858258). Interacts with SIRT2; the interaction is enhanced by H(2)O(2) treatment (PubMed:24769394). {ECO:0000269|PubMed:10745013, ECO:0000269|PubMed:15858258, ECO:0000269|PubMed:24769394}.",X,154531391,154547572,q28,0.97158,0.318,-0.0326,2.0008,19.813,0.668416850153645,ENST00000393562,0.833139534883721,0.10389902524368907,1548,,,,,,,0.27857671264692585,7.200015802769397,Testis,broadly expressed,4.461168364606229,4.837574954544716,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:40593,TRPC5OS,TRPC5 opposite strand,Approved,TRPC5-AS1,,Xq23,gene with protein product,protein-coding gene,ENSG00000204025,100329135,ENSG00000204025,A6NMA1,MGI:3641805,RGD:6503255,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,111876051,111903990,q23,,,,,,0.10926222290778911,ENST00000635763,0.2851190476190476,0.0715071232191952,336,,,,,,,0.9716009260488035,4.878421274454463,Testis,tissue-specific,0.12270213558958899,0.03752089681502486,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:4077,GABRA3,gamma-aminobutyric acid type A receptor subunit alpha3,Approved,,,Xq28,gene with protein product,protein-coding gene,ENSG00000011677,2556,ENSG00000011677,P34903,MGI:95615,RGD:2648,X,305660,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: GABA, the major inhibitory neurotransmitter in the vertebrate brain, mediates neuronal inhibition by binding to the GABA/benzodiazepine receptor and opening an integral chloride channel.","chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]",benzodiazepine receptor activity [GO:0008503]; chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315],"SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell membrane; Multi-pass membrane protein. Cell membrane; Multi-pass membrane protein.","SUBUNIT: Generally pentameric. There are five types of GABA(A) receptor chains: alpha, beta, gamma, delta, and rho. Binds UBQLN1 (By similarity). Interacts with GPHN (PubMed:26613940). {ECO:0000250|UniProtKB:P26049, ECO:0000269|PubMed:26613940}.",X,152166234,152451315,q28,0.038786,0.699,0.68431,2.5284,15.031,0.21979426234745383,ENST00000370314,0.8956727518593645,0.2708822794301425,1479,3,"GABRA1 (67, 70, chr5); GABRA2 (66, 64, chr4); GABRA5 (66, 70, chr15)",TRUE,,,,0.9274414955904904,2.9263752296278223,Other_Brain_tissues,tissue-specific,2.9263752296278223,1.5126617789734844,TRUE,discordant,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,no disorder
HGNC:4085,GABRE,gamma-aminobutyric acid type A receptor subunit epsilon,Approved,,,Xq28,gene with protein product,protein-coding gene,ENSG00000102287,2564,ENSG00000102287,P78334,MGI:1330235,RGD:68320,X,300093,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: GABA, the major inhibitory neurotransmitter in the vertebrate brain, mediates neuronal inhibition by binding to the GABA/benzodiazepine receptor and opening an integral chloride channel.","chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; negative regulation of chloride transport [GO:2001226]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]",chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315],"SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell membrane; Multi-pass membrane protein. Cell membrane; Multi-pass membrane protein.",SUBUNIT: Generally pentameric. Associates with alpha and beta subunits.,X,151953124,151974680,q28,1.8436e-4,1.023,0.6053,-0.072032,14.106,0.4616553550418215,ENST00000370328,0.5318211702827087,0.07528117970507373,1521,,,,,,,0.3962755417999382,6.810982856674956,Vagina,broadly expressed,1.0234469890976685,0.8563766224579116,FALSE,discordant,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:4098,GAGE1,G antigen 1,Approved,,CT4.1,Xp11.23,gene with protein product,protein-coding gene,ENSG00000205777,2543,ENSG00000205777,P0DTW1,,,X,300594,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Antigen, recognized on melanoma by autologous cytolytic T-lymphocytes. {ECO:0000269|PubMed:7544395}.","","","","",X,49599025,49608536,p11.23,0.013113,1.941,-2.3508,-1.5742,0.95547,0.5766057550161634,ENST00000381700,0.05875706214689266,0.031017245688577857,354,11,"GAGE12G (98, 98, chrX); GAGE12F (98, 98, chrX); GAGE12J (98, 98, chrX); GAGE13 (98, 98, chrX); GAGE12E (97, 97, chrX); GAGE12D (97, 97, chrX); GAGE12C (97, 97, chrX); GAGE12H (97, 97, chrX); GAGE2A (95, 96, chrX); GAGE2E (93, 99, chrX); GAGE10 (91, 91, chrX)",TRUE,11,"GAGE12G (98, 98, chrX); GAGE12F (98, 98, chrX); GAGE12J (98, 98, chrX); GAGE13 (98, 98, chrX); GAGE12E (97, 97, chrX); GAGE12D (97, 97, chrX); GAGE12C (97, 97, chrX); GAGE12H (97, 97, chrX); GAGE2A (95, 96, chrX); GAGE2E (93, 99, chrX); GAGE10 (91, 91, chrX)",TRUE,0.9766529833001021,1.689079943705033,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:4099,GAGE2A,G antigen 2A,Approved,GAGE2,CT4.2,Xp11.23,gene with protein product,protein-coding gene,ENSG00000189064,729447,ENSG00000189064,Q6NT46,,,X,300720,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,49589529,49596827,p11.23,0.10091,1.873,0.58062,-0.7857,1.1947,0.5643640884497573,ENST00000362097,0.06495726495726496,0.04248937765558611,351,11,"GAGE12G (97, 97, chrX); GAGE12F (97, 97, chrX); GAGE13 (97, 97, chrX); GAGE12E (97, 96, chrX); GAGE12D (97, 96, chrX); GAGE12C (97, 96, chrX); GAGE12H (96, 95, chrX); GAGE1 (96, 95, chrX); GAGE12J (96, 95, chrX); GAGE10 (92, 92, chrX); GAGE2E (91, 96, chrX)",TRUE,11,"GAGE12G (97, 97, chrX); GAGE12F (97, 97, chrX); GAGE13 (97, 97, chrX); GAGE12E (97, 96, chrX); GAGE12D (97, 96, chrX); GAGE12C (97, 96, chrX); GAGE12H (96, 95, chrX); GAGE1 (96, 95, chrX); GAGE12J (96, 95, chrX); GAGE10 (92, 92, chrX); GAGE2E (91, 96, chrX)",TRUE,0.9767441860465116,4.9963209490350335,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:4107,PAGE1,PAGE family member 1,Approved,GAGEB1,"PAGE-1, GAGE-9, CT16.3",Xp11.23,gene with protein product,protein-coding gene,ENSG00000068985,8712,ENSG00000068985,O75459,,,X,300288,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,49687447,49695984,p11.23,0.82048,0.528,-0.37214,-0.12942,5.6693,0.3912552157772515,ENST00000376150,0.035147392290249435,0.06145963509122719,441,,,,,,,0.9767441860465116,5.0820510838263,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:4108,PAGE4,PAGE family member 4,Approved,GAGEC1,"PAGE-4, CT16.7",Xp11.23,gene with protein product,protein-coding gene,ENSG00000101951,9506,ENSG00000101951,O60829,,,X,300287,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Intrinsically disordered protein that potentiates the transcriptional activator activity of JUN (PubMed:24263171, PubMed:28289210). Protects cells from stress-induced apoptosis by inhibiting reactive oxygen species (ROS) production and via regulation of the MAPK signaling pathway (PubMed:21357425, PubMed:25374899, PubMed:30658679). {ECO:0000269|PubMed:21357425, ECO:0000269|PubMed:24263171, ECO:0000269|PubMed:25374899, ECO:0000269|PubMed:28289210, ECO:0000269|PubMed:30658679}.",negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; regulation of stress-activated MAPK cascade [GO:0032872]; response to oxidative stress [GO:0006979]; response to starvation [GO:0042594],DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713],"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12489849, ECO:0000269|PubMed:24559171, ECO:0000269|PubMed:25374899}. Nucleus {ECO:0000269|PubMed:24559171}. Mitochondrion {ECO:0000269|PubMed:25374899}. Note=Translocates to mitochondria in response to stress. {ECO:0000269|PubMed:25374899}.","SUBUNIT: Interacts with JUN. {ECO:0000269|PubMed:24263171, ECO:0000269|PubMed:24559171, ECO:0000269|PubMed:26242913}.",X,49829260,49834264,p11.23,0.6939,0.769,0.32084,0.083585,3.8813,0.26218701425173696,ENST00000218068,0.12588996763754046,0.08502874281429643,309,,,,,,,0.9272947788487428,5.321267910877546,Prostate,tissue-specific,0,0.1674799671259542,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:4110,PAGE3,PAGE family member 3,Approved,GAGED1,"PAGE-3, CT16.6",Xp11.21,gene with protein product,protein-coding gene,ENSG00000204279,139793,ENSG00000204279,Q5JUK9,,,X,300739,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,55258412,55264846,p11.21,0.0086303,1.797,-0.53601,-0.64955,3.4837,0.3466235578517706,ENST00000374951,0.07309941520467836,0.0730817295676081,342,,,,,,,0.9767441860465116,4.131680020313456,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:4111,XAGE1A,X antigen family member 1A,Approved,"GAGED2, XAGE1","XAGE-1, CT12.1a",Xp11.22,gene with protein product,protein-coding gene,ENSG00000204379,653220,ENSG00000204379,Q9HD64,,,X,"300742, 300743",FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,52495808,52500812,p11.22,,,,,,0.4155934308836156,ENST00000375602,0.09268292682926829,0.01612096975756061,246,1,"XAGE1B (100, 100, chrX)",TRUE,1,"XAGE1B (100, 100, chrX)",TRUE,0.9767441860465116,0.0951112870760136,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:4112,XAGE2,X antigen family member 2,Approved,"GAGED3, XAGE2B","XAGE-2, CT12.2",Xp11.22,gene with protein product,protein-coding gene,ENSG00000155622,9502,ENSG00000155622,Q96GT9,,,X,300416,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,52369021,52375680,p11.22,,,,,,0.2774484828612505,ENST00000286049,0.05416666666666667,0.0364158960259935,336,2,"XAGE3 (72, 72, chrX); XAGE5 (68, 69, chrX)",TRUE,,,,0.9268631882932806,1.3907172051345387,Lung,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:4170,GATA1,GATA binding protein 1,Approved,GF1,"ERYF1, NFE1, GATA-1, NF-E1",Xp11.23,gene with protein product,protein-coding gene,ENSG00000102145,2623,ENSG00000102145,P15976,MGI:95661,RGD:2663,X,305371,TRUE,"Anemia, X-linked, with/without neutropenia and/or platelet abnormalities // Leukemia, megakaryoblastic, with or without Down syndrome, somatic // Thrombocytopenia with beta-thalassemia, X-linked // Thrombocytopenia, X-linked, with or without dyserythropoietic anemia",300835 // 190685 // 314050 // 300367,X-linked recessive //  // X-linked recessive // X-linked recessive,,,,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Transcriptional activator or repressor which probably serves as a general switch factor for erythroid development. It binds to DNA sites with the consensus sequence 5'-[AT]GATA[AG]-3' within regulatory regions of globin genes and of other genes expressed in erythroid cells. Activates the transcription of genes involved in erythroid differentiation of K562 erythroleukemia cells, including HBB, HBG1/2, ALAS2 and HMBS (PubMed:24245781). {ECO:0000269|PubMed:22235304, ECO:0000269|PubMed:24245781}.","basophil differentiation [GO:0030221]; blood coagulation [GO:0007596]; cell-cell signaling [GO:0007267]; cell fate commitment [GO:0045165]; cellular response to thyroid hormone stimulus [GO:0097067]; dendritic cell differentiation [GO:0097028]; embryonic hemopoiesis [GO:0035162]; eosinophil differentiation [GO:0030222]; eosinophil fate commitment [GO:0035854]; erythrocyte development [GO:0048821]; erythrocyte differentiation [GO:0030218]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; male gonad development [GO:0008584]; megakaryocyte differentiation [GO:0030219]; negative regulation of apoptotic process [GO:0043066]; negative regulation of bone mineralization [GO:0030502]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; platelet aggregation [GO:0070527]; platelet formation [GO:0030220]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of definitive erythrocyte differentiation [GO:0010724]; regulation of glycoprotein biosynthetic process [GO:0010559]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of primitive erythrocyte differentiation [GO:0010725]; transcriptional activation by promoter-enhancer looping [GO:0071733]","C2H2 zinc finger domain binding [GO:0070742]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; p53 binding [GO:0002039]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor binding [GO:0001085]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]",SUBCELLULAR LOCATION: Nucleus.,"SUBUNIT: May form homodimers or heterodimers with other isoforms. Interacts (via the N-terminal zinc finger) with ZFPM1. Interacts with GFI1B. Interacts with PIAS4; the interaction enhances sumoylation and represses the transactivational activity in a sumoylation-independent manner. Interacts with LMCD1. Interacts with BRD3 (By similarity). Interacts with CREBBP; the interaction stimulates acetylation and transcriptional activity in vivo (By similarity). Interacts with EP300. Interacts with MED1, CCAR1 and CALCOCO1. Interacts with CEBPE (PubMed:26019275). {ECO:0000250|UniProtKB:P17679, ECO:0000269|PubMed:10700180, ECO:0000269|PubMed:11418466, ECO:0000269|PubMed:11675338, ECO:0000269|PubMed:11809723, ECO:0000269|PubMed:12200364, ECO:0000269|PubMed:17420275, ECO:0000269|PubMed:24245781, ECO:0000269|PubMed:26019275, ECO:0000269|PubMed:8524811, ECO:0000269|PubMed:9859997}.",X,48786562,48794311,p11.23,0.94798,0.321,0.10802,1.1352,9.3201,0.1969580916949338,ENST00000376670,0.6470209339774557,0.14126468382904275,1242,,,,,,,0.875410941781645,4.744597068116355,Whole Blood,tissue-specific,0.15178999164955553,0.11362676249689325,FALSE,high confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:41913,SMIM10,small integral membrane protein 10,Approved,CXorf69,,Xq26.3,gene with protein product,protein-coding gene,ENSG00000184785,644538,ENSG00000184785,Q96HG1,,RGD:1585506,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","",SUBCELLULAR LOCATION: Membrane {ECO:0000255}; Single-pass membrane protein {ECO:0000255}.,"",X,134990991,134992473,q26.3,0.31638,1.861,0.92958,0.81273,0.32846,0.4958601443760234,ENST00000330288,0.5928571428571429,0.12284428892776805,252,4,"SMIM10L2B (67, 72, chrX); SMIM10L2A (67, 72, chrX); AC009412.1 (59, 72, chr7); SMIM10L1 (53, 65, chr12)",TRUE,,,,0.4015837878406618,6.582569550796201,Artery - Tibial,broadly expressed,3.175599648022176,2.4514854451248973,FALSE,high confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,no difference_Post1_Post2,no disorder
HGNC:41915,SMIM9,small integral membrane protein 9,Approved,CXorf68,,Xq28,gene with protein product,protein-coding gene,ENSG00000203870,100132963,ENSG00000203870,A6NGZ8,MGI:3588243,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","",SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}.,"",X,154823348,154834662,q28,0.0073927,1.832,1.0021,0.3591,3.2239,0.1617620415663742,ENST00000369529,0.167,0.06300924768807799,300,,,,,,,0.9503658272057443,1.3499879707215268,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:4206,OPN1MW,"opsin 1, medium wave sensitive",Approved,"GCP, CBBM, CBD","OPN1MW1, COD5",Xq28,gene with protein product,protein-coding gene,ENSG00000268221,2652,ENSG00000268221,P04001,,RGD:620978,X,300821,TRUE,"Blue cone monochromacy // Colorblindness, deutan",303700 // 303800,X-linked recessive // X-linked,,,,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Visual pigments are the light-absorbing molecules that mediate vision. They consist of an apoprotein, opsin, covalently linked to cis-retinal. {ECO:0000305|PubMed:12051694, ECO:0000305|PubMed:1302020, ECO:0000305|PubMed:2937147}.",cellular response to light stimulus [GO:0071482]; G protein-coupled receptor signaling pathway [GO:0007186]; phototransduction [GO:0007602]; positive regulation of cytokinesis [GO:0032467]; protein-chromophore linkage [GO:0018298]; retinoid metabolic process [GO:0001523]; visual perception [GO:0007601],G protein-coupled photoreceptor activity [GO:0008020]; identical protein binding [GO:0042802]; photoreceptor activity [GO:0009881],SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:20579627}; Multi-pass membrane protein {ECO:0000255}.,SUBUNIT: Monomer. Homodimer. Homotetramer. {ECO:0000269|PubMed:28402104}.,X,154182596,154196861,q28,0.037781,1.78,-2.352,0.74686,2.7425,0.3758877876036164,ENST00000595290,0.6441095890410959,0.12391902024493877,1095,3,"OPN1MW2 (100, 100, chrX); OPN1MW3 (100, 100, chrX); OPN1LW (96, 96, chrX)",TRUE,3,"OPN1MW2 (100, 100, chrX); OPN1MW3 (100, 100, chrX); OPN1LW (96, 96, chrX)",TRUE,,0,,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:4226,GDI1,GDP dissociation inhibitor 1,Approved,"MRX48, MRX41, GDIL","RABGDIA, XAP-4, OPHN2, FLJ41411",Xq28,gene with protein product,protein-coding gene,ENSG00000203879,2664,ENSG00000203879,P31150,MGI:99846,RGD:2676,X,300104,TRUE,"Mental retardation, X-linked 41",300849,X-linked dominant,,,,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Regulates the GDP/GTP exchange reaction of most Rab proteins by inhibiting the dissociation of GDP from them, and the subsequent binding of GTP to them. Promotes the dissociation of GDP-bound Rab proteins from the membrane and inhibits their activation. Promotes the dissociation of RAB1A, RAB3A, RAB5A and RAB10 from membranes. {ECO:0000269|PubMed:23815289}.",negative regulation of axonogenesis [GO:0050771]; negative regulation of protein targeting to membrane [GO:0090315]; positive regulation of axon extension [GO:0045773]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of small GTPase mediated signal transduction [GO:0051056]; response to calcium ion [GO:0051592]; signal transduction [GO:0007165]; vesicle-mediated transport [GO:0016192],GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093]; Rab GTPase binding [GO:0017137],"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19570034}. Golgi apparatus, trans-Golgi network {ECO:0000269|PubMed:19570034}.","SUBUNIT: Interacts with RHOH (PubMed:11809807). Interacts with the non-phosphorylated forms of RAB1A, RAB3A, RAB5A, RAB5B, RAB5C, RAB8A, RAB8B, RAB10, RAB12, RAB35, and RAB43 (PubMed:19570034, PubMed:23815289, PubMed:26824392, PubMed:29125462). {ECO:0000269|PubMed:11809807, ECO:0000269|PubMed:19570034, ECO:0000269|PubMed:23815289, ECO:0000269|PubMed:26824392, ECO:0000269|PubMed:29125462}.",X,154436913,154443467,q28,0.99471,0.192,-1.7345,3.2905,15.551,0.6135540116122641,ENST00000447750,0.9198660714285715,0.2604598850287428,1344,1,"GDI2 (86, 86, chr10)",TRUE,1,"GDI2 (86, 86, chr10)",TRUE,0.25282877794311653,9.203916892662422,Cerebellar_tissues,broadly expressed,8.08977884059742,9.203916892662422,TRUE,low confidence non-escapee,no_difference_Pre_Post,Pre_higher_vs_Post1,no difference_Pre_Post2,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:42787,CXorf51B,chromosome X open reading frame 51B,Approved,,,Xq27.3,gene with protein product,protein-coding gene,ENSG00000235699,100133053,ENSG00000235699,P0DPH9,,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,146809771,146810411,q27.3,,,,,,0.24205903055358263,ENST00000438525,0.01926605504587156,0.07630592351912022,327,1,"CXorf51A (100, 100, chrX)",TRUE,1,"CXorf51A (100, 100, chrX)",TRUE,0.9767441860465116,0.2519771642573176,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:4283,GJB1,gap junction protein beta 1,Approved,"CMTX1, CMTX",CX32,Xq13.1,gene with protein product,protein-coding gene,ENSG00000169562,2705,ENSG00000169562,P08034,MGI:95719,RGD:61926,X,304040,TRUE,"Charcot-Marie-Tooth neuropathy, X-linked dominant, 1",302800,X-linked dominant,,,,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,confirmed +CS,FALSE,TRUE,confirmed,"FUNCTION: One gap junction consists of a cluster of closely packed pairs of transmembrane channels, the connexons, through which materials of low MW diffuse from one cell to a neighboring cell.",cell-cell signaling [GO:0007267]; gap junction assembly [GO:0016264]; nervous system development [GO:0007399],gap junction channel activity [GO:0005243],"SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein. Cell junction, gap junction.",SUBUNIT: A connexon is composed of a hexamer of connexins. Interacts with CNST (By similarity). {ECO:0000250}.,X,71212811,71225516,q13.1,0.84627,0.486,0.41298,2.028,6.1541,0.29427853290034,ENST00000361726,0.8813380281690141,0.3783554111472132,852,,,,,,,0.8086137276991333,7.556314448981907,Liver,tissue-specific,3.6729796829638013,2.503715087389099,FALSE,,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:4289,GK,glycerol kinase,Approved,,"GK1, GKD",Xp21.2,gene with protein product,protein-coding gene,ENSG00000198814,2710,ENSG00000198814,P32189,"MGI:106594, MGI:891990",RGD:70893,X,300474,TRUE,Glycerol kinase deficiency,307030,X-linked recessive,,,,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,FUNCTION: Key enzyme in the regulation of glycerol uptake and metabolism.,glycerol-3-phosphate biosynthetic process [GO:0046167]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; phosphorylation [GO:0016310]; triglyceride biosynthetic process [GO:0019432]; triglyceride metabolic process [GO:0006641],"ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]","SUBCELLULAR LOCATION: Mitochondrion outer membrane; Peripheral membrane protein; Cytoplasmic side. Cytoplasm. Note=In sperm and fetal tissues, the majority of the enzyme is bound to mitochondria, but in adult tissues, such as liver found in the cytoplasm.","",X,30653359,30731456,p21.2,0.98937,0.288,0.77642,3.1858,26.9,0.6159152500615915,ENST00000427190,0.9356547619047619,0.21917020744813798,1680,2,"GK3P (97, 99, chr4); GK2 (87, 88, chr4)",TRUE,2,"GK3P (97, 99, chr4); GK2 (87, 88, chr4)",TRUE,0.5325838406069439,4.752288311115511,Whole Blood,broadly expressed,1.481009546756681,2.2244601757026157,FALSE,high confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:4296,GLA,galactosidase alpha,Approved,,GALA,Xq22.1,gene with protein product,protein-coding gene,ENSG00000102393,2717,ENSG00000102393,P06280,MGI:1347344,RGD:1589721,X,300644,TRUE,"Fabry disease // Fabry disease, cardiac variant",301500 // 301500,X-linked // X-linked,,,,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Catalyzes the hydrolysis of glycosphingolipids and participates to their degradation in the lysosome. {ECO:0000269|PubMed:10838196, ECO:0000269|PubMed:8804427}.",glycoside catabolic process [GO:0016139]; glycosphingolipid catabolic process [GO:0046479]; glycosphingolipid metabolic process [GO:0006687]; glycosylceramide catabolic process [GO:0046477]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of nitric-oxide synthase activity [GO:0051001]; neutrophil degranulation [GO:0043312]; oligosaccharide metabolic process [GO:0009311],alpha-galactosidase activity [GO:0004557]; catalytic activity [GO:0003824]; galactoside binding [GO:0016936]; galactosylgalactosylglucosylceramidase activity [GO:0017041]; hydrolase activity [GO:0016787]; protein homodimerization activity [GO:0042803]; raffinose alpha-galactosidase activity [GO:0052692]; signaling receptor binding [GO:0005102],SUBCELLULAR LOCATION: Lysosome.,SUBUNIT: Homodimer. {ECO:0000269|PubMed:15003450}.,X,101393273,101408012,q22.1,0.99675,0.177,0.55907,1.8759,16.859,0.5473910300856536,ENST00000218516,0.7009302325581396,0.2319170207448138,1290,,,,,,,0.23150502463477707,5.152860791146398,Lung,broadly expressed,2.7175788236730574,3.571179243130031,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:4327,GLRA2,glycine receptor alpha 2,Approved,GLR,,Xp22.2,gene with protein product,protein-coding gene,ENSG00000101958,2742,ENSG00000101958,P23416,MGI:95748,RGD:2705,X,305990,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Glycine receptors are ligand-gated chloride channels. Channel opening is triggered by extracellular glycine (PubMed:2155780, PubMed:15302677, PubMed:16144831, PubMed:23895467, PubMed:25445488). Channel opening is also triggered by taurine and beta-alanine (PubMed:15302677). Plays a role in the down-regulation of neuronal excitability. Contributes to the generation of inhibitory postsynaptic currents (PubMed:25445488). Plays a role in cellular responses to ethanol (PubMed:23895467). {ECO:0000269|PubMed:15302677, ECO:0000269|PubMed:16144831, ECO:0000269|PubMed:2155780, ECO:0000269|PubMed:23895467, ECO:0000269|PubMed:25445488}.","cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]",extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888],"SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell membrane {ECO:0000250|UniProtKB:Q7TNC8}; Multi-pass membrane protein {ECO:0000250|UniProtKB:P23415}. Cell junction, synapse {ECO:0000250|UniProtKB:Q7TNC8}. Cell membrane {ECO:0000269|PubMed:15302677, ECO:0000269|PubMed:16144831, ECO:0000269|PubMed:2155780, ECO:0000269|PubMed:23895467, ECO:0000269|PubMed:25445488}; Multi-pass membrane protein {ECO:0000250|UniProtKB:P23415}. Cell projection {ECO:0000250|UniProtKB:Q7TNC8}.","SUBUNIT: Homopentamer (in vitro). Interacts with GLRB (PubMed:16144831). Heteropentamer composed of GLRA2 and GLRB. Both homopentamers and heteropentamers form functional ion channels, but their characteristics are subtly different (PubMed:15302677). {ECO:0000269|PubMed:16144831, ECO:0000305|PubMed:15302677}.",X,14529298,14731812,p22.2,0.97334,0.304,0.26404,2.7002,15.58,0.3390455131748664,ENST00000218075,0.9573951434878587,0.4202699325168708,1359,3,"GLRA3 (79, 77, chr4); GLRA1 (76, 75, chr5); GLRA4 (73, 79, chrX)",TRUE,,,,0.9578478296904595,3.992745775204089,Cerebellar_tissues,tissue-specific,1.432430322089567,3.992745775204089,TRUE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:4336,GLUD2,glutamate dehydrogenase 2,Approved,GLUDP1,,Xq24,gene with protein product,protein-coding gene,ENSG00000182890,2747,ENSG00000182890,P49448,,,X,300144,TRUE,,,,"{Parkinson disease, age of onset, modifier}",168600,"Multifactorial, Autosomal dominant",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PMT +CS,FALSE,,PMT,"FUNCTION: Important for recycling the chief excitatory neurotransmitter, glutamate, during neurotransmission.",glutamate biosynthetic process [GO:0006537]; glutamate catabolic process [GO:0006538]; glutamate metabolic process [GO:0006536]; oxidation-reduction process [GO:0055114],ADP binding [GO:0043531]; glutamate dehydrogenase (NAD+) activity [GO:0004352]; glutamate dehydrogenase [NAD(P)+] activity [GO:0004353]; GTP binding [GO:0005525]; leucine binding [GO:0070728],SUBCELLULAR LOCATION: Mitochondrion matrix {ECO:0000269|PubMed:22709669}.,SUBUNIT: Homohexamer. {ECO:0000250}.,X,121047610,121050094,q24,0.03152,1.273,-0.39879,0.82505,6.0453,0.5274160326793119,ENST00000328078,0.8292188431723315,0.4453636590852287,1677,1,"GLUD1 (96, 96, chr10)",TRUE,1,"GLUD1 (96, 96, chr10)",TRUE,0.8246549277955506,5.064788025061184,Testis,tissue-specific,0.8878823910397242,0.3779172214411068,FALSE,high confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,no difference_Post1_Post2,PMT
HGNC:43879,CENPVL2,centromere protein V like 2,Approved,CENPVP2,,Xp11.22,gene with protein product,protein-coding gene,ENSG00000283093,441495,ENSG00000283093,P0DPI3,,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","",carbon-sulfur lyase activity [GO:0016846]; metal ion binding [GO:0046872],"","",X,51681212,51682831,p11.22,,,,,,0.6893730493015363,ENST00000634648,0.10146520146520147,0.03176705823544114,819,2,"CENPVL1 (100, 100, chrX); CENPVL3 (96, 91, chrX)",TRUE,2,"CENPVL1 (100, 100, chrX); CENPVL3 (96, 91, chrX)",TRUE,,0,,tissue-specific,0,0,FALSE,,,,,,no disorder
HGNC:43880,CENPVL3,centromere protein V like 3,Approved,CENPVP3,,Xp11.22,gene with protein product,protein-coding gene,ENSG00000224109,347549,ENSG00000224109,A0A0U1RRI6,,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","",carbon-sulfur lyase activity [GO:0016846]; metal ion binding [GO:0046872],"","",X,51617024,51618968,p11.22,,,,,,0.7079924480805538,ENST00000417339,0.13483796296296297,0.09532616845788552,864,2,"CENPVL1 (91, 96, chrX); CENPVL2 (91, 96, chrX)",TRUE,2,"CENPVL1 (91, 96, chrX); CENPVL2 (91, 96, chrX)",TRUE,0.970945507918914,1.60025072046735,Testis,tissue-specific,0.2677862629416101,0,FALSE,,,,,,no disorder
HGNC:44205,MPC1L,mitochondrial pyruvate carrier 1 like,Approved,,SLC54A3,Xp11.4,gene with protein product,protein-coding gene,ENSG00000238205,347411,ENSG00000238205,P0DKB6,,RGD:1563528,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",mitochondrial pyruvate transmembrane transport [GO:0006850],pyruvate transmembrane transporter activity [GO:0050833],SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.,"",X,40623566,40624136,p11.4,,,,,,0.6067529511208192,ENST00000423387,0.25742092457420923,0.07565608597850537,411,,,,,,,0.9764529364513513,5.184585783300685,Testis,tissue-specific,0,0.06493036594979532,FALSE,low confidence escapee,,,,,no disorder
HGNC:44268,FAM236A,family with sequence similarity 235 member A,Approved,"DMRTC1-AS1, LINC00684",,Xq13.1,gene with protein product,protein-coding gene,ENSG00000275520,100129407,ENSG00000275520,A0A1B0GUQ0,,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,72938163,72938958,q13.1,,,,,,0.32083782242220676,ENST00000611003,0.12166666666666666,0.03236690827293177,240,3,"FAM236B (100, 100, chrX); FAM236C (91, 91, chrX); FAM236D (91, 91, chrX)",TRUE,3,"FAM236B (100, 100, chrX); FAM236C (91, 91, chrX); FAM236D (91, 91, chrX)",TRUE,0.9767441860465116,5.88556948379808,Testis,tissue-specific,0,0,FALSE,,,,,,no disorder
HGNC:44269,ETDB,embryonic testis differentiation homolog B,Approved,LINC00633,,Xq26.3,gene with protein product,protein-coding gene,ENSG00000224107,100129515,ENSG00000224107,P0DPP9,MGI:1916751,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,135118955,135120526,q26.3,,,,,,0.1512373102444373,ENST00000423661,0.05388888888888889,0.035291177205698576,180,2,"ETDA (100, 100, chrX); ETDC (78, 78, chrX)",TRUE,1,"ETDA (100, 100, chrX)",TRUE,0.9767441860465116,2.7872569231548727,Testis,tissue-specific,0,0,FALSE,,,,,,no disorder
HGNC:4451,GPC3,glypican 3,Approved,SDYS,"OCI-5, SGBS, SGBS1, SGB, DGSX",Xq26.2,gene with protein product,protein-coding gene,ENSG00000147257,2719,ENSG00000147257,P51654,MGI:104903,RGD:2725,X,300037,TRUE,"Simpson-Golabi-Behmel syndrome, type 1 // Wilms tumor, somatic",312870 // 194070,X-linked recessive //,,,,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Cell surface proteoglycan that bears heparan sulfate (PubMed:14610063). Negatively regulates the hedgehog signaling pathway when attached via the GPI-anchor to the cell surface by competing with the hedgehog receptor PTC1 for binding to hedgehog proteins (By similarity). Binding to the hedgehog protein SHH triggers internalization of the complex by endocytosis and its subsequent lysosomal degradation (By similarity). Positively regulates the canonical Wnt signaling pathway by binding to the Wnt receptor Frizzled and stimulating the binding of the Frizzled receptor to Wnt ligands (PubMed:16227623, PubMed:24496449). Positively regulates the non-canonical Wnt signaling pathway (By similarity). Binds to CD81 which decreases the availability of free CD81 for binding to the transcriptional repressor HHEX, resulting in nuclear translocation of HHEX and transcriptional repression (By similarity). Inhibits the dipeptidyl peptidase activity of DPP4 (PubMed:17549790). Plays a role in limb patterning and skeletal development by controlling the cellular response to BMP4 (By similarity). Modulates the effects of growth factors BMP2, BMP7 and FGF7 on renal branching morphogenesis (By similarity). Required for coronary vascular development (By similarity). Plays a role in regulating cell movements during gastrulation (By similarity). {ECO:0000250|UniProtKB:Q6V9Y8, ECO:0000250|UniProtKB:Q8CFZ4, ECO:0000269|PubMed:14610063, ECO:0000269|PubMed:16227623, ECO:0000269|PubMed:17549790, ECO:0000269|PubMed:24496449}.","anatomical structure morphogenesis [GO:0009653]; anterior/posterior axis specification [GO:0009948]; body morphogenesis [GO:0010171]; bone mineralization [GO:0030282]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell migration [GO:0016477]; cell migration involved in gastrulation [GO:0042074]; cell proliferation involved in kidney development [GO:0072111]; cell proliferation involved in metanephros development [GO:0072203]; cellular protein metabolic process [GO:0044267]; coronary vasculature development [GO:0060976]; embryonic hindlimb morphogenesis [GO:0035116]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan catabolic process [GO:0006027]; lung development [GO:0030324]; mesenchymal cell proliferation involved in ureteric bud development [GO:0072138]; mesonephric duct morphogenesis [GO:0072180]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of growth [GO:0045926]; negative regulation of smoothened signaling pathway [GO:0045879]; osteoclast differentiation [GO:0030316]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of endocytosis [GO:0045807]; positive regulation of glucose import [GO:0046326]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; post-translational protein modification [GO:0043687]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of non-canonical Wnt signaling pathway [GO:2000050]; regulation of protein localization to membrane [GO:1905475]; response to bacterium [GO:0009617]; retinoid metabolic process [GO:0001523]",peptidyl-dipeptidase inhibitor activity [GO:0060422],"SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:14610063}; Lipid-anchor, GPI-anchor {ECO:0000250|UniProtKB:P13265}; Extracellular side {ECO:0000250|UniProtKB:P13265}.","SUBUNIT: Heterodimer; disulfide-linked (PubMed:14610063). Cleavage by a furin-like convertase results in production of alpha and beta chains which form a disulfide-linked heterodimer (PubMed:14610063). Interacts with DPP4 (PubMed:17549790). Interacts with FGF2 (By similarity). Interacts with WNT5A (PubMed:14610063). Also interacts with WNT3A and WNT7B (PubMed:16227623). Interacts with hedgehog protein SHH; the heparan sulfate chains are not required for the interaction (By similarity). Also interacts with hedgehog protein IHH (By similarity). Interacts with CD81 (By similarity). Interacts with Wnt receptors FZD4, FZD7 and FZD8; the heparan sulfate chains are required for the interaction (PubMed:24496449). {ECO:0000250|UniProtKB:P13265, ECO:0000250|UniProtKB:Q8CFZ4, ECO:0000269|PubMed:14610063, ECO:0000269|PubMed:16227623, ECO:0000269|PubMed:17549790, ECO:0000269|PubMed:24496449}.",X,133535745,133985594,q26.2,0.9982,0.162,0.037836,1.4519,18.441,0.6056885614896664,ENST00000370818,0.878657487091222,0.4054986253436641,1743,,,,,,,0.5169567132521603,7.660709038782062,Lung,broadly expressed,0.5635828207426857,0.5953971969471661,FALSE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:4452,GPC4,glypican 4,Approved,,K-glypican,Xq26.2,gene with protein product,protein-coding gene,ENSG00000076716,2239,ENSG00000076716,O75487,MGI:104902,RGD:1359399,X,300168,TRUE,Keipert syndrome,301026,X-linked recessive,,,,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,FUNCTION: Cell surface proteoglycan that bears heparan sulfate. May be involved in the development of kidney tubules and of the central nervous system (By similarity). {ECO:0000250}.,cell migration [GO:0016477]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan catabolic process [GO:0006027]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of presynapse assembly [GO:1905606]; regulation of protein localization to membrane [GO:1905475]; regulation of signal transduction [GO:0009966]; retinoid metabolic process [GO:0001523]; synaptic membrane adhesion [GO:0099560]; Wnt signaling pathway [GO:0016055],"coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Lipid-anchor, GPI-anchor {ECO:0000250}; Extracellular side {ECO:0000250}.; SUBCELLULAR LOCATION: [Secreted glypican-4]: Secreted, extracellular space {ECO:0000250}.","",X,133300103,133415489,q26.2,0.92613,0.368,0.55201,1.6555,17.131,0.7585841266976492,ENST00000370828,0.8480550568521843,0.41799550112471884,1671,1,"GPC6 (63, 63, chr13)",TRUE,,,,0.38571752163560835,6.055442967070315,Esophagus - Muscularis,broadly expressed,2.333446633464732,1.4910706228621877,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:4461,GPM6B,glycoprotein M6B,Approved,,"M6B, MGC17150, MGC54284",Xp22.2,gene with protein product,protein-coding gene,ENSG00000046653,2824,ENSG00000046653,Q13491,MGI:107672,RGD:620580,X,300051,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May be involved in neural development. Involved in regulation of osteoblast function and bone formation. Involved in matrix vesicle release by osteoblasts; this function seems to involve maintenance of the actin cytoskeleton. May be involved in cellular trafficking of SERT and thereby in regulation of serotonin uptake. {ECO:0000269|PubMed:21638316}.,extracellular matrix assembly [GO:0085029]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of serotonin uptake [GO:0051612]; nervous system development [GO:0007399]; neuron projection development [GO:0031175]; ossification [GO:0001503]; positive regulation of bone mineralization [GO:0030501]; protein transport [GO:0015031]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of focal adhesion assembly [GO:0051893],"",SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}. Note=Colocalizes with SERT at the plasma membrane. {ECO:0000250}.,SUBUNIT: Interacts with SERT. {ECO:0000269|PubMed:18581270}.,X,13770939,13938638,p22.2,0.34626,0.592,-0.41295,1.9881,13.09,0.36231631607918,ENST00000316715,0.9361702127659575,0.18775306173456635,987,,,,,,,0.5732878639259978,7.88992978839712,Nerve - Tibial,broadly expressed,7.843431173946327,6.942520369941308,FALSE,high confidence escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,no difference_Post1_Post2,no disorder
HGNC:447,ZBED1,zinc finger BED-type containing 1,Approved,ALTE,"TRAMP, KIAA0785, DREF, hDREF",Xp22.33 and Yp11,gene with protein product,protein-coding gene,ENSG00000214717,9189,ENSG00000214717,O96006,,,X,300178,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,TRUE,,no disorder,"FUNCTION: Functions as an E3-type small ubiquitin-like modifier (SUMO) ligase which sumoylates CHD3/Mi2-alpha, causing its release from DNA (PubMed:27068747). This results in suppression of CHD3/Mi2-alpha transcription repression, increased recruitment of RNA polymerase II to gene promoters and positive regulation of transcription including H1-5 and ribosomal proteins such as: RPS6, RPL10A, and RPL12 (PubMed:12663651, PubMed:17209048, PubMed:17220279, PubMed:27068747). The resulting increased transcriptional activity drives cell proliferation (PubMed:12663651, PubMed:17220279). Binds to 5'-TGTCG[CT]GA[CT]A-3' consensus sequences in gene promoters of ribosomal proteins (PubMed:12663651, PubMed:17209048, PubMed:17220279, PubMed:27068747). {ECO:0000269|PubMed:12663651, ECO:0000269|PubMed:17209048, ECO:0000269|PubMed:17220279, ECO:0000269|PubMed:27068747}.; FUNCTION: (Microbial infection) Binds to human adenovirus gene promoters and contributes to transcriptional repression and virus growth inhibition during early stages of infection. {ECO:0000269|PubMed:25210186}.",negative regulation by host of viral genome replication [GO:0044828]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autosumoylation [GO:1990466],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]","SUBCELLULAR LOCATION: Nucleus, PML body {ECO:0000269|PubMed:25210186, ECO:0000269|PubMed:27068747}. Nucleus {ECO:0000269|PubMed:12663651, ECO:0000269|PubMed:17209048}. Note=In granular structures. {ECO:0000269|PubMed:12663651, ECO:0000269|PubMed:17209048}.; SUBCELLULAR LOCATION: Nucleus, PML body. Note=(Microbial infection) Upon interaction with human adenovirus early E1A protein, the protein is redistributed to the peripheral areas of PML bodies. {ECO:0000269|PubMed:25210186}.","SUBUNIT: Homodimer and homomultimer (PubMed:17209048). Homodimerization is necessary for protein nuclear localization and DNA binding (PubMed:17209048). Interacts with KPNB1; required for nuclear import of ZBED1/hDREF (PubMed:17209048). Interacts with CHD3/Mi2-alpha (PubMed:27068747). Interacts with SUMO1 (PubMed:27068747). Interacts with UBE2I/UBC9 (PubMed:27068747). {ECO:0000269|PubMed:17209048, ECO:0000269|PubMed:27068747}.; SUBUNIT: (Microbial infection) Interacts (via C-terminus) with human adenovirus early E1A protein (via C-terminus); the interaction is direct. {ECO:0000269|PubMed:25210186}.",X,2486414,2500976,p22.33,3.6187e-4,0.782,-0.99887,0.84749,20.073,0.44342128082100946,ENST00000652001,0.8192326139088729,0.013046738315421144,2085,,,,,,,0.16525635350137988,5.874900222584679,Cells - EBV-transformed lymphocytes,broadly expressed,4.057805486688872,4.661139608477696,FALSE,low confidence escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:4478,LPAR4,lysophosphatidic acid receptor 4,Approved,GPR23,"P2Y9, P2Y5-LIKE, P2RY9, LPA4",Xq21.1,gene with protein product,protein-coding gene,ENSG00000147145,2846,ENSG00000147145,Q99677,MGI:1925384,RGD:1563686,X,300086,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Receptor for lysophosphatidic acid (LPA), a mediator of diverse cellular activities. Transduces a signal by increasing the intracellular calcium ions and by stimulating adenylyl cyclase activity. The rank order of potency for agonists of this receptor is 1-oleoyl- > 1-stearoyl- > 1-palmitoyl- > 1-myristoyl- > 1-alkyl- > 1-alkenyl-LPA. {ECO:0000269|PubMed:12724320}.",G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of Rho protein signal transduction [GO:0035025],G protein-coupled receptor activity [GO:0004930]; lysophosphatidic acid binding [GO:0035727]; lysophosphatidic acid receptor activity [GO:0070915],SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.,"",X,78747709,78757094,q21.1,0.0022346,1.766,-0.36398,0.93864,4.5135,0.20222710756525086,ENST00000435339,0.9113207547169812,0.3658835291177206,1113,,,,,,,0.800614503752856,2.007152435237814,Ovary,tissue-specific,0.31263264866588636,0.32862107767447735,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:4490,GPR34,G protein-coupled receptor 34,Approved,,,Xp11.4,gene with protein product,protein-coding gene,ENSG00000171659,2857,ENSG00000171659,Q9UPC5,MGI:1346334,RGD:1563681,X,300241,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Orphan receptor.,G protein-coupled receptor signaling pathway [GO:0007186],G protein-coupled purinergic nucleotide receptor activity [GO:0045028]; G protein-coupled receptor activity [GO:0004930],SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}.,"",X,41688973,41697275,p11.4,0.26387,0.816,1.1452,1.7093,7.712,0.3068661296509398,ENST00000378142,0.6706806282722513,0.1327418145463634,1146,,,,,,,0.5135064571849562,4.405168699599781,Spleen,broadly expressed,2.11625495330588,0.8341642874497459,FALSE,high confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:4506,GPR50,G protein-coupled receptor 50,Approved,,"H9, Mel1c",Xq28,gene with protein product,protein-coding gene,ENSG00000102195,9248,ENSG00000102195,Q13585,MGI:1333877,RGD:619863,X,300207,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Does not bind melatonin.,cell-cell signaling [GO:0007267]; G protein-coupled receptor signaling pathway [GO:0007186],G protein-coupled receptor activity [GO:0004930]; identical protein binding [GO:0042802]; melatonin receptor activity [GO:0008502],SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.,"SUBUNIT: Homodimer, and heterodimer with MTNR1A and MTNR1B. {ECO:0000269|PubMed:16778767}.",X,151176584,151181465,q28,0.64639,0.623,-0.81833,0.072249,7.6151,0.6774976905091747,ENST00000218316,0.40420711974110035,0.09217695576105973,1854,,,,,,,0.9743089016235289,4.831932962185305,Pituitary,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:4516,ADGRG2,adhesion G protein-coupled receptor G2,Approved,GPR64,"HE6, TM7LN2, EDDM6",Xp22.13,gene with protein product,protein-coding gene,ENSG00000173698,10149,ENSG00000173698,Q8IZP9,MGI:2446854,RGD:628618,X,300572,TRUE,"Congenital bilateral absence of vas deferens, X-linked",300985,X-linked,,,,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,FUNCTION: Orphan receptor. Could be involved in a signal transduction pathway controlling epididymal function and male fertility. May regulate fluid exchange within epididymis. {ECO:0000250|UniProtKB:Q8CJ12}.,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; spermatogenesis [GO:0007283],G protein-coupled receptor activity [GO:0004930],SUBCELLULAR LOCATION: Apical cell membrane {ECO:0000269|PubMed:12420295}; Multi-pass membrane protein {ECO:0000255}.,SUBUNIT: Heterodimer of 2 chains generated by proteolytic processing; the large extracellular N-terminal fragment and the membrane-bound C-terminal fragment predominantly remain associated and non-covalently linked. {ECO:0000305}.,X,18989307,19122637,p22.13,0.92694,0.34,0.46196,1.8863,34.8,0.7388680830719527,ENST00000379869,0.776686313032089,0.11312171957010747,3054,,,,,,,0.602361249179358,2.833596508615339,Nerve - Tibial,tissue-specific,0.16089308900364255,0.07464579430970747,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:4533,GPR82,G protein-coupled receptor 82,Approved,,,Xp11.4,gene with protein product,protein-coding gene,ENSG00000171657,27197,ENSG00000171657,Q96P67,MGI:2441734,RGD:2318147,X,300748,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Orphan receptor.,"",G protein-coupled receptor activity [GO:0004930],SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.,"",X,41724181,41730130,p11.4,0.14409,1.076,-1.7036,0.56214,5.8341,0.12004801920768308,ENST00000302548,0.7140454995054402,0.1562359410147463,1011,,,,,,,0.7933764432385125,1.218285204549108,Small Intestine - Terminal Ileum,tissue-specific,0.0657476576589994,0.07294893882741346,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:4540,CXCR3,C-X-C motif chemokine receptor 3,Approved,GPR9,"CKR-L2, CMKAR3, IP10-R, MigR, CD183",Xq13.1,gene with protein product,protein-coding gene,ENSG00000186810,2833,ENSG00000186810,P49682,MGI:1277207,RGD:621528,X,300574,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: [Isoform 1]: Receptor for the C-X-C chemokine CXCL9, CXCL10 and CXCL11 and mediates the proliferation, survival and angiogenic activity of human mesangial cells (HMC) through a heterotrimeric G-protein signaling pathway (PubMed:12782716). Binds to CCL21. Probably promotes cell chemotaxis response. {ECO:0000269|PubMed:12782716}.; FUNCTION: [Isoform 2]: Receptor for the C-X-C chemokine CXCL4 and also mediates the inhibitory activities of CXCL9, CXCL10 and CXCL11 on the proliferation, survival and angiogenic activity of human microvascular endothelial cells (HMVEC) through a cAMP-mediated signaling pathway (PubMed:12782716). Does not promote cell chemotaxis respons. Interaction with CXCL4 or CXCL10 leads to activation of the p38MAPK pathway and contributes to inhibition of angiogenesis. Overexpression in renal cancer cells down-regulates expression of the anti-apoptotic protein HMOX1 and promotes apoptosis. {ECO:0000269|PubMed:12782716}.; FUNCTION: [Isoform 3]: Mediates the activity of CXCL11.",adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; calcium-mediated signaling [GO:0019722]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell surface receptor signaling pathway [GO:0007166]; chemokine (C-C motif) ligand 11 production [GO:0071954]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of execution phase of apoptosis [GO:1900118]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemotaxis [GO:0050921]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell adhesion [GO:0030155]; regulation of leukocyte migration [GO:0002685]; T cell chemotaxis [GO:0010818],C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; chemokine binding [GO:0019956]; chemokine receptor activity [GO:0004950]; C-X-C chemokine binding [GO:0019958]; C-X-C chemokine receptor activity [GO:0016494]; identical protein binding [GO:0042802]; signaling receptor activity [GO:0038023],SUBCELLULAR LOCATION: [Isoform 1]: Cell membrane {ECO:0000269|PubMed:12782716}; Multi-pass membrane protein {ECO:0000269|PubMed:12782716}.; SUBCELLULAR LOCATION: [Isoform 2]: Cell membrane {ECO:0000269|PubMed:12782716}; Multi-pass membrane protein {ECO:0000269|PubMed:12782716}.,SUBUNIT: Homomer. Forms heteromers with ACKR4. {ECO:0000269|PubMed:23121557}.,X,71615916,71618511,q13.1,0.181,0.968,0.94795,1.7447,6.4955,0.2859584645330266,ENST00000373693,0.3533875338753388,0.12156960759810047,1107,,,,,,,0.8417818330671422,4.293856009761943,Cells - EBV-transformed lymphocytes,tissue-specific,0.0417606612356607,0.046819793765196856,FALSE,high confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:4573,GRIA3,glutamate ionotropic receptor AMPA type subunit 3,Approved,GLUR3,"GluA3, GLURC, MRX94",Xq25,gene with protein product,protein-coding gene,ENSG00000125675,2892,ENSG00000125675,P42263,MGI:95810,RGD:70958,X,305915,TRUE,"Intellectual developmental disorder, X-linked, syndromic, Wu type",300699,X-linked recessive,,,,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Receptor for glutamate that functions as ligand-gated ion channel in the central nervous system and plays an important role in excitatory synaptic transmission. L-glutamate acts as an excitatory neurotransmitter at many synapses in the central nervous system. Binding of the excitatory neurotransmitter L-glutamate induces a conformation change, leading to the opening of the cation channel, and thereby converts the chemical signal to an electrical impulse. The receptor then desensitizes rapidly and enters a transient inactive state, characterized by the presence of bound agonist. In the presence of CACNG4 or CACNG7 or CACNG8, shows resensitization which is characterized by a delayed accumulation of current flux upon continued application of glutamate. {ECO:0000269|PubMed:21172611}.",glutamate receptor signaling pathway [GO:0007215]; regulation of NMDA receptor activity [GO:2000310],AMPA glutamate receptor activity [GO:0004971]; amyloid-beta binding [GO:0001540]; ligand-gated ion channel activity [GO:0015276]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315],"SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein. Cell junction, synapse, postsynaptic cell membrane; Multi-pass membrane protein. Note=Interaction with CNIH2 and CNIH3 promotes cell surface expression. {ECO:0000250}.","SUBUNIT: Homotetramer or heterotetramer of pore-forming glutamate receptor subunits. Tetramers may be formed by the dimerization of dimers. Interacts with PRKCABP, GRIP1 and GRIP2 (By similarity). Found in a complex with GRIA1, GRIA2, GRIA4, CNIH2, CNIH3, CACNG2, CACNG3, CACNG4, CACNG5, CACNG7 and CACNG8. Interacts with CACNG5 (By similarity). {ECO:0000250}.",X,123184153,123490915,q25,0.99976,0.193,0.30167,4.2268,32.645,0.48982067853351463,ENST00000620443,0.9700186219739292,0.4110472381904524,2685,3,"GRIA4 (71, 70, chr11); GRIA2 (69, 69, chr4); GRIA1 (66, 64, chr5)",TRUE,,,,0.7559748970970802,4.532341897665899,Other_Brain_tissues,tissue-specific,4.532341897665899,3.158242492640827,TRUE,discordant,no_difference_Pre_Post,Pre_higher_vs_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:4609,GRPR,gastrin releasing peptide receptor,Approved,,"BB2, BB2R",Xp22.2,gene with protein product,protein-coding gene,ENSG00000126010,2925,ENSG00000126010,P30550,MGI:95836,RGD:2750,X,305670,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Receptor for gastrin-releasing peptide (GRP) (PubMed:1655761). Signals via association with G proteins that activate a phosphatidylinositol-calcium second messenger system, resulting in Akt phosphorylation. Contributes to the regulation of food intake. Contributes to the perception of prurient stimuli and transmission of itch signals in the spinal cord that promote scratching behavior, but does not play a role in the perception of pain. Contributes primarily to nonhistaminergic itch sensation. Contributes to long-term fear memory, but not normal spatial memory (By similarity). {ECO:0000250|UniProtKB:P21729, ECO:0000269|PubMed:1655761}.",G protein-coupled receptor signaling pathway [GO:0007186]; learning or memory [GO:0007611]; motor behavior [GO:0061744]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; psychomotor behavior [GO:0036343]; regulation of cell population proliferation [GO:0042127]; response to external biotic stimulus [GO:0043207]; social behavior [GO:0035176],G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; neuropeptide receptor activity [GO:0008188],SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:1655761}; Multi-pass membrane protein {ECO:0000255}.,"",X,16123565,16153518,p22.2,0.22444,0.878,0.31824,0.72477,7.1682,0.21432617381852695,ENST00000380289,0.8465800865800865,0.1839040239940015,1155,1,"NMBR (55, 54, chr6)",TRUE,,,,0.8667432805549051,2.6625268224788097,Pancreas,tissue-specific,0.07183953777772363,0.12142155364408964,FALSE,discordant,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:461,AMELX,amelogenin X-linked,Approved,"AMG, AIH1",,Xp22.2,gene with protein product,protein-coding gene,ENSG00000125363,265,ENSG00000125363,Q99217,MGI:88005,RGD:2107,X,300391,TRUE,"Amelogenesis imperfecta, type 1E",301200,X-linked dominant,,,,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,TRUE,confirmed,FUNCTION: Plays a role in biomineralization. Seems to regulate the formation of crystallites during the secretory stage of tooth enamel development. Thought to play a major role in the structural organization and mineralization of developing enamel.,biomineral tissue development [GO:0031214]; cell adhesion [GO:0007155]; cellular protein metabolic process [GO:0044267]; chondrocyte differentiation [GO:0002062]; enamel mineralization [GO:0070166]; epithelial to mesenchymal transition [GO:0001837]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of tooth mineralization [GO:0070172]; post-translational protein modification [GO:0043687]; regulation of cell population proliferation [GO:0042127]; response to calcium ion [GO:0051592]; response to drug [GO:0042493]; response to nutrient [GO:0007584]; signal transduction [GO:0007165]; tooth mineralization [GO:0034505],growth factor activity [GO:0008083]; hydroxyapatite binding [GO:0046848]; identical protein binding [GO:0042802]; structural constituent of tooth enamel [GO:0030345],"SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular matrix.","",X,11293413,11300761,p22.2,0.074507,0.947,-1.54,0.95694,8.1845,0.11998725135454359,ENST00000380714,0.9328125,0.1284928767808048,576,1,"AMELY (89, 88, chrY)",TRUE,1,"AMELY (89, 88, chrY)",TRUE,0.9767441860465116,0.4741587699508969,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:4622,GSPT2,G1 to S phase transition 2,Approved,,"eRF3b, FLJ10441",Xp11.22,gene with protein product,protein-coding gene,ENSG00000189369,23708,ENSG00000189369,Q8IYD1,MGI:1316727,RGD:1563213,X,300418,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Involved in translation termination in response to the termination codons UAA, UAG and UGA. May play a role as a potent stimulator of the release factor activity of ETF1. Exhibits GTPase activity, which is ribosome- and ETF1-dependent. May play a role in cell cycle progression. Component of the transient SURF complex which recruits UPF1 to stalled ribosomes in the context of nonsense-mediated decay (NMD) of mRNAs containing premature stop codons. {ECO:0000269|PubMed:11524954, ECO:0000269|PubMed:15987998, ECO:0000269|PubMed:17562865}.","cell cycle [GO:0007049]; cytoplasmic translational termination [GO:0002184]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; translation [GO:0006412]",GTPase activity [GO:0003924]; GTP binding [GO:0005525]; RNA binding [GO:0003723]; translation release factor activity [GO:0003747],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}.,"SUBUNIT: Interacts with ETF1 (By similarity). Component of the transient SURF (SMG1-UPF1-eRF1-eRF3) complex. Interacts with UPF1 and PABPC1. {ECO:0000250, ECO:0000269|PubMed:18447585, ECO:0000269|PubMed:19417104}.",X,51743442,51746232,p11.22,0.98321,0.24,0.63729,2.4902,12.434,0.4932067746138098,ENST00000340438,0.9065182829888713,0.494976255936016,1887,1,"GSPT1 (88, 86, chr16)",TRUE,1,"GSPT1 (88, 86, chr16)",TRUE,0.37831849181279575,4.93646833875984,Testis,broadly expressed,3.0996873890018173,4.119215054972631,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:467,AMMECR1,AMMECR nuclear protein 1,Approved,,,Xq23,gene with protein product,protein-coding gene,ENSG00000101935,9949,ENSG00000101935,Q9Y4X0,MGI:1860206,RGD:1561004,X,300195,TRUE,"Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis",300990,X-linked recessive,,,,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,confirmed +CS,FALSE,TRUE,confirmed,"","","",SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:27811305}.,"",X,110194186,110440233,q23,0.82117,0.472,0.27324,1.0801,10.047,0.6494062893195214,ENST00000262844,0.9884231536926148,0.4646838290427393,1002,1,"AMMECR1L (62, 67, chr2)",TRUE,,,,0.4486593386204643,3.8932165747080023,Cells - Cultured fibroblasts,broadly expressed,0.8710392992208139,1.4834959309781823,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:4691,GUCY2F,"guanylate cyclase 2F, retinal",Approved,,"GUC2DL, GC-F, RetGC-2, ROS-GC2, CYGF",Xq22.3-q23,gene with protein product,protein-coding gene,ENSG00000101890,2986,ENSG00000101890,P51841,MGI:105119,RGD:620439,X,300041,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Responsible for the synthesis of cyclic GMP (cGMP) in rods and cones of photoreceptors (PubMed:7777544). Plays an essential role in phototransduction, by mediating cGMP replenishment (By similarity). May also participate in the trafficking of membrane-asociated proteins to the photoreceptor outer segment membrane (By similarity). {ECO:0000250|UniProtKB:Q5SDA5, ECO:0000269|PubMed:7777544}.",cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; detection of light stimulus involved in visual perception [GO:0050908]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; signal transduction [GO:0007165]; visual perception [GO:0007601],ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; identical protein binding [GO:0042802]; peptide receptor activity [GO:0001653]; protein-containing complex binding [GO:0044877]; protein kinase activity [GO:0004672]; signaling receptor activity [GO:0038023],SUBCELLULAR LOCATION: Photoreceptor outer segment membrane {ECO:0000250|UniProtKB:O02740}; Single-pass type I membrane protein {ECO:0000255}.,"SUBUNIT: Homodimer (By similarity). Interacts with RD3; promotes the exit of GUCY2F from the endoplasmic reticulum and its trafficking to the photoreceptor outer segments (By similarity). {ECO:0000250|UniProtKB:P51842, ECO:0000250|UniProtKB:Q5SDA5}.",X,109372906,109482086,q23,1.0552e-13,0.968,-1.7299,-0.20523,37.276,0.1628094396913133,ENST00000218006,0.788277727682597,0.19001509054325955,3327,,,,,,,0.9470792280800654,0.6698649183578442,Testis,tissue-specific,0,0,FALSE,variable escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:4700,GYG2,glycogenin 2,Approved,,GN-2,Xp22.33,gene with protein product,protein-coding gene,ENSG00000056998,8908,ENSG00000056998,O15488,,,X,300198,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Self-glucosylates, via an inter-subunit mechanism, to form an oligosaccharide primer that serves as substrate for glycogen synthase. {ECO:0000269|PubMed:9346895, ECO:0000269|PubMed:9857012}.",glycogen biosynthetic process [GO:0005978],glycogenin glucosyltransferase activity [GO:0008466]; metal ion binding [GO:0046872]; UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity [GO:0102751],"","SUBUNIT: Homodimer, tightly complexed to glycogen synthase.",X,2828822,2882820,p22.33,7.0587e-10,1.568,-0.023814,0.076037,13.865,0.6022301139891226,ENST00000398806,0.4425336164189667,0.028192951762059486,1413,,,,,,,0.6760722430901228,6.32316647759922,Adipose - Subcutaneous,tissue-specific,2.7843574026926183,2.2552333188142115,FALSE,high confidence escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:48,ABCB7,ATP binding cassette subfamily B member 7,Approved,ABC7,"EST140535, Atm1p, ASAT",Xq13.3,gene with protein product,protein-coding gene,ENSG00000131269,22,ENSG00000131269,O75027,MGI:109533,RGD:1303086,X,300135,TRUE,"Anemia, sideroblastic, with ataxia",301310,X-linked recessive,,,,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,confirmed +CS,FALSE,,confirmed,FUNCTION: Could be involved in the transport of heme from the mitochondria to the cytosol. Plays a central role in the maturation of cytosolic iron-sulfur (Fe/S) cluster-containing proteins. {ECO:0000269|PubMed:10196363}.,cellular iron ion homeostasis [GO:0006879]; transmembrane transport [GO:0055085],ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; heme transmembrane transporter activity [GO:0015232],SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000255|PROSITE-ProRule:PRU00441}.,SUBUNIT: Homodimer or heterodimer. Interacts with C10orf88/PAAT (PubMed:25063848). {ECO:0000269|PubMed:25063848}.,X,75051048,75156732,q13.3,0.99994,0.109,-0.095823,2.9037,27.459,0.41576584067852984,ENST00000373394,0.8906595838866755,0.12861784553861536,2259,,,,,,,0.24732104929668894,5.498257251120078,Cells - EBV-transformed lymphocytes,broadly expressed,2.6460220682033775,3.9323399671479358,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:4800,HSD17B10,hydroxysteroid 17-beta dehydrogenase 10,Approved,"HADH2, MRXS10","ERAB, MHBD, 17b-HSD10, ABAD, SDR5C1, MRPP2, CAMR",Xp11.22,gene with protein product,protein-coding gene,ENSG00000072506,3028,ENSG00000072506,Q99714,MGI:1333871,RGD:69231,X,300256,TRUE,HSD10 mitochondrial disease,300438,X-linked dominant,,,,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,confirmed +CS,FALSE,TRUE,confirmed,"FUNCTION: Mitochondrial dehydrogenase that catalyzes the beta-oxidation at position 17 of androgens and estrogens and has 3-alpha-hydroxysteroid dehydrogenase activity with androsterone (PubMed:9553139, PubMed:23042678, PubMed:12917011, PubMed:18996107, PubMed:25925575, PubMed:28888424). Catalyzes the third step in the beta-oxidation of fatty acids (PubMed:9553139, PubMed:12917011, PubMed:18996107, PubMed:25925575, PubMed:28888424). Carries out oxidative conversions of 7-alpha-OH and 7-beta-OH bile acids (PubMed:12917011). Also exhibits 20-beta-OH and 21-OH dehydrogenase activities with C21 steroids (PubMed:12917011). By interacting with intracellular amyloid-beta, it may contribute to the neuronal dysfunction associated with Alzheimer disease (AD) (PubMed:9338779). Essential for structural and functional integrity of mitochondria (PubMed:20077426). {ECO:0000269|PubMed:12917011, ECO:0000269|PubMed:18996107, ECO:0000269|PubMed:20077426, ECO:0000269|PubMed:23042678, ECO:0000269|PubMed:25925575, ECO:0000269|PubMed:26950678, ECO:0000269|PubMed:28888424, ECO:0000269|PubMed:9338779, ECO:0000269|PubMed:9553139}.; FUNCTION: In addition to mitochondrial dehydrogenase activity, moonlights as a component of mitochondrial ribonuclease P, a complex that cleaves tRNA molecules in their 5'-ends (PubMed:18984158, PubMed:24549042, PubMed:25925575, PubMed:26950678, PubMed:28888424). Together with HSD17B10/MRPP2, forms a subcomplex of the mitochondrial ribonuclease P, named MRPP1-MRPP2 subcomplex, which displays functions that are independent of the ribonuclease P activity (PubMed:23042678, PubMed:29040705). The MRPP1-MRPP2 subcomplex catalyzes the formation of N(1)-methylguanine and N(1)-methyladenine at position 9 (m1G9 and m1A9, respectively) in tRNAs; HSD17B10/MRPP2 acting as a non-catalytic subunit (PubMed:23042678, PubMed:25925575, PubMed:28888424). The MRPP1-MRPP2 subcomplex also acts as a tRNA maturation platform: following 5'-end cleavage by the mitochondrial ribonuclease P complex, the MRPP1-MRPP2 subcomplex enhances the efficiency of 3'-processing catalyzed by ELAC2, retains the tRNA product after ELAC2 processing and presents the nascent tRNA to the mitochondrial CCA tRNA nucleotidyltransferase TRNT1 enzyme (PubMed:29040705). {ECO:0000269|PubMed:18984158, ECO:0000269|PubMed:23042678, ECO:0000269|PubMed:24549042, ECO:0000269|PubMed:25925575, ECO:0000269|PubMed:26950678, ECO:0000269|PubMed:28888424, ECO:0000269|PubMed:29040705}.",branched-chain amino acid catabolic process [GO:0009083]; lipid metabolic process [GO:0006629]; mitochondrial tRNA 3'-end processing [GO:1990180]; mitochondrial tRNA 5'-end processing [GO:0097745]; mitochondrial tRNA methylation [GO:0070901]; mitochondrial tRNA processing [GO:0090646]; mitochondrion organization [GO:0007005]; protein homotetramerization [GO:0051289],3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity [GO:0047015]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; cholate 7-alpha-dehydrogenase activity [GO:0008709]; dihydrotestosterone 17-beta-dehydrogenase activity [GO:0035410]; RNA binding [GO:0003723]; testosterone dehydrogenase [NAD(P)] activity [GO:0030283]; tRNA binding [GO:0000049],"SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:12917011, ECO:0000269|PubMed:18984158}.","SUBUNIT: Homotetramer (PubMed:15342248, PubMed:20077426, PubMed:25925575). Component of mitochondrial ribonuclease P, a complex composed of TRMT10C/MRPP1, HSD17B10/MRPP2 and PRORP/MRPP3 (PubMed:18984158, PubMed:25925575, PubMed:26950678, PubMed:28888424). Interacts with TRMT10C/MRPP1; forming the MRPP1-MRPP2 subcomplex of the mitochondrial ribonuclease P complex (PubMed:23042678, PubMed:29040705). {ECO:0000269|PubMed:15342248, ECO:0000269|PubMed:18984158, ECO:0000269|PubMed:20077426, ECO:0000269|PubMed:23042678, ECO:0000269|PubMed:25925575, ECO:0000269|PubMed:26950678, ECO:0000269|PubMed:28888424, ECO:0000269|PubMed:29040705}.",X,53431258,53434370,p11.22,0.93604,0.342,0.43334,2.594,8.7363,0.410657854633536,ENST00000168216,0.8753180661577609,0.17263184203949014,786,,,,,,,0.10845420919364139,7.157498524075402,Liver,broadly expressed,5.167984073081832,5.522118539187344,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:48335,TCP11X2,"t-complex 11 family, X-linked 2",Approved,,,Xq22.1,gene with protein product,protein-coding gene,ENSG00000215029,100996648,ENSG00000215029,Q5H9J9,MGI:1919091,RGD:1598081,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",protein kinase A signaling [GO:0010737]; regulation of sperm capacitation [GO:1902490]; signal transduction [GO:0007165],"","","",X,102456862,102471842,q22.1,,,,,,0.2837105797448378,ENST00000642911,0.4234592445328032,0.05401149712571857,1509,2,"TCP11X1 (100, 100, chrX); TCP11 (69, 67, chr6)",TRUE,1,"TCP11X1 (100, 100, chrX)",TRUE,0.9508502442916374,0.5436502905495028,Pituitary,tissue-specific,0,0.01608527511110275,FALSE,,,,,,no disorder
HGNC:48369,TCP11X1,"t-complex 11 family, X-linked 1",Approved,,,Xq22.1,gene with protein product,protein-coding gene,ENSG00000268235,100996631,ENSG00000268235,B4DZS4,,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",protein kinase A signaling [GO:0010737]; regulation of sperm capacitation [GO:1902490]; signal transduction [GO:0007165],"","","",X,102215301,102229532,q22.1,,,,,,0.2787939991140546,ENST00000622971,0.4253147779986746,0.04648837790552362,1509,2,"TCP11X2 (100, 100, chrX); TCP11 (68, 66, chr6)",TRUE,1,"TCP11X2 (100, 100, chrX)",TRUE,0.951217728384528,0.4176586576441357,Pituitary,tissue-specific,0,0.0171513387167284,FALSE,,,,,,no disorder
HGNC:4837,HCCS,holocytochrome c synthase,Approved,MLS,CCHL,Xp22.2,gene with protein product,protein-coding gene,ENSG00000004961,3052,ENSG00000004961,P53701,MGI:106911,RGD:1563855,X,300056,TRUE,Linear skin defects with multiple congenital anomalies 1,309801,X-linked dominant,,,,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,FUNCTION: Links covalently the heme group to the apoprotein of cytochrome c. {ECO:0000250}.,animal organ morphogenesis [GO:0009887]; cytochrome c-heme linkage [GO:0018063]; oxidation-reduction process [GO:0055114],holocytochrome-c synthase activity [GO:0004408]; metal ion binding [GO:0046872],SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000305}. Membrane {ECO:0000305}; Lipid-anchor {ECO:0000305}.,"",X,11111301,11123086,p22.2,0.88624,0.414,0.53325,1.1951,11.455,0.42246727932245637,ENST00000380762,0.7670384138785625,0.04318920269932517,807,,,,,,,0.20223715880974424,5.0201599107546615,Cells - EBV-transformed lymphocytes,broadly expressed,3.1061707358004744,4.218033282929032,FALSE,high confidence non-escapee,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:4839,HCFC1,host cell factor C1,Approved,"HFC1, MRX3","HCF-1, HCF1, CFF, VCAF, MGC70925, PPP1R89",Xq28,gene with protein product,protein-coding gene,ENSG00000172534,3054,ENSG00000172534,P51610,MGI:105942,RGD:1563804,X,300019,TRUE,"Mental retardation, X-linked 3 (methylmalonic acidemia and homocysteinemia, cblX type )",309541,X-linked recessive,,,,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Involved in control of the cell cycle (PubMed:10629049, PubMed:10779346, PubMed:15190068, PubMed:16624878, PubMed:23629655). Also antagonizes transactivation by ZBTB17 and GABP2; represses ZBTB17 activation of the p15(INK4b) promoter and inhibits its ability to recruit p300 (PubMed:10675337, PubMed:12244100). Coactivator for EGR2 and GABP2 (PubMed:12244100, PubMed:14532282). Tethers the chromatin modifying Set1/Ash2 histone H3 'Lys-4' methyltransferase (H3K4me) and Sin3 histone deacetylase (HDAC) complexes (involved in the activation and repression of transcription, respectively) together (PubMed:12670868). Component of a THAP1/THAP3-HCFC1-OGT complex that is required for the regulation of the transcriptional activity of RRM1 (PubMed:20200153). As part of the NSL complex it may be involved in acetylation of nucleosomal histone H4 on several lysine residues (PubMed:20018852). Recruits KMT2E/MLL5 to E2F1 responsive promoters promoting transcriptional activation and thereby facilitates G1 to S phase transition (PubMed:23629655). {ECO:0000269|PubMed:10629049, ECO:0000269|PubMed:10675337, ECO:0000269|PubMed:10779346, ECO:0000269|PubMed:12244100, ECO:0000269|PubMed:12670868, ECO:0000269|PubMed:14532282, ECO:0000269|PubMed:15190068, ECO:0000269|PubMed:16624878, ECO:0000269|PubMed:20018852, ECO:0000269|PubMed:20200153, ECO:0000269|PubMed:23629655}.; FUNCTION: (Microbial infection) In case of human herpes simplex virus (HSV) infection, HCFC1 forms a multiprotein-DNA complex with the viral transactivator protein VP16 and POU2F1 thereby enabling the transcription of the viral immediate early genes. {ECO:0000269|PubMed:10629049, ECO:0000269|PubMed:17578910}.","blastocyst hatching [GO:0001835]; cell cycle [GO:0007049]; cellular response to organic cyclic compound [GO:0071407]; chromatin remodeling [GO:0006338]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; mitochondrion organization [GO:0007005]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle [GO:0045787]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of protein-containing complex assembly [GO:0043254]; regulation of transcription, DNA-templated [GO:0006355]; release from viral latency [GO:0019046]",activating transcription factor binding [GO:0033613]; cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; protein-macromolecule adaptor activity [GO:0030674]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134],"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12235138}. Nucleus {ECO:0000269|PubMed:10623756, ECO:0000269|PubMed:12235138, ECO:0000269|PubMed:19188440, ECO:0000269|PubMed:20018852, ECO:0000269|PubMed:21285374, ECO:0000269|PubMed:23629655}. Note=HCFC1R1 modulates its subcellular localization and overexpression of HCFC1R1 leads to accumulation of HCFC1 in the cytoplasm (PubMed:12235138). Non-processed HCFC1 associates with chromatin. Colocalizes with CREB3 and CANX in the ER. {ECO:0000269|PubMed:12235138}.","SUBUNIT: Composed predominantly of six polypeptides ranging from 110 to 150 kDa and a minor 300 kDa polypeptide (PubMed:10920196). The majority of N- and C-terminal cleavage products remain tightly, albeit non-covalently, associated (PubMed:10920196). Interacts with POU2F1, CREB3, ZBTB17, EGR2, E2F4, CREBZF, SP1, GABP2, Sin3 HDAC complex (SIN3A, HDAC1, HDAC2, SUDS3), SAP30, SIN3B and FHL2 (PubMed:9271389, PubMed:9389645, PubMed:10675337, PubMed:10976766, PubMed:10629049, PubMed:10871379, PubMed:10984507, PubMed:12244100, PubMed:14532282, PubMed:12670868, PubMed:15705566, PubMed:16624878). Component of a MLL1 complex, composed of at least the core components KMT2A/MLL1, ASH2L, HCFC1, WDR5 and RBBP5, as well as the facultative components BAP18, CHD8, DPY30, E2F6, HCFC2, HSP70, INO80C, KANSL1, LAS1L, MAX, MCRS1, MEN1, MGA, KAT8, PELP1, PHF20, PRP31, RING2, RUVBL1, RUVBL2, SENP3, TAF1, TAF4, TAF6, TAF7, TAF9 and TEX10 (PubMed:15199122, PubMed:15960975). Component of a THAP1/THAP3-HCFC1-OGT complex that is required for the regulation of the transcriptional activity of RRM1 (PubMed:20200153). Interacts directly with THAP3 (via its HBM) (PubMed:20200153). Interacts (via the Kelch-repeat domain) with THAP1 (via the HBM); the interaction recruits HCHC1 to the RRM1 (PubMed:20200153). Interacts directly with OGT; the interaction, which requires the HCFC1 cleavage site domain, glycosylates and promotes the proteolytic processing of HCFC1, retains OGT in the nucleus and impacts the expression of herpes simplex virus immediate early viral genes (PubMed:12670868, PubMed:21285374, PubMed:23353889). Component of the SET1 complex, at least composed of the catalytic subunit (SETD1A or SETD1B), WDR5, WDR82, RBBP5, ASH2L, CXXC1, HCFC1 and DPY30 (PubMed:17998332, PubMed:18838538). Component of the NSL complex at least composed of MOF/KAT8, KANSL1, KANSL2, KANSL3, MCRS1, PHF20, OGT1/OGT, WDR5 and HCFC1 (PubMed:20018852). Component of a complex at least composed of ZNF335, HCFC1, CCAR2, EMSY, MKI67, RBBP5, ASH2L and WDR5; the complex is formed as a result of interactions between components of a nuclear receptor-mediated transcription complex and a histone methylation complex (PubMed:19131338). Within the complex interacts with ZNF335 (PubMed:19131338). Interacts with TET2 and TET3 (PubMed:23353889). Interacts with HCFC1R1 (PubMed:12235138). Interacts with THAP11 (By similarity). Interacts (via Kelch domain) with KMT2E/MLL5 isoform 3 (via HBM motif) (PubMed:23629655). Interacts with E2F1 (PubMed:23629655). {ECO:0000250|UniProtKB:Q61191, ECO:0000269|PubMed:10629049, ECO:0000269|PubMed:10675337, ECO:0000269|PubMed:10871379, ECO:0000269|PubMed:10920196, ECO:0000269|PubMed:10976766, ECO:0000269|PubMed:10984507, ECO:0000269|PubMed:12235138, ECO:0000269|PubMed:12244100, ECO:0000269|PubMed:12670868, ECO:0000269|PubMed:14532282, ECO:0000269|PubMed:15199122, ECO:0000269|PubMed:15705566, ECO:0000269|PubMed:15960975, ECO:0000269|PubMed:16624878, ECO:0000269|PubMed:17998332, ECO:0000269|PubMed:18838538, ECO:0000269|PubMed:19131338, ECO:0000269|PubMed:20018852, ECO:0000269|PubMed:20200153, ECO:0000269|PubMed:21285374, ECO:0000269|PubMed:23353889, ECO:0000269|PubMed:23629655, ECO:0000269|PubMed:9271389, ECO:0000269|PubMed:9389645}.; SUBUNIT: (Microbial infection) Associates with the VP16-induced complex; binding to HCFC1 activates the viral transcriptional activator VP16 for association with POU2F1, to form a multiprotein-DNA complex responsible for activating transcription of the viral immediate early genes (PubMed:10629049). Interacts with the viral transactivator protein VP16 (PubMed:9271389, PubMed:9389645, PubMed:10629049). {ECO:0000269|PubMed:10629049, ECO:0000269|PubMed:9271389, ECO:0000269|PubMed:9389645}.",X,153947557,153971818,q28,1,0.06,-2.0753,5.6341,49.151,0.8134461659219376,ENST00000310441,0.7784381139489195,0.28967758060484877,6108,,,,,,,0.19095291750207713,5.5945157063672255,Uterus,broadly expressed,3.43929733092317,5.176057429600791,FALSE,variable escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:48576,SERTM2,serine rich and transmembrane domain containing 2,Approved,LINC00890,,Xq23,gene with protein product,protein-coding gene,ENSG00000260802,401613,ENSG00000260802,A0A1B0GWG4,,RGD:7673510,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","",SUBCELLULAR LOCATION: Membrane {ECO:0000255}; Single-pass membrane protein {ECO:0000255}.,"",X,111511662,111522399,q23,,,,,,0.12115200411916814,ENST00000569275,0.9266666666666666,0.19697575606098475,270,,,,,,,0.8814451315988413,4.25441263661076,Uterus,tissue-specific,0.01661897585208834,0,FALSE,,,,,,no disorder
HGNC:4866,HEPH,hephaestin,Approved,,"KIAA0698, CPL",Xq12,gene with protein product,protein-coding gene,ENSG00000089472,9843,ENSG00000089472,Q9BQS7,MGI:1332240,RGD:71060,X,300167,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May function as a ferroxidase for ferrous (II) to ferric ion (III) conversion and may be involved in copper transport and homeostasis. Implicated in iron homeostasis and may mediate iron efflux associated to ferroportin 1.,cellular iron ion homeostasis [GO:0006879]; copper ion transport [GO:0006825]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826],copper ion binding [GO:0005507]; ferrous iron binding [GO:0008198]; ferroxidase activity [GO:0004322]; oxidoreductase activity [GO:0016491],SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}.,"",X,66162549,66268867,q12,4.6122e-5,0.563,-1.9621,-0.71488,40.995,0.13260515805237616,ENST00000441993,0.6808785529715762,0.13921519620094977,3483,,,,,,,0.4618343813414082,6.162060956570854,Artery - Aorta,broadly expressed,3.1799982358645695,2.0722258771156614,FALSE,low confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,no difference_Post1_Post2,no disorder
HGNC:5004,HMGB3,high mobility group box 3,Approved,HMG4,"HMG2A, MGC90319",Xq28,gene with protein product,protein-coding gene,ENSG00000029993,3149,ENSG00000029993,O15347,MGI:1098219,RGD:1564407,X,300193,TRUE,,,,"?Microphthalmia, syndromic 13",300915,X-linked,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,PMT +CS,FALSE,,PMT,"FUNCTION: Multifunctional protein with various roles in different cellular compartments. May act in a redox sensitive manner. Associates with chromatin and binds DNA with a preference to non-canonical DNA structures such as single-stranded DNA. Can bent DNA and enhance DNA flexibility by looping thus providing a mechanism to promote activities on various gene promoters (By similarity). Proposed to be involved in the innate immune response to nucleic acids by acting as a cytoplasmic promiscuous immunogenic DNA/RNA sensor (By similarity). Negatively regulates B-cell and myeloid cell differentiation. In hematopoietic stem cells may regulate the balance between self-renewal and differentiation. Involved in negative regulation of canonical Wnt signaling (By similarity). {ECO:0000250|UniProtKB:O54879, ECO:0000250|UniProtKB:P09429, ECO:0000250|UniProtKB:P40618}.","chromatin remodeling [GO:0006338]; DNA geometric change [GO:0032392]; DNA recombination [GO:0006310]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; negative regulation of B cell differentiation [GO:0045578]; negative regulation of myeloid cell differentiation [GO:0045638]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]","chromatin binding [GO:0003682]; DNA binding, bending [GO:0008301]; double-stranded DNA binding [GO:0003690]; four-way junction DNA binding [GO:0000400]; RNA binding [GO:0003723]; transcription factor binding [GO:0008134]","SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P40618, ECO:0000255|PROSITE-ProRule:PRU00267}. Chromosome {ECO:0000305}. Cytoplasm {ECO:0000250|UniProtKB:O54879}.","",X,150980509,150990771,q28,0.79758,0.566,-1.8591,1.7775,5.2851,0.837770122142186,ENST00000325307,0.9247097844112769,0.1693576605848538,603,2,"HMGB1 (76, 70, chr13); HMGB2 (74, 71, chr4)",TRUE,,,,0.42554729978355404,4.852068772157568,Cells - EBV-transformed lymphocytes,broadly expressed,3.0635409074655895,2.156145789802042,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,PMT
HGNC:5042,HNRNPH2,heterogeneous nuclear ribonucleoprotein H2,Approved,HNRPH2,"hnRNPH', FTP3, HNRPH'",Xq22.1,gene with protein product,protein-coding gene,ENSG00000126945,3188,ENSG00000126945,P55795,MGI:1201779,RGD:1549784,X,300610,TRUE,"Mental retardation, X-linked, syndromic, Bain type",300986,X-linked dominant,,,,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,confirmed +CS,FALSE,TRUE,confirmed,"FUNCTION: This protein is a component of the heterogeneous nuclear ribonucleoprotein (hnRNP) complexes which provide the substrate for the processing events that pre-mRNAs undergo before becoming functional, translatable mRNAs in the cytoplasm. Binds poly(RG).","mRNA splicing, via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484]; RNA metabolic process [GO:0016070]",RNA binding [GO:0003723],"SUBCELLULAR LOCATION: Nucleus, nucleoplasm.",SUBUNIT: Interacts with TXNL4/DIM1. {ECO:0000269|PubMed:11054566}.,X,101408222,101414133,q22.1,0.95448,0.309,0.33181,3.6248,9.6934,0.5177293868320366,ENST00000316594,0.9658518518518519,0.25351162209447636,1350,2,"HNRNPH1 (94, 89, chr5); HNRNPF (69, 75, chr10)",TRUE,1,"HNRNPH1 (94, 89, chr5)",TRUE,0.09085068184084294,7.140185589509612,Cells - Cultured fibroblasts,broadly expressed,6.134483821510794,6.99552409069093,FALSE,high confidence non-escapee,no_difference_Pre_Post,Pre_higher_vs_Post1,no difference_Pre_Post2,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:50713,NBDY,negative regulator of P-body association,Approved,LINC01420,NoBody,Xp11.21,gene with protein product,protein-coding gene,ENSG00000204272,550643,ENSG00000204272,A0A0U1RRE5,MGI:1917373,,X,300992,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Promotes dispersal of P-body components and is likely to play a role in the mRNA decapping process. {ECO:0000269|PubMed:27918561}.,mRNA processing [GO:0006397]; negative regulation of cytoplasmic mRNA processing body assembly [GO:0010607]; nuclear-transcribed mRNA catabolic process [GO:0000956],"","SUBCELLULAR LOCATION: Cytoplasm, P-body {ECO:0000269|PubMed:27918561}. Note=Localizes to P-bodies at low concentrations without dissociating them. {ECO:0000269|PubMed:27918561}.","SUBUNIT: Interacts with mRNA decapping proteins DCP1A, DCP2 and EDC4. {ECO:0000269|PubMed:27918561}.",X,56729241,56819179,p11.21,,,,,,0.40069892402485646,ENST00000374922,0.9681159420289855,0.2097225693576606,207,,,,,,,0.17715510152597536,5.930988013610245,Artery - Aorta,broadly expressed,4.646836602433672,4.916935176608402,FALSE,,,,,,no disorder
HGNC:50767,PNMA6E,PNMA family member 6E,Approved,,,Xq28,gene with protein product,protein-coding gene,ENSG00000214897,649238,ENSG00000214897,A0A0J9YXQ4,,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,153395639,153401392,q28,,,,,,0.5514416259650228,ENST00000445091,0.05169753086419753,0.011972006998250437,1944,1,"PNMA6F (68, 77, chrX)",TRUE,,,,,,,tissue-specific,,,FALSE,,,,,,no disorder
HGNC:51259,CLDN34,claudin 34,Approved,,,Xp22.2,gene with protein product,protein-coding gene,ENSG00000234469,100288814,ENSG00000234469,H7C241,MGI:3645962,RGD:1594343,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Plays a major role in tight junction-specific obliteration of the intercellular space, through calcium-independent cell-adhesion activity. {ECO:0000250|UniProtKB:O88552}.",bicellular tight junction assembly [GO:0070830]; cell adhesion [GO:0007155],structural molecule activity [GO:0005198],"SUBCELLULAR LOCATION: Cell junction, tight junction {ECO:0000250|UniProtKB:O88552}. Cell membrane {ECO:0000250|UniProtKB:O88552}; Multi-pass membrane protein {ECO:0000250|UniProtKB:O88552}.",SUBUNIT: Can form homo- and heteropolymers with other CLDN. {ECO:0000250|UniProtKB:O88552}.,X,9967358,9968352,p22.2,,,,,,0.37203620412016214,ENST00000445307,0.2627906976744186,0.06343414146463384,645,,,,,,,0.9374387830223694,2.242520194513621,Testis,tissue-specific,0.06307683566394785,0,FALSE,,,,,,no disorder
HGNC:51260,CT45A7,cancer/testis antigen family 45 member A7,Approved,,,Xq26.3,gene with protein product,protein-coding gene,ENSG00000273696,101060211,ENSG00000273696,P0DMV0,,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",snRNA 3'-end processing [GO:0034472],"","","",X,135829247,135837268,q26.3,,,,,,0.4258471669639183,ENST00000610598,0.1819298245614035,0.0077230692326918276,570,8,"CT45A5 (100, 100, chrX); CT45A6 (100, 100, chrX); CT45A3 (99, 99, chrX); CT45A1 (99, 99, chrX); CT45A8 (98, 98, chrX); CT45A2 (98, 98, chrX); CT45A9 (98, 98, chrX); CT45A10 (95, 95, chrX)",TRUE,8,"CT45A5 (100, 100, chrX); CT45A6 (100, 100, chrX); CT45A3 (99, 99, chrX); CT45A1 (99, 99, chrX); CT45A8 (98, 98, chrX); CT45A2 (98, 98, chrX); CT45A9 (98, 98, chrX); CT45A10 (95, 95, chrX)",TRUE,,0,,tissue-specific,0,0,FALSE,,,,,,no disorder
HGNC:51261,CT45A8,cancer/testis antigen family 45 member A8,Approved,,,Xq26.3,gene with protein product,protein-coding gene,ENSG00000278085,102723737,ENSG00000278085,P0DMV1,,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",snRNA 3'-end processing [GO:0034472],"","","",X,135846497,135854538,q26.3,,,,,,0.4206145399805189,ENST00000611660,0.16298245614035087,0.005373656585853537,570,8,"CT45A2 (100, 100, chrX); CT45A9 (100, 100, chrX); CT45A3 (98, 98, chrX); CT45A1 (98, 98, chrX); CT45A5 (98, 98, chrX); CT45A7 (98, 98, chrX); CT45A6 (98, 98, chrX); CT45A10 (95, 95, chrX)",TRUE,8,"CT45A2 (100, 100, chrX); CT45A9 (100, 100, chrX); CT45A3 (98, 98, chrX); CT45A1 (98, 98, chrX); CT45A5 (98, 98, chrX); CT45A7 (98, 98, chrX); CT45A6 (98, 98, chrX); CT45A10 (95, 95, chrX)",TRUE,,0,,tissue-specific,0,0,FALSE,,,,,,no disorder
HGNC:51262,CT45A9,cancer/testis antigen family 45 member A9,Approved,,,Xq26.3,gene with protein product,protein-coding gene,ENSG00000270946,102723680,ENSG00000270946,P0DMV2,,RGD:1592859,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",snRNA 3'-end processing [GO:0034472],"","","",X,135863418,135871812,q26.3,,,,,,0.42903268609845635,ENST00000620704,0.21526315789473685,0.014452820379516507,570,8,"CT45A2 (100, 100, chrX); CT45A8 (100, 100, chrX); CT45A3 (98, 98, chrX); CT45A1 (98, 98, chrX); CT45A5 (98, 98, chrX); CT45A7 (98, 98, chrX); CT45A6 (98, 98, chrX); CT45A10 (95, 95, chrX)",TRUE,8,"CT45A2 (100, 100, chrX); CT45A8 (100, 100, chrX); CT45A3 (98, 98, chrX); CT45A1 (98, 98, chrX); CT45A5 (98, 98, chrX); CT45A7 (98, 98, chrX); CT45A6 (98, 98, chrX); CT45A10 (95, 95, chrX)",TRUE,,0,,tissue-specific,0,0,FALSE,,,,,,no disorder
HGNC:51263,CT45A10,cancer/testis antigen family 45 member A10,Approved,,,Xq26.3,gene with protein product,protein-coding gene,ENSG00000269586,102723631,ENSG00000269586,P0DMU9,,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",snRNA 3'-end processing [GO:0034472],identical protein binding [GO:0042802],"","",X,135881063,135889086,q26.3,,,,,,0.44213600818174914,ENST00000611668,0.19017543859649122,0.061434641339665086,570,8,"CT45A5 (95, 95, chrX); CT45A7 (95, 95, chrX); CT45A8 (95, 95, chrX); CT45A6 (95, 95, chrX); CT45A2 (95, 95, chrX); CT45A9 (95, 95, chrX); CT45A3 (94, 94, chrX); CT45A1 (94, 94, chrX)",TRUE,8,"CT45A5 (95, 95, chrX); CT45A7 (95, 95, chrX); CT45A8 (95, 95, chrX); CT45A6 (95, 95, chrX); CT45A2 (95, 95, chrX); CT45A9 (95, 95, chrX); CT45A3 (94, 94, chrX); CT45A1 (94, 94, chrX)",TRUE,0.9756243454962789,2.264338253241035,Testis,tissue-specific,0.10903500520317483,0,FALSE,,,,,,no disorder
HGNC:5157,HPRT1,hypoxanthine phosphoribosyltransferase 1,Approved,HPRT,HGPRT,Xq26.2-q26.3,gene with protein product,protein-coding gene,ENSG00000165704,3251,ENSG00000165704,P00492,MGI:96217,RGD:2826,X,308000,TRUE,"Hyperuricemia, HRPT-related // Lesch-Nyhan syndrome",300323 // 300322,X-linked recessive // X-linked recessive,,,,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Converts guanine to guanosine monophosphate, and hypoxanthine to inosine monophosphate. Transfers the 5-phosphoribosyl group from 5-phosphoribosylpyrophosphate onto the purine. Plays a central role in the generation of purine nucleotides through the purine salvage pathway.",adenine salvage [GO:0006168]; central nervous system neuron development [GO:0021954]; cerebral cortex neuron differentiation [GO:0021895]; dendrite morphogenesis [GO:0048813]; dopamine metabolic process [GO:0042417]; GMP catabolic process [GO:0046038]; GMP salvage [GO:0032263]; grooming behavior [GO:0007625]; guanine salvage [GO:0006178]; hypoxanthine metabolic process [GO:0046100]; hypoxanthine salvage [GO:0043103]; IMP metabolic process [GO:0046040]; IMP salvage [GO:0032264]; locomotory behavior [GO:0007626]; lymphocyte proliferation [GO:0046651]; positive regulation of dopamine metabolic process [GO:0045964]; protein homotetramerization [GO:0051289]; purine-containing compound salvage [GO:0043101]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside salvage [GO:0006166]; response to amphetamine [GO:0001975]; striatum development [GO:0021756]; T cell mediated cytotoxicity [GO:0001913],guanine phosphoribosyltransferase activity [GO:0052657]; hypoxanthine phosphoribosyltransferase activity [GO:0004422]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166],SUBCELLULAR LOCATION: Cytoplasm.,"SUBUNIT: Homotetramer. {ECO:0000269|PubMed:10338013, ECO:0000269|PubMed:10360366, ECO:0000269|PubMed:15990111, ECO:0000269|PubMed:8044844}.",X,134460165,134520513,q26.2,0.93728,0.34,1.6223,2.3178,8.792,0.5731567522743347,ENST00000298556,0.9700152207001522,0.08382904273931517,657,1,"PRTFDC1 (67, 65, chr10)",TRUE,,,,0.3291285837362086,7.0170310805278415,Cells - EBV-transformed lymphocytes,broadly expressed,5.312864808062789,6.026208034631815,FALSE,high confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:5174,ERAS,ES cell expressed Ras,Approved,"HRAS2, HRASP",,Xp11.23,gene with protein product,protein-coding gene,ENSG00000187682,3266,ENSG00000187682,Q7Z444,MGI:2665023,RGD:1585907,X,300437,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Ras proteins bind GDP/GTP and possess intrinsic GTPase activity. Plays an important role in the tumor-like growth properties of embryonic stem cells (By similarity). {ECO:0000250}.,Ras protein signal transduction [GO:0007265],GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525],SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Lipid-anchor {ECO:0000250}; Cytoplasmic side {ECO:0000250}.,SUBUNIT: Interacts with PIK3CD. {ECO:0000250}.,X,48826513,48830138,p11.23,0.22267,1.445,-0.7982,1.4761,3.0662,0.521704978765435,ENST00000636362,0.3331908831908832,0.08727818045488628,702,,,,,,,0.8185908371208716,2.3099241223537796,Cerebellar_tissues,tissue-specific,0.9394959058202085,2.3099241223537796,TRUE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:51831,OPN1MW3,"opsin 1, medium wave sensitive 3",Approved,,,Xq28,gene with protein product,protein-coding gene,ENSG00000269433,101060233,ENSG00000269433,P0DN78,,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Visual pigments are the light-absorbing molecules that mediate vision. They consist of an apoprotein, opsin, covalently linked to cis-retinal. {ECO:0000250|UniProtKB:P04001}.",cellular response to light stimulus [GO:0071482]; G protein-coupled receptor signaling pathway [GO:0007186]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; visual perception [GO:0007601],G protein-coupled photoreceptor activity [GO:0008020],SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:P04001}; Multi-pass membrane protein {ECO:0000255}.,"",X,154257538,154271805,q28,,,,,,0.36983094152793866,ENST00000599405,0.6918721461187215,0.1361909522619345,1095,3,"OPN1MW2 (100, 100, chrX); OPN1MW (100, 100, chrX); OPN1LW (96, 96, chrX)",TRUE,3,"OPN1MW2 (100, 100, chrX); OPN1MW (100, 100, chrX); OPN1LW (96, 96, chrX)",TRUE,,0,,tissue-specific,0,0,FALSE,,,,,,no disorder
HGNC:52277,TEX13C,TEX13 family member C,Approved,,,Xq25,gene with protein product,protein-coding gene,ENSG00000282815,100129520,ENSG00000282815,A0A0J9YWL9,MGI:2685208,RGD:1563975,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","",metal ion binding [GO:0046872],"","",X,125320120,125325214,q25,,,,,,0.313510572315057,ENST00000632600,0.034439973172367536,0.10403846153846154,2982,,,,,,,0.9741721752666007,2.275585201964116,Testis,tissue-specific,0.018316119534182614,0.041328083306895844,FALSE,,,,,,no disorder
HGNC:52278,TEX13D,TEX13 family member D,Approved,,,Xq25,gene with protein product,protein-coding gene,ENSG00000282419,100132015,ENSG00000282419,A0A0J9YY54,MGI:3780650,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","",metal ion binding [GO:0046872],"","",X,124246249,124336863,q25,,,,,,0.3056324325765081,ENST00000632372,0.056363636363636366,0.061584603849037745,2145,,,,,,,0.9683634270630571,2.934676896957955,Testis,tissue-specific,0.03153592981772969,0,FALSE,,,,,,no disorder
HGNC:52395,HSFX3,"heat shock transcription factor family, X-linked member 3",Approved,,,Xq28,gene with protein product,protein-coding gene,ENSG00000283697,101928917,ENSG00000283697,A0A1B0GWH4,,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",cellular response to heat [GO:0034605]; positive regulation of transcription from RNA polymerase II promoter in response to heat stress [GO:0061408]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]",SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.,"",X,149548210,149549932,q28,,,,,,0.19611641661823548,ENST00000431993,0.055089820359281436,0.027268182954261436,1002,1,"HSFX4 (100, 100, chrX)",TRUE,1,"HSFX4 (100, 100, chrX)",TRUE,,,,tissue-specific,,,FALSE,,,,,,no disorder
HGNC:52398,HSFX4,"heat shock transcription factor family, X-linked member 4",Approved,,,Xq28,gene with protein product,protein-coding gene,ENSG00000283463,101927685,ENSG00000283463,A0A1B0GTS1,,RGD:2318522,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",cellular response to heat [GO:0034605]; positive regulation of transcription from RNA polymerase II promoter in response to heat stress [GO:0061408]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618],DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565],SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.,"",X,149929573,149931287,q28,,,,,,0.2102185317191098,ENST00000457775,0.05159680638722555,0.022969257685578604,1002,1,"HSFX3 (100, 100, chrX)",TRUE,1,"HSFX3 (100, 100, chrX)",TRUE,,,,tissue-specific,,,FALSE,,,,,,no disorder
HGNC:52640,FAM236B,family with sequence similarity 236 member B,Approved,,,Xq13.1,gene with protein product,protein-coding gene,ENSG00000268994,100132304,ENSG00000268994,A0A1B0GV22,,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,72781865,72782660,q13.1,,,,,,0.32160804020100503,ENST00000596535,0.14375,0.028817795551112222,240,3,"FAM236A (100, 100, chrX); FAM236C (91, 91, chrX); FAM236D (91, 91, chrX)",TRUE,3,"FAM236A (100, 100, chrX); FAM236C (91, 91, chrX); FAM236D (91, 91, chrX)",TRUE,0.9767441860465116,0.34865961131207795,Testis,tissue-specific,0,0,FALSE,,,,,,no disorder
HGNC:52641,FAM236C,family with sequence similarity 236 member C,Approved,,,Xq13.1,gene with protein product,protein-coding gene,ENSG00000283594,109729126,ENSG00000283594,P0DP71,,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,72912615,72913401,q13.1,,,,,,0.32469235893948345,ENST00000636267,0.11708333333333333,0.043764058985253686,240,3,"FAM236D (100, 100, chrX); FAM236A (91, 91, chrX); FAM236B (91, 91, chrX)",TRUE,3,"FAM236D (100, 100, chrX); FAM236A (91, 91, chrX); FAM236B (91, 91, chrX)",TRUE,0.9738037801437055,1.1389651512507089,Testis,tissue-specific,0,0.14400785371460895,FALSE,,,,,,no disorder
HGNC:52642,FAM236D,family with sequence similarity 236 member D,Approved,,,Xq13.1,gene with protein product,protein-coding gene,ENSG00000225396,105373251,ENSG00000225396,A0A1B0GTK5,,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,72807425,72808210,q13.1,,,,,,0.3289936559717303,ENST00000458170,0.13771929824561405,0.048062984253936514,228,3,"FAM236C (100, 100, chrX); FAM236A (91, 91, chrX); FAM236B (91, 91, chrX)",TRUE,3,"FAM236C (100, 100, chrX); FAM236A (91, 91, chrX); FAM236B (91, 91, chrX)",TRUE,0.9767441860465116,0.866054172181346,Testis,tissue-specific,0,0,FALSE,,,,,,no disorder
HGNC:5276,HTATSF1,HIV-1 Tat specific factor 1,Approved,,TAT-SF1,Xq26.3,gene with protein product,protein-coding gene,ENSG00000102241,27336,ENSG00000102241,O43719,MGI:1919709,RGD:1563377,X,300346,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Functions as a general transcription factor playing a role in the process of transcriptional elongation. May mediate the reciprocal stimulatory effect of splicing on transcriptional elongation. In case of infection by HIV-1, it is up-regulated by the HIV-1 proteins NEF and gp120, acts as a cofactor required for the Tat-enhanced transcription of the virus. {ECO:0000269|PubMed:10393184, ECO:0000269|PubMed:10454543, ECO:0000269|PubMed:10913173, ECO:0000269|PubMed:11420046, ECO:0000269|PubMed:11780068, ECO:0000269|PubMed:15905670, ECO:0000269|PubMed:8849451, ECO:0000269|PubMed:9765201}.","mRNA splicing, via spliceosome [GO:0000398]; regulation of DNA-templated transcription, elongation [GO:0032784]; regulation of transcription by RNA polymerase II [GO:0006357]; viral genome replication [GO:0019079]",RNA binding [GO:0003723],"SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:15485897, ECO:0000269|PubMed:8849451}.","SUBUNIT: Component of a complex which is at least composed of HTATSF1/Tat-SF1, the P-TEFb complex components CDK9 and CCNT1, RNA polymerase II, SUPT5H, and NCL/nucleolin. Interacts with GTF2F2/RAP30 and POLR2A. Interacts with TCERG1/CA150. Interacts with SF3A2/SAP62 and the spliceosomal U small nuclear ribonucleoproteins (snRNPs). {ECO:0000269|PubMed:10393184, ECO:0000269|PubMed:10454543, ECO:0000269|PubMed:10913173, ECO:0000269|PubMed:11780068, ECO:0000269|PubMed:15485897, ECO:0000269|PubMed:9649438, ECO:0000269|PubMed:9710584}.",X,136497079,136512346,q26.3,0.9974,0.217,-0.3031,1.9835,21.869,0.837030610397519,ENST00000218364,0.5298059964726631,0.11817045738565359,2268,,,,,,,0.30458250792938824,8.024458205669069,Pituitary,broadly expressed,5.801184529158698,6.69200865761905,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:5295,HTR2C,5-hydroxytryptamine receptor 2C,Approved,HTR1C,"5-HT2C, 5HTR2C",Xq23,gene with protein product,protein-coding gene,ENSG00000147246,3358,ENSG00000147246,P28335,MGI:96281,RGD:2848,X,312861,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: G-protein coupled receptor for 5-hydroxytryptamine (serotonin). Also functions as a receptor for various drugs and psychoactive substances, including ergot alkaloid derivatives, 1-2,5,-dimethoxy-4-iodophenyl-2-aminopropane (DOI) and lysergic acid diethylamide (LSD). Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors. Beta-arrestin family members inhibit signaling via G proteins and mediate activation of alternative signaling pathways. Signaling activates a phosphatidylinositol-calcium second messenger system that modulates the activity of phosphatidylinositol 3-kinase and down-stream signaling cascades and promotes the release of Ca(2+) ions from intracellular stores. Regulates neuronal activity via the activation of short transient receptor potential calcium channels in the brain, and thereby modulates the activation of pro-opiomelacortin neurons and the release of CRH that then regulates the release of corticosterone. Plays a role in the regulation of appetite and eating behavior, responses to anxiogenic stimuli and stress. Plays a role in insulin sensitivity and glucose homeostasis. {ECO:0000269|PubMed:12970106, ECO:0000269|PubMed:18703043, ECO:0000269|PubMed:19057895, ECO:0000269|PubMed:7895773}.","behavioral fear response [GO:0001662]; cellular calcium ion homeostasis [GO:0006874]; cGMP-mediated signaling [GO:0019934]; chemical synaptic transmission [GO:0007268]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; locomotory behavior [GO:0007626]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; phospholipase C-activating serotonin receptor signaling pathway [GO:0007208]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of phosphatidylinositol biosynthetic process [GO:0010513]; regulation of appetite [GO:0032098]; regulation of corticotropin-releasing hormone secretion [GO:0043397]; regulation of nervous system process [GO:0031644]; release of sequestered calcium ion into cytosol [GO:0051209]; response to drug [GO:0042493]; serotonin receptor signaling pathway [GO:0007210]","1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding [GO:0071886]; drug binding [GO:0008144]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; Gq/11-coupled serotonin receptor activity [GO:0001587]; identical protein binding [GO:0042802]; neurotransmitter receptor activity [GO:0030594]; serotonin binding [GO:0051378]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:12970106, ECO:0000269|PubMed:18703043, ECO:0000269|PubMed:19057895, ECO:0000269|PubMed:7895773}; Multi-pass membrane protein {ECO:0000269|PubMed:12970106, ECO:0000269|PubMed:18703043, ECO:0000269|PubMed:19057895, ECO:0000269|PubMed:7895773}.","SUBUNIT: Interacts with MPDZ. Interacts with ARRB2. {ECO:0000269|PubMed:11150294, ECO:0000269|PubMed:16319069}.",X,114584078,114910061,q23,0.037023,0.867,0.96012,1.2063,10.562,0.6737481901976806,ENST00000276198,0.8132171387073348,0.3005498625343664,1377,,,,,,,0.9571237306964053,1.4367641693600561,Other_Brain_tissues,tissue-specific,1.4367641693600561,0.1300102157474835,TRUE,low confidence escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:53119,PNMA6F,PNMA family member 6F,Approved,,PNMA6BL,Xq28,gene with protein product,protein-coding gene,ENSG00000225110,105373377,ENSG00000225110,A0A0J9YX94,,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,153317680,153321767,q28,,,,,,0.34176312529233344,ENST00000436629,0.027461139896373058,0.028267933016745815,1737,1,"PNMA6E (77, 68, chrX)",TRUE,,,,,,,tissue-specific,,,FALSE,,,,,,no disorder
HGNC:53449,ETDA,embryonic testis differentiation homolog A,Approved,,,Xq26.3,gene with protein product,protein-coding gene,ENSG00000238210,101928677,ENSG00000238210,Q3ZM63,MGI:1916751,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,135252061,135253583,q26.3,,,,,,0.14704801117564886,ENST00000427686,0.11444444444444445,0.042614346413396655,180,2,"ETDB (100, 100, chrX); ETDC (78, 78, chrX)",TRUE,1,"ETDB (100, 100, chrX)",TRUE,,,,tissue-specific,,,FALSE,,,,,,no disorder
HGNC:53450,ETDC,embryonic testis differentiation homolog C,Approved,,,Xq26.3,gene with protein product,protein-coding gene,ENSG00000283644,110806299,ENSG00000283644,A0A1B0GVM5,MGI:1916751,,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,135309480,135309659,q26.3,,,,,,0.09717812622671401,ENST00000635820,0.12055555555555555,0.039440139965008746,180,2,"ETDA (78, 78, chrX); ETDB (78, 78, chrX)",TRUE,,,,,,,tissue-specific,,,FALSE,,,,,,no disorder
HGNC:5386,IDH3G,isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit gamma,Approved,,,Xq28,gene with protein product,protein-coding gene,ENSG00000067829,3421,ENSG00000067829,P51553,MGI:1099463,RGD:2863,X,300089,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Regulatory subunit which plays a role in the allosteric regulation of the enzyme catalyzing the decarboxylation of isocitrate (ICT) into alpha-ketoglutarate. The heterodimer composed of the alpha (IDH3A) and beta (IDH3B) subunits and the heterodimer composed of the alpha (IDH3A) and gamma (IDH3G) subunits, have considerable basal activity but the full activity of the heterotetramer (containing two subunits of IDH3A, one of IDH3B and one of IDH3G) requires the assembly and cooperative function of both heterodimers. {ECO:0000269|PubMed:28139779}.",carbohydrate metabolic process [GO:0005975]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099],ATP binding [GO:0005524]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287],SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:11256614}.,"SUBUNIT: Heterooligomer of subunits alpha (IDH3A), beta (IDH3B), and gamma (IDH3G) in the apparent ratio of 2:1:1. The heterodimer containing one IDH3A and one IDH3B subunit and the heterodimer containing one IDH3A and one IDH3G subunit assemble into a heterotetramer (which contains two subunits of IDH3A, one of IDH3B and one of IDH3G) and further into the heterooctamer. {ECO:0000269|PubMed:28098230, ECO:0000269|PubMed:28139779}.",X,153785766,153794523,q28,0.085247,0.711,-0.19704,2.1937,12.868,0.5387055906270641,ENST00000217901,0.7420473773265651,0.06823294176455887,1182,,,,,,,0.12076287331561147,6.542131111786353,Cerebellar_tissues,broadly expressed,5.296137996777272,6.542131111786353,TRUE,high confidence non-escapee,no_difference_Pre_Post,Pre_higher_vs_Post1,no difference_Pre_Post2,Post2_higher_vs_Post1,no disorder
HGNC:5389,IDS,iduronate 2-sulfatase,Approved,SIDS,ID2S,Xq28,gene with protein product,protein-coding gene,ENSG00000010404,3423,ENSG00000010404,P22304,MGI:96417,RGD:1560491,X,300823,TRUE,Mucopolysaccharidosis II,309900,X-linked recessive,,,,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Lysosomal enzyme involved in the degradation pathway of dermatan sulfate and heparan sulfate. {ECO:0000269|PubMed:10838181, ECO:0000269|PubMed:11731225, ECO:0000269|PubMed:28593992}.",chondroitin sulfate catabolic process [GO:0030207]; glycosaminoglycan catabolic process [GO:0006027],calcium ion binding [GO:0005509]; iduronate-2-sulfatase activity [GO:0004423]; sulfuric ester hydrolase activity [GO:0008484],SUBCELLULAR LOCATION: Lysosome {ECO:0000269|PubMed:10838181}.,"SUBUNIT: Monomer (PubMed:28593992). The 58-kDa mature form is composed of two chains resulting from proteolitic processing, the 42-kDa chain and the 14-kDa chain that remain stably associated and form the 58-kDa intermediate form which is enzymatically active (PubMed:28593992). {ECO:0000269|PubMed:28593992}.",X,149476988,149521096,q28,0.9964,0.18,-0.21377,1.58,16.584,0.39082803163692476,ENST00000340855,0.7215970961887477,0.13679080229942514,1653,1,"AC244197.3 (62, 100, chrX)",TRUE,,,,0.2940599498972387,7.735989190466284,Other_Brain_tissues,broadly expressed,7.735989190466284,7.313409125437592,TRUE,low confidence non-escapee,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:5461,IGBP1,immunoglobulin binding protein 1,Approved,IBP1,α4,Xq13.1,gene with protein product,protein-coding gene,ENSG00000089289,3476,ENSG00000089289,P78318,MGI:1346500,RGD:62011,X,300139,TRUE,"Corpus callosum, agenesis of, with mental retardation, ocular coloboma and micrognathia",300472,X-linked recessive,,,,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Associated to surface IgM-receptor; may be involved in signal transduction. Involved in regulation of the catalytic activity of the phosphatases PP2A, PP4 and PP6 by protecting their partially folded catalytic subunits from degradative polyubiquitination until they associate with regulatory subunits. {ECO:0000269|PubMed:19818709, ECO:0000269|PubMed:23591866}.",B cell activation [GO:0042113]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of stress-activated MAPK cascade [GO:0032873]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of dephosphorylation [GO:0035303]; regulation of microtubule-based movement [GO:0060632]; response to interleukin-1 [GO:0070555]; response to tumor necrosis factor [GO:0034612]; signal transduction [GO:0007165],protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}.,"SUBUNIT: Interacts with partially folded PPP2CA, but not with the fully active protein. Interacts with PPP2CB, and with PP4 and PP6. Interacts with MID1 and MID2. Interacts with ubiquitin. {ECO:0000269|PubMed:11806752, ECO:0000269|PubMed:19818709, ECO:0000269|PubMed:20092282, ECO:0000269|PubMed:23591866, ECO:0000269|PubMed:9647778}.",X,70133447,70166324,q13.1,0.98274,0.242,-0.87235,1.3042,12.36,0.4792371671915175,ENST00000356413,0.7497058823529412,0.18950262434391402,1020,1,"IGBP1P2 (85, 85, chr17)",TRUE,1,"IGBP1P2 (85, 85, chr17)",TRUE,0.18050798581015595,7.507374453535761,Ovary,broadly expressed,5.157674347029788,6.14479078116436,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:560,AP1S2,adaptor related protein complex 1 subunit sigma 2,Approved,"MRX59, MRXS5, PGS",SIGMA1B,Xp22.2,gene with protein product,protein-coding gene,ENSG00000182287,8905,ENSG00000182287,P56377,MGI:1889383,RGD:1561862,X,300629,TRUE,"Mental retardation, X-linked syndromic 5",304340,X-linked recessive,,,,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE,confirmed +CS,FALSE,,confirmed,FUNCTION: Subunit of clathrin-associated adaptor protein complex 1 that plays a role in protein sorting in the late-Golgi/trans-Golgi network (TGN) and/or endosomes. The AP complexes mediate both the recruitment of clathrin to membranes and the recognition of sorting signals within the cytosolic tails of transmembrane cargo molecules.,antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intracellular protein transport [GO:0006886]; regulation of defense response to virus by virus [GO:0050690]; vesicle-mediated transport [GO:0016192],"","SUBCELLULAR LOCATION: Golgi apparatus. Cytoplasmic vesicle membrane; Peripheral membrane protein; Cytoplasmic side. Membrane, clathrin-coated pit. Note=Component of the coat surrounding the cytoplasmic face of coated vesicles located at the Golgi complex.","SUBUNIT: Adaptor protein complex 1 (AP-1) is a heterotetramer composed of two large adaptins (gamma-type subunit AP1G1 and beta-type subunit AP1B1), a medium adaptin (mu-type subunit AP1M1 or AP1M2) and a small adaptin (sigma-type subunit AP1S1 or AP1S2 or AP1S3). Binds to MUC1.",X,15825806,15854931,p22.2,0.86702,0.454,-0.42483,2.012,6.5975,0.8222997934073539,ENST00000672987,0.9813664596273292,0.28350412396900776,483,2,"AP1S1 (79, 66, chr7); AP1S3 (68, 66, chr2)",TRUE,,,,0.3109924021429473,5.443135842364698,Nerve - Tibial,broadly expressed,3.97702342158069,4.3482890832891155,FALSE,high confidence escapee,no_difference_Pre_Post,Pre_higher_vs_Post1,no difference_Pre_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:592,XIAP,X-linked inhibitor of apoptosis,Approved,"API3, BIRC4","hILP, ILP-1",Xq25,gene with protein product,protein-coding gene,ENSG00000101966,331,ENSG00000101966,P98170,MGI:107572,RGD:620692,X,300079,TRUE,"Lymphoproliferative syndrome, X-linked, 2",300635,X-linked recessive,,,,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,TRUE,confirmed,"FUNCTION: Multi-functional protein which regulates not only caspases and apoptosis, but also modulates inflammatory signaling and immunity, copper homeostasis, mitogenic kinase signaling, cell proliferation, as well as cell invasion and metastasis. Acts as a direct caspase inhibitor. Directly bind to the active site pocket of CASP3 and CASP7 and obstructs substrate entry. Inactivates CASP9 by keeping it in a monomeric, inactive state. Acts as an E3 ubiquitin-protein ligase regulating NF-kappa-B signaling and the target proteins for its E3 ubiquitin-protein ligase activity include: RIPK1, CASP3, CASP7, CASP8, CASP9, MAP3K2/MEKK2, DIABLO/SMAC, AIFM1, CCS and BIRC5/survivin. Ubiquitinion of CCS leads to enhancement of its chaperone activity toward its physiologic target, SOD1, rather than proteasomal degradation. Ubiquitinion of MAP3K2/MEKK2 and AIFM1 does not lead to proteasomal degradation. Plays a role in copper homeostasis by ubiquitinationg COMMD1 and promoting its proteasomal degradation. Can also function as E3 ubiquitin-protein ligase of the NEDD8 conjugation pathway, targeting effector caspases for neddylation and inactivation. Regulates the BMP signaling pathway and the SMAD and MAP3K7/TAK1 dependent pathways leading to NF-kappa-B and JNK activation. Acts as an important regulator of innate immune signaling via regulation of Nodlike receptors (NLRs). Protects cells from spontaneous formation of the ripoptosome, a large multi-protein complex that has the capability to kill cancer cells in a caspase-dependent and caspase-independent manner. Suppresses ripoptosome formation by ubiquitinating RIPK1 and CASP8. Acts as a positive regulator of Wnt signaling and ubiquitinates TLE1, TLE2, TLE3, TLE4 and AES. Ubiquitination of TLE3 results in inhibition of its interaction with TCF7L2/TCF4 thereby allowing efficient recruitment and binding of the transcriptional coactivator beta-catenin to TCF7L2/TCF4 that is required to initiate a Wnt-specific transcriptional program. {ECO:0000269|PubMed:11447297, ECO:0000269|PubMed:12121969, ECO:0000269|PubMed:14645242, ECO:0000269|PubMed:14685266, ECO:0000269|PubMed:17560374, ECO:0000269|PubMed:17967870, ECO:0000269|PubMed:19473982, ECO:0000269|PubMed:20154138, ECO:0000269|PubMed:21145488, ECO:0000269|PubMed:22103349, ECO:0000269|PubMed:22304967, ECO:0000269|PubMed:9230442}.",cellular response to DNA damage stimulus [GO:0006974]; copper ion homeostasis [GO:0055070]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; mitotic spindle assembly [GO:0090307]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; neuron apoptotic process [GO:0051402]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein linear polyubiquitination [GO:1902530]; positive regulation of protein ubiquitination [GO:0031398]; regulation of BMP signaling pathway [GO:0030510]; regulation of cell population proliferation [GO:0042127]; regulation of inflammatory response [GO:0050727]; regulation of innate immune response [GO:0045088]; regulation of nucleotide-binding oligomerization domain containing signaling pathway [GO:0070424]; Wnt signaling pathway [GO:0016055],cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842],SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Note=TLE3 promotes its nuclear localization.,"SUBUNIT: Monomer, and homodimer. Interacts with DIABLO/SMAC and with PRSS25; these interactions inhibit apoptotic suppressor activity. Interacts with TAB1/MAP3K7IP1 and AIFM1. Interaction with SMAC hinders binding of TAB1/MAP3K7IP1 and AIFM1. Interacts with TCF25 and COMMD1. Interacts with SEPTIN4 isoform 6, but not with other SEPTIN4 isoforms. Interacts with RIP1, RIP2, RIP3, RIP4, CCS and USP19. Interacts (via BIR 2 domain and BIR 3 domain) with HAX1 (via C-terminus) and this interaction blocks ubiquitination of XIAP/BIRC4. Interacts with the monomeric form of BIRC5/survivin. Interacts with TLE3 and TCF7L2/TCF4. Interacts (via BIR 3 and RING domains) with PDCL3 (PubMed:19012568). {ECO:0000269|PubMed:11140637, ECO:0000269|PubMed:11257231, ECO:0000269|PubMed:12620238, ECO:0000269|PubMed:14685266, ECO:0000269|PubMed:15029247, ECO:0000269|PubMed:17560374, ECO:0000269|PubMed:17698078, ECO:0000269|PubMed:17967870, ECO:0000269|PubMed:18068114, ECO:0000269|PubMed:19012568, ECO:0000269|PubMed:19473982, ECO:0000269|PubMed:20154138, ECO:0000269|PubMed:20171186, ECO:0000269|PubMed:21536684, ECO:0000269|PubMed:21849505, ECO:0000269|PubMed:21931591, ECO:0000269|PubMed:22304967}.",X,123859724,123913976,q25,0.91837,0.374,0.91206,1.4931,16.842,0.6050164048151118,ENST00000371199,0.8668674698795181,0.1723069232691827,1494,,,,,,,0.15793523992199132,4.214723213117083,Cells - Cultured fibroblasts,broadly expressed,3.276594926352567,3.986774976394751,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:5948,IGSF1,immunoglobulin superfamily member 1,Approved,,"KIAA0364, IGDC1, IGCD1, INHBP, MGC75490, PGSF2",Xq25,gene with protein product,protein-coding gene,ENSG00000147255,3547,ENSG00000147255,Q8N6C5,MGI:2147913,RGD:631402,X,300137,TRUE,"Hypothyroidism, central, and testicular enlargement",300888,X-linked recessive,,,,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,confirmed +CS,FALSE,TRUE,confirmed,"FUNCTION: Seems to be a coreceptor in inhibin signaling, but seems not to be a high-affinity inhibin receptor. Antagonizes activin A signaling in the presence or absence of inhibin B (By similarity). Necessary to mediate a specific antagonistic effect of inhibin B on activin-stimulated transcription. {ECO:0000250, ECO:0000269|PubMed:11266516}.","negative regulation of activin receptor signaling pathway [GO:0032926]; regulation of transcription, DNA-templated [GO:0006355]",activin receptor antagonist activity [GO:0038102]; coreceptor activity [GO:0015026]; inhibin binding [GO:0034711],SUBCELLULAR LOCATION: [Isoform 1]: Membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.; SUBCELLULAR LOCATION: [Isoform 2]: Membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.; SUBCELLULAR LOCATION: [Isoform 3]: Secreted {ECO:0000305}.,"SUBUNIT: Interacts with INHA (By similarity). In PubMed:12385827 does not interact with INHA; standard receptor binding assay. Interacts with ACVR1B; the interaction appears to be ligand-dependent as it is diminished by inhibin B and activin A. Interacts with ACVR2A, ACVR2B, ACVRL1 and BMPR1B. Interacts with HECTD1. {ECO:0000250, ECO:0000269|PubMed:11266516, ECO:0000269|PubMed:12421765}.",X,131273506,131578899,q26.2,0.99993,0.214,-1.0483,1.1512,49.082,0.24563693416207705,ENST00000361420,0.7045624532535527,0.23386653336665833,4011,,,,,,,0.8619785211209352,7.543666002527542,Pituitary,tissue-specific,1.6263643716162464,0.9864193092305029,FALSE,low confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,Post1_higher_vs_Post2,confirmed monogenic disorder
HGNC:5961,IKBKG,inhibitor of nuclear factor kappa B kinase regulatory subunit gamma,Approved,"IP2, IP1","IKK-gamma, NEMO, Fip3p, FIP-3, FIP3, ZC2HC9",Xq28,gene with protein product,protein-coding gene,ENSG00000269335,8517,ENSG00000269335,Q9Y6K9,MGI:1338074,RGD:735223,X,300248,TRUE,Ectodermal dysplasia and immunodeficiency 1 // Immunodeficiency 33 // Incontinentia pigmenti,300291 // 300636 // 308300,X-linked recessive // X-linked recessive // X-linked dominant,,,,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Regulatory subunit of the IKK core complex which phosphorylates inhibitors of NF-kappa-B thus leading to the dissociation of the inhibitor/NF-kappa-B complex and ultimately the degradation of the inhibitor. Its binding to scaffolding polyubiquitin seems to play a role in IKK activation by multiple signaling receptor pathways. However, the specific type of polyubiquitin recognized upon cell stimulation (either 'Lys-63'-linked or linear polyubiquitin) and its functional importance is reported conflictingly. Also considered to be a mediator for TAX activation of NF-kappa-B. Could be implicated in NF-kappa-B-mediated protection from cytokine toxicity. Essential for viral activation of IRF3. Involved in TLR3- and IFIH1-mediated antiviral innate response; this function requires 'Lys-27'-linked polyubiquitination. {ECO:0000269|PubMed:14695475, ECO:0000269|PubMed:19854139, ECO:0000269|PubMed:20724660}.","activation of MAPK activity [GO:0000187]; anoikis [GO:0043276]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; establishment of vesicle localization [GO:0051650]; Fc-epsilon receptor signaling pathway [GO:0038095]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; JNK cascade [GO:0007254]; MyD88-independent toll-like receptor signaling pathway [GO:0002756]; negative regulation of neuron death [GO:1901215]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of macroautophagy [GO:0016239]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; protein deubiquitination [GO:0016579]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; response to virus [GO:0009615]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]; viral process [GO:0016032]",identical protein binding [GO:0042802]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; linear polyubiquitin binding [GO:1990450]; metal ion binding [GO:0046872]; peroxisome proliferator activated receptor binding [GO:0042975]; protein-containing complex binding [GO:0044877]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transferrin receptor binding [GO:1990459]; ubiquitin protein ligase binding [GO:0031625],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:14651848}. Nucleus {ECO:0000269|PubMed:14651848}. Note=Sumoylated NEMO accumulates in the nucleus in response to genotoxic stress.,"SUBUNIT: Homodimer; disulfide-linked. Component of the I-kappa-B-kinase (IKK) core complex consisting of CHUK, IKBKB and IKBKG; probably four alpha/CHUK-beta/IKBKB dimers are associated with four gamma/IKBKG subunits. The IKK core complex seems to associate with regulatory or adapter proteins to form a IKK-signalosome holo-complex. The IKK complex associates with TERF2IP/RAP1, leading to promote IKK-mediated phosphorylation of RELA/p65. Part of a complex composed of NCOA2, NCOA3, CHUK/IKKA, IKBKB, IKBKG and CREBBP. Interacts with COPS3, CYLD, NALP2, TRPC4AP and PIDD1. Interacts with ATM; the complex is exported from the nucleus. Interacts with TRAF6. Interacts with IKBKE. Interacts with TANK; the interaction is enhanced by IKBKE and TBK1. Part of a ternary complex consisting of TANK, IKBKB and IKBKG. Interacts with ZFAND5. Interacts with RIPK2. Interacts with TNIP1 and TNFAIP3; TNIP1 facilitates the TNFAIP3-mediated de-ubiquitination of IKBKG. Interacts with TNFAIP3; the interaction is induced by TNF stimulation and by polyubiquitin. Binds polyubiquitin; the interaction is mediated by two domains; reports about the binding to 'Lys-63'-linked and/or linear polyubiquitin, respective binding affinities and stoichiometry are conflicting. Interacts with NLRP10. Interacts with TANK; this interaction increases in response to DNA damage (PubMed:25861989). Interacts with USP10; this interaction increases in response to DNA damage (PubMed:25861989). Interacts with ZC3H12A; this interaction increases in response to DNA damage (PubMed:25861989). Interacts with IFIT5; the interaction synergizes the recruitment of IKK to MAP3K7 and enhances IKK phosphorylation (PubMed:26334375). Interacts with TRIM29; this interaction induces IKBKG/NEMO ubiquitination and proteolytic degradation (PubMed:27695001). Interacts with TRIM13; this interaction leads to IKBKG/NEMO ubiquitination (PubMed:25152375). Interacts with ARFIP2 (PubMed:26296658). Interacts with RIPK1 (By similarity). {ECO:0000250|UniProtKB:O88522, ECO:0000269|PubMed:11080499, ECO:0000269|PubMed:11389905, ECO:0000269|PubMed:11418127, ECO:0000269|PubMed:11971985, ECO:0000269|PubMed:12133833, ECO:0000269|PubMed:12917691, ECO:0000269|PubMed:14754897, ECO:0000269|PubMed:15456791, ECO:0000269|PubMed:16360037, ECO:0000269|PubMed:16497931, ECO:0000269|PubMed:17728323, ECO:0000269|PubMed:17977820, ECO:0000269|PubMed:18079694, ECO:0000269|PubMed:18164680, ECO:0000269|PubMed:18462684, ECO:0000269|PubMed:22099304, ECO:0000269|PubMed:22672233, ECO:0000269|PubMed:23453969, ECO:0000269|PubMed:25861989, ECO:0000269|PubMed:26296658, ECO:0000269|PubMed:26334375, ECO:0000269|PubMed:27695001}.; SUBUNIT: (Microbial infection) Interacts with Molluscum contagiosum virus protein MC005; this interaction inhibits NF-kappa-B activation. {ECO:0000269|PubMed:28490597}.; SUBUNIT: (Microbial infection) Interacts with HTLV-1 Tax oncoprotein; the interaction activates IKBKG. {ECO:0000269|PubMed:10364167, ECO:0000269|PubMed:11064457}.; SUBUNIT: (Microbial infection) Interacts with Shigella flexneri ipah9.8; the interaction promotes TNIP1-dependent 'Lys-27'-linked polyubiquitination of IKBKG which perturbs NF-kappa-B activation during bacterial infection. {ECO:0000269|PubMed:20010814}.",X,154541199,154565046,q28,0.084853,1.373,0.30062,0.030862,4.4669,0.6838797021564645,ENST00000594239,0.7814285714285715,0.11024743814046488,1260,,,,,,,0.19671077942358778,3.0770959869713965,Cells - Cultured fibroblasts,broadly expressed,1.4411594211082424,2.564570840243624,FALSE,discordant,Pre_higher_vs_Post,Pre_higher_vs_Post1,no difference_Pre_Post2,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:5974,IL13RA1,interleukin 13 receptor subunit alpha 1,Approved,,"IL-13Ra, NR4, CD213a1",Xq24,gene with protein product,protein-coding gene,ENSG00000131724,3597,ENSG00000131724,P78552,MGI:105052,RGD:628741,X,300119,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Binds with low affinity to interleukin-13 (IL13). Together with IL4RA can form a functional receptor for IL13. Also serves as an alternate accessory protein to the common cytokine receptor gamma chain for interleukin-4 (IL4) signaling, but cannot replace the function of IL2RG in allowing enhanced interleukin-2 (IL2) binding activity.",cell surface receptor signaling pathway [GO:0007166]; cytokine-mediated signaling pathway [GO:0019221]; oncostatin-M-mediated signaling pathway [GO:0038165]; positive regulation of cell population proliferation [GO:0008284],ciliary neurotrophic factor receptor binding [GO:0005127]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; leukemia inhibitory factor receptor activity [GO:0004923],SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.,"SUBUNIT: Interleukin-13 receptor is a complex of IL4R, IL13RA1, and possibly other components. Interacts with TRAF3IP1. {ECO:0000269|PubMed:10791955, ECO:0000269|PubMed:18243101}.",X,118727133,118794535,q24,0.96333,0.323,0.4541,0.52199,14.7,0.5627196316884384,ENST00000371666,0.7288161993769471,0.10977255686078481,1284,,,,,,,0.20605289642058275,6.554349405822667,Artery - Aorta,broadly expressed,3.359994775679603,2.1561911036764303,FALSE,low confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,no difference_Post1_Post2,no disorder
HGNC:5975,IL13RA2,interleukin 13 receptor subunit alpha 2,Approved,,"IL-13R, IL13BP, CD213a2, CT19",Xq23,gene with protein product,protein-coding gene,ENSG00000123496,3598,ENSG00000123496,Q14627,MGI:1277954,RGD:620838,X,300130,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Binds as a monomer with high affinity to interleukin-13 (IL13), but not to interleukin-4 (IL4). {ECO:0000269|PubMed:20223216}.",cytokine-mediated signaling pathway [GO:0019221]; immunoglobulin mediated immune response [GO:0016064]; negative regulation of immunoglobulin production [GO:0002638]; negative regulation of mast cell degranulation [GO:0043305],cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896],SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.,"",X,115003975,115019977,q23,4.021e-7,1.182,1.1446,0.76001,16.444,0.3302899473895298,ENST00000243213,0.5510936132983377,0.10759810047488128,1143,,,,,,,0.8333531927506783,5.705535628521214,Testis,tissue-specific,1.1032626266060845,0.261035490172882,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:5996,IL1RAPL1,interleukin 1 receptor accessory protein like 1,Approved,"IL1RAPL, MRX34, MRX21, MRX10","OPHN4, TIGIRR-2, IL1R8",Xp21.3-p21.2,gene with protein product,protein-coding gene,ENSG00000169306,11141,ENSG00000169306,Q9NZN1,MGI:2687319,RGD:727891,X,300206,TRUE,"Mental retardation, X-linked 21/34",300143,X-linked recessive,,,,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,TRUE,confirmed,"FUNCTION: May regulate secretion and presynaptic differentiation through inhibition of the activity of N-type voltage-gated calcium channel (PubMed:12783849). May activate the MAP kinase JNK (PubMed:15123616). Plays a role in neurite outgrowth (By similarity). During dendritic spine formation can bidirectionally induce pre- and post-synaptic differentiation of neurons by trans-synaptically binding to PTPRD (By similarity). {ECO:0000250|UniProtKB:P59823, ECO:0000250|UniProtKB:P59824, ECO:0000269|PubMed:12783849, ECO:0000269|PubMed:15123616}.",cellular response to cytokine stimulus [GO:0071345]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; negative regulation of exocytosis [GO:0045920]; neuron differentiation [GO:0030182]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of synapse assembly [GO:0051965]; presynaptic membrane assembly [GO:0097105]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; signal transduction [GO:0007165]; trans-synaptic signaling by trans-synaptic complex [GO:0099545],"NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; signaling receptor binding [GO:0005102]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:12783849}; Single-pass type I membrane protein {ECO:0000269|PubMed:12783849}. Cytoplasm {ECO:0000269|PubMed:12783849}. Cell projection, axon {ECO:0000250}. Cell projection, dendrite {ECO:0000250}. Note=May localize to the cell body and growth cones of dendrite-like processes. {ECO:0000250}.","SUBUNIT: Homodimer (PubMed:15123616). Interacts (calcium-independent) with NCS1 (PubMed:12783849). Interacts (via the first immunoglobilin domain) with PTPRD (via the second immunoglobilin domain); this interaction is PTPRD-splicing-dependent and induces pre- and post-synaptic differentiation of neurons and is required for IL1RAPL1-mediated synapse formation (By similarity). {ECO:0000250|UniProtKB:P59823, ECO:0000269|PubMed:12783849, ECO:0000269|PubMed:15123616}.",X,28587446,29956718,p21.3,0.99886,0.197,-0.0065702,2.7685,24.08,0.39761647984138915,ENST00000378993,0.9675753228120516,0.5832041989502624,2091,1,"IL1RAPL2 (61, 62, chrX)",TRUE,,,,0.9036776934287272,1.7687813975403435,Nerve - Tibial,tissue-specific,0.7421071312948425,0.5017830579488577,FALSE,discordant,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:5997,IL1RAPL2,interleukin 1 receptor accessory protein like 2,Approved,,"IL-1R9, TIGIRR-1, IL1RAPL-2, IL1R9",Xq22.3,gene with protein product,protein-coding gene,ENSG00000189108,26280,ENSG00000189108,Q9NP60,MGI:1913106,RGD:1561761,X,300277,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",central nervous system development [GO:0007417],"interleukin-1, type II, blocking receptor activity [GO:0004910]; interleukin-1 receptor activity [GO:0004908]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]",SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.,"",X,104566199,105767829,q22.3,0.98424,0.294,0.079642,1.9994,21.425,0.5526283976983685,ENST00000372582,0.9524987869966036,0.151137215696076,2061,1,"IL1RAPL1 (62, 61, chrX)",TRUE,,,,0.8363744815854872,0.4837141563720712,Testis,tissue-specific,0.06758351346126472,0.0549492364374587,FALSE,discordant,Pre_higher_vs_Post,Pre_higher_vs_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:6010,IL2RG,interleukin 2 receptor subunit gamma,Approved,"SCIDX1, IMD4, CIDX",CD132,Xq13.1,gene with protein product,protein-coding gene,ENSG00000147168,3561,ENSG00000147168,P31785,MGI:96551,RGD:621466,X,308380,TRUE,"Combined immunodeficiency, X-linked, moderate // Severe combined immunodeficiency, X-linked",312863 // 300400,X-linked recessive // X-linked recessive,,,,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Common subunit for the receptors for a variety of interleukins. Probably in association with IL15RA, involved in the stimulation of neutrophil phagocytosis by IL15 (PubMed:15123770). {ECO:0000269|PubMed:15123770}.",cytokine-mediated signaling pathway [GO:0019221]; immune response [GO:0006955]; interleukin-15-mediated signaling pathway [GO:0035723]; interleukin-21-mediated signaling pathway [GO:0038114]; interleukin-2-mediated signaling pathway [GO:0038110]; interleukin-4-mediated signaling pathway [GO:0035771]; interleukin-7-mediated signaling pathway [GO:0038111]; interleukin-9-mediated signaling pathway [GO:0038113]; MAPK cascade [GO:0000165]; positive regulation of phagocytosis [GO:0050766]; signal transduction [GO:0007165]; viral process [GO:0016032],cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; interleukin-15 receptor activity [GO:0042010]; interleukin-2 binding [GO:0019976],SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:15123770}; Single-pass type I membrane protein {ECO:0000255}. Cell surface {ECO:0000269|PubMed:15123770}.,"SUBUNIT: The gamma subunit is common to the IL2, IL4, IL7, IL15, IL21 and probably also the IL13 receptors. Interacts with SHB upon interleukin stimulation. {ECO:0000269|PubMed:12200137, ECO:0000269|PubMed:16293754, ECO:0000269|PubMed:16477002}.; SUBUNIT: (Microbial infection) Interacts with HTLV-1 accessory protein p12I. {ECO:0000269|PubMed:8648694}.",X,71107404,71112108,q13.1,0.99152,0.209,0.066477,1.4894,14.282,0.17266951497575986,ENST00000374202,0.7451351351351352,0.27058235441139716,1110,1,"AL590764.2 (85, 92, chrX)",TRUE,1,"AL590764.2 (85, 92, chrX)",TRUE,0.6616851628805781,8.68532698486845,Whole Blood,tissue-specific,1.0059676115959308,0.7335894915876555,FALSE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:6012,IL3RA,interleukin 3 receptor subunit alpha,Approved,,CD123,Xp22.3 and Yp13.3,gene with protein product,protein-coding gene,ENSG00000185291,3563,ENSG00000185291,P26951,MGI:96553,RGD:628728,X,"308385, 430000",FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,TRUE,,no disorder,FUNCTION: This is a receptor for interleukin-3.,cytokine-mediated signaling pathway [GO:0019221]; MAPK cascade [GO:0000165],cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; interleukin-3 receptor activity [GO:0004912],SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.,"SUBUNIT: Heterodimer of an alpha and a beta subunit. The beta subunit is common to the IL3, IL5 and GM-CSF receptors.",X,1336616,1382689,p22.33,2.9891e-27,1.881,-4.261,-1.5017,22.977,0.3562828640228021,ENST00000331035,0.02216358839050132,0.01949512621844539,1137,,,,,,,0.33097570454440556,5.7271934797798,Lung,broadly expressed,2.488196202914026,4.080670453138186,FALSE,low confidence escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:6030,IL9R,interleukin 9 receptor,Approved,,CD129,Xq28 and Yq12,gene with protein product,protein-coding gene,ENSG00000124334,3581,ENSG00000124334,Q01113,MGI:96564,RGD:2907,X,300007,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,TRUE,,no disorder,FUNCTION: This is a receptor for interleukin-9.,interleukin-9-mediated signaling pathway [GO:0038113]; regulation of cell population proliferation [GO:0042127]; signal transduction [GO:0007165],interleukin-9 receptor activity [GO:0004919],SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane protein. Secreted.,"",X,155997581,156010817,q28,2.6805e-22,1.868,-2.3953,-2.2716,19.562,0.17483909946207837,ENST00000244174,0.26143039591315453,0.03901524618845289,1566,,,,,,,0.8970516735916073,1.6923647037579135,Cells - EBV-transformed lymphocytes,tissue-specific,0,0.04647918611191029,FALSE,discordant,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:61,ABCD1,ATP binding cassette subfamily D member 1,Approved,ALD,"AMN, ALDP, adrenoleukodystrophy",Xq28,gene with protein product,protein-coding gene,ENSG00000101986,215,ENSG00000101986,P33897,MGI:1349215,RGD:1562128,X,300371,TRUE,"Adrenoleukodystrophy // Adrenomyeloneuropathy, adult",300100 // 300100,X-linked recessive // X-linked recessive,,,,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Plays a role in the transport of free very-long-chain fatty acids (VLCFAs) as well as their CoA-esters across the peroxisomal membrane by acting as an ATP-specific binding subunit releasing ADP after ATP hydrolysis (PubMed:15682271, PubMed:11248239, PubMed:16946495, PubMed:18757502). Thus, plays a role in regulation of VLCFAs and energy metabolism namely, in the degradation and biosynthesis of fatty acids by beta-oxidation, mitochondrial function and microsomal fatty acid elongation (PubMed:23671276). Involved in several processes; namely, controls the active myelination phase by negatively regulating the microsomal fatty acid elongation activity and may also play a role in axon and myelin maintenance. Controls also the cellular response to oxidative stress by regulating mitochondrial function like, mitochondrial oxidative phosphorylation and depolarization. And finally controls the inflammatory response by positively regulating peroxisomal beta-oxidation of VLCFAs (By similarity). {ECO:0000250|UniProtKB:P48410, ECO:0000269|PubMed:11248239, ECO:0000269|PubMed:15682271, ECO:0000269|PubMed:16946495, ECO:0000269|PubMed:18757502, ECO:0000269|PubMed:23671276}.",alpha-linolenic acid metabolic process [GO:0036109]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid elongation [GO:0030497]; fatty acid homeostasis [GO:0055089]; linoleic acid metabolic process [GO:0043651]; long-chain fatty acid catabolic process [GO:0042758]; long-chain fatty acid import into peroxisome [GO:0015910]; myelin maintenance [GO:0043217]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; neuron projection maintenance [GO:1990535]; peroxisomal membrane transport [GO:0015919]; peroxisome organization [GO:0007031]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of unsaturated fatty acid biosynthetic process [GO:2001280]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of fatty acid beta-oxidation [GO:0031998]; regulation of mitochondrial depolarization [GO:0051900]; regulation of oxidative phosphorylation [GO:0002082]; sterol homeostasis [GO:0055092]; transmembrane transport [GO:0055085]; very long-chain fatty acid catabolic process [GO:0042760]; very long-chain fatty-acyl-CoA catabolic process [GO:0036113],ADP binding [GO:0043531]; ATPase activity [GO:0016887]; ATPase-coupled fatty-acyl-CoA transmembrane transporter activity [GO:0015607]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; long-chain fatty acid transporter activity [GO:0005324]; protein homodimerization activity [GO:0042803],"SUBCELLULAR LOCATION: Peroxisome membrane {ECO:0000269|PubMed:10777694, ECO:0000269|PubMed:16946495, ECO:0000269|PubMed:17609205, ECO:0000269|PubMed:18757502}; Multi-pass membrane protein {ECO:0000255}. Mitochondrion membrane {ECO:0000269|PubMed:16946495}; Multi-pass membrane protein. Lysosome membrane {ECO:0000269|PubMed:16946495}; Multi-pass membrane protein. Endoplasmic reticulum membrane {ECO:0000269|PubMed:16946495}; Multi-pass membrane protein.","SUBUNIT: Can form homooligomers, homodimers and heterodimers with ABCD2/ALDR and ABCD3/PMP70. Dimerization is necessary to form an active transporter (PubMed:17609205, PubMed:10551832). Interacts with PEX19; facilitates ABCD1 insertion into the peroxisome membrane (PubMed:10777694, PubMed:10704444). {ECO:0000269|PubMed:10551832, ECO:0000269|PubMed:10704444, ECO:0000269|PubMed:10777694, ECO:0000269|PubMed:17609205, ECO:0000305|PubMed:18757502}.",X,153724856,153744755,q28,0.99896,0.15,0.44075,1.8659,19.909,0.6208119195888561,ENST00000218104,0.7683646112600536,0.24553861534616347,2238,1,"ABCD2 (63, 64, chr12)",TRUE,,,,0.31024672979766804,5.344867545793411,Testis,broadly expressed,1.846501339272337,1.603171731710161,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post1_higher_vs_Post2,confirmed monogenic disorder
HGNC:6106,FOXP3,forkhead box P3,Approved,IPEX,"JM2, XPID, AIID, PIDX, DIETER, SCURFIN",Xp11.23,gene with protein product,protein-coding gene,ENSG00000049768,50943,ENSG00000049768,Q9BZS1,MGI:1891436,RGD:1562112,X,300292,TRUE,"Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked",304790,X-linked recessive,,,,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Transcriptional regulator which is crucial for the development and inhibitory function of regulatory T-cells (Treg). Plays an essential role in maintaining homeostasis of the immune system by allowing the acquisition of full suppressive function and stability of the Treg lineage, and by directly modulating the expansion and function of conventional T-cells. Can act either as a transcriptional repressor or a transcriptional activator depending on its interactions with other transcription factors, histone acetylases and deacetylases. The suppressive activity of Treg involves the coordinate activation of many genes, including CTLA4 and TNFRSF18 by FOXP3 along with repression of genes encoding cytokines such as interleukin-2 (IL2) and interferon-gamma (IFNG). Inhibits cytokine production and T-cell effector function by repressing the activity of two key transcription factors, RELA and NFATC2 (PubMed:15790681). Mediates transcriptional repression of IL2 via its association with histone acetylase KAT5 and histone deacetylase HDAC7 (PubMed:17360565). Can activate the expression of TNFRSF18, IL2RA and CTLA4 and repress the expression of IL2 and IFNG via its association with transcription factor RUNX1 (PubMed:17377532). Inhibits the differentiation of IL17 producing helper T-cells (Th17) by antagonizing RORC function, leading to down-regulation of IL17 expression, favoring Treg development (PubMed:18368049). Inhibits the transcriptional activator activity of RORA (PubMed:18354202). Can repress the expression of IL2 and IFNG via its association with transcription factor IKZF4 (By similarity). {ECO:0000250|UniProtKB:Q99JB6, ECO:0000269|PubMed:15790681, ECO:0000269|PubMed:17360565, ECO:0000269|PubMed:17377532, ECO:0000269|PubMed:18354202, ECO:0000269|PubMed:18368049, ECO:0000269|PubMed:21458306, ECO:0000269|PubMed:23169781}.","B cell homeostasis [GO:0001782]; CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment [GO:0002362]; chromatin remodeling [GO:0006338]; cytokine production [GO:0001816]; myeloid cell homeostasis [GO:0002262]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chronic inflammatory response [GO:0002677]; negative regulation of CREB transcription factor activity [GO:0032792]; negative regulation of cytokine biosynthetic process [GO:0042036]; negative regulation of cytokine secretion [GO:0050710]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of histone acetylation [GO:0035067]; negative regulation of histone deacetylation [GO:0031064]; negative regulation of immune response [GO:0050777]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of interleukin-4 production [GO:0032713]; negative regulation of interleukin-5 production [GO:0032714]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of isotype switching to IgE isotypes [GO:0048294]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of T cell cytokine production [GO:0002725]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation [GO:0032831]; positive regulation of histone acetylation [GO:0035066]; positive regulation of immature T cell proliferation in thymus [GO:0033092]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of peripheral T cell tolerance induction [GO:0002851]; positive regulation of T cell anergy [GO:0002669]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta1 production [GO:0032914]; regulation of isotype switching to IgG isotypes [GO:0048302]; regulation of regulatory T cell differentiation [GO:0045589]; regulation of T cell anergy [GO:0002667]; regulation of transcription, DNA-templated [GO:0006355]; regulation of Wnt signaling pathway [GO:0030111]; response to virus [GO:0009615]; T cell activation [GO:0042110]; T cell homeostasis [GO:0043029]; T cell mediated immunity [GO:0002456]; T cell receptor signaling pathway [GO:0050852]; tolerance induction to self antigen [GO:0002513]","DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone acetyltransferase binding [GO:0035035]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; NFAT protein binding [GO:0051525]; NF-kappaB binding [GO:0051059]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription corepressor activity [GO:0003714]","SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00089, ECO:0000269|PubMed:17360565, ECO:0000269|PubMed:18354202, ECO:0000269|PubMed:22678915, ECO:0000269|PubMed:23396208, ECO:0000269|PubMed:23973222, ECO:0000269|PubMed:23973223}. Cytoplasm {ECO:0000269|PubMed:22678915}. Note=Predominantly expressed in the cytoplasm in activated conventional T-cells whereas predominantly expressed in the nucleus in regulatory T-cells (Treg). The 41 kDa form derived by proteolytic processing is found exclusively in the chromatin fraction of activated Treg cells (By similarity). {ECO:0000250|UniProtKB:Q99JB6, ECO:0000269|PubMed:22678915}.","SUBUNIT: Homodimer (PubMed:21458306, PubMed:25567984). Dimerization is essential for its transcriptional regulator activity (PubMed:21458306). Interacts with IKZF3. Isoform 1 (via LXXLL motif), but not isoform 2, interacts with isoform 4 of RORA (via AF-2 motif). Interacts with STUB1, HSPA8 and HSPA1A/B. Interacts with PPP1CA, PPP1CB and PPP1CG. Interacts with KAT5 and HDAC7. Interacts with HDAC9 in the absence of T-cell stimulation. Interacts with USP7. Interacts with isoform 2 of ZFP90 and can form a complex with TRIM28 in the presence of isoform 2 of ZFP90. Interacts with RUNX1. Interacts with RORC. Interacts with RELA and NFATC2. Interacts with RUNX2, RUNX3 and IKZF4 (By similarity). {ECO:0000250|UniProtKB:Q99JB6, ECO:0000269|PubMed:15790681, ECO:0000269|PubMed:17360565, ECO:0000269|PubMed:17377532, ECO:0000269|PubMed:18354202, ECO:0000269|PubMed:18368049, ECO:0000269|PubMed:20676092, ECO:0000269|PubMed:21458306, ECO:0000269|PubMed:23396208, ECO:0000269|PubMed:23543754, ECO:0000269|PubMed:23973222, ECO:0000269|PubMed:23973223, ECO:0000269|PubMed:25567984}.",X,49250438,49270477,p11.23,0.99424,0.195,1.1916,1.6724,15.325,0.25037310501924437,ENST00000376207,0.7746141975308642,0.30752311922019493,1296,,,,,,,0.6719905461946462,1.9423906393745778,Testis,tissue-specific,0.6063578907840296,1.3663977570264905,FALSE,high confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:6112,IRAK1,interleukin 1 receptor associated kinase 1,Approved,,"IRAK, pelle",Xq28,gene with protein product,protein-coding gene,ENSG00000184216,3654,ENSG00000184216,P51617,MGI:107420,RGD:1563841,X,300283,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Serine/threonine-protein kinase that plays a critical role in initiating innate immune response against foreign pathogens. Involved in Toll-like receptor (TLR) and IL-1R signaling pathways. Is rapidly recruited by MYD88 to the receptor-signaling complex upon TLR activation. Association with MYD88 leads to IRAK1 phosphorylation by IRAK4 and subsequent autophosphorylation and kinase activation. Phosphorylates E3 ubiquitin ligases Pellino proteins (PELI1, PELI2 and PELI3) to promote pellino-mediated polyubiquitination of IRAK1. Then, the ubiquitin-binding domain of IKBKG/NEMO binds to polyubiquitinated IRAK1 bringing together the IRAK1-MAP3K7/TAK1-TRAF6 complex and the NEMO-IKKA-IKKB complex. In turn, MAP3K7/TAK1 activates IKKs (CHUK/IKKA and IKBKB/IKKB) leading to NF-kappa-B nuclear translocation and activation. Alternatively, phosphorylates TIRAP to promote its ubiquitination and subsequent degradation. Phosphorylates the interferon regulatory factor 7 (IRF7) to induce its activation and translocation to the nucleus, resulting in transcriptional activation of type I IFN genes, which drive the cell in an antiviral state. When sumoylated, translocates to the nucleus and phosphorylates STAT3. {ECO:0000269|PubMed:11397809, ECO:0000269|PubMed:12860405, ECO:0000269|PubMed:14684752, ECO:0000269|PubMed:15084582, ECO:0000269|PubMed:15465816, ECO:0000269|PubMed:15767370, ECO:0000269|PubMed:17997719, ECO:0000269|PubMed:20400509}.",activation of MAPK activity [GO:0000187]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; aging [GO:0007568]; cellular response to heat [GO:0034605]; cellular response to hypoxia [GO:0071456]; cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of apoptotic process [GO:0043066]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of type I interferon production [GO:0032481]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cytokine-mediated signaling pathway [GO:0001959]; response to interleukin-1 [GO:0070555]; response to lipopolysaccharide [GO:0032496]; toll-like receptor 2 signaling pathway [GO:0034134]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor 9 signaling pathway [GO:0034162]; toll-like receptor signaling pathway [GO:0002224]; type I interferon signaling pathway [GO:0060337]; viral process [GO:0016032],ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; NF-kappaB-inducing kinase activity [GO:0004704]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16690127}. Nucleus {ECO:0000269|PubMed:16690127}. Lipid droplet {ECO:0000250}. Note=Translocates to the nucleus when sumoylated. RSAD2/viperin recruits it to the lipid droplet (By similarity). {ECO:0000250}.,"SUBUNIT: Homodimer (By similarity). Forms a complex with TRAF6, PELI1, IRAK4 and MYD88 (PubMed:16951688). Direct binding of SMAD6 to PELI1 prevents complex formation and hence negatively regulates IL1R-TLR signaling and eventually NF-kappa-B-mediated gene expression (PubMed:16951688). The TRAF6-PELI1-IRAK4-MYD88 complex recruits MAP3K7/TAK1, TAB1 and TAB2 to mediate NF-kappa-B activation (PubMed:16951688). Interaction with MYD88 recruits IRAK1 to the stimulated receptor complex (PubMed:9430229). Interacts with TOLLIP; this interaction occurs in the cytosol prior to receptor activation (PubMed:10854325). Interacts with IL1RL1 (PubMed:16286016). Interacts with PELI1 and TRAF6 (PubMed:12496252). Interacts (when polyubiquitinated) with IKBKG/NEMO (PubMed:18347055). Interacts with RSAD2/viperin (By similarity). Interacts with IRAK1BP1 (By similarity). Interacts with PELI2 (By similarity). Interacts with ZC3H12A; this interaction increases the interaction between ZC3H12A and IKBKB/IKKB (By similarity). Interacts with IRAK4 (PubMed:11960013). Interacts with PELI3 (PubMed:12874243). Interacts with INAVA; the interaction takes place upon PRR stimulation (PubMed:28436939). Interacts (via C-terminus) with NFATC4 (via N-terminus) (PubMed:18691762). {ECO:0000250|UniProtKB:Q62406, ECO:0000269|PubMed:10854325, ECO:0000269|PubMed:11960013, ECO:0000269|PubMed:12496252, ECO:0000269|PubMed:12874243, ECO:0000269|PubMed:16286016, ECO:0000269|PubMed:16951688, ECO:0000269|PubMed:18347055, ECO:0000269|PubMed:18691762, ECO:0000269|PubMed:28436939, ECO:0000269|PubMed:29883609, ECO:0000269|PubMed:9430229}.; SUBUNIT: (Microbial infection) Interacts with mumps virus protein SH; this interaction inhibits downstream NF-kappa-B pathway activation. {ECO:0000269|PubMed:28659487}.",X,154010506,154019902,q28,0.98774,0.285,0.6256,1.9888,22.106,0.5310029601527577,ENST00000369980,0.47367928938756426,0.22449387653086728,2139,,,,,,,0.20712508151969564,7.084074897820051,Cells - Cultured fibroblasts,broadly expressed,4.616575308260575,4.973011941298907,FALSE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:6128,IRS4,insulin receptor substrate 4,Approved,,"PY160, IRS-4",Xq22.3,gene with protein product,protein-coding gene,ENSG00000133124,8471,ENSG00000133124,O14654,MGI:1338009,RGD:1562442,X,300904,TRUE,"Hypothyroidism, congenital, nongoitrous, 9",301035,X-linked recessive,,,,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,TRUE,confirmed,"FUNCTION: Acts as an interface between multiple growth factor receptors possessing tyrosine kinase activity, such as insulin receptor, IGF1R and FGFR1, and a complex network of intracellular signaling molecules containing SH2 domains. Involved in the IGF1R mitogenic signaling pathway. Promotes the AKT1 signaling pathway and BAD phosphorylation during insulin stimulation without activation of RPS6KB1 or the inhibition of apoptosis. Interaction with GRB2 enhances insulin-stimulated mitogen-activated protein kinase activity. May be involved in nonreceptor tyrosine kinase signaling in myoblasts. Plays a pivotal role in the proliferation/differentiation of hepatoblastoma cell through EPHB2 activation upon IGF1 stimulation. May play a role in the signal transduction in response to insulin and to a lesser extent in response to IL4 and GH on mitogenesis. Plays a role in growth, reproduction and glucose homeostasis. May act as negative regulators of the IGF1 signaling pathway by suppressing the function of IRS1 and IRS2. {ECO:0000269|PubMed:10531310, ECO:0000269|PubMed:10594015, ECO:0000269|PubMed:12639902, ECO:0000269|PubMed:17408801, ECO:0000269|PubMed:9553137}.",insulin receptor signaling pathway [GO:0008286]; signal transduction [GO:0007165],insulin receptor binding [GO:0005158]; phosphatidylinositol 3-kinase binding [GO:0043548],SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:9553137}; Peripheral membrane protein {ECO:0000269|PubMed:9553137}; Cytoplasmic side {ECO:0000269|PubMed:9553137}.,"SUBUNIT: Interacts with SOCS6 in response to stimulation with either insulin or IGF1 (By similarity). Interacts with CRK and CRKL. Interaction with CRK is stronger than with CRKL. Interacts with CRK via the phosphorylated YXXM motifs. Interacts with GRB2 and PIK3R1. Interacts with PLC-gamma, SHC1, PTK6, PPP4C and NISCH. {ECO:0000250, ECO:0000269|PubMed:10594015, ECO:0000269|PubMed:11316748, ECO:0000269|PubMed:11912194, ECO:0000269|PubMed:15316024, ECO:0000269|PubMed:15331607, ECO:0000269|PubMed:15870689, ECO:0000269|PubMed:9553137, ECO:0000269|PubMed:9614078}.",X,108732482,108736409,q22.3,0.57796,0.43,-3.5621,0.089282,24.438,0.6484199030782881,ENST00000372129,0.6381822999470058,0.4485378655336166,3774,,,,,,,0.9178565308108433,3.394666415347471,Pituitary,tissue-specific,0.13561353619442645,0,FALSE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:6154,ITGB1BP2,integrin subunit beta 1 binding protein 2,Approved,,CHORDC3,Xq13.1,gene with protein product,protein-coding gene,ENSG00000147166,26548,ENSG00000147166,Q9UKP3,MGI:1353420,RGD:1565015,X,300332,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May play a role during maturation and/or organization of muscles cells.,muscle organ development [GO:0007517]; signal transduction [GO:0007165],calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; SH3 domain binding [GO:0017124]; zinc ion binding [GO:0008270],"","SUBUNIT: Interacts with beta-1 integrin subunit. This interaction is regulated by divalent cations, and it occurs only in absence of calcium.",X,71301750,71305371,q13.1,2.5951e-8,1.336,1.166,0.77906,15.459,0.19561815336463223,ENST00000373829,0.9308429118773947,0.48430392401899525,1044,,,,,,,0.6753121779392363,5.691698859479988,Heart - Atrial Appendage,tissue-specific,0.31384950931774236,1.4453850555940653,FALSE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:6173,ITM2A,integral membrane protein 2A,Approved,,"BRICD2A, E25A",Xq21.1,gene with protein product,protein-coding gene,ENSG00000078596,9452,ENSG00000078596,O43736,MGI:107706,RGD:1559423,X,300222,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",immunoglobulin production [GO:0002377]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; plasma cell differentiation [GO:0002317],amyloid-beta binding [GO:0001540],SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type II membrane protein {ECO:0000305}.,"",X,79360384,79367667,q21.1,0.19657,0.933,-0.93526,0.13432,6.7474,0.3663202102987574,ENST00000373298,0.9,0.21249687578105475,792,,,,,,,0.3161875831778354,7.39376797581875,Ovary,broadly expressed,5.716395591327566,4.807308548971719,FALSE,low confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,no difference_Post1_Post2,no disorder
HGNC:6211,ANOS1,anosmin 1,Approved,"KAL, ADMLX, KAL1","KALIG-1, WFDC19",Xp22.31,gene with protein product,protein-coding gene,ENSG00000011201,3730,ENSG00000011201,P23352,,RGD:2318138,X,300836,TRUE,Hypogonadotropic hypogonadism 1 with or without anosmia (Kallmann syndrome 1),308700,X-linked recessive,,,,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,TRUE,confirmed,"FUNCTION: Has a dual branch-promoting and guidance activity, which may play an important role in the patterning of mitral and tufted cell collaterals to the olfactory cortex (By similarity). Chemoattractant for fetal olfactory epithelial cells. {ECO:0000250, ECO:0000269|PubMed:19696444}.",axon guidance [GO:0007411]; cell adhesion [GO:0007155]; chemotaxis [GO:0006935]; fibroblast growth factor receptor signaling pathway [GO:0008543]; neuron differentiation [GO:0030182],extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; serine-type endopeptidase inhibitor activity [GO:0004867],SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:8842728}; Peripheral membrane protein {ECO:0000269|PubMed:8842728}. Secreted {ECO:0000269|PubMed:8842728}. Note=Proteolytic cleavage may release it from the cell surface into the extracellular space.,"SUBUNIT: Interacts with FGFR1; this interaction does not interfere with FGF2-binding to FGFR1. Binds heparin. Heparin may promote or interfere with ANOS1-FGFR1-FGF2 complex formation depending on the sequential order of its binding to the various constituents. For instance, heparin-ANOS1 interaction favors subsequent binding to pre-existing binary FGFR1-FGF2 complex, while heparin-FGF2 complex does not interact with ANOS1-FGFR1. {ECO:0000269|PubMed:19696444}.",X,8528874,8732137,p22.31,0.99793,0.248,0.092754,0.885,31.301,0.6324275747372032,ENST00000262648,0.8152227116984826,0.06723319170207448,2043,,,,,,,0.644587539368644,3.7096655994640515,Lung,tissue-specific,2.648840448976284,1.0024818242587625,FALSE,high confidence escapee,no_difference_Pre_Post,Pre_higher_vs_Post1,no difference_Pre_Post2,Post1_higher_vs_Post2,confirmed monogenic disorder
HGNC:6237,KCND1,potassium voltage-gated channel subfamily D member 1,Approved,,Kv4.1,Xp11.23,gene with protein product,protein-coding gene,ENSG00000102057,3750,ENSG00000102057,Q9NSA2,MGI:96671,RGD:621364,X,300281,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Pore-forming (alpha) subunit of voltage-gated rapidly inactivating A-type potassium channels. May contribute to I(To) current in heart and I(Sa) current in neurons. Channel properties are modulated by interactions with other alpha subunits and with regulatory subunits.,cardiac conduction [GO:0061337]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765],A-type (transient outward) potassium channel activity [GO:0005250]; metal ion binding [GO:0046872]; voltage-gated potassium channel activity [GO:0005249],"SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein. Cell projection, dendrite {ECO:0000250}.","SUBUNIT: Homotetramer or heterotetramer with KCND2 and/or KCND3. Associates with the regulatory subunits KCNIP1, KCNIP2, KCNIP3 and KCNIP4 (By similarity). Interacts with DPP10 (Probable). {ECO:0000250, ECO:0000305}.",X,48961378,48971844,p11.23,0.25536,0.561,0.58344,1.9266,16.331,0.27993027191408687,ENST00000218176,0.82690329218107,0.306848287928018,1944,2,"KCND3 (66, 65, chr1); KCND2 (65, 67, chr7)",TRUE,,,,0.5609171332817964,4.170253577892951,Cerebellar_tissues,broadly expressed,1.2614285141578396,4.170253577892951,TRUE,high confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,no difference_Post1_Post2,no disorder
HGNC:6241,KCNE5,potassium voltage-gated channel subfamily E regulatory subunit 5,Approved,KCNE1L,,Xq23,gene with protein product,protein-coding gene,ENSG00000176076,23630,ENSG00000176076,Q9UJ90,MGI:1913490,RGD:1583501,X,300328,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Potassium channel ancillary subunit that is essential for generation of some native K(+) currents by virtue of formation of heteromeric ion channel complex with voltage-gated potassium (Kv) channel pore-forming alpha subunits. Functions as an inhibitory beta-subunit of the repolarizing cardiac potassium ion channel KCNQ1. {ECO:0000269|PubMed:12324418}.,atrial cardiac muscle cell action potential [GO:0086014]; cardiac muscle contraction [GO:0060048]; membrane repolarization during action potential [GO:0086011]; membrane repolarization during ventricular cardiac muscle cell action potential [GO:0098915]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of potassium ion export across plasma membrane [GO:1903765]; negative regulation of potassium ion transmembrane transport [GO:1901380]; positive regulation of potassium ion transmembrane transport [GO:1901381]; potassium ion export across plasma membrane [GO:0097623]; regulation of atrial cardiac muscle cell membrane repolarization [GO:0060372]; regulation of cation channel activity [GO:2001257]; regulation of heart contraction [GO:0008016]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization [GO:0060306]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; ventricular cardiac muscle cell action potential [GO:0086005],ion channel binding [GO:0044325]; potassium channel regulator activity [GO:0015459]; voltage-gated potassium channel activity [GO:0005249],SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:20533308}; Single-pass type I membrane protein {ECO:0000305}.,"SUBUNIT: Interacts with KCNQ1; impairs KCNQ1 localization in lipid rafts and only conducts current upon strong and continued depolarization. {ECO:0000269|PubMed:12324418, ECO:0000269|PubMed:20533308}.",X,109623700,109625172,q23,0.11854,1.831,1.3181,0.40656,1.5281,0.403229015511053,ENST00000372101,0.5655011655011655,0.23729067733066733,429,,,,,,,0.7969076604964389,2.8118932961213314,Cerebellar_tissues,tissue-specific,2.383496944155365,2.8118932961213314,TRUE,low confidence non-escapee,no_difference_Pre_Post,Post1_higher_vs_Pre,no difference_Pre_Post2,Post1_higher_vs_Post2,no disorder
HGNC:630,SHROOM2,shroom family member 2,Approved,APXL,,Xp22.2,gene with protein product,protein-coding gene,ENSG00000146950,357,ENSG00000146950,Q13796,MGI:107194,RGD:1565163,X,300103,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: May be involved in endothelial cell morphology changes during cell spreading. In the retinal pigment epithelium, may regulate the biogenesis of melanosomes and promote their association with the apical cell surface by inducing gamma-tubulin redistribution (By similarity). {ECO:0000250}.",actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; apical protein localization [GO:0045176]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; camera-type eye morphogenesis [GO:0048593]; cell migration [GO:0016477]; cellular pigment accumulation [GO:0043482]; ear development [GO:0043583]; establishment of melanosome localization [GO:0032401]; eye pigment granule organization [GO:0008057]; lens morphogenesis in camera-type eye [GO:0002089]; melanosome organization [GO:0032438],actin binding [GO:0003779]; actin filament binding [GO:0051015]; beta-catenin binding [GO:0008013]; ligand-gated sodium channel activity [GO:0015280],"SUBCELLULAR LOCATION: Apical cell membrane {ECO:0000250}. Cell junction, tight junction {ECO:0000250}. Cytoplasm, cytoskeleton {ECO:0000250}. Note=Associates with cortical F-actin. {ECO:0000250}.",SUBUNIT: Interacts with F-actin. {ECO:0000250}.,X,9786429,9949443,p22.2,0.0029403,0.528,-1.2551,-0.32535,34.475,0.796695524246025,ENST00000380913,0.5111935683364255,0.06628342914271432,4851,,,,,,,0.5824592036265928,3.4005201690240927,Ovary,broadly expressed,2.044513027503858,1.4789588660059432,FALSE,variable escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,no difference_Pre_Post2,Post2_higher_vs_Post1,no disorder
HGNC:6351,KLF8,Kruppel like factor 8,Approved,,"BKLF3, ZNF741, DXS741",Xp11.21,gene with protein product,protein-coding gene,ENSG00000102349,11279,ENSG00000102349,O95600,MGI:2442430,RGD:1565831,X,300286,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Transcriptional repressor and activator. Binds to CACCC-boxes promoter elements. Also binds the GT-box of cyclin D1 promoter and mediates cell cycle progression at G(1) phase as a downstream target of focal adhesion kinase (FAK). {ECO:0000269|PubMed:10756197, ECO:0000269|PubMed:12820964, ECO:0000269|PubMed:16617055}.",negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription regulatory region sequence-specific DNA binding [GO:0000976]",SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:16617055}.,"SUBUNIT: Interacts with corepressor CtBP2. Interacts with PIAS1, PIAS2, AND PIAS4; the interaction with each ligase sumoylates KLF8. {ECO:0000269|PubMed:10756197, ECO:0000269|PubMed:16617055}.",X,56232356,56291531,p11.21,0.0022471,1.313,-0.2285,0.38121,7.9701,0.35945857081386706,ENST00000468660,0.6686111111111112,0.2686328417895526,1080,,,,,,,0.3772298845395625,5.311234256228929,Skin - Not Sun Exposed (Suprapubic),broadly expressed,1.2470768319308174,2.5126655710637174,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:6355,KLHL4,kelch like family member 4,Approved,,"KIAA1687, DKELCHL, KHL4",Xq21.31,gene with protein product,protein-coding gene,ENSG00000102271,56062,ENSG00000102271,Q9C0H6,MGI:2442829,RGD:1565441,X,300348,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","",actin binding [GO:0003779],"SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton.","",X,87517409,87670050,q21.31,0.66283,0.436,-0.89795,0.8917,20.996,0.2745907114125837,ENST00000373119,0.8988873435326843,0.2513871532116971,2157,2,"KLHL1 (65, 62, chr13); KLHL5 (63, 60, chr4)",TRUE,,,,0.839925185142069,5.004254180316652,Adrenal Gland,tissue-specific,2.031448131766238,0.8623799739216685,FALSE,low confidence non-escapee,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:644,AR,androgen receptor,Approved,"DHTR, SBMA","AIS, NR3C4, SMAX1, HUMARA",Xq12,gene with protein product,protein-coding gene,ENSG00000169083,367,ENSG00000169083,P10275,MGI:88064,RGD:2147,X,313700,TRUE,"Androgen insensitivity // Androgen insensitivity, partial, with or without breast cancer // Hypospadias 1, X-linked // Spinal and bulbar muscular atrophy of Kennedy",300068 // 312300 // 300633 // 313200,X-linked recessive // X-linked recessive // X-linked recessive // X-linked recessive,"{Prostate cancer, susceptibility to}",176807,"Somatic mutation, Autosomal dominant",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Steroid hormone receptors are ligand-activated transcription factors that regulate eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Transcription factor activity is modulated by bound coactivator and corepressor proteins like ZBTB7A that recruits NCOR1 and NCOR2 to the androgen response elements/ARE on target genes, negatively regulating androgen receptor signaling and androgen-induced cell proliferation (PubMed:20812024). Transcription activation is also down-regulated by NR0B2. Activated, but not phosphorylated, by HIPK3 and ZIPK/DAPK3. {ECO:0000269|PubMed:14664718, ECO:0000269|PubMed:15563469, ECO:0000269|PubMed:17591767, ECO:0000269|PubMed:17911242, ECO:0000269|PubMed:18084323, ECO:0000269|PubMed:19345326, ECO:0000269|PubMed:20812024, ECO:0000269|PubMed:20980437, ECO:0000269|PubMed:25091737}.; FUNCTION: Isoform 3 and isoform 4 lack the C-terminal ligand-binding domain and may therefore constitutively activate the transcription of a specific set of genes independently of steroid hormones. {ECO:0000269|PubMed:19244107}.","activation of prostate induction by androgen receptor signaling pathway [GO:0060520]; androgen receptor signaling pathway [GO:0030521]; animal organ formation [GO:0048645]; cell-cell signaling [GO:0007267]; cellular response to estrogen stimulus [GO:0071391]; cellular response to steroid hormone stimulus [GO:0071383]; cellular response to testosterone stimulus [GO:0071394]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; epithelial cell morphogenesis [GO:0003382]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular receptor signaling pathway [GO:0030522]; in utero embryonic development [GO:0001701]; lateral sprouting involved in mammary gland duct morphogenesis [GO:0060599]; Leydig cell differentiation [GO:0033327]; male genitalia morphogenesis [GO:0048808]; male somatic sex determination [GO:0019102]; mammary gland alveolus development [GO:0060749]; morphogenesis of an epithelial fold [GO:0060571]; multicellular organism growth [GO:0035264]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of integrin biosynthetic process [GO:0045720]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation involved in prostate gland development [GO:0060769]; positive regulation of gene expression [GO:0010628]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of integrin biosynthetic process [GO:0045726]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; prostate gland epithelium morphogenesis [GO:0060740]; prostate gland growth [GO:0060736]; protein deubiquitination [GO:0016579]; regulation of developmental growth [GO:0048638]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of systemic arterial blood pressure [GO:0003073]; seminiferous tubule development [GO:0072520]; signal transduction [GO:0007165]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]; tertiary branching involved in mammary gland duct morphogenesis [GO:0060748]; transcription initiation from RNA polymerase II promoter [GO:0006367]","androgen binding [GO:0005497]; ATPase binding [GO:0051117]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; nuclear receptor activity [GO:0004879]; POU domain binding [GO:0070974]; repressing transcription factor binding [GO:0070491]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II general transcription initiation factor binding [GO:0001091]; RNA polymerase II transcription coactivator binding [GO:0001225]; RNA polymerase II transcription factor binding [GO:0001085]; signaling receptor binding [GO:0005102]; steroid binding [GO:0005496]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12958311, ECO:0000269|PubMed:15634333, ECO:0000269|PubMed:17587566, ECO:0000269|PubMed:19244107, ECO:0000269|PubMed:19345326, ECO:0000269|PubMed:25091737}. Cytoplasm {ECO:0000269|PubMed:12958311, ECO:0000269|PubMed:17587566, ECO:0000269|PubMed:19244107}. Note=Detected at the promoter of target genes (PubMed:25091737). Predominantly cytoplasmic in unligated form but translocates to the nucleus upon ligand-binding. Can also translocate to the nucleus in unligated form in the presence of RACK1. {ECO:0000269|PubMed:12958311, ECO:0000269|PubMed:17587566, ECO:0000269|PubMed:25091737}.","SUBUNIT: Binds DNA as a homodimer. Part of a ternary complex containing AR, EFCAB6/DJBP and PARK7. Interacts with HIPK3 and NR0B2 in the presence of androgen. The ligand binding domain interacts with KAT7/HBO1 in the presence of dihydrotestosterone. Interacts with EFCAB6/DJBP, PELP1, PQBP1, RANBP9, RBAK, SPDEF, SRA1, TGFB1I1 and RREB1. Interacts with ZMIZ1/ZIMP10 and ZMIZ2/ZMIP7 which both enhance its transactivation activity. Interacts with SLC30A9 and RAD54L2/ARIP4. Interacts via the ligand-binding domain with LXXLL and FXXLF motifs from NCOA1, NCOA2, NCOA3, NCOA4 and MAGEA11. The AR N-terminal poly-Gln region binds Ran resulting in enhancement of AR-mediated transactivation. Ran-binding decreases as the poly-Gln length increases. Interacts with HIP1 (via coiled coil domain). Interacts (via ligand-binding domain) with TRIM68. Interacts with TNK2. Interacts with USP26. Interacts with RNF6. Interacts (regulated by RNF6 probably through polyubiquitination) with RNF14; regulates AR transcriptional activity. Interacts with PRMT2 and TRIM24. Interacts with RACK1. Interacts with RANBP10; this interaction enhances dihydrotestosterone-induced AR transcriptional activity. Interacts with PRPF6 in a hormone-independent way; this interaction enhances dihydrotestosterone-induced AR transcriptional activity. Interacts with STK4/MST1. Interacts with ZIPK/DAPK3. Interacts with LPXN. Interacts with MAK. Part of a complex containing AR, MAK and NCOA3. Interacts with CRY1. Interacts with CCAR1 and GATA2. Interacts with ZNF318 (By similarity). Interacts with BUD31 (PubMed:25091737). Interacts with ARID4A (PubMed:23487765). Interacts with ARID4B (By similarity). Interacts (via NR LBD domain) with ZBTB7A; the interaction is direct and androgen-dependent (PubMed:20812024). Interacts with NCOR1 (PubMed:20812024). Interacts with NCOR2 (PubMed:20812024). Interacts with CRY2 in a ligand-dependent manner (By similarity). {ECO:0000250|UniProtKB:P15207, ECO:0000250|UniProtKB:P19091, ECO:0000269|PubMed:10075738, ECO:0000269|PubMed:10332029, ECO:0000269|PubMed:10383460, ECO:0000269|PubMed:10400640, ECO:0000269|PubMed:10625666, ECO:0000269|PubMed:10930412, ECO:0000269|PubMed:12039962, ECO:0000269|PubMed:12361945, ECO:0000269|PubMed:12415108, ECO:0000269|PubMed:12612053, ECO:0000269|PubMed:12958311, ECO:0000269|PubMed:14609956, ECO:0000269|PubMed:14664718, ECO:0000269|PubMed:15525515, ECO:0000269|PubMed:15563469, ECO:0000269|PubMed:16027218, ECO:0000269|PubMed:16051670, ECO:0000269|PubMed:16951154, ECO:0000269|PubMed:17311914, ECO:0000269|PubMed:17494760, ECO:0000269|PubMed:17550981, ECO:0000269|PubMed:17587566, ECO:0000269|PubMed:17591767, ECO:0000269|PubMed:17711855, ECO:0000269|PubMed:17911242, ECO:0000269|PubMed:18007036, ECO:0000269|PubMed:18084323, ECO:0000269|PubMed:18222118, ECO:0000269|PubMed:18451096, ECO:0000269|PubMed:18451177, ECO:0000269|PubMed:19345326, ECO:0000269|PubMed:19909775, ECO:0000269|PubMed:20501646, ECO:0000269|PubMed:20812024, ECO:0000269|PubMed:20980437, ECO:0000269|PubMed:21512132, ECO:0000269|PubMed:22170608, ECO:0000269|PubMed:23487765, ECO:0000269|PubMed:23887938, ECO:0000269|PubMed:25091737}.",X,67544021,67730619,q12,0.98837,0.291,-0.83775,1.2272,26.657,0.4523130291083023,ENST00000374690,0.7803112558812885,0.3429392651837041,2763,,,,,,,0.5421859593741769,5.394579305960151,Cervix - Endocervix,broadly expressed,0.6004372334491411,0.29155051679668,FALSE,high confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:646,ARAF,"A-Raf proto-oncogene, serine/threonine kinase",Approved,ARAF1,,Xp11.3,gene with protein product,protein-coding gene,ENSG00000078061,369,ENSG00000078061,P10398,MGI:88065,RGD:2148,X,311010,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Involved in the transduction of mitogenic signals from the cell membrane to the nucleus. May also regulate the TOR signaling cascade. {ECO:0000269|PubMed:22609986}.; FUNCTION: [Isoform 2]: Serves as a positive regulator of myogenic differentiation by inducing cell cycle arrest, the expression of myogenin and other muscle-specific proteins, and myotube formation. {ECO:0000269|PubMed:22609986}.",cellular protein modification process [GO:0006464]; MAPK cascade [GO:0000165]; negative regulation of apoptotic process [GO:0043066]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of TOR signaling [GO:0032006],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674],"",SUBUNIT: Interacts with TH1L/NELFD. {ECO:0000269|PubMed:11952167}.,X,47561100,47571920,p11.3,0.96322,0.33,-0.43339,2.4483,23.51,0.47760281594620285,ENST00000377045,0.8417353102690829,0.17023244188952763,1821,1,"RAF1 (62, 56, chr3)",TRUE,,,,0.09265340886512259,6.209254493957519,Thyroid,broadly expressed,3.50049614888789,4.829466515062104,FALSE,high confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:6470,L1CAM,L1 cell adhesion molecule,Approved,"HSAS1, SPG1, HSAS, MASA, MIC5, S10",CD171,Xq28,gene with protein product,protein-coding gene,ENSG00000198910,3897,ENSG00000198910,P32004,MGI:96721,RGD:619777,X,308840,TRUE,"Corpus callosum, partial agenesis of // CRASH syndrome // Hydrocephalus due to aqueductal stenosis // Hydrocephalus with congenital idiopathic intestinal pseudoobstruction // Hydrocephalus with Hirschsprung disease // MASA syndrome",304100 // 303350 // 307000 // 307000 // 307000 // 303350,X-linked recessive // X-linked recessive // X-linked recessive // X-linked recessive // X-linked recessive // X-linked recessive,,,,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Neural cell adhesion molecule involved in the dynamics of cell adhesion and in the generation of transmembrane signals at tyrosine kinase receptors. During brain development, critical in multiple processes, including neuronal migration, axonal growth and fasciculation, and synaptogenesis. In the mature brain, plays a role in the dynamics of neuronal structure and function, including synaptic plasticity. {ECO:0000269|PubMed:20621658, ECO:0000305}.",axon development [GO:0061564]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; chemotaxis [GO:0006935]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; leukocyte migration [GO:0050900]; nervous system development [GO:0007399]; neuron projection development [GO:0031175]; positive regulation of axon extension [GO:0045773]; synapse organization [GO:0050808],axon guidance receptor activity [GO:0008046]; protein domain specific binding [GO:0019904],"SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:12514225, ECO:0000269|PubMed:20621658, ECO:0000269|PubMed:22973895, ECO:0000269|PubMed:26891472}; Single-pass type I membrane protein {ECO:0000250|UniProtKB:Q05695}. Cell projection, growth cone {ECO:0000250|UniProtKB:Q05695}. Cell projection, axon {ECO:0000269|PubMed:20621658}. Cell projection, dendrite. Note=Colocalized with SHTN1 in close apposition with actin filaments in filopodia and lamellipodia of axonalne growth cones of hippocampal neurons (By similarity). In neurons, detected predominantly in axons and cell body, weak localization to dendrites (PubMed:20621658). {ECO:0000250|UniProtKB:Q05695, ECO:0000269|PubMed:20621658}.","SUBUNIT: Interacts with SHTN1; the interaction occurs in axonal growth cones (By similarity). Interacts with isoform 2 of BSG (By similarity). {ECO:0000250|UniProtKB:P11627, ECO:0000250|UniProtKB:Q05695}.",X,153861514,153886173,q28,1,0.129,-0.65932,2.836,48.97,0.4849894527166214,ENST00000370060,0.5391891891891892,0.0583104223944014,3774,,,,,,,0.6459294814970813,7.958021938020773,Cerebellar_tissues,tissue-specific,4.562920102702882,7.958021938020773,TRUE,high confidence escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:6501,LAMP2,lysosomal associated membrane protein 2,Approved,,CD107b,Xq24,gene with protein product,protein-coding gene,ENSG00000005893,3920,ENSG00000005893,P13473,MGI:96748,RGD:2990,X,309060,TRUE,Danon disease,300257,X-linked dominant,,,,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,TRUE,confirmed,"FUNCTION: Plays an important role in chaperone-mediated autophagy, a process that mediates lysosomal degradation of proteins in response to various stresses and as part of the normal turnover of proteins with a long biological half-live (PubMed:8662539, PubMed:11082038, PubMed:18644871, PubMed:24880125, PubMed:27628032). Functions by binding target proteins, such as GAPDH and MLLT11, and targeting them for lysosomal degradation (PubMed:8662539, PubMed:11082038, PubMed:18644871, PubMed:24880125). Plays a role in lysosomal protein degradation in response to starvation (By similarity). Required for the fusion of autophagosomes with lysosomes during autophagy (PubMed:27628032). Cells that lack LAMP2 express normal levels of VAMP8, but fail to accumulate STX17 on autophagosomes, which is the most likely explanation for the lack of fusion between autophagosomes and lysosomes (PubMed:27628032). Required for normal degradation of the contents of autophagosomes (PubMed:27628032). Required for efficient MHCII-mediated presentation of exogenous antigens via its function in lysosomal protein degradation; antigenic peptides generated by proteases in the endosomal/lysosomal compartment are captured by nascent MHCII subunits (PubMed:20518820). Is not required for efficient MHCII-mediated presentation of endogenous antigens (PubMed:20518820). {ECO:0000250|UniProtKB:P17046, ECO:0000269|PubMed:11082038, ECO:0000269|PubMed:18644871, ECO:0000269|PubMed:20518820, ECO:0000269|PubMed:24880125, ECO:0000269|PubMed:27628032, ECO:0000269|PubMed:8662539}.; FUNCTION: [Isoform LAMP-2C]: Modulates chaperone-mediated autophagy. Decreases presentation of endogenous antigens by MHCII. Does not play a role in the presentation of exogenous and membrane-derived antigens by MHCII. {ECO:0000269|PubMed:26856698}.",autophagosome maturation [GO:0097352]; cellular response to starvation [GO:0009267]; chaperone-mediated autophagy [GO:0061684]; establishment of protein localization to organelle [GO:0072594]; lysosomal protein catabolic process [GO:1905146]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of protein-containing complex assembly [GO:0031333]; neutrophil degranulation [GO:0043312]; platelet degranulation [GO:0002576]; protein import [GO:0017038]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; protein targeting to lysosome involved in chaperone-mediated autophagy [GO:0061740]; regulation of protein stability [GO:0031647],enzyme binding [GO:0019899]; protein domain specific binding [GO:0019904],"SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:17897319, ECO:0000269|PubMed:2912382}; Single-pass type I membrane protein {ECO:0000255|PROSITE-ProRule:PRU00740, ECO:0000269|PubMed:17897319}. Endosome membrane {ECO:0000269|PubMed:17897319}; Single-pass type I membrane protein {ECO:0000255|PROSITE-ProRule:PRU00740, ECO:0000269|PubMed:17897319}. Lysosome membrane {ECO:0000255|PROSITE-ProRule:PRU00740, ECO:0000269|PubMed:11082038, ECO:0000269|PubMed:17897319, ECO:0000269|PubMed:18644871, ECO:0000269|PubMed:2912382}; Single-pass type I membrane protein {ECO:0000255|PROSITE-ProRule:PRU00740, ECO:0000269|PubMed:17897319}. Cytoplasmic vesicle, autophagosome membrane {ECO:0000250|UniProtKB:P17047}. Note=This protein shuttles between lysosomes, endosomes, and the plasma membrane.","SUBUNIT: Monomer (PubMed:18644871, PubMed:25342746). Homodimer (PubMed:25342746). Homotrimer (PubMed:25342746). Forms large homooligomers (PubMed:18644871). Interacts (via its cytoplasmic region) with HSPA8 (PubMed:25342746). Interacts with HSP90 in the lysosome lumen; this enhances LAMP2 stability (By similarity). Interacts with MLLT11 (PubMed:24880125). {ECO:0000250|UniProtKB:P17046, ECO:0000269|PubMed:18644871, ECO:0000269|PubMed:24880125, ECO:0000269|PubMed:25342746}.",X,120426148,120469365,q24,0.26698,0.641,1.0586,0.83952,12.096,0.4348407813754348,ENST00000200639,0.6139497161394971,0.1701574606348413,1233,,,,,,,0.20195739230895948,6.8256330070819535,Cells - Cultured fibroblasts,broadly expressed,5.364089118543056,4.510015631332776,FALSE,low confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:6548,LDOC1,LDOC1 regulator of NFKB signaling,Approved,BCUR1,"Mar7, Mart7, SIRH7, RTL7",Xq27.1,gene with protein product,protein-coding gene,ENSG00000182195,23641,ENSG00000182195,O95751,MGI:2685212,RGD:1565644,X,300402,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May have an important role in the development and/or progression of some cancers.,cellular response to lipopolysaccharide [GO:0071222]; cellular response to muramyl dipeptide [GO:0071225]; maternal placenta development [GO:0001893]; maternal process involved in parturition [GO:0060137]; negative regulation of cell population proliferation [GO:0008285]; regulation of growth hormone activity [GO:1903547],"",SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10403563}.,SUBUNIT: Interacts with NOD2. {ECO:0000269|PubMed:27812135}.,X,141111605,141177129,q27.1,0.52431,1.284,0.27184,1.5629,2.1564,0.540930743722632,ENST00000370526,0.9061224489795918,0.1889777555611097,441,,,,,,,0.4030768711812145,9.105811627429897,Artery - Aorta,broadly expressed,6.411185550489572,6.669387535931981,FALSE,high confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,Post2_higher_vs_Post1,no disorder
HGNC:6587,LHFPL1,LHFPL tetraspan subfamily member 1,Approved,,,Xq23,gene with protein product,protein-coding gene,ENSG00000182508,340596,ENSG00000182508,Q86WI0,MGI:1891214,RGD:727927,X,300566,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","",SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.,"",X,112630648,112680054,q23,0.13548,1.107,0.96747,0.47382,5.6636,0.25749063670411987,ENST00000371968,0.9399698340874811,0.17090727318170457,663,1,"LHFPL6 (57, 63, chr13)",TRUE,,,,0.8461885137895162,1.8654398157017826,Pituitary,tissue-specific,0.8784711066028749,0.11297356842954158,FALSE,discordant,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,no difference_Post1_Post2,no disorder
HGNC:6645,PRICKLE3,prickle planar cell polarity protein 3,Approved,LMO6,,Xp11.23,gene with protein product,protein-coding gene,ENSG00000012211,4007,ENSG00000012211,O43900,MGI:1859635,RGD:1359685,X,300111,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Involved in the planar cell polarity (PCP) pathway that is essential for the polarization of epithelial cells during morphogenetic processes, including gastrulation and neurulation (By similarity). PCP is maintained by two molecular modules, the global and the core modules, PRICKLE3 being part of the core module (By similarity). Distinct complexes of the core module segregate to opposite sides of the cell, where they interact with the opposite complex in the neighboring cell at or near the adherents junctions (By similarity). Involved in the organization of the basal body (By similarity). Involved in cilia growth and positioning (By similarity). {ECO:0000250|UniProtKB:A8WH69}.",cell projection organization [GO:0030030]; multicellular organism development [GO:0007275],zinc ion binding [GO:0008270],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:A8WH69}. Cell membrane {ECO:0000250|UniProtKB:A8WH69}; Peripheral membrane protein {ECO:0000250|UniProtKB:A8WH69}; Cytoplasmic side {ECO:0000250|UniProtKB:A8WH69}. Note=Recruited by VANGL2 to anterior cell borders. This polarity is controlled by Wnt proteins (By similarity). WTIP is involved in the recruitment of PRICKLE3 to the basal body (By similarity). {ECO:0000250|UniProtKB:A8WH69}.,SUBUNIT: Interacts with VANGL2 via its C-terminus (By similarity). The VANGL2-dependent membrane recruitment of PRICKLE3 is a prerequisite for its polarization (By similarity). Interacts with WTIP. WTIP is involved in the recruitment of PRICKLE3 to the basal body (By similarity). {ECO:0000250|UniProtKB:A8WH69}.,X,49174802,49186528,p11.23,0.63198,0.478,0.88505,1.1912,16.227,0.44416121120831165,ENST00000599218,0.6643398268398268,0.18000499875031242,1848,,,,,,,0.25624578112089225,4.400783822554961,Esophagus - Mucosa,broadly expressed,1.1515146585014302,1.118260042980951,FALSE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:674,ARHGAP4,Rho GTPase activating protein 4,Approved,,"KIAA0131, C1, p115, RhoGAP4, SrGAP4",Xq28,gene with protein product,protein-coding gene,ENSG00000089820,393,ENSG00000089820,P98171,MGI:2159577,RGD:628901,X,300023,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Inhibitory effect on stress fiber organization. May down-regulate Rho-like GTPase in hematopoietic cells.,cytoskeleton organization [GO:0007010]; negative regulation of axon extension [GO:0030517]; negative regulation of cell migration [GO:0030336]; negative regulation of fibroblast migration [GO:0010764]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266],GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; Rac GTPase binding [GO:0048365],SUBCELLULAR LOCATION: Cytoplasm. Note=Just below the plasma membrane.,SUBUNIT: Interacts with NCKAP1L. {ECO:0000269|PubMed:16417406}.,X,153907367,153934999,q28,0.97693,0.313,-2.3345,0.68696,33.613,0.43566496812476563,ENST00000350060,0.543576205561422,0.05033741564608848,2841,,,,,,,0.45227597584954593,7.925975689824228,Spleen,broadly expressed,2.8508934132255366,4.923249033957507,FALSE,variable escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:676,ARHGAP6,Rho GTPase activating protein 6,Approved,,rhoGAPX-1,Xp22.2,gene with protein product,protein-coding gene,ENSG00000047648,395,ENSG00000047648,O43182,MGI:1196332,RGD:2323364,X,300118,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: GTPase activator for the Rho-type GTPases by converting them to an inactive GDP-bound state. Could regulate the interactions of signaling molecules with the actin cytoskeleton. Promotes continuous elongation of cytoplasmic processes during cell motility and simultaneous retraction of the cell body changing the cell morphology. {ECO:0000269|PubMed:10699171}.,actin filament polymerization [GO:0030041]; activation of phospholipase C activity [GO:0007202]; focal adhesion assembly [GO:0048041]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of phospholipase activity [GO:0010518]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266],GTPase activator activity [GO:0005096]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; SH3 domain binding [GO:0017124],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10699171}.,"",X,11117651,11665920,p22.2,0.99845,0.228,0.63587,1.8229,27.668,0.611385639370714,ENST00000337414,0.7635213675213676,0.2187703074231442,2925,,,,,,,0.4033451532309286,4.775951285991394,Prostate,broadly expressed,1.4260500120170903,0.817799235109493,FALSE,high confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,no difference_Post1_Post2,no disorder
HGNC:6796,MAGEA1,MAGE family member A1,Approved,MAGE1,"MGC9326, CT1.1",Xq28,gene with protein product,protein-coding gene,ENSG00000198681,4100,ENSG00000198681,P43355,,,X,300016,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May be involved in transcriptional regulation through interaction with SNW1 and recruiting histone deactelyase HDAC1. May inhibit notch intracellular domain (NICD) transactivation. May play a role in embryonal development and tumor transformation or aspects of tumor progression. Antigen recognized on a melanoma by autologous cytolytic T-lymphocytes. {ECO:0000269|PubMed:15316101}.,negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122],histone deacetylase binding [GO:0042826],SUBCELLULAR LOCATION: Cytoplasm. Nucleus.,"SUBUNIT: Interacts with SNW1 and HDCA1. {ECO:0000269|PubMed:15316101, ECO:0000269|PubMed:15537658, ECO:0000269|PubMed:19177349}.",X,153179284,153183880,q28,,,0.32809,0.98203,,0.27119697661078435,ENST00000356661,0.06881720430107527,0.01704573856535866,930,9,"MAGEA4 (77, 75, chrX); MAGEA8 (69, 67, chrX); MAGEA6 (69, 68, chrX); MAGEA12 (68, 67, chrX); MAGEA2 (68, 67, chrX); MAGEA2B (68, 67, chrX); MAGEA3 (68, 67, chrX); MAGEA9B (62, 61, chrX); MAGEA9 (62, 61, chrX)",TRUE,,,,0.9767441860465116,3.5386871433770293,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:6797,MAGEA10,MAGE family member A10,Approved,MAGE10,"MGC10599, CT1.10",Xq28,gene with protein product,protein-coding gene,ENSG00000124260,4109,ENSG00000124260,P43363,MGI:3588211,RGD:1563693,X,300343,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Not known, though may play a role in embryonal development and tumor transformation or aspects of tumor progression.","","",SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:21710496}.,"",X,152133310,152138578,q28,,,-1.0953,0.30754,,0.28905563116501465,ENST00000370323,0.08036036036036036,0.002274431392151962,1110,,,,,,,0.9733265787121109,2.2765472856309192,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:6798,MAGEA11,MAGE family member A11,Approved,MAGE11,"MAGE-11, MAGEA-11, MGC10511, CT1.11",Xq28,gene with protein product,protein-coding gene,ENSG00000185247,4110,ENSG00000185247,P43364,MGI:1333839,,X,300344,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Acts as androgen receptor coregulator that increases androgen receptor activity by modulating the receptors interdomain interaction. May play a role in embryonal development and tumor transformation or aspects of tumor progression. {ECO:0000269|PubMed:15684378}.,"","",SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:15684378}. Cytoplasm {ECO:0000269|PubMed:15684378}.,"",X,149688228,149717268,q28,0.68445,0.791,-0.96107,1.2785,3.7716,0.2584480196420495,ENST00000355220,0.03782945736434109,0.0023744063984004,1290,,,,,,,0.9739273737630324,3.5243395472689514,Testis,tissue-specific,0,0,FALSE,variable escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:6799,MAGEA12,MAGE family member A12,Approved,MAGE12,CT1.12,Xq28,gene with protein product,protein-coding gene,ENSG00000213401,4111,ENSG00000213401,P43365,,,X,300177,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Not known, though may play a role tumor transformation or progression. In vitro promotes cell viability in melanoma cell lines. {ECO:0000269|PubMed:17942928}.","","","","",X,152733757,152737669,q28,,,-4.7414,-0.40502,,0.3046296084747957,ENST00000393869,0.042645502645502646,0.012646838290427393,945,9,"MAGEA2 (88, 88, chrX); MAGEA2B (88, 88, chrX); MAGEA3 (85, 85, chrX); MAGEA6 (84, 84, chrX); MAGEA4 (68, 68, chrX); MAGEA1 (67, 68, chrX); MAGEA8 (65, 64, chrX); MAGEA9B (60, 59, chrX); MAGEA9 (60, 59, chrX)",TRUE,4,"MAGEA2 (88, 88, chrX); MAGEA2B (88, 88, chrX); MAGEA3 (85, 85, chrX); MAGEA6 (84, 84, chrX)",TRUE,0.9723104129112753,2.779927849722173,Testis,tissue-specific,0.3009027160092956,0.16167424444018635,FALSE,low confidence escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:6800,MAGEA2,MAGE family member A2,Approved,MAGE2,"MAGEA2A, CT1.2",Xq28,gene with protein product,protein-coding gene,ENSG00000268606,4101,ENSG00000268606,P43356,,,X,300173,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Reduces p53/TP53 transactivation function through recruitment of HDAC3 to p53/TP53 transcription sites. Also represses p73/TP73 activity. Proposed to enhance ubiquitin ligase activity of RING-type zinc finger-containing E3 ubiquitin-protein ligases. In vitro enhances ubiquitin ligase activity of TRIM28 and stimulates p53/TP53 ubiquitination by TRIM28 potentially in presence of Ubl-conjugating enzyme UBE2H. Proposed to act through recruitment and/or stabilization of the Ubl-conjugating enzyme (E2) at the E3:substrate complex. May play a role in embryonal development and tumor transformation or aspects of tumor progression. In vitro promotes cell viability in melanoma cell lines. Antigen recognized on a melanoma by autologous cytolytic T-lymphocytes. Negatively regulates acetylation and sumoylation of PML and represses PML-induced p53/TP53 acetylation and activation. {ECO:0000269|PubMed:16847267, ECO:0000269|PubMed:17942928, ECO:0000269|PubMed:20864041, ECO:0000269|PubMed:22117195}.",cellular protein catabolic process [GO:0044257]; cellular senescence [GO:0090398]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; signal transduction by p53 class mediator [GO:0072331],histone deacetylase binding [GO:0042826]; repressing transcription factor binding [GO:0070491]; ubiquitin protein ligase binding [GO:0031625],"SUBCELLULAR LOCATION: Nucleus. Nucleus, PML body.","SUBUNIT: Interacts with TRIM28 and UBE2H. Interacts with HDAC3. Interacts with PML (isoform PML-1, isoform PML-2, isoform PML-3, isoform PML-4 and isoform PML-5). {ECO:0000269|PubMed:16847267, ECO:0000269|PubMed:20864041, ECO:0000269|PubMed:22117195}.",X,152749863,152753884,q28,,,,,,0.3160252021017492,ENST00000620710,0.047724867724867726,0.0034491377155711073,945,9,"MAGEA2B (100, 100, chrX); MAGEA12 (88, 88, chrX); MAGEA3 (84, 84, chrX); MAGEA6 (84, 84, chrX); MAGEA4 (68, 67, chrX); MAGEA1 (67, 68, chrX); MAGEA8 (63, 63, chrX); MAGEA9B (59, 59, chrX); MAGEA9 (59, 59, chrX)",TRUE,4,"MAGEA2B (100, 100, chrX); MAGEA12 (88, 88, chrX); MAGEA3 (84, 84, chrX); MAGEA6 (84, 84, chrX)",TRUE,0.9767441860465116,0.08291373320946227,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:6801,MAGEA3,MAGE family member A3,Approved,MAGE3,"HYPD, HIP8, MGC14613, CT1.3",Xq28,gene with protein product,protein-coding gene,ENSG00000221867,4102,ENSG00000221867,P43357,,,X,300174,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Proposed to enhance ubiquitin ligase activity of RING-type zinc finger-containing E3 ubiquitin-protein ligases. May enhance ubiquitin ligase activity of TRIM28 and stimulate p53/TP53 ubiquitination by TRIM28. Proposed to act through recruitment and/or stabilization of the Ubl-conjugating enzyme (E2) at the E3:substrate complex. May play a role in embryonal development and tumor transformation or aspects of tumor progression. In vitro promotes cell viability in melanoma cell lines. Antigen recognized on a melanoma by autologous cytolytic T-lymphocytes. {ECO:0000269|PubMed:20864041}.,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of protein processing [GO:0010955],caspase binding [GO:0089720],"","SUBUNIT: Interacts with TRIM28. {ECO:0000269|PubMed:17942928, ECO:0000269|PubMed:20864041, ECO:0000269|Ref.10}.",X,152698767,152702347,q28,,,-4.9796,-2.3371,,0.3265412748171369,ENST00000370278,0.06888888888888889,0.028217945513621594,945,9,"MAGEA6 (96, 96, chrX); MAGEA12 (85, 85, chrX); MAGEA2 (84, 84, chrX); MAGEA2B (84, 84, chrX); MAGEA4 (68, 67, chrX); MAGEA1 (67, 68, chrX); MAGEA8 (63, 63, chrX); MAGEA9B (60, 60, chrX); MAGEA9 (60, 60, chrX)",TRUE,4,"MAGEA6 (96, 96, chrX); MAGEA12 (85, 85, chrX); MAGEA2 (84, 84, chrX); MAGEA2B (84, 84, chrX)",TRUE,0.9767441860465116,3.787714539822571,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:6802,MAGEA4,MAGE family member A4,Approved,MAGE4,"MAGE4A, MAGE4B, MAGE-41, MAGE-X2, MGC21336, CT1.4",Xq28,gene with protein product,protein-coding gene,ENSG00000147381,4103,ENSG00000147381,P43358,,,X,300175,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Not known, though may play a role in embryonal development and tumor transformation or aspects of tumor progression.","","","","",X,151912509,151925170,q28,,,-2.2445,-1.5381,,0.3714390392560414,ENST00000276344,0.07274633123689728,0.002274431392151962,954,9,"MAGEA1 (75, 77, chrX); MAGEA8 (72, 72, chrX); MAGEA12 (68, 68, chrX); MAGEA6 (67, 68, chrX); MAGEA3 (67, 68, chrX); MAGEA2 (67, 68, chrX); MAGEA2B (67, 68, chrX); MAGEA9B (65, 65, chrX); MAGEA9 (65, 65, chrX)",TRUE,,,,0.9767441860465116,4.8288600309309375,Testis,tissue-specific,0,0,FALSE,low confidence escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:6804,MAGEA6,MAGE family member A6,Approved,MAGE6,"CT1.6, MAGE3B, MAGE-3b",Xq28,gene with protein product,protein-coding gene,ENSG00000197172,4105,ENSG00000197172,P43360,,,X,300176,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Proposed to enhance ubiquitin ligase activity of RING-type zinc finger-containing E3 ubiquitin-protein ligases. May enhance ubiquitin ligase activity of TRIM28 and stimulate p53/TP53 ubiquitination by TRIM28. Proposed to act through recruitment and/or stabilization of the Ubl-conjugating enzyme (E2) at the E3:substrate complex. May play a role in tumor transformation or aspects of tumor progression. In vitro promotes cell viability in melanoma cell lines. {ECO:0000269|PubMed:17942928, ECO:0000269|PubMed:20864041}.","","","",SUBUNIT: Interacts with TRIM28. {ECO:0000269|PubMed:20864041}.,X,152766136,152769747,q28,,,-5.2194,-4.3589,,0.3312934247457783,ENST00000329342,0.059365079365079364,0.008122969257685578,945,9,"MAGEA3 (96, 96, chrX); MAGEA12 (84, 84, chrX); MAGEA2 (84, 84, chrX); MAGEA2B (84, 84, chrX); MAGEA4 (68, 67, chrX); MAGEA1 (68, 69, chrX); MAGEA8 (63, 63, chrX); MAGEA9B (58, 58, chrX); MAGEA9 (58, 58, chrX)",TRUE,4,"MAGEA3 (96, 96, chrX); MAGEA12 (84, 84, chrX); MAGEA2 (84, 84, chrX); MAGEA2B (84, 84, chrX)",TRUE,0.9767441860465116,3.58705289336177,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:6806,MAGEA8,MAGE family member A8,Approved,MAGE8,"MGC2182, CT1.8",Xq28,gene with protein product,protein-coding gene,ENSG00000156009,4107,ENSG00000156009,P43361,,,X,300341,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Not known, though may play a role in embryonal development and tumor transformation or aspects of tumor progression.","","","","",X,149881141,149885835,q28,,,0.68888,0.33345,,0.25286357806041404,ENST00000286482,0.05475444096133751,0.011497125718570358,957,9,"MAGEA4 (72, 72, chrX); MAGEA9B (67, 68, chrX); MAGEA9 (67, 68, chrX); MAGEA1 (67, 69, chrX); MAGEA12 (64, 65, chrX); MAGEA2 (63, 63, chrX); MAGEA2B (63, 63, chrX); MAGEA6 (63, 63, chrX); MAGEA3 (63, 63, chrX)",TRUE,,,,0.9059458895166199,1.9612565889713778,Testis,tissue-specific,0.02282954359583195,0.5093056661982112,FALSE,variable escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:6807,MAGEA9,MAGE family member A9,Approved,MAGE9,"MGC8421, CT1.9",Xq28,gene with protein product,protein-coding gene,ENSG00000123584,4108,ENSG00000123584,P43362,,RGD:1565494,X,300342,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Not known, though may play a role in embryonal development and tumor transformation or aspects of tumor progression.","","","","",X,149781930,149787737,q28,,,,,,0.3055007294258989,ENST00000243314,0.03417721518987342,0.005648587853036741,948,9,"MAGEA9B (100, 100, chrX); MAGEA8 (68, 67, chrX); MAGEA4 (65, 65, chrX); MAGEA1 (61, 62, chrX); MAGEA3 (60, 60, chrX); MAGEA12 (59, 60, chrX); MAGEA2 (59, 59, chrX); MAGEA2B (59, 59, chrX); MAGEA6 (58, 58, chrX)",TRUE,1,"MAGEA9B (100, 100, chrX)",TRUE,0.9767441860465116,0.20303322373274074,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:6808,MAGEB1,MAGE family member B1,Approved,,"MAGEL1, MAGE-Xp, DAM10, MGC9322, CT3.1",Xp21.2,gene with protein product,protein-coding gene,ENSG00000214107,4112,ENSG00000214107,P43366,"MGI:105109, MGI:105117, MGI:105118",,X,300097,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,30243730,30252040,p21.2,,,-0.65856,0.14018,,0.17258897379152924,ENST00000378981,0.2225095785440613,0.01804548862784304,1044,3,"MAGEB4 (67, 67, chrX); MAGEB2 (60, 65, chrX); MAGEB17 (53, 55, chrX)",TRUE,,,,0.9765437441264707,4.958387992302271,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:6809,MAGEB2,MAGE family member B2,Approved,,"DAM6, MAGE-XP-2, MGC26438, CT3.2",Xp21.2,gene with protein product,protein-coding gene,ENSG00000099399,4113,ENSG00000099399,O15479,MGI:2148568,RGD:1560904,X,300098,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May enhance ubiquitin ligase activity of RING-type zinc finger-containing E3 ubiquitin-protein ligases. Proposed to act through recruitment and/or stabilization of the Ubl-conjugating enzyme (E2) at the E3:substrate complex. {ECO:0000269|PubMed:20864041}.,"","","",SUBUNIT: Interacts with TRIM28. {ECO:0000269|PubMed:20864041}.,X,30215563,30220089,p21.2,,,0.43002,-1.3049,,0.3092773541322354,ENST00000378988,0.16458333333333333,0.029192701824543865,960,2,"MAGEB1 (65, 60, chrX); MAGEB4 (65, 60, chrX)",TRUE,,,,0.9764889691136449,5.600183508030035,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:6810,MAGEB3,MAGE family member B3,Approved,,CT3.5,Xp21.2,gene with protein product,protein-coding gene,ENSG00000198798,4114,ENSG00000198798,O15480,,RGD:1562343,X,300152,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,30230436,30237492,p21.2,0.43183,1.614,-0.070254,0.64603,1.3361,0.314075831864738,ENST00000361644,0.21767531219980787,0.006398400399900025,1041,,,,,,,0.9767441860465116,3.157388169069676,Testis,tissue-specific,0,0,FALSE,low confidence escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:6811,MAGEB4,MAGE family member B4,Approved,,"MGC33144, CT3.6",Xp21.2,gene with protein product,protein-coding gene,ENSG00000120289,4115,ENSG00000120289,O15481,,RGD:1565746,X,300153,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","",SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:A2A9R3}.,"",X,30242000,30244187,p21.2,,,-1.1955,0.59119,,0.1632266647079467,ENST00000378982,0.053218059558117196,0.01569607598100475,1041,3,"MAGEB1 (67, 67, chrX); MAGEB2 (60, 65, chrX); MAGEB17 (55, 56, chrX)",TRUE,,,,0.9767441860465116,3.9771241956306733,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:6812,MAGEC1,MAGE family member C1,Approved,,"MAGE-C1, CT7, MGC39366, CT7.1",Xq27.2,gene with protein product,protein-coding gene,ENSG00000155495,9947,ENSG00000155495,O60732,,,X,300223,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","","","","",X,141903894,141909374,q27.2,0.079896,1.913,-4.4958,-5.1696,0.74261,0.24716641361533842,ENST00000285879,0.020764071157771947,0.02649337665583604,3429,,,,,,,0.9763339078460406,4.0455478139748235,Testis,tissue-specific,0.00838287463407624,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:6813,MAGED1,MAGE family member D1,Approved,,"NRAGE, DLXIN-1",Xp11.22,gene with protein product,protein-coding gene,ENSG00000179222,9500,ENSG00000179222,Q9Y5V3,MGI:1930187,RGD:70898,X,300224,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Involved in the apoptotic response after nerve growth factor (NGF) binding in neuronal cells. Inhibits cell cycle progression, and facilitates NGFR-mediated apoptosis. May act as a regulator of the function of DLX family members. May enhance ubiquitin ligase activity of RING-type zinc finger-containing E3 ubiquitin-protein ligases. Proposed to act through recruitment and/or stabilization of the Ubl-conjugating enzyme (E2) at the E3:substrate complex. Plays a role in the circadian rhythm regulation. May act as RORA co-regulator, modulating the expression of core clock genes such as ARNTL/BMAL1 and NFIL3, induced, or NR1D1, repressed. {ECO:0000269|PubMed:20864041}.","circadian regulation of gene expression [GO:0032922]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of circadian rhythm [GO:0042752]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]",identical protein binding [GO:0042802]; transcription coactivator activity [GO:0003713],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cell membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}. Nucleus {ECO:0000250}. Note=Expression shifts from the cytoplasm to the plasma membrane upon stimulation with NGF. {ECO:0000250}.,"SUBUNIT: Interacts with DLX5, DLX7 and MSX2 and forms homomultimers. Interacts with UNC5A. Interacts with TRIM28 and PJA1. Interacts with NGFR/p75NTR and RORA. {ECO:0000269|PubMed:20864041}.",X,51803007,51902354,p11.22,0.99831,0.229,1.3402,2.3263,27.44,0.36199095022624433,ENST00000326587,0.787505348737698,0.38352911772056986,2337,,,,,,,0.293218905527368,7.5257791790998,Cells - Cultured fibroblasts,broadly expressed,5.215119424517295,6.328664157558051,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:6833,MAOA,monoamine oxidase A,Approved,,,Xp11.3,gene with protein product,protein-coding gene,ENSG00000189221,4128,ENSG00000189221,P21397,MGI:96915,RGD:61898,X,309850,TRUE,Brunner syndrome,300615,X-linked recessive,{Antisocial behavior},300615,X-linked recessive,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,TRUE,confirmed,"FUNCTION: Catalyzes the oxidative deamination of biogenic and xenobiotic amines and has important functions in the metabolism of neuroactive and vasoactive amines in the central nervous system and peripheral tissues. MAOA preferentially oxidizes biogenic amines such as 5-hydroxytryptamine (5-HT), norepinephrine and epinephrine.",cellular biogenic amine metabolic process [GO:0006576]; cytokine-mediated signaling pathway [GO:0019221]; dopamine catabolic process [GO:0042420]; neurotransmitter catabolic process [GO:0042135]; neurotransmitter metabolic process [GO:0042133]; positive regulation of signal transduction [GO:0009967],primary amine oxidase activity [GO:0008131],SUBCELLULAR LOCATION: Mitochondrion outer membrane; Single-pass type IV membrane protein; Cytoplasmic side.,"SUBUNIT: Monomer, homo- or heterodimer (containing two subunits of similar size). Each subunit contains a covalently bound flavin. Enzymatically active as monomer. {ECO:0000269|PubMed:16129825, ECO:0000269|PubMed:18391214}.",X,43654907,43746824,p11.3,0.99928,0.143,1.2196,2.3802,20.904,0.5540105225309843,ENST00000338702,0.8109217171717171,0.0978755311172207,1584,1,"MAOB (72, 72, chrX)",TRUE,,,,0.25152286677490576,7.075425665826001,Adipose - Subcutaneous,broadly expressed,4.078370731898802,2.54734741044843,FALSE,discordant,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:6834,MAOB,monoamine oxidase B,Approved,,,Xp11.3,gene with protein product,protein-coding gene,ENSG00000069535,4129,ENSG00000069535,P27338,MGI:96916,RGD:3041,X,309860,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Catalyzes the oxidative deamination of biogenic and xenobiotic amines and has important functions in the metabolism of neuroactive and vasoactive amines in the central nervous system and peripheral tissues. MAOB preferentially degrades benzylamine and phenylethylamine.,dopamine catabolic process [GO:0042420]; hydrogen peroxide biosynthetic process [GO:0050665]; negative regulation of serotonin secretion [GO:0014063]; neurotransmitter catabolic process [GO:0042135]; positive regulation of dopamine metabolic process [GO:0045964]; response to aluminum ion [GO:0010044]; response to corticosterone [GO:0051412]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; response to selenium ion [GO:0010269]; response to toxic substance [GO:0009636]; substantia nigra development [GO:0021762],electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; primary amine oxidase activity [GO:0008131],SUBCELLULAR LOCATION: Mitochondrion outer membrane; Single-pass type IV membrane protein; Cytoplasmic side.,"SUBUNIT: Monomer, homo- or heterodimer (containing two subunits of similar size). Each subunit contains a covalently bound flavin. Enzymatically active as monomer (By similarity). {ECO:0000250}.",X,43766610,43882450,p11.3,0.99903,0.148,-0.56418,1.7504,20.112,0.331312574801259,ENST00000378069,0.8786948176583493,0.03284178955261185,1563,1,"MAOA (72, 72, chrX)",TRUE,,,,0.3485601107570449,7.915544802062268,Ovary,broadly expressed,6.092488658400641,4.682382273675988,FALSE,low confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:685,ARHGEF6,Rac/Cdc42 guanine nucleotide exchange factor 6,Approved,MRX46,"alphaPIX, Cool-2, KIAA0006, alpha-PIX, Cool2, αPix",Xq26.3,gene with protein product,protein-coding gene,ENSG00000129675,9459,ENSG00000129675,Q15052,MGI:1920591,RGD:1359674,X,300267,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Acts as a RAC1 guanine nucleotide exchange factor (GEF).,apoptotic process [GO:0006915]; G protein-coupled receptor signaling pathway [GO:0007186]; JNK cascade [GO:0007254]; lamellipodium assembly [GO:0030032]; positive regulation of apoptotic process [GO:0043065]; regulation of small GTPase mediated signal transduction [GO:0051056],GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rho guanyl-nucleotide exchange factor activity [GO:0005089],"SUBCELLULAR LOCATION: Cell projection, lamellipodium {ECO:0000250}.","SUBUNIT: Interacts with PAK kinases through the SH3 domain. Interacts with GIT1. Component of cytoplasmic complexes, which also contain PXN, GIT1 and PAK1 (By similarity). Interacts with PARVB. Interacts with BIN2. Identified in a complex with BIN2 and GIT2. {ECO:0000250, ECO:0000269|PubMed:15005707, ECO:0000269|PubMed:23285027}.",X,136665547,136780932,q26.3,0.99998,0.136,0.82631,1.3479,34.974,0.21921520954981166,ENST00000250617,0.887945087945088,0.2976255936015996,2331,1,"ARHGEF7 (62, 56, chr13)",TRUE,,,,0.26807752563387766,5.2505637167376955,Spleen,broadly expressed,3.855850203475297,2.6666986557238057,FALSE,high confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,no difference_Post1_Post2,no disorder
HGNC:6940,MCF2,MCF.2 cell line derived transforming sequence,Approved,,"DBL, ARHGEF21",Xq27.1,gene with protein product,protein-coding gene,ENSG00000101977,4168,ENSG00000101977,P10911,MGI:96932,RGD:1566098,X,311030,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Guanine nucleotide exchange factor (GEF) that modulates the Rho family of GTPases. Promotes the conversion of some member of the Rho family GTPase from the GDP-bound to the GTP-bound form. Isoform 1 exhibits no activity toward RHOA, RAC1 or CDC42. Isoform 2 exhibits decreased GEF activity toward CDC42. Isoform 3 exhibits a weak but significant activity toward RAC1 and CDC42. Isoform 4 exhibits significant activity toward RHOA and CDC42. The truncated DBL oncogene is active toward RHOA, RAC1 and CDC42.",cellular response to leukemia inhibitory factor [GO:1990830]; dendrite development [GO:0016358]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; negative regulation of axonogenesis [GO:0050771]; positive regulation of apoptotic process [GO:0043065]; regulation of small GTPase mediated signal transduction [GO:0051056],Rho guanyl-nucleotide exchange factor activity [GO:0005089],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15157669}.; SUBCELLULAR LOCATION: [Isoform 1]: Membrane.; SUBCELLULAR LOCATION: [Isoform 3]: Membrane. Note=Colocalizes with CDC42 to plasma membrane.,"SUBUNIT: Interacts with an array of inositol phospholipids such as phosphatidylinositol 3-phosphate (PI3P), phosphatidylinositol 4-phosphate (PI4P) and phosphatidylinositol 5-phosphate (PI5P). May interact with CCPG1. {ECO:0000269|PubMed:15157669}.",X,139581770,139708227,q27.1,0.9718,0.314,0.12457,1.1015,41.881,0.18491261030037207,ENST00000414978,0.7738336713995944,0.10324918770307423,2958,,,,,,,0.8473412169276238,4.186112258156535,Testis,tissue-specific,2.2483131929817612,1.9879447466495475,FALSE,high confidence non-escapee,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:6990,MECP2,methyl-CpG binding protein 2,Approved,"RTT, MRX16, MRX79",,Xq28,gene with protein product,protein-coding gene,ENSG00000169057,4204,ENSG00000169057,P51608,MGI:99918,RGD:3075,X,300005,TRUE,"Encephalopathy, neonatal severe // Mental retardation, X-linked syndromic, Lubs type // Mental retardation, X-linked, syndromic 13 // Rett syndrome // Rett syndrome, atypical // Rett syndrome, preserved speech variant",300673 // 300260 // 300055 // 312750 // 312750 // 312750,X-linked recessive // X-linked recessive // X-linked recessive // X-linked dominant // X-linked dominant // X-linked dominant,"{Autism susceptibility, X-linked 3}",300496,X-linked,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Chromosomal protein that binds to methylated DNA. It can bind specifically to a single methyl-CpG pair. It is not influenced by sequences flanking the methyl-CpGs. Mediates transcriptional repression through interaction with histone deacetylase and the corepressor SIN3A. Binds both 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC)-containing DNA, with a preference for 5-methylcytosine (5mC). {ECO:0000250|UniProtKB:Q9Z2D6}.","adult locomotory behavior [GO:0008344]; behavioral fear response [GO:0001662]; cardiolipin metabolic process [GO:0032048]; catecholamine secretion [GO:0050432]; cellular biogenic amine metabolic process [GO:0006576]; cerebellum development [GO:0021549]; chromatin silencing [GO:0006342]; dendrite development [GO:0016358]; excitatory postsynaptic potential [GO:0060079]; glucocorticoid metabolic process [GO:0008211]; glutamine metabolic process [GO:0006541]; histone acetylation [GO:0016573]; histone methylation [GO:0016571]; inositol metabolic process [GO:0006020]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; mitotic spindle organization [GO:0007052]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation [GO:2000820]; nervous system process involved in regulation of systemic arterial blood pressure [GO:0001976]; neuron maturation [GO:0042551]; pathogenesis [GO:0009405]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA methylation [GO:1905643]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of histone H3-K9 trimethylation [GO:1900114]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; proprioception [GO:0019230]; protein localization [GO:0008104]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; respiratory gaseous exchange by respiratory system [GO:0007585]; response to hypoxia [GO:0001666]; sensory perception of pain [GO:0019233]; social behavior [GO:0035176]; startle response [GO:0001964]; synapse assembly [GO:0007416]; transcription initiation from RNA polymerase II promoter [GO:0006367]; ventricular system development [GO:0021591]; visual learning [GO:0008542]",chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; double-stranded methylated DNA binding [GO:0010385]; methyl-CpG binding [GO:0008327]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; siRNA binding [GO:0035197]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134],SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q9Z2D6}. Note=Colocalized with methyl-CpG in the genome. Colocalized with TBL1X to the heterochromatin foci. {ECO:0000269|PubMed:28348241}.,"SUBUNIT: Interacts with FNBP3 (By similarity). Interacts with CDKL5 (PubMed:15917271). Interacts with ATRX; MECP2 recruits ATRX to pericentric heterochromatin in neuronal cells (By similarity). Interacts with NCOR2 (By similarity). Interacts with TBL1XR1; bridges interaction between MECP2 and NCOR1 (PubMed:28348241). Interacts with TBL1X; recruits TBL1X to the heterochromatin foci (PubMed:28348241). {ECO:0000250|UniProtKB:Q9Z2D6, ECO:0000269|PubMed:15917271, ECO:0000269|PubMed:28348241}.",X,154021573,154137103,q28,0.89382,0.407,-7.9451,-1.2125,11.661,0.6808184362988595,ENST00000453960,0.9008016032064128,0.3134216445888528,1497,,,,,,,0.23859055331066398,5.235106659486004,Cerebellar_tissues,broadly expressed,3.5371220882066976,5.235106659486004,TRUE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:7082,CD99,CD99 molecule (Xg blood group),Approved,MIC2,,Xp22.32 and Yp11.3,gene with protein product,protein-coding gene,ENSG00000002586,4267,ENSG00000002586,P14209,,RGD:1594332,X,"313470, 450000",FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,TRUE,,no disorder,"FUNCTION: Involved in T-cell adhesion processes and in spontaneous rosette formation with erythrocytes. Plays a role in a late step of leukocyte extravasation helping leukocytes to overcome the endothelial basement membrane. Acts at the same site as, but independently of, PECAM1. Involved in T-cell adhesion processes (By similarity). {ECO:0000250}.",homotypic cell-cell adhesion [GO:0034109]; positive regulation of neutrophil extravasation [GO:2000391]; regulation of immune response [GO:0050776]; T cell extravasation [GO:0072683],"",SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}.,"",X,2691187,2741309,p22.33,0.0026127,0.965,-0.16373,-0.52942,12.271,0.6180739815826439,ENST00000381192,0.18853046594982079,0.01647088227943014,558,,,,,,,0.168955335510663,8.503376564664537,Cells - Cultured fibroblasts,broadly expressed,5.20534167992933,4.796714547818124,FALSE,low confidence escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:7095,MID1,midline 1,Approved,,"OS, FXY, TRIM18, RNF59",Xp22,gene with protein product,protein-coding gene,ENSG00000101871,4281,ENSG00000101871,O15344,MGI:1100537,RGD:2640,X,300552,TRUE,"Opitz GBBB syndrome, type I",300000,X-linked recessive,,,,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Has E3 ubiquitin ligase activity towards IGBP1, promoting its monoubiquitination, which results in deprotection of the catalytic subunit of protein phosphatase PP2A, and its subsequent degradation by polyubiquitination. {ECO:0000269|PubMed:10400985, ECO:0000269|PubMed:11685209, ECO:0000269|PubMed:22613722}.",interferon-gamma-mediated signaling pathway [GO:0060333]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule depolymerization [GO:0007026]; pattern specification process [GO:0007389]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein localization to microtubule [GO:0035372],enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; phosphoprotein binding [GO:0051219]; protein homodimerization activity [GO:0042803]; transferase activity [GO:0016740]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10077590}. Cytoplasm, cytoskeleton {ECO:0000269|PubMed:10077590}. Cytoplasm, cytoskeleton, spindle {ECO:0000269|PubMed:10077590}. Note=Microtubule-associated. It is associated with microtubules throughout the cell cycle, co-localizing with cytoplasmic fibers in interphase and with the mitotic spindle and midbodies during mitosis and cytokinesis.","SUBUNIT: Homodimer or heterodimer with MID2. Interacts with IGBP1. Interacts with TRIM16. {ECO:0000269|PubMed:11806752, ECO:0000269|PubMed:22613722, ECO:0000269|PubMed:22629402}.",X,10445310,10833654,p22.2,0.97967,0.304,-0.18749,2.9209,20.731,0.444936621250173,ENST00000317552,0.9485528942115768,0.17693076730817295,2004,1,"MID2 (70, 69, chrX)",TRUE,,,,0.438279598369277,4.594064783441354,Colon - Sigmoid,broadly expressed,1.7350411987820344,3.7820939895637933,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:7096,MID2,midline 2,Approved,,"FXY2, TRIM1, RNF60, MRX101",Xq22.3,gene with protein product,protein-coding gene,ENSG00000080561,11043,ENSG00000080561,Q9UJV3,MGI:1344333,RGD:1565674,X,300204,TRUE,,,,"?Mental retardation, X-linked 101",300928,X-linked recessive,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,PMT +CS,FALSE,,PMT,FUNCTION: May play a role in microtubule stabilization. {ECO:0000303|PubMed:24115387}.,innate immune response [GO:0045087]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral release from host cell [GO:1902187]; negative regulation of viral transcription [GO:0032897]; positive regulation of autophagy [GO:0010508]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein localization to microtubule [GO:0035372]; protein ubiquitination [GO:0016567],enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; phosphoprotein binding [GO:0051219]; protein homodimerization activity [GO:0042803]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270],"SUBCELLULAR LOCATION: Cytoplasm. Cytoplasm, cytoskeleton. Note=Microtubule-associated.",SUBUNIT: Homodimer or heterodimer with MID1. Interacts with IGBP1. {ECO:0000269|PubMed:11806752}.,X,107825755,107927193,q22.3,0.1755,0.496,1.1151,1.5832,23.87,0.6003504545778598,ENST00000262843,0.9332880434782609,0.330817295676081,2208,1,"MID1 (69, 70, chrX)",TRUE,,,,0.2859635057790143,3.8840605952986453,Skin - Sun Exposed (Lower leg),broadly expressed,1.4010405993651476,2.1850212906529203,FALSE,discordant,no_difference_Pre_Post,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,PMT
HGNC:710,ARR3,arrestin 3,Approved,,ARRX,Xq13.1,gene with protein product,protein-coding gene,ENSG00000120500,407,ENSG00000120500,P36575,MGI:2159617,RGD:621385,X,301770,TRUE,"Myopia 26, X-linked, female-limited",301010,X-linked,,,,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,TRUE,confirmed,FUNCTION: May play a role in an as yet undefined retina-specific signal transduction. Could bind to photoactivated-phosphorylated red/green opsins.,G protein-coupled receptor internalization [GO:0002031]; regulation of protein phosphorylation [GO:0001932]; signal transduction [GO:0007165]; visual perception [GO:0007601],G protein-coupled receptor binding [GO:0001664]; opsin binding [GO:0002046]; phosphoprotein binding [GO:0051219],"SUBCELLULAR LOCATION: Photoreceptor inner segment {ECO:0000250|UniProtKB:Q9EQP6}. Cell projection, cilium, photoreceptor outer segment {ECO:0000250|UniProtKB:Q9EQP6}.","SUBUNIT: Homodimer; disulfide-linked in response to retinal illumination (By similarity). Interacts with CXCR4; the interaction is dependent on the C-terminal phosphorylation of CXCR4 and modulates the calcium ion mobilization activity of CXCR4 (PubMed:20048153). {ECO:0000250|UniProtKB:Q9N0H5, ECO:0000269|PubMed:20048153}.",X,70268305,70281840,q13.1,0.10401,0.589,0.41098,0.57247,17.844,0.10472086198928661,ENST00000307959,0.770694087403599,0.20937265683579107,1167,1,"ARRB1 (59, 55, chr11)",TRUE,,,,0.6447319576334288,0.6457745061536354,Small Intestine - Terminal Ileum,tissue-specific,0.046595268534024716,0.05819837334615061,FALSE,high confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:7139,FOXO4,forkhead box O4,Approved,MLLT7,AFX1,Xq13.1,gene with protein product,protein-coding gene,ENSG00000184481,4303,ENSG00000184481,P98177,MGI:1891915,RGD:1561201,X,300033,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Transcription factor involved in the regulation of the insulin signaling pathway. Binds to insulin-response elements (IREs) and can activate transcription of IGFBP1. Down-regulates expression of HIF1A and suppresses hypoxia-induced transcriptional activation of HIF1A-modulated genes. Also involved in negative regulation of the cell cycle. Involved in increased proteasome activity in embryonic stem cells (ESCs) by activating expression of PSMD11 in ESCs, leading to enhanced assembly of the 26S proteasome, followed by higher proteasome activity. {ECO:0000269|PubMed:10217147, ECO:0000269|PubMed:10783894, ECO:0000269|PubMed:12761217, ECO:0000269|PubMed:15126506, ECO:0000269|PubMed:16054032, ECO:0000269|PubMed:16964248, ECO:0000269|PubMed:20874444, ECO:0000269|PubMed:22972301}.","aging [GO:0007568]; cell cycle arrest [GO:0007050]; glucose homeostasis [GO:0042593]; insulin receptor signaling pathway [GO:0008286]; mitotic G2 DNA damage checkpoint [GO:0007095]; muscle organ development [GO:0007517]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; regulation of transcription, DNA-templated [GO:0006355]; response to nutrient levels [GO:0031667]; response to water-immersion restraint stress [GO:1990785]; stem cell differentiation [GO:0048863]","beta-catenin binding [GO:0008013]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; promoter-specific chromatin binding [GO:1990841]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]","SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Note=When phosphorylated, translocated from nucleus to cytoplasm. Dephosphorylation triggers nuclear translocation. Monoubiquitination increases nuclear localization. When deubiquitinated, translocated from nucleus to cytoplasm.","SUBUNIT: Interacts with CREBBP/CBP, CTNNB1, MYOCD, SIRT1, SRF and YWHAZ. Acetylated by CREBBP/CBP and deacetylated by SIRT1. Binding of YWHAZ inhibits DNA-binding. Interacts with USP7; the interaction is enhanced in presence of hydrogen peroxide and occurs independently of TP53. Interacts with NLK, and this inhibits monoubiquitination and transcriptional activity. Interacts with FOXK1; the interaction inhibits MEF2C transactivation activity (By similarity). {ECO:0000250|UniProtKB:Q9WVH3, ECO:0000269|PubMed:15126506, ECO:0000269|PubMed:16054032, ECO:0000269|PubMed:16114898, ECO:0000269|PubMed:16964248, ECO:0000269|PubMed:20874444}.",X,71095851,71103532,q13.1,0.81332,0.479,1.3486,1.6521,9.9076,0.4298834229083725,ENST00000374259,0.7723320158102767,0.4201199700074981,1518,,,,,,,0.19135740253780822,5.644081232648215,Ovary,broadly expressed,5.167305736691165,5.090938093168833,FALSE,variable escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:717,ARSD,arylsulfatase D,Approved,,,Xp22.33,gene with protein product,protein-coding gene,ENSG00000006756,414,ENSG00000006756,P51689,,,X,300002,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","",arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872],SUBCELLULAR LOCATION: Lysosome {ECO:0000305}.,"",X,2903972,2929349,p22.33,0.0016285,0.858,0.70405,1.0875,15.322,0.5797502462291529,ENST00000381154,0.48709315375982043,0.06585853536615846,1782,3,"ARSL (62, 60, chrX); ARSH (60, 64, chrX); ARSF (58, 58, chrX)",TRUE,,,,0.2926317050386038,4.844164671926594,Kidney - Medulla,broadly expressed,1.876047349649734,1.9971966463655388,FALSE,high confidence escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:719,ARSL,arylsulfatase L,Approved,"CDPX, CDPX1, ARSE",,Xp22.33,gene with protein product,protein-coding gene,ENSG00000157399,415,ENSG00000157399,P51690,,RGD:1304917,X,300180,TRUE,"Chondrodysplasia punctata, X-linked recessive",302950,X-linked recessive,,,,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,FUNCTION: May be essential for the correct composition of cartilage and bone matrix during development. Has no activity toward steroid sulfates.,skeletal system development [GO:0001501],arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872],"SUBCELLULAR LOCATION: Golgi apparatus, Golgi stack.","",X,2934521,2968475,p22.33,0.58982,0.492,0.61169,1.9544,15.752,0.36428024678833937,ENST00000381134,0.4986440677966102,0.048787803049237695,1770,3,"ARSD (60, 62, chrX); ARSH (54, 59, chrX); ARSF (54, 56, chrX)",TRUE,,,,0.7452890530368628,4.768030782088507,Pancreas,tissue-specific,1.0965789681893165,0.5548064059639524,FALSE,low confidence escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:721,ARSF,arylsulfatase F,Approved,,,Xp22.33,gene with protein product,protein-coding gene,ENSG00000062096,416,ENSG00000062096,P54793,,,X,300003,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","",arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872],SUBCELLULAR LOCATION: Secreted {ECO:0000305}.,"",X,3041471,3112727,p22.33,3.1126e-14,1.549,-2.3232,-0.38659,18.715,0.2972062611452348,ENST00000381127,0.39176536943034407,0.17323169207698075,1773,3,"ARSD (58, 58, chrX); ARSH (56, 59, chrX); ARSL (56, 54, chrX)",TRUE,,,,0.8909663896934836,2.9212173200840996,Skin - Not Sun Exposed (Suprapubic),tissue-specific,1.4614814118057253,0.18564140390335376,FALSE,low confidence escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,no difference_Post1_Post2,no disorder
HGNC:7219,MPP1,membrane palmitoylated protein 1,Approved,DXS552E,PEMP,Xq28,gene with protein product,protein-coding gene,ENSG00000130830,4354,ENSG00000130830,Q00013,MGI:105941,RGD:1594331,X,305360,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Essential regulator of neutrophil polarity. Regulates neutrophil polarization by regulating AKT1 phosphorylation through a mechanism that is independent of PIK3CG activity (By similarity). {ECO:0000250}.,regulation of neutrophil chemotaxis [GO:0090022]; signal transduction [GO:0007165],guanylate kinase activity [GO:0004385],"SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:19144871}; Lipid-anchor {ECO:0000305|PubMed:1713685}. Cell projection, stereocilium {ECO:0000250|UniProtKB:P70290}. Note=Colocalizes with WHRN at stereocilium tip during hair cell development (By similarity). Colocalizes with MPP5 in the retina, at the outer limiting membrane (OLM) (By similarity). Colocalizes with WHRN in the retina, at the outer limiting membrane (OLM), outer plexifirm layer (OPL), basal bodies and at the connecting cilium (CC) (By similarity). Colocalizes with NF2 in non-myelin-forming Schwann cells (PubMed:19144871). {ECO:0000250|UniProtKB:P70290, ECO:0000269|PubMed:19144871}.","SUBUNIT: Heterodimer with MPP5. Interacts with DLG5 and NF2. Interacts (via guanylate kinase-like domain) with WHRN (via third PDZ domain). {ECO:0000269|PubMed:17584769, ECO:0000269|PubMed:19144871}.",X,154778684,154821007,q28,0.9877,0.268,0.51205,1.6708,17.687,0.46994058608304523,ENST00000369534,0.8428979300499643,0.05051237190702324,1401,,,,,,,0.3862299458264964,7.537855142874196,Whole Blood,broadly expressed,4.58658462037084,5.943170020237872,FALSE,low confidence non-escapee,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:7370,MSL3,MSL complex subunit 3,Approved,MSL3L1,,Xp22.2,gene with protein product,protein-coding gene,ENSG00000005302,10943,ENSG00000005302,Q8N5Y2,MGI:1341851,RGD:1549763,X,300609,TRUE,Basilicata-Akhtar syndrome,301032,X-linked dominant,,,,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,confirmed +CS,FALSE,TRUE,confirmed,"FUNCTION: Has a role in chromatin remodeling and transcriptional regulation (PubMed:20018852, PubMed:20657587, PubMed:20943666, PubMed:21217699, PubMed:30224647). Has a role in X inactivation (PubMed:21217699). Component of the MSL complex which is responsible for the majority of histone H4 acetylation at 'Lys-16' which is implicated in the formation of higher-order chromatin structure (PubMed:16227571, PubMed:20657587, PubMed:16543150, PubMed:30224647). Specifically recognizes histone H4 monomethylated at 'Lys-20' (H4K20Me1) in a DNA-dependent manner and is proposed to be involved in chromosomal targeting of the MSL complex (PubMed:20657587, PubMed:20943666). {ECO:0000269|PubMed:16227571, ECO:0000269|PubMed:16543150, ECO:0000269|PubMed:20018852, ECO:0000269|PubMed:20657587, ECO:0000269|PubMed:20943666, ECO:0000269|PubMed:21217699, ECO:0000269|PubMed:22547026, ECO:0000269|PubMed:30224647}.","chromatin silencing [GO:0006342]; histone acetylation [GO:0016573]; histone deacetylation [GO:0016575]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; histone H4-K16 acetylation [GO:0043984]; regulation of transcription, DNA-templated [GO:0006355]",DNA binding [GO:0003677]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; methylated histone binding [GO:0035064],SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:30224647}.,"SUBUNIT: Component of the MSL histone acetyltransferase complex at least composed of the KAT8/MOF, MSL1/hampin, MSL2 and MSL3 (PubMed:20018852, PubMed:20657587, PubMed:21217699, PubMed:22547026, PubMed:16543150). Interacts (via the MRG domain) with MSL1 and KAT8/MOF (PubMed:21217699, PubMed:30224647). {ECO:0000269|PubMed:16543150, ECO:0000269|PubMed:20018852, ECO:0000269|PubMed:20657587, ECO:0000269|PubMed:21217699, ECO:0000269|PubMed:22547026, ECO:0000269|PubMed:30224647}.",X,11758159,11775772,p22.2,0.99665,0.178,0.67186,1.9314,16.776,0.6670794686344979,ENST00000312196,0.9361430395913155,0.1540864783804049,1566,,,,,,,0.33665313201694735,5.899975562923458,Cells - EBV-transformed lymphocytes,broadly expressed,3.1370181719678953,4.048253626251501,FALSE,discordant,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:7373,MSN,moesin,Approved,,,Xq12,gene with protein product,protein-coding gene,ENSG00000147065,4478,ENSG00000147065,P26038,MGI:97167,RGD:621260,X,309845,TRUE,Immunodeficiency 50,300988,X-linked recessive,,,,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,TRUE,confirmed,"FUNCTION: Ezrin-radixin-moesin (ERM) family protein that connects the actin cytoskeleton to the plasma membrane and thereby regulates the structure and function of specific domains of the cell cortex. Tethers actin filaments by oscillating between a resting and an activated state providing transient interactions between moesin and the actin cytoskeleton (PubMed:10212266). Once phosphorylated on its C-terminal threonine, moesin is activated leading to interaction with F-actin and cytoskeletal rearrangement (PubMed:10212266). These rearrangements regulate many cellular processes, including cell shape determination, membrane transport, and signal transduction (PubMed:12387735, PubMed:15039356). The role of moesin is particularly important in immunity acting on both T and B-cells homeostasis and self-tolerance, regulating lymphocyte egress from lymphoid organs (PubMed:9298994, PubMed:9616160). Modulates phagolysosomal biogenesis in macrophages (By similarity). Participates also in immunologic synapse formation (PubMed:27405666). {ECO:0000250|UniProtKB:P26041, ECO:0000269|PubMed:10212266, ECO:0000269|PubMed:12387735, ECO:0000269|PubMed:15039356, ECO:0000269|PubMed:27405666, ECO:0000269|PubMed:9298994, ECO:0000269|PubMed:9616160}.",cellular response to testosterone stimulus [GO:0071394]; establishment of endothelial barrier [GO:0061028]; establishment of epithelial cell apical/basal polarity [GO:0045198]; gland morphogenesis [GO:0022612]; immunological synapse formation [GO:0001771]; interleukin-12-mediated signaling pathway [GO:0035722]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte migration [GO:0050900]; membrane to membrane docking [GO:0022614]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of gene expression [GO:0010628]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein localization to early endosome [GO:1902966]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of lymphocyte migration [GO:2000401]; regulation of organelle assembly [GO:1902115]; T cell aggregation [GO:0070489]; T cell migration [GO:0072678]; T cell proliferation [GO:0042098]; viral process [GO:0016032],actin binding [GO:0003779]; cell adhesion molecule binding [GO:0050839]; double-stranded RNA binding [GO:0003725]; enzyme binding [GO:0019899]; protein kinase binding [GO:0019901]; signaling receptor binding [GO:0005102]; structural constituent of cytoskeleton [GO:0005200],"SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:11728332, ECO:0000269|PubMed:15039356, ECO:0000269|PubMed:18586956, ECO:0000269|PubMed:7884872, ECO:0000269|PubMed:9298994}; Peripheral membrane protein {ECO:0000250|UniProtKB:P26041}; Cytoplasmic side {ECO:0000250|UniProtKB:P26041}. Cytoplasm, cytoskeleton {ECO:0000250|UniProtKB:P26041}. Apical cell membrane {ECO:0000250|UniProtKB:P26041}; Peripheral membrane protein {ECO:0000250|UniProtKB:P26041}; Cytoplasmic side {ECO:0000250|UniProtKB:P26041}. Cell projection, microvillus membrane {ECO:0000250|UniProtKB:P26041}; Peripheral membrane protein {ECO:0000250|UniProtKB:P26041}; Cytoplasmic side {ECO:0000250|UniProtKB:P26041}. Cell projection, microvillus {ECO:0000250|UniProtKB:P26041}. Note=Phosphorylated form is enriched in microvilli-like structures at apical membrane. Increased cell membrane localization of both phosphorylated and non-phosphorylated forms seen after thrombin treatment (By similarity). Localizes at the uropods of T lymphoblasts. {ECO:0000250|UniProtKB:P26041, ECO:0000269|PubMed:18586956, ECO:0000269|PubMed:9298994}.","SUBUNIT: In resting T-cells, part of a PAG1-SLC9A3R1-MSN complex which is disrupted upon TCR activation. Interacts with SLC9A3R1 (PubMed:9314537, PubMed:15020681). Interacts with PPP1R16B (PubMed:18586956). Interacts with PDZD8. Interacts with SELPLG and SYK; these interaction mediate the activation of SYK by SELPLG (PubMed:12387735). Interacts with PDPN (via cytoplasmic domain); this interaction activates RHOA and promotes epithelial-mesenchymal transition (PubMed:17046996). Interacts with SPN/CD43 (PubMed:9616160, PubMed:11728332). Interacts with CD44 (PubMed:9298994). Interacts with ICAM2 (By similarity). Interacts with ICAM3 (via C-terminus) (PubMed:9298994). Interacts with PDZD8 (PubMed:21549406). Interacts with F-actin (PubMed:10212266). Interacts with CD46 (PubMed:7884872). Interacts with PTPN6 (By similarity). {ECO:0000250|UniProtKB:P26041, ECO:0000269|PubMed:10212266, ECO:0000269|PubMed:11728332, ECO:0000269|PubMed:12387735, ECO:0000269|PubMed:15020681, ECO:0000269|PubMed:17046996, ECO:0000269|PubMed:18586956, ECO:0000269|PubMed:21549406, ECO:0000269|PubMed:7884872, ECO:0000269|PubMed:9298994, ECO:0000269|PubMed:9314537, ECO:0000269|PubMed:9616160}.; SUBUNIT: (Microbial infection) Interacts with HIV-1 envelope protein gp120. {ECO:0000269|PubMed:9213396}.",X,65588377,65741931,q12,0.99967,0.13,0.077094,2.9335,22.976,0.3611076719904255,ENST00000360270,0.9565743944636678,0.19825043739065235,1734,2,"RDX (81, 78, chr11); EZR (74, 73, chr6)",TRUE,,,,0.19792713497598768,8.519388575487257,Lung,broadly expressed,4.8012259250975955,4.286452414456942,FALSE,discordant,no_difference_Pre_Post,no difference_Pre_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:7423,MTCP1,mature T cell proliferation 1,Approved,,"P13MTCP1, p8MTCP1, TCL1C",Xq28,gene with protein product,protein-coding gene,ENSG00000214827,4515,ENSG00000214827,P56278,MGI:102699,RGD:1561352,X,300116,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Enhances the phosphorylation and activation of AKT1 and AKT2. {ECO:0000269|PubMed:10983986}.,positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein serine/threonine kinase activity [GO:0071902],protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539],"",SUBUNIT: Interacts with AKT1 and AKT2 (via PH domain). Does not interact with AKT3. {ECO:0000269|PubMed:10983986}.,X,155064034,155147937,q28,0.45211,0.851,1.4316,1.6369,5.5708,0.7037927767540161,ENST00000369476,0.995679012345679,0.16698325418645338,324,,,,,,,0.17369401702880055,3.690718789516797,Cells - EBV-transformed lymphocytes,broadly expressed,2.4083260039806946,2.6505784670226284,FALSE,high confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,no difference_Post1_Post2,no disorder
HGNC:7448,MTM1,myotubularin 1,Approved,,,Xq28,gene with protein product,protein-coding gene,ENSG00000171100,4534,ENSG00000171100,Q13496,MGI:1099452,RGD:1304582,X,300415,TRUE,"Myotubular myopathy, X-linked",310400,X-linked recessive,,,,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,TRUE,confirmed,"FUNCTION: Lipid phosphatase which dephosphorylates phosphatidylinositol 3-monophosphate (PI3P) and phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2) (PubMed:11001925, PubMed:10900271, PubMed:12646134, PubMed:14722070). Has also been shown to dephosphorylate phosphotyrosine- and phosphoserine-containing peptides (PubMed:9537414). Negatively regulates EGFR degradation through regulation of EGFR trafficking from the late endosome to the lysosome (PubMed:14722070). Plays a role in vacuolar formation and morphology. Regulates desmin intermediate filament assembly and architecture (PubMed:21135508). Plays a role in mitochondrial morphology and positioning (PubMed:21135508). Required for skeletal muscle maintenance but not for myogenesis (PubMed:21135508). In skeletal muscles, stabilizes MTMR12 protein levels (PubMed:23818870). {ECO:0000269|PubMed:10900271, ECO:0000269|PubMed:11001925, ECO:0000269|PubMed:12646134, ECO:0000269|PubMed:14722070, ECO:0000269|PubMed:21135508, ECO:0000269|PubMed:23818870, ECO:0000269|PubMed:9537414}.",endosome to lysosome transport [GO:0008333]; intermediate filament organization [GO:0045109]; mitochondrion distribution [GO:0048311]; mitochondrion morphogenesis [GO:0070584]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of skeletal muscle tissue growth [GO:0048633]; protein dephosphorylation [GO:0006470]; protein transport [GO:0015031]; regulation of vacuole organization [GO:0044088],"intermediate filament binding [GO:0019215]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphatidylinositol binding [GO:0035091]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10900271, ECO:0000269|PubMed:11001925, ECO:0000269|PubMed:12847286}. Cell membrane; Peripheral membrane protein {ECO:0000269|PubMed:11001925, ECO:0000269|PubMed:12847286}. Cell projection, filopodium {ECO:0000269|PubMed:12118066}. Cell projection, ruffle {ECO:0000269|PubMed:12118066}. Late endosome {ECO:0000269|PubMed:14722070}. Cytoplasm, myofibril, sarcomere {ECO:0000250|UniProtKB:Q9Z2C5}. Note=Localizes as a dense cytoplasmic network (PubMed:11001925). Also localizes to the plasma membrane, including plasma membrane extensions such as filopodia and ruffles (PubMed:12118066). Predominantly located in the cytoplasm following interaction with MTMR12 (PubMed:12847286). Recruited to the late endosome following EGF stimulation (PubMed:14722070). In skeletal muscles, co-localizes with MTMR12 in the sarcomere (By similarity). {ECO:0000250|UniProtKB:Q9Z2C5, ECO:0000269|PubMed:11001925, ECO:0000269|PubMed:12118066, ECO:0000269|PubMed:12847286, ECO:0000269|PubMed:14722070}.","SUBUNIT: Heterodimer with MTMR12 (PubMed:12847286, PubMed:23818870). Interacts with KMT2A/MLL1 (via SET domain) (PubMed:9537414). Interacts with DES in skeletal muscle but not in cardiac muscle (PubMed:21135508). Interacts with SPEG (PubMed:25087613). {ECO:0000269|PubMed:12847286, ECO:0000269|PubMed:21135508, ECO:0000269|PubMed:23818870, ECO:0000269|PubMed:25087613, ECO:0000269|PubMed:9537414}.",X,150568621,150673143,q28,0.99961,0.176,1.6543,2.395,26.916,0.574631743968777,ENST00000370396,0.8869757174392936,0.1580604848787803,1812,1,"MTMR2 (65, 60, chr11)",TRUE,,,,0.21953823917289658,4.25173423893108,Testis,broadly expressed,3.0031488497973484,3.1127076380797636,FALSE,high confidence non-escapee,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:7449,MTMR1,myotubularin related protein 1,Approved,,,Xq28,gene with protein product,protein-coding gene,ENSG00000063601,8776,ENSG00000063601,Q13613,MGI:1858271,RGD:1306569,X,300171,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Lipid phosphatase that has high specificity for phosphatidylinositol 3-phosphate and has no activity with phosphatidylinositol 4-phosphate, phosphatidylinositol (4,5)-bisphosphate and phosphatidylinositol (3,4,5)-trisphosphate (PubMed:11733541, PubMed:27018598). Activity with phosphatidylinositol (3,5)-bisphosphate is controversial; it has been shown by PubMed:27018598, while PubMed:11733541 find no activity with this substrate. {ECO:0000269|PubMed:11733541, ECO:0000269|PubMed:27018598}.",phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of phosphatidylinositol dephosphorylation [GO:0060304],"phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein homodimerization activity [GO:0042803]; protein tyrosine phosphatase activity [GO:0004725]",SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q9Z2C4}; Peripheral membrane protein {ECO:0000250|UniProtKB:Q9Z2C4}; Cytoplasmic side {ECO:0000250|UniProtKB:Q9Z2C4}. Cytoplasm {ECO:0000250|UniProtKB:Q9Z2C4}.,SUBUNIT: Homodimer. {ECO:0000269|PubMed:27018598}.,X,150692971,150765108,q28,0.9976,0.238,0.0058644,2.0202,26.488,0.5206245048170869,ENST00000445323,0.8381800197823936,0.06678330417395652,2022,1,"MTMR2 (66, 69, chr11)",TRUE,,,,0.20980638204044125,5.077240862237986,Cerebellar_tissues,broadly expressed,3.5810016797074686,5.077240862237986,TRUE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,no disorder
HGNC:750,ASMT,acetylserotonin O-methyltransferase,Approved,,"HIOMT, ASMTY, HIOMTY",Xp22.3 and Yp11.3,gene with protein product,protein-coding gene,ENSG00000196433,438,ENSG00000196433,P46597,MGI:96090,RGD:708472,X,"300015, 402500",FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,TRUE,,no disorder,"FUNCTION: Isoform 1 catalyzes the transfer of a methyl group onto N-acetylserotonin, producing melatonin (N-acetyl-5-methoxytryptamine). Isoform 2 and isoform 3 lack enzyme activity. {ECO:0000269|PubMed:22775292}.",aromatic compound biosynthetic process [GO:0019438]; indolalkylamine biosynthetic process [GO:0046219]; melatonin biosynthetic process [GO:0030187]; methylation [GO:0032259]; translation [GO:0006412],acetylserotonin O-methyltransferase activity [GO:0017096]; identical protein binding [GO:0042802]; O-methyltransferase activity [GO:0008171]; protein homodimerization activity [GO:0042803]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; S-methyltransferase activity [GO:0008172],"",SUBUNIT: Homodimer. {ECO:0000269|PubMed:22775292}.,X,1615059,1643081,p22.33,1.2722e-20,1.934,-2.5108,-1.6969,15.833,0.4280405471136448,ENST00000381241,0.6562388591800357,0.02663161150634086,1122,,,,,,,0.6666488247454789,1.3358890925708538,Pituitary,tissue-specific,0.21984691173396198,0.5386285465119678,FALSE,low confidence escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:751,ASMTL,acetylserotonin O-methyltransferase like,Approved,,,Xp22.3 and Yp11.3,gene with protein product,protein-coding gene,ENSG00000169093,8623,ENSG00000169093,O95671,,RGD:1306877,X,"300162, 400011",FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,TRUE,,no disorder,"FUNCTION: Nucleoside triphosphate pyrophosphatase that hydrolyzes dTTP and UTP. Can also hydrolyze CTP and the modified nucleotides pseudo-UTP, 5-methyl-UTP (m(5)UTP) and 5-methyl-CTP (m(5)CTP). Has weak activity with dCTP, 8-oxo-GTP and N(4)-methyl-dCTP (PubMed:24210219). May have a dual role in cell division arrest and in preventing the incorporation of modified nucleotides into cellular nucleic acids (PubMed:24210219). In addition, the presence of the putative catalytic domain of S-adenosyl-L-methionine binding in the C-terminal region argues for a methyltransferase activity (Probable). {ECO:0000269|PubMed:24210219, ECO:0000305}.",methylation [GO:0032259]; nucleotide metabolic process [GO:0009117],dTTP diphosphatase activity [GO:0036218]; NADH pyrophosphatase activity [GO:0035529]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; O-methyltransferase activity [GO:0008171],"",SUBUNIT: Homodimer. {ECO:0000269|PubMed:24210219}.,X,1403139,1453762,p22.33,1.2704e-9,0.997,-1.3289,-0.60919,26.771,0.4737224596483568,ENST00000381317,0.5563772775991426,0.019195201199700074,1866,,,,,,,0.1546531305025578,5.4870618134932,Cells - EBV-transformed lymphocytes,broadly expressed,3.999828669790962,4.711638067756956,FALSE,low confidence escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:7539,MXRA5,matrix remodeling associated 5,Approved,,DKFZp564I1922,Xp22.33,gene with protein product,protein-coding gene,ENSG00000101825,25878,ENSG00000101825,Q9NR99,,,X,300938,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: In kidney, has anti-inflammatory and anti-fibrotic properties by limiting the induction of chemokines, fibronectin and collagen expression in response to TGB1 and pro-inflammatory stimuli. {ECO:0000269|PubMed:27599751}.",response to transforming growth factor beta [GO:0071559],extracellular matrix structural constituent [GO:0005201],SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:27599751}.,"",X,3308565,3346652,p22.33,0.043013,0.398,-0.1945,-0.72839,54.987,0.6299905652130664,ENST00000217939,0.4200306350889596,0.035516120969757564,8487,,,,,,,0.4838336225941618,4.323391687706097,Cells - Cultured fibroblasts,broadly expressed,0.31689991820399716,0.16643973213130953,FALSE,high confidence escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,Post1_higher_vs_Post2,no disorder
HGNC:7638,NAP1L2,nucleosome assembly protein 1 like 2,Approved,,"BPX, MGC26243",Xq13.2,gene with protein product,protein-coding gene,ENSG00000186462,4674,ENSG00000186462,Q9ULW6,MGI:106654,RGD:1563260,X,300026,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Acidic protein which may be involved in interactions with other proteins or DNA. {ECO:0000250}.,cell differentiation [GO:0030154]; nucleosome assembly [GO:0006334]; positive regulation of histone H3-K14 acetylation [GO:0071442]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of neuron differentiation [GO:0045666]; regulation of stem cell division [GO:2000035],chromatin binding [GO:0003682]; histone binding [GO:0042393],SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.,"",X,73212299,73214851,q13.2,0.78108,0.506,-2.1331,0.10248,9.3776,0.45390070921985815,ENST00000373517,0.6882140274765004,0.42351912021994503,1383,,,,,,,0.633910412630166,6.967261424999802,Cerebellar_tissues,tissue-specific,5.030049100082215,6.967261424999802,TRUE,high confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:7639,NAP1L3,nucleosome assembly protein 1 like 3,Approved,,"MB20, NPL3, MGC26312",Xq21.32,gene with protein product,protein-coding gene,ENSG00000186310,4675,ENSG00000186310,Q99457,MGI:1859565,RGD:620990,X,300117,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",cell differentiation [GO:0030154]; nucleosome assembly [GO:0006334],chromatin binding [GO:0003682]; histone binding [GO:0042393],SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.,"",X,93670930,93673578,q21.32,0.087902,0.898,0.87482,0.49235,8.6355,0.5043358045787757,ENST00000373079,0.6287310979618672,0.47140714821294677,1521,,,,,,,0.6612625212848056,7.63359104885638,Cerebellar_tissues,tissue-specific,6.045508498662565,7.63359104885638,TRUE,low confidence escapee,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:7678,NDP,norrin cystine knot growth factor NDP,Approved,EVR2,norrin,Xp11.3,gene with protein product,protein-coding gene,ENSG00000124479,4693,ENSG00000124479,Q00604,MGI:102570,RGD:1563968,X,300658,TRUE,"Exudative vitreoretinopathy 2, X-linked // Norrie disease",305390 // 310600,"X-linked dominant, X-linked recessive // X-linked recessive",,,,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Activates the canonical Wnt signaling pathway through FZD4 and LRP5 coreceptor. Plays a central role in retinal vascularization by acting as a ligand for FZD4 that signals via stabilizing beta-catenin (CTNNB1) and activating LEF/TCF-mediated transcriptional programs. Acts in concert with TSPAN12 to activate FZD4 independently of the Wnt-dependent activation of FZD4, suggesting the existence of a Wnt-independent signaling that also promote accumulation the beta-catenin (CTNNB1). May be involved in a pathway that regulates neural cell differentiation and proliferation. Possible role in neuroectodermal cell-cell interaction.","extracellular matrix-cell signaling [GO:0035426]; nervous system development [GO:0007399]; Norrin signaling pathway [GO:0110135]; placenta development [GO:0001890]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription, DNA-templated [GO:0045893]; retina vasculature morphogenesis in camera-type eye [GO:0061299]; vacuole organization [GO:0007033]; visual perception [GO:0007601]; Wnt signaling pathway [GO:0016055]",cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; protein homodimerization activity [GO:0042803],SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:9407136}.,"SUBUNIT: Homodimer; disulfide-linked. Component of a complex, at least composed of TSPAN12, FZD4, LRP5/6 and norrin (NDP). Binds FZD4 with high affinity. Interacts with LRP6 (via Beta-propellers 1 and 2). {ECO:0000269|PubMed:24186977}.",X,43948776,43973395,p11.3,0.65042,0.876,-0.75723,0.96913,3.3942,0.40194884287454324,ENST00000642620,0.9485074626865672,0.48560359910022494,402,,,,,,,0.7834989426053043,5.320076651005098,Ovary,tissue-specific,4.635574478425891,5.263214731443789,FALSE,discordant,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:7683,NDUFA1,NADH:ubiquinone oxidoreductase subunit A1,Approved,,"MWFE, CI-MWFE",Xq24,gene with protein product,protein-coding gene,ENSG00000125356,4694,ENSG00000125356,O15239,MGI:1929511,RGD:1560955,X,300078,TRUE,"Mitochondrial complex I deficiency, nuclear type 12",301020,X-linked recessive,,,,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone. {ECO:0000269|PubMed:27626371}.","mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]",NADH dehydrogenase (ubiquinone) activity [GO:0008137],SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000305|PubMed:12611891}; Single-pass membrane protein {ECO:0000255}; Matrix side {ECO:0000305}.,"SUBUNIT: Complex I is composed of 45 different subunits. {ECO:0000269|PubMed:12611891, ECO:0000269|PubMed:27626371}.",X,119871832,119876662,q24,0.55315,1.178,0.19654,0.96306,2.4232,0.7358495057904864,ENST00000371437,0.7333333333333333,0.2637590602349413,213,,,,,,,0.15168224428917296,9.561475072821944,Heart - Left Ventricle,broadly expressed,8.184810891174706,8.645546758807635,FALSE,low confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:7820,NHS,NHS actin remodeling regulator,Approved,,,Xp22.2-p22.13,gene with protein product,protein-coding gene,ENSG00000188158,4810,ENSG00000188158,Q6T4R5,MGI:2684894,RGD:1561818,X,300457,TRUE,"Cataract 40, X-linked // Nance-Horan syndrome",302200 // 302350,X-linked // X-linked dominant,,,,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: May function in cell morphology by maintaining the integrity of the circumferential actin ring and controlling lamellipod formation. Involved in the regulation eye, tooth, brain and craniofacial development. {ECO:0000269|PubMed:20332100}.",cell differentiation [GO:0030154]; lens development in camera-type eye [GO:0002088],"","SUBCELLULAR LOCATION: [Isoform 1]: Apical cell membrane; Peripheral membrane protein. Cell projection, lamellipodium. Cell junction, tight junction. Cell junction, focal adhesion. Note=Colocalizes with the tight junction protein TJP1 in epithelial cells. Localizes to the leading edge of lamellipodia in motile cells.; SUBCELLULAR LOCATION: [Isoform 3]: Cytoplasm.","SUBUNIT: Interacts with the tight junction protein TJP1/ZO-1. Associates with actin-rich structures. Interacts with BRK1 and with all three members of the WAVE protein family, WASF1, WASF2 and WASF3. {ECO:0000269|PubMed:19447104, ECO:0000269|PubMed:20332100}.",X,17375200,17735994,p22.2,0.99999,0.087,1.2953,1.8225,34.148,0.6972215259433507,ENST00000676302,0.7885794995964488,0.35768557860534866,4956,,,,,,,0.45906621897743233,3.880087951433873,Artery - Aorta,broadly expressed,1.306454741790673,1.740828283945758,FALSE,variable escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:7871,NONO,non-POU domain containing octamer binding,Approved,,"NRB54, NMT55, P54NRB, P54, PPP1R114",Xq13.1,gene with protein product,protein-coding gene,ENSG00000147140,4841,ENSG00000147140,Q15233,MGI:1855692,RGD:1549738,X,300084,TRUE,"Mental retardation, X-linked, syndromic 34",300967,X-linked,,,,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,confirmed +CS,FALSE,TRUE,confirmed,"FUNCTION: DNA- and RNA binding protein, involved in several nuclear processes. Binds the conventional octamer sequence in double-stranded DNA. Also binds single-stranded DNA and RNA at a site independent of the duplex site. Involved in pre-mRNA splicing, probably as a heterodimer with SFPQ. Interacts with U5 snRNA, probably by binding to a purine-rich sequence located on the 3' side of U5 snRNA stem 1b. Together with PSPC1, required for the formation of nuclear paraspeckles. The SFPQ-NONO heteromer associated with MATR3 may play a role in nuclear retention of defective RNAs. The SFPQ-NONO heteromer may be involved in DNA unwinding by modulating the function of topoisomerase I/TOP1. The SFPQ-NONO heteromer may be involved in DNA non-homologous end joining (NHEJ) required for double-strand break repair and V(D)J recombination and may stabilize paired DNA ends. In vitro, the complex strongly stimulates DNA end joining, binds directly to the DNA substrates and cooperates with the Ku70/G22P1-Ku80/XRCC5 (Ku) dimer to establish a functional preligation complex. NONO is involved in transcriptional regulation. The SFPQ-NONO-NR5A1 complex binds to the CYP17 promoter and regulates basal and cAMP-dependent transcriptional activity. NONO binds to an enhancer element in long terminal repeats of endogenous intracisternal A particles (IAPs) and activates transcription. Regulates the circadian clock by repressing the transcriptional activator activity of the CLOCK-ARNTL/BMAL1 heterodimer. Important for the functional organization of GABAergic synapses. Plays a specific and important role in the regulation of synaptic RNAs and GPHN/gephyrin scaffold structure, through the regulation of GABRA2 transcript. Plays a role in the regulation of DNA virus-mediated innate immune response by assembling into the HDP-RNP complex, a complex that serves as a platform for IRF3 phosphorylation and subsequent innate immune response activation through the cGAS-STING pathway (PubMed:28712728). {ECO:0000250|UniProtKB:Q99K48, ECO:0000269|PubMed:10858305, ECO:0000269|PubMed:11525732, ECO:0000269|PubMed:11897684, ECO:0000269|PubMed:15590677, ECO:0000269|PubMed:22416126, ECO:0000269|PubMed:26571461, ECO:0000269|PubMed:28712728}.","activation of innate immune response [GO:0002218]; circadian rhythm [GO:0007623]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; innate immune response [GO:0045087]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of circadian rhythm [GO:0042752]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]",chromatin binding [GO:0003682]; E-box binding [GO:0070888]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription regulatory region sequence-specific DNA binding [GO:0000976],"SUBCELLULAR LOCATION: Nucleus. Nucleus, nucleolus. Nucleus speckle. Note=Detected in punctate subnuclear structures often located adjacent to splicing speckles, called paraspeckles.","SUBUNIT: Monomer and component of the SFPQ-NONO complex, which is probably a heterotetramer of two 52 kDa (NONO) and two 100 kDa (SFPQ) subunits (PubMed:8439294, PubMed:15590677). NONO is a component of spliceosome and U5.4/6 snRNP complexes (PubMed:12403470). Interacts with CPNE4 (via VWFA domain) (By similarity). Forms heterodimers with PSPC1; this involves formation of a coiled coil domain by helices from both proteins (PubMed:16148043, PubMed:22416126). Part of complex consisting of SFPQ, NONO and MATR3 (PubMed:11525732). Part of a complex consisting of SFPQ, NONO and NR5A1 (PubMed:11897684). Part of a complex consisting of SFPQ, NONO and TOP1 (PubMed:9756848). Interacts with SPI1 (By similarity). Interacts with RNF43 (PubMed:18655028). Interacts with PER1 and PER2 (By similarity). Part of the HDP-RNP complex composed of at least HEXIM1, PRKDC, XRCC5, XRCC6, paraspeckle proteins (SFPQ, NONO, PSPC1, RBM14, and MATR3) and NEAT1 RNA (PubMed:28712728). Interacts (via second RRM domain) with WASL; the interaction is direct (PubMed:16767080). Component of a multiprotein complex with WASL and SFPQ (PubMed:16767080). Interacts with ERCC6 (PubMed:26030138). {ECO:0000250|UniProtKB:Q99K48, ECO:0000269|PubMed:11525732, ECO:0000269|PubMed:11897684, ECO:0000269|PubMed:12403470, ECO:0000269|PubMed:15590677, ECO:0000269|PubMed:16148043, ECO:0000269|PubMed:16767080, ECO:0000269|PubMed:18655028, ECO:0000269|PubMed:22416126, ECO:0000269|PubMed:26030138, ECO:0000269|PubMed:28712728, ECO:0000269|PubMed:8439294, ECO:0000269|PubMed:9756848}.",X,71283192,71301168,q13.1,0.9935,0.244,0.32086,3.5885,19.407,0.5774936067434212,ENST00000276079,0.955861581920904,0.21224693826543364,1416,,,,,,,0.15105776431630635,7.906265292265289,Cells - EBV-transformed lymphocytes,broadly expressed,5.343493102242721,7.140170248354181,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:7889,NOX1,NADPH oxidase 1,Approved,,"NOH1, NOH-1, MOX1, GP91-2",Xq22.1,gene with protein product,protein-coding gene,ENSG00000007952,27035,ENSG00000007952,Q9Y5S8,MGI:2450016,RGD:620598,X,300225,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: NOH-1S is a voltage-gated proton channel that mediates the H(+) currents of resting phagocytes and other tissues. It participates in the regulation of cellular pH and is blocked by zinc. NOH-1L is a pyridine nucleotide-dependent oxidoreductase that generates superoxide and might conduct H(+) ions as part of its electron transport mechanism, whereas NOH-1S does not contain an electron transport chain.",angiogenesis [GO:0001525]; cell migration [GO:0016477]; cellular response to hyperoxia [GO:0071455]; cellular stress response to acidic pH [GO:1990451]; defense response [GO:0006952]; extracellular matrix organization [GO:0030198]; hydrogen peroxide metabolic process [GO:0042743]; inflammatory response [GO:0006954]; intracellular pH elevation [GO:0051454]; NADP metabolic process [GO:0006739]; oxidation-reduction process [GO:0055114]; oxygen metabolic process [GO:0072592]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of integrin biosynthetic process [GO:0045726]; positive regulation of JNK cascade [GO:0046330]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of blood pressure [GO:0008217]; regulation of ion transmembrane transport [GO:0034765]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; respiratory burst [GO:0045730]; signal transduction [GO:0007165]; superoxide anion generation [GO:0042554],metal ion binding [GO:0046872]; NADP binding [GO:0050661]; Rac GTPase binding [GO:0048365]; superoxide-generating NADPH oxidase activity [GO:0016175]; voltage-gated ion channel activity [GO:0005244],"SUBCELLULAR LOCATION: Cell projection, invadopodium membrane {ECO:0000269|PubMed:19755710}; Multi-pass membrane protein {ECO:0000269|PubMed:19755710}. Cell membrane {ECO:0000269|PubMed:26301257}.","SUBUNIT: NOX1, NOXA1, NOXO1, RAC1 and CYBA forms a functional multimeric complex supporting reactive oxygen species (ROS) production. Interacts with NOXA1 and NOXO1. {ECO:0000269|PubMed:16329988, ECO:0000269|PubMed:16636067}.",X,100843324,100874359,q22.1,8.6564e-8,1.064,0.99302,-0.050681,20.573,0.14332910512473215,ENST00000372966,0.7269026548672567,0.12289427643089228,1695,2,"CYBB (59, 58, chrX); NOX3 (57, 56, chr6)",TRUE,,,,0.8976652815892971,4.782057284636287,Colon - Transverse,tissue-specific,0.46025293405732487,0.9662189205130364,FALSE,low confidence escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:7960,NR0B1,nuclear receptor subfamily 0 group B member 1,Approved,"AHC, DSS","DAX1, AHCH",Xp21.2,gene with protein product,protein-coding gene,ENSG00000169297,190,ENSG00000169297,P51843,MGI:1352460,RGD:62028,X,300473,TRUE,"46XY sex reversal 2, dosage-sensitive // Adrenal hypoplasia, congenital",300018 // 300200,X-linked // X-linked recessive,,,,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,FUNCTION: Orphan nuclear receptor. Component of a cascade required for the development of the hypothalamic-pituitary-adrenal-gonadal axis. Acts as a coregulatory protein that inhibits the transcriptional activity of other nuclear receptors through heterodimeric interactions. May also have a role in the development of the embryo and in the maintenance of embryonic stem cell pluripotency (By similarity). {ECO:0000250}.,"adrenal gland development [GO:0030325]; gonad development [GO:0008406]; hypothalamus development [GO:0021854]; Leydig cell differentiation [GO:0033327]; male gonad development [GO:0008584]; male sex determination [GO:0030238]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of intracellular steroid hormone receptor signaling pathway [GO:0033144]; negative regulation of steroid biosynthetic process [GO:0010894]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pituitary gland development [GO:0021983]; protein localization [GO:0008104]; response to immobilization stress [GO:0035902]; Sertoli cell differentiation [GO:0060008]; spermatogenesis [GO:0007283]; transcription initiation from RNA polymerase II promoter [GO:0006367]","AF-2 domain binding [GO:0050682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA hairpin binding [GO:0032448]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; steroid hormone receptor binding [GO:0035258]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]",SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:16709599}. Cytoplasm {ECO:0000269|PubMed:16709599}. Note=Shuttles between the cytoplasm and nucleus. Homodimers exits in the cytoplasm and in the nucleus.,"SUBUNIT: Homodimer. Interacts with NR5A1, NR5A2, NR0B2 and with COPS2. Interacts with ESRRB; represses ESRRB activity at the GATA6 promoter (By similarity). {ECO:0000250|UniProtKB:Q61066, ECO:0000269|PubMed:10713076, ECO:0000269|PubMed:12482977}.",X,30304206,30309390,p21.2,0.97025,0.275,-0.84106,1.0824,10.872,0.5622576925780085,ENST00000378970,0.567515923566879,0.20804798800299926,1413,,,,,,,0.8983909125729937,5.4415863927617965,Adrenal Gland,tissue-specific,0.8182092205688508,0.39157692411644013,FALSE,discordant,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,Post1_higher_vs_Post2,confirmed monogenic disorder
HGNC:8013,HMGN5,high mobility group nucleosome binding domain 5,Approved,NSBP1,,Xq21.1,gene with protein product,protein-coding gene,ENSG00000198157,79366,ENSG00000198157,P82970,MGI:1355295,RGD:6497694,X,300385,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Preferentially binds to euchromatin and modulates cellular transcription by counteracting linker histone-mediated chromatin compaction. {ECO:0000250}.,"chromatin organization [GO:0006325]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle arrest [GO:0071157]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]",chromatin binding [GO:0003682]; nucleosomal DNA binding [GO:0031492]; RNA binding [GO:0003723],SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11161810}. Note=Associates with nucleosomes in euchromatin and is largely excluded from constitutive heterochromatin. {ECO:0000250}.,"",X,81113699,81201913,q21.1,0.30957,1.147,1.0298,-0.1511,4.0843,0.2738740115855076,ENST00000358130,0.27926972909305064,0.1947263184203949,849,,,,,,,0.5161289955597673,6.539977657158227,Testis,broadly expressed,3.417990197105771,1.9512651291558947,FALSE,discordant,Post_higher_vs_Pre,Post1_higher_vs_Pre,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:8072,NXF2,nuclear RNA export factor 2,Approved,,"CT39, TAPL-2",Xq22.1,gene with protein product,protein-coding gene,ENSG00000269405,56001,ENSG00000269405,Q9GZY0,MGI:1933192,,X,300315,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Involved in the export of mRNA from the nucleus to the cytoplasm.,mRNA export from nucleus [GO:0006406]; multicellular organism development [GO:0007275]; poly(A)+ mRNA export from nucleus [GO:0016973]; RNA transport [GO:0050658],RNA binding [GO:0003723],"SUBCELLULAR LOCATION: Nucleus, nucleoplasm. Cytoplasm. Note=Localized in the nucleoplasm and at the nuclear envelope. Shuttles between the nucleus and the cytoplasm.","SUBUNIT: Interacts with NXT1, NXT2, E1B-AP5, the REF proteins and with nucleoporins, Nup62, Nup153 and Nup214. Interacts with LUZP4. {ECO:0000269|PubMed:10567585, ECO:0000269|PubMed:25662211}.",X,102247167,102326722,q22.1,0.44568,0.861,1.5751,1.477,5.5055,0.3347525446423901,ENST00000625106,0.49457735247208934,0.03514121469632592,1881,2,"NXF2B (100, 100, chrX); NXF1 (57, 57, chr11)",TRUE,1,"NXF2B (100, 100, chrX)",TRUE,0.9684828504742783,0.07888113421902022,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:8073,NXF3,nuclear RNA export factor 3,Approved,,,Xq22.1,gene with protein product,protein-coding gene,ENSG00000147206,56000,ENSG00000147206,Q9H4D5,MGI:2685230,RGD:1564923,X,300316,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May function as a tissue-specific nuclear mRNA export factor.,mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973],mRNA binding [GO:0003729]; RNA binding [GO:0003723],SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Note=Shuttles between the nucleus and the cytoplasm.,"SUBUNIT: Interacts with NXT1, NXT2, E1B-AP5 and CRM1 nuclear export factor.",X,103075810,103093143,q22.1,0.0085216,0.599,0.39561,0.77469,24.109,0.3206691295837314,ENST00000395065,0.45895989974937346,0.14213946513371656,1596,,,,,,,0.8729575939635322,7.742221844233985,Testis,tissue-specific,0.08669559875109219,0.06556224784729502,FALSE,variable escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:8075,NXF5,nuclear RNA export factor 5,Approved,,,Xq22.1,gene with protein product,protein-coding gene,ENSG00000126952,55998,ENSG00000126952,Q9H1B4,MGI:1933192,RGD:1566170,X,300319,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Could be involved in the export of mRNA from the nucleus to the cytoplasm. Could also have a role in polarized cytoplasmic transport and localization of mRNA in neurons.,mRNA export from nucleus [GO:0006406]; multicellular organism development [GO:0007275]; poly(A)+ mRNA export from nucleus [GO:0016973]; RNA transport [GO:0050658],RNA binding [GO:0003723],SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Note=Mainly localized in the cytoplasm of cells and more particularly in the cell body and neurites of hippocampal neurons. Although nuclear localization is also observed. Not detected at nuclear rim.,SUBUNIT: Interacts with NXT1 and NXT2.,X,101832112,101857577,q22.1,3.7443e-14,1.693,-1.162,-0.3742,16.257,0.17605591916654176,ENST00000473265,0.5887067395264116,0.07288177955511123,1098,,,,,,,0.8037386858637205,0.8025154345583879,Cerebellar_tissues,tissue-specific,0.21472041594393762,0.8025154345583879,TRUE,high confidence escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:8079,FRMD7,FERM domain containing 7,Approved,"NYS, NYS1",FLJ43346,Xq26.2,gene with protein product,protein-coding gene,ENSG00000165694,90167,ENSG00000165694,Q6ZUT3,MGI:2686379,RGD:1562057,X,300628,TRUE,"Nystagmus 1, congenital, X-linked // Nystagmus, infantile periodic alternating, X-linked",310700 // 310700,X-linked // X-linked,,,,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Plays a role in neurite development, may be through the activation of the GTPase RAC1. Plays a role in the control of eye movement and gaze stability. {ECO:0000250|UniProtKB:A2AD83, ECO:0000269|PubMed:17013395, ECO:0000269|PubMed:23946638}.",negative regulation of protein binding [GO:0032091]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; regulation of neuron projection development [GO:0010975],"","SUBCELLULAR LOCATION: Cell projection, neuron projection {ECO:0000250|UniProtKB:A2AD83}. Cell projection, growth cone {ECO:0000250|UniProtKB:A2AD83}. Note=In undifferentiated neurons, located in the actin-rich regions of the cell body. In differentiated neurons, located in the actin-rich regions of the cell body and primary neurite processes but is almost absent from secondary extensions arising from the primary neurite. Also found at the actin-rich distal end of growth cones (By similarity). {ECO:0000250|UniProtKB:A2AD83}.","",X,132076993,132128020,q26.2,0.72983,0.419,0.25842,0.70381,21.846,0.15739356260328954,ENST00000298542,0.777995337995338,0.34396400899775054,2145,,,,,,,0.9214670000695223,2.599522518072115,Uterus,tissue-specific,0,0,FALSE,variable escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:808,ATP1B4,ATPase Na+/K+ transporting family member beta 4,Approved,,,Xq24,gene with protein product,protein-coding gene,ENSG00000101892,23439,ENSG00000101892,Q9UN42,MGI:1915071,RGD:620994,X,,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: May act as a transcriptional coregulator during muscle development through its interaction with SNW1. Has lost its ancestral function as a Na,K-ATPase beta-subunit. {ECO:0000269|PubMed:17592128}.","positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]",monovalent inorganic cation transmembrane transporter activity [GO:0015077],"SUBCELLULAR LOCATION: Nucleus inner membrane {ECO:0000250}; Single-pass type II membrane protein {ECO:0000250}. Note=Detected in nuclear envelops. {ECO:0000269|PubMed:14656723, ECO:0000269|PubMed:17592128}.","SUBUNIT: Associates with a SMAD7-transcriptional complex. Interacts with SNW1 and TOR1AIP1 (By similarity). According to PubMed:17592128, does not associate with known Na,K-ATPase alpha-subunits. {ECO:0000250}.",X,120362085,120383249,q24,3.5587e-4,0.919,-1.1766,0.22358,15.712,0.12244960433471598,ENST00000218008,0.909683426443203,0.33656585853536614,1074,,,,,,,0.9714087906156286,3.6676196787279345,Muscle - Skeletal,tissue-specific,0.01728270594542684,0.004057610318107512,FALSE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:8082,NYX,nyctalopin,Approved,"CSNB1, CSNB4","CLRP, CSNB1A",Xp11.4,gene with protein product,protein-coding gene,ENSG00000188937,60506,ENSG00000188937,Q9GZU5,MGI:2448607,RGD:1561300,X,300278,TRUE,"Night blindness, congenital stationary (complete), 1A, X-linked",310500,X-linked recessive,,,,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"",response to stimulus [GO:0050896]; visual perception [GO:0007601],"","SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular matrix {ECO:0000250}.","",X,41447343,41475710,p11.4,0.12961,1.131,2.7687,2.1145,5.543,0.2835825664621677,ENST00000378220,0.7282849239280774,0.14938765308672833,1446,,,,,,,0.9617958520148879,0.6585560885813723,Testis,tissue-specific,0,0,FALSE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:8092,TBC1D25,TBC1 domain family member 25,Approved,OATL1,,Xp11.23,gene with protein product,protein-coding gene,ENSG00000068354,4943,ENSG00000068354,Q3MII6,MGI:2444862,RGD:1559711,X,311240,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Acts as a GTPase-activating protein specific for RAB33B. Involved in the regulation of autophagosome maturation, the process in which autophagosomes fuse with endosomes and lysosomes. {ECO:0000269|PubMed:21383079}.",activation of GTPase activity [GO:0090630]; autophagy [GO:0006914]; intracellular protein transport [GO:0006886]; regulation of autophagosome maturation [GO:1901096],GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137],"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:21383079}. Cytoplasmic vesicle, autophagosome {ECO:0000269|PubMed:21383079}. Note=It is dispersed in the cytoplasm under nutrient-rich conditions. Localizes at autophagosomes under cell starving conditions.","SUBUNIT: Interacts (via N-terminus) with MAP1LC3B, GABARAP and GABARAPL2. {ECO:0000269|PubMed:21383079}.",X,48539714,48562609,p11.23,0.52262,0.471,0.92546,3.1034,19.431,0.46395330043828376,ENST00000376771,0.7636671504596033,0.2239940014996251,2067,,,,,,,0.21582280050308297,4.8697480514650655,Cerebellar_tissues,broadly expressed,3.022786799602765,4.8697480514650655,TRUE,low confidence non-escapee,no_difference_Pre_Post,Pre_higher_vs_Post1,no difference_Pre_Post2,Post2_higher_vs_Post1,no disorder
HGNC:8108,OCRL,OCRL inositol polyphosphate-5-phosphatase,Approved,,"OCRL1, Dent-2",Xq26.1,gene with protein product,protein-coding gene,ENSG00000122126,4952,ENSG00000122126,Q01968,MGI:109589,RGD:1594526,X,300535,TRUE,Dent disease 2 // Lowe syndrome,300555 // 309000,X-linked recessive // X-linked recessive,,,,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Catalyzes the hydrolysis of the 4-position phosphate of phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2) and phosphatidylinositol-3,4,5-bisphosphate (PtdIns(3,4,5)P3), with the greatest catalytic activity towards PtdIns(4,5)P2 (PubMed:7761412, PubMed:15474001, PubMed:9430698, PubMed:10764818). Able also to hydrolyzes the 4-phosphate of inositol 1,4,5-trisphosphate and of inositol 1,3,4,5-tetrakisphosphate (PubMed:7761412, PubMed:25869668). Regulates traffic in the endosomal pathway by regulating the specific pool of phosphatidylinositol 4,5-bisphosphate that is associated with endosomes (PubMed:21971085). Involved in primary cilia assembly (PubMed:22228094, PubMed:22543976). Acts as a regulator of phagocytosis, hydrolyzing PtdIns(4,5)P2 to promote phagosome closure, through attenuation of PI3K signaling (PubMed:22072788). {ECO:0000269|PubMed:10764818, ECO:0000269|PubMed:15474001, ECO:0000269|PubMed:21971085, ECO:0000269|PubMed:22072788, ECO:0000269|PubMed:22228094, ECO:0000269|PubMed:22543976, ECO:0000269|PubMed:25869668, ECO:0000269|PubMed:7761412, ECO:0000269|PubMed:9430698}.",cilium assembly [GO:0060271]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; in utero embryonic development [GO:0001701]; lipid metabolic process [GO:0006629]; membrane organization [GO:0061024]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165],"GTPase activator activity [GO:0005096]; inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol phosphate phosphatase activity [GO:0052745]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; Rac GTPase binding [GO:0048365]","SUBCELLULAR LOCATION: Cytoplasmic vesicle, phagosome membrane {ECO:0000250|UniProtKB:D3ZGS3}. Early endosome membrane {ECO:0000269|PubMed:21971085, ECO:0000269|PubMed:25869668}. Membrane, clathrin-coated pit {ECO:0000269|PubMed:25869668}. Cell projection, cilium, photoreceptor outer segment {ECO:0000269|PubMed:22543976}. Cell projection, cilium {ECO:0000269|PubMed:22543976}. Cytoplasmic vesicle {ECO:0000250|UniProtKB:D3ZGS3}. Endosome {ECO:0000269|PubMed:21971085, ECO:0000269|PubMed:25869668}. Golgi apparatus, trans-Golgi network {ECO:0000250|UniProtKB:D3ZGS3}. Lysosome {ECO:0000269|PubMed:9430698}. Note=Also found on macropinosomes (PubMed:25869668). Colocalized with APPL1 on phagosomes (PubMed:22072788). {ECO:0000269|PubMed:22072788, ECO:0000269|PubMed:25869668}.","SUBUNIT: Interacts with APPL1, FAM109A/SES1 and FAM109B/SES2; APPL1-binding and FAM109A-binding are mutually exclusive. Interacts with clathrin heavy chain. Interacts with several Rab GTPases, at least RAB1B, RAB5A, RAB6A, RAB8A and RAB31; these interactions may play a dual role in targeting OCRL to the specific membranes and stimulating the phosphatase activity. Interaction with RAB8A modulates OCRL recruitment to cilia. Interacts with INPP5F (PubMed:25869668). {ECO:0000269|PubMed:17765681, ECO:0000269|PubMed:19536138, ECO:0000269|PubMed:20133602, ECO:0000269|PubMed:21233288, ECO:0000269|PubMed:21378754, ECO:0000269|PubMed:21666675, ECO:0000269|PubMed:22543976, ECO:0000269|PubMed:25869668}.",X,129539849,129592561,q26.1,0.99999,0.155,0.49024,2.9631,40.685,0.4830125400991543,ENST00000371113,0.9121581670362158,0.2160459885028743,2706,,,,,,,0.24274548272968058,5.935146186869022,Esophagus - Gastroesophageal Junction,broadly expressed,3.856248721506335,4.9094611104030514,FALSE,high confidence non-escapee,no_difference_Pre_Post,Pre_higher_vs_Post1,no difference_Pre_Post2,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:8117,TENM1,teneurin transmembrane protein 1,Approved,"ODZ3, TNM, ODZ1","TEN-M1, TEN1",Xq25,gene with protein product,protein-coding gene,ENSG00000009694,10178,ENSG00000009694,Q9UKZ4,MGI:1345185,RGD:1561678,X,300588,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Involved in neural development, regulating the establishment of proper connectivity within the nervous system. May function as a cellular signal transducer (By similarity). {ECO:0000250}.; FUNCTION: [Teneurin C-terminal-associated peptide]: Plays a role in the regulation of neuroplasticity in the limbic system. Mediates a rapid reorganization of actin- and tubulin-based cytoskeleton elements with an increase in dendritic arborization and spine density formation of neurons in the hippocampus and amygdala. Induces BDNF transcription inhibition in neurons. Activates the mitogen-activated protein (MAP) kinase 2 (MEK2) and extracellular signal-regulated kinase (ERK) cascade. Acts also as a bioactive neuroprotective peptide on limbic neurons of the brain and regulates stress-induced behavior: attenuates alkalosis-associated necrotic cell death and the effects of corticotropin-releasing factor (CRF) on c-fos/FOS induction and on the reinstatement of cocaine seeking (By similarity). {ECO:0000250}.; FUNCTION: [Ten-1 intracellular domain]: Induces gene transcription activation. {ECO:0000250}.",heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; immune response [GO:0006955]; negative regulation of cell population proliferation [GO:0008285]; nervous system development [GO:0007399]; neuron development [GO:0048666]; neuropeptide signaling pathway [GO:0007218]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of transcription by RNA polymerase III [GO:0006359],cell adhesion molecule binding [GO:0050839]; heparin binding [GO:0008201]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803],"SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Single-pass membrane protein {ECO:0000250}.; SUBCELLULAR LOCATION: [Ten-1 intracellular domain]: Nucleus {ECO:0000250}. Nucleus speckle {ECO:0000250}. Nucleus matrix {ECO:0000250}. Cytoplasm, cytoskeleton {ECO:0000250}.; SUBCELLULAR LOCATION: [Teneurin C-terminal-associated peptide]: Nucleus {ECO:0000250}. Cytoplasm {ECO:0000250}. Cell membrane {ECO:0000250}. Note=Colocalizes with the dystroglycan complex at the cell membrane in hippocampal cells. Binds hippocampal cell membranes and is incorporated in the cytoplasm by endocytosis in a caveoli-dependent manner. Upon cell internalization is transported arround and in the nucleus (By similarity). {ECO:0000250}.",SUBUNIT: Homodimer; disulfide-linked. Heterodimer with either TENM2 or TENM3. May also form heterodimer with TENM4. Ten-1 ICD interacts with SORBS1 (via third SH3 domain). Interacts with MBD1 (By similarity). {ECO:0000250}.,X,124375903,124963817,q25,1,0.193,0.35792,3.4329,88.068,0.3178258119963029,ENST00000422452,0.9350530552506403,0.27188202949262685,8199,3,"TENM4 (64, 63, chr11); TENM3 (59, 59, chr4); TENM2 (57, 56, chr5)",TRUE,,,,0.7215057220538711,5.204803912873617,Cerebellar_tissues,tissue-specific,1.3080287945962108,5.204803912873617,TRUE,discordant,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:8127,OGT,O-linked N-acetylglucosamine (GlcNAc) transferase,Approved,,"O-GLCNAC, HRNT1, MGC22921, FLJ23071, OGT1",Xq13.1,gene with protein product,protein-coding gene,ENSG00000147162,8473,ENSG00000147162,O15294,MGI:1339639,RGD:62060,X,300255,TRUE,"Mental retardation, X-linked 106",300997,X-linked recessive,,,,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Catalyzes the transfer of a single N-acetylglucosamine from UDP-GlcNAc to a serine or threonine residue in cytoplasmic and nuclear proteins resulting in their modification with a beta-linked N-acetylglucosamine (O-GlcNAc) (PubMed:26678539, PubMed:23103939, PubMed:21240259, PubMed:21285374, PubMed:15361863). Glycosylates a large and diverse number of proteins including histone H2B, AKT1, EZH2, PFKL, KMT2E/MLL5, MAPT/TAU and HCFC1. Can regulate their cellular processes via cross-talk between glycosylation and phosphorylation or by affecting proteolytic processing (PubMed:21285374). Probably by glycosylating KMT2E/MLL5, stabilizes KMT2E/MLL5 by preventing its ubiquitination (PubMed:26678539). Involved in insulin resistance in muscle and adipocyte cells via glycosylating insulin signaling components and inhibiting the 'Thr-308' phosphorylation of AKT1, enhancing IRS1 phosphorylation and attenuating insulin signaling (By similarity). Involved in glycolysis regulation by mediating glycosylation of 6-phosphofructokinase PFKL, inhibiting its activity (PubMed:22923583). Component of a THAP1/THAP3-HCFC1-OGT complex that is required for the regulation of the transcriptional activity of RRM1. Plays a key role in chromatin structure by mediating O-GlcNAcylation of 'Ser-112' of histone H2B: recruited to CpG-rich transcription start sites of active genes via its interaction with TET proteins (TET1, TET2 or TET3) (PubMed:22121020, PubMed:23353889). As part of the NSL complex indirectly involved in acetylation of nucleosomal histone H4 on several lysine residues (PubMed:20018852). O-GlcNAcylation of 'Ser-75' of EZH2 increases its stability, and facilitating the formation of H3K27me3 by the PRC2/EED-EZH2 complex (PubMed:24474760). Regulates circadian oscillation of the clock genes and glucose homeostasis in the liver. Stabilizes clock proteins ARNTL/BMAL1 and CLOCK through O-glycosylation, which prevents their ubiquitination and subsequent degradation. Promotes the CLOCK-ARNTL/BMAL1-mediated transcription of genes in the negative loop of the circadian clock such as PER1/2 and CRY1/2 (PubMed:12150998, PubMed:19451179, PubMed:20018868, PubMed:20200153, PubMed:21285374, PubMed:15361863). O-glycosylates HCFC1 and regulates its proteolytic processing and transcriptional activity (PubMed:21285374, PubMed:28584052, PubMed:28302723). Regulates mitochondrial motility in neurons by mediating glycosylation of TRAK1 (By similarity). Glycosylates HOXA1 (By similarity). O-glycosylates FNIP1 (PubMed:30699359). {ECO:0000250|UniProtKB:P56558, ECO:0000250|UniProtKB:Q8CGY8, ECO:0000269|PubMed:12150998, ECO:0000269|PubMed:15361863, ECO:0000269|PubMed:19451179, ECO:0000269|PubMed:20018852, ECO:0000269|PubMed:20018868, ECO:0000269|PubMed:20200153, ECO:0000269|PubMed:21240259, ECO:0000269|PubMed:21285374, ECO:0000269|PubMed:22121020, ECO:0000269|PubMed:22923583, ECO:0000269|PubMed:23103939, ECO:0000269|PubMed:23353889, ECO:0000269|PubMed:24474760, ECO:0000269|PubMed:26678539, ECO:0000269|PubMed:28302723, ECO:0000269|PubMed:28584052, ECO:0000269|PubMed:30699359}.; FUNCTION: [Isoform 2]: the mitochondrial isoform (mOGT) is cytotoxic and triggers apoptosis in several cell types including INS1, an insulinoma cell line. {ECO:0000269|PubMed:20824293}.",apoptotic process [GO:0006915]; circadian regulation of gene expression [GO:0032922]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein ubiquitination [GO:0031397]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of Rac protein signal transduction [GO:0035020]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]; response to nutrient [GO:0007584]; signal transduction [GO:0007165]; viral process [GO:0016032],"acetylglucosaminyltransferase activity [GO:0008375]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:26678539}. Cytoplasm {ECO:0000269|PubMed:26678539}. Note=Predominantly localizes to the nucleus. {ECO:0000269|PubMed:26678539}.; SUBCELLULAR LOCATION: [Isoform 2]: Mitochondrion {ECO:0000269|PubMed:20824293}. Membrane {ECO:0000269|PubMed:20824293}. Note=Associates with the mitochondrial inner membrane. {ECO:0000269|PubMed:20824293}.; SUBCELLULAR LOCATION: [Isoform 3]: Cytoplasm {ECO:0000269|PubMed:21285374}. Nucleus {ECO:0000269|PubMed:20018852, ECO:0000269|PubMed:21285374}. Cell membrane {ECO:0000250|UniProtKB:P56558}. Mitochondrion membrane {ECO:0000250|UniProtKB:P56558}. Cell projection {ECO:0000250|UniProtKB:P56558}. Note=Mostly in the nucleus. Retained in the nucleus via interaction with HCFC1 (PubMed:21285374). After insulin induction, translocated from the nucleus to the cell membrane via phosphatidylinositide binding. Colocalizes with AKT1 at the plasma membrane. TRAK1 recruits this protein to mitochondria. In the absence of TRAK1, localizes in cytosol and nucleus (By similarity). {ECO:0000250|UniProtKB:P56558, ECO:0000269|PubMed:21285374}.; SUBCELLULAR LOCATION: [Isoform 4]: Cytoplasm. Nucleus.","SUBUNIT: Monomer; may exist in different oligomerization states in cells (PubMed:21240259). Homotrimer, oligomerizes via TPR repeats 6 and 7. Trimerization is not necessary for activity in vitro, however it increases affinity for UDP-GlcNAc (By similarity). Component of a THAP1/THAP3-HCFC1-OGT complex (PubMed:20200153). Component of the NSL complex at least composed of MOF/KAT8, KANSL1, KANSL2, KANSL3, MCRS1, PHF20, OGT1/OGT, WDR5 and HCFC1 (PubMed:20018852). Interacts directly with HCFC1; the interaction O-glycosylates HCFC1, regulates its proteolytic processing and transcriptional activity and, in turn, stabilizes OGT in the nucleus (PubMed:12670868, PubMed:20200153, PubMed:21285374, PubMed:23353889). Interacts (via TPRs 1-6) with SIN3A; the interaction mediates transcriptional repression in parallel with histone deacetylase (PubMed:12150998). Interacts (via TPR 5-6) with TET1, TET2 and TET3 (PubMed:23353889, PubMed:23222540). Interacts (via TPR repeats 6 and 7) with ATXN10 (By similarity). Interacts with histone H2B (PubMed:22121020). Interacts with ARNTL/BMAL1. Found in a complex composed of at least SINHCAF, SIN3A, HDAC1, SAP30, RBBP4, OGT and TET1. Interacts with SINHCAF (By similarity). Component of a complex composed of KMT2E/MLL5 (isoform 3), OGT (isoform 1) and USP7; the complex stabilizes KMT2E/MLL5, preventing KMT2E/MLL5 ubiquitination and proteosomal-mediated degradation (PubMed:26678539). Isoform 1 interacts (via TRP repeats) with isoform 3 KMT2E/MLL5 (via N-terminus) (PubMed:26678539, PubMed:23629655). Isoform 1 interacts with USP7 (PubMed:26678539). Interacts with TRAK1; this interaction is not required for glycosylation of TRAK1 by this protein. Found in a complex with KIF5B, RHOT1, RHOT2 and TRAK1 (PubMed:24995978). Interacts (via TPR repeats domain) with HOXA1; the interaction takes place mainly in the nucleus (By similarity). {ECO:0000250|UniProtKB:P56558, ECO:0000250|UniProtKB:Q8CGY8, ECO:0000269|PubMed:12150998, ECO:0000269|PubMed:12670868, ECO:0000269|PubMed:20018852, ECO:0000269|PubMed:20200153, ECO:0000269|PubMed:21240259, ECO:0000269|PubMed:21285374, ECO:0000269|PubMed:22121020, ECO:0000269|PubMed:23222540, ECO:0000269|PubMed:23353889, ECO:0000269|PubMed:23629655, ECO:0000269|PubMed:24995978, ECO:0000269|PubMed:26678539}.; SUBUNIT: (Microbial infection) Interacts with human T-cell leukemia virus 1/HTLV-1 protein Tax; this interaction increases Tax interacting partner CREB1 O-GlcNAcylation. {ECO:0000269|PubMed:28742148}.",X,71533104,71575892,q13.1,1,0.08,1.2967,5.6667,37.002,0.6492932967628433,ENST00000373719,0.9748806112702961,0.31272181954511374,3141,,,,,,,0.13107944381272632,8.04306557262308,Fallopian Tube,broadly expressed,5.238763935225308,7.59150364657863,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:8148,OPHN1,oligophrenin 1,Approved,MRX60,"OPN1, ARHGAP41",Xq12,gene with protein product,protein-coding gene,ENSG00000079482,4983,ENSG00000079482,O60890,MGI:2151070,RGD:1563435,X,300127,TRUE,"Mental retardation, X-linked, with cerebellar hypoplasia and distinctive facial appearance",300486,X-linked recessive,,,,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,confirmed +CS,FALSE,TRUE,confirmed,"FUNCTION: Stimulates GTP hydrolysis of members of the Rho family. Its action on RHOA activity and signaling is implicated in growth and stabilization of dendritic spines, and therefore in synaptic function. Critical for the stabilization of AMPA receptors at postsynaptic sites. Critical for the regulation of synaptic vesicle endocytosis at presynaptic terminals. Required for the localization of NR1D1 to dendrites, can suppress its repressor activity and protect it from proteasomal degradation (By similarity). {ECO:0000250}.","actin cytoskeleton organization [GO:0030036]; axon guidance [GO:0007411]; cell junction assembly [GO:0034329]; cell morphogenesis involved in neuron differentiation [GO:0048667]; cerebellar granule cell differentiation [GO:0021707]; cerebral cortex neuron differentiation [GO:0021895]; establishment of epithelial cell apical/basal polarity [GO:0045198]; negative regulation of proteasomal protein catabolic process [GO:1901799]; nervous system development [GO:0007399]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; regulation of endocytosis [GO:0030100]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; regulation of synaptic transmission, glutamatergic [GO:0051966]; signal transduction [GO:0007165]; substrate-dependent cell migration, cell extension [GO:0006930]; synaptic vesicle endocytosis [GO:0048488]",actin binding [GO:0003779]; GTPase activator activity [GO:0005096]; ionotropic glutamate receptor binding [GO:0035255]; phospholipid binding [GO:0005543],"SUBCELLULAR LOCATION: Cell junction, synapse, postsynapse {ECO:0000250|UniProtKB:P0CAX5}. Cell junction, synapse, presynapse {ECO:0000250|UniProtKB:P0CAX5}. Cell projection, axon {ECO:0000250|UniProtKB:P0CAX5}. Cell projection, dendritic spine {ECO:0000250|UniProtKB:P0CAX5}. Cell projection, dendrite {ECO:0000250|UniProtKB:Q99J31}. Cytoplasm {ECO:0000250|UniProtKB:Q99J31}.",SUBUNIT: Interacts with HOMER1. Interacts with AMPA receptor complexes. Interacts with SH3GL2 (endophilin-A1) (By similarity). Interacts (via C-terminus) with NR1D1 (By similarity). {ECO:0000250}.,X,68042344,68433913,q12,0.99985,0.161,0.18004,2.5929,29.485,0.4435657491316002,ENST00000355520,0.8771689497716895,0.16660834791302176,2409,,,,,,,0.43732764599196267,4.19503256501146,Cervix - Ectocervix,broadly expressed,3.2299031894461123,3.2991193471671587,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:816,ATP2B3,ATPase plasma membrane Ca2+ transporting 3,Approved,"SCAX1, CLA2","PMCA3, CFAP39",Xq28,gene with protein product,protein-coding gene,ENSG00000067842,492,ENSG00000067842,Q16720,MGI:1347353,RGD:621304,X,300014,TRUE,,,,"?Spinocerebellar ataxia, X-linked 1",302500,X-linked recessive,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,PMT +CS,FALSE,,PMT,FUNCTION: This magnesium-dependent enzyme catalyzes the hydrolysis of ATP coupled with the transport of calcium out of the cell.,calcium ion export across plasma membrane [GO:1990034]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]; regulation of cardiac conduction [GO:1903779]; regulation of cytosolic calcium ion concentration [GO:0051480],"ATPase-coupled cation transmembrane transporter activity [GO:0019829]; ATP binding [GO:0005524]; calcium ion transmembrane transporter activity [GO:0015085]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]",SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.,SUBUNIT: Interacts with PDZD11. {ECO:0000269|PubMed:12763866}.,X,153517676,153582939,q28,0.99945,0.222,-0.14356,2.7453,34.854,0.5308737023786161,ENST00000349466,0.7743652743652744,0.06185953511622094,3663,3,"ATP2B2 (83, 82, chr3); ATP2B1 (81, 81, chr12); ATP2B4 (75, 76, chr1)",TRUE,,,,0.9182722047572853,5.297439060404919,Cerebellar_tissues,tissue-specific,2.8315246293720207,5.297439060404919,TRUE,discordant,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,PMT
HGNC:8512,OTC,ornithine transcarbamylase,Approved,,OTCase,Xp11.4,gene with protein product,protein-coding gene,ENSG00000036473,5009,ENSG00000036473,P00480,MGI:97448,RGD:3236,X,300461,TRUE,Ornithine transcarbamylase deficiency,311250,X-linked recessive,,,,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,confirmed +CS,FALSE,TRUE,confirmed,"",ammonia homeostasis [GO:0097272]; anion homeostasis [GO:0055081]; arginine biosynthetic process via ornithine [GO:0042450]; citrulline biosynthetic process [GO:0019240]; liver development [GO:0001889]; midgut development [GO:0007494]; ornithine catabolic process [GO:0006593]; response to biotin [GO:0070781]; response to drug [GO:0042493]; response to insulin [GO:0032868]; response to zinc ion [GO:0010043]; urea cycle [GO:0000050],amino acid binding [GO:0016597]; identical protein binding [GO:0042802]; ornithine carbamoyltransferase activity [GO:0004585]; phosphate ion binding [GO:0042301]; phospholipid binding [GO:0005543],SUBCELLULAR LOCATION: Mitochondrion matrix.,"SUBUNIT: Homotrimer. {ECO:0000269|PubMed:10813810, ECO:0000269|PubMed:9852088}.",X,38352586,38421446,p11.4,0.87295,0.406,0.19199,1.3274,15.524,0.22185930422457092,ENST00000039007,0.9323943661971831,0.15466133466633342,1065,,,,,,,0.908465968933338,5.708642490659604,Liver,tissue-specific,0.24052804610187958,0.09667766448383099,FALSE,discordant,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:8542,P2RY4,pyrimidinergic receptor P2Y4,Approved,,"NRU, P2Y4, UNR, P2P",Xq13.1,gene with protein product,protein-coding gene,ENSG00000186912,5030,ENSG00000186912,P51582,MGI:1926594,RGD:61798,X,300038,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Receptor for UTP and UDP coupled to G-proteins that activate a phosphatidylinositol-calcium second messenger system. Not activated by ATP or ADP.,cellular response to ATP [GO:0071318]; cellular response to prostaglandin E stimulus [GO:0071380]; G protein-coupled receptor signaling pathway [GO:0007186]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; transepithelial chloride transport [GO:0030321],ATP binding [GO:0005524]; G protein-coupled purinergic nucleotide receptor activity [GO:0045028]; G protein-coupled UTP receptor activity [GO:0045030],SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.,"",X,70258170,70259764,q13.1,0.1687,1,0.6005,-0.31675,6.286,0.24835272295477653,ENST00000374519,0.6787795992714025,0.27400649837540614,1098,,,,,,,0.735391699530901,1.1933112688777776,Skin - Not Sun Exposed (Suprapubic),tissue-specific,0.026472468423193625,0.06518763354165752,FALSE,low confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:8592,PAK3,p21 (RAC1) activated kinase 3,Approved,"MRX30, MRX47","hPAK3, bPAK",Xq23,gene with protein product,protein-coding gene,ENSG00000077264,5063,ENSG00000077264,O75914,MGI:1339656,RGD:3251,X,300142,TRUE,"Mental retardation, X-linked 30/47",300558,X-linked recessive,,,,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Serine/threonine protein kinase that plays a role in a variety of different signaling pathways including cytoskeleton regulation, cell migration, or cell cycle regulation. Plays a role in dendrite spine morphogenesis as well as synapse formation and plasticity. Acts as downstream effector of the small GTPases CDC42 and RAC1. Activation by the binding of active CDC42 and RAC1 results in a conformational change and a subsequent autophosphorylation on several serine and/or threonine residues. Phosphorylates MAPK4 and MAPK6 and activates the downstream target MAPKAPK5, a regulator of F-actin polymerization and cell migration. Additionally, phosphorylates TNNI3/troponin I to modulate calcium sensitivity and relaxation kinetics of thin myofilaments. May also be involved in early neuronal development. {ECO:0000269|PubMed:21177870}.",activation of protein kinase activity [GO:0032147]; axonogenesis [GO:0007409]; cellular response to organic cyclic compound [GO:0071407]; dendrite development [GO:0016358]; dendritic spine morphogenesis [GO:0060997]; ephrin receptor signaling pathway [GO:0048013]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of neuron apoptotic process [GO:0043525]; regulation of actin filament polymerization [GO:0030833]; regulation of axonogenesis [GO:0050770]; signal transduction by protein phosphorylation [GO:0023014]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated protein kinase signaling cascade [GO:0031098]; synapse organization [GO:0050808]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852],ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho GTPase binding [GO:0017048]; SH3 domain binding [GO:0017124],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.,"SUBUNIT: Interacts tightly with GTP-bound but not GDP-bound CDC42/p21 and RAC1. Shows highly specific binding to the SH3 domains of phospholipase C-gamma and of adapter protein NCK. Interacts with the C-terminal of APP (By similarity). Interacts with ARHGEF6 and ARHGEF7. {ECO:0000250, ECO:0000269|PubMed:11741931}.",X,110944285,111227361,q23,0.98716,0.286,0.31885,3.5336,21.98,0.3948147660722511,ENST00000372007,0.9680733944954129,0.29250187453136717,1635,2,"PAK1 (73, 77, chr11); PAK2 (70, 78, chr3)",TRUE,,,,0.7209578392954261,4.749072960565994,Pituitary,tissue-specific,3.25060994954212,1.2812115829612363,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:8656,PCDH11X,protocadherin 11 X-linked,Approved,PCDH11,"PCDH-X, PCDHX, PPP1R119",Xq21.31,gene with protein product,protein-coding gene,ENSG00000102290,27328,ENSG00000102290,Q9BZA7,MGI:2442849,RGD:1562864,X,300246,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Potential calcium-dependent cell-adhesion protein.,cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of phosphatase activity [GO:0010923],calcium ion binding [GO:0005509],SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}.,"",X,91779261,92623230,q21.31,0.015836,0.56,-0.87839,2.2979,25.785,0.3566969859104691,ENST00000373094,0.8312809099901088,0.2147963009247688,4044,1,"PCDH11Y (95, 96, chrY)",TRUE,1,"PCDH11Y (95, 96, chrY)",TRUE,0.9038793801051305,1.9673678406606003,Artery - Aorta,tissue-specific,0.7231111583520099,0.04777860854681306,FALSE,discordant,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:868,ATP6AP1,ATPase H+ transporting accessory protein 1,Approved,"ATP6S1, ATP6IP1","ORF, XAP-3, VATPS1, 16A, Ac45, XAP3, CF2",Xq28,gene with protein product,protein-coding gene,ENSG00000071553,537,ENSG00000071553,Q15904,MGI:109629,RGD:620423,X,300197,TRUE,Immunodeficiency 47,300972,X-linked recessive,,,,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Accessory subunit of the proton-transporting vacuolar (V)-ATPase protein pump, which is required for luminal acidification of secretory vesicles. Guides the V-type ATPase into specialized subcellular compartments, such as neuroendocrine regulated secretory vesicles or the ruffled border of the osteoclast, thereby regulating its activity. Involved in membrane trafficking and Ca(2+)-dependent membrane fusion. May play a role in the assembly of the V-type ATPase complex. In aerobic conditions, involved in intracellular iron homeostasis, thus triggering the activity of Fe(2+) prolyl hydroxylase (PHD) enzymes, and leading to HIF1A hydroxylation and subsequent proteasomal degradation (PubMed:28296633). {ECO:0000269|PubMed:28296633, ECO:0000305|PubMed:27231034}.",cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; establishment of organelle localization [GO:0051656]; insulin receptor signaling pathway [GO:0008286]; ion transmembrane transport [GO:0034220]; pH reduction [GO:0045851]; positive regulation of bone resorption [GO:0045780]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of exocytosis [GO:0045921]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoclast development [GO:2001206]; proton transmembrane transport [GO:1902600]; regulation of cellular pH [GO:0030641]; transferrin transport [GO:0033572],ATP binding [GO:0005524]; Rab GTPase binding [GO:0017137],SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:27231034}; Single-pass membrane protein {ECO:0000305}. Endoplasmic reticulum-Golgi intermediate compartment membrane {ECO:0000269|PubMed:27231034}. Note=Not detected in trans-Golgi network. {ECO:0000269|PubMed:27231034}.,"SUBUNIT: Accessory component of the multisubunit proton-transporting vacuolar (V)-ATPase protein pump. Interacts (via N-terminus) with ATP6AP2 (via N-terminus). {ECO:0000269|PubMed:29127204, ECO:0000305|PubMed:27231034}.",X,154428645,154436516,q28,0.99079,0.213,0.22052,1.5308,14.06,0.5124448433947923,ENST00000369762,0.6670912951167728,0.08102974256435891,1413,,,,,,,0.18625512953979426,7.2297273021890005,Cerebellar_tissues,broadly expressed,5.73851655904072,7.2297273021890005,TRUE,low confidence non-escapee,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:869,ATP7A,ATPase copper transporting alpha,Approved,MNK,,Xq21.1,gene with protein product,protein-coding gene,ENSG00000165240,538,ENSG00000165240,Q04656,MGI:99400,RGD:2179,X,300011,TRUE,"Menkes disease // Occipital horn syndrome // Spinal muscular atrophy, distal, X-linked 3",309400 // 304150 // 300489,X-linked recessive // X-linked recessive // X-linked recessive,,,,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: May supply copper to copper-requiring proteins within the secretory pathway, when localized in the trans-Golgi network. Under conditions of elevated extracellular copper, it relocalized to the plasma membrane where it functions in the efflux of copper from cells.",antimicrobial humoral response [GO:0019730]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; cartilage development [GO:0051216]; catecholamine metabolic process [GO:0006584]; cellular copper ion homeostasis [GO:0006878]; cellular response to amino acid stimulus [GO:0071230]; cellular response to antibiotic [GO:0071236]; cellular response to cadmium ion [GO:0071276]; cellular response to cobalt ion [GO:0071279]; cellular response to copper ion [GO:0071280]; cellular response to hypoxia [GO:0071456]; cellular response to iron ion [GO:0071281]; cellular response to lead ion [GO:0071284]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; central nervous system neuron development [GO:0021954]; cerebellar Purkinje cell differentiation [GO:0021702]; collagen fibril organization [GO:0030199]; copper ion export [GO:0060003]; copper ion import [GO:0015677]; copper ion transport [GO:0006825]; detoxification of copper ion [GO:0010273]; dopamine metabolic process [GO:0042417]; elastic fiber assembly [GO:0048251]; elastin biosynthetic process [GO:0051542]; epinephrine metabolic process [GO:0042414]; extracellular matrix organization [GO:0030198]; hair follicle morphogenesis [GO:0031069]; in utero embryonic development [GO:0001701]; ion transmembrane transport [GO:0034220]; lactation [GO:0007595]; liver development [GO:0001889]; locomotory behavior [GO:0007626]; lung alveolus development [GO:0048286]; mitochondrion organization [GO:0007005]; negative regulation of iron ion transmembrane transport [GO:0034760]; neuron projection morphogenesis [GO:0048812]; norepinephrine metabolic process [GO:0042415]; peptidyl-lysine modification [GO:0018205]; pigmentation [GO:0043473]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell size [GO:0045793]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of response to wounding [GO:1903036]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; pyramidal neuron development [GO:0021860]; regulation of cytochrome-c oxidase activity [GO:1904959]; regulation of gene expression [GO:0010468]; regulation of oxidative phosphorylation [GO:0002082]; removal of superoxide radicals [GO:0019430]; response to iron(III) ion [GO:0010041]; response to manganese ion [GO:0010042]; response to zinc ion [GO:0010043]; serotonin metabolic process [GO:0042428]; skin development [GO:0043588]; T-helper cell differentiation [GO:0042093]; tryptophan metabolic process [GO:0006568],"ATP binding [GO:0005524]; chaperone binding [GO:0051087]; copper-dependent protein binding [GO:0032767]; copper ion binding [GO:0005507]; copper ion transmembrane transporter activity [GO:0005375]; copper transmembrane transporter activity, phosphorylative mechanism [GO:0043682]; cuprous ion binding [GO:1903136]; Rac GTPase binding [GO:0048365]; superoxide dismutase copper chaperone activity [GO:0016532]","SUBCELLULAR LOCATION: Golgi apparatus, trans-Golgi network membrane {ECO:0000269|PubMed:10484781, ECO:0000269|PubMed:9147644, ECO:0000269|PubMed:9467005}; Multi-pass membrane protein {ECO:0000255}. Cell membrane {ECO:0000269|PubMed:10484781, ECO:0000269|PubMed:9147644}; Multi-pass membrane protein {ECO:0000255}. Note=Cycles constitutively between the trans-Golgi network (TGN) and the plasma membrane (PubMed:9147644). Predominantly found in the TGN and relocalized to the plasma membrane in response to elevated copper levels. {ECO:0000269|PubMed:9147644}.; SUBCELLULAR LOCATION: [Isoform 3]: Cytoplasm, cytosol {ECO:0000305}.; SUBCELLULAR LOCATION: [Isoform 5]: Endoplasmic reticulum {ECO:0000269|PubMed:9467005}.","SUBUNIT: Monomer. Interacts with PDZD11. Interacts with ATOX1 and COMMD1 (PubMed:21667063). {ECO:0000269|PubMed:16051599, ECO:0000269|PubMed:21667063}.",X,77910656,78050395,q21.1,0.99983,0.216,1.9983,1.5302,42.442,0.47538076170625126,ENST00000341514,0.8619142793693093,0.12554361409647588,4503,1,"ATP7B (54, 56, chr13)",TRUE,,,,0.3758106471625627,3.839697621869984,Skin - Sun Exposed (Lower leg),broadly expressed,0.9780645362068482,0.8690082940477518,FALSE,discordant,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:8749,CDK16,cyclin dependent kinase 16,Approved,PCTK1,"PCTAIRE, PCTAIRE1, PCTGAIRE, FLJ16665",Xp11.3,gene with protein product,protein-coding gene,ENSG00000102225,5127,ENSG00000102225,Q00536,MGI:97516,RGD:620584,X,311550,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Protein kinase that plays a role in vesicle-mediated transport processes and exocytosis. Regulates GH1 release by brain neurons. Phosphorylates NSF, and thereby regulates NSF oligomerization. Required for normal spermatogenesis. Regulates neuron differentiation and dendrite development (By similarity). Plays a role in the regulation of insulin secretion in response to changes in blood glucose levels. Can phosphorylate CCNY at 'Ser-336' (in vitro). {ECO:0000250, ECO:0000269|PubMed:22184064, ECO:0000269|PubMed:22796189, ECO:0000269|PubMed:22798068}.",exocytosis [GO:0006887]; growth hormone secretion [GO:0030252]; neuron projection development [GO:0031175]; protein phosphorylation [GO:0006468]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; spermatogenesis [GO:0007283],ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine/threonine kinase activity [GO:0004674],"SUBCELLULAR LOCATION: Cytoplasm. Cytoplasmic vesicle, secretory vesicle. Cell membrane; Peripheral membrane protein; Cytoplasmic side. Cell junction, synapse, synaptosome {ECO:0000250}. Note=Colocalizes with insulin in pancreas islets. Recruited to the cell membrane by CCNY.","SUBUNIT: Found in a complex containing CABLES1, CDK17 and TDRD7. Interacts with YWHAH, YWHAQ and YWHAZ. Interacts with NSF. Identified in a complex with NSF, syntaxin-1, synaptotagmin, SYN1, SYP and CDK5R1 (By similarity). Interacts with BRSK2. Interacts with CCNY; this increases the CDK16 kinase activity. {ECO:0000250, ECO:0000269|PubMed:22184064, ECO:0000269|PubMed:22796189, ECO:0000269|PubMed:22798068}.",X,47217860,47229997,p11.3,0.9948,0.258,1.3209,2.9103,24.418,0.6162475554465594,ENST00000357227,0.8184439973172367,0.254336415896026,1491,2,"CDK17 (63, 68, chr12); CDK18 (53, 60, chr1)",TRUE,,,,0.24993261869193187,7.2823332299435375,Cerebellar_tissues,broadly expressed,5.082281060542067,7.2823332299435375,TRUE,high confidence escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:8755,PCYT1B,"phosphate cytidylyltransferase 1, choline, beta",Approved,,"CCT-beta, CTB",Xp22.11,gene with protein product,protein-coding gene,ENSG00000102230,9468,ENSG00000102230,Q9Y5K3,MGI:2147987,RGD:708434,X,300948,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Controls phosphatidylcholine synthesis.,ovarian follicle development [GO:0001541]; phosphatidylcholine biosynthetic process [GO:0006656]; spermatogenesis [GO:0007283],choline-phosphate cytidylyltransferase activity [GO:0004105]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210],SUBCELLULAR LOCATION: Endoplasmic reticulum.,SUBUNIT: Homodimer. {ECO:0000250|UniProtKB:P19836}.,X,24558087,24672677,p22.11,0.89723,0.403,-0.49869,2.1588,11.758,0.3543178053555136,ENST00000379144,0.9459459459459459,0.30747313171707075,1110,1,"PCYT1A (68, 66, chr3)",TRUE,,,,0.7591031738618332,3.8191470026324503,Testis,tissue-specific,3.391982128971707,2.5754309366458217,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,no disorder
HGNC:8768,AIFM1,apoptosis inducing factor mitochondria associated 1,Approved,"PDCD8, NAMSD, AUNX1","AIF, CMTX4, DFNX5",Xq26.1,gene with protein product,protein-coding gene,ENSG00000156709,9131,ENSG00000156709,O95831,MGI:1349419,RGD:620817,X,300169,TRUE,"Combined oxidative phosphorylation deficiency 6 // Cowchock syndrome // Deafness, X-linked 5 // Spondyloepimetaphyseal dysplasia, X-linked, with hypomyelinating leukodystrophy",300816 // 310490 // 300614 // 300232,X-linked recessive // X-linked recessive // X-linked recessive // X-linked recessive,,,,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Functions both as NADH oxidoreductase and as regulator of apoptosis (PubMed:20362274, PubMed:23217327, PubMed:17094969). In response to apoptotic stimuli, it is released from the mitochondrion intermembrane space into the cytosol and to the nucleus, where it functions as a proapoptotic factor in a caspase-independent pathway. The soluble form (AIFsol) found in the nucleus induces 'parthanatos' i.e. caspase-independent fragmentation of chromosomal DNA (By similarity). Binds to DNA in a sequence-independent manner (PubMed:27178839). Interacts with EIF3G, and thereby inhibits the EIF3 machinery and protein synthesis, and activates caspase-7 to amplify apoptosis (PubMed:17094969). Plays a critical role in caspase-independent, pyknotic cell death in hydrogen peroxide-exposed cells (PubMed:19418225). In contrast, participates in normal mitochondrial metabolism. Plays an important role in the regulation of respiratory chain biogenesis by interacting with CHCHD4 and controlling CHCHD4 mitochondrial import (PubMed:26004228). {ECO:0000250|UniProtKB:Q9Z0X1, ECO:0000269|PubMed:17094969, ECO:0000269|PubMed:19418225, ECO:0000269|PubMed:20362274, ECO:0000269|PubMed:23217327, ECO:0000269|PubMed:26004228, ECO:0000269|PubMed:27178839}.; FUNCTION: [Isoform 4]: Has NADH oxidoreductase activity. Does not induce nuclear apoptosis. {ECO:0000269|PubMed:16644725}.; FUNCTION: [Isoform 5]: Pro-apoptotic isoform. {ECO:0000269|PubMed:16365034}.",activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; cellular response to aldosterone [GO:1904045]; cellular response to estradiol stimulus [GO:0071392]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to nitric oxide [GO:0071732]; cellular response to oxygen-glucose deprivation [GO:0090650]; chromosome condensation [GO:0030261]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; mitochondrial respiratory chain complex assembly [GO:0033108]; mitochondrial respiratory chain complex I assembly [GO:0032981]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; oxidation-reduction process [GO:0055114]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron apoptotic process [GO:0043525]; protein import into mitochondrial intermembrane space [GO:0045041]; regulation of apoptotic DNA fragmentation [GO:1902510]; response to ischemia [GO:0002931]; response to L-glutamate [GO:1902065]; response to toxic substance [GO:0009636],"DNA binding [GO:0003677]; FAD binding [GO:0071949]; NAD(P)H oxidase (H(2)O(2)-forming activity [GO:0016174]; oxidoreductase activity, acting on NAD(P)H [GO:0016651]; protein dimerization activity [GO:0046983]","SUBCELLULAR LOCATION: Mitochondrion intermembrane space {ECO:0000269|PubMed:15775970, ECO:0000269|PubMed:24914854, ECO:0000269|PubMed:26004228}. Mitochondrion inner membrane. Cytoplasm {ECO:0000269|PubMed:15775970}. Nucleus {ECO:0000269|PubMed:15775970, ECO:0000269|PubMed:17094969}. Cytoplasm, perinuclear region {ECO:0000269|PubMed:17094969}. Note=Proteolytic cleavage during or just after translocation into the mitochondrial intermembrane space (IMS) results in the formation of an inner-membrane-anchored mature form (AIFmit). During apoptosis, further proteolytic processing leads to a mature form, which is confined to the mitochondrial IMS in a soluble form (AIFsol). AIFsol is released to the cytoplasm in response to specific death signals, and translocated to the nucleus, where it induces nuclear apoptosis (PubMed:15775970). Colocalizes with EIF3G in the nucleus and perinuclear region (PubMed:17094969). {ECO:0000269|PubMed:15775970, ECO:0000269|PubMed:17094969}.; SUBCELLULAR LOCATION: [Isoform 3]: Mitochondrion intermembrane space {ECO:0000269|PubMed:20111043}. Mitochondrion inner membrane {ECO:0000269|PubMed:20111043}. Note=Has a stronger membrane anchorage than isoform 1. {ECO:0000269|PubMed:20111043}.; SUBCELLULAR LOCATION: [Isoform 4]: Mitochondrion {ECO:0000269|PubMed:16644725}. Cytoplasm, cytosol {ECO:0000269|PubMed:16644725}. Note=In pro-apoptotic conditions, is released from mitochondria to cytosol in a calpain/cathepsin-dependent manner. {ECO:0000269|PubMed:16644725}.; SUBCELLULAR LOCATION: [Isoform 5]: Cytoplasm {ECO:0000269|PubMed:16365034}.","SUBUNIT: Monomer (oxidized form). Homodimer (reduced form). Upon reduction with NADH, undergoes dimerization and forms tight, long-lived FADH2-NAD charge transfer complexes (CTC) resistant to oxidation (PubMed:24914854, PubMed:20111043, PubMed:23217327, PubMed:27818101). Also dimerizes with isoform 3 preventing its release from mitochondria (PubMed:20111043). Interacts with XIAP/BIRC4 (PubMed:17967870). Interacts (via N-terminus) with EIF3G (via C-terminus) (PubMed:17094969). Interacts with PRELID1 (PubMed:21364629). Interacts with CHCHD4; the interaction increases in presence of NADH (PubMed:26004228). {ECO:0000269|PubMed:17094969, ECO:0000269|PubMed:17967870, ECO:0000269|PubMed:20111043, ECO:0000269|PubMed:21364629, ECO:0000269|PubMed:23217327, ECO:0000269|PubMed:24914854, ECO:0000269|PubMed:26004228, ECO:0000269|PubMed:27818101}.",X,130124666,130165879,q26.1,0.99795,0.234,0.56874,2.4941,26.913,0.5953693495038589,ENST00000287295,0.9135179153094463,0.18350412396900775,1842,,,,,,,0.2370558566862986,5.995902794573325,Adrenal Gland,broadly expressed,3.6000080271734483,4.464910002712354,FALSE,low confidence non-escapee,no_difference_Pre_Post,Pre_higher_vs_Post1,no difference_Pre_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:8806,PDHA1,pyruvate dehydrogenase E1 subunit alpha 1,Approved,PDHA,,Xp22.12,gene with protein product,protein-coding gene,ENSG00000131828,5160,ENSG00000131828,P08559,MGI:97532,RGD:3286,X,300502,TRUE,Pyruvate dehydrogenase E1-alpha deficiency,312170,X-linked dominant,,,,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,confirmed +CS,FALSE,TRUE,confirmed,"FUNCTION: The pyruvate dehydrogenase complex catalyzes the overall conversion of pyruvate to acetyl-CoA and CO(2), and thereby links the glycolytic pathway to the tricarboxylic cycle. {ECO:0000269|PubMed:19081061, ECO:0000269|PubMed:7782287}.",acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glucose metabolic process [GO:0006006]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732]; pyruvate metabolic process [GO:0006090]; tricarboxylic acid cycle [GO:0006099],pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; pyruvate dehydrogenase (NAD+) activity [GO:0034604],SUBCELLULAR LOCATION: Mitochondrion matrix.,"SUBUNIT: Heterotetramer of two PDHA1 and two PDHB subunits. The heterotetramer interacts with DLAT, and is part of the multimeric pyruvate dehydrogenase complex that contains multiple copies of pyruvate dehydrogenase (E1), dihydrolipoamide acetyltransferase (DLAT, E2) and lipoamide dehydrogenase (DLD, E3). These subunits are bound to an inner core composed of about 48 DLAT and 12 PDHX molecules. {ECO:0000269|PubMed:12651851, ECO:0000269|PubMed:14638692, ECO:0000269|PubMed:19081061}.",X,19343893,19361718,p22.12,0.98842,0.266,1.0404,2.572,17.85,0.5887322534021365,ENST00000422285,0.8950554134697357,0.08242939265183705,1173,1,"PDHA2 (78, 86, chr4)",TRUE,,,,0.2233496207402906,7.106128430797901,Heart - Left Ventricle,broadly expressed,4.891885751300387,5.827474819513687,FALSE,low confidence non-escapee,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:8811,PDK3,pyruvate dehydrogenase kinase 3,Approved,,,Xp22.11,gene with protein product,protein-coding gene,ENSG00000067992,5165,ENSG00000067992,Q15120,MGI:2384308,RGD:1593276,X,300906,TRUE,,,,"?Charcot-Marie-Tooth disease, X-linked dominant, 6",300905,X-linked dominant,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PMT +CS,FALSE,,PMT,"FUNCTION: Inhibits pyruvate dehydrogenase activity by phosphorylation of the E1 subunit PDHA1, and thereby regulates glucose metabolism and aerobic respiration. Can also phosphorylate PDHA2. Decreases glucose utilization and increases fat metabolism in response to prolonged fasting, and as adaptation to a high-fat diet. Plays a role in glucose homeostasis and in maintaining normal blood glucose levels in function of nutrient levels and under starvation. Plays a role in the generation of reactive oxygen species. {ECO:0000269|PubMed:10748134, ECO:0000269|PubMed:11486000, ECO:0000269|PubMed:15861126, ECO:0000269|PubMed:16436377, ECO:0000269|PubMed:17683942, ECO:0000269|PubMed:18718909, ECO:0000269|PubMed:22865452}.",cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; hypoxia-inducible factor-1alpha signaling pathway [GO:0097411]; negative regulation of pyruvate dehydrogenase activity [GO:1904183]; peptidyl-serine phosphorylation [GO:0018105]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of glucose metabolic process [GO:0010906]; regulation of reactive oxygen species metabolic process [GO:2000377],ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740],SUBCELLULAR LOCATION: Mitochondrion matrix.,"SUBUNIT: Homodimer. Interacts with the pyruvate dehydrogenase complex subunit DLAT, and is part of the multimeric pyruvate dehydrogenase complex that contains multiple copies of pyruvate dehydrogenase (E1), dihydrolipoamide acetyltransferase (DLAT, E2) and lipoamide dehydrogenase (DLD, E3). {ECO:0000269|PubMed:10748134, ECO:0000269|PubMed:11978179, ECO:0000269|PubMed:15861126, ECO:0000269|PubMed:17532006, ECO:0000269|PubMed:17683942}.",X,24465270,24550466,p22.11,0.44547,0.546,0.77008,2.3184,14.199,0.6046863189720333,ENST00000379162,0.9103194103194103,0.1353661584603849,1221,3,"PDK1 (66, 60, chr2); PDK2 (65, 66, chr17); PDK4 (60, 61, chr7)",TRUE,,,,0.46602668537880987,5.108436637885513,Artery - Tibial,broadly expressed,1.3189415123509853,1.1101594207244037,FALSE,low confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,Post2_higher_vs_Post1,PMT
HGNC:886,ATRX,ATRX chromatin remodeler,Approved,"RAD54, JMS, MRX52","XH2, XNP",Xq21.1,gene with protein product,protein-coding gene,ENSG00000085224,546,ENSG00000085224,P46100,MGI:103067,RGD:619795,X,300032,TRUE,"Alpha-thalassemia myelodysplasia syndrome, somatic // Alpha-thalassemia/mental retardation syndrome // Mental retardation-hypotonic facies syndrome, X-linked",300448 // 301040 // 309580,// X-linked dominant // X-linked recessive,,,,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Involved in transcriptional regulation and chromatin remodeling. Facilitates DNA replication in multiple cellular environments and is required for efficient replication of a subset of genomic loci. Binds to DNA tandem repeat sequences in both telomeres and euchromatin and in vitro binds DNA quadruplex structures. May help stabilizing G-rich regions into regular chromatin structures by remodeling G4 DNA and incorporating H3.3-containing nucleosomes. Catalytic component of the chromatin remodeling complex ATRX:DAXX which has ATP-dependent DNA translocase activity and catalyzes the replication-independent deposition of histone H3.3 in pericentric DNA repeats outside S-phase and telomeres, and the in vitro remodeling of H3.3-containing nucleosomes. Its heterochromatin targeting is proposed to involve a combinatorial readout of histone H3 modifications (specifically methylation states of H3K9 and H3K4) and association with CBX5. Involved in maintaining telomere structural integrity in embryonic stem cells which probably implies recruitment of CBX5 to telomeres. Reports on the involvement in transcriptional regulation of telomeric repeat-containing RNA (TERRA) are conflicting; according to a report, it is not sufficient to decrease chromatin condensation at telomeres nor to increase expression of telomeric RNA in fibroblasts (PubMed:24500201). May be involved in telomere maintenance via recombination in ALT (alternative lengthening of telomeres) cell lines. Acts as negative regulator of chromatin incorporation of transcriptionally repressive histone MACROH2A1, particularily at telomeres and the alpha-globin cluster in erythroleukemic cells. Participates in the allele-specific gene expression at the imprinted IGF2/H19 gene locus. On the maternal allele, required for the chromatin occupancy of SMC1 and CTCTF within the H19 imprinting control region (ICR) and involved in esatblishment of histone tails modifications in the ICR. May be involved in brain development and facial morphogenesis. Binds to zinc-finger coding genes with atypical chromatin signatures and regulates its H3K9me3 levels. Forms a complex with ZNF274, TRIM28 and SETDB1 to facilitate the deposition and maintenance of H3K9me3 at the 3' exons of zinc-finger genes (PubMed:27029610). {ECO:0000269|PubMed:12953102, ECO:0000269|PubMed:14990586, ECO:0000269|PubMed:20504901, ECO:0000269|PubMed:20651253, ECO:0000269|PubMed:21029860, ECO:0000269|PubMed:22391447, ECO:0000269|PubMed:22829774, ECO:0000269|PubMed:24500201, ECO:0000269|PubMed:27029610}.","cellular response to hydroxyurea [GO:0072711]; chromatin remodeling [GO:0006338]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA methylation [GO:0006306]; DNA repair [GO:0006281]; DNA replication-independent nucleosome assembly [GO:0006336]; forebrain development [GO:0030900]; meiotic spindle organization [GO:0000212]; multicellular organism growth [GO:0035264]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; negative regulation of telomeric RNA transcription from RNA pol II promoter [GO:1901581]; nucleosome assembly [GO:0006334]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of telomeric RNA transcription from RNA pol II promoter [GO:1901582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic forelimb morphogenesis [GO:0035128]; protein localization to chromosome, telomeric region [GO:0070198]; regulation of histone H3-K9 trimethylation [GO:1900112]; regulation of transcription, DNA-templated [GO:0006355]; replication fork processing [GO:0031297]; seminiferous tubule development [GO:0072520]; Sertoli cell development [GO:0060009]; spermatogenesis [GO:0007283]",ATP binding [GO:0005524]; chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064],"SUBCELLULAR LOCATION: Nucleus. Chromosome, telomere. Nucleus, PML body. Note=Associated with pericentromeric heterochromatin during interphase and mitosis, probably by interacting with CBX5/HP1 alpha. Colocalizes with histone H3.3, DAXX, HIRA and ASF1A at PML-nuclear bodies. Colocalizes with cohesin (SMC1 and SMC3) and MECP2 at the maternal H19 ICR (By similarity). {ECO:0000250}.","SUBUNIT: Interacts with DAXX to form the chromatin remodeling complex ATRX:DAXX. Probably binds EZH2. Binds annexin V in a calcium and phosphatidylcholine/phosphatidylserine-dependent manner. Interacts directly with CBX5 via the PxVxL motif. Interacts with RAD50, MRE11 and NBN; indicative for an association with the MRN complex. Interacts with histone MACROH2A1. Interacts with histone H3 peptides methylated at 'Lys-10' with preferences H3K9me3 > H3K9me2 > H3K9me1. Interacts with histone H3 peptides unmethylated at 'Lys-5' (H3K4me0). Interacts with MECP2, SMC1 and SMC3. Interacts with SETDB1, TRIM28 and ZNF274 (PubMed:27029610). {ECO:0000269|PubMed:10699177, ECO:0000269|PubMed:12953102, ECO:0000269|PubMed:14990586, ECO:0000269|PubMed:15882967, ECO:0000269|PubMed:17296936, ECO:0000269|PubMed:21421568, ECO:0000269|PubMed:21666677, ECO:0000269|PubMed:21666679, ECO:0000269|PubMed:22391447, ECO:0000269|PubMed:24651726, ECO:0000269|PubMed:27029610, ECO:0000269|PubMed:9499421}.",X,77504880,77786233,q21.1,1,0.119,-0.82377,3.1025,88.494,0.5419687013074995,ENST00000373344,0.8526540981414628,0.24571357160709822,7479,,,,,,,0.20498602682332304,4.562046998323958,Cells - EBV-transformed lymphocytes,broadly expressed,3.000476010826026,4.399916179866091,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:8864,CFP,complement factor properdin,Approved,PFC,,Xp11.23,gene with protein product,protein-coding gene,ENSG00000126759,5199,ENSG00000126759,P27918,MGI:97545,RGD:1594557,X,300383,TRUE,"Properdin deficiency, X-linked",312060,X-linked recessive,,,,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: A positive regulator of the alternate pathway (AP) of complement (PubMed:20382442, PubMed:28264884). It binds to and stabilizes the C3- and C5-convertase enzyme complexes (PubMed:20382442, PubMed:28264884). Inhibits CFI-CFH mediated degradation of Complement C3 beta chain (C3b) (PubMed:31507604). {ECO:0000269|PubMed:20382442, ECO:0000269|PubMed:28264884, ECO:0000269|PubMed:31507604}.","complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; defense response to bacterium [GO:0042742]; immune response [GO:0006955]; neutrophil degranulation [GO:0043312]; regulation of complement activation [GO:0030449]","","SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:28264884, ECO:0000269|PubMed:31507604}.","SUBUNIT: In plasma, properdin exists as dimers, trimers or tetramers in the relative proportions of 26:54:20 (PubMed:20382442, PubMed:15491616, PubMed:28264884, PubMed:31507604). Interacts with the pro-C3-convertase enzyme complex (C3b-Bb) comprised of Complement C3 beta chain (C3b) and the Complement factor B Bb fragment (Bb), where it binds (via its TSP type-1 5 domain) with C3b and Bb (PubMed:28264884, PubMed:31507604). This interaction stabilizes the complex and allows it to become the active C3-convertase enzyme complex (C3b-Bb-FP) (PubMed:28264884, PubMed:31507604). Interacts with C3b (PubMed:28264884, PubMed:31507604). Interacts with CFB (PubMed:31507604). {ECO:0000269|PubMed:15491616, ECO:0000269|PubMed:20382442, ECO:0000269|PubMed:28264884, ECO:0000269|PubMed:31507604}.",X,47623172,47630305,p11.23,0.68778,0.43,0.98775,2.1655,21.3,0.21873235174047784,ENST00000396992,0.489645390070922,0.12631842039490127,1410,,,,,,,0.7344996646540743,7.864836139749187,Whole Blood,tissue-specific,1.420768029336243,2.7892034011784395,FALSE,high confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:8872,PFKFB1,"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1",Approved,PFRX,,Xp11.21,gene with protein product,protein-coding gene,ENSG00000158571,5207,ENSG00000158571,P16118,MGI:107816,RGD:3307,X,311790,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Synthesis and degradation of fructose 2,6-bisphosphate.","animal organ regeneration [GO:0031100]; fructose 2,6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; negative regulation of glycolytic process [GO:0045820]; positive regulation of glucokinase activity [GO:0033133]; positive regulation of glycolytic process [GO:0045821]; response to cAMP [GO:0051591]; response to glucagon [GO:0033762]; response to glucocorticoid [GO:0051384]; response to insulin [GO:0032868]; response to starvation [GO:0042594]","6-phosphofructo-2-kinase activity [GO:0003873]; ATP binding [GO:0005524]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]","",SUBUNIT: Homodimer. {ECO:0000269|PubMed:12379646}.,X,54932961,54998534,p11.21,4.878e-7,0.892,0.57811,-0.048076,24.528,0.10673730735735408,ENST00000375006,0.8040254237288136,0.2596350912271932,1416,3,"PFKFB4 (74, 75, chr3); PFKFB3 (69, 57, chr10); PFKFB2 (68, 63, chr1)",TRUE,,,,0.8043137870491268,4.834053824828505,Liver,tissue-specific,0.3296138857336301,0.34130834676176086,FALSE,discordant,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:8896,PGK1,phosphoglycerate kinase 1,Approved,,,Xq21.1,gene with protein product,protein-coding gene,ENSG00000102144,5230,ENSG00000102144,P00558,MGI:97555,RGD:619878,X,311800,TRUE,Phosphoglycerate kinase 1 deficiency,300653,X-linked recessive,,,,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,confirmed +CS,FALSE,TRUE,confirmed,"FUNCTION: Catalyzes one of the two ATP producing reactions in the glycolytic pathway via the reversible conversion of 1,3-diphosphoglycerate to 3-phosphoglycerate (PubMed:30323285, PubMed:7391028). In addition to its role as a glycolytic enzyme, it seems that PGK-1 acts as a polymerase alpha cofactor protein (primer recognition protein) (PubMed:2324090). May play a role in sperm motility (PubMed:26677959). {ECO:0000269|PubMed:2324090, ECO:0000269|PubMed:26677959, ECO:0000269|PubMed:30323285, ECO:0000269|PubMed:7391028}.",canonical glycolysis [GO:0061621]; cellular response to hypoxia [GO:0071456]; epithelial cell differentiation [GO:0030855]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; negative regulation of angiogenesis [GO:0016525]; phosphorylation [GO:0016310]; plasminogen activation [GO:0031639]; positive regulation of oxidative phosphorylation [GO:1903862],ADP binding [GO:0043531]; ATP binding [GO:0005524]; phosphoglycerate kinase activity [GO:0004618]; protein-disulfide reductase activity [GO:0047134],SUBCELLULAR LOCATION: Cytoplasm.,SUBUNIT: Monomer. {ECO:0000269|PubMed:18463139}.,X,77910739,78129295,q21.1,0.76537,0.465,0.029371,0.33828,13.535,0.576036866359447,ENST00000373316,0.9648325358851675,0.14656335916020996,1254,1,"PGK2 (87, 87, chr6)",TRUE,1,"PGK2 (87, 87, chr6)",TRUE,0.2837183344883968,9.482844250485009,Cells - EBV-transformed lymphocytes,broadly expressed,6.0300778004800595,6.993691342524484,FALSE,low confidence non-escapee,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:8918,PHEX,phosphate regulating endopeptidase homolog X-linked,Approved,"HYP, HPDR","PEX, HPDR1, HYP1, XLH",Xp22.11,gene with protein product,protein-coding gene,ENSG00000102174,5251,ENSG00000102174,P78562,MGI:107489,RGD:3323,X,300550,TRUE,"Hypophosphatemic rickets, X-linked dominant",307800,X-linked dominant,,,,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Peptidase that cleaves SIBLING (small integrin-binding ligand, N-linked glycoprotein)-derived ASARM peptides, thus regulating their biological activity (PubMed:9593714, PubMed:15664000, PubMed:18162525, PubMed:18597632). Cleaves ASARM peptides between Ser and Glu or Asp residues (PubMed:18597632). Regulates osteogenic cell differentiation and bone mineralization through the cleavage of the MEPE-derived ASARM peptide (PubMed:18597632). Promotes dentin mineralization and renal phosphate reabsorption by cleaving DMP1- and MEPE-derived ASARM peptides (PubMed:18597632, PubMed:18162525). Inhibits the cleavage of MEPE by CTSB/cathepsin B thus preventing MEPE degradation (PubMed:12220505). {ECO:0000250|UniProtKB:P70669, ECO:0000269|PubMed:12220505, ECO:0000269|PubMed:18162525, ECO:0000269|PubMed:18597632}.",bone development [GO:0060348]; bone mineralization [GO:0030282]; cell-cell signaling [GO:0007267]; cellular protein modification process [GO:0006464]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to vitamin D [GO:0071305]; lung development [GO:0030324]; odontogenesis [GO:0042476]; organophosphate metabolic process [GO:0019637]; proteolysis [GO:0006508]; response to growth hormone [GO:0060416]; response to insulin-like growth factor stimulus [GO:1990418]; response to sodium phosphate [GO:1904383]; skeletal system development [GO:0001501],metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:9593714}; Single-pass type II membrane protein {ECO:0000269|PubMed:9593714}.,"SUBUNIT: Interacts with MEPE; the interaction is zinc-dependent (via ASARM motif). {ECO:0000269|PubMed:15664000, ECO:0000269|PubMed:18162525}.",X,22032325,22251310,p22.11,0.99996,0.143,-0.30927,1.7091,33.244,0.33236846586071855,ENST00000379374,0.9345333333333333,0.2939265183704074,2250,,,,,,,0.8013261525387799,2.6060678843041827,Lung,tissue-specific,0.5634559148880188,0.8872495726723225,FALSE,variable escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:8925,PHKA1,phosphorylase kinase regulatory subunit alpha 1,Approved,PHKA,,Xq13.1,gene with protein product,protein-coding gene,ENSG00000067177,5255,ENSG00000067177,P46020,MGI:97576,RGD:621522,X,311870,TRUE,Muscle glycogenosis,300559,X-linked recessive,,,,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Phosphorylase b kinase catalyzes the phosphorylation of serine in certain substrates, including troponin I. The alpha chain may bind calmodulin.",generation of precursor metabolites and energy [GO:0006091]; glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977],calmodulin binding [GO:0005516]; phosphorylase kinase activity [GO:0004689],SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Lipid-anchor {ECO:0000305}; Cytoplasmic side {ECO:0000305}.,"SUBUNIT: Hexadecamer of 4 heterotetramers, each composed of alpha, beta, gamma, and delta subunits. Alpha (PHKA1 or PHKA2) and beta (PHKB) are regulatory subunits, gamma (PHKG1 or PHKG2) is the catalytic subunit, and delta is calmodulin.",X,72578814,72714319,q13.1,2.0904e-7,0.547,-0.54566,1.8803,57.431,0.629281617825832,ENST00000373542,0.8591503267973857,0.12724318920269934,3672,1,"PHKA2 (69, 69, chrX)",TRUE,,,,0.5267446750545753,6.055421274658836,Muscle - Skeletal,broadly expressed,2.7547186435289848,2.848063028562373,FALSE,low confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:8926,PHKA2,phosphorylase kinase regulatory subunit alpha 2,Approved,"PHK, PYK",,Xp22.13,gene with protein product,protein-coding gene,ENSG00000044446,5256,ENSG00000044446,P46019,MGI:97577,RGD:1596945,X,300798,TRUE,"Glycogen storage disease, type IXa1 // Glycogen storage disease, type IXa2",306000 // 306000,X-linked recessive // X-linked recessive,,,,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Phosphorylase b kinase catalyzes the phosphorylation of serine in certain substrates, including troponin I. The alpha chain may bind calmodulin.",carbohydrate metabolic process [GO:0005975]; cellular protein modification process [GO:0006464]; generation of precursor metabolites and energy [GO:0006091]; glycogen catabolic process [GO:0005980],calmodulin binding [GO:0005516]; phosphorylase kinase activity [GO:0004689],SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Lipid-anchor {ECO:0000305}; Cytoplasmic side {ECO:0000305}.,"SUBUNIT: Hexadecamer of 4 heterotetramers, each composed of alpha, beta, gamma, and delta subunits. Alpha (PHKA1 or PHKA2) and beta (PHKB) are regulatory subunits, gamma (PHKG1 or PHKG2) is the catalytic subunit, and delta is calmodulin.",X,18892298,18984114,p22.13,0.3839,0.373,-2.0362,1.8249,48.789,0.6211960717427603,ENST00000379942,0.8707389428263215,0.07588102974256436,3708,1,"PHKA1 (69, 69, chrX)",TRUE,,,,0.24465685389169356,5.073901618186647,Ovary,broadly expressed,2.3166815836995864,4.090235242050451,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:8957,PIGA,phosphatidylinositol glycan anchor biosynthesis class A,Approved,,GPI3,Xp22.2,gene with protein product,protein-coding gene,ENSG00000165195,5277,ENSG00000165195,P37287,MGI:99461,RGD:1589723,X,311770,TRUE,"Multiple congenital anomalies-hypotonia-seizures syndrome 2 // Paroxysmal nocturnal hemoglobinuria, somatic",300868 // 300818,X-linked recessive //,,,,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Necessary for the synthesis of N-acetylglucosaminyl-phosphatidylinositol, the very early intermediate in GPI-anchor biosynthesis.",cellular response to leukemia inhibitory factor [GO:1990830]; GPI anchor biosynthetic process [GO:0006506]; positive regulation of metabolic process [GO:0009893]; preassembly of GPI anchor in ER membrane [GO:0016254],phosphatidylinositol N-acetylglucosaminyltransferase activity [GO:0017176]; UDP-glycosyltransferase activity [GO:0008194],SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Single-pass membrane protein.,"SUBUNIT: Associates with PIGC, PIGH, PIGP, PIGQ and DPM2. The latter is not essential for activity. Interacts directly with PIGY. {ECO:0000269|PubMed:16162815}.",X,15319452,15335554,p22.2,0.96072,0.296,1.6066,2.1683,10.104,0.6242882260703738,ENST00000333590,0.8491408934707904,0.10127468132966759,1455,,,,,,,0.33338517571646453,4.020564427335638,Lung,broadly expressed,2.041824709871916,2.9733899412251885,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:897,AVPR2,arginine vasopressin receptor 2,Approved,"DIR3, DIR",V2R,Xq28,gene with protein product,protein-coding gene,ENSG00000126895,554,ENSG00000126895,P30518,MGI:88123,RGD:2186,X,300538,TRUE,"Diabetes insipidus, nephrogenic // Nephrogenic syndrome of inappropriate antidiuresis",304800 // 300539,X-linked recessive // X-linked recessive,,,,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,FUNCTION: Receptor for arginine vasopressin. The activity of this receptor is mediated by G proteins which activate adenylate cyclase. Involved in renal water reabsorption. {ECO:0000269|PubMed:19440390}.,activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; excretion [GO:0007588]; G protein-coupled receptor signaling pathway [GO:0007186]; hemostasis [GO:0007599]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; interferon-gamma production [GO:0032609]; membrane organization [GO:0061024]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of renal sodium excretion [GO:0035814]; negative regulation of urine volume [GO:0035811]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of vasoconstriction [GO:0045907]; regulation of systemic arterial blood pressure by vasopressin [GO:0001992]; renal water homeostasis [GO:0003091]; response to cytokine [GO:0034097]; telencephalon development [GO:0021537],G protein-coupled receptor activity [GO:0004930]; peptide binding [GO:0042277]; vasopressin receptor activity [GO:0005000],SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:23236378}; Multi-pass membrane protein {ECO:0000305}.,"SUBUNIT: Interacts with ARRDC4 (PubMed:23236378). Identified in a complex containing at least ARRDC4, V2R and HGS (PubMed:23236378). Interacts with TMEM147 (PubMed:21056967). {ECO:0000269|PubMed:21056967, ECO:0000269|PubMed:23236378}.",X,153902531,153907166,q28,0.55589,0.715,-1.0961,1.0114,6.6315,0.3151377298011646,ENST00000646375,0.4474014336917563,0.1435391152211947,1116,,,,,,,0.5645972743405115,3.9376927816513194,Adipose - Subcutaneous,broadly expressed,0.11843840418204518,2.0318221538838666,FALSE,discordant,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:8987,PIM2,"Pim-2 proto-oncogene, serine/threonine kinase",Approved,,,Xp11.23,gene with protein product,protein-coding gene,ENSG00000102096,11040,ENSG00000102096,Q9P1W9,MGI:97587,RGD:1560759,X,300295,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Proto-oncogene with serine/threonine kinase activity involved in cell survival and cell proliferation. Exerts its oncogenic activity through: the regulation of MYC transcriptional activity, the regulation of cell cycle progression, the regulation of cap-dependent protein translation and through survival signaling by phosphorylation of a pro-apoptotic protein, BAD. Phosphorylation of MYC leads to an increase of MYC protein stability and thereby an increase transcriptional activity. The stabilization of MYC exerted by PIM2 might explain partly the strong synergism between these 2 oncogenes in tumorigenesis. Regulates cap-dependent protein translation in a mammalian target of rapamycin complex 1 (mTORC1)-independent manner and in parallel to the PI3K-Akt pathway. Mediates survival signaling through phosphorylation of BAD, which induces release of the anti-apoptotic protein Bcl-X(L)/BCL2L1. Promotes cell survival in response to a variety of proliferative signals via positive regulation of the I-kappa-B kinase/NF-kappa-B cascade; this process requires phosphorylation of MAP3K8/COT. Promotes growth factor-independent proliferation by phosphorylation of cell cycle factors such as CDKN1A and CDKN1B. Involved in the positive regulation of chondrocyte survival and autophagy in the epiphyseal growth plate. {ECO:0000269|PubMed:18593906, ECO:0000269|PubMed:18675992, ECO:0000269|PubMed:20307683}.","apoptotic process [GO:0006915]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of autophagy [GO:0010508]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of mitotic cell cycle [GO:0007346]; response to virus [GO:0009615]",ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674],"",SUBUNIT: Interacts with MYC. {ECO:0000250}.,X,48913182,48919024,p11.23,0.94801,0.321,-0.63091,1.336,9.3215,0.45913240029923874,ENST00000376509,0.7170940170940171,0.3140714821294676,936,2,"PIM3 (59, 56, chr22); PIM1 (54, 54, chr6)",TRUE,,,,0.5879106780219531,8.408066443475267,Cells - EBV-transformed lymphocytes,broadly expressed,3.1411351962109224,4.399697478907761,FALSE,low confidence non-escapee,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,no difference_Post1_Post2,no disorder
HGNC:8992,PIN4,"peptidylprolyl cis/trans isomerase, NIMA-interacting 4",Approved,,"PAR14, PAR17, EPVH",Xq13.1,gene with protein product,protein-coding gene,ENSG00000102309,5303,ENSG00000102309,Q9Y237,MGI:1916963,RGD:1590326,X,300252,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Isoform 1 is involved as a ribosomal RNA processing factor in ribosome biogenesis. Binds to tightly bent AT-rich stretches of double-stranded DNA. {ECO:0000269|PubMed:19369196}.; FUNCTION: Isoform 2 binds to double-stranded DNA. {ECO:0000269|PubMed:19369196}.,rRNA processing [GO:0006364],bent DNA binding [GO:0003681]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723],"SUBCELLULAR LOCATION: [Isoform 1]: Nucleus, nucleolus. Cytoplasm, cytoskeleton, spindle. Cytoplasm. Note=Colocalizes in the nucleolus during interphase and on the spindle apparatus during mitosis with NPM1.; SUBCELLULAR LOCATION: [Isoform 2]: Mitochondrion. Mitochondrion matrix. Note=Imported in a time- and membrane potential-dependent manner to the mitochondrial matrix, but without concomitant processing of the protein. Directed to mitochondria by a novel N-terminal domain that functions as non-cleavable mitochondrial targeting peptide.",SUBUNIT: Isoform 1 is found in pre-ribosomal ribonucleoprotein (pre-rRNP) complexes. {ECO:0000250}.,X,72181353,72302926,q13.1,0.71293,0.727,-1.3104,-0.12202,4.1092,0.4411778509945275,ENST00000373669,0.9580808080808081,0.09654262338347849,396,,,,,,,0.1731743066401716,3.7428685510244426,Thyroid,broadly expressed,2.9043318722970866,3.331083898480843,FALSE,discordant,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:9044,PLAC1,placenta enriched 1,Approved,,"CT92, OOSP2L, OOSP2B",Xq26.3,gene with protein product,protein-coding gene,ENSG00000170965,10761,ENSG00000170965,Q9HBJ0,MGI:1926287,RGD:1563777,X,300296,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May play a role in placental development. {ECO:0000269|PubMed:10995572}.,placenta development [GO:0001890],"",SUBCELLULAR LOCATION: Secreted {ECO:0000305}.,"",X,134565838,134764322,q26.3,,,-0.33991,0.26051,,0.16571381224625073,ENST00000359237,0.29608763693270734,0.15901024743814046,639,,,,,,,0.9436185372928719,1.405556763343757,Testis,tissue-specific,0,0,FALSE,variable escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:9086,PLP1,proteolipid protein 1,Approved,"SPG2, PLP",GPM6C,Xq22.2,gene with protein product,protein-coding gene,ENSG00000123560,5354,ENSG00000123560,P60201,MGI:97623,RGD:3354,X,300401,TRUE,"Pelizaeus-Merzbacher disease // Spastic paraplegia 2, X-linked",312080 // 312920,X-linked recessive // X-linked recessive,,,,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE,confirmed +CS,FALSE,,confirmed,FUNCTION: This is the major myelin protein from the central nervous system. It plays an important role in the formation or maintenance of the multilamellar structure of myelin.,astrocyte development [GO:0014002]; axon development [GO:0061564]; axon ensheathment [GO:0008366]; central nervous system myelination [GO:0022010]; chemical synaptic transmission [GO:0007268]; inflammatory response [GO:0006954]; long-chain fatty acid biosynthetic process [GO:0042759]; neuron projection development [GO:0031175]; positive regulation of gene expression [GO:0010628]; substantia nigra development [GO:0021762],identical protein binding [GO:0042802]; structural constituent of myelin sheath [GO:0019911]; structural molecule activity [GO:0005198],"SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:24103481}; Multi-pass membrane protein {ECO:0000269|PubMed:24103481}. Myelin membrane {ECO:0000250}. Note=Colocalizes with SIRT2 in internodal regions, at paranodal axoglial junction and Schmidt-Lanterman incisures of myelin sheat. {ECO:0000250}.","",X,103773718,103792619,q22.2,0.92845,0.355,-0.13697,2.0373,8.417,0.18099547511312217,ENST00000621218,0.971462829736211,0.20792301924518872,834,,,,,,,0.688520156427092,9.495533282007658,Other_Brain_tissues,tissue-specific,9.495533282007658,7.320656159353633,TRUE,high confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:9087,PLP2,proteolipid protein 2,Approved,,"A4, A4-LSB, MGC126187",Xp11.23,gene with protein product,protein-coding gene,ENSG00000102007,5355,ENSG00000102007,Q04941,MGI:1298382,RGD:1587363,X,300112,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May play a role in cell differentiation in the intestinal epithelium.,chemotaxis [GO:0006935]; cytokine-mediated signaling pathway [GO:0019221]; ion transport [GO:0006811],chemokine binding [GO:0019956]; ion transmembrane transporter activity [GO:0015075],SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.,"",X,49171898,49175235,p11.23,0.0043931,1.553,0.23621,0.24938,5.6835,0.5269222239452802,ENST00000376327,0.7361655773420479,0.19335166208447888,459,,,,,,,0.19106437771825643,8.88587936744668,Artery - Aorta,broadly expressed,3.011271989459657,4.954326612441532,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:9091,PLS3,plastin 3,Approved,,T-plastin,Xq23,gene with protein product,protein-coding gene,ENSG00000102024,5358,ENSG00000102024,P13797,MGI:104807,RGD:621409,X,300131,TRUE,"Bone mineral density QTL18, osteoporosis",300910,X-linked dominant,,,,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,TRUE,confirmed,"FUNCTION: Actin-bundling protein found in intestinal microvilli, hair cell stereocilia, and fibroblast filopodia. May play a role in the regulation of bone development.",actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]; bone development [GO:0060348],actin filament binding [GO:0051015]; calcium ion binding [GO:0005509],SUBCELLULAR LOCATION: Cytoplasm.,SUBUNIT: Monomer.,X,115561174,115650861,q23,0.98844,0.283,-0.55275,2.7103,22.265,0.510705406736,ENST00000355899,0.937823560486001,0.2303174206448388,1893,2,"LCP1 (80, 80, chr13); PLS1 (75, 75, chr3)",TRUE,,,,0.3709886831122334,9.557515396446169,Artery - Aorta,broadly expressed,4.525166845373195,3.247908530489212,FALSE,discordant,no_difference_Pre_Post,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:9101,PLXNA3,plexin A3,Approved,PLXN4,"SEX, XAP-6, 6.3, Plxn3",Xq28,gene with protein product,protein-coding gene,ENSG00000130827,55558,ENSG00000130827,P51805,MGI:107683,RGD:1584973,X,300022,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Coreceptor for SEMA3A and SEMA3F. Necessary for signaling by class 3 semaphorins and subsequent remodeling of the cytoskeleton. Plays a role in axon guidance in the developing nervous system. Regulates the migration of sympathetic neurons, but not of neural crest precursors. Required for normal dendrite spine morphology in pyramidal neurons. May play a role in regulating semaphorin-mediated programmed cell death in the developing nervous system. Class 3 semaphorins bind to a complex composed of a neuropilin and a plexin. The plexin modulates the affinity of the complex for specific semaphorins, and its cytoplasmic domain is required for the activation of down-stream signaling events in the cytoplasm.",branchiomotor neuron axon guidance [GO:0021785]; facial nerve structural organization [GO:0021612]; hippocampus development [GO:0021766]; multicellular organism development [GO:0007275]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of cell adhesion [GO:0007162]; neuron projection extension [GO:1990138]; positive regulation of axonogenesis [GO:0050772]; positive regulation of cytoskeleton organization [GO:0051495]; pyramidal neuron development [GO:0021860]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; trigeminal nerve structural organization [GO:0021637],semaphorin receptor activity [GO:0017154]; transmembrane signaling receptor activity [GO:0004888],SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Single-pass type I membrane protein {ECO:0000250}.,SUBUNIT: Interacts with CBFA2T3/MTG16. {ECO:0000269|PubMed:20138877}.,X,154458281,154477779,q28,0.054893,0.384,-4.9812,0.67634,60.081,0.550379964149562,ENST00000369682,0.7379095441595441,0.07267576616018542,5616,3,"PLXNA1 (67, 66, chr3); PLXNA4 (60, 59, chr7); PLXNA2 (60, 59, chr1)",TRUE,,,,0.3355276392680905,5.982272617297192,Pituitary,broadly expressed,2.669285338617232,5.651954349213129,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:9105,PLXNB3,plexin B3,Approved,PLXN6,"PLEXR, PLEXB3",Xq28,gene with protein product,protein-coding gene,ENSG00000198753,5365,ENSG00000198753,Q9ULL4,MGI:2154240,RGD:1560615,X,300214,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Receptor for SEMA5A that plays a role in axon guidance, invasive growth and cell migration. Stimulates neurite outgrowth and mediates Ca(2+)/Mg(2+)-dependent cell aggregation. In glioma cells, SEMA5A stimulation of PLXNB3 results in the disassembly of F-actin stress fibers, disruption of focal adhesions and cellular collapse as well as inhibition of cell migration and invasion through ARHGDIA-mediated inactivation of RAC1. {ECO:0000269|PubMed:15218527, ECO:0000269|PubMed:20696765, ECO:0000269|PubMed:21706053}.",cell chemotaxis [GO:0060326]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell migration [GO:0030336]; negative regulation of GTPase activity [GO:0034260]; negative regulation of lamellipodium assembly [GO:0010593]; positive chemotaxis [GO:0050918]; positive regulation of axonogenesis [GO:0050772]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of neuron projection development [GO:0010976]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287],cell-cell adhesion mediator activity [GO:0098632]; protein domain specific binding [GO:0019904]; Rho GDP-dissociation inhibitor binding [GO:0051022]; semaphorin receptor activity [GO:0017154],"SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:15218527, ECO:0000269|PubMed:16122393}; Single-pass type I membrane protein {ECO:0000269|PubMed:15218527, ECO:0000269|PubMed:16122393}. Note=Colocalizes with RIT2/RIN at the plasma membrane.","SUBUNIT: Interacts (via cytoplasmic domain) with RAC1 and ARHGDIA (By similarity). Binds MET and MST1R. Interacts (via cytoplasmic domain) with FSCN1. Interacts with RIT2/RIN. May form homodimers (via Sema domain). {ECO:0000250, ECO:0000269|PubMed:15184888, ECO:0000269|PubMed:16122393, ECO:0000269|PubMed:21706053}.",X,153764196,153779346,q28,0.23163,0.371,-4.4886,0.2265,55.666,0.26591392570774014,ENST00000361971,0.5699301919720768,0.06020994751312172,5730,,,,,,,0.5193392866572211,6.709304422880729,Nerve - Tibial,broadly expressed,4.313332933367071,5.448040295994875,FALSE,low confidence escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:9173,POLA1,"DNA polymerase alpha 1, catalytic subunit",Approved,"POLA, NSX",p180,Xp22.11-p21.3,gene with protein product,protein-coding gene,ENSG00000101868,5422,ENSG00000101868,P09884,MGI:99660,RGD:621816,X,312040,TRUE,"Pigmentary disorder, reticulate, with systemic manifestations, X-linked // Van Esch-O'Driscoll syndrome",301220 // 301030,X-linked recessive // X-linked recessive,,,,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Catalytic subunit of the DNA polymerase alpha complex (also known as the alpha DNA polymerase-primase complex) which plays an essential role in the initiation of DNA synthesis. During the S phase of the cell cycle, the DNA polymerase alpha complex (composed of a catalytic subunit POLA1, a regulatory subunit POLA2 and two primase subunits PRIM1 and PRIM2) is recruited to DNA at the replicative forks via direct interactions with MCM10 and WDHD1. The primase subunit of the polymerase alpha complex initiates DNA synthesis by oligomerising short RNA primers on both leading and lagging strands. These primers are initially extended by the polymerase alpha catalytic subunit and subsequently transferred to polymerase delta and polymerase epsilon for processive synthesis on the lagging and leading strand, respectively. The reason this transfer occurs is because the polymerase alpha has limited processivity and lacks intrinsic 3' exonuclease activity for proofreading error, and therefore is not well suited for replicating long complexes. In the cytosol, responsible for a substantial proportion of the physiological concentration of cytosolic RNA:DNA hybrids, which are necessary to prevent spontaneous activation of type I interferon responses (PubMed:27019227). {ECO:0000269|PubMed:27019227, ECO:0000269|PubMed:31006512, ECO:0000269|PubMed:9518481}.","DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication, synthesis of RNA primer [GO:0006269]; DNA replication initiation [GO:0006270]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA synthesis involved in DNA repair [GO:0000731]; double-strand break repair via nonhomologous end joining [GO:0006303]; G1/S transition of mitotic cell cycle [GO:0000082]; lagging strand elongation [GO:0006273]; leading strand elongation [GO:0006272]; mitotic DNA replication initiation [GO:1902975]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; regulation of type I interferon production [GO:0032479]; telomere maintenance via semi-conservative replication [GO:0032201]; viral process [GO:0016032]","4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; DNA replication origin binding [GO:0003688]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; protein kinase binding [GO:0019901]; purine nucleotide binding [GO:0017076]; pyrimidine nucleotide binding [GO:0019103]; single-stranded DNA binding [GO:0003697]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:27019227}. Cytoplasm, cytosol {ECO:0000269|PubMed:27019227}. Note=In the cytosol, colocalizes with RNA:DNA hybrids with a speckled pattern. {ECO:0000269|PubMed:27019227}.","SUBUNIT: Component of the alpha DNA polymerase complex (also known as the alpha DNA polymerase-primase complex) consisting of four subunits: the catalytic subunit POLA1, the regulatory subunit POLA2, and the primase complex subunits PRIM1 and PRIM2 respectively (PubMed:9705292). Interacts with PARP1; this interaction functions as part of the control of replication fork progression (PubMed:9518481). Interacts with MCM10 and WDHD1; these interactions recruit the polymerase alpha complex to the pre-replicative complex bound to DNA (PubMed:19608746). Interacts with RPA1; this interaction stabilizes the replicative complex and reduces the misincorporation rate of DNA polymerase alpha by acting as a fidelity clamp (PubMed:9214288). {ECO:0000269|PubMed:19608746, ECO:0000269|PubMed:9214288, ECO:0000269|PubMed:9518481, ECO:0000269|PubMed:9705292}.; SUBUNIT: (Microbial infection) Interacts with SV40 Large T antigen; this interaction allows viral DNA replication. {ECO:0000269|PubMed:3025630}.; SUBUNIT: (Microbial infection) Interacts with herpes simplex virus 1/HHV-1 replication origin-binding protein UL9. {ECO:0000269|PubMed:7644508}.",X,24693909,24996986,p22.11,1,0.051,-0.91111,1.9947,57.659,0.5385512970110403,ENST00000379068,0.9010437939641479,0.28385403649087726,4407,,,,,,,0.41328093984927095,4.464184674037117,Cells - EBV-transformed lymphocytes,broadly expressed,1.7917182355284327,2.7737400341497622,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:9217,POU3F4,POU class 3 homeobox 4,Approved,DFN3,"BRN4, OTF9, DFNX2",Xq21.1,gene with protein product,protein-coding gene,ENSG00000196767,5456,ENSG00000196767,P49335,MGI:101894,RGD:61947,X,300039,TRUE,"Deafness, X-linked 2",304400,X-linked recessive,,,,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,TRUE,confirmed,FUNCTION: Probable transcription factor which exert its primary action widely during early neural development and in a very limited set of neurons in the mature brain.,brain development [GO:0007420]; cell differentiation [GO:0030154]; cochlea morphogenesis [GO:0090103]; negative regulation of mesenchymal cell apoptotic process [GO:2001054]; positive regulation of transcription by RNA polymerase II [GO:0045944]; sensory perception of sound [GO:0007605],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]",SUBCELLULAR LOCATION: Nucleus.,SUBUNIT: Interacts with HNRNPU. {ECO:0000269|PubMed:9105675}.,X,83508290,83512127,q21.1,0.5746,0.695,-0.57166,1.926,6.828,0.6008632991813238,ENST00000644024,0.8712707182320442,0.52831792051987,1086,1,"POU3F2 (66, 54, chr6)",TRUE,,,,0.915856070658295,1.9903504351234695,Cerebellar_tissues,tissue-specific,1.8899640922538374,1.9903504351234695,TRUE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:9243,PPEF1,protein phosphatase with EF-hand domain 1,Approved,PPEF,PPP7CA,Xp22.13,gene with protein product,protein-coding gene,ENSG00000086717,5475,ENSG00000086717,O14829,MGI:1097157,RGD:1562772,X,300109,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: May have a role in the recovery or adaptation response of photoreceptors. May have a role in development.,detection of stimulus involved in sensory perception [GO:0050906]; protein dephosphorylation [GO:0006470]; regulation of rhodopsin mediated signaling pathway [GO:0022400],calcium ion binding [GO:0005509]; iron ion binding [GO:0005506]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722],"","",X,18675909,18827921,p22.13,0.9873,0.293,0.68135,1.944,26.419,0.2370417193426043,ENST00000361511,0.686085626911315,0.1601849537615596,1962,,,,,,,0.9259825662819817,4.717857348296403,Testis,tissue-specific,0.7775169264771302,0.33768768917025294,FALSE,variable escapee,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,no disorder
HGNC:9330,PQBP1,polyglutamine binding protein 1,Approved,"RENS1, MRXS8, SHS, MRX55, MRX2, MRXS3",,Xp11.23,gene with protein product,protein-coding gene,ENSG00000102103,10084,ENSG00000102103,O60828,MGI:1859638,RGD:1549750,X,300463,TRUE,Renpenning syndrome,309500,X-linked recessive,,,,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Intrinsically disordered protein that acts as a scaffold, and which is involved in different processes, such as pre-mRNA splicing, transcription regulation, innate immunity and neuron development (PubMed:10198427, PubMed:10332029, PubMed:12062018, PubMed:20410308, PubMed:23512658). Interacts with splicing-related factors via the intrinsically disordered region and regulates alternative splicing of target pre-mRNA species (PubMed:10332029, PubMed:12062018, PubMed:23512658, PubMed:20410308). May suppress the ability of POU3F2 to transactivate the DRD1 gene in a POU3F2 dependent manner. Can activate transcription directly or via association with the transcription machinery (PubMed:10198427). May be involved in ATXN1 mutant-induced cell death (PubMed:12062018). The interaction with ATXN1 mutant reduces levels of phosphorylated RNA polymerase II large subunit (PubMed:12062018). Involved in the assembly of cytoplasmic stress granule, possibly by participating in the transport of neuronal RNA granules (PubMed:21933836). Also acts as an innate immune sensor of infection by retroviruses, such as HIV, by detecting the presence of reverse-transcribed DNA in the cytosol (PubMed:26046437). Directly binds retroviral reverse-transcribed DNA in the cytosol and interacts with CGAS, leading to activate the cGAS-STING signaling pathway, triggering type-I interferon production (PubMed:26046437). {ECO:0000269|PubMed:10198427, ECO:0000269|PubMed:10332029, ECO:0000269|PubMed:12062018, ECO:0000269|PubMed:20410308, ECO:0000269|PubMed:21933836, ECO:0000269|PubMed:23512658, ECO:0000269|PubMed:26046437}.","activation of innate immune response [GO:0002218]; alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; mRNA splicing, via spliceosome [GO:0000398]; neuron projection development [GO:0031175]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of type I interferon production [GO:0032481]; regulation of dendrite morphogenesis [GO:0048814]; regulation of RNA splicing [GO:0043484]; regulation of transcription, DNA-templated [GO:0006355]",DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; ribonucleoprotein complex binding [GO:0043021]; transcription coactivator activity [GO:0003713],"SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10198427, ECO:0000269|PubMed:10332029, ECO:0000269|PubMed:12062018, ECO:0000269|PubMed:23512658}. Nucleus speckle {ECO:0000250|UniProtKB:Q91VJ5}. Cytoplasmic granule {ECO:0000269|PubMed:21933836}. Note=Colocalizes with SRSF2 in nuclear speckles (By similarity). Colocalized with POU3F2 (PubMed:10332029). Colocalized with ATXN1 in nuclear inclusion bodies (PubMed:12062018). Localizes to cytoplasmic stress granules (PubMed:21933836). {ECO:0000250|UniProtKB:Q91VJ5, ECO:0000269|PubMed:10332029, ECO:0000269|PubMed:12062018, ECO:0000269|PubMed:21933836}.","SUBUNIT: Interacts with POU3F2/Brn-2, ATXN1, TXNL4A, HTT and AR (PubMed:10332029, PubMed:10873650, PubMed:19303059, PubMed:24781215). Interaction with ATXN1 correlates positively with the length of the polyglutamine tract (PubMed:12062018). Interacts with RNA polymerase II large subunit in a phosphorylation-dependent manner (PubMed:12062018). Forms a ternary complex with ATXN1 mutant and phosphorylated RNA polymerase II (PubMed:12062018). Interacts (via C-terminus) with TXNL4A and CD2BP2 (PubMed:10873650, PubMed:19303059, PubMed:24781215). Interacts (via WW domain) with ATN1 and SF3B1, and may interact with additional splice factors (PubMed:23512658, PubMed:20410308). Interacts (via WW domain) with WBP11; Leading to reduce interaction between PQBP1 and TXNL4A (PubMed:23512658, PubMed:20410308, PubMed:27314904). Interacts with CAPRIN1 (PubMed:21933836). Interacts with DDX1 (PubMed:21933836). Interacts with SFPQ (PubMed:21933836). Interacts with KHSRP (PubMed:21933836). {ECO:0000269|PubMed:10332029, ECO:0000269|PubMed:10873650, ECO:0000269|PubMed:12062018, ECO:0000269|PubMed:19303059, ECO:0000269|PubMed:20410308, ECO:0000269|PubMed:21933836, ECO:0000269|PubMed:23512658, ECO:0000269|PubMed:24781215, ECO:0000269|PubMed:27314904, ECO:0000269|PubMed:9875212}.",X,48890197,48903143,p11.23,0.78935,0.499,0.23176,1.9194,9.5076,0.5596452709974601,ENST00000447146,0.8461152882205514,0.10549862534366408,798,,,,,,,0.14477381667624994,6.815319245777306,Ovary,broadly expressed,5.260691882646512,6.651139255086214,FALSE,discordant,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:9441,PRKX,protein kinase X-linked,Approved,,PKX1,Xp22.33,gene with protein product,protein-coding gene,ENSG00000183943,5613,ENSG00000183943,P51817,MGI:1309999,RGD:1564076,X,300083,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Serine/threonine protein kinase regulated by and mediating cAMP signaling in cells. Acts through phosphorylation of downstream targets that may include CREB, SMAD6 and PKD1 and has multiple functions in cellular differentiation and epithelial morphogenesis. Regulates myeloid cell differentiation through SMAD6 phosphorylation. Involved in nephrogenesis by stimulating renal epithelial cell migration and tubulogenesis. Also involved in angiogenesis through stimulation of endothelial cell proliferation, migration and vascular-like structure formation. {ECO:0000269|PubMed:12082174, ECO:0000269|PubMed:16236808, ECO:0000269|PubMed:16491121, ECO:0000269|PubMed:17980165, ECO:0000269|PubMed:19367327, ECO:0000269|PubMed:21684272, ECO:0000269|PubMed:9860982}.",angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell-substrate adhesion [GO:0031589]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; epithelial tube morphogenesis [GO:0060562]; kidney morphogenesis [GO:0060993]; myeloid cell differentiation [GO:0030099]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of epithelial cell differentiation involved in kidney development [GO:2000696]; signal transduction [GO:0007165],ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691],SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Note=cAMP induces nuclear translocation.,"SUBUNIT: Like other cAMP-dependent protein kinases, the inactive holoenzyme is probably composed of 2 PRKX catalytic subunits and a dimer of regulatory subunits. Interacts (cAMP-dependent) specifically with the regulatory subunits PRKAR1A and PRKAR1B. Compared to other cAMP-dependent serine/threonine protein kinases, does not interact with the 2 other PKA regulatory subunits PRKAR2A and PRKAR2B. Interacts with cAMP-dependent protein kinase inhibitor/PKI proteins; inhibits PRKX. Interacts with GPKOW. Interacts with SMAD6. Interacts with PKD1; involved in differentiation and controlled morphogenesis of the kidney. Interacts with PIN1 (via WW domain). {ECO:0000269|PubMed:10026146, ECO:0000269|PubMed:16491121, ECO:0000269|PubMed:17980165, ECO:0000269|PubMed:19367327, ECO:0000269|PubMed:20819953}.",X,3604340,3713649,p22.33,0.032585,0.895,-1.1025,1.6002,10.225,0.6542570591943063,ENST00000262848,0.7711234911792015,0.029742564358910272,1077,1,"PRKY (66, 86, chrY)",TRUE,,,,0.4743511762245552,5.744637429281275,Thyroid,broadly expressed,2.2212305841262885,1.809815708731617,FALSE,high confidence escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:9462,PRPS1,phosphoribosyl pyrophosphate synthetase 1,Approved,DFN2,"CMTX5, DFNX1",Xq22.3,gene with protein product,protein-coding gene,ENSG00000147224,5631,ENSG00000147224,P60891,MGI:97775,RGD:61955,X,311850,TRUE,"Arts syndrome // Charcot-Marie-Tooth disease, X-linked recessive, 5 // Deafness, X-linked 1 // Gout, PRPS-related // Phosphoribosylpyrophosphate synthetase superactivity",301835 // 311070 // 304500 // 300661 // 300661,X-linked recessive // X-linked recessive // X-linked // X-linked recessive // X-linked recessive,,,,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,confirmed +CS,FALSE,,confirmed,FUNCTION: Catalyzes the synthesis of phosphoribosylpyrophosphate (PRPP) that is essential for nucleotide synthesis.,5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; hypoxanthine biosynthetic process [GO:0046101]; nervous system development [GO:0007399]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; purine nucleobase metabolic process [GO:0006144]; purine nucleotide biosynthetic process [GO:0006164]; pyrimidine nucleotide biosynthetic process [GO:0006221]; ribonucleoside monophosphate biosynthetic process [GO:0009156]; urate biosynthetic process [GO:0034418],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; ribose phosphate diphosphokinase activity [GO:0004749],"",SUBUNIT: Homodimer. The active form is probably a hexamer composed of 3 homodimers. {ECO:0000269|PubMed:16939420}.,X,107628428,107651993,q22.3,0.91542,0.377,0.48069,3.7321,7.9356,0.46206485230875477,ENST00000372435,0.9373040752351097,0.1554361409647588,957,2,"PRPS2 (80, 80, chrX); PRPS1L1 (79, 80, chr7)",TRUE,,,,0.21910346456930135,6.304626029367539,Cells - EBV-transformed lymphocytes,broadly expressed,4.814458137245317,5.875784976871567,FALSE,high confidence non-escapee,no_difference_Pre_Post,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,confirmed monogenic disorder
HGNC:9465,PRPS2,phosphoribosyl pyrophosphate synthetase 2,Approved,,,Xp22.2,gene with protein product,protein-coding gene,ENSG00000101911,5634,ENSG00000101911,P11908,MGI:97776,RGD:3415,X,311860,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Catalyzes the synthesis of phosphoribosylpyrophosphate (PRPP) that is essential for nucleotide synthesis.,5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; AMP biosynthetic process [GO:0006167]; animal organ regeneration [GO:0031100]; nucleobase-containing compound metabolic process [GO:0006139]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; purine nucleotide biosynthetic process [GO:0006164],ADP binding [GO:0043531]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; carbohydrate binding [GO:0030246]; GDP binding [GO:0019003]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; ribose phosphate diphosphokinase activity [GO:0004749],"",SUBUNIT: Homodimer. The active form is probably a hexamer composed of 3 homodimers (By similarity). {ECO:0000250}.,X,12791355,12824222,p22.2,0.93544,0.343,0.4616,3.0509,8.7098,0.6260655911988565,ENST00000380668,0.8917450365726228,0.08965258685328668,957,2,"PRPS1L1 (90, 91, chr7); PRPS1 (80, 80, chrX)",TRUE,1,"PRPS1L1 (90, 91, chr7)",TRUE,0.406827036619917,7.495663187645602,Ovary,broadly expressed,3.0913190139275923,3.1789767082984226,FALSE,low confidence non-escapee,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,no difference_Post1_Post2,no disorder
HGNC:9469,PRRG1,proline rich and Gla domain 1,Approved,,PRGP1,Xp21.1,gene with protein product,protein-coding gene,ENSG00000130962,5638,ENSG00000130962,O14668,MGI:1917364,RGD:1561320,X,300935,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"","",calcium ion binding [GO:0005509],SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}.,"",X,37349309,37457292,p21.1,0.13149,1.123,-0.59571,0.40866,5.5819,0.5371606026270511,ENST00000378628,0.9228310502283105,0.24576355911022243,657,,,,,,,0.4040667826629841,3.8720899893347926,Nerve - Tibial,broadly expressed,2.954776994608934,1.6141727082676833,FALSE,low confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:9555,PSMD10,"proteasome 26S subunit, non-ATPase 10",Approved,,p28,Xq22.3,gene with protein product,protein-coding gene,ENSG00000101843,5716,ENSG00000101843,O75832,MGI:1858898,RGD:620350,X,300880,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Acts as a chaperone during the assembly of the 26S proteasome, specifically of the PA700/19S regulatory complex (RC). In the initial step of the base subcomplex assembly is part of an intermediate PSMD10:PSMC4:PSMC5:PAAF1 module which probably assembles with a PSMD5:PSMC2:PSMC1:PSMD2 module. Independently of the proteasome, regulates EGF-induced AKT activation through inhibition of the RHOA/ROCK/PTEN pathway, leading to prolonged AKT activation. Plays an important role in RAS-induced tumorigenesis.; FUNCTION: Acts as an proto-oncoprotein by being involved in negative regulation of tumor suppressors RB1 and p53/TP53. Overexpression is leading to phosphorylation of RB1 and proteasomal degradation of RB1. Regulates CDK4-mediated phosphorylation of RB1 by competing with CDKN2A for binding with CDK4. Facilitates binding of MDM2 to p53/TP53 and the mono- and polyubiquitination of p53/TP53 by MDM2 suggesting a function in targeting the TP53:MDM2 complex to the 26S proteasome. Involved in p53-independent apoptosis. Involved in regulation of NF-kappa-B by retaining it in the cytoplasm. Binds to the NF-kappa-B component RELA and accelerates its XPO1/CRM1-mediated nuclear export.","anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; apoptotic process [GO:0006915]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of transcription by RNA polymerase II [GO:0000122]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; proteasome regulatory particle assembly [GO:0070682]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]",transcription factor binding [GO:0008134],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:18040287}. Nucleus {ECO:0000269|PubMed:18040287}.,"SUBUNIT: Part of transient complex containing PSMD10, PSMC4, PSMC5 and PAAF1 formed during the assembly of the 26S proteasome. Stays associated throughout the assembly of the PA700/19S RC and is released upon association with the 20S core. Interacts with PSMC4. Interacts with RB1. Interacts with CDK4. Interacts with MDM2. Interacts with RELA. Associates with a CDK4:CCND2 serine/threonine kinase complex. Interacts with ARHGDIA and increases the interaction between ARHGDIA and RHOA, hence promotes ARHGDIA inactivation of RHOA and ROCK. {ECO:0000269|PubMed:10613832, ECO:0000269|PubMed:11779854, ECO:0000269|PubMed:11900540, ECO:0000269|PubMed:16023600, ECO:0000269|PubMed:18040287, ECO:0000269|PubMed:19490896, ECO:0000269|PubMed:20628200}.",X,108084207,108091549,q22.3,0.50136,0.781,0.32271,0.88324,6.0703,0.5474543373314089,ENST00000217958,0.9374449339207048,0.2107973006748313,681,,,,,,,0.1664805298975859,6.346093495346539,Cells - EBV-transformed lymphocytes,broadly expressed,5.744346803688001,6.073035061634541,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,no disorder
HGNC:9773,RAB33A,"RAB33A, member RAS oncogene family",Approved,,RabS10,Xq26.1,gene with protein product,protein-coding gene,ENSG00000134594,9363,ENSG00000134594,Q14088,MGI:109493,RGD:1563280,X,300333,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",antigen processing and presentation [GO:0019882]; Rab protein signal transduction [GO:0032482],GTPase activity [GO:0003924]; GTP binding [GO:0005525],SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Lipid-anchor {ECO:0000305}; Cytoplasmic side {ECO:0000305}.,"",X,130171962,130184870,q26.1,0.82154,0.526,0.57776,1.9281,5.6881,0.5340405762586489,ENST00000257017,0.8582633053221288,0.29062734316420896,714,,,,,,,0.7082198671413692,5.301265711184111,Cells - EBV-transformed lymphocytes,tissue-specific,3.9236151042856546,5.246607603190731,FALSE,low confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,no disorder
HGNC:9792,RAB9A,"RAB9A, member RAS oncogene family",Approved,RAB9,,Xp22.2,gene with protein product,protein-coding gene,ENSG00000123595,9367,ENSG00000123595,P51151,MGI:1890695,RGD:619740,X,300284,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Involved in the transport of proteins between the endosomes and the trans Golgi network. Involved in the recruitment of SGSM2 to melanosomes and is required for the proper trafficking of melanogenic enzymes TYR, TYRP1 and DCT/TYRP2 to melanosomes in melanocytes. {ECO:0000250|UniProtKB:P24408, ECO:0000250|UniProtKB:Q9R0M6}.","negative regulation by host of symbiont molecular function [GO:0052405]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of protein localization [GO:0032880]; retrograde transport, endosome to Golgi [GO:0042147]",GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802],"SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Lipid-anchor {ECO:0000305}; Cytoplasmic side {ECO:0000305}. Endoplasmic reticulum membrane {ECO:0000305}. Golgi apparatus membrane {ECO:0000305}. Late endosome {ECO:0000269|PubMed:16176980}. Cytoplasmic vesicle, phagosome membrane {ECO:0000305}; Lipid-anchor {ECO:0000305}; Cytoplasmic side {ECO:0000305}. Cytoplasmic vesicle, phagosome {ECO:0000269|PubMed:21255211}. Cytoplasmic vesicle membrane {ECO:0000250|UniProtKB:Q9R0M6}. Melanosome {ECO:0000250|UniProtKB:Q9R0M6}. Note=Colocalizes with OSBPL1A at the late endosome (PubMed:16176980). Recruited to phagosomes containing S.aureus or M.tuberculosis (PubMed:21255211). {ECO:0000269|PubMed:16176980, ECO:0000269|PubMed:21255211}.","SUBUNIT: Interacts (preferentially in its GTP-bound form) with GCC2 (via its GRIP domain) (PubMed:18243103, PubMed:16885419). Interacts (GTP-bound form) with SGSM1; the GDP-bound form has much lower affinity for SGSM1 (PubMed:22637480). Interacts with SGSM2 (PubMed:21808068). The GTP-bound form but not the GDP-bound form interacts with HPS4 and BLOC-3 complex (heterodimer of HPS1 and HPS4) but does not interact with HPS1 alone (PubMed:20048159). {ECO:0000269|PubMed:16885419, ECO:0000269|PubMed:18243103, ECO:0000269|PubMed:20048159, ECO:0000269|PubMed:21808068, ECO:0000269|PubMed:22637480}.",X,13689128,13710504,p22.2,0.83175,0.51,0.95749,1.2764,5.8735,0.6252004279389136,ENST00000464506,0.9265676567656765,0.08010497375656087,606,1,"RAB9B (76, 76, chrX)",TRUE,,,,0.248476346634414,5.991603473662633,Cells - EBV-transformed lymphocytes,broadly expressed,3.833031745662764,3.919235190027174,FALSE,high confidence escapee,Post_higher_vs_Pre,no difference_Pre_Post1,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:9835,RAI2,retinoic acid induced 2,Approved,,,Xp22.13,gene with protein product,protein-coding gene,ENSG00000131831,10742,ENSG00000131831,Q9Y5P3,MGI:1344378,RGD:1560139,X,300217,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"",embryo development ending in birth or egg hatching [GO:0009792],"","","",X,17800049,17861337,p22.13,0.61158,0.656,-0.47065,-0.060573,7.2258,0.7091026753135886,ENST00000451717,0.7730696798493408,0.393376655836041,1593,,,,,,,0.36879819421541304,7.454850353397018,Fallopian Tube,broadly expressed,2.670572977543851,3.871853502949985,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,Post2_higher_vs_Post1,no disorder
HGNC:9890,RBBP7,"RB binding protein 7, chromatin remodeling factor",Approved,,RbAp46,Xp22.2,gene with protein product,protein-coding gene,ENSG00000102054,5931,ENSG00000102054,Q16576,MGI:1194910,RGD:620125,X,300825,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Core histone-binding subunit that may target chromatin remodeling factors, histone acetyltransferases and histone deacetylases to their histone substrates in a manner that is regulated by nucleosomal DNA. Component of several complexes which regulate chromatin metabolism. These include the type B histone acetyltransferase (HAT) complex, which is required for chromatin assembly following DNA replication; the core histone deacetylase (HDAC) complex, which promotes histone deacetylation and consequent transcriptional repression; the nucleosome remodeling and histone deacetylase complex (the NuRD complex), which promotes transcriptional repression by histone deacetylation and nucleosome remodeling; and the PRC2/EED-EZH2 complex, which promotes repression of homeotic genes during development; and the NURF (nucleosome remodeling factor) complex. {ECO:0000269|PubMed:10866654}.","cellular heat acclimation [GO:0070370]; CENP-A containing nucleosome assembly [GO:0034080]; DNA replication [GO:0006260]; negative regulation of cell growth [GO:0030308]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; post-translational protein modification [GO:0043687]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to steroid hormone [GO:0048545]",RNA binding [GO:0003723],SUBCELLULAR LOCATION: Nucleus.,"SUBUNIT: Binds directly to helix 1 of the histone fold of histone H4, a region that is not accessible when H4 is in chromatin (PubMed:18571423). Subunit of the type B histone acetyltransferase (HAT) complex, composed of RBBP7 and HAT1. Subunit of the core histone deacetylase (HDAC) complex, which is composed of HDAC1, HDAC2, RBBP4 and RBBP7. The core HDAC complex associates with SIN3A, ARID4B/SAP180, SAP18, SAP30, SAP130, SUDS3/SAP45 and possibly ARID4A/RBP1 and ING1 to form the SIN3 HDAC complex. The core HDAC complex may also associate with MTA2, MBD3, CHD3 and CHD4 to form the nucleosome remodeling and histone deacetylase complex (the NuRD complex). The NuRD complex may also interact with MBD3L1 and MBD3L2. Interacts with MTA1. Subunit of the PRC2/EED-EZH2 complex, which is composed of at least EED, EZH2, RBBP4, RBBP7 and SUZ12 (PubMed:12435631). The PRC2/EED-EZH2 complex may also associate with HDAC1. Part of the nucleosome remodeling factor (NURF) complex which consists of SMARCA1; BPTF; RBBP4 and RBBP7. Interacts with the viral protein-binding domain of the retinoblastoma protein (RB1) (PubMed:7503932, PubMed:10220405). Interacts with CREBBP, and this interaction may be enhanced by the binding of phosphorylated CREB1 to CREBBP. Interacts with BRCA1, HDAC7 and SUV39H1. Interacts with CENPA (PubMed:25556658). {ECO:0000269|PubMed:10220405, ECO:0000269|PubMed:10444591, ECO:0000269|PubMed:10866654, ECO:0000269|PubMed:11102443, ECO:0000269|PubMed:11118440, ECO:0000269|PubMed:11784859, ECO:0000269|PubMed:12435631, ECO:0000269|PubMed:12920132, ECO:0000269|PubMed:14609955, ECO:0000269|PubMed:15456747, ECO:0000269|PubMed:18571423, ECO:0000269|PubMed:25556658, ECO:0000269|PubMed:7503932, ECO:0000269|PubMed:9150135, ECO:0000269|PubMed:9427644, ECO:0000269|PubMed:9651585, ECO:0000269|PubMed:9790534}.",X,16839283,16870362,p22.2,0.98393,0.28,-0.80494,2.7889,16.963,0.8203253175830872,ENST00000380087,0.9395148669796557,0.2567608097975506,1278,1,"RBBP4 (81, 89, chr1)",TRUE,,,,0.21458661955483455,7.973726062092384,Adrenal Gland,broadly expressed,5.222711839875469,5.7011081969091375,FALSE,low confidence escapee,no_difference_Pre_Post,Pre_higher_vs_Post1,no difference_Pre_Post2,Post2_higher_vs_Post1,no disorder
HGNC:9896,RBM10,RNA binding motif protein 10,Approved,,"DXS8237E, KIAA0122, GPATC9, ZRANB5, GPATCH9, S1-1",Xp11.3,gene with protein product,protein-coding gene,ENSG00000182872,8241,ENSG00000182872,P98175,MGI:2384310,RGD:631366,X,300080,TRUE,TARP syndrome,311900,X-linked recessive,,,,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: May be involved in post-transcriptional processing, most probably in mRNA splicing. Binds to RNA homopolymers, with a preference for poly(G) and poly(U) and little for poly(A) (By similarity). May bind to specific miRNA hairpins (PubMed:28431233). {ECO:0000250|UniProtKB:P70501, ECO:0000269|PubMed:18315527, ECO:0000269|PubMed:28431233}.","3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]",identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA binding [GO:0003723],"SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:18315527}. Note=In the extranucleolar nucleoplasm constitutes hundreds of nuclear domains, which dynamically change their structures in a reversible manner. Upon globally reducing RNA polymerase II transcription, the nuclear bodies enlarge and decrease in number. They occur closely adjacent to nuclear speckles or IGCs (interchromatin granule clusters) but coincide with TIDRs (transcription-inactivation-dependent RNA domains).","SUBUNIT: Associates with the spliceosome. Component of a large chromatin remodeling complex, at least composed of MYSM1, PCAF, RBM10 and KIF11/TRIP5. {ECO:0000269|PubMed:17707232}.",X,47145221,47186813,p11.3,1,0.11,0.24196,4.4623,43.07,0.528429507503699,ENST00000377604,0.8481203007518797,0.23504123969007748,2793,,,,,,,0.1708139286594498,6.7836661809078285,Cerebellar_tissues,broadly expressed,4.918324212493051,6.7836661809078285,TRUE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:9900,RBM3,RNA binding motif protein 3,Approved,,IS1-RNPL,Xp11.23,gene with protein product,protein-coding gene,ENSG00000102317,5935,ENSG00000102317,P98179,"MGI:1099460, MGI:3642874",RGD:620145,X,300027,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Cold-inducible mRNA binding protein that enhances global protein synthesis at both physiological and mild hypothermic temperatures. Reduces the relative abundance of microRNAs, when overexpressed. Enhances phosphorylation of translation initiation factors and active polysome formation (By similarity). {ECO:0000250}.","positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of translation [GO:0045727]; regulation of translation [GO:0006417]; RNA processing [GO:0006396]",ribosomal large subunit binding [GO:0043023]; RNA binding [GO:0003723],"SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Cytoplasm {ECO:0000250}. Cell projection, dendrite {ECO:0000250}. Note=Localizes in mRNA granules in dentrites. {ECO:0000250}.",SUBUNIT: Interacts with RPL4. Associates with the 60S ribosomal subunits in an RNA-independent manner. Associates with ribosomes (By similarity). {ECO:0000250}.,X,48574449,48581162,p11.23,0.82616,0.519,-0.15298,1.3192,5.7708,0.5351025394918771,ENST00000376759,0.9310126582278481,0.28385403649087726,474,,,,,,,0.16564866445467813,8.096383098789058,Adipose - Subcutaneous,broadly expressed,4.738146317438276,5.718647944603934,FALSE,discordant,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,no disorder
HGNC:9910,RBMX,RNA binding motif protein X-linked,Approved,,"RNMX, hnRNP-G, HNRNPG",Xq26.3,gene with protein product,protein-coding gene,ENSG00000147274,27316,ENSG00000147274,P38159,MGI:1343044,RGD:1565256,X,300199,TRUE,,,,"?Mental retardation, X-linked, syndromic 11, Shashi type",300238,X-linked recessive,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,PMT +CS,FALSE,,PMT,"FUNCTION: RNA-binding protein that plays several role in the regulation of pre- and post-transcriptional processes. Implicated in tissue-specific regulation of gene transcription and alternative splicing of several pre-mRNAs. Binds to and stimulates transcription from the tumor suppressor TXNIP gene promoter; may thus be involved in tumor suppression. When associated with SAFB, binds to and stimulates transcription from the SREBF1 promoter. Associates with nascent mRNAs transcribed by RNA polymerase II. Component of the supraspliceosome complex that regulates pre-mRNA alternative splice site selection. Can either activate or suppress exon inclusion; acts additively with TRA2B to promote exon 7 inclusion of the survival motor neuron SMN2. Represses the splicing of MAPT/Tau exon 10. Binds preferentially to single-stranded 5'-CC[A/C]-rich RNA sequence motifs localized in a single-stranded conformation; probably binds RNA as a homodimer. Binds non-specifically to pre-mRNAs. Plays also a role in the cytoplasmic TNFR1 trafficking pathways; promotes both the IL-1-beta-mediated inducible proteolytic cleavage of TNFR1 ectodomains and the release of TNFR1 exosome-like vesicles to the extracellular compartment. {ECO:0000269|PubMed:12165565, ECO:0000269|PubMed:12761049, ECO:0000269|PubMed:16707624, ECO:0000269|PubMed:18445477, ECO:0000269|PubMed:18541147, ECO:0000269|PubMed:19282290, ECO:0000269|PubMed:21327109}.","cellular response to interleukin-1 [GO:0071347]; membrane protein ectodomain proteolysis [GO:0006509]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; osteoblast differentiation [GO:0001649]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA metabolic process [GO:0016070]; transcription by RNA polymerase II [GO:0006366]",chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978],"SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:19282290, ECO:0000269|PubMed:21327109}. Note=Component of ribonucleosomes. Localizes in numerous small granules in the nucleus.","SUBUNIT: Homomultimer. Interacts with SAFB/SAFB1 (By similarity). Found in the supraspliceosome complex. Identified in the spliceosome C complex. Interacts with KHDRBS3. Forms a complex with ILF2, ILF3, YLPM1, KHDRBS1, NCOA5 and PPP1CA. Interacts with CLK2, KHDRBS2, SAFB, TRA2B and YTHDC1. Interacts with ERAP1; the interaction is RNA-independent (PubMed:18445477). Interacts with PPIA/CYPA (PubMed:25678563). {ECO:0000250|UniProtKB:Q9WV02, ECO:0000269|PubMed:10332027, ECO:0000269|PubMed:11991638, ECO:0000269|PubMed:12165565, ECO:0000269|PubMed:17890166, ECO:0000269|PubMed:18445477, ECO:0000269|PubMed:19282290, ECO:0000269|PubMed:25678563}.",X,136848004,136880764,q26.3,0.82878,0.432,-0.49777,2.9043,14.588,0.6757939962855994,ENST00000320676,0.9666666666666667,0.18145463634091477,1176,2,"RBMXL1 (95, 95, chr1); RBMXL2 (74, 74, chr11)",TRUE,1,"RBMXL1 (95, 95, chr1)",TRUE,0.20910199262553866,7.677176987615914,Ovary,broadly expressed,4.704462552715645,6.082697267764718,FALSE,high confidence non-escapee,Pre_higher_vs_Post,Pre_higher_vs_Post1,Pre_higher_vs_Post2,no difference_Post1_Post2,PMT
HGNC:9936,OPN1LW,"opsin 1, long wave sensitive",Approved,"CBBM, RCP, CBP",COD5,Xq28,gene with protein product,protein-coding gene,ENSG00000102076,5956,ENSG00000102076,P04000,MGI:1097692,,X,300822,TRUE,"Blue cone monochromacy // Colorblindness, protan",303700 // 303900,X-linked recessive // X-linked,,,,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,confirmed +CS,FALSE,,confirmed,"FUNCTION: Visual pigments are the light-absorbing molecules that mediate vision. They consist of an apoprotein, opsin, covalently linked to cis-retinal.",cellular response to light stimulus [GO:0071482]; G protein-coupled receptor signaling pathway [GO:0007186]; phototransduction [GO:0007602]; positive regulation of cytokinesis [GO:0032467]; protein-chromophore linkage [GO:0018298]; retinoid metabolic process [GO:0001523]; signal transduction [GO:0007165]; visual perception [GO:0007601],G protein-coupled photoreceptor activity [GO:0008020]; photoreceptor activity [GO:0009881],SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.,"",X,154144243,154159032,q28,0.97535,0.263,-0.18642,0.4657,11.388,0.354595100900705,ENST00000369951,0.6130593607305936,0.06145963509122719,1095,3,"OPN1MW2 (96, 96, chrX); OPN1MW3 (96, 96, chrX); OPN1MW (96, 96, chrX)",TRUE,3,"OPN1MW2 (96, 96, chrX); OPN1MW3 (96, 96, chrX); OPN1MW (96, 96, chrX)",TRUE,0.9696217228209686,0.107482597031996,Testis,tissue-specific,0,0,FALSE,,no_difference_Pre_Post,no difference_Pre_Post1,no difference_Pre_Post2,no difference_Post1_Post2,confirmed monogenic disorder
HGNC:9959,RENBP,renin binding protein,Approved,,"RNBP, RBP",Xq28,gene with protein product,protein-coding gene,ENSG00000102032,5973,ENSG00000102032,P51606,MGI:105940,RGD:621688,X,312420,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Catalyzes the interconversion of N-acetylglucosamine to N-acetylmannosamine. Binds to renin forming a protein complex called high molecular weight (HMW) renin and inhibits renin activity. Involved in the N-glycolylneuraminic acid (Neu5Gc) degradation pathway: although human is not able to catalyze formation of Neu5Gc due to the inactive CMAHP enzyme, Neu5Gc is present in food and must be degraded. {ECO:0000269|PubMed:9990133}.",N-acetylglucosamine metabolic process [GO:0006044]; N-acetylmannosamine metabolic process [GO:0006051]; N-acetylneuraminate catabolic process [GO:0019262]; regulation of blood pressure [GO:0008217]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048],ATP binding [GO:0005524]; endopeptidase inhibitor activity [GO:0004866]; identical protein binding [GO:0042802]; N-acylglucosamine 2-epimerase activity [GO:0050121]; peptidase inhibitor activity [GO:0030414],"",SUBUNIT: Homodimer. {ECO:0000269|PubMed:9990133}.,X,153935269,153944687,q28,0.44916,0.491,-0.91043,0.7909,18.644,0.3434267063515305,ENST00000393700,0.6521806853582555,0.13281679580104974,1284,,,,,,,0.4719667212027914,6.49270243335128,Spleen,broadly expressed,3.7345904066961992,2.195909761848338,FALSE,low confidence escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,no difference_Post1_Post2,no disorder
HGNC:9963,REPS2,RALBP1 associated Eps domain containing 2,Approved,,POB1,Xp22.2,gene with protein product,protein-coding gene,ENSG00000169891,9185,ENSG00000169891,Q8NFH8,MGI:2663511,RGD:1561642,X,300317,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,FUNCTION: Involved in growth factor signaling through its influence on the Ral signaling pathway.,endocytosis [GO:0006897]; endosomal transport [GO:0016197]; epidermal growth factor receptor signaling pathway [GO:0007173]; membrane organization [GO:0061024]; protein-containing complex assembly [GO:0065003],calcium ion binding [GO:0005509],SUBCELLULAR LOCATION: Cytoplasm.,"SUBUNIT: Interacts with ASAP1 and this complex can bind paxillin. May form a ternary complex with RALBP1 and ASAP1 (By similarity). Interacts with RALBP1 and GRB2. Binding to RALBP1 does not affect the Ral-binding activity of the latter. It can form a ternary complex with activated Ral and RALBP1. Binds EPN1. {ECO:0000250, ECO:0000269|PubMed:10557078}.",X,16946658,17153272,p22.2,0.20309,0.486,-0.54945,1.3121,24.352,0.5800048961452272,ENST00000357277,0.8531013615733737,0.1817795551112222,1983,,,,,,,0.5101666380906827,4.648232453125686,Cerebellar_tissues,broadly expressed,3.7243665065277347,4.648232453125686,TRUE,discordant,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
HGNC:9989,RGN,regucalcin,Approved,,"SMP30, RC",Xp11.3,gene with protein product,protein-coding gene,ENSG00000130988,9104,ENSG00000130988,Q15493,MGI:108024,RGD:3560,X,300212,FALSE,,,,,,,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,no disorder,FALSE,,no disorder,"FUNCTION: Gluconolactonase with low activity towards other sugar lactones, including gulonolactone and galactonolactone. Can also hydrolyze diisopropyl phosphorofluoridate and phenylacetate (in vitro). Calcium-binding protein. Modulates Ca(2+) signaling, and Ca(2+)-dependent cellular processes and enzyme activities (By similarity). {ECO:0000250}.",aging [GO:0007568]; cellular calcium ion homeostasis [GO:0006874]; kidney development [GO:0001822]; L-ascorbic acid biosynthetic process [GO:0019853]; liver regeneration [GO:0097421]; negative regulation of apoptotic process [GO:0043066]; negative regulation of bone development [GO:1903011]; negative regulation of calcium-dependent ATPase activity [GO:1903611]; negative regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051344]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of DNA catabolic process [GO:1903625]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of flagellated sperm motility [GO:1901318]; negative regulation of GTPase activity [GO:0034260]; negative regulation of leucine-tRNA ligase activity [GO:1903634]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of RNA biosynthetic process [GO:1902679]; positive regulation of ATPase activity [GO:0032781]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of dUTP diphosphatase activity [GO:1903629]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phosphatase activity [GO:0010922]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; positive regulation of superoxide dismutase activity [GO:1901671]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of calcium-mediated signaling [GO:0050848]; spermatogenesis [GO:0007283],calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]; gluconolactonase activity [GO:0004341]; zinc ion binding [GO:0008270],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.,SUBUNIT: Monomer. {ECO:0000269|PubMed:23349732}.,X,47078355,47093314,p11.3,0.022123,0.991,0.19035,-0.91289,9.2315,0.39875058151126475,ENST00000397180,0.8361111111111111,0.07163209197700575,900,,,,,,,0.5663972567259468,7.3492060231296055,Adrenal Gland,broadly expressed,3.92250234291858,5.1896822586528435,FALSE,low confidence non-escapee,Post_higher_vs_Pre,Post1_higher_vs_Pre,Post2_higher_vs_Pre,Post2_higher_vs_Post1,no disorder
